data_1r84_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1r84 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.822 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.29 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.576 3.15 . . . . 10.0 117.276 160.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.67 65.05 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.331 2.652 . . . . 10.0 114.448 155.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.03 2.79 41.14 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.44 2.447 . . . . 10.0 111.488 168.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.684 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.477 2.277 . . . . 10.0 113.201 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.14 4.32 0.94 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.736 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.473 -0.767 . . . . 10.0 112.619 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.6 83.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.887 0.875 . . . . 10.0 109.3 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.43 -52.56 63.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.399 0.68 . . . . 10.0 111.882 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.41 -53.59 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.141 0.576 . . . . 10.0 112.247 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.85 -46.83 51.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.381 1.472 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.62 -44.93 84.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.88 -56.2 12.58 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.346 0.974 . . . . 10.0 111.567 166.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.4 m -49.8 -52.47 31.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.844 1.257 . . . . 10.0 112.209 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.177 0.991 . . . . 10.0 112.139 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.31 -48.56 78.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.663 0.785 . . . . 10.0 112.809 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.8 mtt -59.22 -46.62 87.97 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.293 1.037 . . . . 10.0 111.606 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.49 -58.6 13.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.232 0.92 . . . . 10.0 113.735 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -46.12 79.6 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.64 1.22 . . . . 10.0 112.127 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.56 -41.74 74.3 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.755 1.169 . . . . 10.0 113.242 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -63.12 -57.83 9.26 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 118.297 -0.859 . . . . 10.0 111.412 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.49 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.81 -57.99 9.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.571 1.148 . . . . 10.0 112.973 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.05 -67.5 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.662 1.185 . . . . 10.0 113.611 169.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.756 1.741 . . . . 10.0 110.866 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.863 2.465 . . . . 10.0 109.319 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.93 93.06 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.143 2.177 . . . . 10.0 113.619 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.73 -84.38 1.19 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.732 0.682 . . . . 10.0 112.477 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.404 2.681 . . . . 10.0 116.922 166.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.66 -50.84 10.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.902 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.53 6.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.737 1.273 . . . . 10.0 110.967 -172.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.59 -29.63 89.61 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.724 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.52 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.106 1.362 . . . . 10.0 113.551 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.58 -47.4 19.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.231 1.413 . . . . 10.0 113.441 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.09 62.12 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.513 0.725 . . . . 10.0 110.939 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -56.97 -50.21 73.35 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.044 0.538 . . . . 10.0 112.334 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.38 -51.27 65.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.356 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.384 0.883 . . . . 10.0 113.384 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.55 -58.11 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.914 1.286 . . . . 10.0 110.228 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -68.09 -18.03 64.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.368 . . . . 10.0 113.745 -172.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -86.6 -40.36 15.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.397 1.079 . . . . 10.0 112.059 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.3 mt -60.37 -41.55 93.95 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.387 -0.82 . . . . 10.0 112.525 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.8 t -41.2 -60.45 1.74 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.719 1.607 . . . . 10.0 113.769 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.95 -26.72 10.76 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.721 2.947 . . . . 10.0 114.262 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.85 97.72 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.938 1.699 . . . . 10.0 113.01 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -52.12 -54.86 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.14 1.376 . . . . 10.0 109.345 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.77 -45.21 78.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.629 1.171 . . . . 10.0 113.131 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.43 -57.3 9.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.422 1.465 . . . . 10.0 112.209 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -50.15 -52.4 35.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.164 1.386 . . . . 10.0 110.434 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.15 -48.02 63.44 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.805 0.842 . . . . 10.0 113.089 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.16 -40.08 76.56 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.845 -1.55 . . . . 10.0 113.085 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.407 1.458 . . . . 10.0 111.281 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.65 -41.06 61.05 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.7 mtm -66.88 -50.85 61.16 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.484 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.54 -52.69 21.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.826 0.851 . . . . 10.0 112.975 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.5 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.857 1.058 . . . . 10.0 113.857 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.09 43.02 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.252 1.575 . . . . 10.0 115.252 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.55 61.04 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.332 0.893 . . . . 10.0 115.332 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.43 26.41 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.042 2.137 . . . . 10.0 108.957 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.49 171.14 15.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.053 0.941 . . . . 10.0 111.0 166.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 136.0 53.43 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.9 0.88 . . . . 10.0 109.691 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.52 129.6 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.039 1.336 . . . . 10.0 110.959 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.36 38.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.826 0.676 . . . . 10.0 112.826 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -82.0 0.15 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.41 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.6 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.338 1.569 . . . . 10.0 112.217 -165.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.91 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.46 1.504 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.45 120.76 69.66 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.36 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.046 1.738 . . . . 10.0 111.71 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.69 85.05 4.74 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 123.058 1.409 . . . . 10.0 113.037 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.864 -1.147 . . . . 10.0 113.951 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.82 52.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.292 1.037 . . . . 10.0 113.147 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -50.68 -55.51 16.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.858 0.863 . . . . 10.0 111.515 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -64.02 -39.11 93.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.69 1.596 . . . . 10.0 112.182 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.69 65.36 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.48 1.112 . . . . 10.0 110.916 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -61.96 2.23 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.18 1.792 . . . . 10.0 112.764 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -53.65 -38.12 63.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.368 2.267 . . . . 10.0 113.177 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.46 -44.01 62.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.493 1.517 . . . . 10.0 112.183 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -99.4 -47.99 4.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 113.254 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.0 t -60.02 -37.6 80.24 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.454 -0.779 . . . . 10.0 113.058 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.5 m -68.38 -48.55 34.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.753 -1.217 . . . . 10.0 112.638 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.62 -42.9 41.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.585 2.856 . . . . 10.0 115.278 164.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.58 -49.28 78.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.889 0.768 . . . . 10.0 112.076 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tt -53.01 -44.68 67.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.678 1.191 . . . . 10.0 112.679 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.62 -47.71 81.43 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.038 -1.039 . . . . 10.0 112.413 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.838 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.3 -54.04 36.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.298 0.954 . . . . 10.0 111.187 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.1 88.63 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.656 0.782 . . . . 10.0 112.099 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.69 38.43 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.94 0.896 . . . . 10.0 112.078 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.16 79.38 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.704 0.801 . . . . 10.0 112.731 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.71 -38.59 91.68 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.065 1.346 . . . . 10.0 112.313 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.56 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.829 1.652 . . . . 10.0 112.113 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.981 -1.699 . . . . 10.0 112.458 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.92 54.27 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.67 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.888 1.675 . . . . 10.0 113.465 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.26 5.29 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.139 1.352 . . . . 10.0 115.26 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.01 -46.74 87.86 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.158 -1.401 . . . . 10.0 111.354 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.97 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.087 1.355 . . . . 10.0 111.072 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.57 -51.33 67.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.82 43.16 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.424 0.689 . . . . 10.0 110.985 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.399 2.28 . . . . 10.0 114.849 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.07 -46.35 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 123.725 0.81 . . . . 10.0 111.349 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.31 64.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.659 0.647 . . . . 10.0 112.624 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.27 74.91 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.13 -45.32 87.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.583 0.753 . . . . 10.0 111.946 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.55 -56.47 4.87 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.455 1.502 . . . . 10.0 113.037 167.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 83.6 mt -56.45 -55.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.757 0.823 . . . . 10.0 110.322 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -48.98 -56.71 8.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.609 1.095 . . . . 10.0 113.115 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 123.116 0.566 . . . . 10.0 112.203 178.36 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 112.033 0.383 . . . . 10.0 112.033 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.98 -59.46 8.72 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.704 1.621 . . . . 10.0 112.096 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.79 -37.76 20.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.209 2.204 . . . . 10.0 113.434 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.7 -6.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.398 1.629 . . . . 10.0 115.398 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.67 116.72 10.4 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.207 -1.558 . . . . 10.0 110.356 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.248 2.619 . . . . 10.0 113.289 177.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.65 106.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.816 0.847 . . . . 10.0 110.128 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.764 1.226 . . . . 10.0 114.019 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.54 -42.01 15.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.458 1.503 . . . . 10.0 113.498 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.22 -24.59 63.13 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.897 1.443 . . . . 10.0 114.897 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.83 -41.87 67.86 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 118.901 0.773 . . . . 10.0 110.82 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.64 -31.88 70.23 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.854 1.262 . . . . 10.0 114.241 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.29 -52.26 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.152 0.887 . . . . 10.0 109.625 168.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -60.47 -45.24 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -52.64 -49.54 64.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.713 1.142 . . . . 10.0 112.71 173.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -53.92 48.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.139 . . . . 10.0 111.915 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.2 mt -54.62 -47.59 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.625 1.17 . . . . 10.0 111.481 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -57.57 -53.34 59.26 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.07 1.348 . . . . 10.0 112.394 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.6 t -67.82 -33.48 74.86 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.766 0.826 . . . . 10.0 112.308 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.63 73.34 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.258 0.935 . . . . 10.0 112.347 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.55 80.62 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.468 -0.77 . . . . 10.0 112.535 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.65 -52.99 62.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.267 1.027 . . . . 10.0 111.913 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.77 -49.62 65.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.069 1.748 . . . . 10.0 111.665 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -49.5 -54.71 16.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.722 0.809 . . . . 10.0 112.184 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.0 mt -54.11 -54.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.592 0.757 . . . . 10.0 110.86 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.35 -36.62 69.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.709 0.804 . . . . 10.0 113.07 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -57.24 -58.19 9.3 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.035 0.934 . . . . 10.0 113.059 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -40.96 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.373 -0.823 . . . . 10.0 111.468 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.76 -49.39 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.831 1.196 . . . . 10.0 112.169 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.26 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.075 -1.641 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.69 -21.98 60.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 10.0 113.477 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.588 0.614 . . . . 10.0 113.548 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.271 1.828 . . . . 10.0 113.067 -166.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.09 -56.44 14.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.032 1.123 . . . . 10.0 114.032 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.69 -50.58 65.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.115 0.959 . . . . 10.0 112.303 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.11 -46.02 82.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.136 0.975 . . . . 10.0 112.143 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.51 80.02 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.27 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.043 1.737 . . . . 10.0 114.235 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.477 1.911 . . . . 10.0 114.876 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.94 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.536 1.636 . . . . 10.0 114.171 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.24 35.04 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.277 1.984 . . . . 10.0 113.079 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.1 67.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.288 173.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.14 -53.07 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.83 75.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.246 0.618 . . . . 10.0 111.905 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -56.18 24.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.917 0.887 . . . . 10.0 112.709 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.211 1.004 . . . . 10.0 113.05 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.61 -49.44 46.85 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.253 0.621 . . . . 10.0 111.101 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.43 78.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.67 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.797 0.726 . . . . 10.0 110.487 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.57 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.83 30.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.86 2.064 . . . . 10.0 111.026 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.45 -58.36 8.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.796 0.438 . . . . 10.0 111.266 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.6 t -52.14 -46.64 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.112 0.965 . . . . 10.0 112.296 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.9 m -58.83 -64.85 0.79 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.971 2.509 . . . . 10.0 111.484 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.6 -49.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.928 1.291 . . . . 10.0 111.241 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.9 -64.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.844 0.858 . . . . 10.0 112.28 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.12 -43.02 81.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.037 0.835 . . . . 10.0 112.174 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -52.14 -54.29 32.43 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.128 0.971 . . . . 10.0 112.459 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 114.029 1.122 . . . . 10.0 114.029 -179.366 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 119.504 -0.284 . . . . 10.0 111.315 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -55.32 -52.34 63.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.894 1.277 . . . . 10.0 112.498 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 56.0 tp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.971 1.308 . . . . 10.0 112.449 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -88.15 -5.08 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 115.222 1.564 . . . . 10.0 115.222 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.47 -169.3 32.89 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-O 122.576 1.098 . . . . 10.0 113.873 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -40.85 64.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.828 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -54.94 -31.49 60.51 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.524 2.73 . . . . 10.0 115.154 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.62 -103.88 0.95 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.366 0.985 . . . . 10.0 113.623 -167.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.19 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.331 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.884 0.314 . . . . 10.0 113.884 173.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.64 -42.74 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.055 1.742 . . . . 10.0 108.716 166.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.27 133.38 24.9 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.448 1.899 . . . . 10.0 109.392 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.7 153.77 72.61 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.754 2.969 . . . . 10.0 111.468 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.38 21.89 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.93 -40.48 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.668 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.35 -49.77 42.87 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.517 0.599 . . . . 10.0 111.946 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.68 -47.08 83.31 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.07 1.748 . . . . 10.0 113.002 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -58.8 5.62 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.335 1.054 . . . . 10.0 109.989 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -53.42 -43.88 68.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.876 -1.059 . . . . 10.0 112.956 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -54.53 -52.55 61.68 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.3 1.409 . . . . 10.0 112.492 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.18 -48.97 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.49 1.116 . . . . 10.0 110.939 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.0 mp -57.09 -53.53 57.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.747 1.619 . . . . 10.0 112.152 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -54.68 -56.04 23.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.065 1.746 . . . . 10.0 111.807 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.476 0.852 0 O-C-N 121.398 -0.814 . . . . 10.0 111.264 177.376 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.347 0 CA-C-O 120.997 0.22 . . . . 10.0 112.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.4 -57.28 3.14 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.549 1.939 . . . . 10.0 112.687 167.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.56 -38.92 89.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.582 1.087 . . . . 10.0 113.642 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -69.47 -27.56 65.33 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 115.614 1.709 . . . . 10.0 115.614 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.36 -57.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 165.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.87 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.877 0.871 . . . . 10.0 113.174 -172.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.61 5.23 2.54 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.28 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.89 4.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.113 0.965 . . . . 10.0 111.03 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.19 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.771 0.829 . . . . 10.0 110.957 170.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.94 77.05 7.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.874 0.87 . . . . 10.0 112.084 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.897 2.879 . . . . 10.0 116.462 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.81 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.75 1.22 . . . . 10.0 110.642 -175.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.72 3.533 . . . . 10.0 119.677 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.516 2.727 . . . . 10.0 113.457 166.652 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.87 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.569 3.148 . . . . 10.0 117.225 160.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.306 2.643 . . . . 10.0 114.448 155.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.45 137.93 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.41 1.884 . . . . 10.0 113.372 -158.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.76 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.015 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.83 41.48 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.487 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.649 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.304 . . . . 10.0 113.21 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.28 4.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.732 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.507 -0.746 . . . . 10.0 112.625 176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.84 -49.64 83.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.892 0.877 . . . . 10.0 109.3 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.36 -52.66 62.8 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.379 0.672 . . . . 10.0 111.867 175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.3 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.224 0.61 . . . . 10.0 112.276 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.8 51.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.332 1.453 . . . . 10.0 113.335 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.66 -44.95 84.75 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.289 1.435 . . . . 10.0 112.997 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.6 -56.54 11.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.526 1.06 . . . . 10.0 111.511 166.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.59 -52.51 29.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.904 1.282 . . . . 10.0 112.248 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.5 -58.81 6.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.172 0.989 . . . . 10.0 112.161 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt -57.47 -48.62 78.71 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 10.0 112.836 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.14 -49.09 78.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.008 0.923 . . . . 10.0 111.281 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.53 -58.66 13.26 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.273 0.939 . . . . 10.0 113.931 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.18 -45.63 79.68 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.748 1.274 . . . . 10.0 112.175 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.85 -39.87 88.81 Favored Glycine 0 CA--C 1.533 1.205 0 O-C-N 120.779 -1.2 . . . . 10.0 113.588 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.3 m -60.21 -60.71 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 10.0 110.801 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.06 9.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 112.972 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.61 -38.67 81.92 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.254 0.835 . . . . 10.0 113.254 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.621 1.168 . . . . 10.0 113.589 169.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.813 1.768 . . . . 10.0 110.859 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.04 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.628 1.011 . . . . 10.0 115.628 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.2 mmm -59.47 -45.05 92.73 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.4 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.743 0.687 . . . . 10.0 112.511 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.07 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.401 2.68 . . . . 10.0 116.959 166.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 m -79.68 -50.83 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.168 -1.378 . . . . 10.0 113.892 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.5 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.66 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.67 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.111 0.565 . . . . 10.0 111.476 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.06 22.84 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.078 1.351 . . . . 10.0 113.566 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.57 -47.41 19.74 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.455 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.78 -53.1 61.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.933 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.9 -50.27 73.04 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.107 0.563 . . . . 10.0 112.353 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.27 65.25 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.99 1.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.85 -56.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.825 1.25 . . . . 10.0 110.736 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -69.81 -18.61 63.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.935 1.294 . . . . 10.0 113.498 -172.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.4 m -84.98 -42.52 14.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.478 1.111 . . . . 10.0 111.913 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.6 mt -57.49 -41.56 80.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.211 0.819 . . . . 10.0 113.211 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.4 t -50.17 -61.79 3.33 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.092 -0.956 . . . . 10.0 112.457 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -46.76 -47.27 16.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.627 3.551 . . . . 10.0 115.925 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.49 90.16 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.858 1.208 . . . . 10.0 113.811 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.25 -51.52 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.592 1.157 . . . . 10.0 109.326 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.24 76.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.093 0.957 . . . . 10.0 113.165 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -50.13 -56.23 11.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.681 1.592 . . . . 10.0 112.179 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.77 -52.82 29.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.3 1.44 . . . . 10.0 110.733 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.84 -48.13 64.27 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.976 0.91 . . . . 10.0 113.013 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -56.49 -40.75 75.47 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.195 1.362 . . . . 10.0 113.447 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.53 34.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.752 1.16 . . . . 10.0 111.292 170.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.14 61.12 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.174 1.546 . . . . 10.0 115.174 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.85 -50.82 61.34 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.594 0.758 . . . . 10.0 110.469 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.72 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.887 0.875 . . . . 10.0 112.92 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.86 -5.6 49.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 10.0 113.831 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.67 5.58 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.564 0.986 . . . . 10.0 115.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.01 43.5 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.53 61.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.339 0.896 . . . . 10.0 115.339 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.4 26.46 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.081 2.153 . . . . 10.0 109.031 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.711 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.64 129.62 23.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.028 1.331 . . . . 10.0 110.909 -176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.23 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.72 164.4 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.79 -3.28 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.669 2.228 . . . . 10.0 118.669 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.358 1.579 . . . . 10.0 112.194 -165.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.444 1.498 . . . . 10.0 111.081 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.45 120.78 69.66 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.5 131.91 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.184 3.256 . . . . 10.0 112.137 171.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.29 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.075 1.75 . . . . 10.0 111.763 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -93.63 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.063 1.411 . . . . 10.0 113.106 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.27 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.847 -1.158 . . . . 10.0 113.905 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.72 -26.61 35.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.271 1.029 . . . . 10.0 112.532 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -55.08 -48.31 73.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.01 1.324 . . . . 10.0 112.927 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -71.2 -38.87 72.04 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.955 0.902 . . . . 10.0 111.122 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.39 -48.95 65.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.32 1.048 . . . . 10.0 112.228 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.514 1.526 . . . . 10.0 111.558 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -55.27 -34.28 63.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.357 1.463 . . . . 10.0 112.503 -170.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.7 tp -48.82 -43.74 38.71 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.114 1.766 . . . . 10.0 112.141 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -101.9 -38.15 7.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.493 0.717 . . . . 10.0 112.764 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.7 p -64.72 -43.69 92.58 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.283 1.402 . . . . 10.0 113.92 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.277 74.8 p -65.04 -42.56 62.45 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 114.72 1.378 . . . . 10.0 114.72 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.89 -43.04 60.83 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.428 2.752 . . . . 10.0 115.247 167.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.23 -47.28 86.67 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.447 -0.783 . . . . 10.0 111.704 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.61 -50.01 55.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.414 1.485 . . . . 10.0 111.51 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mp -56.24 -47.52 78.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.111 0.965 . . . . 10.0 112.956 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.22 78.29 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.777 0.831 . . . . 10.0 112.903 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.02 36.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.285 0.948 . . . . 10.0 111.214 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.09 88.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.093 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.75 37.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.017 0.927 . . . . 10.0 111.974 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.25 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.67 53.41 12.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.838 1.655 . . . . 10.0 112.126 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.95 47.51 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.935 -1.728 . . . . 10.0 112.405 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.85 54.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.77 -39.72 2.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.93 1.692 . . . . 10.0 113.467 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.2 5.34 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.304 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.46 -52.93 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.154 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.57 -51.37 67.61 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.522 0.564 . . . . 10.0 112.522 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.05 -44.93 42.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.469 0.708 . . . . 10.0 110.959 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.814 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.393 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.14 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.614 0.626 . . . . 10.0 112.675 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.63 -46.92 73.97 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.187 0.81 . . . . 10.0 113.187 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -57.13 -45.54 83.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.023 0.929 . . . . 10.0 111.974 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.02 -55.58 5.59 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.201 1.382 . . . . 10.0 113.082 167.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.4 mt -56.77 -49.47 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.626 0.77 . . . . 10.0 111.893 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 64.4 ttp -49.39 -57.82 6.23 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 10.0 112.184 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.475 0.803 0 O-C-N 121.659 -0.651 . . . . 10.0 111.058 177.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 110.35 -0.241 . . . . 10.0 110.35 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.03 -60.84 5.78 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.833 1.682 . . . . 10.0 112.212 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.01 -37.66 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.484 1.913 . . . . 10.0 113.86 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.0 mt -99.27 -6.41 28.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -69.66 116.73 10.4 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.19 -1.569 . . . . 10.0 110.409 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.53 -49.55 72.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.186 2.594 . . . . 10.0 113.255 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.66 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.86 -59.52 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.72 1.208 . . . . 10.0 114.087 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.12 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.451 1.5 . . . . 10.0 113.485 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.64 63.25 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.956 1.465 . . . . 10.0 114.956 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.82 -41.94 67.91 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.848 0.749 . . . . 10.0 110.712 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.51 -32.01 70.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.903 1.281 . . . . 10.0 114.249 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.1 -51.77 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.59 168.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -62.46 -43.15 99.52 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -53.93 -48.38 70.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.48 1.112 . . . . 10.0 112.617 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.68 -53.14 61.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.693 0.797 . . . . 10.0 111.681 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.14 -54.33 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.809 1.244 . . . . 10.0 112.009 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 p -58.01 -43.15 86.53 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.252 -0.905 . . . . 10.0 112.852 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.2 m -61.73 -41.31 97.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.568 1.147 . . . . 10.0 112.56 174.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.41 -46.75 87.82 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.345 0.975 . . . . 10.0 112.343 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.74 79.81 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.668 0.787 . . . . 10.0 112.393 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.8 ttp -54.54 -54.54 39.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.037 0.935 . . . . 10.0 112.085 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.1 -50.4 61.71 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.314 1.446 . . . . 10.0 111.572 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.39 -54.66 20.14 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.048 0.939 . . . . 10.0 112.562 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.1 mt -53.52 -55.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.831 0.853 . . . . 10.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.8 mt -57.48 -35.6 70.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.2 -0.905 . . . . 10.0 112.902 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.31 -58.14 9.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.251 0.932 . . . . 10.0 113.047 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.92 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 118.342 -0.837 . . . . 10.0 111.441 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.44 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.83 1.195 . . . . 10.0 112.115 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.92 -70.4 0.46 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.866 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.73 -21.86 60.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.587 1.155 . . . . 10.0 113.468 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.37 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.14 -56.49 14.22 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.955 1.094 . . . . 10.0 113.955 172.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.64 -50.55 65.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.112 0.958 . . . . 10.0 112.299 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.16 -45.97 83.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.192 0.997 . . . . 10.0 112.149 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.42 80.59 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.54 -11.23 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.044 1.738 . . . . 10.0 114.225 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.62 29.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.427 1.891 . . . . 10.0 114.865 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.95 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.451 1.596 . . . . 10.0 114.14 -170.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.841 3.256 . . . . 10.0 105.549 170.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.86 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.27 1.98 . . . . 10.0 113.032 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.11 67.96 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.17 -53.01 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.274 0.63 . . . . 10.0 111.902 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.06 -56.14 25.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.933 0.893 . . . . 10.0 112.687 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.26 -53.21 60.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.019 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.55 -49.48 46.08 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.36 78.91 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.691 1.367 . . . . 10.0 114.691 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.62 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.815 0.734 . . . . 10.0 110.487 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.64 -51.61 69.18 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.82 -47.73 31.03 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.796 2.039 . . . . 10.0 111.047 174.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.57 -58.33 9.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.798 0.439 . . . . 10.0 111.253 174.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.09 -47.03 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.109 0.963 . . . . 10.0 112.298 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.9 m -58.76 -64.22 1.01 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.034 2.534 . . . . 10.0 111.53 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -50.19 -49.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.613 1.165 . . . . 10.0 111.288 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.46 -63.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.002 0.921 . . . . 10.0 112.269 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.9 -43.41 98.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.505 0.593 . . . . 10.0 112.529 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -55.05 -51.01 67.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.478 0.711 . . . . 10.0 111.757 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 114.134 1.161 . . . . 10.0 114.134 178.603 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.0 t . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 119.6 -0.238 . . . . 10.0 111.525 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -55.26 -54.26 45.68 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.964 1.306 . . . . 10.0 112.251 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.0 tp -52.86 -46.67 67.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.182 1.393 . . . . 10.0 112.514 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.6 pt -85.8 -4.92 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.62 -169.33 32.7 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-O 122.551 1.084 . . . . 10.0 113.789 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.07 -39.65 63.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.157 -1.021 . . . . 10.0 111.908 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.43 -32.87 65.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.377 2.671 . . . . 10.0 115.271 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.44 -104.34 1.11 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-O 122.142 0.857 . . . . 10.0 112.698 -167.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.19 35.82 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.285 170.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.34 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.93 0.332 . . . . 10.0 113.93 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.775 166.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.33 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.464 1.906 . . . . 10.0 109.351 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.76 153.84 72.32 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.438 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.25 -39.75 3.13 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.299 1.039 . . . . 10.0 112.223 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.43 21.33 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.54 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.651 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.83 41.93 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.564 0.62 . . . . 10.0 111.907 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.0 83.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.038 1.735 . . . . 10.0 113.017 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.36 -52.33 62.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.016 0.926 . . . . 10.0 112.06 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.63 -59.66 4.2 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.361 1.064 . . . . 10.0 109.913 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -52.82 -47.13 67.89 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.986 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -50.32 -52.72 34.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 121.283 1.856 . . . . 10.0 113.258 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.3 t -60.81 -48.12 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.817 1.247 . . . . 10.0 111.479 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.49 -50.17 74.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.319 1.448 . . . . 10.0 111.907 175.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.35 -57.41 11.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.469 2.308 . . . . 10.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.478 0.958 0 O-C-N 121.221 -0.924 . . . . 10.0 111.844 177.024 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.305 0 CA-C-O 121.104 0.28 . . . . 10.0 112.614 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -42.44 -56.54 2.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.824 2.049 . . . . 10.0 112.36 166.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.16 -39.89 82.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.649 1.119 . . . . 10.0 113.997 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.3 -27.14 65.13 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 115.75 1.759 . . . . 10.0 115.75 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.38 -57.56 11.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.604 -0.887 . . . . 10.0 108.604 165.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.68 0.85 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.949 0.899 . . . . 10.0 113.145 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.37 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.273 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.1 178.02 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.04 0.936 . . . . 10.0 110.995 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.68 98.15 1.87 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 10.0 110.921 170.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.93 77.04 7.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 10.0 112.107 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.06 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.892 2.877 . . . . 10.0 116.451 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.4 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.738 1.215 . . . . 10.0 110.622 -175.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.35 169.46 40.29 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.631 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.446 0 C-N-CA 128.524 2.73 . . . . 10.0 113.492 166.576 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.82 -2.038 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.34 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.588 3.155 . . . . 10.0 117.251 160.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.302 2.641 . . . . 10.0 114.511 155.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.4 137.96 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.344 -158.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.1 2.75 41.49 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.473 2.463 . . . . 10.0 111.463 167.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.3 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.668 -168.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.547 2.302 . . . . 10.0 113.252 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.25 4.34 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.732 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.13 61.76 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.615 176.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.42 -52.59 63.09 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 10.0 111.902 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.41 -53.6 56.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.234 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.78 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -56.1 12.46 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.655 1.122 . . . . 10.0 111.583 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -50.16 -52.35 36.07 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.895 1.278 . . . . 10.0 112.288 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.207 1.003 . . . . 10.0 112.161 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.77 -49.18 77.45 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 10.0 112.541 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.9 mmt -56.08 -49.95 72.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.603 0.761 . . . . 10.0 111.306 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.04 -58.47 14.44 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.312 0.958 . . . . 10.0 113.63 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.22 -45.59 79.85 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.656 1.228 . . . . 10.0 112.142 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.0 74.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.026 1.298 . . . . 10.0 113.273 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -59.79 -60.57 3.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.24 1.016 . . . . 10.0 111.14 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.96 62.5 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.955 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.84 -58.03 9.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.593 1.157 . . . . 10.0 112.929 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.63 81.94 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.621 1.168 . . . . 10.0 113.62 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.87 -44.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.332 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.16 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.04 92.92 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.154 2.182 . . . . 10.0 113.587 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.35 1.19 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.756 0.693 . . . . 10.0 112.497 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.96 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.396 2.678 . . . . 10.0 116.95 166.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.198 -1.365 . . . . 10.0 113.866 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.52 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.765 1.291 . . . . 10.0 110.957 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.65 89.48 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.708 2.939 . . . . 10.0 113.735 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -60.65 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.5 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.281 1.432 . . . . 10.0 113.444 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 110.967 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.28 65.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.891 -0.576 . . . . 10.0 112.321 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.7 -57.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.865 1.266 . . . . 10.0 110.417 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -69.28 -17.08 63.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.071 1.348 . . . . 10.0 113.693 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -86.91 -42.98 12.76 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.64 1.109 . . . . 10.0 112.018 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -56.75 -41.45 77.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.885 0.698 . . . . 10.0 112.885 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.3 t -49.97 -61.45 3.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.629 1.172 . . . . 10.0 112.569 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.95 -46.53 24.73 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.598 3.532 . . . . 10.0 116.029 164.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.2 93.39 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.973 1.26 . . . . 10.0 113.922 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mt -58.13 -52.23 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.496 1.118 . . . . 10.0 109.48 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.49 -43.97 72.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.006 0.922 . . . . 10.0 113.185 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -52.2 -57.96 8.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.137 1.375 . . . . 10.0 111.871 171.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.59 -52.91 20.57 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.507 1.523 . . . . 10.0 110.886 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.3 mmt -68.64 -48.21 64.6 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.966 0.906 . . . . 10.0 112.981 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -55.64 -41.71 73.96 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.163 1.347 . . . . 10.0 113.283 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.56 34.36 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.475 1.034 . . . . 10.0 111.317 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.05 61.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.91 -50.83 61.17 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.442 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.55 -52.67 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.883 0.873 . . . . 10.0 112.963 172.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.58 49.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.3 -34.73 5.53 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.575 0.99 . . . . 10.0 115.575 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.13 42.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.56 61.17 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.326 0.89 . . . . 10.0 115.326 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.45 26.4 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.021 2.129 . . . . 10.0 109.034 171.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.14 15.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.045 166.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.84 0.856 . . . . 10.0 109.745 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.56 129.57 23.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 125.071 1.348 . . . . 10.0 110.971 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.69 116.17 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.67 164.41 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.647 -0.981 . . . . 10.0 110.647 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.354 1.577 . . . . 10.0 112.231 -165.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.86 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.45 120.73 69.66 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.42 131.91 38.41 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.253 3.302 . . . . 10.0 112.167 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.16 126.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.044 1.738 . . . . 10.0 111.716 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.262 1.506 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.44 -28.23 66.78 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.641 -1.287 . . . . 10.0 113.881 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.14 62.2 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.225 1.194 . . . . 10.0 114.225 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -65.93 -22.98 66.53 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 120.112 -1.618 . . . . 10.0 113.821 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -77.26 -42.1 38.41 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.55 -1.344 . . . . 10.0 111.691 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.22 -47.91 54.7 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.444 1.498 . . . . 10.0 111.211 166.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -52.56 -70.76 0.08 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.626 1.97 . . . . 10.0 112.031 168.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -56.83 -32.76 66.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.26 1.024 . . . . 10.0 113.448 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.3 tp -50.17 -40.66 47.5 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.858 1.663 . . . . 10.0 111.871 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -105.29 -39.72 6.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.411 0.685 . . . . 10.0 112.521 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.3 p -61.6 -43.12 99.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.793 1.633 . . . . 10.0 113.794 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.299 68.0 p -69.94 -40.62 13.35 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 115.234 1.568 . . . . 10.0 115.234 -175.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.37 -42.98 62.93 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.208 2.605 . . . . 10.0 115.083 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.29 -47.43 86.04 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.484 -0.76 . . . . 10.0 111.684 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.11 -49.55 51.35 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.745 1.618 . . . . 10.0 111.527 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -57.11 -47.4 81.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.273 1.029 . . . . 10.0 113.146 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.24 78.11 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.843 0.857 . . . . 10.0 112.891 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.33 -54.02 37.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.179 169.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.14 88.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.65 -54.69 38.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.942 0.897 . . . . 10.0 112.063 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.13 79.42 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.682 0.793 . . . . 10.0 112.729 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.78 -38.54 91.49 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.42 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.269 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.46 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.845 1.658 . . . . 10.0 112.086 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.51 135.88 54.32 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.662 0.616 . . . . 10.0 112.662 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.84 -39.73 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.438 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.18 5.34 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.148 1.356 . . . . 10.0 115.25 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.08 -46.8 87.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.39 -52.91 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.161 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.66 -51.3 67.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -59.82 4.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.366 2.266 . . . . 10.0 114.793 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.05 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 123.667 0.787 . . . . 10.0 111.398 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.17 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.617 0.627 . . . . 10.0 112.664 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.61 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.46 0.911 . . . . 10.0 113.46 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.02 -47.21 78.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.319 0.648 . . . . 10.0 111.684 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -54.23 5.95 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.825 1.203 . . . . 10.0 113.013 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.44 -51.22 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.744 0.818 . . . . 10.0 112.043 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 52.5 ttp -48.62 -57.15 6.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.019 1.327 . . . . 10.0 111.659 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.7 mm . . . . . 0 N--CA 1.472 0.626 0 C-N-CA 123.227 0.611 . . . . 10.0 111.907 178.004 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 111.697 0.258 . . . . 10.0 111.697 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.39 -59.21 8.63 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.713 1.625 . . . . 10.0 112.062 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.89 -37.84 20.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.913 2.085 . . . . 10.0 113.563 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.43 -6.63 27.35 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.7 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.199 -1.563 . . . . 10.0 110.398 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.65 71.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.255 2.622 . . . . 10.0 113.251 177.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.72 106.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.86 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.732 1.213 . . . . 10.0 114.101 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.02 15.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.7 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -53.7 -42.01 67.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.855 0.752 . . . . 10.0 110.807 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.35 -32.29 71.27 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.898 1.279 . . . . 10.0 114.213 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.97 -51.76 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.015 0.825 . . . . 10.0 109.608 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -61.96 -45.24 94.51 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 174.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -51.38 -49.24 61.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.35 1.06 . . . . 10.0 112.531 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.53 -52.63 64.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.191 0.996 . . . . 10.0 111.894 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.53 -52.0 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.831 1.252 . . . . 10.0 111.619 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -54.65 -47.06 73.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 10.0 111.99 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.8 m -60.49 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.53 1.532 . . . . 10.0 112.52 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.58 -48.43 80.95 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.19 0.905 . . . . 10.0 112.312 172.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.08 81.68 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.737 0.815 . . . . 10.0 112.484 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.05 -55.07 35.14 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.182 0.993 . . . . 10.0 112.101 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.13 -48.06 68.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.386 1.474 . . . . 10.0 111.947 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.07 -54.58 23.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 10.0 112.46 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.47 -55.17 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.787 0.835 . . . . 10.0 110.751 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.7 mt -57.42 -35.79 70.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.35 -0.833 . . . . 10.0 112.914 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.3 -58.23 9.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.042 0.937 . . . . 10.0 112.994 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.296 -0.859 . . . . 10.0 111.469 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.75 -49.42 75.3 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.873 1.215 . . . . 10.0 112.13 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.882 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.7 -21.95 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.671 1.188 . . . . 10.0 113.453 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.48 51.33 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.227 1.811 . . . . 10.0 113.037 -166.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.1 m -52.05 -56.42 14.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.64 -50.59 65.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.121 0.962 . . . . 10.0 112.314 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.03 82.89 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.161 0.984 . . . . 10.0 112.135 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.52 80.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.097 1.759 . . . . 10.0 114.195 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.61 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.432 1.893 . . . . 10.0 114.894 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.89 -92.61 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.521 1.629 . . . . 10.0 114.185 -170.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.99 72.63 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.767 3.227 . . . . 10.0 105.539 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.87 -46.23 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.269 1.979 . . . . 10.0 113.06 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.12 67.94 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.247 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.248 0.619 . . . . 10.0 111.937 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.93 -56.2 24.6 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.886 0.874 . . . . 10.0 112.765 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.16 -53.26 60.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 113.028 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.51 45.76 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.16 -48.43 78.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.99 -49.62 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.462 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.65 69.0 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.78 -47.78 30.53 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.816 2.046 . . . . 10.0 111.044 174.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.44 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.845 0.458 . . . . 10.0 111.274 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -52.23 -47.07 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.075 0.95 . . . . 10.0 111.989 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.0 m -58.62 -62.96 1.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.437 2.695 . . . . 10.0 111.822 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.33 -50.34 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.675 1.19 . . . . 10.0 111.071 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.85 -60.2 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.053 0.941 . . . . 10.0 112.068 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.54 -50.05 75.41 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.663 0.665 . . . . 10.0 112.743 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -53.39 -50.84 64.29 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.752 0.821 . . . . 10.0 111.382 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 178.611 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 118.945 -0.55 . . . . 10.0 112.161 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -56.33 -52.2 65.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.984 0.914 . . . . 10.0 112.321 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.4 tp -53.91 -45.42 71.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.513 1.125 . . . . 10.0 112.5 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -87.45 -5.28 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 115.248 1.573 . . . . 10.0 115.248 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.56 -169.3 32.76 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 122.611 1.117 . . . . 10.0 113.805 -168.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -40.73 64.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.165 -1.017 . . . . 10.0 111.838 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -54.56 -32.27 58.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.406 2.683 . . . . 10.0 115.379 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.92 0.99 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 10.0 113.38 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.18 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.318 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.45 65.28 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.29 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -68.73 153.79 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.15 -39.81 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.199 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.36 -52.38 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.681 1.363 . . . . 10.0 114.681 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.9 -40.5 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.674 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.31 -49.75 42.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.533 0.606 . . . . 10.0 111.974 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.72 -47.07 83.45 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.983 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.3 -52.33 62.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.016 0.926 . . . . 10.0 112.101 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 92.9 mt -52.51 -58.72 5.86 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 124.321 1.048 . . . . 10.0 110.003 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -52.08 -47.08 65.36 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.692 -1.147 . . . . 10.0 112.35 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.73 -52.14 57.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.308 1.413 . . . . 10.0 112.765 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.84 -49.64 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.461 1.104 . . . . 10.0 111.377 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mp -55.62 -52.86 62.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.56 . . . . 10.0 111.702 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -53.54 -56.41 17.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.957 2.103 . . . . 10.0 111.047 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.169 0.987 . . . . 10.0 111.374 176.289 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.313 0 CA-C-O 121.093 0.274 . . . . 10.0 113.083 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -43.06 -56.88 3.14 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.003 2.121 . . . . 10.0 112.382 166.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.97 -40.79 74.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.338 0.971 . . . . 10.0 114.095 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.75 -27.2 64.75 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 115.962 1.838 . . . . 10.0 115.962 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.52 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.78 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.92 0.888 . . . . 10.0 113.2 -172.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.5 5.12 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.308 1.596 . . . . 10.0 115.308 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.25 0.32 15.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.217 1.007 . . . . 10.0 113.292 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.026 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.21 1.87 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.812 0.845 . . . . 10.0 110.891 170.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.97 77.04 7.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.914 0.885 . . . . 10.0 112.03 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.464 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.48 0.3 OUTLIER 71.77 -55.37 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.765 1.226 . . . . 10.0 110.668 -175.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.781 3.562 . . . . 10.0 119.618 171.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.45 2.7 . . . . 10.0 113.408 166.649 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.305 2.642 . . . . 10.0 114.486 155.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.47 138.01 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.384 1.873 . . . . 10.0 113.344 -158.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.8 -165.18 1.69 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 113.978 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.76 41.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 127.403 2.43 . . . . 10.0 111.491 168.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.57 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.634 -168.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.67 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.522 2.293 . . . . 10.0 113.212 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.15 4.32 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.782 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.41 -43.08 61.88 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.587 176.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.62 83.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.912 0.885 . . . . 10.0 109.315 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.35 -52.64 62.84 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.377 0.671 . . . . 10.0 111.928 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.187 0.595 . . . . 10.0 112.245 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.83 51.95 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.412 1.485 . . . . 10.0 113.287 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.64 -44.98 84.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -57.06 10.07 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.247 0.927 . . . . 10.0 111.3 166.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -48.98 -52.46 24.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.642 1.177 . . . . 10.0 112.302 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.9 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.148 0.979 . . . . 10.0 112.166 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.66 -50.29 73.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.682 0.793 . . . . 10.0 112.579 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -53.69 -50.35 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.503 1.121 . . . . 10.0 111.348 175.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.36 -58.28 15.41 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.338 0.971 . . . . 10.0 113.471 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.91 79.79 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.539 1.17 . . . . 10.0 112.146 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.29 -42.53 73.99 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.956 1.265 . . . . 10.0 113.185 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.9 m -61.82 -58.75 6.75 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.852 0.861 . . . . 10.0 111.448 171.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.79 -58.04 9.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.974 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.7 82.13 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.176 0.806 . . . . 10.0 113.176 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.602 1.161 . . . . 10.0 113.64 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.718 1.723 . . . . 10.0 110.86 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.305 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 115.609 1.004 . . . . 10.0 115.609 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.02 92.93 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.46 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.798 0.713 . . . . 10.0 112.441 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.931 166.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.174 -1.375 . . . . 10.0 113.866 174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.769 1.293 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.58 -29.67 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.756 2.971 . . . . 10.0 113.682 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.17 -40.07 22.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.078 1.351 . . . . 10.0 113.534 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.43 19.58 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.434 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 111.015 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.94 -50.25 73.17 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.35 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.41 -51.26 65.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.353 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.2 mt -48.51 -58.0 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.892 1.277 . . . . 10.0 110.193 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -68.54 -16.48 63.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.218 1.407 . . . . 10.0 113.819 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -88.66 -39.72 13.83 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.624 1.102 . . . . 10.0 112.188 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.34 -42.17 90.89 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.457 -0.777 . . . . 10.0 112.29 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -41.13 -61.84 1.21 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 126.214 1.806 . . . . 10.0 113.782 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.13 -26.83 17.6 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.028 2.485 . . . . 10.0 114.436 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.69 89.49 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.504 1.502 . . . . 10.0 113.387 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -55.54 -53.81 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.426 1.09 . . . . 10.0 109.128 170.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -42.63 71.67 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.312 1.045 . . . . 10.0 113.751 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -52.93 -56.73 13.79 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.575 1.534 . . . . 10.0 111.915 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.96 -52.51 32.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.347 1.459 . . . . 10.0 110.735 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.21 62.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 118.168 -0.92 . . . . 10.0 112.982 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -56.3 -40.91 75.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.37 1.441 . . . . 10.0 113.013 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.23 -54.57 34.25 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.179 1.354 . . . . 10.0 111.333 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.66 -41.03 61.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.259 1.577 . . . . 10.0 115.259 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.91 -50.85 61.1 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.451 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.5 48.9 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.328 1.051 . . . . 10.0 113.835 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.01 43.21 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.26 1.578 . . . . 10.0 115.26 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.12 3.59 61.28 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.302 0.881 . . . . 10.0 115.302 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.4 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.035 2.134 . . . . 10.0 109.036 172.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.028 0.931 . . . . 10.0 111.0 166.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.887 0.875 . . . . 10.0 109.712 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.56 129.54 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.068 1.347 . . . . 10.0 110.976 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.74 116.3 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.384 -1.044 . . . . 10.0 109.384 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.76 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.695 -0.962 . . . . 10.0 110.695 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.37 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.708 2.243 . . . . 10.0 118.708 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.54 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.263 -165.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.87 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.081 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.47 120.82 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.53 131.92 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.11 126.38 22.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.0 1.72 . . . . 10.0 111.684 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.746 1.26 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.3 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.54 -31.14 61.87 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.231 1.012 . . . . 10.0 112.305 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 82' ' ' ARG . 16.1 ttm-85 -46.97 -44.48 20.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.198 2.199 . . . . 10.0 113.104 167.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -82.12 -38.9 24.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.651 1.581 . . . . 10.0 111.794 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.17 -49.25 52.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.073 1.349 . . . . 10.0 111.629 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -53.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.038 1.735 . . . . 10.0 111.849 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -54.95 -33.23 62.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.936 -1.031 . . . . 10.0 113.549 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.13 -40.39 46.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.399 1.48 . . . . 10.0 112.051 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.28 -46.1 4.5 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.253 1.021 . . . . 10.0 112.303 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.1 m -52.32 -43.68 64.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.879 1.271 . . . . 10.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 m -72.87 -45.5 8.79 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 114.313 1.227 . . . . 10.0 114.313 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.88 -41.63 69.36 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.339 2.693 . . . . 10.0 115.1 167.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.0 mt -59.6 -47.14 86.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.285 0.634 . . . . 10.0 111.431 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.8 -51.45 22.5 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.349 1.86 . . . . 10.0 111.412 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.06 -47.28 83.64 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.92 1.288 . . . . 10.0 113.165 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.29 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.849 0.859 . . . . 10.0 112.889 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.34 -53.96 37.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.256 0.934 . . . . 10.0 111.2 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -42.05 88.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.62 0.768 . . . . 10.0 112.087 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 37.95 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.017 0.927 . . . . 10.0 112.024 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.29 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.752 0.821 . . . . 10.0 112.699 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.76 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.81 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.312 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.45 12.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.847 1.659 . . . . 10.0 112.159 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.92 54.38 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.69 2.61 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.523 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.79 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.46 -52.9 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.07 1.348 . . . . 10.0 111.128 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.61 -51.26 68.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.88 43.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.504 0.722 . . . . 10.0 110.923 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.357 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.82 -46.37 74.53 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.044 0.757 . . . . 10.0 113.044 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.52 -45.24 85.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.138 . . . . 10.0 112.08 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.99 -56.76 5.07 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.618 1.58 . . . . 10.0 112.797 166.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.46 -52.1 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 10.0 111.054 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 55.1 ttp -48.0 -59.79 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.855 1.262 . . . . 10.0 112.037 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 123.658 0.783 . . . . 10.0 111.889 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 111.967 0.358 . . . . 10.0 111.967 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.22 -59.25 9.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.911 1.719 . . . . 10.0 112.387 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.03 -42.94 3.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.313 2.645 . . . . 10.0 113.254 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.0 mt -101.42 -6.67 23.71 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.499 1.666 . . . . 10.0 115.499 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.7 10.36 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.19 -1.569 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.47 -49.62 72.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.187 2.595 . . . . 10.0 113.268 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.087 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.9 -59.53 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.07 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.501 1.52 . . . . 10.0 113.503 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.56 63.15 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.15 -41.26 68.24 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.89 0.768 . . . . 10.0 110.899 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.97 -31.98 69.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.837 1.255 . . . . 10.0 114.221 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.076 0.853 . . . . 10.0 109.713 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -60.03 -48.32 82.19 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -48.93 -49.61 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.575 1.079 . . . . 10.0 113.014 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.85 63.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 10.0 111.945 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.69 -51.28 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.983 1.313 . . . . 10.0 111.786 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.2 t -55.89 -46.24 78.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.615 1.166 . . . . 10.0 111.793 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.9 m -60.88 -42.64 98.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 10.0 112.557 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.78 79.17 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.228 0.922 . . . . 10.0 112.31 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.02 82.52 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.587 0.755 . . . . 10.0 112.607 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -55.38 -55.33 32.86 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.319 1.048 . . . . 10.0 112.142 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 tt -51.24 -50.54 58.98 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.949 1.7 . . . . 10.0 111.185 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -50.93 -54.9 20.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.021 0.928 . . . . 10.0 112.792 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.1 -54.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.592 0.757 . . . . 10.0 110.861 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.46 -36.58 69.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.692 0.797 . . . . 10.0 113.115 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.16 9.45 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.036 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.87 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.467 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.78 -49.44 75.29 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.115 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.087 -1.633 . . . . 10.0 112.871 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.68 -21.99 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 10.0 113.466 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.76 -79.06 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.621 0.629 . . . . 10.0 113.553 171.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.236 1.814 . . . . 10.0 113.045 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -50.55 65.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.057 0.932 . . . . 10.0 112.297 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.07 82.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.133 0.973 . . . . 10.0 112.167 173.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.45 80.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.532 1.308 . . . . 10.0 114.532 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.25 1.2 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.033 1.733 . . . . 10.0 114.254 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.65 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.391 1.876 . . . . 10.0 114.878 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.93 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.7 153.92 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.841 3.256 . . . . 10.0 105.592 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.82 -46.23 35.14 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.275 1.983 . . . . 10.0 113.06 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.15 68.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.236 173.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.1 -53.05 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.027 0.931 . . . . 10.0 109.832 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.8 75.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.274 0.63 . . . . 10.0 111.892 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.15 25.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.882 0.873 . . . . 10.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.25 -53.22 60.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 112.987 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.53 45.44 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.115 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.48 78.54 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.91 -49.63 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.843 0.747 . . . . 10.0 110.522 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.64 69.02 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.81 30.15 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.889 2.075 . . . . 10.0 111.037 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.836 0.454 . . . . 10.0 111.263 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.4 t -52.08 -47.39 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 112.209 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -65.29 0.66 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.209 2.604 . . . . 10.0 111.46 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.93 -48.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.783 1.233 . . . . 10.0 111.548 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.7 t -60.52 -61.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.945 0.898 . . . . 10.0 112.653 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.08 -48.78 73.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.766 0.712 . . . . 10.0 111.608 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -50.11 -53.03 30.14 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.647 1.179 . . . . 10.0 112.53 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.469 0.52 0 C-N-CA 124.278 1.031 . . . . 10.0 113.589 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 118.692 -0.671 . . . . 10.0 112.605 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -58.73 -56.1 26.59 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.547 1.139 . . . . 10.0 111.944 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.2 tt -58.36 -41.69 85.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.915 0.886 . . . . 10.0 112.697 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -81.27 -5.52 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.22 -169.29 33.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-O 122.587 1.104 . . . . 10.0 113.953 -169.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.43 65.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.847 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.46 -16.76 64.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.647 1.721 . . . . 10.0 115.647 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.05 -105.91 1.08 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.32 1.418 . . . . 10.0 113.799 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.17 35.81 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.617 -1.519 . . . . 10.0 109.325 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.894 0.318 . . . . 10.0 113.894 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.725 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.29 133.35 24.88 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.69 153.8 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.786 2.99 . . . . 10.0 111.433 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.77 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.307 1.043 . . . . 10.0 112.213 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.35 -52.35 22.07 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.712 1.375 . . . . 10.0 114.712 176.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.92 -40.5 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.476 1.11 . . . . 10.0 109.692 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.32 -49.78 42.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.513 0.597 . . . . 10.0 111.973 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.04 83.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.001 1.72 . . . . 10.0 112.993 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.35 -52.35 62.14 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.02 0.928 . . . . 10.0 112.03 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -58.52 6.5 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.363 1.065 . . . . 10.0 109.975 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -53.44 -44.95 69.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.759 -1.115 . . . . 10.0 112.839 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.45 -53.0 57.66 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.66 -47.51 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.819 1.248 . . . . 10.0 111.678 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.12 -51.62 68.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.629 1.571 . . . . 10.0 111.815 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.21 -51.63 69.14 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.917 1.687 . . . . 10.0 111.788 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 124.669 1.188 . . . . 10.0 110.987 172.786 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.221 0 CA-C-O 121.028 0.238 . . . . 10.0 112.903 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -44.94 -58.02 3.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.542 1.937 . . . . 10.0 112.293 166.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.49 -38.5 70.62 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.005 0.812 . . . . 10.0 113.235 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -70.29 -27.65 64.57 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 116.215 1.932 . . . . 10.0 116.215 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.68 -57.49 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.63 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.921 0.889 . . . . 10.0 113.2 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.53 5.15 2.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.37 0.41 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.18 0.992 . . . . 10.0 113.272 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.08 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.011 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.86 76.98 7.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.874 0.87 . . . . 10.0 112.106 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.869 2.868 . . . . 10.0 116.475 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.719 1.208 . . . . 10.0 110.644 -175.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.21 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.666 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.483 2.713 . . . . 10.0 113.459 166.653 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.834 -2.032 . . . . 10.0 105.789 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 129.651 3.18 . . . . 10.0 117.196 160.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.65 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.306 2.642 . . . . 10.0 114.484 155.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.46 137.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.407 1.883 . . . . 10.0 113.345 -158.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.77 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.22 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.465 2.459 . . . . 10.0 111.487 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.62 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.25 -2.786 . . . . 10.0 116.634 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.543 2.301 . . . . 10.0 113.217 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -67.19 4.31 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.782 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.11 61.74 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.534 -0.729 . . . . 10.0 112.615 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.6 84.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.38 -52.63 62.91 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.448 0.699 . . . . 10.0 111.882 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.59 56.42 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.183 0.593 . . . . 10.0 112.218 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 51.97 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.98 10.25 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.149 0.881 . . . . 10.0 111.202 166.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.27 -52.3 28.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.574 1.15 . . . . 10.0 112.187 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.122 0.969 . . . . 10.0 112.167 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.3 mt -57.86 -50.14 74.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.449 0.699 . . . . 10.0 112.751 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -49.7 68.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.442 1.097 . . . . 10.0 111.248 175.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.32 15.2 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.3 0.952 . . . . 10.0 113.608 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.02 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.485 1.142 . . . . 10.0 112.089 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -41.59 75.74 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.863 1.22 . . . . 10.0 113.232 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.55 -58.44 7.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.823 0.849 . . . . 10.0 111.421 171.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -40.98 62.49 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.045 0.938 . . . . 10.0 110.944 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.1 9.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.968 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.68 81.85 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.257 0.836 . . . . 10.0 113.257 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.46 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.586 1.154 . . . . 10.0 113.62 169.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.77 1.748 . . . . 10.0 110.892 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.013 . . . . 10.0 115.634 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.58 -44.96 93.16 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.162 2.185 . . . . 10.0 113.589 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.435 2.694 . . . . 10.0 116.939 166.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.64 -50.92 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.179 -1.373 . . . . 10.0 113.879 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.771 1.294 . . . . 10.0 110.957 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.59 -29.63 89.65 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.743 2.962 . . . . 10.0 113.69 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.09 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.108 1.363 . . . . 10.0 113.564 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.44 19.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.405 172.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.967 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.97 -50.23 73.29 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.334 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.29 65.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.337 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.53 -57.42 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.851 1.26 . . . . 10.0 110.533 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -67.99 -20.75 65.05 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.965 1.306 . . . . 10.0 113.552 -172.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -84.07 -40.92 17.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.414 1.086 . . . . 10.0 112.18 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.07 -41.52 88.15 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.469 -0.77 . . . . 10.0 112.983 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.37 -62.84 1.45 Allowed Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 124.603 1.161 . . . . 10.0 113.447 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.79 -26.34 32.56 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.001 2.467 . . . . 10.0 113.771 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.86 -45.94 83.92 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 120.547 1.522 . . . . 10.0 113.156 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.76 -51.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 120.982 -1.073 . . . . 10.0 109.302 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.82 72.84 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.42 0.896 . . . . 10.0 113.42 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -52.81 -56.42 15.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.119 1.368 . . . . 10.0 111.816 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.67 -52.78 28.58 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.263 1.425 . . . . 10.0 110.749 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.29 -47.97 62.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.99 0.916 . . . . 10.0 112.98 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.15 -41.2 75.04 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.365 1.439 . . . . 10.0 113.11 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.57 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.948 1.249 . . . . 10.0 111.297 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.61 -41.12 61.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.86 -50.85 61.22 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.525 0.73 . . . . 10.0 110.485 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.5 48.82 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.539 0.976 . . . . 10.0 115.539 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.55 61.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.42 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.042 2.137 . . . . 10.0 109.036 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.57 171.13 15.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.028 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.01 53.42 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.912 0.885 . . . . 10.0 109.712 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.51 129.62 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.079 1.352 . . . . 10.0 110.96 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.444 -1.022 . . . . 10.0 109.444 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.37 38.2 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.42 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.632 -0.987 . . . . 10.0 110.632 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.78 -3.35 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.317 1.558 . . . . 10.0 112.28 -165.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.93 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -89.52 120.74 69.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -165.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -61.49 131.92 38.28 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.137 171.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.1 126.33 21.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.055 1.742 . . . . 10.0 111.752 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.63 85.01 4.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.958 1.361 . . . . 10.0 113.085 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.36 -28.28 66.71 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.898 -1.126 . . . . 10.0 113.928 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.8 38.3 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.26 1.024 . . . . 10.0 112.491 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -54.27 -48.3 71.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.032 1.333 . . . . 10.0 112.714 168.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -71.25 -38.49 71.91 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.485 1.114 . . . . 10.0 110.993 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.52 67.09 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.797 1.239 . . . . 10.0 112.367 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.15 -69.51 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.883 1.673 . . . . 10.0 111.624 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -56.84 -32.5 65.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.067 1.347 . . . . 10.0 112.836 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.35 -44.27 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.679 1.592 . . . . 10.0 111.876 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -100.14 -41.94 6.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 10.0 112.593 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.4 p -62.6 -42.72 99.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.836 1.198 . . . . 10.0 113.925 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 71.5 p -65.85 -44.01 60.98 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 114.663 1.357 . . . . 10.0 114.663 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -43.95 53.12 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.053 2.502 . . . . 10.0 115.637 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.46 -46.4 88.87 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.491 -0.756 . . . . 10.0 111.454 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 tp -50.76 -49.2 58.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.567 1.547 . . . . 10.0 112.038 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.09 -47.47 83.11 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.94 1.296 . . . . 10.0 112.513 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.22 78.28 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.78 0.832 . . . . 10.0 112.889 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.31 -54.04 36.64 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.309 0.959 . . . . 10.0 111.173 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.06 88.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 10.0 112.14 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 38.1 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 112.002 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.35 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.682 0.793 . . . . 10.0 112.704 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.76 -38.57 91.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.81 1.43 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.055 1.342 . . . . 10.0 112.296 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.9 47.62 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.443 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.93 54.46 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.664 0.616 . . . . 10.0 112.664 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.72 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.499 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.04 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.339 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.43 -52.9 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.075 1.35 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.27 67.89 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.87 43.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.429 0.692 . . . . 10.0 110.945 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.655 0.782 . . . . 10.0 111.375 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.9 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.78 -46.58 74.45 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -56.07 -48.3 76.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.896 0.879 . . . . 10.0 110.903 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.79 -54.57 4.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.951 1.263 . . . . 10.0 113.195 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.15 -51.01 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.903 0.881 . . . . 10.0 112.119 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -54.19 -51.96 62.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.866 1.212 . . . . 10.0 111.987 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 N--CA 1.471 0.576 0 O-C-N 121.801 -0.562 . . . . 10.0 111.034 177.406 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 112.139 0.422 . . . . 10.0 112.139 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.0 -58.98 9.34 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.919 1.723 . . . . 10.0 112.398 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.92 -43.3 3.03 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.057 2.543 . . . . 10.0 113.466 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.43 -6.33 24.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.461 1.652 . . . . 10.0 115.461 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.63 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.222 -1.549 . . . . 10.0 110.41 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.68 71.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.26 2.624 . . . . 10.0 113.251 177.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.61 106.3 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.52 3.03 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.771 1.229 . . . . 10.0 114.065 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.05 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.48 1.512 . . . . 10.0 113.519 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.63 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.907 1.447 . . . . 10.0 114.907 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -53.91 -41.81 68.05 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.914 0.779 . . . . 10.0 110.75 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.72 -31.49 69.52 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.355 1.243 . . . . 10.0 114.355 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.44 -52.01 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.041 0.837 . . . . 10.0 109.551 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -61.84 -42.56 99.19 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -53.67 -49.2 68.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.233 1.013 . . . . 10.0 112.759 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -52.58 64.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.636 0.774 . . . . 10.0 111.503 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.6 -55.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.987 1.315 . . . . 10.0 112.051 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 p -57.04 -43.63 82.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.905 0.882 . . . . 10.0 112.696 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -43.93 98.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.758 1.223 . . . . 10.0 112.157 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.41 81.7 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.229 0.922 . . . . 10.0 112.561 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.23 78.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.989 0.916 . . . . 10.0 112.43 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.8 ttp -56.56 -51.06 70.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.285 1.034 . . . . 10.0 112.382 171.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.02 -48.06 76.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.32 1.448 . . . . 10.0 112.681 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -48.53 -53.52 17.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.394 1.078 . . . . 10.0 111.794 169.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.72 -55.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.68 0.792 . . . . 10.0 110.899 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -56.52 -36.42 69.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.226 0.824 . . . . 10.0 113.226 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.28 -58.15 9.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.049 0.939 . . . . 10.0 113.059 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.5 -40.82 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.289 -0.863 . . . . 10.0 111.429 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.84 -49.4 75.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.909 1.231 . . . . 10.0 112.093 171.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.99 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.858 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.615 1.166 . . . . 10.0 113.447 -174.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.11 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.651 0.643 . . . . 10.0 113.554 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.242 1.817 . . . . 10.0 113.011 -166.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.06 -56.46 14.2 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.005 1.113 . . . . 10.0 114.005 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.69 -50.55 65.61 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.096 0.951 . . . . 10.0 112.272 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.14 -46.02 83.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.16 0.984 . . . . 10.0 112.151 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.51 80.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.43 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.124 1.77 . . . . 10.0 114.235 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.59 29.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.425 1.89 . . . . 10.0 114.851 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.5 1.619 . . . . 10.0 114.164 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.805 3.242 . . . . 10.0 105.562 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.84 -46.22 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.306 2.004 . . . . 10.0 113.069 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.11 68.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.057 2.943 . . . . 10.0 113.236 173.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.82 75.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.282 0.633 . . . . 10.0 111.917 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.19 24.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.913 0.885 . . . . 10.0 112.698 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.226 1.011 . . . . 10.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.55 -49.53 45.86 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.26 0.624 . . . . 10.0 111.115 174.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.15 -48.41 78.76 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.94 -49.7 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.801 0.728 . . . . 10.0 110.467 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.51 -51.63 69.07 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.8 -47.76 30.85 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 126.852 2.061 . . . . 10.0 111.04 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.48 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.862 0.465 . . . . 10.0 111.271 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.1 -47.33 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.078 0.951 . . . . 10.0 112.093 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.4 m -58.36 -64.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.126 2.57 . . . . 10.0 111.492 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -50.18 -49.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.676 1.19 . . . . 10.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.36 -63.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.974 0.91 . . . . 10.0 112.043 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.58 -45.45 81.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.142 0.883 . . . . 10.0 112.378 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -53.03 -51.88 60.27 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.107 0.963 . . . . 10.0 112.236 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 114.243 1.201 . . . . 10.0 114.243 179.724 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 112.77 0.655 . . . . 10.0 112.77 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -59.63 -55.18 37.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.563 1.145 . . . . 10.0 112.115 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.81 -41.68 82.67 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.764 0.826 . . . . 10.0 112.494 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -81.42 -5.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 115.003 1.483 . . . . 10.0 115.003 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.4 -169.31 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 122.576 1.098 . . . . 10.0 113.924 -168.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.56 65.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.822 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -67.92 -15.74 63.75 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.542 1.682 . . . . 10.0 115.542 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.53 -105.94 1.05 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 120.428 1.467 . . . . 10.0 114.03 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.304 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.32 1.35 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 113.855 0.302 . . . . 10.0 113.855 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.77 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.12 1.768 . . . . 10.0 108.692 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.26 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.368 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.73 153.81 72.45 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.456 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.297 1.039 . . . . 10.0 112.199 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.3 -52.42 21.47 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 10.0 114.685 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.36 -49.77 42.93 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.563 0.62 . . . . 10.0 111.937 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.7 -47.05 83.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.979 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.28 -52.35 62.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.974 0.91 . . . . 10.0 112.123 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -58.96 5.1 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.303 1.041 . . . . 10.0 109.992 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -52.32 -44.57 65.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.679 -1.153 . . . . 10.0 112.6 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -55.26 -51.76 65.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.608 1.549 . . . . 10.0 112.511 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.43 -46.68 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.936 1.294 . . . . 10.0 111.629 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.91 -52.68 64.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.556 1.542 . . . . 10.0 111.601 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.57 -54.11 49.78 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.785 1.634 . . . . 10.0 111.933 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.475 0.778 0 O-C-N 121.22 -0.925 . . . . 10.0 112.456 -178.842 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.306 0 CA-C-O 120.909 0.172 . . . . 10.0 112.985 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -45.18 -56.3 4.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.414 1.886 . . . . 10.0 112.284 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.04 -40.03 71.93 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.072 0.844 . . . . 10.0 113.635 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.48 -27.69 64.4 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 115.774 1.768 . . . . 10.0 115.774 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.42 -57.52 11.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 165.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.65 0.86 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.907 0.883 . . . . 10.0 113.168 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.58 5.24 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.31 15.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.266 1.026 . . . . 10.0 113.28 172.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.038 0.935 . . . . 10.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.12 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.771 0.828 . . . . 10.0 110.973 170.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.85 76.99 7.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.87 0.868 . . . . 10.0 112.117 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.471 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.41 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.622 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.51 39.93 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.519 2.727 . . . . 10.0 113.439 166.61 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.782 -2.056 . . . . 10.0 105.826 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.51 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.615 3.166 . . . . 10.0 117.211 160.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.1 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.356 2.662 . . . . 10.0 114.417 155.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.365 1.866 . . . . 10.0 113.391 -158.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.78 -165.13 1.69 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.306 1.842 . . . . 10.0 114.055 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.96 2.84 40.82 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 127.489 2.471 . . . . 10.0 111.487 168.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.55 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.96 -60.65 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.488 2.281 . . . . 10.0 113.191 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -67.23 4.37 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.8 2.44 . . . . 10.0 115.742 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.13 61.79 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.464 -0.772 . . . . 10.0 112.621 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.41 -52.65 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.422 0.689 . . . . 10.0 111.83 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.33 -53.59 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.174 0.59 . . . . 10.0 112.225 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 -46.81 52.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.368 1.467 . . . . 10.0 113.305 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.61 -45.04 84.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.83 -58.68 7.4 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.355 0.978 . . . . 10.0 110.765 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -48.4 -52.34 22.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.745 1.218 . . . . 10.0 112.072 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 -58.9 5.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.175 0.99 . . . . 10.0 112.15 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.74 -49.77 75.44 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.707 0.803 . . . . 10.0 112.207 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.2 mmm -57.78 -45.95 85.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.374 0.67 . . . . 10.0 111.603 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.47 -58.1 16.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.46 1.029 . . . . 10.0 113.895 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.21 -45.99 79.66 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.406 1.103 . . . . 10.0 112.077 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -42.02 75.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.821 1.2 . . . . 10.0 113.168 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 -58.58 7.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.676 0.79 . . . . 10.0 111.474 171.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.01 62.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.023 0.929 . . . . 10.0 110.974 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.78 -57.99 9.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.582 1.153 . . . . 10.0 113.011 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.68 82.0 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.621 1.168 . . . . 10.0 113.637 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.748 . . . . 10.0 110.878 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.937 2.495 . . . . 10.0 109.365 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.89 23.09 0.86 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.94 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.614 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.9 m -79.61 -50.87 10.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.231 -1.35 . . . . 10.0 113.902 174.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.52 6.44 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.794 1.309 . . . . 10.0 110.975 -172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.54 -29.69 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.705 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.66 2.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.111 0.565 . . . . 10.0 111.447 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.53 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.056 1.342 . . . . 10.0 113.588 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.49 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.249 1.42 . . . . 10.0 113.468 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.13 61.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.486 0.714 . . . . 10.0 110.946 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.91 -50.28 73.03 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.26 65.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.341 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.02 1.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.407 0.892 . . . . 10.0 113.407 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.36 -57.26 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.921 1.288 . . . . 10.0 110.645 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -68.39 -20.17 64.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.999 1.32 . . . . 10.0 113.508 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.9 m -84.92 -39.69 17.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.488 1.115 . . . . 10.0 112.303 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.59 -42.89 97.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.8 t -43.39 -63.77 0.93 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.898 1.279 . . . . 10.0 112.482 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.43 -27.56 33.52 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.94 2.426 . . . . 10.0 114.217 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.79 89.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.459 1.481 . . . . 10.0 113.033 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.2 mt -61.84 -46.97 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 120.86 -1.15 . . . . 10.0 109.908 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.61 71.14 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.027 0.751 . . . . 10.0 113.027 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -50.82 -56.87 10.12 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.193 1.397 . . . . 10.0 111.677 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -48.91 -53.39 19.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.237 1.415 . . . . 10.0 111.087 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.99 -48.34 63.33 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.034 0.933 . . . . 10.0 112.909 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -55.22 -41.94 72.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.309 1.413 . . . . 10.0 113.287 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.56 34.44 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.619 1.099 . . . . 10.0 111.356 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.64 -41.03 61.02 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.256 1.576 . . . . 10.0 115.256 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtm -66.95 -50.8 61.2 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 123.568 0.747 . . . . 10.0 110.456 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.67 -52.63 22.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.837 0.855 . . . . 10.0 112.91 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.93 -5.53 48.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.875 1.065 . . . . 10.0 113.875 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.22 -34.66 5.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 115.601 1.0 . . . . 10.0 115.601 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.38 -43.06 43.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.59 61.05 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.363 0.905 . . . . 10.0 115.363 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.39 26.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.072 2.149 . . . . 10.0 109.066 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.48 171.09 15.15 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.059 0.943 . . . . 10.0 111.048 166.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.1 53.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.862 0.865 . . . . 10.0 109.693 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.75 116.29 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.4 38.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 118.703 2.241 . . . . 10.0 118.703 170.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.9 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.302 1.551 . . . . 10.0 112.223 -165.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.78 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.544 1.537 . . . . 10.0 111.159 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.43 120.81 69.68 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 112.981 0.734 . . . . 10.0 112.981 -165.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.58 131.93 38.12 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.209 3.273 . . . . 10.0 112.144 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.12 126.32 21.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.054 1.742 . . . . 10.0 111.746 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.57 84.96 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.057 1.408 . . . . 10.0 113.065 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.31 -28.26 66.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.787 -1.195 . . . . 10.0 113.98 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.73 62.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.056 1.502 . . . . 10.0 115.056 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.411 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -63.86 -29.62 70.79 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 119.847 -1.783 . . . . 10.0 113.284 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -70.78 -43.99 67.57 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.254 -0.904 . . . . 10.0 112.012 171.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.1 -46.67 45.18 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.164 1.386 . . . . 10.0 111.669 167.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -56.92 -70.82 0.11 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.102 1.361 . . . . 10.0 111.675 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.411 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.2 m0 -53.4 -33.51 54.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.422 1.489 . . . . 10.0 112.835 -170.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.5 tp -46.29 -48.95 18.02 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.942 1.697 . . . . 10.0 111.913 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -90.8 -44.5 9.39 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.324 1.05 . . . . 10.0 112.311 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.2 p -78.91 -32.98 45.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.133 1.16 . . . . 10.0 114.133 -165.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.317 69.8 p -61.55 -44.98 93.66 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.594 -1.193 . . . . 10.0 112.767 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.52 -44.99 43.01 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.911 2.407 . . . . 10.0 115.892 166.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.41 -47.4 85.59 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.319 -0.863 . . . . 10.0 111.881 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.17 -49.51 60.79 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.898 1.679 . . . . 10.0 111.3 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.05 -48.06 76.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.237 1.015 . . . . 10.0 112.907 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.21 78.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.823 0.849 . . . . 10.0 112.863 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.37 -53.99 37.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.299 0.954 . . . . 10.0 111.163 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.12 88.8 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.151 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.71 38.29 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.951 0.9 . . . . 10.0 112.031 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.21 79.4 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.736 0.814 . . . . 10.0 112.669 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.75 -38.58 91.64 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.41 1.263 . . . . 10.0 114.41 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.269 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.89 47.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.966 -1.709 . . . . 10.0 112.437 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.87 54.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.79 -39.77 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.922 1.689 . . . . 10.0 113.452 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.74 87.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.382 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.49 -52.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.003 1.321 . . . . 10.0 111.16 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.28 67.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.516 0.562 . . . . 10.0 112.516 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.91 42.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.446 0.698 . . . . 10.0 110.932 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -59.9 4.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.429 2.292 . . . . 10.0 114.821 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -47.01 74.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -58.52 -44.28 89.48 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.703 0.801 . . . . 10.0 111.769 175.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -56.27 5.14 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.418 1.485 . . . . 10.0 113.384 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.59 -49.84 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 117.697 0.749 . . . . 10.0 111.245 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -53.85 -57.05 12.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.93 1.292 . . . . 10.0 112.587 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.479 0.978 0 CA-C-N 118.795 0.725 . . . . 10.0 111.625 173.406 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 110.23 -0.285 . . . . 10.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.88 -60.71 6.75 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.4 1.952 . . . . 10.0 112.533 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.61 -42.56 3.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.645 2.378 . . . . 10.0 113.219 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -100.77 -6.68 24.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.65 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 120.186 -1.571 . . . . 10.0 110.355 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.49 -49.6 72.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.154 2.582 . . . . 10.0 113.304 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.36 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.053 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.88 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.111 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.06 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.465 1.506 . . . . 10.0 113.56 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.74 63.26 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.03 -41.72 68.35 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.855 0.752 . . . . 10.0 110.768 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -69.33 -32.33 71.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.764 1.226 . . . . 10.0 114.25 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -52.15 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.051 0.841 . . . . 10.0 109.955 168.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -59.11 -51.71 68.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -48.24 -46.96 36.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.164 0.986 . . . . 10.0 113.388 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.44 -52.07 67.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 10.0 111.524 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.2 mt -54.22 -51.53 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.134 1.374 . . . . 10.0 111.514 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -54.45 -47.82 72.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.423 1.089 . . . . 10.0 112.13 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 73.6 m -63.0 -43.1 99.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.042 1.337 . . . . 10.0 111.663 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.46 73.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.238 1.015 . . . . 10.0 112.365 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.9 78.14 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.761 0.824 . . . . 10.0 112.497 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.97 -52.72 64.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.652 1.181 . . . . 10.0 111.959 172.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.08 -49.27 63.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.315 1.446 . . . . 10.0 111.414 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -49.33 -54.93 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.949 0.9 . . . . 10.0 112.681 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 42.0 mm -52.16 -55.88 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.852 0.751 . . . . 10.0 110.41 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.68 -35.22 72.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.463 -0.78 . . . . 10.0 111.735 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.36 -58.14 9.56 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.003 0.921 . . . . 10.0 113.008 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.85 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.438 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.4 75.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.857 1.208 . . . . 10.0 112.101 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -76.99 -70.32 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.119 -1.613 . . . . 10.0 112.851 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.89 60.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.634 1.174 . . . . 10.0 113.42 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.14 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.627 0.632 . . . . 10.0 113.514 171.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.41 51.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.26 1.824 . . . . 10.0 113.059 -166.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.54 13.8 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.96 1.096 . . . . 10.0 113.96 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.63 -50.54 65.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.084 0.945 . . . . 10.0 112.329 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.02 83.1 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.16 0.984 . . . . 10.0 112.117 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.47 80.12 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.32 1.23 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.124 1.77 . . . . 10.0 114.189 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.58 29.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.398 1.879 . . . . 10.0 114.917 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.86 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 123.48 1.61 . . . . 10.0 114.146 -170.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.66 153.96 72.74 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.798 3.239 . . . . 10.0 105.561 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.21 35.4 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.334 2.023 . . . . 10.0 113.008 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.032 2.933 . . . . 10.0 113.288 173.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.14 -53.08 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.059 0.943 . . . . 10.0 109.816 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.86 75.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.317 0.647 . . . . 10.0 111.907 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.96 -56.22 24.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.953 0.901 . . . . 10.0 112.675 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.18 -53.22 60.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.181 0.993 . . . . 10.0 113.059 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.53 -49.56 45.57 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.36 78.88 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.06 -49.58 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.832 0.742 . . . . 10.0 110.481 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.61 69.16 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.81 -47.74 30.95 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.883 2.073 . . . . 10.0 111.07 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.59 -58.33 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.815 0.446 . . . . 10.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.1 t -51.96 -47.94 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.091 0.956 . . . . 10.0 111.994 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.2 m -57.66 -63.41 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.397 2.679 . . . . 10.0 111.878 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.52 -49.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.526 1.131 . . . . 10.0 111.284 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.62 -60.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.1 0.96 . . . . 10.0 112.056 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.44 -48.08 83.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -52.26 -51.07 60.55 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.707 0.803 . . . . 10.0 111.597 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 114.028 1.121 . . . . 10.0 114.028 178.691 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 119.279 -0.391 . . . . 10.0 111.531 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -55.68 -52.91 62.24 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.412 1.085 . . . . 10.0 112.581 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -57.49 -43.15 83.92 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.854 0.861 . . . . 10.0 112.304 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -83.98 -5.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.097 1.517 . . . . 10.0 115.097 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.37 -169.35 33.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 122.559 1.088 . . . . 10.0 113.887 -168.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -41.23 64.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.889 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.7 -16.79 64.31 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.731 1.752 . . . . 10.0 115.731 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.89 -105.93 1.09 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.364 1.438 . . . . 10.0 113.711 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.4 127.13 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.368 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.52 65.4 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.081 1.753 . . . . 10.0 108.725 166.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.39 24.91 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.78 153.79 72.38 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.733 2.955 . . . . 10.0 111.463 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.09 -39.84 2.92 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.295 1.038 . . . . 10.0 112.232 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.31 -52.35 21.87 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.95 -40.45 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.388 1.075 . . . . 10.0 109.639 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.86 41.86 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.535 0.607 . . . . 10.0 111.946 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.4 m -57.71 -47.01 83.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.006 1.723 . . . . 10.0 112.995 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.33 -52.33 62.29 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.938 0.895 . . . . 10.0 112.054 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.61 -59.07 4.91 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.307 1.043 . . . . 10.0 109.979 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.97 -46.99 68.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.479 -1.248 . . . . 10.0 112.297 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -50.98 -52.34 43.58 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.739 1.609 . . . . 10.0 113.035 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.32 -48.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.553 1.141 . . . . 10.0 111.636 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.98 -50.45 72.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.143 1.377 . . . . 10.0 111.763 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.14 -59.79 4.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.713 2.005 . . . . 10.0 110.198 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.477 0.909 0 C-N-CA 124.552 1.141 . . . . 10.0 111.989 175.282 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.294 0 N-CA-C 112.534 -0.226 . . . . 10.0 112.534 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -43.05 -57.39 2.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.759 2.024 . . . . 10.0 112.536 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.92 -41.59 84.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.388 0.994 . . . . 10.0 113.945 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.92 -27.18 64.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 115.703 1.742 . . . . 10.0 115.703 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.21 -57.65 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.947 0.899 . . . . 10.0 113.155 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.53 5.13 2.54 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.3 0.37 15.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.24 1.016 . . . . 10.0 113.324 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 110.972 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.95 77.07 7.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.824 0.849 . . . . 10.0 112.087 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.83 2.852 . . . . 10.0 116.458 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.91 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.721 1.209 . . . . 10.0 110.61 -175.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.77 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.656 171.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.468 2.707 . . . . 10.0 113.408 166.584 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.83 -2.033 . . . . 10.0 105.851 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.614 3.165 . . . . 10.0 117.211 160.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.272 2.629 . . . . 10.0 114.49 155.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.97 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.361 1.864 . . . . 10.0 113.378 -158.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.77 -165.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.272 1.829 . . . . 10.0 113.99 -174.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.16 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.58 -51.38 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.306 -2.759 . . . . 10.0 116.604 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.498 2.285 . . . . 10.0 113.205 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.21 4.31 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.737 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.39 -43.03 61.79 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.496 -0.752 . . . . 10.0 112.642 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.69 83.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.954 0.902 . . . . 10.0 109.305 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.872 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.33 -53.57 56.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.238 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.81 51.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.376 1.47 . . . . 10.0 113.354 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.64 -44.99 84.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.294 1.438 . . . . 10.0 113.026 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.95 -55.68 14.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.575 1.084 . . . . 10.0 111.769 166.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -50.16 -52.5 34.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.916 1.286 . . . . 10.0 112.317 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.145 0.978 . . . . 10.0 112.204 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.2 mt -58.11 -49.31 77.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.451 0.7 . . . . 10.0 112.609 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.2 mmt -55.16 -50.27 69.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.686 0.794 . . . . 10.0 111.198 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.08 -58.57 13.9 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.388 0.994 . . . . 10.0 113.634 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.15 -45.65 79.56 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.593 1.196 . . . . 10.0 112.138 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.62 80.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.529 1.062 . . . . 10.0 113.389 172.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -60.17 -60.49 3.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.09 0.956 . . . . 10.0 110.984 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.96 62.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.939 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.09 9.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.654 1.181 . . . . 10.0 112.929 172.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.72 82.1 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.649 1.179 . . . . 10.0 113.619 169.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.698 1.713 . . . . 10.0 110.835 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.86 -44.8 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.878 2.471 . . . . 10.0 109.338 171.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.97 23.1 0.87 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.611 1.005 . . . . 10.0 115.611 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.48 -45.0 92.93 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.145 2.178 . . . . 10.0 113.605 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.765 0.698 . . . . 10.0 112.432 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.04 88.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.361 2.665 . . . . 10.0 116.933 166.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.67 -50.88 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.224 -1.353 . . . . 10.0 113.854 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.47 6.4 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.782 1.301 . . . . 10.0 110.957 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.57 -29.64 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.08 0.552 . . . . 10.0 111.442 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.15 22.67 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.142 1.377 . . . . 10.0 113.549 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.47 19.23 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.232 1.413 . . . . 10.0 113.46 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.11 61.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.952 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.95 -50.23 73.26 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.035 0.534 . . . . 10.0 112.351 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.36 -51.29 65.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.939 -0.553 . . . . 10.0 112.358 173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.78 -56.88 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 10.0 110.489 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -69.23 -17.57 63.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.18 1.392 . . . . 10.0 113.6 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.6 m -86.6 -42.91 13.09 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.688 1.131 . . . . 10.0 111.953 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -57.13 -41.32 78.82 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -50.62 -61.35 3.95 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.985 1.314 . . . . 10.0 112.254 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.27 -46.78 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.393 3.395 . . . . 10.0 115.726 163.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.96 79.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.241 1.2 . . . . 10.0 114.241 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.09 -36.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 120.256 -1.528 . . . . 10.0 111.698 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.87 77.61 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.13 0.877 . . . . 10.0 112.603 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.8 -56.0 14.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 10.0 111.89 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -48.61 -53.21 19.37 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.498 1.519 . . . . 10.0 111.113 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.59 -48.14 64.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.142 0.977 . . . . 10.0 112.921 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -55.34 -42.16 73.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.009 1.277 . . . . 10.0 113.196 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.66 32.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.292 0.951 . . . . 10.0 111.25 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.55 -41.13 60.89 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.255 1.576 . . . . 10.0 115.255 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 47.0 mtm -66.91 -50.77 61.37 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.531 0.732 . . . . 10.0 110.459 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.7 -52.58 22.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.828 0.851 . . . . 10.0 112.924 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.46 48.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.23 -34.76 5.51 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.524 0.97 . . . . 10.0 115.524 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.26 -43.08 42.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.09 3.57 61.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.063 2.145 . . . . 10.0 109.001 171.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.13 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.03 166.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.726 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.6 129.63 23.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 125.069 1.348 . . . . 10.0 110.908 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.81 116.27 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 109.382 -1.045 . . . . 10.0 109.382 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.78 0.659 . . . . 10.0 112.78 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.718 -0.953 . . . . 10.0 110.718 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.43 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.664 2.225 . . . . 10.0 118.664 170.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.379 1.59 . . . . 10.0 112.202 -165.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.478 1.511 . . . . 10.0 111.059 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -61.52 131.9 38.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.169 3.246 . . . . 10.0 112.166 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.7 85.01 4.72 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.717 1.246 . . . . 10.0 113.066 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.29 -28.31 66.64 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.26 -33.59 63.3 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.283 1.033 . . . . 10.0 112.155 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.43 ' HD2' ' CZ2' ' A' ' 86' ' ' TRP . 8.1 tpp180 -39.06 -54.23 1.73 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.24 2.616 . . . . 10.0 111.938 165.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.71 -38.11 48.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.047 1.739 . . . . 10.0 112.579 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.2 -47.35 62.29 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.72 1.146 . . . . 10.0 110.387 167.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -68.36 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.362 1.865 . . . . 10.0 111.485 168.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.43 ' CZ2' ' HD2' ' A' ' 82' ' ' ARG . 54.5 m0 -54.76 -35.83 64.19 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.608 0.966 . . . . 10.0 113.608 -172.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.14 -42.19 50.24 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.104 1.762 . . . . 10.0 111.825 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -103.5 -36.96 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.543 -0.741 . . . . 10.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.4 p -61.15 -46.22 91.43 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 121.155 1.798 . . . . 10.0 113.6 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.301 76.4 p -65.93 -43.89 59.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 -175.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.99 -43.14 62.34 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.429 2.753 . . . . 10.0 115.261 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.95 -47.78 84.85 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.318 -0.864 . . . . 10.0 111.698 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.5 tp -49.95 -49.59 49.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.136 1.374 . . . . 10.0 112.189 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.87 -47.93 76.46 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.111 -0.993 . . . . 10.0 112.658 170.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.26 78.28 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.781 0.832 . . . . 10.0 112.894 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -52.24 -54.05 35.98 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.31 0.959 . . . . 10.0 111.203 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.72 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.657 0.783 . . . . 10.0 112.158 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.74 -54.74 37.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.983 0.913 . . . . 10.0 112.016 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.15 79.17 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.677 174.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.82 -38.54 91.48 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.426 1.269 . . . . 10.0 114.426 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.018 1.327 . . . . 10.0 112.296 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.5 53.49 11.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.821 1.648 . . . . 10.0 112.175 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.92 47.52 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.938 -1.726 . . . . 10.0 112.392 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.89 54.27 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.7 2.63 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.861 1.664 . . . . 10.0 113.456 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.25 5.27 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.02 -46.8 87.62 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.88 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.997 1.319 . . . . 10.0 111.163 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.67 -51.28 67.84 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.55 0.574 . . . . 10.0 112.55 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.88 43.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.452 0.701 . . . . 10.0 110.908 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.52 -59.96 4.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.436 2.294 . . . . 10.0 114.815 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.99 -46.29 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 123.665 0.786 . . . . 10.0 111.428 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.71 -50.25 64.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.655 0.645 . . . . 10.0 112.63 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.71 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.234 0.827 . . . . 10.0 113.234 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -55.12 -48.3 73.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.591 1.156 . . . . 10.0 111.259 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -55.51 5.22 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.39 1.472 . . . . 10.0 113.246 168.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.61 -51.99 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.549 0.74 . . . . 10.0 111.735 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.2 tmm? -50.65 -56.38 12.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.969 1.707 . . . . 10.0 112.038 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm . . . . . 0 N--CA 1.473 0.692 0 O-C-N 121.652 -0.655 . . . . 10.0 112.423 175.457 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.0 t . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 119.683 -0.198 . . . . 10.0 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.26 6.3 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.714 1.626 . . . . 10.0 112.092 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.59 -37.55 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.387 1.875 . . . . 10.0 113.893 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.6 mt -99.14 -6.35 28.45 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.162 1.541 . . . . 10.0 115.162 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.68 116.69 10.37 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.128 -1.607 . . . . 10.0 110.365 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.221 2.608 . . . . 10.0 113.274 177.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.62 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.812 0.845 . . . . 10.0 110.066 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.95 -59.53 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.033 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.06 14.92 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.413 1.485 . . . . 10.0 113.52 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -70.2 -24.58 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.66 -42.2 67.64 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.917 0.78 . . . . 10.0 110.692 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.53 -31.54 69.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.853 1.261 . . . . 10.0 114.348 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.36 -51.86 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.0 0.818 . . . . 10.0 109.622 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -61.68 -43.03 99.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.387 1.255 . . . . 10.0 114.387 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.26 -49.03 67.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.545 1.138 . . . . 10.0 112.585 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.87 71.74 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.717 0.807 . . . . 10.0 111.675 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.4 mt -56.35 -54.33 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.924 1.289 . . . . 10.0 111.943 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -57.39 -42.04 81.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.451 0.7 . . . . 10.0 112.468 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.2 m -58.91 -46.73 87.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.89 1.276 . . . . 10.0 112.6 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.312 0.96 . . . . 10.0 112.371 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.99 83.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.982 0.913 . . . . 10.0 112.805 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.71 -53.61 56.19 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.468 1.107 . . . . 10.0 111.982 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.66 -47.61 70.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.422 1.489 . . . . 10.0 111.982 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -50.1 -54.56 19.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.001 0.92 . . . . 10.0 112.416 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.4 mt -53.78 -54.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.79 0.836 . . . . 10.0 110.728 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.56 -36.56 69.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.17 9.4 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -40.86 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.8 -49.43 75.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.883 1.22 . . . . 10.0 112.145 171.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.043 -1.66 . . . . 10.0 112.874 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.72 -21.91 60.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.607 1.163 . . . . 10.0 113.466 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.644 0.64 . . . . 10.0 113.522 171.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.43 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.037 -166.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.16 -56.42 14.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.953 1.094 . . . . 10.0 113.953 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.7 -50.51 65.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.145 0.974 . . . . 10.0 112.307 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.05 82.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.192 0.997 . . . . 10.0 112.152 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.53 80.03 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.42 -11.29 1.19 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.084 1.754 . . . . 10.0 114.223 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.411 1.884 . . . . 10.0 114.867 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.97 -92.62 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.501 1.619 . . . . 10.0 114.135 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.68 153.93 72.68 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.837 3.255 . . . . 10.0 105.604 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.345 2.03 . . . . 10.0 113.083 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.07 68.07 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.285 173.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.13 -53.05 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.105 0.962 . . . . 10.0 109.816 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.82 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.06 -56.11 25.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.864 0.865 . . . . 10.0 112.731 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.2 -53.24 60.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.229 1.012 . . . . 10.0 112.988 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.56 45.38 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.324 0.65 . . . . 10.0 111.097 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.14 -48.44 78.67 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.66 1.356 . . . . 10.0 114.66 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.97 -49.58 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.807 0.731 . . . . 10.0 110.482 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.14 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.169 0.803 . . . . 10.0 113.169 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.72 31.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.84 2.056 . . . . 10.0 111.068 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.61 -58.29 9.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.781 0.432 . . . . 10.0 111.245 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.85 -49.3 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.07 0.948 . . . . 10.0 111.497 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 29.7 m -56.19 -64.01 1.0 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.115 2.566 . . . . 10.0 111.952 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.02 -49.11 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.666 1.186 . . . . 10.0 111.347 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.31 -61.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.09 0.956 . . . . 10.0 112.372 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -58.04 -46.84 84.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.421 0.688 . . . . 10.0 111.932 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -51.29 -52.8 41.82 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.16 0.984 . . . . 10.0 112.101 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 113.789 1.033 . . . . 10.0 113.789 179.78 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 119.438 -0.315 . . . . 10.0 111.483 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -55.59 -53.3 58.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.697 1.199 . . . . 10.0 112.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -56.25 -44.51 79.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.936 0.894 . . . . 10.0 112.655 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -84.52 -5.81 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.08 1.511 . . . . 10.0 115.08 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.26 33.1 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-O 122.627 1.126 . . . . 10.0 113.94 -168.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -41.1 64.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.202 -0.999 . . . . 10.0 111.846 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -54.43 -31.66 55.77 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.503 2.721 . . . . 10.0 115.359 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.34 -103.85 0.96 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.433 1.015 . . . . 10.0 113.506 -167.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.15 35.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.653 -1.498 . . . . 10.0 109.357 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.4 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.69 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.721 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.33 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.388 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.72 153.8 72.51 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.792 2.995 . . . . 10.0 111.483 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.83 3.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.364 1.065 . . . . 10.0 112.19 171.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.41 21.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.0 -40.42 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.363 1.065 . . . . 10.0 109.625 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.34 -49.81 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.61 0.641 . . . . 10.0 111.944 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.05 83.37 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.055 1.742 . . . . 10.0 112.976 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.4 -52.29 62.24 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.934 0.894 . . . . 10.0 112.054 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -58.73 5.84 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.338 1.055 . . . . 10.0 109.955 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -52.51 -45.36 66.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.604 -1.189 . . . . 10.0 112.684 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.8 -52.67 59.56 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.48 1.491 . . . . 10.0 112.856 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.51 -46.17 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.055 1.342 . . . . 10.0 111.551 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.28 -54.25 49.02 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.302 1.441 . . . . 10.0 111.589 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -54.03 -58.74 6.18 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.523 1.929 . . . . 10.0 111.278 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.474 0.746 0 O-C-N 121.153 -0.967 . . . . 10.0 112.185 -179.527 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.308 0 CA-C-O 121.11 0.284 . . . . 10.0 112.4 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -40.7 -60.13 1.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.904 2.081 . . . . 10.0 112.324 163.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.03 72.45 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.13 0.872 . . . . 10.0 113.745 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -69.94 -27.55 64.85 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 115.997 1.851 . . . . 10.0 115.997 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.73 -57.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.493 -0.929 . . . . 10.0 108.493 165.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.88 0.872 . . . . 10.0 113.171 -172.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.62 5.23 2.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 10.0 115.341 -171.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.4 15.7 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.174 0.99 . . . . 10.0 113.32 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.998 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.72 98.24 1.9 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.73 0.812 . . . . 10.0 110.953 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.92 77.04 7.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.87 0.868 . . . . 10.0 112.037 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.904 2.881 . . . . 10.0 116.466 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.48 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.765 1.226 . . . . 10.0 110.635 -175.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.74 Favored Glycine 0 C--O 1.238 0.388 0 C-N-CA 129.738 3.542 . . . . 10.0 119.647 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.476 2.711 . . . . 10.0 113.421 166.567 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.794 -2.05 . . . . 10.0 105.835 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.49 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.595 3.158 . . . . 10.0 117.209 160.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.1 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.306 2.642 . . . . 10.0 114.452 155.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.51 137.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.357 1.863 . . . . 10.0 113.393 -158.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.74 -165.2 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.76 40.74 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.412 2.434 . . . . 10.0 111.516 168.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.31 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.679 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.66 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.477 2.277 . . . . 10.0 113.238 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.19 4.37 0.95 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.751 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.42 -43.07 61.9 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.458 -0.776 . . . . 10.0 112.604 176.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.348 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.46 -52.62 63.01 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.386 0.675 . . . . 10.0 111.84 175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.82 -46.8 51.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.353 1.461 . . . . 10.0 113.335 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.68 -44.93 84.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.267 1.427 . . . . 10.0 113.056 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.06 -55.78 14.31 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.373 0.987 . . . . 10.0 111.689 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.97 -52.41 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.874 1.27 . . . . 10.0 112.336 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.47 -58.89 5.72 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.172 0.989 . . . . 10.0 112.14 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -57.42 -48.79 78.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.619 0.768 . . . . 10.0 112.684 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.41 -47.1 85.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.221 1.008 . . . . 10.0 111.502 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.64 13.52 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.309 0.957 . . . . 10.0 113.721 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.21 -46.03 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.658 1.229 . . . . 10.0 112.112 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.18 -42.68 73.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.987 1.28 . . . . 10.0 113.175 172.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -62.05 -58.35 8.17 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.718 0.807 . . . . 10.0 111.534 172.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.32 -40.99 62.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.937 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.74 -58.07 9.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.616 1.166 . . . . 10.0 112.999 172.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.71 81.93 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.244 0.831 . . . . 10.0 113.244 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.625 1.17 . . . . 10.0 113.659 169.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.728 1.727 . . . . 10.0 110.868 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.875 2.47 . . . . 10.0 109.33 171.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.11 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.01 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.101 2.161 . . . . 10.0 113.623 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.175 -1.375 . . . . 10.0 113.841 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.84 117.52 6.35 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.745 1.278 . . . . 10.0 110.957 -172.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.63 -29.66 89.87 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.678 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.085 0.554 . . . . 10.0 111.448 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.22 -40.04 23.08 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.583 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.53 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.219 1.408 . . . . 10.0 113.446 172.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.81 -53.04 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.939 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -56.99 -50.27 73.21 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.316 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.29 -51.33 64.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.39 0.541 . . . . 10.0 112.395 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.44 -58.06 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 10.0 110.256 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -67.78 -18.71 64.95 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.234 1.414 . . . . 10.0 113.725 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -86.74 -40.64 14.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.381 1.072 . . . . 10.0 112.292 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.13 -42.92 91.77 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.44 -0.787 . . . . 10.0 112.708 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.2 t -42.2 -62.29 1.25 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.504 1.522 . . . . 10.0 113.285 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.17 -26.12 21.54 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.069 2.513 . . . . 10.0 114.24 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.94 80.63 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.855 1.662 . . . . 10.0 113.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.5 -49.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.026 -1.046 . . . . 10.0 109.778 169.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.56 -45.96 73.6 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 175.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -50.98 -56.32 13.04 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.758 1.623 . . . . 10.0 112.046 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -49.4 -52.76 26.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.303 1.441 . . . . 10.0 110.626 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.415 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.6 mmt -68.87 -47.97 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.005 0.922 . . . . 10.0 113.047 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -57.27 -40.13 77.08 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.201 -1.381 . . . . 10.0 113.346 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.3 -54.6 34.04 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.037 1.29 . . . . 10.0 111.301 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.04 61.0 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.211 1.56 . . . . 10.0 115.211 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.94 -50.78 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.476 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.65 21.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.883 . . . . 10.0 112.9 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.03 -5.51 49.06 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.34 1.056 . . . . 10.0 113.769 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.554 0.982 . . . . 10.0 115.554 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.04 43.04 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.28 1.585 . . . . 10.0 115.28 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.304 0.882 . . . . 10.0 115.304 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.26 143.37 26.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.082 2.153 . . . . 10.0 109.018 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.008 0.923 . . . . 10.0 111.021 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.01 53.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.751 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.56 129.58 23.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 125.12 1.368 . . . . 10.0 110.991 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.77 116.28 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.379 -1.047 . . . . 10.0 109.379 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.41 -81.94 0.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.634 -0.986 . . . . 10.0 110.634 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.55 -171.82 4.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.23 -165.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.91 93.89 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.527 1.531 . . . . 10.0 111.056 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -89.45 120.79 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.989 0.737 . . . . 10.0 112.989 -165.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -61.57 131.93 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.196 3.264 . . . . 10.0 112.129 171.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.004 1.721 . . . . 10.0 111.739 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.62 84.98 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.005 1.384 . . . . 10.0 113.035 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.32 -28.31 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.839 -1.163 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.92 45.45 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.259 1.023 . . . . 10.0 113.197 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -50.42 -60.96 2.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.706 1.202 . . . . 10.0 111.05 168.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -58.17 -42.44 86.01 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.32 2.248 . . . . 10.0 112.633 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.32 63.44 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.487 1.04 . . . . 10.0 112.418 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.415 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -62.39 -60.46 3.53 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.384 0.993 . . . . 10.0 111.759 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -52.96 -36.24 59.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 112.328 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.4 tp -50.49 -42.64 54.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.536 1.934 . . . . 10.0 112.14 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -102.35 -39.05 7.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.83 0.852 . . . . 10.0 112.842 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 71.2 p -63.08 -45.9 89.95 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 120.559 1.527 . . . . 10.0 113.308 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 72.6 p -62.86 -44.21 85.0 Favored Pre-proline 0 N--CA 1.478 0.944 0 N-CA-C 114.825 1.417 . . . . 10.0 114.825 -177.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.07 -43.29 60.73 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.521 2.814 . . . . 10.0 115.32 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.48 -47.5 85.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.803 0.729 . . . . 10.0 111.71 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.0 mt -53.6 -45.27 69.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.39 1.076 . . . . 10.0 112.204 172.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.81 -47.42 82.65 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.111 -0.993 . . . . 10.0 112.769 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.29 78.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.88 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.29 -54.06 36.2 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.258 0.936 . . . . 10.0 111.161 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.1 88.76 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.62 0.768 . . . . 10.0 112.146 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.75 37.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.986 0.914 . . . . 10.0 112.028 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.14 79.14 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.677 0.791 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.61 91.75 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.76 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.045 1.338 . . . . 10.0 112.313 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.844 1.658 . . . . 10.0 112.104 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.85 47.66 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.903 -1.748 . . . . 10.0 112.446 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 135.96 54.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.705 0.632 . . . . 10.0 112.705 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.71 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.856 1.663 . . . . 10.0 113.471 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.27 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.178 1.37 . . . . 10.0 115.262 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.04 -46.83 87.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.323 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.37 -52.95 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.02 1.328 . . . . 10.0 111.124 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.32 67.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.09 -44.92 42.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.49 0.716 . . . . 10.0 110.98 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -59.94 4.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.396 2.279 . . . . 10.0 114.8 174.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.93 -46.38 96.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.69 0.796 . . . . 10.0 111.423 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.29 64.24 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.674 0.654 . . . . 10.0 112.593 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.32 74.83 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.37 -45.72 84.13 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.164 0.986 . . . . 10.0 111.995 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.07 -55.62 5.61 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.332 1.444 . . . . 10.0 112.982 167.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.21 -53.57 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.02 -0.99 . . . . 10.0 110.768 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 57.4 ttp -46.02 -58.1 3.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.504 1.502 . . . . 10.0 112.653 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.1 mm . . . . . 0 N--CA 1.473 0.718 0 O-C-N 121.694 -0.629 . . . . 10.0 112.429 179.474 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 111.539 0.2 . . . . 10.0 111.539 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.27 -59.36 9.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.857 1.694 . . . . 10.0 112.448 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.07 -43.2 3.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.475 2.71 . . . . 10.0 113.272 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -101.26 -6.38 24.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.446 1.647 . . . . 10.0 115.446 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.76 10.48 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.222 -1.549 . . . . 10.0 110.397 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.554 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.217 2.607 . . . . 10.0 113.255 177.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.68 106.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.733 0.813 . . . . 10.0 110.065 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.94 -59.54 3.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.029 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.09 14.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.513 1.525 . . . . 10.0 113.486 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.23 -24.6 63.12 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.872 1.434 . . . . 10.0 114.872 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.95 -41.75 68.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.935 0.789 . . . . 10.0 110.776 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.86 70.22 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.356 1.243 . . . . 10.0 114.356 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.46 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.043 0.838 . . . . 10.0 109.621 168.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -60.51 -45.26 94.47 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.015 1.116 . . . . 10.0 114.015 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -52.23 -48.89 64.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.414 1.006 . . . . 10.0 112.895 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -54.45 45.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.092 0.957 . . . . 10.0 111.645 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.0 mt -53.28 -49.83 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.052 1.341 . . . . 10.0 111.592 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -54.84 -48.09 73.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.866 1.266 . . . . 10.0 111.852 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.7 m -65.19 -40.49 94.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.602 1.561 . . . . 10.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.07 -49.41 77.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.049 0.94 . . . . 10.0 112.286 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.45 79.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.746 0.818 . . . . 10.0 112.441 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.7 ttp -55.37 -54.04 48.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.12 0.968 . . . . 10.0 112.243 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -52.07 -50.38 61.66 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.83 1.652 . . . . 10.0 111.407 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -50.15 -54.71 18.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.14 0.976 . . . . 10.0 112.502 172.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.7 mt -53.49 -55.26 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.775 0.83 . . . . 10.0 110.736 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.32 -35.84 70.38 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.287 -0.863 . . . . 10.0 112.866 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.48 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.03 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.85 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.437 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.84 -49.37 75.63 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.866 1.212 . . . . 10.0 112.153 171.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.92 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.94 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.645 1.178 . . . . 10.0 113.412 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.75 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.676 0.655 . . . . 10.0 113.51 171.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.61 -32.43 51.12 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.23 1.812 . . . . 10.0 113.08 -166.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.9 m -52.04 -56.52 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.025 1.12 . . . . 10.0 114.025 172.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.58 -50.62 65.2 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.115 0.959 . . . . 10.0 112.32 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.08 -46.08 82.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.188 0.995 . . . . 10.0 112.105 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.54 79.8 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.516 1.302 . . . . 10.0 114.516 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.33 1.22 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.101 1.76 . . . . 10.0 114.235 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.07 6.67 29.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.433 1.893 . . . . 10.0 114.89 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.96 -92.68 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.473 1.606 . . . . 10.0 114.115 -170.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.68 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 129.805 3.242 . . . . 10.0 105.541 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.93 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.308 2.005 . . . . 10.0 113.052 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.06 68.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.977 2.911 . . . . 10.0 113.259 173.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.16 -53.05 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 124.014 0.925 . . . . 10.0 109.804 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.81 75.57 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.237 0.615 . . . . 10.0 111.952 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.02 -56.13 25.45 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.894 0.877 . . . . 10.0 112.734 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.1 m -57.3 -53.11 61.83 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.139 0.976 . . . . 10.0 113.02 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.6 -49.51 46.41 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.118 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.1 -48.4 78.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.6 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.774 0.715 . . . . 10.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.52 -51.68 68.84 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.77 30.14 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.822 2.049 . . . . 10.0 111.077 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.14 -47.0 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.015 0.926 . . . . 10.0 112.127 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 34.1 m -58.33 -64.16 1.02 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.276 2.631 . . . . 10.0 111.735 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.33 -50.15 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.68 1.192 . . . . 10.0 110.989 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.19 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.962 0.905 . . . . 10.0 111.915 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.07 -48.33 73.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.24 0.927 . . . . 10.0 112.69 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.76 -50.41 70.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.834 0.854 . . . . 10.0 111.66 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 114.397 1.258 . . . . 10.0 114.397 179.104 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 119.322 -0.37 . . . . 10.0 111.472 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -55.5 -52.63 63.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.408 1.083 . . . . 10.0 112.598 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -58.51 -42.97 88.87 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.686 0.794 . . . . 10.0 112.45 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -83.3 -5.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.915 1.45 . . . . 10.0 114.915 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.3 33.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 122.55 1.083 . . . . 10.0 113.964 -168.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.62 65.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.868 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.78 -15.87 63.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.568 1.692 . . . . 10.0 115.568 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.49 -106.06 1.06 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 120.452 1.478 . . . . 10.0 113.965 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.11 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.34 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.28 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.919 0.328 . . . . 10.0 113.919 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.55 -42.78 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.126 1.77 . . . . 10.0 108.725 166.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.29 133.38 24.9 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.419 -174.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.7 153.77 72.6 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.816 3.011 . . . . 10.0 111.469 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.273 1.029 . . . . 10.0 112.251 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.32 -52.42 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.9 -40.52 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.618 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -49.28 -49.77 42.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.574 0.625 . . . . 10.0 111.991 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.07 83.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.086 1.755 . . . . 10.0 113.002 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.35 -52.36 62.11 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.962 0.905 . . . . 10.0 112.063 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.5 -60.0 3.77 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.364 1.066 . . . . 10.0 109.974 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -52.51 -46.96 66.9 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.004 -1.474 . . . . 10.0 111.934 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -50.77 -53.03 35.16 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.376 1.898 . . . . 10.0 113.119 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.27 -48.55 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.083 1.353 . . . . 10.0 111.499 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.5 mp -57.48 -50.86 71.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.101 1.36 . . . . 10.0 111.577 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -56.96 -59.69 4.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.71 2.404 . . . . 10.0 111.089 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.481 1.116 0 O-C-N 120.563 -1.336 . . . . 10.0 112.379 -179.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.333 0 CA-C-O 120.768 0.093 . . . . 10.0 113.128 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -45.22 -56.21 5.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.448 1.899 . . . . 10.0 111.814 166.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.74 -40.5 71.64 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.327 0.965 . . . . 10.0 113.903 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -70.41 -27.77 64.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 115.843 1.794 . . . . 10.0 115.843 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.587 -0.894 . . . . 10.0 108.587 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.7 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.906 0.882 . . . . 10.0 113.193 -172.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.56 5.25 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.28 0.25 15.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.269 1.028 . . . . 10.0 113.301 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.93 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.078 0.951 . . . . 10.0 111.033 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.63 98.21 1.86 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.758 0.823 . . . . 10.0 110.92 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.96 77.04 7.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.866 0.866 . . . . 10.0 112.07 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.474 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.85 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.7 1.2 . . . . 10.0 110.674 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.31 169.51 40.05 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.534 . . . . 10.0 119.647 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.521 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.597 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.554 3.142 . . . . 10.0 117.276 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.64 . . . . 10.0 114.524 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.393 1.877 . . . . 10.0 113.338 -158.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.302 1.841 . . . . 10.0 114.018 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.07 2.79 41.48 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.43 2.443 . . . . 10.0 111.48 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.6 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.649 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.04 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.559 2.307 . . . . 10.0 113.194 -175.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.23 4.31 0.98 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.842 2.457 . . . . 10.0 115.769 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.11 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.493 -0.754 . . . . 10.0 112.669 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.62 83.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.89 0.876 . . . . 10.0 109.272 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.41 -52.63 62.94 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.393 0.677 . . . . 10.0 111.885 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.34 -53.64 55.81 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.231 0.612 . . . . 10.0 112.18 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.77 51.99 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.413 1.485 . . . . 10.0 113.319 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.66 -44.95 84.74 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.316 1.446 . . . . 10.0 112.998 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.56 -56.28 11.64 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.544 1.069 . . . . 10.0 111.549 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -50.18 -52.3 36.63 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.795 1.238 . . . . 10.0 112.171 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.86 5.8 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.154 0.981 . . . . 10.0 112.143 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.06 -48.9 77.43 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.67 0.788 . . . . 10.0 112.786 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 54.6 mtt -61.27 -44.48 97.17 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.905 0.882 . . . . 10.0 111.363 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.69 13.26 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.326 0.965 . . . . 10.0 113.967 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.22 -45.96 79.7 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.568 1.184 . . . . 10.0 112.131 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.6 -41.96 75.38 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.8 1.19 . . . . 10.0 113.191 173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.9 m -62.46 -58.36 7.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.717 0.807 . . . . 10.0 111.414 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.04 0.936 . . . . 10.0 110.917 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.07 9.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.599 1.16 . . . . 10.0 112.985 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.65 81.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.174 . . . . 10.0 113.585 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.33 40.88 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 123.745 1.736 . . . . 10.0 110.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.79 -44.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.367 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.88 23.09 0.86 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.656 1.023 . . . . 10.0 115.656 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.56 -44.98 93.12 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.178 2.191 . . . . 10.0 113.581 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.58 -84.45 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.787 0.708 . . . . 10.0 112.487 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.01 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.435 2.694 . . . . 10.0 116.933 166.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.64 -50.86 10.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.867 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.52 6.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.765 1.291 . . . . 10.0 110.975 -172.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.64 -29.53 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.702 2.935 . . . . 10.0 113.724 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -60.67 2.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.099 0.56 . . . . 10.0 111.407 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.5 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.097 1.359 . . . . 10.0 113.588 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.46 19.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.26 1.424 . . . . 10.0 113.396 172.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 61.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.459 0.704 . . . . 10.0 110.986 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.91 -50.27 73.05 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.29 65.31 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.321 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.44 -61.93 1.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.52 -57.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.897 1.279 . . . . 10.0 110.562 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 m -67.98 -20.91 65.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.952 1.301 . . . . 10.0 113.488 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.8 m -83.9 -40.68 18.28 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.401 1.08 . . . . 10.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -59.43 -41.87 90.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.393 -0.817 . . . . 10.0 113.182 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.1 t -45.07 -62.74 1.48 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.542 1.137 . . . . 10.0 113.081 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.33 -25.5 30.53 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.842 2.362 . . . . 10.0 113.871 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.41 -46.91 78.14 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.644 1.565 . . . . 10.0 113.188 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.76 -49.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.048 -1.033 . . . . 10.0 109.271 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.11 72.27 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.925 0.89 . . . . 10.0 113.238 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -50.83 -57.21 8.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.812 1.645 . . . . 10.0 111.768 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.49 -53.09 19.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.41 1.484 . . . . 10.0 110.787 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.69 -48.15 64.62 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.008 0.923 . . . . 10.0 113.05 -176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -56.58 -40.73 75.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.185 1.357 . . . . 10.0 113.347 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.58 34.28 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.789 1.177 . . . . 10.0 111.284 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.08 61.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.192 1.553 . . . . 10.0 115.192 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.86 -50.85 61.2 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.458 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.66 -52.63 22.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.873 0.869 . . . . 10.0 112.91 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.54 48.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.328 1.051 . . . . 10.0 113.833 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.69 5.57 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.06 43.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.213 1.561 . . . . 10.0 115.213 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.48 61.33 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.318 0.887 . . . . 10.0 115.318 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.049 2.14 . . . . 10.0 109.034 171.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.53 171.04 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.042 0.937 . . . . 10.0 111.024 166.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.11 53.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.21 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.474 -1.01 . . . . 10.0 109.474 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.7 164.4 38.18 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.38 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.68 -3.42 0.7 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 118.716 2.247 . . . . 10.0 118.716 170.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.57 -171.86 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.327 1.564 . . . . 10.0 112.223 -165.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.501 1.52 . . . . 10.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.18 126.34 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.992 1.717 . . . . 10.0 111.671 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.419 1.581 . . . . 10.0 113.087 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.28 -28.32 66.64 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.485 -1.385 . . . . 10.0 113.937 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.14 62.14 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.231 1.196 . . . . 10.0 114.231 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.426 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -65.12 -24.98 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.221 -1.549 . . . . 10.0 113.861 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -75.01 -42.6 57.07 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.577 -1.327 . . . . 10.0 112.189 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.82 -48.41 59.77 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.203 1.401 . . . . 10.0 111.693 167.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.95 -72.3 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.563 1.945 . . . . 10.0 111.819 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.426 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 49.8 m0 -55.43 -32.02 62.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.738 1.215 . . . . 10.0 112.952 -171.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.7 tp -50.66 -41.57 55.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.104 1.361 . . . . 10.0 111.932 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -103.84 -45.08 4.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.873 0.869 . . . . 10.0 112.626 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.7 p -59.51 -38.9 82.17 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.593 1.088 . . . . 10.0 113.373 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.0 m -66.61 -51.65 39.51 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 117.957 -1.021 . . . . 10.0 113.106 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.56 -40.69 63.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.262 2.641 . . . . 10.0 114.631 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.5 mt -59.37 -48.31 82.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.619 0.767 . . . . 10.0 112.225 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.19 -39.45 86.55 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.584 1.084 . . . . 10.0 112.25 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.12 -49.05 74.99 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.081 -1.012 . . . . 10.0 111.348 167.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.29 78.27 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.852 0.861 . . . . 10.0 112.846 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.22 -54.1 35.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.301 0.955 . . . . 10.0 111.201 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.68 38.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.031 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.21 79.37 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.779 0.832 . . . . 10.0 112.669 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.81 -38.46 91.18 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.41 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.025 1.33 . . . . 10.0 112.298 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.873 1.669 . . . . 10.0 112.13 -173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.31 145.88 47.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.929 -1.732 . . . . 10.0 112.455 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.87 54.25 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.72 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.423 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.18 5.33 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.178 1.37 . . . . 10.0 115.276 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.8 p -62.13 -46.72 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.051 -1.452 . . . . 10.0 111.285 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.48 -52.89 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.036 1.334 . . . . 10.0 111.11 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.6 -51.32 67.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.87 42.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.496 0.718 . . . . 10.0 110.932 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -59.85 4.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.354 2.262 . . . . 10.0 114.784 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.62 -46.64 73.9 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.573 0.749 . . . . 10.0 113.021 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -59.4 -43.7 92.95 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.847 0.859 . . . . 10.0 112.066 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -57.09 4.58 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.801 1.667 . . . . 10.0 113.123 165.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.1 mt -56.63 -49.81 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.94 0.896 . . . . 10.0 111.177 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -53.38 -58.62 6.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.427 1.012 . . . . 10.0 112.394 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.474 0.736 0 CA-C-N 118.417 0.553 . . . . 10.0 111.223 177.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 111.627 0.232 . . . . 10.0 111.627 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.02 -59.68 9.1 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.054 1.787 . . . . 10.0 112.541 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.09 3.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.181 2.592 . . . . 10.0 113.298 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.9 mt -100.83 -6.9 24.17 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.477 1.658 . . . . 10.0 115.477 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.182 -1.574 . . . . 10.0 110.409 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.52 -49.61 72.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.26 2.624 . . . . 10.0 113.239 177.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.58 106.29 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.783 0.833 . . . . 10.0 110.088 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.065 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.06 15.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.458 1.503 . . . . 10.0 113.49 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.65 63.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.884 1.439 . . . . 10.0 114.884 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.05 -41.38 68.04 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.902 0.774 . . . . 10.0 110.891 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -70.13 -31.26 68.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.837 1.255 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.49 -52.25 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.057 0.844 . . . . 10.0 109.629 168.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.26 -46.14 90.85 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.462 0.912 . . . . 10.0 113.462 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -50.95 -48.53 60.9 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.763 1.165 . . . . 10.0 113.213 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.87 -53.94 52.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.78 0.832 . . . . 10.0 111.79 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.72 -53.31 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.091 1.356 . . . . 10.0 111.859 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.6 p -58.67 -44.17 90.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.809 0.844 . . . . 10.0 112.697 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.66 -43.3 97.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.346 1.058 . . . . 10.0 112.346 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.1 78.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.295 0.952 . . . . 10.0 112.449 171.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.49 80.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.864 0.865 . . . . 10.0 112.524 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 35.8 ttp -55.74 -53.46 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.388 1.075 . . . . 10.0 112.024 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.74 -47.96 73.18 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.432 1.493 . . . . 10.0 112.446 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.6 -54.14 19.97 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 10.0 112.062 170.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.07 -54.86 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.593 0.757 . . . . 10.0 110.897 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.48 -36.45 69.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.441 -0.79 . . . . 10.0 113.116 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.35 -58.1 9.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.984 0.913 . . . . 10.0 113.077 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.93 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.344 -0.836 . . . . 10.0 111.461 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.77 -49.41 75.39 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.858 1.208 . . . . 10.0 112.163 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.908 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.9 60.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.624 1.169 . . . . 10.0 113.494 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.86 -79.03 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.601 0.619 . . . . 10.0 113.519 171.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.46 51.49 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.268 1.827 . . . . 10.0 113.067 -166.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.06 -56.45 14.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.022 1.119 . . . . 10.0 114.022 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.72 -50.5 65.79 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.06 0.934 . . . . 10.0 112.302 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.18 -45.98 83.23 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.197 0.999 . . . . 10.0 112.114 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.43 80.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.28 1.23 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.091 1.756 . . . . 10.0 114.194 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.11 6.66 29.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.374 1.87 . . . . 10.0 114.846 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.91 -92.64 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.522 1.63 . . . . 10.0 114.193 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.71 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 129.794 3.238 . . . . 10.0 105.571 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.19 35.55 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.263 1.976 . . . . 10.0 113.032 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.9 -46.13 67.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.04 2.936 . . . . 10.0 113.284 173.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.21 -52.95 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.17 -46.85 75.79 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.251 0.62 . . . . 10.0 111.9 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.19 24.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.9 m -57.19 -53.24 60.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 112.995 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.54 -49.56 45.62 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.292 0.637 . . . . 10.0 111.097 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.57 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.832 0.742 . . . . 10.0 110.54 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.56 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.87 30.11 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.839 2.056 . . . . 10.0 111.038 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.46 -58.35 8.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.769 0.428 . . . . 10.0 111.269 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.8 -48.73 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.116 0.967 . . . . 10.0 111.546 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.9 m -57.05 -63.99 1.03 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.056 2.542 . . . . 10.0 111.863 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.64 -49.15 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.847 1.259 . . . . 10.0 111.235 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.65 -62.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.89 0.876 . . . . 10.0 112.494 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.23 -45.26 84.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.748 0.704 . . . . 10.0 111.976 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -51.78 -53.08 43.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.929 0.892 . . . . 10.0 112.383 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 124.341 1.057 . . . . 10.0 113.65 -179.741 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 118.831 -0.605 . . . . 10.0 112.621 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -59.79 -54.9 40.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.529 1.132 . . . . 10.0 112.184 167.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.3 tp -52.9 -43.82 66.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.882 1.273 . . . . 10.0 112.254 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.75 -4.9 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 115.453 1.649 . . . . 10.0 115.453 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.45 -169.28 32.91 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.521 1.067 . . . . 10.0 113.898 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.23 -41.67 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.838 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.9 -14.16 62.87 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.364 1.616 . . . . 10.0 115.364 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.14 -106.14 1.02 Allowed Glycine 0 CA--C 1.535 1.284 0 CA-C-N 120.523 1.51 . . . . 10.0 114.218 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.08 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.666 -1.49 . . . . 10.0 109.314 168.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.38 65.31 1.34 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.7 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.36 24.89 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.66 153.8 72.64 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.814 3.009 . . . . 10.0 111.456 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.22 -39.77 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.193 171.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.36 21.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.98 -40.45 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.429 1.092 . . . . 10.0 109.617 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.35 -49.76 42.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.603 0.638 . . . . 10.0 111.952 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.7 -47.06 83.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.004 1.721 . . . . 10.0 112.979 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.32 -52.32 62.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.957 0.903 . . . . 10.0 112.1 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.53 -58.93 5.2 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.362 1.065 . . . . 10.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.99 -47.21 65.0 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.641 -1.171 . . . . 10.0 112.359 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.52 -52.11 56.3 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.57 1.532 . . . . 10.0 112.846 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.91 -47.97 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.51 1.124 . . . . 10.0 111.189 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.9 mp -57.94 -51.33 70.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.74 1.616 . . . . 10.0 112.159 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -54.46 -56.01 23.05 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.292 2.237 . . . . 10.0 111.309 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.476 0.869 0 O-C-N 121.582 -0.699 . . . . 10.0 111.233 175.59 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.281 0 N-CA-C 112.602 -0.199 . . . . 10.0 112.602 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.7 -56.88 2.49 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.816 2.046 . . . . 10.0 112.554 166.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.48 -41.41 88.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.785 1.184 . . . . 10.0 114.256 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -69.31 -27.23 65.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 115.609 1.707 . . . . 10.0 115.609 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.2 -57.58 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 165.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.67 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.92 0.888 . . . . 10.0 113.167 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.54 5.21 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.324 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.09 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.028 0.931 . . . . 10.0 111.014 174.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.56 98.21 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.781 0.832 . . . . 10.0 110.949 170.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.95 76.99 7.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.908 0.883 . . . . 10.0 112.093 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.07 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 128.888 2.875 . . . . 10.0 116.499 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.87 -55.47 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.641 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.48 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.676 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.495 0 C-N-CA 128.527 2.731 . . . . 10.0 113.461 166.594 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.808 -2.044 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.657 3.183 . . . . 10.0 117.239 160.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.0 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.297 2.639 . . . . 10.0 114.49 155.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.427 1.891 . . . . 10.0 113.339 -158.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.8 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 114.015 -174.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.83 40.9 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.675 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.02 -60.65 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.502 2.286 . . . . 10.0 113.202 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.11 4.28 0.94 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.787 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.509 -0.744 . . . . 10.0 112.625 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.898 0.879 . . . . 10.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.42 -52.64 62.91 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.455 0.702 . . . . 10.0 111.84 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.39 -53.58 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.205 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.77 52.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.332 1.453 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.66 -44.98 84.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.354 1.462 . . . . 10.0 112.997 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.66 -56.86 10.43 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.32 0.962 . . . . 10.0 111.3 165.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.47 -52.29 30.12 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.615 1.166 . . . . 10.0 112.199 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.92 5.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.159 0.984 . . . . 10.0 112.139 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -57.68 -50.31 73.6 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.599 0.76 . . . . 10.0 112.604 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -49.99 68.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.252 1.021 . . . . 10.0 111.071 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.92 -58.18 15.95 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.407 1.003 . . . . 10.0 113.673 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.19 -45.69 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.511 1.155 . . . . 10.0 112.086 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.7 -42.08 76.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.88 1.229 . . . . 10.0 113.302 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -60.51 -60.36 3.93 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.046 0.938 . . . . 10.0 111.071 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.97 62.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.0 9.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 113.004 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.71 -38.61 82.09 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.1 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.66 1.184 . . . . 10.0 113.628 169.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.759 1.742 . . . . 10.0 110.852 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.88 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.869 2.468 . . . . 10.0 109.286 171.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.12 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.594 0.998 . . . . 10.0 115.594 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.0 92.89 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.163 2.185 . . . . 10.0 113.605 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.43 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.742 0.687 . . . . 10.0 112.407 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.962 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.84 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.904 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.811 1.32 . . . . 10.0 110.972 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.54 -29.67 89.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.719 2.946 . . . . 10.0 113.716 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.23 -60.75 2.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.133 0.573 . . . . 10.0 111.441 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.07 -40.08 22.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.126 1.37 . . . . 10.0 113.58 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.59 -47.39 19.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.444 172.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.06 62.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.48 0.712 . . . . 10.0 110.955 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.97 -50.24 73.26 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.137 0.575 . . . . 10.0 112.313 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.22 65.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.868 -0.586 . . . . 10.0 112.362 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.77 -57.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.867 1.267 . . . . 10.0 110.329 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -69.27 -16.25 63.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.14 1.376 . . . . 10.0 113.69 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.1 m -87.87 -42.99 12.14 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.779 1.172 . . . . 10.0 111.96 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -56.56 -41.6 77.17 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 173.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -49.46 -61.61 3.31 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.804 1.242 . . . . 10.0 112.595 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.64 -47.62 20.14 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.593 3.529 . . . . 10.0 116.115 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.1 93.62 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.938 1.245 . . . . 10.0 113.966 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.9 mt -58.57 -51.76 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.398 1.079 . . . . 10.0 109.525 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -43.04 71.76 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 10.0 113.246 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -52.69 -57.95 8.42 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.131 1.332 . . . . 10.0 111.912 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -48.33 -52.89 19.48 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.57 1.548 . . . . 10.0 110.967 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.89 -48.12 64.16 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.916 0.886 . . . . 10.0 113.029 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -55.85 -41.44 74.31 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.27 1.395 . . . . 10.0 113.225 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.54 34.8 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.719 1.145 . . . . 10.0 111.292 170.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.23 1.567 . . . . 10.0 115.23 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.88 -50.82 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.519 0.728 . . . . 10.0 110.528 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.57 -52.69 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.835 0.854 . . . . 10.0 112.922 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.96 -5.53 48.97 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.65 5.6 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.527 0.971 . . . . 10.0 115.527 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.1 42.74 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.63 61.1 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.351 0.9 . . . . 10.0 115.351 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.35 26.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.034 2.133 . . . . 10.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.052 166.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.717 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.6 129.58 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.76 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.72 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.664 2.226 . . . . 10.0 118.664 170.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.343 1.571 . . . . 10.0 112.237 -165.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.85 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.096 -175.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.09 126.33 22.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.028 1.731 . . . . 10.0 111.682 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.61 85.06 4.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.384 1.564 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.42 -28.26 66.77 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.523 -1.361 . . . . 10.0 113.926 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.38 62.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -64.89 -24.45 67.54 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.232 -1.543 . . . . 10.0 113.876 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -75.87 -42.93 47.9 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.462 -1.399 . . . . 10.0 112.257 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.88 53.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.064 1.346 . . . . 10.0 111.368 168.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -52.41 -71.09 0.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.715 2.006 . . . . 10.0 111.836 168.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -56.17 -32.74 64.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.644 1.178 . . . . 10.0 113.153 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.88 -39.74 54.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.389 1.475 . . . . 10.0 112.084 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.72 -41.41 5.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.549 0.739 . . . . 10.0 112.95 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 p -59.31 -41.1 88.24 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 120.792 1.633 . . . . 10.0 113.347 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -68.47 -47.5 35.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.99 -41.47 74.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.574 2.849 . . . . 10.0 114.872 168.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -47.66 85.08 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.586 0.755 . . . . 10.0 111.728 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.7 tt -50.47 -49.61 54.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 10.0 111.548 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.18 -47.83 77.53 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.129 -0.982 . . . . 10.0 112.848 170.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.26 78.42 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.829 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.27 -54.03 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.343 0.974 . . . . 10.0 111.165 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -42.09 88.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.641 0.776 . . . . 10.0 112.093 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.81 36.63 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.996 0.918 . . . . 10.0 112.021 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.1 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.875 1.67 . . . . 10.0 112.106 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.938 -1.726 . . . . 10.0 112.437 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.55 135.96 54.46 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.9 -39.66 2.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.474 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.18 5.36 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.15 1.357 . . . . 10.0 115.266 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -46.75 87.76 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.123 -1.418 . . . . 10.0 111.351 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.038 1.335 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.58 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.534 0.568 . . . . 10.0 112.534 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.86 43.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.716 . . . . 10.0 110.911 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.64 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.382 2.273 . . . . 10.0 114.814 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.04 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.647 0.779 . . . . 10.0 111.403 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.67 -46.76 74.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.24 0.83 . . . . 10.0 113.24 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.64 -44.11 89.94 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 10.0 112.217 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.87 -56.23 5.2 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.33 1.443 . . . . 10.0 113.072 166.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 90.0 mt -56.81 -51.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.674 0.789 . . . . 10.0 111.55 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -52.1 -57.61 9.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.268 1.027 . . . . 10.0 112.185 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 122.776 0.43 . . . . 10.0 111.81 177.621 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 110.328 -0.249 . . . . 10.0 110.328 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.39 -60.9 6.34 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.099 1.809 . . . . 10.0 112.704 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -44.22 -41.12 5.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.245 2.218 . . . . 10.0 113.585 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.26 -6.7 25.58 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.444 1.646 . . . . 10.0 115.444 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.74 116.75 10.49 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.375 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.58 72.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.66 106.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.043 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.62 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -53.99 -41.66 68.15 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.89 0.768 . . . . 10.0 110.807 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.78 -31.59 69.6 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.318 1.229 . . . . 10.0 114.318 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.22 -51.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.976 0.807 . . . . 10.0 109.636 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -61.92 -42.8 99.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.423 1.268 . . . . 10.0 114.423 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.65 -48.85 69.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.237 1.015 . . . . 10.0 112.758 171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.24 70.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.534 0.734 . . . . 10.0 111.614 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.16 -55.03 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.079 1.352 . . . . 10.0 111.974 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.1 p -57.2 -40.83 78.21 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.432 -0.792 . . . . 10.0 112.706 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.4 m -61.92 -44.84 95.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.756 1.223 . . . . 10.0 112.326 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.6 80.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.314 0.961 . . . . 10.0 112.251 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.95 85.51 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.503 -0.748 . . . . 10.0 112.816 173.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.272 1.029 . . . . 10.0 112.26 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.88 -45.81 78.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.831 1.652 . . . . 10.0 112.231 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -54.81 -53.93 48.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 171.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 44.1 mt -54.21 -54.75 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.716 0.689 . . . . 10.0 110.856 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.27 1.0 OUTLIER -60.02 -32.71 71.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 117.467 -1.254 . . . . 10.0 112.904 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.25 -58.13 9.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.987 1.267 . . . . 10.0 113.071 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -40.89 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.312 -0.851 . . . . 10.0 111.446 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.78 -49.41 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.847 1.203 . . . . 10.0 112.145 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.05 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.046 -1.659 . . . . 10.0 112.833 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -73.79 -21.9 60.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.626 1.17 . . . . 10.0 113.398 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.588 0.614 . . . . 10.0 113.488 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.63 -32.45 51.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.62 -50.58 65.39 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.067 0.937 . . . . 10.0 112.286 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.17 -45.98 83.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.105 0.962 . . . . 10.0 112.15 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.46 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.506 1.299 . . . . 10.0 114.506 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.46 -11.34 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.078 1.751 . . . . 10.0 114.238 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.57 29.14 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.85 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.456 1.598 . . . . 10.0 114.171 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.77 153.88 72.49 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.834 3.254 . . . . 10.0 105.57 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.8 -46.21 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.329 2.019 . . . . 10.0 113.083 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.03 68.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.985 2.914 . . . . 10.0 113.27 173.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.19 -53.03 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.78 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.26 23.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.12 -53.23 60.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.164 0.986 . . . . 10.0 113.028 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.54 46.07 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.337 0.655 . . . . 10.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.06 -48.46 78.5 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.02 -49.61 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.767 0.712 . . . . 10.0 110.487 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.48 -51.69 68.77 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.74 30.88 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.818 2.047 . . . . 10.0 111.065 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.81 0.444 . . . . 10.0 111.269 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.99 -47.42 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.046 0.938 . . . . 10.0 112.238 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.9 m -58.19 -64.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.953 2.501 . . . . 10.0 111.482 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.27 -48.64 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.845 1.258 . . . . 10.0 111.373 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.27 -61.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.863 0.865 . . . . 10.0 112.606 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.19 -47.06 79.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.754 0.706 . . . . 10.0 111.934 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -50.11 -54.29 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.645 1.178 . . . . 10.0 112.149 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 m . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 124.509 1.123 . . . . 10.0 113.588 179.731 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.4 -56.63 19.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.544 1.138 . . . . 10.0 112.404 167.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.4 tt -57.59 -40.46 79.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.755 0.822 . . . . 10.0 112.355 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.18 -5.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 115.2 1.555 . . . . 10.0 115.2 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.35 32.95 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.573 1.096 . . . . 10.0 113.895 -168.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.93 65.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.176 -1.012 . . . . 10.0 111.88 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.88 -13.45 62.43 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.75 -106.13 0.98 Allowed Glycine 0 CA--C 1.535 1.311 0 CA-C-N 120.606 1.548 . . . . 10.0 114.45 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.12 35.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.595 -1.533 . . . . 10.0 109.368 168.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.904 0.321 . . . . 10.0 113.904 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.64 -42.7 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.687 166.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.34 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.382 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.69 153.79 72.59 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.774 2.983 . . . . 10.0 111.476 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.8 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.38 1.072 . . . . 10.0 112.169 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -52.34 22.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.49 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.695 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.35 -49.78 42.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.515 0.598 . . . . 10.0 111.925 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.38 -52.26 62.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.923 0.889 . . . . 10.0 112.124 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.6 -58.82 5.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.319 1.048 . . . . 10.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -52.55 -46.14 66.68 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 117.629 -1.176 . . . . 10.0 112.506 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.01 -51.89 60.21 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.55 1.523 . . . . 10.0 112.789 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.68 -47.0 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.81 1.244 . . . . 10.0 111.598 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.73 -50.04 75.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 10.0 111.795 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -57.15 -57.4 12.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.879 2.072 . . . . 10.0 111.508 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.479 0.985 0 O-C-N 120.887 -1.133 . . . . 10.0 111.917 178.92 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 CA-C-O 121.129 0.294 . . . . 10.0 112.904 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -43.09 -56.91 3.14 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.999 2.12 . . . . 10.0 112.266 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.7 -40.43 71.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.303 0.954 . . . . 10.0 114.186 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -69.75 -27.32 64.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 115.882 1.808 . . . . 10.0 115.882 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -57.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.593 -0.892 . . . . 10.0 108.593 165.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.76 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.898 . . . . 10.0 113.193 -172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.17 2.53 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.23 0.3 15.74 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.22 1.008 . . . . 10.0 113.344 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.046 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.61 98.12 1.83 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.826 0.85 . . . . 10.0 110.941 170.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.88 77.04 7.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.824 0.85 . . . . 10.0 112.067 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.838 2.855 . . . . 10.0 116.491 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.738 1.215 . . . . 10.0 110.656 -175.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.44 39.92 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.757 3.551 . . . . 10.0 119.665 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.487 2.715 . . . . 10.0 113.44 166.597 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.75 -2.072 . . . . 10.0 105.863 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.62 65.01 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.252 2.621 . . . . 10.0 114.537 155.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.97 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.344 1.857 . . . . 10.0 113.339 -158.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.77 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.08 2.8 41.62 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.489 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.653 -168.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.92 -60.7 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.522 2.293 . . . . 10.0 113.196 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -67.19 4.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.726 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.29 -43.14 61.56 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.515 -0.741 . . . . 10.0 112.619 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.59 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.331 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.43 -52.63 62.96 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.455 0.702 . . . . 10.0 111.882 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.341 1.456 . . . . 10.0 113.315 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.12 -55.44 15.52 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.501 1.048 . . . . 10.0 111.801 166.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -50.26 -52.48 35.85 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.834 1.253 . . . . 10.0 112.284 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.87 5.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.16 0.984 . . . . 10.0 112.167 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.1 -48.86 77.57 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.615 0.766 . . . . 10.0 112.858 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -61.59 -43.94 97.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.649 0.78 . . . . 10.0 111.531 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.59 -58.75 12.93 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.145 0.879 . . . . 10.0 113.785 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -45.99 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.605 1.202 . . . . 10.0 112.119 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.08 -42.88 72.68 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.028 1.299 . . . . 10.0 113.132 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -62.1 -58.23 8.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.285 -0.864 . . . . 10.0 111.489 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.33 -40.99 62.62 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.041 0.936 . . . . 10.0 110.937 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.02 9.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.636 1.175 . . . . 10.0 112.968 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.71 82.15 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.45 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.632 1.173 . . . . 10.0 113.633 169.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.743 1.735 . . . . 10.0 110.88 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.9 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.839 2.455 . . . . 10.0 109.358 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.94 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.02 93.01 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.196 2.198 . . . . 10.0 113.546 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.39 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.437 2.695 . . . . 10.0 116.948 166.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.8 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.18 -1.373 . . . . 10.0 113.868 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.51 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.769 1.293 . . . . 10.0 110.981 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.55 -29.67 89.57 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.706 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.28 -60.69 2.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.111 0.565 . . . . 10.0 111.437 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.1 22.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.1 1.36 . . . . 10.0 113.549 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.44 19.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.199 1.4 . . . . 10.0 113.446 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.71 -53.07 62.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.48 0.712 . . . . 10.0 110.967 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -57.0 -50.22 73.37 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.297 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.2 65.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.34 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.99 1.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.8 mt -48.53 -57.93 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.865 1.266 . . . . 10.0 110.332 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -67.92 -19.03 64.95 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.105 1.362 . . . . 10.0 113.703 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -86.0 -40.87 15.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.45 1.1 . . . . 10.0 112.22 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.8 mt -59.17 -42.61 91.21 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.915 0.78 . . . . 10.0 112.921 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.9 t -44.03 -61.19 2.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.67 1.588 . . . . 10.0 113.154 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -70.74 -25.42 24.09 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.895 2.396 . . . . 10.0 114.041 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.11 -50.13 67.26 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 120.732 1.605 . . . . 10.0 113.795 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.28 -39.05 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 120.329 -1.482 . . . . 10.0 110.735 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.26 81.18 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 118.54 -0.743 . . . . 10.0 112.96 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -50.58 -55.71 15.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.581 1.553 . . . . 10.0 111.755 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.08 -53.19 21.58 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.363 1.465 . . . . 10.0 110.867 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.35 -48.19 65.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.102 0.961 . . . . 10.0 113.011 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.4 -41.1 75.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.241 1.382 . . . . 10.0 113.222 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.53 35.06 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.656 1.116 . . . . 10.0 111.313 170.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.15 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.9 mtm -66.78 -50.88 61.25 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.565 0.746 . . . . 10.0 110.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.54 -52.71 21.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 10.0 112.925 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.58 49.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.27 -34.66 5.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 115.542 0.977 . . . . 10.0 115.542 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.12 43.3 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.56 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.081 2.153 . . . . 10.0 109.056 171.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.062 166.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.883 0.873 . . . . 10.0 109.723 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.3 t -129.61 129.6 23.17 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.037 1.335 . . . . 10.0 110.927 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.78 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -81.96 0.15 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.697 -0.961 . . . . 10.0 110.697 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.91 4.07 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.317 1.558 . . . . 10.0 112.27 -165.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.47 1.508 . . . . 10.0 111.107 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.46 120.76 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.52 131.92 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.198 3.265 . . . . 10.0 112.137 171.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.03 1.732 . . . . 10.0 111.69 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.04 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.865 1.317 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.4 -28.28 66.77 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.77 -26.47 46.07 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.296 1.038 . . . . 10.0 111.165 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -44.08 -63.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.374 1.47 . . . . 10.0 110.146 165.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -63.62 -39.73 95.1 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.223 2.209 . . . . 10.0 111.119 -172.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.26 -49.03 67.76 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.733 0.813 . . . . 10.0 112.024 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -63.67 1.21 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.96 1.304 . . . . 10.0 111.64 170.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -53.7 -36.95 62.75 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.805 1.642 . . . . 10.0 112.72 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.69 -42.17 56.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.036 1.734 . . . . 10.0 112.226 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -103.68 -35.29 8.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.932 0.716 . . . . 10.0 112.932 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.5 p -62.17 -49.04 77.42 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 121.387 1.903 . . . . 10.0 113.483 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.284 69.9 p -63.54 -41.73 68.4 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 114.722 1.379 . . . . 10.0 114.722 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.8 -43.24 51.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.481 2.787 . . . . 10.0 115.265 168.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 mt -60.62 -46.9 88.53 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.491 -0.756 . . . . 10.0 111.515 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.68 -49.83 56.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.646 1.578 . . . . 10.0 111.359 171.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.65 -47.46 79.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.247 1.019 . . . . 10.0 113.046 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.854 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.31 -54.01 36.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.173 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.11 88.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.69 0.796 . . . . 10.0 112.068 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.69 -54.75 37.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 111.974 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.725 0.81 . . . . 10.0 112.704 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.82 -38.56 91.57 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.78 1.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.062 1.345 . . . . 10.0 112.337 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.49 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.88 47.66 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.454 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.84 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.714 0.635 . . . . 10.0 112.714 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.8 -39.68 2.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.24 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.131 1.348 . . . . 10.0 115.235 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.06 -46.77 87.69 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.13 -1.414 . . . . 10.0 111.312 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.5 -52.91 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.029 1.332 . . . . 10.0 111.101 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.27 67.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.23 -44.85 43.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.424 0.69 . . . . 10.0 110.924 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.55 -59.88 4.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.419 2.288 . . . . 10.0 114.815 174.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.08 -46.29 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.667 0.787 . . . . 10.0 111.385 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.67 74.42 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 173.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.0 -45.99 82.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.851 0.86 . . . . 10.0 111.994 174.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -55.38 5.49 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.362 1.458 . . . . 10.0 113.142 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.73 -50.15 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.902 0.881 . . . . 10.0 111.74 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -50.99 -57.13 9.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.589 1.556 . . . . 10.0 111.873 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 123.121 0.568 . . . . 10.0 112.488 174.795 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 111.764 0.283 . . . . 10.0 111.764 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.55 -58.99 9.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.085 1.803 . . . . 10.0 112.338 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.49 -43.48 2.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.251 2.62 . . . . 10.0 113.294 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.3 mt -101.2 -6.4 24.3 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.423 1.638 . . . . 10.0 115.423 -174.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.67 116.73 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.165 -1.584 . . . . 10.0 110.419 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.59 72.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.217 2.607 . . . . 10.0 113.269 177.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.61 106.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.09 15.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 10.0 113.468 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.66 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -53.84 -41.91 67.92 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.902 0.774 . . . . 10.0 110.806 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.21 -32.57 71.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.817 1.247 . . . . 10.0 114.198 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.91 -52.12 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.022 0.828 . . . . 10.0 109.991 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -59.45 -51.76 68.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.491 0.922 . . . . 10.0 113.491 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.38 -46.59 37.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.428 1.091 . . . . 10.0 113.427 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.38 -52.55 65.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.945 0.898 . . . . 10.0 111.659 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.4 mt -54.07 -50.98 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.126 1.37 . . . . 10.0 111.49 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 m -53.84 -49.19 68.96 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.479 1.112 . . . . 10.0 112.108 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 76.5 m -61.34 -43.34 99.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.992 1.317 . . . . 10.0 111.618 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.45 -50.16 73.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.14 0.976 . . . . 10.0 112.477 170.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.87 82.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.736 0.814 . . . . 10.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.1 ttp -57.94 -53.13 61.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.496 1.118 . . . . 10.0 111.953 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -51.92 -50.01 61.95 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.772 1.629 . . . . 10.0 111.398 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -49.51 -54.89 15.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.06 0.944 . . . . 10.0 112.436 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -53.4 -55.29 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.829 0.852 . . . . 10.0 110.729 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.5 mt -57.49 -35.65 70.48 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.283 -0.865 . . . . 10.0 112.91 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.18 9.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.89 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.5 mt -56.77 -49.45 75.27 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.845 1.202 . . . . 10.0 112.099 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.877 -175.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.65 -21.99 60.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.635 1.174 . . . . 10.0 113.446 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.625 0.631 . . . . 10.0 113.527 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.55 -32.52 51.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.322 1.849 . . . . 10.0 113.019 -166.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.11 -56.4 14.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.56 65.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.121 0.962 . . . . 10.0 112.331 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.07 82.87 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.188 0.995 . . . . 10.0 112.134 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.77 -47.52 79.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.249 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.01 6.58 29.19 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.433 1.893 . . . . 10.0 114.907 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.65 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.535 1.636 . . . . 10.0 114.139 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.73 153.98 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.81 3.244 . . . . 10.0 105.572 170.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.85 -46.21 35.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.301 2.001 . . . . 10.0 113.052 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.96 -46.08 68.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.27 173.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.22 -53.05 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 C-N-CA 124.055 0.942 . . . . 10.0 109.788 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.86 75.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.275 0.63 . . . . 10.0 111.917 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.98 -56.13 25.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.88 0.872 . . . . 10.0 112.761 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.028 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.58 -49.52 46.19 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.337 0.655 . . . . 10.0 111.052 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.17 -48.4 78.82 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.636 1.347 . . . . 10.0 114.636 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.801 0.728 . . . . 10.0 110.506 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.164 0.801 . . . . 10.0 113.164 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.8 30.26 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.1 t -51.9 -49.1 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.044 0.937 . . . . 10.0 111.472 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.4 m -56.01 -63.95 1.01 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.62 2.768 . . . . 10.0 111.921 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.31 -49.51 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.488 1.115 . . . . 10.0 111.313 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.7 -62.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.172 0.989 . . . . 10.0 112.063 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.51 -47.17 85.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.974 0.806 . . . . 10.0 112.612 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -55.01 -50.31 69.35 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.683 0.793 . . . . 10.0 111.752 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.902 1.075 . . . . 10.0 113.902 179.256 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 119.43 -0.319 . . . . 10.0 111.596 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -56.39 -51.01 69.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.46 1.104 . . . . 10.0 112.53 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.2 tp -54.44 -45.53 73.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.59 1.156 . . . . 10.0 112.22 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -86.54 -5.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.15 1.537 . . . . 10.0 115.15 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.54 -169.29 32.79 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 122.602 1.112 . . . . 10.0 113.806 -168.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.75 65.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.868 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -67.29 -16.13 64.1 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.487 1.662 . . . . 10.0 115.487 -175.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.77 -105.99 1.04 Allowed Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.494 1.497 . . . . 10.0 114.104 -173.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.11 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.35 168.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 CA-C-N 117.878 0.308 . . . . 10.0 113.862 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.59 -42.73 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.73 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.416 1.886 . . . . 10.0 109.366 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.79 153.79 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.19 -39.78 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.18 171.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.38 21.9 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.682 1.364 . . . . 10.0 114.682 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.27 -49.83 41.77 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.603 0.638 . . . . 10.0 111.991 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.66 -47.06 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.999 1.72 . . . . 10.0 113.026 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.32 -52.29 62.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.974 0.91 . . . . 10.0 112.093 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.61 -59.0 4.99 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 109.975 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.83 -44.65 66.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.793 -1.098 . . . . 10.0 112.657 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -54.16 -52.64 60.51 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.579 1.536 . . . . 10.0 112.689 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.2 t -60.86 -46.26 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.69 1.196 . . . . 10.0 111.353 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -59.15 -52.44 65.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.364 1.466 . . . . 10.0 112.122 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -55.46 -54.64 41.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.507 1.923 . . . . 10.0 111.062 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.478 0.945 0 O-C-N 121.071 -1.018 . . . . 10.0 111.635 174.07 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.267 0 CA-C-O 121.036 0.242 . . . . 10.0 112.758 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -43.47 -57.08 3.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.79 2.036 . . . . 10.0 112.488 166.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.98 -41.26 76.54 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.326 0.965 . . . . 10.0 113.993 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.79 -26.99 64.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.911 1.819 . . . . 10.0 115.911 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.5 -57.47 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.88 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.908 0.883 . . . . 10.0 113.187 -172.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.15 2.56 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.197 0.999 . . . . 10.0 113.296 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.05 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.983 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.13 1.82 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.771 0.828 . . . . 10.0 110.961 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.88 76.97 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.857 0.863 . . . . 10.0 112.094 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.862 2.865 . . . . 10.0 116.505 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.79 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.731 1.212 . . . . 10.0 110.698 -175.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.49 39.98 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.591 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.789 -2.053 . . . . 10.0 105.817 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.638 3.175 . . . . 10.0 117.211 160.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.69 65.0 0.11 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.306 2.642 . . . . 10.0 114.49 155.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.84 41.28 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.483 2.468 . . . . 10.0 111.523 168.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.667 -168.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -64.0 -60.6 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.519 2.292 . . . . 10.0 113.212 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.19 4.33 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.847 2.459 . . . . 10.0 115.787 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.46 -0.775 . . . . 10.0 112.619 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.57 84.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.859 0.863 . . . . 10.0 109.315 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.37 -52.66 62.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.426 0.69 . . . . 10.0 111.898 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.34 -53.64 55.84 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.221 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.81 51.95 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.366 1.466 . . . . 10.0 113.307 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.63 -45.0 84.75 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 10.0 113.026 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.41 -56.69 10.41 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.526 1.06 . . . . 10.0 111.465 166.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -49.7 -52.48 30.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.836 1.255 . . . . 10.0 112.19 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 -58.9 5.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.174 0.99 . . . . 10.0 112.207 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.31 -48.46 78.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.577 0.751 . . . . 10.0 112.825 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.0 mtt -58.89 -47.46 84.88 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.223 1.009 . . . . 10.0 111.523 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.85 -58.76 12.88 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.267 0.937 . . . . 10.0 113.66 174.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.18 -46.06 79.52 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.728 1.264 . . . . 10.0 112.1 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.33 75.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.76 1.172 . . . . 10.0 113.244 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -61.93 -58.49 7.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.742 0.817 . . . . 10.0 111.419 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.97 62.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.8 -58.07 9.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.986 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.63 81.86 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.236 0.828 . . . . 10.0 113.236 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.46 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.654 1.182 . . . . 10.0 113.581 169.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.44 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.781 1.753 . . . . 10.0 110.846 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.83 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.906 2.483 . . . . 10.0 109.366 171.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.98 93.05 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.143 2.177 . . . . 10.0 113.584 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.37 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.387 2.675 . . . . 10.0 116.975 166.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.65 -50.87 10.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.891 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.94 117.59 6.51 Favored Pre-proline 0 CA--C 1.536 0.432 0 O-C-N 124.741 1.275 . . . . 10.0 110.916 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.67 -29.6 89.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.695 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.04 22.82 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.114 1.366 . . . . 10.0 113.551 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.6 -47.44 19.94 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.242 1.417 . . . . 10.0 113.384 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.08 62.22 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.535 0.734 . . . . 10.0 110.935 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -57.02 -50.21 73.43 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.115 0.566 . . . . 10.0 112.348 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.26 65.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.903 -0.57 . . . . 10.0 112.378 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.01 1.91 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.412 0.893 . . . . 10.0 113.412 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.53 -58.07 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.918 1.287 . . . . 10.0 110.121 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 m -68.16 -16.99 64.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.297 1.439 . . . . 10.0 113.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -88.35 -39.78 14.08 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.571 1.078 . . . . 10.0 112.146 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -59.8 -42.18 92.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.939 0.791 . . . . 10.0 112.372 170.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -41.44 -60.7 1.69 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 126.094 1.758 . . . . 10.0 113.807 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.98 -25.67 16.07 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.158 2.572 . . . . 10.0 114.372 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.7 -45.07 84.2 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.674 1.579 . . . . 10.0 113.502 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -54.02 -52.81 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.01 0.924 . . . . 10.0 109.447 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.19 -45.9 72.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.465 1.106 . . . . 10.0 113.428 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -51.1 -57.58 8.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.058 1.343 . . . . 10.0 112.15 171.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 m -49.36 -52.63 26.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.302 1.441 . . . . 10.0 110.699 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.5 mmt -69.14 -48.13 63.2 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.895 0.878 . . . . 10.0 113.044 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -57.09 -39.95 76.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.927 -1.511 . . . . 10.0 113.218 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.35 -54.56 34.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.266 1.394 . . . . 10.0 111.281 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.64 -41.13 61.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.197 1.555 . . . . 10.0 115.197 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.85 -50.78 61.47 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.545 0.738 . . . . 10.0 110.511 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.64 -52.67 21.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.864 0.865 . . . . 10.0 112.908 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.91 -5.54 48.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.343 1.057 . . . . 10.0 113.835 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.544 0.978 . . . . 10.0 115.544 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.246 1.572 . . . . 10.0 115.246 -175.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.57 61.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.39 26.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.049 2.14 . . . . 10.0 109.041 171.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.1 15.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.004 166.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.02 53.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.703 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.52 129.6 23.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 125.048 1.339 . . . . 10.0 110.995 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.74 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.469 -1.012 . . . . 10.0 109.469 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.48 38.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.31 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.735 -0.946 . . . . 10.0 110.735 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.83 -3.35 0.69 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 118.656 2.223 . . . . 10.0 118.656 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.317 1.559 . . . . 10.0 112.21 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.85 9.04 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.491 1.516 . . . . 10.0 111.137 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.54 131.95 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.23 3.287 . . . . 10.0 112.145 171.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.35 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.043 1.737 . . . . 10.0 111.66 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.65 85.01 4.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.295 1.521 . . . . 10.0 113.037 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.587 -1.321 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.19 -35.99 62.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.998 1.11 . . . . 10.0 113.998 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.417 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.5 ptp180 -64.4 -23.32 67.25 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.589 -1.319 . . . . 10.0 114.169 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -77.69 -42.77 33.34 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.148 -0.97 . . . . 10.0 111.763 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.95 44.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.355 1.462 . . . . 10.0 111.726 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -51.8 -71.88 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.551 1.941 . . . . 10.0 111.805 169.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.417 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.0 m0 -56.48 -31.96 64.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 117.507 -1.235 . . . . 10.0 113.536 -172.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 tp -48.59 -45.56 38.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.004 1.722 . . . . 10.0 112.077 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.91 -43.78 6.59 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.059 0.944 . . . . 10.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.0 m -51.45 -48.86 62.63 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.58 1.552 . . . . 10.0 113.444 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 41.5 p -69.41 -46.62 27.48 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.57 1.322 . . . . 10.0 114.57 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.53 -42.41 49.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.143 2.562 . . . . 10.0 115.185 169.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.41 -48.36 81.92 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.555 -0.716 . . . . 10.0 112.245 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -36.55 82.52 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.523 1.056 . . . . 10.0 112.555 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.66 -49.03 76.25 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.097 -1.002 . . . . 10.0 111.674 165.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.82 -38.25 78.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.823 0.849 . . . . 10.0 112.874 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -52.36 -53.97 37.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.298 0.954 . . . . 10.0 111.173 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.676 0.79 . . . . 10.0 112.131 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.72 38.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.94 0.896 . . . . 10.0 112.039 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.22 79.25 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.778 0.831 . . . . 10.0 112.692 174.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.75 -38.6 91.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.399 1.259 . . . . 10.0 114.399 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.81 1.37 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.236 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.55 11.94 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.33 145.89 47.49 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.95 -1.719 . . . . 10.0 112.458 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.9 54.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.8 -39.72 2.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.316 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.44 -52.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.088 1.355 . . . . 10.0 111.101 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.26 67.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.543 0.571 . . . . 10.0 112.543 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.441 0.696 . . . . 10.0 110.943 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.8 4.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.849 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.12 -46.31 96.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.706 0.802 . . . . 10.0 111.374 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.31 64.04 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.701 0.667 . . . . 10.0 112.624 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.36 75.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.358 0.873 . . . . 10.0 113.358 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -53.22 -51.41 62.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.699 1.2 . . . . 10.0 110.641 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.42 -54.29 4.78 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.092 1.329 . . . . 10.0 113.276 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.53 -54.76 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 118.068 -0.968 . . . . 10.0 112.395 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . 0.309 3.1 ppp? -61.45 -42.64 99.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.605 1.548 . . . . 10.0 113.552 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.0 mm . . . . . 0 N--CA 1.477 0.913 0 CA-C-N 120.214 1.37 . . . . 10.0 111.702 170.393 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 111.701 0.26 . . . . 10.0 111.701 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.18 -58.69 11.07 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.058 1.79 . . . . 10.0 112.379 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.57 -43.4 2.71 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.209 2.604 . . . . 10.0 113.304 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.9 mt -101.19 -6.41 24.29 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.485 1.661 . . . . 10.0 115.485 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.75 10.47 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.165 -1.584 . . . . 10.0 110.366 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.61 72.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.248 2.619 . . . . 10.0 113.275 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.69 106.34 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.79 0.836 . . . . 10.0 110.05 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.82 -59.63 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.051 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.42 -42.11 14.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.513 1.525 . . . . 10.0 113.496 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.63 63.2 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.19 -41.58 68.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.855 0.752 . . . . 10.0 110.826 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.21 -32.64 72.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.771 1.228 . . . . 10.0 114.216 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.79 -51.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.073 0.851 . . . . 10.0 109.638 169.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -62.33 -46.23 89.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -52.22 -47.68 65.54 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.088 0.955 . . . . 10.0 112.686 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.37 -53.88 53.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.099 0.96 . . . . 10.0 111.804 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.13 -53.16 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.905 1.282 . . . . 10.0 111.509 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.1 t -53.34 -51.31 62.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.343 1.457 . . . . 10.0 111.908 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.9 m -61.0 -42.97 99.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.459 1.504 . . . . 10.0 112.401 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.78 -51.74 68.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.407 1.003 . . . . 10.0 112.452 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.79 77.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.925 0.89 . . . . 10.0 112.89 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 32.5 ttp -60.7 -50.67 72.55 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.062 -1.023 . . . . 10.0 112.403 169.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.1 -47.51 71.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.632 1.573 . . . . 10.0 111.626 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -47.07 -54.37 10.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 10.0 112.261 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.2 mt -53.43 -55.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.814 0.846 . . . . 10.0 110.692 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -57.04 -36.15 70.13 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.121 0.785 . . . . 10.0 113.121 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.25 -58.2 9.25 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.077 0.951 . . . . 10.0 113.017 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.278 -0.867 . . . . 10.0 111.44 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.78 -49.44 75.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.897 1.226 . . . . 10.0 112.106 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.38 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.856 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.65 -21.93 60.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.607 1.163 . . . . 10.0 113.467 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.11 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.629 0.633 . . . . 10.0 113.548 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.44 51.0 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.262 1.825 . . . . 10.0 113.067 -166.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.02 1.118 . . . . 10.0 114.02 172.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.74 -50.45 65.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.05 0.929 . . . . 10.0 112.285 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.21 -46.01 83.28 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.181 0.993 . . . . 10.0 112.088 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.47 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.078 1.751 . . . . 10.0 114.268 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.6 29.1 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.428 1.891 . . . . 10.0 114.907 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.59 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.536 1.636 . . . . 10.0 114.195 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.77 -46.28 34.7 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.308 2.005 . . . . 10.0 113.066 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.03 67.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.968 2.907 . . . . 10.0 113.33 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.23 -53.03 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.086 0.954 . . . . 10.0 109.794 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.254 0.622 . . . . 10.0 111.926 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -60.03 -56.15 25.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.919 0.887 . . . . 10.0 112.709 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 10.0 113.036 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.52 46.16 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.284 0.634 . . . . 10.0 111.068 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.11 -48.4 78.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.04 -49.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.791 0.723 . . . . 10.0 110.428 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.56 -51.65 68.98 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.76 30.28 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.817 2.047 . . . . 10.0 111.044 174.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.53 -58.26 9.34 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.757 0.423 . . . . 10.0 111.314 174.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.09 -45.01 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.054 0.942 . . . . 10.0 111.504 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -56.74 -67.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.281 2.633 . . . . 10.0 110.918 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.92 -48.15 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.005 1.322 . . . . 10.0 110.915 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -62.11 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.755 0.822 . . . . 10.0 112.484 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.75 -48.08 80.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.211 0.914 . . . . 10.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -51.75 -51.08 58.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.301 1.04 . . . . 10.0 112.193 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 113.793 1.034 . . . . 10.0 113.793 178.908 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 119.308 -0.377 . . . . 10.0 111.445 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.2 t90 -55.47 -51.81 65.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.287 1.035 . . . . 10.0 112.501 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 35.5 tp -54.04 -45.22 71.54 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.77 1.228 . . . . 10.0 112.281 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.49 -4.98 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.17 1.545 . . . . 10.0 115.17 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.3 32.95 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.576 1.098 . . . . 10.0 113.886 -168.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.871 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.66 -17.08 64.47 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.661 1.726 . . . . 10.0 115.661 -175.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.32 -106.07 1.14 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.339 1.427 . . . . 10.0 113.714 -172.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.637 -1.508 . . . . 10.0 109.353 168.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 113.905 0.322 . . . . 10.0 113.905 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.771 166.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.366 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -68.82 153.84 72.19 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.752 2.968 . . . . 10.0 111.424 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.81 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.329 1.052 . . . . 10.0 112.221 171.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.31 -52.4 21.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.95 -40.47 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.646 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.29 -49.85 41.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.586 0.63 . . . . 10.0 111.964 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.08 83.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.092 1.757 . . . . 10.0 112.983 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.3 -52.32 62.44 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.931 0.892 . . . . 10.0 112.141 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.59 -59.29 4.64 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.362 1.065 . . . . 10.0 109.944 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -52.9 -46.54 68.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.417 -1.278 . . . . 10.0 112.241 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -51.36 -53.38 36.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.687 1.585 . . . . 10.0 112.723 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.12 -49.68 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.202 1.401 . . . . 10.0 111.562 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -56.17 -50.9 69.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.141 1.376 . . . . 10.0 111.458 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -57.06 -62.66 1.6 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.195 1.798 . . . . 10.0 110.954 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.482 1.162 0 CA-C-N 120.49 1.495 . . . . 10.0 112.793 -178.343 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.333 0 CA-C-O 121.309 0.394 . . . . 10.0 113.228 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -54.73 -57.04 13.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.192 1.797 . . . . 10.0 112.656 172.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -53.02 -37.16 53.42 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.063 0.839 . . . . 10.0 113.596 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.58 -28.01 65.6 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 115.989 1.848 . . . . 10.0 115.989 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.62 -57.49 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 119.319 0.963 . . . . 10.0 108.445 165.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.848 0.859 . . . . 10.0 113.186 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.317 1.599 . . . . 10.0 115.317 -171.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.141 0.976 . . . . 10.0 113.292 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.049 0.94 . . . . 10.0 111.019 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.744 0.818 . . . . 10.0 110.957 170.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.92 77.0 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.896 0.879 . . . . 10.0 112.1 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.461 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.82 -55.45 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.731 1.212 . . . . 10.0 110.686 -175.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.44 40.12 Favored Glycine 0 C--O 1.239 0.451 0 C-N-CA 129.755 3.55 . . . . 10.0 119.677 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.484 2.714 . . . . 10.0 113.438 166.603 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.822 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.29 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.576 3.15 . . . . 10.0 117.276 160.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.67 65.05 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.331 2.652 . . . . 10.0 114.448 155.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.03 2.79 41.14 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.44 2.447 . . . . 10.0 111.488 168.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.684 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.477 2.277 . . . . 10.0 113.201 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.14 4.32 0.94 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.736 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.473 -0.767 . . . . 10.0 112.619 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.6 83.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.887 0.875 . . . . 10.0 109.3 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.43 -52.56 63.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.399 0.68 . . . . 10.0 111.882 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.41 -53.59 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.141 0.576 . . . . 10.0 112.247 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.85 -46.83 51.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.381 1.472 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.62 -44.93 84.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.88 -56.2 12.58 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.346 0.974 . . . . 10.0 111.567 166.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.4 m -49.8 -52.47 31.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.844 1.257 . . . . 10.0 112.209 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.177 0.991 . . . . 10.0 112.139 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.31 -48.56 78.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.663 0.785 . . . . 10.0 112.809 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.8 mtt -59.22 -46.62 87.97 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.293 1.037 . . . . 10.0 111.606 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.49 -58.6 13.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.232 0.92 . . . . 10.0 113.735 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -46.12 79.6 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.64 1.22 . . . . 10.0 112.127 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.56 -41.74 74.3 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.755 1.169 . . . . 10.0 113.242 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -63.12 -57.83 9.26 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 118.297 -0.859 . . . . 10.0 111.412 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.49 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.81 -57.99 9.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.571 1.148 . . . . 10.0 112.973 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.05 -67.5 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.662 1.185 . . . . 10.0 113.611 169.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.756 1.741 . . . . 10.0 110.866 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.863 2.465 . . . . 10.0 109.319 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.93 93.06 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.143 2.177 . . . . 10.0 113.619 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.73 -84.38 1.19 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.732 0.682 . . . . 10.0 112.477 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.404 2.681 . . . . 10.0 116.922 166.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.66 -50.84 10.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.902 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.53 6.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.737 1.273 . . . . 10.0 110.967 -172.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.59 -29.63 89.61 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.724 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.52 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.106 1.362 . . . . 10.0 113.551 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.58 -47.4 19.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.231 1.413 . . . . 10.0 113.441 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.09 62.12 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.513 0.725 . . . . 10.0 110.939 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -56.97 -50.21 73.35 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.044 0.538 . . . . 10.0 112.334 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.38 -51.27 65.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.356 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.384 0.883 . . . . 10.0 113.384 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.55 -58.11 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.914 1.286 . . . . 10.0 110.228 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -68.09 -18.03 64.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.368 . . . . 10.0 113.745 -172.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -86.6 -40.36 15.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.397 1.079 . . . . 10.0 112.059 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.3 mt -60.37 -41.55 93.95 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.387 -0.82 . . . . 10.0 112.525 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.8 t -41.2 -60.45 1.74 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.719 1.607 . . . . 10.0 113.769 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.95 -26.72 10.76 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.721 2.947 . . . . 10.0 114.262 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.85 97.72 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.938 1.699 . . . . 10.0 113.01 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -52.12 -54.86 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.14 1.376 . . . . 10.0 109.345 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.77 -45.21 78.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.629 1.171 . . . . 10.0 113.131 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.43 -57.3 9.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.422 1.465 . . . . 10.0 112.209 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -50.15 -52.4 35.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.164 1.386 . . . . 10.0 110.434 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.15 -48.02 63.44 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.805 0.842 . . . . 10.0 113.089 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.16 -40.08 76.56 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.845 -1.55 . . . . 10.0 113.085 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.407 1.458 . . . . 10.0 111.281 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.65 -41.06 61.05 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.7 mtm -66.88 -50.85 61.16 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.484 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.54 -52.69 21.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.826 0.851 . . . . 10.0 112.975 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.5 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.857 1.058 . . . . 10.0 113.857 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.09 43.02 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.252 1.575 . . . . 10.0 115.252 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.55 61.04 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.332 0.893 . . . . 10.0 115.332 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.43 26.41 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.042 2.137 . . . . 10.0 108.957 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.49 171.14 15.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.053 0.941 . . . . 10.0 111.0 166.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 136.0 53.43 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.9 0.88 . . . . 10.0 109.691 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.52 129.6 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.039 1.336 . . . . 10.0 110.959 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.36 38.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.826 0.676 . . . . 10.0 112.826 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -82.0 0.15 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.41 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.6 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.338 1.569 . . . . 10.0 112.217 -165.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.91 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.46 1.504 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.45 120.76 69.66 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.36 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.046 1.738 . . . . 10.0 111.71 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.69 85.05 4.74 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 123.058 1.409 . . . . 10.0 113.037 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.864 -1.147 . . . . 10.0 113.951 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.82 52.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.292 1.037 . . . . 10.0 113.147 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -50.68 -55.51 16.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.858 0.863 . . . . 10.0 111.515 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -64.02 -39.11 93.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.69 1.596 . . . . 10.0 112.182 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.69 65.36 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.48 1.112 . . . . 10.0 110.916 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -61.96 2.23 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.18 1.792 . . . . 10.0 112.764 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -53.65 -38.12 63.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.368 2.267 . . . . 10.0 113.177 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.46 -44.01 62.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.493 1.517 . . . . 10.0 112.183 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -99.4 -47.99 4.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 113.254 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.0 t -60.02 -37.6 80.24 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.454 -0.779 . . . . 10.0 113.058 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.5 m -68.38 -48.55 34.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.753 -1.217 . . . . 10.0 112.638 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.62 -42.9 41.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.585 2.856 . . . . 10.0 115.278 164.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.58 -49.28 78.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.889 0.768 . . . . 10.0 112.076 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tt -53.01 -44.68 67.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.678 1.191 . . . . 10.0 112.679 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.62 -47.71 81.43 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.038 -1.039 . . . . 10.0 112.413 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.838 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.3 -54.04 36.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.298 0.954 . . . . 10.0 111.187 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.1 88.63 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.656 0.782 . . . . 10.0 112.099 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.69 38.43 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.94 0.896 . . . . 10.0 112.078 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.16 79.38 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.704 0.801 . . . . 10.0 112.731 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.71 -38.59 91.68 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.065 1.346 . . . . 10.0 112.313 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.56 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.829 1.652 . . . . 10.0 112.113 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.981 -1.699 . . . . 10.0 112.458 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.92 54.27 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.67 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.888 1.675 . . . . 10.0 113.465 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.26 5.29 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.139 1.352 . . . . 10.0 115.26 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.01 -46.74 87.86 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.158 -1.401 . . . . 10.0 111.354 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.97 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.087 1.355 . . . . 10.0 111.072 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.57 -51.33 67.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.82 43.16 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.424 0.689 . . . . 10.0 110.985 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.399 2.28 . . . . 10.0 114.849 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.07 -46.35 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 123.725 0.81 . . . . 10.0 111.349 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.31 64.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.659 0.647 . . . . 10.0 112.624 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.27 74.91 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.13 -45.32 87.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.583 0.753 . . . . 10.0 111.946 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.55 -56.47 4.87 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.455 1.502 . . . . 10.0 113.037 167.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 83.6 mt -56.45 -55.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.757 0.823 . . . . 10.0 110.322 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -48.98 -56.71 8.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.609 1.095 . . . . 10.0 113.115 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.3 mm -68.86 -46.42 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.116 0.566 . . . . 10.0 112.203 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.65 -44.71 79.46 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.388 0.994 . . . . 10.0 113.075 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.9 m -61.52 -44.21 97.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.404 1.482 . . . . 10.0 111.159 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.06 -51.42 19.58 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.244 0.925 . . . . 10.0 113.185 165.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.57 -50.19 66.1 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 127.931 2.492 . . . . 10.0 111.096 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t -59.65 -50.34 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 125.449 1.5 . . . . 10.0 112.033 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.98 -59.46 8.72 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.704 1.621 . . . . 10.0 112.096 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.79 -37.76 20.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.209 2.204 . . . . 10.0 113.434 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.7 -6.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.398 1.629 . . . . 10.0 115.398 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.67 116.72 10.4 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.207 -1.558 . . . . 10.0 110.356 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.248 2.619 . . . . 10.0 113.289 177.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.65 106.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.816 0.847 . . . . 10.0 110.128 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.764 1.226 . . . . 10.0 114.019 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.54 -42.01 15.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.458 1.503 . . . . 10.0 113.498 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.22 -24.59 63.13 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.897 1.443 . . . . 10.0 114.897 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.83 -41.87 67.86 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 118.901 0.773 . . . . 10.0 110.82 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.64 -31.88 70.23 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.854 1.262 . . . . 10.0 114.241 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.29 -52.26 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.152 0.887 . . . . 10.0 109.625 168.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -60.47 -45.24 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -52.64 -49.54 64.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.713 1.142 . . . . 10.0 112.71 173.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -53.92 48.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.139 . . . . 10.0 111.915 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.2 mt -54.62 -47.59 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.625 1.17 . . . . 10.0 111.481 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -57.57 -53.34 59.26 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.07 1.348 . . . . 10.0 112.394 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.6 t -67.82 -33.48 74.86 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.766 0.826 . . . . 10.0 112.308 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.63 73.34 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.258 0.935 . . . . 10.0 112.347 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.55 80.62 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.468 -0.77 . . . . 10.0 112.535 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.65 -52.99 62.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.267 1.027 . . . . 10.0 111.913 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.77 -49.62 65.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.069 1.748 . . . . 10.0 111.665 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -49.5 -54.71 16.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.722 0.809 . . . . 10.0 112.184 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.0 mt -54.11 -54.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.592 0.757 . . . . 10.0 110.86 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.35 -36.62 69.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.709 0.804 . . . . 10.0 113.07 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -57.24 -58.19 9.3 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.035 0.934 . . . . 10.0 113.059 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -40.96 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.373 -0.823 . . . . 10.0 111.468 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.76 -49.39 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.831 1.196 . . . . 10.0 112.169 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.26 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.075 -1.641 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.69 -21.98 60.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 10.0 113.477 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.588 0.614 . . . . 10.0 113.548 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.271 1.828 . . . . 10.0 113.067 -166.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.09 -56.44 14.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.032 1.123 . . . . 10.0 114.032 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.69 -50.58 65.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.115 0.959 . . . . 10.0 112.303 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.11 -46.02 82.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.136 0.975 . . . . 10.0 112.143 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.51 80.02 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.27 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.043 1.737 . . . . 10.0 114.235 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.477 1.911 . . . . 10.0 114.876 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.94 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.536 1.636 . . . . 10.0 114.171 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.24 35.04 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.277 1.984 . . . . 10.0 113.079 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.1 67.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.288 173.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.14 -53.07 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.83 75.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.246 0.618 . . . . 10.0 111.905 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -56.18 24.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.917 0.887 . . . . 10.0 112.709 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.211 1.004 . . . . 10.0 113.05 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.61 -49.44 46.85 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.253 0.621 . . . . 10.0 111.101 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.43 78.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.67 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.797 0.726 . . . . 10.0 110.487 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.57 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.83 30.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.86 2.064 . . . . 10.0 111.026 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.45 -58.36 8.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.796 0.438 . . . . 10.0 111.266 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.6 t -52.14 -46.64 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.112 0.965 . . . . 10.0 112.296 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.9 m -58.83 -64.85 0.79 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.971 2.509 . . . . 10.0 111.484 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.6 -49.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.928 1.291 . . . . 10.0 111.241 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.9 -64.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.844 0.858 . . . . 10.0 112.28 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.12 -43.02 81.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.037 0.835 . . . . 10.0 112.174 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -52.14 -54.29 32.43 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.128 0.971 . . . . 10.0 112.459 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.8 p -51.88 -33.13 35.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.029 1.122 . . . . 10.0 114.029 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.24 -43.44 94.92 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.92 1.082 . . . . 10.0 113.92 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -45.87 -57.35 8.17 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 115.151 1.537 . . . . 10.0 115.151 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.09 -34.02 90.45 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.278 1.985 . . . . 10.0 113.01 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.1 t -64.02 -51.61 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.234 0.925 . . . . 10.0 110.821 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.1 t -53.55 -50.7 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.811 1.244 . . . . 10.0 111.315 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -55.32 -52.34 63.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.894 1.277 . . . . 10.0 112.498 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 56.0 tp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.971 1.308 . . . . 10.0 112.449 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -88.15 -5.08 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 115.222 1.564 . . . . 10.0 115.222 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.47 -169.3 32.89 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-O 122.576 1.098 . . . . 10.0 113.873 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -40.85 64.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.828 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -54.94 -31.49 60.51 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.524 2.73 . . . . 10.0 115.154 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.62 -103.88 0.95 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.366 0.985 . . . . 10.0 113.623 -167.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.19 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.331 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.884 0.314 . . . . 10.0 113.884 173.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.64 -42.74 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.055 1.742 . . . . 10.0 108.716 166.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.27 133.38 24.9 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.448 1.899 . . . . 10.0 109.392 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.7 153.77 72.61 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.754 2.969 . . . . 10.0 111.468 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.38 21.89 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.93 -40.48 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.668 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.35 -49.77 42.87 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.517 0.599 . . . . 10.0 111.946 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.68 -47.08 83.31 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.07 1.748 . . . . 10.0 113.002 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -58.8 5.62 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.335 1.054 . . . . 10.0 109.989 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -53.42 -43.88 68.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.876 -1.059 . . . . 10.0 112.956 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -54.53 -52.55 61.68 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.3 1.409 . . . . 10.0 112.492 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.18 -48.97 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.49 1.116 . . . . 10.0 110.939 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.0 mp -57.09 -53.53 57.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.747 1.619 . . . . 10.0 112.152 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -54.68 -56.04 23.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.065 1.746 . . . . 10.0 111.807 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 66.0 t -57.1 -47.44 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.398 -0.814 . . . . 10.0 111.264 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 46.1 m -55.95 -50.51 70.56 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.901 0.88 . . . . 10.0 112.042 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -71.75 -0.93 12.24 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.424 1.889 . . . . 10.0 114.315 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -130.14 -68.76 0.69 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.476 1.11 . . . . 10.0 111.671 -175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.6 t -68.85 -51.91 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.186 0.994 . . . . 10.0 110.253 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.52 -56.45 23.55 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 123.999 0.809 . . . . 10.0 112.866 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.4 -57.28 3.14 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.549 1.939 . . . . 10.0 112.687 167.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.56 -38.92 89.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.582 1.087 . . . . 10.0 113.642 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -69.47 -27.56 65.33 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 115.614 1.709 . . . . 10.0 115.614 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.36 -57.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 165.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.87 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.877 0.871 . . . . 10.0 113.174 -172.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.61 5.23 2.54 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.28 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.89 4.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.113 0.965 . . . . 10.0 111.03 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.19 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.771 0.829 . . . . 10.0 110.957 170.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.94 77.05 7.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.874 0.87 . . . . 10.0 112.084 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.897 2.879 . . . . 10.0 116.462 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.81 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.75 1.22 . . . . 10.0 110.642 -175.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.72 3.533 . . . . 10.0 119.677 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.516 2.727 . . . . 10.0 113.457 166.652 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.87 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.569 3.148 . . . . 10.0 117.225 160.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.306 2.643 . . . . 10.0 114.448 155.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.45 137.93 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.41 1.884 . . . . 10.0 113.372 -158.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.76 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.015 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.83 41.48 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.487 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.649 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.304 . . . . 10.0 113.21 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.28 4.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.732 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.507 -0.746 . . . . 10.0 112.625 176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.84 -49.64 83.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.892 0.877 . . . . 10.0 109.3 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.36 -52.66 62.8 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.379 0.672 . . . . 10.0 111.867 175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.3 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.224 0.61 . . . . 10.0 112.276 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.8 51.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.332 1.453 . . . . 10.0 113.335 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.66 -44.95 84.75 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.289 1.435 . . . . 10.0 112.997 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.6 -56.54 11.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.526 1.06 . . . . 10.0 111.511 166.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.59 -52.51 29.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.904 1.282 . . . . 10.0 112.248 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.5 -58.81 6.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.172 0.989 . . . . 10.0 112.161 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt -57.47 -48.62 78.71 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 10.0 112.836 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.14 -49.09 78.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.008 0.923 . . . . 10.0 111.281 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.53 -58.66 13.26 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.273 0.939 . . . . 10.0 113.931 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.18 -45.63 79.68 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.748 1.274 . . . . 10.0 112.175 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.85 -39.87 88.81 Favored Glycine 0 CA--C 1.533 1.205 0 O-C-N 120.779 -1.2 . . . . 10.0 113.588 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.3 m -60.21 -60.71 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 10.0 110.801 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.06 9.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 112.972 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.61 -38.67 81.92 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.254 0.835 . . . . 10.0 113.254 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.621 1.168 . . . . 10.0 113.589 169.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.813 1.768 . . . . 10.0 110.859 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.04 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.628 1.011 . . . . 10.0 115.628 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.2 mmm -59.47 -45.05 92.73 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.4 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.743 0.687 . . . . 10.0 112.511 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.07 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.401 2.68 . . . . 10.0 116.959 166.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 m -79.68 -50.83 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.168 -1.378 . . . . 10.0 113.892 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.5 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.66 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.67 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.111 0.565 . . . . 10.0 111.476 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.06 22.84 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.078 1.351 . . . . 10.0 113.566 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.57 -47.41 19.74 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.455 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.78 -53.1 61.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.933 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.9 -50.27 73.04 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.107 0.563 . . . . 10.0 112.353 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.27 65.25 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.99 1.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.85 -56.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.825 1.25 . . . . 10.0 110.736 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -69.81 -18.61 63.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.935 1.294 . . . . 10.0 113.498 -172.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.4 m -84.98 -42.52 14.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.478 1.111 . . . . 10.0 111.913 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.6 mt -57.49 -41.56 80.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.211 0.819 . . . . 10.0 113.211 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.4 t -50.17 -61.79 3.33 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.092 -0.956 . . . . 10.0 112.457 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -46.76 -47.27 16.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.627 3.551 . . . . 10.0 115.925 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.49 90.16 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.858 1.208 . . . . 10.0 113.811 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.25 -51.52 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.592 1.157 . . . . 10.0 109.326 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.24 76.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.093 0.957 . . . . 10.0 113.165 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -50.13 -56.23 11.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.681 1.592 . . . . 10.0 112.179 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.77 -52.82 29.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.3 1.44 . . . . 10.0 110.733 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.84 -48.13 64.27 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.976 0.91 . . . . 10.0 113.013 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -56.49 -40.75 75.47 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.195 1.362 . . . . 10.0 113.447 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.53 34.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.752 1.16 . . . . 10.0 111.292 170.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.14 61.12 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.174 1.546 . . . . 10.0 115.174 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.85 -50.82 61.34 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.594 0.758 . . . . 10.0 110.469 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.72 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.887 0.875 . . . . 10.0 112.92 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.86 -5.6 49.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 10.0 113.831 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.67 5.58 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.564 0.986 . . . . 10.0 115.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.01 43.5 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.53 61.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.339 0.896 . . . . 10.0 115.339 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.4 26.46 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.081 2.153 . . . . 10.0 109.031 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.711 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.64 129.62 23.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.028 1.331 . . . . 10.0 110.909 -176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.23 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.72 164.4 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.79 -3.28 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.669 2.228 . . . . 10.0 118.669 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.358 1.579 . . . . 10.0 112.194 -165.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.444 1.498 . . . . 10.0 111.081 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.45 120.78 69.66 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.5 131.91 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.184 3.256 . . . . 10.0 112.137 171.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.29 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.075 1.75 . . . . 10.0 111.763 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -93.63 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.063 1.411 . . . . 10.0 113.106 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.27 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.847 -1.158 . . . . 10.0 113.905 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.72 -26.61 35.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.271 1.029 . . . . 10.0 112.532 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -55.08 -48.31 73.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.01 1.324 . . . . 10.0 112.927 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -71.2 -38.87 72.04 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.955 0.902 . . . . 10.0 111.122 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.39 -48.95 65.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.32 1.048 . . . . 10.0 112.228 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.514 1.526 . . . . 10.0 111.558 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -55.27 -34.28 63.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.357 1.463 . . . . 10.0 112.503 -170.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.7 tp -48.82 -43.74 38.71 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.114 1.766 . . . . 10.0 112.141 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -101.9 -38.15 7.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.493 0.717 . . . . 10.0 112.764 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.7 p -64.72 -43.69 92.58 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.283 1.402 . . . . 10.0 113.92 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.277 74.8 p -65.04 -42.56 62.45 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 114.72 1.378 . . . . 10.0 114.72 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.89 -43.04 60.83 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.428 2.752 . . . . 10.0 115.247 167.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.23 -47.28 86.67 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.447 -0.783 . . . . 10.0 111.704 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.61 -50.01 55.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.414 1.485 . . . . 10.0 111.51 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mp -56.24 -47.52 78.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.111 0.965 . . . . 10.0 112.956 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.22 78.29 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.777 0.831 . . . . 10.0 112.903 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.02 36.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.285 0.948 . . . . 10.0 111.214 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.09 88.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.093 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.75 37.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.017 0.927 . . . . 10.0 111.974 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.25 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.67 53.41 12.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.838 1.655 . . . . 10.0 112.126 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.95 47.51 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.935 -1.728 . . . . 10.0 112.405 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.85 54.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.77 -39.72 2.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.93 1.692 . . . . 10.0 113.467 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.2 5.34 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.304 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.46 -52.93 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.154 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.57 -51.37 67.61 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.522 0.564 . . . . 10.0 112.522 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.05 -44.93 42.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.469 0.708 . . . . 10.0 110.959 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.814 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.393 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.14 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.614 0.626 . . . . 10.0 112.675 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.63 -46.92 73.97 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.187 0.81 . . . . 10.0 113.187 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -57.13 -45.54 83.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.023 0.929 . . . . 10.0 111.974 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.02 -55.58 5.59 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.201 1.382 . . . . 10.0 113.082 167.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.4 mt -56.77 -49.47 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.626 0.77 . . . . 10.0 111.893 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 64.4 ttp -49.39 -57.82 6.23 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 10.0 112.184 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.82 -47.12 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 O-C-N 121.659 -0.651 . . . . 10.0 111.058 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -50.71 -62.54 5.16 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.82 1.2 . . . . 10.0 112.563 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 p -59.07 -36.17 74.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.707 0.803 . . . . 10.0 112.817 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.36 -56.93 8.68 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.321 0.962 . . . . 10.0 113.88 165.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.87 -47.22 85.68 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.791 1.637 . . . . 10.0 111.644 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.7 t -52.81 -51.81 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.253 0.621 . . . . 10.0 110.35 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.03 -60.84 5.78 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.833 1.682 . . . . 10.0 112.212 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.01 -37.66 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.484 1.913 . . . . 10.0 113.86 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.0 mt -99.27 -6.41 28.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -69.66 116.73 10.4 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.19 -1.569 . . . . 10.0 110.409 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.53 -49.55 72.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.186 2.594 . . . . 10.0 113.255 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.66 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.86 -59.52 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.72 1.208 . . . . 10.0 114.087 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.12 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.451 1.5 . . . . 10.0 113.485 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.64 63.25 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.956 1.465 . . . . 10.0 114.956 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.82 -41.94 67.91 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.848 0.749 . . . . 10.0 110.712 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.51 -32.01 70.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.903 1.281 . . . . 10.0 114.249 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.1 -51.77 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.59 168.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -62.46 -43.15 99.52 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -53.93 -48.38 70.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.48 1.112 . . . . 10.0 112.617 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.68 -53.14 61.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.693 0.797 . . . . 10.0 111.681 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.14 -54.33 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.809 1.244 . . . . 10.0 112.009 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 p -58.01 -43.15 86.53 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.252 -0.905 . . . . 10.0 112.852 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.2 m -61.73 -41.31 97.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.568 1.147 . . . . 10.0 112.56 174.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.41 -46.75 87.82 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.345 0.975 . . . . 10.0 112.343 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.74 79.81 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.668 0.787 . . . . 10.0 112.393 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.8 ttp -54.54 -54.54 39.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.037 0.935 . . . . 10.0 112.085 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.1 -50.4 61.71 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.314 1.446 . . . . 10.0 111.572 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.39 -54.66 20.14 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.048 0.939 . . . . 10.0 112.562 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.1 mt -53.52 -55.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.831 0.853 . . . . 10.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.8 mt -57.48 -35.6 70.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.2 -0.905 . . . . 10.0 112.902 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.31 -58.14 9.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.251 0.932 . . . . 10.0 113.047 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.92 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 118.342 -0.837 . . . . 10.0 111.441 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.44 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.83 1.195 . . . . 10.0 112.115 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.92 -70.4 0.46 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.866 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.73 -21.86 60.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.587 1.155 . . . . 10.0 113.468 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.37 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.14 -56.49 14.22 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.955 1.094 . . . . 10.0 113.955 172.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.64 -50.55 65.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.112 0.958 . . . . 10.0 112.299 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.16 -45.97 83.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.192 0.997 . . . . 10.0 112.149 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.42 80.59 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.54 -11.23 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.044 1.738 . . . . 10.0 114.225 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.62 29.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.427 1.891 . . . . 10.0 114.865 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.95 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.451 1.596 . . . . 10.0 114.14 -170.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.841 3.256 . . . . 10.0 105.549 170.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.86 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.27 1.98 . . . . 10.0 113.032 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.11 67.96 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.17 -53.01 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.274 0.63 . . . . 10.0 111.902 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.06 -56.14 25.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.933 0.893 . . . . 10.0 112.687 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.26 -53.21 60.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.019 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.55 -49.48 46.08 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.36 78.91 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.691 1.367 . . . . 10.0 114.691 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.62 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.815 0.734 . . . . 10.0 110.487 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.64 -51.61 69.18 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.82 -47.73 31.03 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.796 2.039 . . . . 10.0 111.047 174.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.57 -58.33 9.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.798 0.439 . . . . 10.0 111.253 174.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.09 -47.03 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.109 0.963 . . . . 10.0 112.298 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.9 m -58.76 -64.22 1.01 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.034 2.534 . . . . 10.0 111.53 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -50.19 -49.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.613 1.165 . . . . 10.0 111.288 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.46 -63.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.002 0.921 . . . . 10.0 112.269 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.9 -43.41 98.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.505 0.593 . . . . 10.0 112.529 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -55.05 -51.01 67.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.478 0.711 . . . . 10.0 111.757 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.5 m -54.92 -29.97 57.5 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.134 1.161 . . . . 10.0 114.134 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.29 -41.94 96.64 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.62 0.97 . . . . 10.0 113.62 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -46.85 -56.27 12.28 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 115.325 1.602 . . . . 10.0 115.325 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -59.68 -35.31 95.25 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.264 1.976 . . . . 10.0 112.85 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.63 -53.07 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.132 0.973 . . . . 10.0 110.909 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.21 -48.79 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.023 1.329 . . . . 10.0 111.525 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -55.26 -54.26 45.68 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.964 1.306 . . . . 10.0 112.251 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.0 tp -52.86 -46.67 67.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.182 1.393 . . . . 10.0 112.514 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.6 pt -85.8 -4.92 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.62 -169.33 32.7 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-O 122.551 1.084 . . . . 10.0 113.789 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.07 -39.65 63.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.157 -1.021 . . . . 10.0 111.908 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.43 -32.87 65.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.377 2.671 . . . . 10.0 115.271 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.44 -104.34 1.11 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-O 122.142 0.857 . . . . 10.0 112.698 -167.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.19 35.82 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.285 170.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.34 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.93 0.332 . . . . 10.0 113.93 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.775 166.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.33 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.464 1.906 . . . . 10.0 109.351 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.76 153.84 72.32 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.438 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.25 -39.75 3.13 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.299 1.039 . . . . 10.0 112.223 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.43 21.33 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.54 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.651 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.83 41.93 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.564 0.62 . . . . 10.0 111.907 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.0 83.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.038 1.735 . . . . 10.0 113.017 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.36 -52.33 62.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.016 0.926 . . . . 10.0 112.06 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.63 -59.66 4.2 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.361 1.064 . . . . 10.0 109.913 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -52.82 -47.13 67.89 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.986 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -50.32 -52.72 34.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 121.283 1.856 . . . . 10.0 113.258 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.3 t -60.81 -48.12 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.817 1.247 . . . . 10.0 111.479 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.49 -50.17 74.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.319 1.448 . . . . 10.0 111.907 175.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.35 -57.41 11.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.469 2.308 . . . . 10.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.96 -45.44 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.221 -0.924 . . . . 10.0 111.844 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.9 m -56.95 -51.75 67.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.963 0.905 . . . . 10.0 112.025 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -77.73 5.9 8.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.68 1.592 . . . . 10.0 114.241 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -128.11 -74.16 0.58 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.767 1.227 . . . . 10.0 111.219 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.4 m -72.79 -41.64 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.268 -0.895 . . . . 10.0 111.972 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.23 -56.61 24.26 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 119.367 0.985 . . . . 10.0 112.614 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -42.44 -56.54 2.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.824 2.049 . . . . 10.0 112.36 166.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.16 -39.89 82.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.649 1.119 . . . . 10.0 113.997 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.3 -27.14 65.13 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 115.75 1.759 . . . . 10.0 115.75 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.38 -57.56 11.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.604 -0.887 . . . . 10.0 108.604 165.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.68 0.85 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.949 0.899 . . . . 10.0 113.145 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.37 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.273 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.1 178.02 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.04 0.936 . . . . 10.0 110.995 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.68 98.15 1.87 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 10.0 110.921 170.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.93 77.04 7.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 10.0 112.107 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.06 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.892 2.877 . . . . 10.0 116.451 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.4 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.738 1.215 . . . . 10.0 110.622 -175.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.35 169.46 40.29 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.631 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.446 0 C-N-CA 128.524 2.73 . . . . 10.0 113.492 166.576 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.82 -2.038 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.34 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.588 3.155 . . . . 10.0 117.251 160.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.302 2.641 . . . . 10.0 114.511 155.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.4 137.96 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.344 -158.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.1 2.75 41.49 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.473 2.463 . . . . 10.0 111.463 167.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.3 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.668 -168.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.547 2.302 . . . . 10.0 113.252 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.25 4.34 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.732 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.13 61.76 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.615 176.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.42 -52.59 63.09 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 10.0 111.902 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.41 -53.6 56.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.234 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.78 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -56.1 12.46 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.655 1.122 . . . . 10.0 111.583 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -50.16 -52.35 36.07 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.895 1.278 . . . . 10.0 112.288 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.207 1.003 . . . . 10.0 112.161 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.77 -49.18 77.45 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 10.0 112.541 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.9 mmt -56.08 -49.95 72.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.603 0.761 . . . . 10.0 111.306 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.04 -58.47 14.44 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.312 0.958 . . . . 10.0 113.63 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.22 -45.59 79.85 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.656 1.228 . . . . 10.0 112.142 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.0 74.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.026 1.298 . . . . 10.0 113.273 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -59.79 -60.57 3.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.24 1.016 . . . . 10.0 111.14 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.96 62.5 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.955 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.84 -58.03 9.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.593 1.157 . . . . 10.0 112.929 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.63 81.94 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.621 1.168 . . . . 10.0 113.62 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.87 -44.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.332 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.16 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.04 92.92 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.154 2.182 . . . . 10.0 113.587 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.35 1.19 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.756 0.693 . . . . 10.0 112.497 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.96 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.396 2.678 . . . . 10.0 116.95 166.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.198 -1.365 . . . . 10.0 113.866 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.52 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.765 1.291 . . . . 10.0 110.957 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.65 89.48 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.708 2.939 . . . . 10.0 113.735 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -60.65 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.5 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.281 1.432 . . . . 10.0 113.444 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 110.967 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.28 65.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.891 -0.576 . . . . 10.0 112.321 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.7 -57.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.865 1.266 . . . . 10.0 110.417 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -69.28 -17.08 63.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.071 1.348 . . . . 10.0 113.693 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -86.91 -42.98 12.76 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.64 1.109 . . . . 10.0 112.018 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -56.75 -41.45 77.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.885 0.698 . . . . 10.0 112.885 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.3 t -49.97 -61.45 3.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.629 1.172 . . . . 10.0 112.569 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.95 -46.53 24.73 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.598 3.532 . . . . 10.0 116.029 164.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.2 93.39 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.973 1.26 . . . . 10.0 113.922 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mt -58.13 -52.23 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.496 1.118 . . . . 10.0 109.48 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.49 -43.97 72.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.006 0.922 . . . . 10.0 113.185 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -52.2 -57.96 8.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.137 1.375 . . . . 10.0 111.871 171.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.59 -52.91 20.57 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.507 1.523 . . . . 10.0 110.886 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.3 mmt -68.64 -48.21 64.6 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.966 0.906 . . . . 10.0 112.981 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -55.64 -41.71 73.96 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.163 1.347 . . . . 10.0 113.283 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.56 34.36 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.475 1.034 . . . . 10.0 111.317 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.05 61.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.91 -50.83 61.17 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.442 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.55 -52.67 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.883 0.873 . . . . 10.0 112.963 172.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.58 49.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.3 -34.73 5.53 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.575 0.99 . . . . 10.0 115.575 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.13 42.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.56 61.17 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.326 0.89 . . . . 10.0 115.326 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.45 26.4 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.021 2.129 . . . . 10.0 109.034 171.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.14 15.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.045 166.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.84 0.856 . . . . 10.0 109.745 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.56 129.57 23.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 125.071 1.348 . . . . 10.0 110.971 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.69 116.17 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.67 164.41 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.647 -0.981 . . . . 10.0 110.647 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.354 1.577 . . . . 10.0 112.231 -165.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.86 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.45 120.73 69.66 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.42 131.91 38.41 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.253 3.302 . . . . 10.0 112.167 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.16 126.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.044 1.738 . . . . 10.0 111.716 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.262 1.506 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.44 -28.23 66.78 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.641 -1.287 . . . . 10.0 113.881 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.14 62.2 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.225 1.194 . . . . 10.0 114.225 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -65.93 -22.98 66.53 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 120.112 -1.618 . . . . 10.0 113.821 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -77.26 -42.1 38.41 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.55 -1.344 . . . . 10.0 111.691 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.22 -47.91 54.7 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.444 1.498 . . . . 10.0 111.211 166.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -52.56 -70.76 0.08 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.626 1.97 . . . . 10.0 112.031 168.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -56.83 -32.76 66.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.26 1.024 . . . . 10.0 113.448 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.3 tp -50.17 -40.66 47.5 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.858 1.663 . . . . 10.0 111.871 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -105.29 -39.72 6.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.411 0.685 . . . . 10.0 112.521 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.3 p -61.6 -43.12 99.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.793 1.633 . . . . 10.0 113.794 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.299 68.0 p -69.94 -40.62 13.35 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 115.234 1.568 . . . . 10.0 115.234 -175.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.37 -42.98 62.93 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.208 2.605 . . . . 10.0 115.083 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.29 -47.43 86.04 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.484 -0.76 . . . . 10.0 111.684 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.11 -49.55 51.35 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.745 1.618 . . . . 10.0 111.527 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -57.11 -47.4 81.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.273 1.029 . . . . 10.0 113.146 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.24 78.11 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.843 0.857 . . . . 10.0 112.891 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.33 -54.02 37.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.179 169.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.14 88.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.65 -54.69 38.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.942 0.897 . . . . 10.0 112.063 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.13 79.42 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.682 0.793 . . . . 10.0 112.729 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.78 -38.54 91.49 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.42 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.269 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.46 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.845 1.658 . . . . 10.0 112.086 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.51 135.88 54.32 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.662 0.616 . . . . 10.0 112.662 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.84 -39.73 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.438 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.18 5.34 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.148 1.356 . . . . 10.0 115.25 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.08 -46.8 87.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.39 -52.91 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.161 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.66 -51.3 67.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.68 -59.82 4.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.366 2.266 . . . . 10.0 114.793 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.05 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 123.667 0.787 . . . . 10.0 111.398 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.17 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.617 0.627 . . . . 10.0 112.664 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.61 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.46 0.911 . . . . 10.0 113.46 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.02 -47.21 78.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.319 0.648 . . . . 10.0 111.684 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -54.23 5.95 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.825 1.203 . . . . 10.0 113.013 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.44 -51.22 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.744 0.818 . . . . 10.0 112.043 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 52.5 ttp -48.62 -57.15 6.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.019 1.327 . . . . 10.0 111.659 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.7 mm -67.6 -46.24 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.227 0.611 . . . . 10.0 111.907 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.44 -55.06 21.42 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.122 1.344 . . . . 10.0 113.263 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.5 p -61.08 -36.13 78.82 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.235 -1.156 . . . . 10.0 112.693 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.66 -57.17 12.84 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-N 119.158 0.89 . . . . 10.0 113.727 165.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.28 -50.71 37.82 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.668 2.787 . . . . 10.0 111.124 173.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.35 -50.55 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.587 1.155 . . . . 10.0 111.697 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.39 -59.21 8.63 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.713 1.625 . . . . 10.0 112.062 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.89 -37.84 20.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.913 2.085 . . . . 10.0 113.563 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.43 -6.63 27.35 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.7 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.199 -1.563 . . . . 10.0 110.398 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.65 71.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.255 2.622 . . . . 10.0 113.251 177.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.72 106.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.86 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.732 1.213 . . . . 10.0 114.101 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.02 15.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.7 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -53.7 -42.01 67.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.855 0.752 . . . . 10.0 110.807 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.35 -32.29 71.27 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.898 1.279 . . . . 10.0 114.213 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.97 -51.76 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.015 0.825 . . . . 10.0 109.608 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -61.96 -45.24 94.51 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 174.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -51.38 -49.24 61.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.35 1.06 . . . . 10.0 112.531 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.53 -52.63 64.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.191 0.996 . . . . 10.0 111.894 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.53 -52.0 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.831 1.252 . . . . 10.0 111.619 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -54.65 -47.06 73.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 10.0 111.99 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.8 m -60.49 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.53 1.532 . . . . 10.0 112.52 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.58 -48.43 80.95 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.19 0.905 . . . . 10.0 112.312 172.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.08 81.68 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.737 0.815 . . . . 10.0 112.484 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.05 -55.07 35.14 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.182 0.993 . . . . 10.0 112.101 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.13 -48.06 68.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.386 1.474 . . . . 10.0 111.947 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.07 -54.58 23.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 10.0 112.46 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.47 -55.17 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.787 0.835 . . . . 10.0 110.751 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.7 mt -57.42 -35.79 70.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.35 -0.833 . . . . 10.0 112.914 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.3 -58.23 9.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.042 0.937 . . . . 10.0 112.994 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.296 -0.859 . . . . 10.0 111.469 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.75 -49.42 75.3 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.873 1.215 . . . . 10.0 112.13 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.882 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.7 -21.95 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.671 1.188 . . . . 10.0 113.453 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.48 51.33 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.227 1.811 . . . . 10.0 113.037 -166.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.1 m -52.05 -56.42 14.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.64 -50.59 65.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.121 0.962 . . . . 10.0 112.314 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.03 82.89 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.161 0.984 . . . . 10.0 112.135 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.52 80.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.097 1.759 . . . . 10.0 114.195 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.61 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.432 1.893 . . . . 10.0 114.894 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.89 -92.61 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.521 1.629 . . . . 10.0 114.185 -170.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.99 72.63 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.767 3.227 . . . . 10.0 105.539 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.87 -46.23 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.269 1.979 . . . . 10.0 113.06 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.12 67.94 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.247 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.248 0.619 . . . . 10.0 111.937 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.93 -56.2 24.6 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.886 0.874 . . . . 10.0 112.765 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.16 -53.26 60.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 113.028 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.51 45.76 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.16 -48.43 78.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.99 -49.62 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.462 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.65 69.0 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.78 -47.78 30.53 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.816 2.046 . . . . 10.0 111.044 174.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.44 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.845 0.458 . . . . 10.0 111.274 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -52.23 -47.07 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.075 0.95 . . . . 10.0 111.989 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.0 m -58.62 -62.96 1.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.437 2.695 . . . . 10.0 111.822 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.33 -50.34 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.675 1.19 . . . . 10.0 111.071 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.85 -60.2 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.053 0.941 . . . . 10.0 112.068 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.54 -50.05 75.41 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.663 0.665 . . . . 10.0 112.743 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -53.39 -50.84 64.29 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.752 0.821 . . . . 10.0 111.382 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -58.52 -21.07 50.98 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.11 73.76 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.684 1.129 . . . . 10.0 113.225 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -45.01 -53.71 15.46 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 115.18 1.548 . . . . 10.0 115.18 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -59.39 -35.25 96.94 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.99 1.793 . . . . 10.0 113.188 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.4 t -67.22 -54.97 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.326 1.05 . . . . 10.0 111.066 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.77 -44.77 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.111 0.869 . . . . 10.0 112.161 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -56.33 -52.2 65.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.984 0.914 . . . . 10.0 112.321 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.4 tp -53.91 -45.42 71.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.513 1.125 . . . . 10.0 112.5 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -87.45 -5.28 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 115.248 1.573 . . . . 10.0 115.248 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.56 -169.3 32.76 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 122.611 1.117 . . . . 10.0 113.805 -168.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -40.73 64.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.165 -1.017 . . . . 10.0 111.838 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -54.56 -32.27 58.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.406 2.683 . . . . 10.0 115.379 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.92 0.99 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 10.0 113.38 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.18 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.318 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.45 65.28 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.29 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -68.73 153.79 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.15 -39.81 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.199 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.36 -52.38 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.681 1.363 . . . . 10.0 114.681 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.9 -40.5 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.674 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.31 -49.75 42.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.533 0.606 . . . . 10.0 111.974 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.72 -47.07 83.45 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.983 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.3 -52.33 62.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.016 0.926 . . . . 10.0 112.101 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 92.9 mt -52.51 -58.72 5.86 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 124.321 1.048 . . . . 10.0 110.003 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -52.08 -47.08 65.36 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.692 -1.147 . . . . 10.0 112.35 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.73 -52.14 57.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.308 1.413 . . . . 10.0 112.765 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.84 -49.64 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.461 1.104 . . . . 10.0 111.377 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mp -55.62 -52.86 62.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.56 . . . . 10.0 111.702 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -53.54 -56.41 17.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.957 2.103 . . . . 10.0 111.047 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 43.6 t -50.58 -51.58 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.169 0.987 . . . . 10.0 111.374 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.2 t -61.59 -43.65 98.46 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.603 0.594 . . . . 10.0 112.603 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.37 -24.61 61.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.108 1.763 . . . . 10.0 114.192 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -100.14 -71.74 0.69 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.716 1.206 . . . . 10.0 111.236 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.13 -50.65 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.465 1.106 . . . . 10.0 111.539 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.11 -55.92 25.78 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.134 0.873 . . . . 10.0 113.083 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -43.06 -56.88 3.14 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.003 2.121 . . . . 10.0 112.382 166.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.97 -40.79 74.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.338 0.971 . . . . 10.0 114.095 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.75 -27.2 64.75 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 115.962 1.838 . . . . 10.0 115.962 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.52 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.78 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.92 0.888 . . . . 10.0 113.2 -172.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.5 5.12 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.308 1.596 . . . . 10.0 115.308 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.25 0.32 15.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.217 1.007 . . . . 10.0 113.292 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.026 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.21 1.87 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.812 0.845 . . . . 10.0 110.891 170.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.97 77.04 7.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.914 0.885 . . . . 10.0 112.03 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.464 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.48 0.3 OUTLIER 71.77 -55.37 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.765 1.226 . . . . 10.0 110.668 -175.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.781 3.562 . . . . 10.0 119.618 171.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.45 2.7 . . . . 10.0 113.408 166.649 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.305 2.642 . . . . 10.0 114.486 155.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.47 138.01 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.384 1.873 . . . . 10.0 113.344 -158.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.8 -165.18 1.69 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 113.978 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.76 41.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 127.403 2.43 . . . . 10.0 111.491 168.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.57 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.634 -168.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.67 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.522 2.293 . . . . 10.0 113.212 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.15 4.32 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.782 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.41 -43.08 61.88 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.587 176.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.62 83.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.912 0.885 . . . . 10.0 109.315 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.35 -52.64 62.84 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.377 0.671 . . . . 10.0 111.928 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.187 0.595 . . . . 10.0 112.245 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.83 51.95 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.412 1.485 . . . . 10.0 113.287 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.64 -44.98 84.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -57.06 10.07 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.247 0.927 . . . . 10.0 111.3 166.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -48.98 -52.46 24.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.642 1.177 . . . . 10.0 112.302 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.9 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.148 0.979 . . . . 10.0 112.166 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.66 -50.29 73.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.682 0.793 . . . . 10.0 112.579 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -53.69 -50.35 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.503 1.121 . . . . 10.0 111.348 175.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.36 -58.28 15.41 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.338 0.971 . . . . 10.0 113.471 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.91 79.79 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.539 1.17 . . . . 10.0 112.146 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.29 -42.53 73.99 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.956 1.265 . . . . 10.0 113.185 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.9 m -61.82 -58.75 6.75 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.852 0.861 . . . . 10.0 111.448 171.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.79 -58.04 9.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.974 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.7 82.13 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.176 0.806 . . . . 10.0 113.176 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.602 1.161 . . . . 10.0 113.64 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.718 1.723 . . . . 10.0 110.86 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.305 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 115.609 1.004 . . . . 10.0 115.609 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.02 92.93 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.46 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.798 0.713 . . . . 10.0 112.441 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.931 166.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.174 -1.375 . . . . 10.0 113.866 174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.769 1.293 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.58 -29.67 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.756 2.971 . . . . 10.0 113.682 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.17 -40.07 22.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.078 1.351 . . . . 10.0 113.534 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.43 19.58 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.434 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 111.015 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.94 -50.25 73.17 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.35 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.41 -51.26 65.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.353 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.2 mt -48.51 -58.0 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.892 1.277 . . . . 10.0 110.193 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -68.54 -16.48 63.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.218 1.407 . . . . 10.0 113.819 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -88.66 -39.72 13.83 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.624 1.102 . . . . 10.0 112.188 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.34 -42.17 90.89 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.457 -0.777 . . . . 10.0 112.29 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -41.13 -61.84 1.21 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 126.214 1.806 . . . . 10.0 113.782 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.13 -26.83 17.6 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.028 2.485 . . . . 10.0 114.436 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.69 89.49 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.504 1.502 . . . . 10.0 113.387 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -55.54 -53.81 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.426 1.09 . . . . 10.0 109.128 170.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -42.63 71.67 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.312 1.045 . . . . 10.0 113.751 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -52.93 -56.73 13.79 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.575 1.534 . . . . 10.0 111.915 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.96 -52.51 32.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.347 1.459 . . . . 10.0 110.735 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.21 62.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 118.168 -0.92 . . . . 10.0 112.982 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -56.3 -40.91 75.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.37 1.441 . . . . 10.0 113.013 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.23 -54.57 34.25 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.179 1.354 . . . . 10.0 111.333 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.66 -41.03 61.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.259 1.577 . . . . 10.0 115.259 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.91 -50.85 61.1 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.451 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.5 48.9 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.328 1.051 . . . . 10.0 113.835 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.01 43.21 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.26 1.578 . . . . 10.0 115.26 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.12 3.59 61.28 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.302 0.881 . . . . 10.0 115.302 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.4 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.035 2.134 . . . . 10.0 109.036 172.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.028 0.931 . . . . 10.0 111.0 166.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.887 0.875 . . . . 10.0 109.712 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.56 129.54 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.068 1.347 . . . . 10.0 110.976 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.74 116.3 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.384 -1.044 . . . . 10.0 109.384 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.76 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.695 -0.962 . . . . 10.0 110.695 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.37 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.708 2.243 . . . . 10.0 118.708 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.54 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.263 -165.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.87 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.081 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.47 120.82 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.53 131.92 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.11 126.38 22.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.0 1.72 . . . . 10.0 111.684 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.746 1.26 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.3 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.54 -31.14 61.87 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.231 1.012 . . . . 10.0 112.305 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 82' ' ' ARG . 16.1 ttm-85 -46.97 -44.48 20.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.198 2.199 . . . . 10.0 113.104 167.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -82.12 -38.9 24.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.651 1.581 . . . . 10.0 111.794 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.17 -49.25 52.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.073 1.349 . . . . 10.0 111.629 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -53.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.038 1.735 . . . . 10.0 111.849 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -54.95 -33.23 62.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.936 -1.031 . . . . 10.0 113.549 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.13 -40.39 46.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.399 1.48 . . . . 10.0 112.051 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.28 -46.1 4.5 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.253 1.021 . . . . 10.0 112.303 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.1 m -52.32 -43.68 64.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.879 1.271 . . . . 10.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 m -72.87 -45.5 8.79 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 114.313 1.227 . . . . 10.0 114.313 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.88 -41.63 69.36 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.339 2.693 . . . . 10.0 115.1 167.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.0 mt -59.6 -47.14 86.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.285 0.634 . . . . 10.0 111.431 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.8 -51.45 22.5 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.349 1.86 . . . . 10.0 111.412 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.06 -47.28 83.64 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.92 1.288 . . . . 10.0 113.165 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.29 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.849 0.859 . . . . 10.0 112.889 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.34 -53.96 37.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.256 0.934 . . . . 10.0 111.2 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -42.05 88.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.62 0.768 . . . . 10.0 112.087 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 37.95 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.017 0.927 . . . . 10.0 112.024 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.29 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.752 0.821 . . . . 10.0 112.699 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.76 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.81 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.312 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.45 12.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.847 1.659 . . . . 10.0 112.159 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.92 54.38 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.69 2.61 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.523 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.79 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.46 -52.9 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.07 1.348 . . . . 10.0 111.128 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.61 -51.26 68.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.88 43.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.504 0.722 . . . . 10.0 110.923 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.357 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.82 -46.37 74.53 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.044 0.757 . . . . 10.0 113.044 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.52 -45.24 85.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.138 . . . . 10.0 112.08 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.99 -56.76 5.07 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.618 1.58 . . . . 10.0 112.797 166.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.46 -52.1 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 10.0 111.054 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 55.1 ttp -48.0 -59.79 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.855 1.262 . . . . 10.0 112.037 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.4 -48.42 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.658 0.783 . . . . 10.0 111.889 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.36 -46.75 57.45 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.631 1.11 . . . . 10.0 113.016 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 63.0 m -59.26 -45.36 91.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.686 1.195 . . . . 10.0 111.779 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.29 -51.7 20.23 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.856 0.741 . . . . 10.0 112.768 167.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.4 -48.36 68.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.077 2.551 . . . . 10.0 111.693 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.71 -49.15 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.397 1.479 . . . . 10.0 111.967 172.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.22 -59.25 9.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.911 1.719 . . . . 10.0 112.387 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.03 -42.94 3.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.313 2.645 . . . . 10.0 113.254 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.0 mt -101.42 -6.67 23.71 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.499 1.666 . . . . 10.0 115.499 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.7 10.36 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.19 -1.569 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.47 -49.62 72.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.187 2.595 . . . . 10.0 113.268 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.087 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.9 -59.53 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.07 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.501 1.52 . . . . 10.0 113.503 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.56 63.15 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.15 -41.26 68.24 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.89 0.768 . . . . 10.0 110.899 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.97 -31.98 69.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.837 1.255 . . . . 10.0 114.221 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.076 0.853 . . . . 10.0 109.713 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -60.03 -48.32 82.19 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -48.93 -49.61 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.575 1.079 . . . . 10.0 113.014 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.85 63.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 10.0 111.945 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.69 -51.28 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.983 1.313 . . . . 10.0 111.786 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.2 t -55.89 -46.24 78.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.615 1.166 . . . . 10.0 111.793 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.9 m -60.88 -42.64 98.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 10.0 112.557 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.78 79.17 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.228 0.922 . . . . 10.0 112.31 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.02 82.52 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.587 0.755 . . . . 10.0 112.607 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -55.38 -55.33 32.86 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.319 1.048 . . . . 10.0 112.142 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 tt -51.24 -50.54 58.98 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.949 1.7 . . . . 10.0 111.185 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -50.93 -54.9 20.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.021 0.928 . . . . 10.0 112.792 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.1 -54.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.592 0.757 . . . . 10.0 110.861 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.46 -36.58 69.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.692 0.797 . . . . 10.0 113.115 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.16 9.45 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.036 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.87 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.467 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.78 -49.44 75.29 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.115 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.087 -1.633 . . . . 10.0 112.871 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.68 -21.99 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 10.0 113.466 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.76 -79.06 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.621 0.629 . . . . 10.0 113.553 171.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.236 1.814 . . . . 10.0 113.045 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -50.55 65.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.057 0.932 . . . . 10.0 112.297 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.07 82.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.133 0.973 . . . . 10.0 112.167 173.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.45 80.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.532 1.308 . . . . 10.0 114.532 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.25 1.2 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.033 1.733 . . . . 10.0 114.254 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.65 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.391 1.876 . . . . 10.0 114.878 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.93 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.7 153.92 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.841 3.256 . . . . 10.0 105.592 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.82 -46.23 35.14 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.275 1.983 . . . . 10.0 113.06 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.15 68.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.236 173.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.1 -53.05 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.027 0.931 . . . . 10.0 109.832 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.8 75.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.274 0.63 . . . . 10.0 111.892 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.15 25.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.882 0.873 . . . . 10.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.25 -53.22 60.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 112.987 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.53 45.44 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.115 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.48 78.54 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.91 -49.63 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.843 0.747 . . . . 10.0 110.522 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.64 69.02 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.81 30.15 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.889 2.075 . . . . 10.0 111.037 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.836 0.454 . . . . 10.0 111.263 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.4 t -52.08 -47.39 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 112.209 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -65.29 0.66 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.209 2.604 . . . . 10.0 111.46 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.93 -48.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.783 1.233 . . . . 10.0 111.548 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.7 t -60.52 -61.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.945 0.898 . . . . 10.0 112.653 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.08 -48.78 73.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.766 0.712 . . . . 10.0 111.608 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -50.11 -53.03 30.14 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.647 1.179 . . . . 10.0 112.53 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m -53.14 -32.02 45.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.278 1.031 . . . . 10.0 113.589 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.85 94.83 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.03 1.122 . . . . 10.0 114.03 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -46.87 -56.67 11.0 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 115.098 1.518 . . . . 10.0 115.098 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.59 -36.7 91.89 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.526 2.151 . . . . 10.0 113.056 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.85 -57.94 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.393 1.077 . . . . 10.0 110.745 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.73 -34.66 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 118.692 -0.671 . . . . 10.0 112.605 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -58.73 -56.1 26.59 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.547 1.139 . . . . 10.0 111.944 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.2 tt -58.36 -41.69 85.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.915 0.886 . . . . 10.0 112.697 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -81.27 -5.52 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.22 -169.29 33.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-O 122.587 1.104 . . . . 10.0 113.953 -169.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.43 65.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.847 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.46 -16.76 64.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.647 1.721 . . . . 10.0 115.647 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.05 -105.91 1.08 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.32 1.418 . . . . 10.0 113.799 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.17 35.81 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.617 -1.519 . . . . 10.0 109.325 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.894 0.318 . . . . 10.0 113.894 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.725 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.29 133.35 24.88 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.69 153.8 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.786 2.99 . . . . 10.0 111.433 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.77 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.307 1.043 . . . . 10.0 112.213 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.35 -52.35 22.07 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.712 1.375 . . . . 10.0 114.712 176.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.92 -40.5 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.476 1.11 . . . . 10.0 109.692 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.32 -49.78 42.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.513 0.597 . . . . 10.0 111.973 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.04 83.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.001 1.72 . . . . 10.0 112.993 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.35 -52.35 62.14 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.02 0.928 . . . . 10.0 112.03 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -58.52 6.5 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.363 1.065 . . . . 10.0 109.975 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -53.44 -44.95 69.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.759 -1.115 . . . . 10.0 112.839 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.45 -53.0 57.66 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.66 -47.51 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.819 1.248 . . . . 10.0 111.678 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.12 -51.62 68.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.629 1.571 . . . . 10.0 111.815 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.21 -51.63 69.14 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.917 1.687 . . . . 10.0 111.788 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.1 t -48.83 -51.52 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.669 1.188 . . . . 10.0 110.987 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.5 m -58.81 -50.71 72.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.461 1.104 . . . . 10.0 111.823 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.91 -28.23 64.37 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.594 1.558 . . . . 10.0 114.459 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.75 -72.16 0.5 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.753 1.221 . . . . 10.0 110.017 173.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.35 -49.88 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.084 1.354 . . . . 10.0 111.575 -167.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.82 -53.66 35.18 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.163 0.887 . . . . 10.0 112.903 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -44.94 -58.02 3.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.542 1.937 . . . . 10.0 112.293 166.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.49 -38.5 70.62 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.005 0.812 . . . . 10.0 113.235 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -70.29 -27.65 64.57 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 116.215 1.932 . . . . 10.0 116.215 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.68 -57.49 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.63 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.921 0.889 . . . . 10.0 113.2 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.53 5.15 2.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.37 0.41 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.18 0.992 . . . . 10.0 113.272 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.08 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.011 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.86 76.98 7.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.874 0.87 . . . . 10.0 112.106 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.869 2.868 . . . . 10.0 116.475 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.719 1.208 . . . . 10.0 110.644 -175.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.21 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.666 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.483 2.713 . . . . 10.0 113.459 166.653 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.834 -2.032 . . . . 10.0 105.789 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 129.651 3.18 . . . . 10.0 117.196 160.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.65 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.306 2.642 . . . . 10.0 114.484 155.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.46 137.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.407 1.883 . . . . 10.0 113.345 -158.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.77 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.22 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.465 2.459 . . . . 10.0 111.487 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.62 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.25 -2.786 . . . . 10.0 116.634 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.543 2.301 . . . . 10.0 113.217 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -67.19 4.31 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.782 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.11 61.74 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.534 -0.729 . . . . 10.0 112.615 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.6 84.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.38 -52.63 62.91 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.448 0.699 . . . . 10.0 111.882 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.59 56.42 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.183 0.593 . . . . 10.0 112.218 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 51.97 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.98 10.25 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.149 0.881 . . . . 10.0 111.202 166.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.27 -52.3 28.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.574 1.15 . . . . 10.0 112.187 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.122 0.969 . . . . 10.0 112.167 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.3 mt -57.86 -50.14 74.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.449 0.699 . . . . 10.0 112.751 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -49.7 68.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.442 1.097 . . . . 10.0 111.248 175.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.32 15.2 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.3 0.952 . . . . 10.0 113.608 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.02 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.485 1.142 . . . . 10.0 112.089 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -41.59 75.74 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.863 1.22 . . . . 10.0 113.232 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.55 -58.44 7.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.823 0.849 . . . . 10.0 111.421 171.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -40.98 62.49 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.045 0.938 . . . . 10.0 110.944 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.1 9.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.968 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.68 81.85 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.257 0.836 . . . . 10.0 113.257 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.46 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.586 1.154 . . . . 10.0 113.62 169.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.77 1.748 . . . . 10.0 110.892 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.013 . . . . 10.0 115.634 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.58 -44.96 93.16 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.162 2.185 . . . . 10.0 113.589 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.435 2.694 . . . . 10.0 116.939 166.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.64 -50.92 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.179 -1.373 . . . . 10.0 113.879 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.771 1.294 . . . . 10.0 110.957 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.59 -29.63 89.65 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.743 2.962 . . . . 10.0 113.69 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.09 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.108 1.363 . . . . 10.0 113.564 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.44 19.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.405 172.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.967 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.97 -50.23 73.29 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.334 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.29 65.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.337 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.53 -57.42 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.851 1.26 . . . . 10.0 110.533 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -67.99 -20.75 65.05 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.965 1.306 . . . . 10.0 113.552 -172.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -84.07 -40.92 17.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.414 1.086 . . . . 10.0 112.18 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.07 -41.52 88.15 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.469 -0.77 . . . . 10.0 112.983 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.37 -62.84 1.45 Allowed Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 124.603 1.161 . . . . 10.0 113.447 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.79 -26.34 32.56 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.001 2.467 . . . . 10.0 113.771 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.86 -45.94 83.92 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 120.547 1.522 . . . . 10.0 113.156 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.76 -51.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 120.982 -1.073 . . . . 10.0 109.302 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.82 72.84 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.42 0.896 . . . . 10.0 113.42 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -52.81 -56.42 15.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.119 1.368 . . . . 10.0 111.816 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.67 -52.78 28.58 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.263 1.425 . . . . 10.0 110.749 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.29 -47.97 62.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.99 0.916 . . . . 10.0 112.98 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.15 -41.2 75.04 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.365 1.439 . . . . 10.0 113.11 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.57 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.948 1.249 . . . . 10.0 111.297 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.61 -41.12 61.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.86 -50.85 61.22 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.525 0.73 . . . . 10.0 110.485 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.5 48.82 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.539 0.976 . . . . 10.0 115.539 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.55 61.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.42 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.042 2.137 . . . . 10.0 109.036 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.57 171.13 15.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.028 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.01 53.42 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.912 0.885 . . . . 10.0 109.712 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.51 129.62 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.079 1.352 . . . . 10.0 110.96 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.444 -1.022 . . . . 10.0 109.444 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.37 38.2 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.42 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.632 -0.987 . . . . 10.0 110.632 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.78 -3.35 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.317 1.558 . . . . 10.0 112.28 -165.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.93 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -89.52 120.74 69.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -165.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -61.49 131.92 38.28 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.137 171.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.1 126.33 21.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.055 1.742 . . . . 10.0 111.752 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.63 85.01 4.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.958 1.361 . . . . 10.0 113.085 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.36 -28.28 66.71 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.898 -1.126 . . . . 10.0 113.928 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.8 38.3 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.26 1.024 . . . . 10.0 112.491 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -54.27 -48.3 71.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.032 1.333 . . . . 10.0 112.714 168.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -71.25 -38.49 71.91 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.485 1.114 . . . . 10.0 110.993 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.52 67.09 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.797 1.239 . . . . 10.0 112.367 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.15 -69.51 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.883 1.673 . . . . 10.0 111.624 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -56.84 -32.5 65.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.067 1.347 . . . . 10.0 112.836 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.35 -44.27 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.679 1.592 . . . . 10.0 111.876 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -100.14 -41.94 6.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 10.0 112.593 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.4 p -62.6 -42.72 99.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.836 1.198 . . . . 10.0 113.925 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 71.5 p -65.85 -44.01 60.98 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 114.663 1.357 . . . . 10.0 114.663 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -43.95 53.12 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.053 2.502 . . . . 10.0 115.637 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.46 -46.4 88.87 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.491 -0.756 . . . . 10.0 111.454 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 tp -50.76 -49.2 58.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.567 1.547 . . . . 10.0 112.038 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.09 -47.47 83.11 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.94 1.296 . . . . 10.0 112.513 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.22 78.28 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.78 0.832 . . . . 10.0 112.889 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.31 -54.04 36.64 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.309 0.959 . . . . 10.0 111.173 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.06 88.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 10.0 112.14 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 38.1 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 112.002 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.35 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.682 0.793 . . . . 10.0 112.704 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.76 -38.57 91.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.81 1.43 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.055 1.342 . . . . 10.0 112.296 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.9 47.62 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.443 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.93 54.46 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.664 0.616 . . . . 10.0 112.664 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.72 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.499 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.04 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.339 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.43 -52.9 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.075 1.35 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.27 67.89 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.87 43.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.429 0.692 . . . . 10.0 110.945 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.655 0.782 . . . . 10.0 111.375 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.9 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.78 -46.58 74.45 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -56.07 -48.3 76.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.896 0.879 . . . . 10.0 110.903 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.79 -54.57 4.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.951 1.263 . . . . 10.0 113.195 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.15 -51.01 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.903 0.881 . . . . 10.0 112.119 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -54.19 -51.96 62.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.866 1.212 . . . . 10.0 111.987 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.1 mm -69.87 -45.53 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.801 -0.562 . . . . 10.0 111.034 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.2 -58.21 11.36 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.21 1.386 . . . . 10.0 113.345 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.0 p -61.31 -33.71 74.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.234 -1.156 . . . . 10.0 112.735 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.95 -55.29 19.01 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 119.395 0.998 . . . . 10.0 113.659 162.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tt -52.78 -45.37 67.11 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.921 2.889 . . . . 10.0 110.881 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.14 -50.4 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.55 1.54 . . . . 10.0 112.139 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.0 -58.98 9.34 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.919 1.723 . . . . 10.0 112.398 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.92 -43.3 3.03 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.057 2.543 . . . . 10.0 113.466 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.43 -6.33 24.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.461 1.652 . . . . 10.0 115.461 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.63 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.222 -1.549 . . . . 10.0 110.41 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.68 71.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.26 2.624 . . . . 10.0 113.251 177.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.61 106.3 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.52 3.03 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.771 1.229 . . . . 10.0 114.065 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.05 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.48 1.512 . . . . 10.0 113.519 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.63 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.907 1.447 . . . . 10.0 114.907 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -53.91 -41.81 68.05 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.914 0.779 . . . . 10.0 110.75 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.72 -31.49 69.52 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.355 1.243 . . . . 10.0 114.355 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.44 -52.01 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.041 0.837 . . . . 10.0 109.551 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -61.84 -42.56 99.19 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -53.67 -49.2 68.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.233 1.013 . . . . 10.0 112.759 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -52.58 64.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.636 0.774 . . . . 10.0 111.503 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.6 -55.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.987 1.315 . . . . 10.0 112.051 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 p -57.04 -43.63 82.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.905 0.882 . . . . 10.0 112.696 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -43.93 98.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.758 1.223 . . . . 10.0 112.157 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.41 81.7 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.229 0.922 . . . . 10.0 112.561 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.23 78.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.989 0.916 . . . . 10.0 112.43 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.8 ttp -56.56 -51.06 70.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.285 1.034 . . . . 10.0 112.382 171.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.02 -48.06 76.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.32 1.448 . . . . 10.0 112.681 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -48.53 -53.52 17.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.394 1.078 . . . . 10.0 111.794 169.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.72 -55.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.68 0.792 . . . . 10.0 110.899 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -56.52 -36.42 69.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.226 0.824 . . . . 10.0 113.226 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.28 -58.15 9.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.049 0.939 . . . . 10.0 113.059 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.5 -40.82 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.289 -0.863 . . . . 10.0 111.429 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.84 -49.4 75.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.909 1.231 . . . . 10.0 112.093 171.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.99 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.858 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.615 1.166 . . . . 10.0 113.447 -174.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.11 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.651 0.643 . . . . 10.0 113.554 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.242 1.817 . . . . 10.0 113.011 -166.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.06 -56.46 14.2 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.005 1.113 . . . . 10.0 114.005 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.69 -50.55 65.61 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.096 0.951 . . . . 10.0 112.272 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.14 -46.02 83.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.16 0.984 . . . . 10.0 112.151 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.51 80.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.43 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.124 1.77 . . . . 10.0 114.235 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.59 29.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.425 1.89 . . . . 10.0 114.851 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.5 1.619 . . . . 10.0 114.164 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.805 3.242 . . . . 10.0 105.562 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.84 -46.22 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.306 2.004 . . . . 10.0 113.069 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.11 68.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.057 2.943 . . . . 10.0 113.236 173.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.82 75.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.282 0.633 . . . . 10.0 111.917 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.19 24.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.913 0.885 . . . . 10.0 112.698 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.226 1.011 . . . . 10.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.55 -49.53 45.86 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.26 0.624 . . . . 10.0 111.115 174.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.15 -48.41 78.76 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.94 -49.7 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.801 0.728 . . . . 10.0 110.467 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.51 -51.63 69.07 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.8 -47.76 30.85 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 126.852 2.061 . . . . 10.0 111.04 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.48 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.862 0.465 . . . . 10.0 111.271 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.1 -47.33 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.078 0.951 . . . . 10.0 112.093 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.4 m -58.36 -64.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.126 2.57 . . . . 10.0 111.492 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -50.18 -49.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.676 1.19 . . . . 10.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.36 -63.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.974 0.91 . . . . 10.0 112.043 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.58 -45.45 81.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.142 0.883 . . . . 10.0 112.378 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -53.03 -51.88 60.27 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.107 0.963 . . . . 10.0 112.236 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 52.6 p -52.39 -33.19 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.243 1.201 . . . . 10.0 114.243 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.32 97.43 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.973 1.101 . . . . 10.0 113.973 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -46.87 -58.07 7.75 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 114.769 1.396 . . . . 10.0 114.769 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.55 -33.5 93.64 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.174 1.916 . . . . 10.0 113.429 177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.1 t -64.23 -58.02 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.143 0.883 . . . . 10.0 110.659 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.69 -35.06 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.46 0.704 . . . . 10.0 112.77 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -59.63 -55.18 37.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.563 1.145 . . . . 10.0 112.115 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.81 -41.68 82.67 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.764 0.826 . . . . 10.0 112.494 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -81.42 -5.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 115.003 1.483 . . . . 10.0 115.003 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.4 -169.31 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 122.576 1.098 . . . . 10.0 113.924 -168.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.56 65.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.822 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -67.92 -15.74 63.75 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.542 1.682 . . . . 10.0 115.542 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.53 -105.94 1.05 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 120.428 1.467 . . . . 10.0 114.03 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.304 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.32 1.35 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 113.855 0.302 . . . . 10.0 113.855 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.77 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.12 1.768 . . . . 10.0 108.692 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.26 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.368 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.73 153.81 72.45 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.456 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.297 1.039 . . . . 10.0 112.199 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.3 -52.42 21.47 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 10.0 114.685 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.36 -49.77 42.93 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.563 0.62 . . . . 10.0 111.937 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.7 -47.05 83.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.979 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.28 -52.35 62.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.974 0.91 . . . . 10.0 112.123 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -58.96 5.1 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.303 1.041 . . . . 10.0 109.992 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -52.32 -44.57 65.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.679 -1.153 . . . . 10.0 112.6 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -55.26 -51.76 65.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.608 1.549 . . . . 10.0 112.511 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.43 -46.68 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.936 1.294 . . . . 10.0 111.629 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.91 -52.68 64.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.556 1.542 . . . . 10.0 111.601 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.57 -54.11 49.78 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.785 1.634 . . . . 10.0 111.933 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.94 -43.88 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.22 -0.925 . . . . 10.0 112.456 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 55.4 p -62.96 -44.84 94.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.74 0.7 . . . . 10.0 112.061 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.05 -28.22 69.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.405 1.482 . . . . 10.0 114.279 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.65 -74.16 0.53 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.507 1.123 . . . . 10.0 110.898 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.05 -48.26 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.675 1.59 . . . . 10.0 111.245 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.54 -55.69 27.36 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.094 0.854 . . . . 10.0 112.985 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -45.18 -56.3 4.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.414 1.886 . . . . 10.0 112.284 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.04 -40.03 71.93 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.072 0.844 . . . . 10.0 113.635 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.48 -27.69 64.4 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 115.774 1.768 . . . . 10.0 115.774 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.42 -57.52 11.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 165.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.65 0.86 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.907 0.883 . . . . 10.0 113.168 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.58 5.24 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.31 15.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.266 1.026 . . . . 10.0 113.28 172.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.038 0.935 . . . . 10.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.12 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.771 0.828 . . . . 10.0 110.973 170.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.85 76.99 7.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.87 0.868 . . . . 10.0 112.117 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.471 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.41 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.622 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.51 39.93 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.519 2.727 . . . . 10.0 113.439 166.61 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.782 -2.056 . . . . 10.0 105.826 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.51 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.615 3.166 . . . . 10.0 117.211 160.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.1 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.356 2.662 . . . . 10.0 114.417 155.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.365 1.866 . . . . 10.0 113.391 -158.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.78 -165.13 1.69 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.306 1.842 . . . . 10.0 114.055 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.96 2.84 40.82 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 127.489 2.471 . . . . 10.0 111.487 168.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.55 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.96 -60.65 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.488 2.281 . . . . 10.0 113.191 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -67.23 4.37 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.8 2.44 . . . . 10.0 115.742 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.13 61.79 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.464 -0.772 . . . . 10.0 112.621 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.41 -52.65 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.422 0.689 . . . . 10.0 111.83 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.33 -53.59 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.174 0.59 . . . . 10.0 112.225 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 -46.81 52.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.368 1.467 . . . . 10.0 113.305 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.61 -45.04 84.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.83 -58.68 7.4 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.355 0.978 . . . . 10.0 110.765 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -48.4 -52.34 22.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.745 1.218 . . . . 10.0 112.072 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 -58.9 5.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.175 0.99 . . . . 10.0 112.15 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.74 -49.77 75.44 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.707 0.803 . . . . 10.0 112.207 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.2 mmm -57.78 -45.95 85.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.374 0.67 . . . . 10.0 111.603 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.47 -58.1 16.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.46 1.029 . . . . 10.0 113.895 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.21 -45.99 79.66 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.406 1.103 . . . . 10.0 112.077 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -42.02 75.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.821 1.2 . . . . 10.0 113.168 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 -58.58 7.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.676 0.79 . . . . 10.0 111.474 171.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.01 62.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.023 0.929 . . . . 10.0 110.974 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.78 -57.99 9.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.582 1.153 . . . . 10.0 113.011 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.68 82.0 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.621 1.168 . . . . 10.0 113.637 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.748 . . . . 10.0 110.878 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.937 2.495 . . . . 10.0 109.365 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.89 23.09 0.86 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.94 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.614 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.9 m -79.61 -50.87 10.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.231 -1.35 . . . . 10.0 113.902 174.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.52 6.44 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.794 1.309 . . . . 10.0 110.975 -172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.54 -29.69 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.705 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.66 2.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.111 0.565 . . . . 10.0 111.447 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.53 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.056 1.342 . . . . 10.0 113.588 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.49 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.249 1.42 . . . . 10.0 113.468 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.13 61.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.486 0.714 . . . . 10.0 110.946 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.91 -50.28 73.03 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.26 65.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.341 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.02 1.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.407 0.892 . . . . 10.0 113.407 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.36 -57.26 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.921 1.288 . . . . 10.0 110.645 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -68.39 -20.17 64.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.999 1.32 . . . . 10.0 113.508 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.9 m -84.92 -39.69 17.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.488 1.115 . . . . 10.0 112.303 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.59 -42.89 97.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.8 t -43.39 -63.77 0.93 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.898 1.279 . . . . 10.0 112.482 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.43 -27.56 33.52 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.94 2.426 . . . . 10.0 114.217 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.79 89.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.459 1.481 . . . . 10.0 113.033 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.2 mt -61.84 -46.97 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 120.86 -1.15 . . . . 10.0 109.908 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.61 71.14 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.027 0.751 . . . . 10.0 113.027 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -50.82 -56.87 10.12 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.193 1.397 . . . . 10.0 111.677 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -48.91 -53.39 19.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.237 1.415 . . . . 10.0 111.087 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.99 -48.34 63.33 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.034 0.933 . . . . 10.0 112.909 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -55.22 -41.94 72.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.309 1.413 . . . . 10.0 113.287 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.56 34.44 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.619 1.099 . . . . 10.0 111.356 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.64 -41.03 61.02 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.256 1.576 . . . . 10.0 115.256 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtm -66.95 -50.8 61.2 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 123.568 0.747 . . . . 10.0 110.456 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.67 -52.63 22.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.837 0.855 . . . . 10.0 112.91 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.93 -5.53 48.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.875 1.065 . . . . 10.0 113.875 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.22 -34.66 5.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 115.601 1.0 . . . . 10.0 115.601 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.38 -43.06 43.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.59 61.05 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.363 0.905 . . . . 10.0 115.363 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.39 26.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.072 2.149 . . . . 10.0 109.066 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.48 171.09 15.15 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.059 0.943 . . . . 10.0 111.048 166.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.1 53.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.862 0.865 . . . . 10.0 109.693 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.75 116.29 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.4 38.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 118.703 2.241 . . . . 10.0 118.703 170.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.9 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.302 1.551 . . . . 10.0 112.223 -165.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.78 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.544 1.537 . . . . 10.0 111.159 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.43 120.81 69.68 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 112.981 0.734 . . . . 10.0 112.981 -165.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.58 131.93 38.12 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.209 3.273 . . . . 10.0 112.144 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.12 126.32 21.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.054 1.742 . . . . 10.0 111.746 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.57 84.96 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.057 1.408 . . . . 10.0 113.065 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.31 -28.26 66.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.787 -1.195 . . . . 10.0 113.98 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.73 62.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.056 1.502 . . . . 10.0 115.056 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.411 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -63.86 -29.62 70.79 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 119.847 -1.783 . . . . 10.0 113.284 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -70.78 -43.99 67.57 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.254 -0.904 . . . . 10.0 112.012 171.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.1 -46.67 45.18 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.164 1.386 . . . . 10.0 111.669 167.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -56.92 -70.82 0.11 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.102 1.361 . . . . 10.0 111.675 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.411 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.2 m0 -53.4 -33.51 54.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.422 1.489 . . . . 10.0 112.835 -170.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.5 tp -46.29 -48.95 18.02 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.942 1.697 . . . . 10.0 111.913 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -90.8 -44.5 9.39 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.324 1.05 . . . . 10.0 112.311 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.2 p -78.91 -32.98 45.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.133 1.16 . . . . 10.0 114.133 -165.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.317 69.8 p -61.55 -44.98 93.66 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.594 -1.193 . . . . 10.0 112.767 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.52 -44.99 43.01 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.911 2.407 . . . . 10.0 115.892 166.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.41 -47.4 85.59 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.319 -0.863 . . . . 10.0 111.881 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.17 -49.51 60.79 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.898 1.679 . . . . 10.0 111.3 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.05 -48.06 76.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.237 1.015 . . . . 10.0 112.907 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.21 78.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.823 0.849 . . . . 10.0 112.863 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.37 -53.99 37.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.299 0.954 . . . . 10.0 111.163 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.12 88.8 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.151 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.71 38.29 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.951 0.9 . . . . 10.0 112.031 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.21 79.4 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.736 0.814 . . . . 10.0 112.669 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.75 -38.58 91.64 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.41 1.263 . . . . 10.0 114.41 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.269 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.89 47.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.966 -1.709 . . . . 10.0 112.437 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.87 54.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.79 -39.77 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.922 1.689 . . . . 10.0 113.452 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.74 87.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.382 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.49 -52.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.003 1.321 . . . . 10.0 111.16 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.28 67.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.516 0.562 . . . . 10.0 112.516 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.91 42.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.446 0.698 . . . . 10.0 110.932 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -59.9 4.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.429 2.292 . . . . 10.0 114.821 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -47.01 74.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -58.52 -44.28 89.48 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.703 0.801 . . . . 10.0 111.769 175.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -56.27 5.14 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.418 1.485 . . . . 10.0 113.384 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.59 -49.84 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 117.697 0.749 . . . . 10.0 111.245 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -53.85 -57.05 12.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.93 1.292 . . . . 10.0 112.587 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.64 -45.99 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.795 0.725 . . . . 10.0 111.625 173.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.24 -59.92 8.33 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.526 1.06 . . . . 10.0 112.805 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.2 p -55.79 -39.45 71.3 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.824 1.25 . . . . 10.0 112.41 172.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.85 -56.11 10.42 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.385 0.993 . . . . 10.0 113.222 167.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.72 -45.69 91.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.403 1.481 . . . . 10.0 112.206 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t -54.07 -50.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.376 -0.827 . . . . 10.0 110.23 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.88 -60.71 6.75 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.4 1.952 . . . . 10.0 112.533 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.61 -42.56 3.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.645 2.378 . . . . 10.0 113.219 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -100.77 -6.68 24.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.65 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 120.186 -1.571 . . . . 10.0 110.355 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.49 -49.6 72.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.154 2.582 . . . . 10.0 113.304 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.36 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.053 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.88 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.111 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.06 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.465 1.506 . . . . 10.0 113.56 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.74 63.26 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.03 -41.72 68.35 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.855 0.752 . . . . 10.0 110.768 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -69.33 -32.33 71.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.764 1.226 . . . . 10.0 114.25 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -52.15 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.051 0.841 . . . . 10.0 109.955 168.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -59.11 -51.71 68.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -48.24 -46.96 36.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.164 0.986 . . . . 10.0 113.388 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.44 -52.07 67.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 10.0 111.524 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.2 mt -54.22 -51.53 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.134 1.374 . . . . 10.0 111.514 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -54.45 -47.82 72.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.423 1.089 . . . . 10.0 112.13 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 73.6 m -63.0 -43.1 99.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.042 1.337 . . . . 10.0 111.663 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.46 73.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.238 1.015 . . . . 10.0 112.365 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.9 78.14 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.761 0.824 . . . . 10.0 112.497 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.97 -52.72 64.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.652 1.181 . . . . 10.0 111.959 172.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.08 -49.27 63.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.315 1.446 . . . . 10.0 111.414 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -49.33 -54.93 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.949 0.9 . . . . 10.0 112.681 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 42.0 mm -52.16 -55.88 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.852 0.751 . . . . 10.0 110.41 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.68 -35.22 72.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.463 -0.78 . . . . 10.0 111.735 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.36 -58.14 9.56 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.003 0.921 . . . . 10.0 113.008 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.85 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.438 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.4 75.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.857 1.208 . . . . 10.0 112.101 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -76.99 -70.32 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.119 -1.613 . . . . 10.0 112.851 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.89 60.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.634 1.174 . . . . 10.0 113.42 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.14 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.627 0.632 . . . . 10.0 113.514 171.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.41 51.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.26 1.824 . . . . 10.0 113.059 -166.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.54 13.8 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.96 1.096 . . . . 10.0 113.96 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.63 -50.54 65.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.084 0.945 . . . . 10.0 112.329 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.02 83.1 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.16 0.984 . . . . 10.0 112.117 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.47 80.12 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.32 1.23 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.124 1.77 . . . . 10.0 114.189 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.58 29.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.398 1.879 . . . . 10.0 114.917 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.86 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 123.48 1.61 . . . . 10.0 114.146 -170.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.66 153.96 72.74 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.798 3.239 . . . . 10.0 105.561 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.21 35.4 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.334 2.023 . . . . 10.0 113.008 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.032 2.933 . . . . 10.0 113.288 173.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.14 -53.08 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.059 0.943 . . . . 10.0 109.816 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.86 75.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.317 0.647 . . . . 10.0 111.907 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.96 -56.22 24.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.953 0.901 . . . . 10.0 112.675 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.18 -53.22 60.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.181 0.993 . . . . 10.0 113.059 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.53 -49.56 45.57 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.36 78.88 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.06 -49.58 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.832 0.742 . . . . 10.0 110.481 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.61 69.16 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.81 -47.74 30.95 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.883 2.073 . . . . 10.0 111.07 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.59 -58.33 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.815 0.446 . . . . 10.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.1 t -51.96 -47.94 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.091 0.956 . . . . 10.0 111.994 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.2 m -57.66 -63.41 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.397 2.679 . . . . 10.0 111.878 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.52 -49.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.526 1.131 . . . . 10.0 111.284 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.62 -60.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.1 0.96 . . . . 10.0 112.056 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.44 -48.08 83.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -52.26 -51.07 60.55 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.707 0.803 . . . . 10.0 111.597 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -53.5 -33.51 54.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.028 1.121 . . . . 10.0 114.028 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.1 97.8 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.006 1.113 . . . . 10.0 114.006 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -48.18 -55.78 16.9 Favored Pre-proline 0 N--CA 1.476 0.851 0 N-CA-C 115.374 1.62 . . . . 10.0 115.374 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -59.63 -33.14 96.79 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.262 1.975 . . . . 10.0 113.441 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.0 -54.71 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.917 0.887 . . . . 10.0 110.324 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.9 t -53.23 -50.11 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.005 1.322 . . . . 10.0 111.531 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -55.68 -52.91 62.24 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.412 1.085 . . . . 10.0 112.581 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -57.49 -43.15 83.92 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.854 0.861 . . . . 10.0 112.304 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -83.98 -5.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.097 1.517 . . . . 10.0 115.097 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.37 -169.35 33.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 122.559 1.088 . . . . 10.0 113.887 -168.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -41.23 64.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.889 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.7 -16.79 64.31 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.731 1.752 . . . . 10.0 115.731 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.89 -105.93 1.09 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.364 1.438 . . . . 10.0 113.711 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.4 127.13 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.368 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.52 65.4 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.081 1.753 . . . . 10.0 108.725 166.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.39 24.91 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.78 153.79 72.38 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.733 2.955 . . . . 10.0 111.463 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.09 -39.84 2.92 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.295 1.038 . . . . 10.0 112.232 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.31 -52.35 21.87 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.95 -40.45 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.388 1.075 . . . . 10.0 109.639 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.86 41.86 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.535 0.607 . . . . 10.0 111.946 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.4 m -57.71 -47.01 83.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.006 1.723 . . . . 10.0 112.995 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.33 -52.33 62.29 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.938 0.895 . . . . 10.0 112.054 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.61 -59.07 4.91 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.307 1.043 . . . . 10.0 109.979 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.97 -46.99 68.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.479 -1.248 . . . . 10.0 112.297 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -50.98 -52.34 43.58 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.739 1.609 . . . . 10.0 113.035 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.32 -48.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.553 1.141 . . . . 10.0 111.636 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.98 -50.45 72.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.143 1.377 . . . . 10.0 111.763 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.14 -59.79 4.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.713 2.005 . . . . 10.0 110.198 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 42.4 t -46.18 -51.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.552 1.141 . . . . 10.0 111.989 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 5.9 t -61.75 -52.6 63.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.888 0.875 . . . . 10.0 112.501 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.24 -21.72 65.73 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.413 1.885 . . . . 10.0 114.41 -176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -101.3 -69.21 0.79 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.924 1.29 . . . . 10.0 111.547 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.8 t -72.54 -50.76 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.507 1.123 . . . . 10.0 111.475 -173.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.07 -55.63 27.18 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.297 0.951 . . . . 10.0 112.534 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -43.05 -57.39 2.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.759 2.024 . . . . 10.0 112.536 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.92 -41.59 84.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.388 0.994 . . . . 10.0 113.945 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.92 -27.18 64.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 115.703 1.742 . . . . 10.0 115.703 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.21 -57.65 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.947 0.899 . . . . 10.0 113.155 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.53 5.13 2.54 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.3 0.37 15.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.24 1.016 . . . . 10.0 113.324 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 110.972 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.95 77.07 7.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.824 0.849 . . . . 10.0 112.087 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.83 2.852 . . . . 10.0 116.458 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.91 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.721 1.209 . . . . 10.0 110.61 -175.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.77 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.656 171.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.468 2.707 . . . . 10.0 113.408 166.584 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.83 -2.033 . . . . 10.0 105.851 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.614 3.165 . . . . 10.0 117.211 160.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.272 2.629 . . . . 10.0 114.49 155.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.97 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.361 1.864 . . . . 10.0 113.378 -158.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.77 -165.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.272 1.829 . . . . 10.0 113.99 -174.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.16 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.58 -51.38 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.306 -2.759 . . . . 10.0 116.604 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.498 2.285 . . . . 10.0 113.205 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.21 4.31 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.737 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.39 -43.03 61.79 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.496 -0.752 . . . . 10.0 112.642 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.69 83.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.954 0.902 . . . . 10.0 109.305 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.872 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.33 -53.57 56.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.238 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.81 51.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.376 1.47 . . . . 10.0 113.354 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.64 -44.99 84.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.294 1.438 . . . . 10.0 113.026 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.95 -55.68 14.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.575 1.084 . . . . 10.0 111.769 166.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -50.16 -52.5 34.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.916 1.286 . . . . 10.0 112.317 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.145 0.978 . . . . 10.0 112.204 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.2 mt -58.11 -49.31 77.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.451 0.7 . . . . 10.0 112.609 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.2 mmt -55.16 -50.27 69.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.686 0.794 . . . . 10.0 111.198 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.08 -58.57 13.9 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.388 0.994 . . . . 10.0 113.634 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.15 -45.65 79.56 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.593 1.196 . . . . 10.0 112.138 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.62 80.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.529 1.062 . . . . 10.0 113.389 172.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -60.17 -60.49 3.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.09 0.956 . . . . 10.0 110.984 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.96 62.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.939 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.09 9.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.654 1.181 . . . . 10.0 112.929 172.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.72 82.1 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.649 1.179 . . . . 10.0 113.619 169.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.698 1.713 . . . . 10.0 110.835 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.86 -44.8 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.878 2.471 . . . . 10.0 109.338 171.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.97 23.1 0.87 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.611 1.005 . . . . 10.0 115.611 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.48 -45.0 92.93 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.145 2.178 . . . . 10.0 113.605 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.765 0.698 . . . . 10.0 112.432 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.04 88.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.361 2.665 . . . . 10.0 116.933 166.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.67 -50.88 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.224 -1.353 . . . . 10.0 113.854 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.47 6.4 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.782 1.301 . . . . 10.0 110.957 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.57 -29.64 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.08 0.552 . . . . 10.0 111.442 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.15 22.67 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.142 1.377 . . . . 10.0 113.549 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.47 19.23 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.232 1.413 . . . . 10.0 113.46 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.11 61.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.952 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.95 -50.23 73.26 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.035 0.534 . . . . 10.0 112.351 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.36 -51.29 65.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.939 -0.553 . . . . 10.0 112.358 173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.78 -56.88 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 10.0 110.489 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -69.23 -17.57 63.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.18 1.392 . . . . 10.0 113.6 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.6 m -86.6 -42.91 13.09 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.688 1.131 . . . . 10.0 111.953 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -57.13 -41.32 78.82 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -50.62 -61.35 3.95 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.985 1.314 . . . . 10.0 112.254 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.27 -46.78 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.393 3.395 . . . . 10.0 115.726 163.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.96 79.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.241 1.2 . . . . 10.0 114.241 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.09 -36.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 120.256 -1.528 . . . . 10.0 111.698 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.87 77.61 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.13 0.877 . . . . 10.0 112.603 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.8 -56.0 14.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 10.0 111.89 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -48.61 -53.21 19.37 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.498 1.519 . . . . 10.0 111.113 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.59 -48.14 64.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.142 0.977 . . . . 10.0 112.921 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -55.34 -42.16 73.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.009 1.277 . . . . 10.0 113.196 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.66 32.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.292 0.951 . . . . 10.0 111.25 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.55 -41.13 60.89 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.255 1.576 . . . . 10.0 115.255 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 47.0 mtm -66.91 -50.77 61.37 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.531 0.732 . . . . 10.0 110.459 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.7 -52.58 22.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.828 0.851 . . . . 10.0 112.924 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.46 48.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.23 -34.76 5.51 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.524 0.97 . . . . 10.0 115.524 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.26 -43.08 42.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.09 3.57 61.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.063 2.145 . . . . 10.0 109.001 171.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.13 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.03 166.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.726 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.6 129.63 23.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 125.069 1.348 . . . . 10.0 110.908 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.81 116.27 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 109.382 -1.045 . . . . 10.0 109.382 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.78 0.659 . . . . 10.0 112.78 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.718 -0.953 . . . . 10.0 110.718 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.43 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.664 2.225 . . . . 10.0 118.664 170.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.379 1.59 . . . . 10.0 112.202 -165.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.478 1.511 . . . . 10.0 111.059 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -61.52 131.9 38.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.169 3.246 . . . . 10.0 112.166 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.7 85.01 4.72 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.717 1.246 . . . . 10.0 113.066 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.29 -28.31 66.64 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.26 -33.59 63.3 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.283 1.033 . . . . 10.0 112.155 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.43 ' HD2' ' CZ2' ' A' ' 86' ' ' TRP . 8.1 tpp180 -39.06 -54.23 1.73 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.24 2.616 . . . . 10.0 111.938 165.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.71 -38.11 48.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.047 1.739 . . . . 10.0 112.579 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.2 -47.35 62.29 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.72 1.146 . . . . 10.0 110.387 167.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -68.36 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.362 1.865 . . . . 10.0 111.485 168.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.43 ' CZ2' ' HD2' ' A' ' 82' ' ' ARG . 54.5 m0 -54.76 -35.83 64.19 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.608 0.966 . . . . 10.0 113.608 -172.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.14 -42.19 50.24 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.104 1.762 . . . . 10.0 111.825 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -103.5 -36.96 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.543 -0.741 . . . . 10.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.4 p -61.15 -46.22 91.43 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 121.155 1.798 . . . . 10.0 113.6 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.301 76.4 p -65.93 -43.89 59.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 -175.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.99 -43.14 62.34 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.429 2.753 . . . . 10.0 115.261 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.95 -47.78 84.85 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.318 -0.864 . . . . 10.0 111.698 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.5 tp -49.95 -49.59 49.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.136 1.374 . . . . 10.0 112.189 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.87 -47.93 76.46 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.111 -0.993 . . . . 10.0 112.658 170.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.26 78.28 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.781 0.832 . . . . 10.0 112.894 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -52.24 -54.05 35.98 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.31 0.959 . . . . 10.0 111.203 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.72 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.657 0.783 . . . . 10.0 112.158 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.74 -54.74 37.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.983 0.913 . . . . 10.0 112.016 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.15 79.17 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.677 174.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.82 -38.54 91.48 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.426 1.269 . . . . 10.0 114.426 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.018 1.327 . . . . 10.0 112.296 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.5 53.49 11.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.821 1.648 . . . . 10.0 112.175 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.92 47.52 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.938 -1.726 . . . . 10.0 112.392 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.89 54.27 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.7 2.63 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.861 1.664 . . . . 10.0 113.456 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.25 5.27 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.02 -46.8 87.62 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.88 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.997 1.319 . . . . 10.0 111.163 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.67 -51.28 67.84 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.55 0.574 . . . . 10.0 112.55 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.88 43.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.452 0.701 . . . . 10.0 110.908 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.52 -59.96 4.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.436 2.294 . . . . 10.0 114.815 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.99 -46.29 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 123.665 0.786 . . . . 10.0 111.428 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.71 -50.25 64.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.655 0.645 . . . . 10.0 112.63 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.71 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.234 0.827 . . . . 10.0 113.234 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -55.12 -48.3 73.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.591 1.156 . . . . 10.0 111.259 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -55.51 5.22 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.39 1.472 . . . . 10.0 113.246 168.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.61 -51.99 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.549 0.74 . . . . 10.0 111.735 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.2 tmm? -50.65 -56.38 12.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.969 1.707 . . . . 10.0 112.038 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.08 -45.44 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.652 -0.655 . . . . 10.0 112.423 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.16 -58.39 12.0 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.948 1.261 . . . . 10.0 113.257 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.4 p -59.46 -35.82 74.78 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.984 0.914 . . . . 10.0 112.513 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.45 -56.86 7.81 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.293 0.949 . . . . 10.0 113.825 164.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.9 tp -58.34 -47.47 83.68 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.266 1.426 . . . . 10.0 112.149 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.0 t -52.75 -51.71 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.583 -0.698 . . . . 10.0 110.518 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.26 6.3 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.714 1.626 . . . . 10.0 112.092 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.59 -37.55 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.387 1.875 . . . . 10.0 113.893 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.6 mt -99.14 -6.35 28.45 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.162 1.541 . . . . 10.0 115.162 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.68 116.69 10.37 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.128 -1.607 . . . . 10.0 110.365 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.221 2.608 . . . . 10.0 113.274 177.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.62 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.812 0.845 . . . . 10.0 110.066 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.95 -59.53 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.033 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.06 14.92 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.413 1.485 . . . . 10.0 113.52 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -70.2 -24.58 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.66 -42.2 67.64 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.917 0.78 . . . . 10.0 110.692 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.53 -31.54 69.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.853 1.261 . . . . 10.0 114.348 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.36 -51.86 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.0 0.818 . . . . 10.0 109.622 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -61.68 -43.03 99.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.387 1.255 . . . . 10.0 114.387 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.26 -49.03 67.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.545 1.138 . . . . 10.0 112.585 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.87 71.74 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.717 0.807 . . . . 10.0 111.675 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.4 mt -56.35 -54.33 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.924 1.289 . . . . 10.0 111.943 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -57.39 -42.04 81.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.451 0.7 . . . . 10.0 112.468 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.2 m -58.91 -46.73 87.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.89 1.276 . . . . 10.0 112.6 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.312 0.96 . . . . 10.0 112.371 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.99 83.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.982 0.913 . . . . 10.0 112.805 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.71 -53.61 56.19 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.468 1.107 . . . . 10.0 111.982 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.66 -47.61 70.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.422 1.489 . . . . 10.0 111.982 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -50.1 -54.56 19.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.001 0.92 . . . . 10.0 112.416 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.4 mt -53.78 -54.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.79 0.836 . . . . 10.0 110.728 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.56 -36.56 69.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.17 9.4 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -40.86 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.8 -49.43 75.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.883 1.22 . . . . 10.0 112.145 171.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.043 -1.66 . . . . 10.0 112.874 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.72 -21.91 60.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.607 1.163 . . . . 10.0 113.466 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.644 0.64 . . . . 10.0 113.522 171.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.43 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.037 -166.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.16 -56.42 14.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.953 1.094 . . . . 10.0 113.953 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.7 -50.51 65.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.145 0.974 . . . . 10.0 112.307 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.05 82.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.192 0.997 . . . . 10.0 112.152 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.53 80.03 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.42 -11.29 1.19 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.084 1.754 . . . . 10.0 114.223 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.411 1.884 . . . . 10.0 114.867 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.97 -92.62 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.501 1.619 . . . . 10.0 114.135 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.68 153.93 72.68 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.837 3.255 . . . . 10.0 105.604 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.345 2.03 . . . . 10.0 113.083 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.07 68.07 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.285 173.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.13 -53.05 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.105 0.962 . . . . 10.0 109.816 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.82 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.06 -56.11 25.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.864 0.865 . . . . 10.0 112.731 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.2 -53.24 60.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.229 1.012 . . . . 10.0 112.988 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.56 45.38 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.324 0.65 . . . . 10.0 111.097 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.14 -48.44 78.67 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.66 1.356 . . . . 10.0 114.66 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.97 -49.58 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.807 0.731 . . . . 10.0 110.482 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.14 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.169 0.803 . . . . 10.0 113.169 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.72 31.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.84 2.056 . . . . 10.0 111.068 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.61 -58.29 9.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.781 0.432 . . . . 10.0 111.245 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.85 -49.3 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.07 0.948 . . . . 10.0 111.497 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 29.7 m -56.19 -64.01 1.0 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.115 2.566 . . . . 10.0 111.952 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.02 -49.11 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.666 1.186 . . . . 10.0 111.347 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.31 -61.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.09 0.956 . . . . 10.0 112.372 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -58.04 -46.84 84.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.421 0.688 . . . . 10.0 111.932 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -51.29 -52.8 41.82 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.16 0.984 . . . . 10.0 112.101 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.6 m -54.46 -31.01 54.76 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.789 1.033 . . . . 10.0 113.789 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.91 93.82 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.816 1.043 . . . . 10.0 113.816 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -47.3 -55.28 16.6 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 115.712 1.745 . . . . 10.0 115.712 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.05 -36.88 97.66 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.552 2.168 . . . . 10.0 112.952 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.97 -54.31 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.429 1.092 . . . . 10.0 110.666 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.4 t -53.51 -49.23 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.758 1.223 . . . . 10.0 111.483 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -55.59 -53.3 58.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.697 1.199 . . . . 10.0 112.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -56.25 -44.51 79.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.936 0.894 . . . . 10.0 112.655 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -84.52 -5.81 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.08 1.511 . . . . 10.0 115.08 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.26 33.1 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-O 122.627 1.126 . . . . 10.0 113.94 -168.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -41.1 64.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.202 -0.999 . . . . 10.0 111.846 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -54.43 -31.66 55.77 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.503 2.721 . . . . 10.0 115.359 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.34 -103.85 0.96 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.433 1.015 . . . . 10.0 113.506 -167.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.15 35.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.653 -1.498 . . . . 10.0 109.357 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.4 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.69 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.721 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.33 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.388 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.72 153.8 72.51 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.792 2.995 . . . . 10.0 111.483 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.83 3.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.364 1.065 . . . . 10.0 112.19 171.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.41 21.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.0 -40.42 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.363 1.065 . . . . 10.0 109.625 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.34 -49.81 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.61 0.641 . . . . 10.0 111.944 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.05 83.37 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.055 1.742 . . . . 10.0 112.976 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.4 -52.29 62.24 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.934 0.894 . . . . 10.0 112.054 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -58.73 5.84 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.338 1.055 . . . . 10.0 109.955 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -52.51 -45.36 66.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.604 -1.189 . . . . 10.0 112.684 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.8 -52.67 59.56 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.48 1.491 . . . . 10.0 112.856 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.51 -46.17 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.055 1.342 . . . . 10.0 111.551 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.28 -54.25 49.02 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.302 1.441 . . . . 10.0 111.589 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -54.03 -58.74 6.18 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.523 1.929 . . . . 10.0 111.278 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.86 -42.94 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.153 -0.967 . . . . 10.0 112.185 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 20.0 m -59.94 -48.57 81.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.755 0.822 . . . . 10.0 112.088 172.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.93 -18.69 64.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.653 1.981 . . . . 10.0 114.536 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -106.4 -74.14 0.66 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.021 1.328 . . . . 10.0 111.812 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.19 -42.31 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 120.629 -1.294 . . . . 10.0 111.785 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -57.84 -55.26 31.49 Favored Glycine 0 N--CA 1.476 1.308 0 C-N-CA 124.06 0.838 . . . . 10.0 112.4 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -40.7 -60.13 1.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.904 2.081 . . . . 10.0 112.324 163.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.03 72.45 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.13 0.872 . . . . 10.0 113.745 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -69.94 -27.55 64.85 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 115.997 1.851 . . . . 10.0 115.997 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.73 -57.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.493 -0.929 . . . . 10.0 108.493 165.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.88 0.872 . . . . 10.0 113.171 -172.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.62 5.23 2.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 10.0 115.341 -171.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.4 15.7 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.174 0.99 . . . . 10.0 113.32 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.998 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.72 98.24 1.9 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.73 0.812 . . . . 10.0 110.953 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.92 77.04 7.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.87 0.868 . . . . 10.0 112.037 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.904 2.881 . . . . 10.0 116.466 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.48 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.765 1.226 . . . . 10.0 110.635 -175.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.74 Favored Glycine 0 C--O 1.238 0.388 0 C-N-CA 129.738 3.542 . . . . 10.0 119.647 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.476 2.711 . . . . 10.0 113.421 166.567 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.794 -2.05 . . . . 10.0 105.835 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.49 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.595 3.158 . . . . 10.0 117.209 160.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.1 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.306 2.642 . . . . 10.0 114.452 155.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.51 137.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.357 1.863 . . . . 10.0 113.393 -158.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.74 -165.2 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.76 40.74 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.412 2.434 . . . . 10.0 111.516 168.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.31 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.679 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.66 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.477 2.277 . . . . 10.0 113.238 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.19 4.37 0.95 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.751 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.42 -43.07 61.9 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.458 -0.776 . . . . 10.0 112.604 176.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.348 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.46 -52.62 63.01 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.386 0.675 . . . . 10.0 111.84 175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.82 -46.8 51.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.353 1.461 . . . . 10.0 113.335 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.68 -44.93 84.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.267 1.427 . . . . 10.0 113.056 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.06 -55.78 14.31 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.373 0.987 . . . . 10.0 111.689 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.97 -52.41 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.874 1.27 . . . . 10.0 112.336 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.47 -58.89 5.72 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.172 0.989 . . . . 10.0 112.14 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -57.42 -48.79 78.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.619 0.768 . . . . 10.0 112.684 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.41 -47.1 85.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.221 1.008 . . . . 10.0 111.502 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.64 13.52 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.309 0.957 . . . . 10.0 113.721 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.21 -46.03 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.658 1.229 . . . . 10.0 112.112 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.18 -42.68 73.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.987 1.28 . . . . 10.0 113.175 172.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -62.05 -58.35 8.17 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.718 0.807 . . . . 10.0 111.534 172.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.32 -40.99 62.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.937 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.74 -58.07 9.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.616 1.166 . . . . 10.0 112.999 172.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.71 81.93 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.244 0.831 . . . . 10.0 113.244 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.625 1.17 . . . . 10.0 113.659 169.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.728 1.727 . . . . 10.0 110.868 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.875 2.47 . . . . 10.0 109.33 171.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.11 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.01 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.101 2.161 . . . . 10.0 113.623 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.175 -1.375 . . . . 10.0 113.841 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.84 117.52 6.35 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.745 1.278 . . . . 10.0 110.957 -172.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.63 -29.66 89.87 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.678 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.085 0.554 . . . . 10.0 111.448 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.22 -40.04 23.08 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.583 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.53 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.219 1.408 . . . . 10.0 113.446 172.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.81 -53.04 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.939 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -56.99 -50.27 73.21 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.316 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.29 -51.33 64.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.39 0.541 . . . . 10.0 112.395 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.44 -58.06 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 10.0 110.256 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -67.78 -18.71 64.95 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.234 1.414 . . . . 10.0 113.725 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -86.74 -40.64 14.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.381 1.072 . . . . 10.0 112.292 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.13 -42.92 91.77 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.44 -0.787 . . . . 10.0 112.708 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.2 t -42.2 -62.29 1.25 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.504 1.522 . . . . 10.0 113.285 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.17 -26.12 21.54 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.069 2.513 . . . . 10.0 114.24 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.94 80.63 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.855 1.662 . . . . 10.0 113.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.5 -49.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.026 -1.046 . . . . 10.0 109.778 169.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.56 -45.96 73.6 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 175.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -50.98 -56.32 13.04 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.758 1.623 . . . . 10.0 112.046 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -49.4 -52.76 26.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.303 1.441 . . . . 10.0 110.626 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.415 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.6 mmt -68.87 -47.97 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.005 0.922 . . . . 10.0 113.047 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -57.27 -40.13 77.08 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.201 -1.381 . . . . 10.0 113.346 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.3 -54.6 34.04 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.037 1.29 . . . . 10.0 111.301 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.04 61.0 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.211 1.56 . . . . 10.0 115.211 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.94 -50.78 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.476 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.65 21.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.883 . . . . 10.0 112.9 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.03 -5.51 49.06 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.34 1.056 . . . . 10.0 113.769 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.554 0.982 . . . . 10.0 115.554 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.04 43.04 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.28 1.585 . . . . 10.0 115.28 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.304 0.882 . . . . 10.0 115.304 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.26 143.37 26.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.082 2.153 . . . . 10.0 109.018 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.008 0.923 . . . . 10.0 111.021 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.01 53.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.751 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.56 129.58 23.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 125.12 1.368 . . . . 10.0 110.991 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.77 116.28 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.379 -1.047 . . . . 10.0 109.379 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.41 -81.94 0.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.634 -0.986 . . . . 10.0 110.634 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.55 -171.82 4.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.23 -165.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.91 93.89 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.527 1.531 . . . . 10.0 111.056 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -89.45 120.79 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.989 0.737 . . . . 10.0 112.989 -165.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -61.57 131.93 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.196 3.264 . . . . 10.0 112.129 171.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.004 1.721 . . . . 10.0 111.739 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.62 84.98 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.005 1.384 . . . . 10.0 113.035 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.32 -28.31 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.839 -1.163 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.92 45.45 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.259 1.023 . . . . 10.0 113.197 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -50.42 -60.96 2.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.706 1.202 . . . . 10.0 111.05 168.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -58.17 -42.44 86.01 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.32 2.248 . . . . 10.0 112.633 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.32 63.44 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.487 1.04 . . . . 10.0 112.418 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.415 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -62.39 -60.46 3.53 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.384 0.993 . . . . 10.0 111.759 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -52.96 -36.24 59.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 112.328 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.4 tp -50.49 -42.64 54.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.536 1.934 . . . . 10.0 112.14 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -102.35 -39.05 7.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.83 0.852 . . . . 10.0 112.842 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 71.2 p -63.08 -45.9 89.95 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 120.559 1.527 . . . . 10.0 113.308 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 72.6 p -62.86 -44.21 85.0 Favored Pre-proline 0 N--CA 1.478 0.944 0 N-CA-C 114.825 1.417 . . . . 10.0 114.825 -177.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.07 -43.29 60.73 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.521 2.814 . . . . 10.0 115.32 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.48 -47.5 85.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.803 0.729 . . . . 10.0 111.71 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.0 mt -53.6 -45.27 69.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.39 1.076 . . . . 10.0 112.204 172.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.81 -47.42 82.65 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.111 -0.993 . . . . 10.0 112.769 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.29 78.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.88 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.29 -54.06 36.2 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.258 0.936 . . . . 10.0 111.161 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.1 88.76 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.62 0.768 . . . . 10.0 112.146 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.75 37.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.986 0.914 . . . . 10.0 112.028 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.14 79.14 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.677 0.791 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.61 91.75 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.76 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.045 1.338 . . . . 10.0 112.313 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.844 1.658 . . . . 10.0 112.104 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.85 47.66 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.903 -1.748 . . . . 10.0 112.446 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 135.96 54.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.705 0.632 . . . . 10.0 112.705 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.71 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.856 1.663 . . . . 10.0 113.471 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.27 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.178 1.37 . . . . 10.0 115.262 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.04 -46.83 87.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.323 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.37 -52.95 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.02 1.328 . . . . 10.0 111.124 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.32 67.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.09 -44.92 42.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.49 0.716 . . . . 10.0 110.98 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -59.94 4.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.396 2.279 . . . . 10.0 114.8 174.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.93 -46.38 96.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.69 0.796 . . . . 10.0 111.423 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.29 64.24 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.674 0.654 . . . . 10.0 112.593 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.32 74.83 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.37 -45.72 84.13 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.164 0.986 . . . . 10.0 111.995 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.07 -55.62 5.61 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.332 1.444 . . . . 10.0 112.982 167.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.21 -53.57 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.02 -0.99 . . . . 10.0 110.768 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 57.4 ttp -46.02 -58.1 3.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.504 1.502 . . . . 10.0 112.653 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.1 mm -71.58 -45.08 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.694 -0.629 . . . . 10.0 112.429 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.5 -47.4 63.31 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.593 1.092 . . . . 10.0 112.884 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.3 m -60.88 -44.85 96.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.313 1.445 . . . . 10.0 111.384 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.49 -55.01 11.46 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.474 1.035 . . . . 10.0 113.402 168.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.85 -48.23 51.23 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.498 2.719 . . . . 10.0 111.636 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.61 -49.1 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 120.951 -1.093 . . . . 10.0 111.539 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.27 -59.36 9.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.857 1.694 . . . . 10.0 112.448 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.07 -43.2 3.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.475 2.71 . . . . 10.0 113.272 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -101.26 -6.38 24.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.446 1.647 . . . . 10.0 115.446 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.76 10.48 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.222 -1.549 . . . . 10.0 110.397 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.554 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.217 2.607 . . . . 10.0 113.255 177.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.68 106.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.733 0.813 . . . . 10.0 110.065 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.94 -59.54 3.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.029 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.09 14.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.513 1.525 . . . . 10.0 113.486 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.23 -24.6 63.12 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.872 1.434 . . . . 10.0 114.872 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.95 -41.75 68.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.935 0.789 . . . . 10.0 110.776 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.86 70.22 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.356 1.243 . . . . 10.0 114.356 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.46 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.043 0.838 . . . . 10.0 109.621 168.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -60.51 -45.26 94.47 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.015 1.116 . . . . 10.0 114.015 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -52.23 -48.89 64.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.414 1.006 . . . . 10.0 112.895 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -54.45 45.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.092 0.957 . . . . 10.0 111.645 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.0 mt -53.28 -49.83 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.052 1.341 . . . . 10.0 111.592 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -54.84 -48.09 73.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.866 1.266 . . . . 10.0 111.852 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.7 m -65.19 -40.49 94.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.602 1.561 . . . . 10.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.07 -49.41 77.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.049 0.94 . . . . 10.0 112.286 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.45 79.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.746 0.818 . . . . 10.0 112.441 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.7 ttp -55.37 -54.04 48.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.12 0.968 . . . . 10.0 112.243 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -52.07 -50.38 61.66 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.83 1.652 . . . . 10.0 111.407 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -50.15 -54.71 18.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.14 0.976 . . . . 10.0 112.502 172.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.7 mt -53.49 -55.26 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.775 0.83 . . . . 10.0 110.736 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.32 -35.84 70.38 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.287 -0.863 . . . . 10.0 112.866 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.48 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.03 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.85 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.437 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.84 -49.37 75.63 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.866 1.212 . . . . 10.0 112.153 171.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.92 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.94 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.645 1.178 . . . . 10.0 113.412 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.75 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.676 0.655 . . . . 10.0 113.51 171.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.61 -32.43 51.12 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.23 1.812 . . . . 10.0 113.08 -166.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.9 m -52.04 -56.52 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.025 1.12 . . . . 10.0 114.025 172.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.58 -50.62 65.2 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.115 0.959 . . . . 10.0 112.32 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.08 -46.08 82.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.188 0.995 . . . . 10.0 112.105 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.54 79.8 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.516 1.302 . . . . 10.0 114.516 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.33 1.22 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.101 1.76 . . . . 10.0 114.235 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.07 6.67 29.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.433 1.893 . . . . 10.0 114.89 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.96 -92.68 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.473 1.606 . . . . 10.0 114.115 -170.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.68 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 129.805 3.242 . . . . 10.0 105.541 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.93 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.308 2.005 . . . . 10.0 113.052 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.06 68.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.977 2.911 . . . . 10.0 113.259 173.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.16 -53.05 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 124.014 0.925 . . . . 10.0 109.804 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.81 75.57 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.237 0.615 . . . . 10.0 111.952 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.02 -56.13 25.45 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.894 0.877 . . . . 10.0 112.734 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.1 m -57.3 -53.11 61.83 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.139 0.976 . . . . 10.0 113.02 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.6 -49.51 46.41 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.118 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.1 -48.4 78.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.6 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.774 0.715 . . . . 10.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.52 -51.68 68.84 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.77 30.14 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.822 2.049 . . . . 10.0 111.077 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.14 -47.0 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.015 0.926 . . . . 10.0 112.127 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 34.1 m -58.33 -64.16 1.02 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.276 2.631 . . . . 10.0 111.735 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.33 -50.15 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.68 1.192 . . . . 10.0 110.989 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.19 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.962 0.905 . . . . 10.0 111.915 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.07 -48.33 73.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.24 0.927 . . . . 10.0 112.69 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.76 -50.41 70.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.834 0.854 . . . . 10.0 111.66 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.0 p -52.27 -33.37 41.56 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.397 1.258 . . . . 10.0 114.397 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.69 -40.16 94.9 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -47.72 -56.12 14.5 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 114.991 1.478 . . . . 10.0 114.991 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.0 -33.36 95.55 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.249 1.966 . . . . 10.0 113.625 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.74 -54.67 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.17 0.895 . . . . 10.0 110.395 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.06 -50.54 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.236 1.415 . . . . 10.0 111.472 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -55.5 -52.63 63.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.408 1.083 . . . . 10.0 112.598 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -58.51 -42.97 88.87 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.686 0.794 . . . . 10.0 112.45 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -83.3 -5.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.915 1.45 . . . . 10.0 114.915 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.3 33.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 122.55 1.083 . . . . 10.0 113.964 -168.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.62 65.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.868 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.78 -15.87 63.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.568 1.692 . . . . 10.0 115.568 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.49 -106.06 1.06 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 120.452 1.478 . . . . 10.0 113.965 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.11 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.34 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.28 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.919 0.328 . . . . 10.0 113.919 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.55 -42.78 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.126 1.77 . . . . 10.0 108.725 166.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.29 133.38 24.9 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.419 -174.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.7 153.77 72.6 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.816 3.011 . . . . 10.0 111.469 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.273 1.029 . . . . 10.0 112.251 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.32 -52.42 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.9 -40.52 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.618 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -49.28 -49.77 42.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.574 0.625 . . . . 10.0 111.991 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.07 83.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.086 1.755 . . . . 10.0 113.002 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.35 -52.36 62.11 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.962 0.905 . . . . 10.0 112.063 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.5 -60.0 3.77 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.364 1.066 . . . . 10.0 109.974 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -52.51 -46.96 66.9 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.004 -1.474 . . . . 10.0 111.934 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -50.77 -53.03 35.16 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.376 1.898 . . . . 10.0 113.119 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.27 -48.55 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.083 1.353 . . . . 10.0 111.499 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.5 mp -57.48 -50.86 71.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.101 1.36 . . . . 10.0 111.577 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -56.96 -59.69 4.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.71 2.404 . . . . 10.0 111.089 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.9 m -57.27 -38.83 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 120.563 -1.336 . . . . 10.0 112.379 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.6 t -62.86 -54.51 37.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.091 0.956 . . . . 10.0 112.024 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.66 -28.7 69.57 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.006 1.722 . . . . 10.0 114.386 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -90.77 -70.66 0.67 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.37 1.068 . . . . 10.0 111.605 173.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 16.9 t -76.59 -48.73 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.506 1.122 . . . . 10.0 111.797 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -54.87 -54.11 35.54 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.409 1.004 . . . . 10.0 113.128 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -45.22 -56.21 5.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.448 1.899 . . . . 10.0 111.814 166.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.74 -40.5 71.64 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.327 0.965 . . . . 10.0 113.903 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -70.41 -27.77 64.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 115.843 1.794 . . . . 10.0 115.843 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.587 -0.894 . . . . 10.0 108.587 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.7 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.906 0.882 . . . . 10.0 113.193 -172.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.56 5.25 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.28 0.25 15.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.269 1.028 . . . . 10.0 113.301 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.93 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.078 0.951 . . . . 10.0 111.033 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.63 98.21 1.86 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.758 0.823 . . . . 10.0 110.92 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.96 77.04 7.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.866 0.866 . . . . 10.0 112.07 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.474 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.85 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.7 1.2 . . . . 10.0 110.674 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.31 169.51 40.05 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.534 . . . . 10.0 119.647 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.521 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.597 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.554 3.142 . . . . 10.0 117.276 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.64 . . . . 10.0 114.524 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.393 1.877 . . . . 10.0 113.338 -158.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.302 1.841 . . . . 10.0 114.018 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.07 2.79 41.48 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.43 2.443 . . . . 10.0 111.48 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.6 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.649 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.04 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.559 2.307 . . . . 10.0 113.194 -175.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.23 4.31 0.98 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.842 2.457 . . . . 10.0 115.769 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.11 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.493 -0.754 . . . . 10.0 112.669 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.62 83.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.89 0.876 . . . . 10.0 109.272 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.41 -52.63 62.94 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.393 0.677 . . . . 10.0 111.885 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.34 -53.64 55.81 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.231 0.612 . . . . 10.0 112.18 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.77 51.99 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.413 1.485 . . . . 10.0 113.319 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.66 -44.95 84.74 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.316 1.446 . . . . 10.0 112.998 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.56 -56.28 11.64 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.544 1.069 . . . . 10.0 111.549 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -50.18 -52.3 36.63 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.795 1.238 . . . . 10.0 112.171 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.86 5.8 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.154 0.981 . . . . 10.0 112.143 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.06 -48.9 77.43 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.67 0.788 . . . . 10.0 112.786 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 54.6 mtt -61.27 -44.48 97.17 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.905 0.882 . . . . 10.0 111.363 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.69 13.26 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.326 0.965 . . . . 10.0 113.967 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.22 -45.96 79.7 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.568 1.184 . . . . 10.0 112.131 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.6 -41.96 75.38 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.8 1.19 . . . . 10.0 113.191 173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.9 m -62.46 -58.36 7.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.717 0.807 . . . . 10.0 111.414 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.04 0.936 . . . . 10.0 110.917 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.07 9.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.599 1.16 . . . . 10.0 112.985 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.65 81.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.174 . . . . 10.0 113.585 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.33 40.88 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 123.745 1.736 . . . . 10.0 110.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.79 -44.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.367 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.88 23.09 0.86 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.656 1.023 . . . . 10.0 115.656 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.56 -44.98 93.12 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.178 2.191 . . . . 10.0 113.581 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.58 -84.45 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.787 0.708 . . . . 10.0 112.487 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.01 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.435 2.694 . . . . 10.0 116.933 166.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.64 -50.86 10.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.867 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.52 6.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.765 1.291 . . . . 10.0 110.975 -172.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.64 -29.53 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.702 2.935 . . . . 10.0 113.724 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -60.67 2.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.099 0.56 . . . . 10.0 111.407 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.5 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.097 1.359 . . . . 10.0 113.588 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.46 19.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.26 1.424 . . . . 10.0 113.396 172.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 61.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.459 0.704 . . . . 10.0 110.986 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.91 -50.27 73.05 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.29 65.31 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.321 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.44 -61.93 1.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.52 -57.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.897 1.279 . . . . 10.0 110.562 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 m -67.98 -20.91 65.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.952 1.301 . . . . 10.0 113.488 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.8 m -83.9 -40.68 18.28 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.401 1.08 . . . . 10.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -59.43 -41.87 90.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.393 -0.817 . . . . 10.0 113.182 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.1 t -45.07 -62.74 1.48 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.542 1.137 . . . . 10.0 113.081 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.33 -25.5 30.53 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.842 2.362 . . . . 10.0 113.871 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.41 -46.91 78.14 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.644 1.565 . . . . 10.0 113.188 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.76 -49.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.048 -1.033 . . . . 10.0 109.271 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.11 72.27 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.925 0.89 . . . . 10.0 113.238 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -50.83 -57.21 8.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.812 1.645 . . . . 10.0 111.768 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.49 -53.09 19.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.41 1.484 . . . . 10.0 110.787 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.69 -48.15 64.62 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.008 0.923 . . . . 10.0 113.05 -176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -56.58 -40.73 75.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.185 1.357 . . . . 10.0 113.347 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.58 34.28 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.789 1.177 . . . . 10.0 111.284 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.08 61.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.192 1.553 . . . . 10.0 115.192 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.86 -50.85 61.2 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.458 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.66 -52.63 22.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.873 0.869 . . . . 10.0 112.91 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.54 48.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.328 1.051 . . . . 10.0 113.833 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.69 5.57 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.06 43.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.213 1.561 . . . . 10.0 115.213 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.48 61.33 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.318 0.887 . . . . 10.0 115.318 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.049 2.14 . . . . 10.0 109.034 171.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.53 171.04 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.042 0.937 . . . . 10.0 111.024 166.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.11 53.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.21 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.474 -1.01 . . . . 10.0 109.474 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.7 164.4 38.18 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.38 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.68 -3.42 0.7 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 118.716 2.247 . . . . 10.0 118.716 170.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.57 -171.86 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.327 1.564 . . . . 10.0 112.223 -165.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.501 1.52 . . . . 10.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.18 126.34 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.992 1.717 . . . . 10.0 111.671 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.419 1.581 . . . . 10.0 113.087 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.28 -28.32 66.64 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.485 -1.385 . . . . 10.0 113.937 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.14 62.14 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.231 1.196 . . . . 10.0 114.231 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.426 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -65.12 -24.98 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.221 -1.549 . . . . 10.0 113.861 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -75.01 -42.6 57.07 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.577 -1.327 . . . . 10.0 112.189 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.82 -48.41 59.77 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.203 1.401 . . . . 10.0 111.693 167.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.95 -72.3 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.563 1.945 . . . . 10.0 111.819 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.426 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 49.8 m0 -55.43 -32.02 62.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.738 1.215 . . . . 10.0 112.952 -171.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.7 tp -50.66 -41.57 55.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.104 1.361 . . . . 10.0 111.932 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -103.84 -45.08 4.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.873 0.869 . . . . 10.0 112.626 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.7 p -59.51 -38.9 82.17 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.593 1.088 . . . . 10.0 113.373 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.0 m -66.61 -51.65 39.51 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 117.957 -1.021 . . . . 10.0 113.106 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.56 -40.69 63.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.262 2.641 . . . . 10.0 114.631 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.5 mt -59.37 -48.31 82.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.619 0.767 . . . . 10.0 112.225 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.19 -39.45 86.55 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.584 1.084 . . . . 10.0 112.25 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.12 -49.05 74.99 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.081 -1.012 . . . . 10.0 111.348 167.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.29 78.27 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.852 0.861 . . . . 10.0 112.846 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.22 -54.1 35.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.301 0.955 . . . . 10.0 111.201 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.68 38.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.031 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.21 79.37 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.779 0.832 . . . . 10.0 112.669 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.81 -38.46 91.18 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.41 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.025 1.33 . . . . 10.0 112.298 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.873 1.669 . . . . 10.0 112.13 -173.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.31 145.88 47.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.929 -1.732 . . . . 10.0 112.455 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.87 54.25 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.72 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.423 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.18 5.33 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.178 1.37 . . . . 10.0 115.276 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.8 p -62.13 -46.72 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.051 -1.452 . . . . 10.0 111.285 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.48 -52.89 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.036 1.334 . . . . 10.0 111.11 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.6 -51.32 67.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.87 42.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.496 0.718 . . . . 10.0 110.932 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -59.85 4.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.354 2.262 . . . . 10.0 114.784 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.62 -46.64 73.9 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.573 0.749 . . . . 10.0 113.021 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -59.4 -43.7 92.95 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.847 0.859 . . . . 10.0 112.066 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -57.09 4.58 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.801 1.667 . . . . 10.0 113.123 165.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.1 mt -56.63 -49.81 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.94 0.896 . . . . 10.0 111.177 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -53.38 -58.62 6.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.427 1.012 . . . . 10.0 112.394 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.9 mp -64.96 -48.36 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.417 0.553 . . . . 10.0 111.223 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.61 -47.81 57.02 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.804 1.193 . . . . 10.0 112.888 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 97.7 m -60.27 -45.76 92.18 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.965 1.306 . . . . 10.0 111.882 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.2 -54.27 12.97 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.115 0.864 . . . . 10.0 112.904 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.55 -49.6 45.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.504 2.722 . . . . 10.0 111.7 173.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.94 -49.09 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 120.922 -1.111 . . . . 10.0 111.627 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.02 -59.68 9.1 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.054 1.787 . . . . 10.0 112.541 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.09 3.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.181 2.592 . . . . 10.0 113.298 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.9 mt -100.83 -6.9 24.17 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.477 1.658 . . . . 10.0 115.477 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.182 -1.574 . . . . 10.0 110.409 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.52 -49.61 72.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.26 2.624 . . . . 10.0 113.239 177.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.58 106.29 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.783 0.833 . . . . 10.0 110.088 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.065 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.06 15.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.458 1.503 . . . . 10.0 113.49 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.65 63.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.884 1.439 . . . . 10.0 114.884 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.05 -41.38 68.04 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.902 0.774 . . . . 10.0 110.891 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -70.13 -31.26 68.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.837 1.255 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.49 -52.25 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.057 0.844 . . . . 10.0 109.629 168.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.26 -46.14 90.85 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.462 0.912 . . . . 10.0 113.462 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -50.95 -48.53 60.9 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.763 1.165 . . . . 10.0 113.213 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.87 -53.94 52.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.78 0.832 . . . . 10.0 111.79 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.72 -53.31 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.091 1.356 . . . . 10.0 111.859 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.6 p -58.67 -44.17 90.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.809 0.844 . . . . 10.0 112.697 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.66 -43.3 97.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.346 1.058 . . . . 10.0 112.346 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.1 78.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.295 0.952 . . . . 10.0 112.449 171.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.49 80.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.864 0.865 . . . . 10.0 112.524 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 35.8 ttp -55.74 -53.46 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.388 1.075 . . . . 10.0 112.024 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.74 -47.96 73.18 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.432 1.493 . . . . 10.0 112.446 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.6 -54.14 19.97 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 10.0 112.062 170.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.07 -54.86 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.593 0.757 . . . . 10.0 110.897 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.48 -36.45 69.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.441 -0.79 . . . . 10.0 113.116 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.35 -58.1 9.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.984 0.913 . . . . 10.0 113.077 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.93 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.344 -0.836 . . . . 10.0 111.461 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.77 -49.41 75.39 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.858 1.208 . . . . 10.0 112.163 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.908 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.9 60.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.624 1.169 . . . . 10.0 113.494 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.86 -79.03 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.601 0.619 . . . . 10.0 113.519 171.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.46 51.49 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.268 1.827 . . . . 10.0 113.067 -166.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.06 -56.45 14.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.022 1.119 . . . . 10.0 114.022 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.72 -50.5 65.79 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.06 0.934 . . . . 10.0 112.302 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.18 -45.98 83.23 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.197 0.999 . . . . 10.0 112.114 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.43 80.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.28 1.23 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.091 1.756 . . . . 10.0 114.194 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.11 6.66 29.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.374 1.87 . . . . 10.0 114.846 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.91 -92.64 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.522 1.63 . . . . 10.0 114.193 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.71 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 129.794 3.238 . . . . 10.0 105.571 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.19 35.55 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.263 1.976 . . . . 10.0 113.032 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.9 -46.13 67.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.04 2.936 . . . . 10.0 113.284 173.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.21 -52.95 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.17 -46.85 75.79 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.251 0.62 . . . . 10.0 111.9 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.19 24.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.9 m -57.19 -53.24 60.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 112.995 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.54 -49.56 45.62 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.292 0.637 . . . . 10.0 111.097 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.57 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.832 0.742 . . . . 10.0 110.54 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.56 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.87 30.11 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.839 2.056 . . . . 10.0 111.038 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.46 -58.35 8.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.769 0.428 . . . . 10.0 111.269 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.8 -48.73 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.116 0.967 . . . . 10.0 111.546 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.9 m -57.05 -63.99 1.03 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.056 2.542 . . . . 10.0 111.863 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.64 -49.15 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.847 1.259 . . . . 10.0 111.235 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.65 -62.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.89 0.876 . . . . 10.0 112.494 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.23 -45.26 84.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.748 0.704 . . . . 10.0 111.976 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -51.78 -53.08 43.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.929 0.892 . . . . 10.0 112.383 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.2 m -53.14 -31.68 43.62 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.341 1.057 . . . . 10.0 113.65 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.83 96.14 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.833 1.049 . . . . 10.0 113.833 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -47.04 -57.38 9.37 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 115.241 1.571 . . . . 10.0 115.241 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -59.89 -35.13 94.73 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.23 1.953 . . . . 10.0 112.917 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.23 -56.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.991 0.916 . . . . 10.0 110.926 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.9 m -62.97 -34.17 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 118.831 -0.605 . . . . 10.0 112.621 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -59.79 -54.9 40.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.529 1.132 . . . . 10.0 112.184 167.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.3 tp -52.9 -43.82 66.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.882 1.273 . . . . 10.0 112.254 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.75 -4.9 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 115.453 1.649 . . . . 10.0 115.453 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.45 -169.28 32.91 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.521 1.067 . . . . 10.0 113.898 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.23 -41.67 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.838 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.9 -14.16 62.87 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.364 1.616 . . . . 10.0 115.364 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.14 -106.14 1.02 Allowed Glycine 0 CA--C 1.535 1.284 0 CA-C-N 120.523 1.51 . . . . 10.0 114.218 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.08 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.666 -1.49 . . . . 10.0 109.314 168.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.38 65.31 1.34 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.7 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.36 24.89 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.66 153.8 72.64 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.814 3.009 . . . . 10.0 111.456 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.22 -39.77 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.193 171.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.36 21.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.98 -40.45 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.429 1.092 . . . . 10.0 109.617 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.35 -49.76 42.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.603 0.638 . . . . 10.0 111.952 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.7 -47.06 83.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.004 1.721 . . . . 10.0 112.979 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.32 -52.32 62.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.957 0.903 . . . . 10.0 112.1 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.53 -58.93 5.2 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.362 1.065 . . . . 10.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.99 -47.21 65.0 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.641 -1.171 . . . . 10.0 112.359 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.52 -52.11 56.3 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.57 1.532 . . . . 10.0 112.846 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.91 -47.97 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.51 1.124 . . . . 10.0 111.189 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.9 mp -57.94 -51.33 70.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.74 1.616 . . . . 10.0 112.159 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -54.46 -56.01 23.05 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.292 2.237 . . . . 10.0 111.309 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.75 -49.36 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.582 -0.699 . . . . 10.0 111.233 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.8 m -56.2 -55.01 38.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.254 1.022 . . . . 10.0 112.33 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.43 1.11 8.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.373 1.869 . . . . 10.0 114.913 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -128.87 -68.83 0.73 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.921 1.288 . . . . 10.0 111.594 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.11 -50.93 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.595 1.158 . . . . 10.0 110.813 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -56.66 -55.87 27.66 Favored Glycine 0 N--CA 1.475 1.281 0 C-N-CA 124.118 0.866 . . . . 10.0 112.602 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.7 -56.88 2.49 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.816 2.046 . . . . 10.0 112.554 166.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.48 -41.41 88.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.785 1.184 . . . . 10.0 114.256 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -69.31 -27.23 65.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 115.609 1.707 . . . . 10.0 115.609 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.2 -57.58 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 165.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.67 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.92 0.888 . . . . 10.0 113.167 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.54 5.21 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.324 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.09 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.028 0.931 . . . . 10.0 111.014 174.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.56 98.21 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.781 0.832 . . . . 10.0 110.949 170.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.95 76.99 7.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.908 0.883 . . . . 10.0 112.093 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.07 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 128.888 2.875 . . . . 10.0 116.499 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.87 -55.47 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.641 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.48 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.676 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.495 0 C-N-CA 128.527 2.731 . . . . 10.0 113.461 166.594 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.808 -2.044 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.657 3.183 . . . . 10.0 117.239 160.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.0 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.297 2.639 . . . . 10.0 114.49 155.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.427 1.891 . . . . 10.0 113.339 -158.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.8 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 114.015 -174.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.83 40.9 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.675 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.02 -60.65 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.502 2.286 . . . . 10.0 113.202 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.11 4.28 0.94 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.787 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.509 -0.744 . . . . 10.0 112.625 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.898 0.879 . . . . 10.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.42 -52.64 62.91 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.455 0.702 . . . . 10.0 111.84 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.39 -53.58 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.205 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.77 52.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.332 1.453 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.66 -44.98 84.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.354 1.462 . . . . 10.0 112.997 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.66 -56.86 10.43 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.32 0.962 . . . . 10.0 111.3 165.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.47 -52.29 30.12 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.615 1.166 . . . . 10.0 112.199 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.92 5.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.159 0.984 . . . . 10.0 112.139 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -57.68 -50.31 73.6 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.599 0.76 . . . . 10.0 112.604 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -49.99 68.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.252 1.021 . . . . 10.0 111.071 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.92 -58.18 15.95 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.407 1.003 . . . . 10.0 113.673 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.19 -45.69 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.511 1.155 . . . . 10.0 112.086 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.7 -42.08 76.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.88 1.229 . . . . 10.0 113.302 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -60.51 -60.36 3.93 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.046 0.938 . . . . 10.0 111.071 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.97 62.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.0 9.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 113.004 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.71 -38.61 82.09 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.1 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.66 1.184 . . . . 10.0 113.628 169.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.759 1.742 . . . . 10.0 110.852 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.88 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.869 2.468 . . . . 10.0 109.286 171.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.12 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.594 0.998 . . . . 10.0 115.594 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.0 92.89 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.163 2.185 . . . . 10.0 113.605 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.43 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.742 0.687 . . . . 10.0 112.407 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.962 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.84 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.904 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.811 1.32 . . . . 10.0 110.972 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.54 -29.67 89.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.719 2.946 . . . . 10.0 113.716 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.23 -60.75 2.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.133 0.573 . . . . 10.0 111.441 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.07 -40.08 22.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.126 1.37 . . . . 10.0 113.58 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.59 -47.39 19.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.444 172.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.06 62.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.48 0.712 . . . . 10.0 110.955 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.97 -50.24 73.26 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.137 0.575 . . . . 10.0 112.313 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.22 65.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.868 -0.586 . . . . 10.0 112.362 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.77 -57.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.867 1.267 . . . . 10.0 110.329 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -69.27 -16.25 63.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.14 1.376 . . . . 10.0 113.69 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.1 m -87.87 -42.99 12.14 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.779 1.172 . . . . 10.0 111.96 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -56.56 -41.6 77.17 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 173.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -49.46 -61.61 3.31 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.804 1.242 . . . . 10.0 112.595 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.64 -47.62 20.14 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.593 3.529 . . . . 10.0 116.115 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.1 93.62 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.938 1.245 . . . . 10.0 113.966 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.9 mt -58.57 -51.76 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.398 1.079 . . . . 10.0 109.525 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -43.04 71.76 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 10.0 113.246 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -52.69 -57.95 8.42 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.131 1.332 . . . . 10.0 111.912 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -48.33 -52.89 19.48 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.57 1.548 . . . . 10.0 110.967 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.89 -48.12 64.16 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.916 0.886 . . . . 10.0 113.029 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -55.85 -41.44 74.31 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.27 1.395 . . . . 10.0 113.225 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.54 34.8 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.719 1.145 . . . . 10.0 111.292 170.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.23 1.567 . . . . 10.0 115.23 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.88 -50.82 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.519 0.728 . . . . 10.0 110.528 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.57 -52.69 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.835 0.854 . . . . 10.0 112.922 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.96 -5.53 48.97 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.65 5.6 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.527 0.971 . . . . 10.0 115.527 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.1 42.74 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.63 61.1 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.351 0.9 . . . . 10.0 115.351 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.35 26.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.034 2.133 . . . . 10.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.052 166.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.717 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.6 129.58 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.76 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.72 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.664 2.226 . . . . 10.0 118.664 170.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.343 1.571 . . . . 10.0 112.237 -165.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.85 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.096 -175.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.09 126.33 22.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.028 1.731 . . . . 10.0 111.682 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.61 85.06 4.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.384 1.564 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.42 -28.26 66.77 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.523 -1.361 . . . . 10.0 113.926 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.38 62.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -64.89 -24.45 67.54 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.232 -1.543 . . . . 10.0 113.876 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -75.87 -42.93 47.9 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.462 -1.399 . . . . 10.0 112.257 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.88 53.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.064 1.346 . . . . 10.0 111.368 168.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -52.41 -71.09 0.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.715 2.006 . . . . 10.0 111.836 168.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -56.17 -32.74 64.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.644 1.178 . . . . 10.0 113.153 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.88 -39.74 54.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.389 1.475 . . . . 10.0 112.084 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.72 -41.41 5.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.549 0.739 . . . . 10.0 112.95 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 p -59.31 -41.1 88.24 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 120.792 1.633 . . . . 10.0 113.347 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 m -68.47 -47.5 35.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.99 -41.47 74.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.574 2.849 . . . . 10.0 114.872 168.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -47.66 85.08 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.586 0.755 . . . . 10.0 111.728 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.7 tt -50.47 -49.61 54.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 10.0 111.548 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.18 -47.83 77.53 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.129 -0.982 . . . . 10.0 112.848 170.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.26 78.42 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.829 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.27 -54.03 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.343 0.974 . . . . 10.0 111.165 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -42.09 88.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.641 0.776 . . . . 10.0 112.093 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.81 36.63 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.996 0.918 . . . . 10.0 112.021 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.1 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.875 1.67 . . . . 10.0 112.106 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.938 -1.726 . . . . 10.0 112.437 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.55 135.96 54.46 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.9 -39.66 2.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.474 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.18 5.36 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.15 1.357 . . . . 10.0 115.266 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -46.75 87.76 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.123 -1.418 . . . . 10.0 111.351 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.038 1.335 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.58 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.534 0.568 . . . . 10.0 112.534 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.86 43.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.716 . . . . 10.0 110.911 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.64 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.382 2.273 . . . . 10.0 114.814 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.04 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.647 0.779 . . . . 10.0 111.403 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.67 -46.76 74.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.24 0.83 . . . . 10.0 113.24 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.64 -44.11 89.94 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 10.0 112.217 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.87 -56.23 5.2 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.33 1.443 . . . . 10.0 113.072 166.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 90.0 mt -56.81 -51.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.674 0.789 . . . . 10.0 111.55 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -52.1 -57.61 9.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.268 1.027 . . . . 10.0 112.185 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.0 mm -66.59 -43.83 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.776 0.43 . . . . 10.0 111.81 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.88 -59.95 9.09 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.823 1.201 . . . . 10.0 113.316 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.6 p -59.45 -35.87 74.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.893 0.877 . . . . 10.0 112.52 173.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -46.27 -58.92 5.49 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.351 0.977 . . . . 10.0 113.543 163.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.9 tp -57.53 -46.28 84.05 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.318 1.447 . . . . 10.0 112.101 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.3 t -53.08 -50.67 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.709 -0.62 . . . . 10.0 110.328 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.39 -60.9 6.34 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.099 1.809 . . . . 10.0 112.704 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -44.22 -41.12 5.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.245 2.218 . . . . 10.0 113.585 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.26 -6.7 25.58 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.444 1.646 . . . . 10.0 115.444 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.74 116.75 10.49 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.375 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.58 72.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.66 106.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.043 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.62 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -53.99 -41.66 68.15 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.89 0.768 . . . . 10.0 110.807 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.78 -31.59 69.6 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.318 1.229 . . . . 10.0 114.318 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.22 -51.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.976 0.807 . . . . 10.0 109.636 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -61.92 -42.8 99.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.423 1.268 . . . . 10.0 114.423 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.65 -48.85 69.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.237 1.015 . . . . 10.0 112.758 171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.24 70.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.534 0.734 . . . . 10.0 111.614 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.16 -55.03 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.079 1.352 . . . . 10.0 111.974 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.1 p -57.2 -40.83 78.21 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.432 -0.792 . . . . 10.0 112.706 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.4 m -61.92 -44.84 95.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.756 1.223 . . . . 10.0 112.326 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.6 80.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.314 0.961 . . . . 10.0 112.251 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.95 85.51 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.503 -0.748 . . . . 10.0 112.816 173.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.272 1.029 . . . . 10.0 112.26 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.88 -45.81 78.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.831 1.652 . . . . 10.0 112.231 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -54.81 -53.93 48.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 171.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 44.1 mt -54.21 -54.75 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.716 0.689 . . . . 10.0 110.856 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.27 1.0 OUTLIER -60.02 -32.71 71.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 117.467 -1.254 . . . . 10.0 112.904 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.25 -58.13 9.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.987 1.267 . . . . 10.0 113.071 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -40.89 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.312 -0.851 . . . . 10.0 111.446 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.78 -49.41 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.847 1.203 . . . . 10.0 112.145 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.05 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.046 -1.659 . . . . 10.0 112.833 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -73.79 -21.9 60.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.626 1.17 . . . . 10.0 113.398 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.588 0.614 . . . . 10.0 113.488 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.63 -32.45 51.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.62 -50.58 65.39 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.067 0.937 . . . . 10.0 112.286 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.17 -45.98 83.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.105 0.962 . . . . 10.0 112.15 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.46 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.506 1.299 . . . . 10.0 114.506 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.46 -11.34 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.078 1.751 . . . . 10.0 114.238 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.57 29.14 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.85 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.456 1.598 . . . . 10.0 114.171 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.77 153.88 72.49 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.834 3.254 . . . . 10.0 105.57 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.8 -46.21 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.329 2.019 . . . . 10.0 113.083 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.03 68.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.985 2.914 . . . . 10.0 113.27 173.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.19 -53.03 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.78 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.26 23.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.12 -53.23 60.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.164 0.986 . . . . 10.0 113.028 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.54 46.07 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.337 0.655 . . . . 10.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.06 -48.46 78.5 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.02 -49.61 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.767 0.712 . . . . 10.0 110.487 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.48 -51.69 68.77 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.74 30.88 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.818 2.047 . . . . 10.0 111.065 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.81 0.444 . . . . 10.0 111.269 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.99 -47.42 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.046 0.938 . . . . 10.0 112.238 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.9 m -58.19 -64.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.953 2.501 . . . . 10.0 111.482 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.27 -48.64 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.845 1.258 . . . . 10.0 111.373 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.27 -61.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.863 0.865 . . . . 10.0 112.606 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.19 -47.06 79.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.754 0.706 . . . . 10.0 111.934 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -50.11 -54.29 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.645 1.178 . . . . 10.0 112.149 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 m -52.31 -33.88 44.44 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.509 1.123 . . . . 10.0 113.588 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.97 96.81 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.017 1.117 . . . . 10.0 114.017 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -46.37 -58.08 7.3 Favored Pre-proline 0 N--CA 1.479 0.986 0 N-CA-C 114.908 1.447 . . . . 10.0 114.908 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.93 -32.79 92.89 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.376 2.051 . . . . 10.0 113.492 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.75 -57.89 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.991 0.916 . . . . 10.0 110.417 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.0 m -61.86 -34.08 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.4 -56.63 19.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.544 1.138 . . . . 10.0 112.404 167.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.4 tt -57.59 -40.46 79.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.755 0.822 . . . . 10.0 112.355 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.18 -5.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 115.2 1.555 . . . . 10.0 115.2 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.35 32.95 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.573 1.096 . . . . 10.0 113.895 -168.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.93 65.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.176 -1.012 . . . . 10.0 111.88 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.88 -13.45 62.43 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.75 -106.13 0.98 Allowed Glycine 0 CA--C 1.535 1.311 0 CA-C-N 120.606 1.548 . . . . 10.0 114.45 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.12 35.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.595 -1.533 . . . . 10.0 109.368 168.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.904 0.321 . . . . 10.0 113.904 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.64 -42.7 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.687 166.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.34 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.382 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.69 153.79 72.59 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.774 2.983 . . . . 10.0 111.476 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.8 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.38 1.072 . . . . 10.0 112.169 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -52.34 22.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.49 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.695 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.35 -49.78 42.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.515 0.598 . . . . 10.0 111.925 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.38 -52.26 62.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.923 0.889 . . . . 10.0 112.124 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.6 -58.82 5.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.319 1.048 . . . . 10.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -52.55 -46.14 66.68 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 117.629 -1.176 . . . . 10.0 112.506 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.01 -51.89 60.21 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.55 1.523 . . . . 10.0 112.789 175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.68 -47.0 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.81 1.244 . . . . 10.0 111.598 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.73 -50.04 75.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 10.0 111.795 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -57.15 -57.4 12.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.879 2.072 . . . . 10.0 111.508 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.53 -40.31 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.887 -1.133 . . . . 10.0 111.917 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 28.0 m -59.45 -51.87 68.03 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.952 0.901 . . . . 10.0 111.867 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.09 -25.8 66.4 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.313 1.845 . . . . 10.0 114.42 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -98.65 -71.66 0.68 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.485 1.114 . . . . 10.0 111.685 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.86 -49.77 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.604 1.162 . . . . 10.0 111.567 -172.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.2 -55.44 28.25 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.254 0.93 . . . . 10.0 112.904 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -43.09 -56.91 3.14 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.999 2.12 . . . . 10.0 112.266 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.7 -40.43 71.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.303 0.954 . . . . 10.0 114.186 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -69.75 -27.32 64.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 115.882 1.808 . . . . 10.0 115.882 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -57.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.593 -0.892 . . . . 10.0 108.593 165.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.76 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.898 . . . . 10.0 113.193 -172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.17 2.53 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.23 0.3 15.74 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.22 1.008 . . . . 10.0 113.344 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.046 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.61 98.12 1.83 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.826 0.85 . . . . 10.0 110.941 170.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.88 77.04 7.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.824 0.85 . . . . 10.0 112.067 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.838 2.855 . . . . 10.0 116.491 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.738 1.215 . . . . 10.0 110.656 -175.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.44 39.92 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.757 3.551 . . . . 10.0 119.665 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.487 2.715 . . . . 10.0 113.44 166.597 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.75 -2.072 . . . . 10.0 105.863 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.62 65.01 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.252 2.621 . . . . 10.0 114.537 155.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.97 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.344 1.857 . . . . 10.0 113.339 -158.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.77 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.08 2.8 41.62 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.489 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.653 -168.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.92 -60.7 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.522 2.293 . . . . 10.0 113.196 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -67.19 4.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.726 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.29 -43.14 61.56 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.515 -0.741 . . . . 10.0 112.619 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.59 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.331 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.43 -52.63 62.96 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.455 0.702 . . . . 10.0 111.882 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.341 1.456 . . . . 10.0 113.315 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.12 -55.44 15.52 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.501 1.048 . . . . 10.0 111.801 166.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -50.26 -52.48 35.85 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.834 1.253 . . . . 10.0 112.284 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.87 5.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.16 0.984 . . . . 10.0 112.167 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.1 -48.86 77.57 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.615 0.766 . . . . 10.0 112.858 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -61.59 -43.94 97.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.649 0.78 . . . . 10.0 111.531 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.59 -58.75 12.93 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.145 0.879 . . . . 10.0 113.785 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -45.99 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.605 1.202 . . . . 10.0 112.119 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.08 -42.88 72.68 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.028 1.299 . . . . 10.0 113.132 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -62.1 -58.23 8.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.285 -0.864 . . . . 10.0 111.489 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.33 -40.99 62.62 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.041 0.936 . . . . 10.0 110.937 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.02 9.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.636 1.175 . . . . 10.0 112.968 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.71 82.15 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.45 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.632 1.173 . . . . 10.0 113.633 169.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.743 1.735 . . . . 10.0 110.88 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.9 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.839 2.455 . . . . 10.0 109.358 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.94 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.02 93.01 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.196 2.198 . . . . 10.0 113.546 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.39 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.437 2.695 . . . . 10.0 116.948 166.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.8 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.18 -1.373 . . . . 10.0 113.868 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.51 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.769 1.293 . . . . 10.0 110.981 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.55 -29.67 89.57 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.706 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.28 -60.69 2.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.111 0.565 . . . . 10.0 111.437 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.1 22.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.1 1.36 . . . . 10.0 113.549 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.44 19.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.199 1.4 . . . . 10.0 113.446 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.71 -53.07 62.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.48 0.712 . . . . 10.0 110.967 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -57.0 -50.22 73.37 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.297 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.2 65.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.34 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.99 1.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.8 mt -48.53 -57.93 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.865 1.266 . . . . 10.0 110.332 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -67.92 -19.03 64.95 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.105 1.362 . . . . 10.0 113.703 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -86.0 -40.87 15.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.45 1.1 . . . . 10.0 112.22 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.8 mt -59.17 -42.61 91.21 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.915 0.78 . . . . 10.0 112.921 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.9 t -44.03 -61.19 2.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.67 1.588 . . . . 10.0 113.154 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -70.74 -25.42 24.09 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.895 2.396 . . . . 10.0 114.041 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.11 -50.13 67.26 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 120.732 1.605 . . . . 10.0 113.795 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.28 -39.05 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 120.329 -1.482 . . . . 10.0 110.735 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.26 81.18 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 118.54 -0.743 . . . . 10.0 112.96 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -50.58 -55.71 15.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.581 1.553 . . . . 10.0 111.755 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.08 -53.19 21.58 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.363 1.465 . . . . 10.0 110.867 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.35 -48.19 65.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.102 0.961 . . . . 10.0 113.011 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.4 -41.1 75.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.241 1.382 . . . . 10.0 113.222 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.53 35.06 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.656 1.116 . . . . 10.0 111.313 170.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.15 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.9 mtm -66.78 -50.88 61.25 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.565 0.746 . . . . 10.0 110.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.54 -52.71 21.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 10.0 112.925 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.58 49.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.27 -34.66 5.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 115.542 0.977 . . . . 10.0 115.542 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.12 43.3 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.56 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.081 2.153 . . . . 10.0 109.056 171.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.062 166.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.883 0.873 . . . . 10.0 109.723 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.3 t -129.61 129.6 23.17 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.037 1.335 . . . . 10.0 110.927 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.78 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -81.96 0.15 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.697 -0.961 . . . . 10.0 110.697 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.91 4.07 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.317 1.558 . . . . 10.0 112.27 -165.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.47 1.508 . . . . 10.0 111.107 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.46 120.76 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.52 131.92 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.198 3.265 . . . . 10.0 112.137 171.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.03 1.732 . . . . 10.0 111.69 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.04 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.865 1.317 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.4 -28.28 66.77 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.77 -26.47 46.07 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.296 1.038 . . . . 10.0 111.165 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -44.08 -63.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.374 1.47 . . . . 10.0 110.146 165.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -63.62 -39.73 95.1 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.223 2.209 . . . . 10.0 111.119 -172.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.26 -49.03 67.76 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.733 0.813 . . . . 10.0 112.024 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -63.67 1.21 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.96 1.304 . . . . 10.0 111.64 170.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -53.7 -36.95 62.75 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.805 1.642 . . . . 10.0 112.72 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.69 -42.17 56.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.036 1.734 . . . . 10.0 112.226 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -103.68 -35.29 8.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.932 0.716 . . . . 10.0 112.932 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.5 p -62.17 -49.04 77.42 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 121.387 1.903 . . . . 10.0 113.483 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.284 69.9 p -63.54 -41.73 68.4 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 114.722 1.379 . . . . 10.0 114.722 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.8 -43.24 51.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.481 2.787 . . . . 10.0 115.265 168.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 mt -60.62 -46.9 88.53 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.491 -0.756 . . . . 10.0 111.515 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.68 -49.83 56.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.646 1.578 . . . . 10.0 111.359 171.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.65 -47.46 79.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.247 1.019 . . . . 10.0 113.046 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.854 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.31 -54.01 36.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.173 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.11 88.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.69 0.796 . . . . 10.0 112.068 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.69 -54.75 37.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 111.974 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.725 0.81 . . . . 10.0 112.704 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.82 -38.56 91.57 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.78 1.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.062 1.345 . . . . 10.0 112.337 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.49 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.88 47.66 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.454 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.84 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.714 0.635 . . . . 10.0 112.714 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.8 -39.68 2.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.24 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.131 1.348 . . . . 10.0 115.235 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.06 -46.77 87.69 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.13 -1.414 . . . . 10.0 111.312 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.5 -52.91 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.029 1.332 . . . . 10.0 111.101 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.27 67.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.23 -44.85 43.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.424 0.69 . . . . 10.0 110.924 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.55 -59.88 4.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.419 2.288 . . . . 10.0 114.815 174.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.08 -46.29 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.667 0.787 . . . . 10.0 111.385 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.67 74.42 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 173.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.0 -45.99 82.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.851 0.86 . . . . 10.0 111.994 174.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -55.38 5.49 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.362 1.458 . . . . 10.0 113.142 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.73 -50.15 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.902 0.881 . . . . 10.0 111.74 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -50.99 -57.13 9.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.589 1.556 . . . . 10.0 111.873 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm -68.66 -42.85 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.121 0.568 . . . . 10.0 112.488 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.2 -53.1 39.57 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.04 1.305 . . . . 10.0 113.501 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.5 p -61.05 -36.52 79.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.208 -1.172 . . . . 10.0 112.307 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.23 -56.77 13.32 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.148 0.88 . . . . 10.0 113.294 165.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.52 -47.29 49.0 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.498 2.719 . . . . 10.0 111.321 174.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.05 -49.68 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.488 1.115 . . . . 10.0 111.764 174.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.55 -58.99 9.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.085 1.803 . . . . 10.0 112.338 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.49 -43.48 2.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.251 2.62 . . . . 10.0 113.294 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.3 mt -101.2 -6.4 24.3 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.423 1.638 . . . . 10.0 115.423 -174.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.67 116.73 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.165 -1.584 . . . . 10.0 110.419 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.59 72.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.217 2.607 . . . . 10.0 113.269 177.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.61 106.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.09 15.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 10.0 113.468 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.66 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -53.84 -41.91 67.92 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.902 0.774 . . . . 10.0 110.806 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.21 -32.57 71.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.817 1.247 . . . . 10.0 114.198 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.91 -52.12 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.022 0.828 . . . . 10.0 109.991 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -59.45 -51.76 68.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.491 0.922 . . . . 10.0 113.491 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.38 -46.59 37.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.428 1.091 . . . . 10.0 113.427 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.38 -52.55 65.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.945 0.898 . . . . 10.0 111.659 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.4 mt -54.07 -50.98 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.126 1.37 . . . . 10.0 111.49 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 m -53.84 -49.19 68.96 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.479 1.112 . . . . 10.0 112.108 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 76.5 m -61.34 -43.34 99.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.992 1.317 . . . . 10.0 111.618 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.45 -50.16 73.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.14 0.976 . . . . 10.0 112.477 170.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.87 82.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.736 0.814 . . . . 10.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.1 ttp -57.94 -53.13 61.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.496 1.118 . . . . 10.0 111.953 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -51.92 -50.01 61.95 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.772 1.629 . . . . 10.0 111.398 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -49.51 -54.89 15.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.06 0.944 . . . . 10.0 112.436 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -53.4 -55.29 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.829 0.852 . . . . 10.0 110.729 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.5 mt -57.49 -35.65 70.48 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.283 -0.865 . . . . 10.0 112.91 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.18 9.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.89 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.5 mt -56.77 -49.45 75.27 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.845 1.202 . . . . 10.0 112.099 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.877 -175.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.65 -21.99 60.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.635 1.174 . . . . 10.0 113.446 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.625 0.631 . . . . 10.0 113.527 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.55 -32.52 51.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.322 1.849 . . . . 10.0 113.019 -166.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.11 -56.4 14.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.56 65.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.121 0.962 . . . . 10.0 112.331 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.07 82.87 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.188 0.995 . . . . 10.0 112.134 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.77 -47.52 79.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.249 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.01 6.58 29.19 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.433 1.893 . . . . 10.0 114.907 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.65 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.535 1.636 . . . . 10.0 114.139 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.73 153.98 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.81 3.244 . . . . 10.0 105.572 170.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.85 -46.21 35.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.301 2.001 . . . . 10.0 113.052 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.96 -46.08 68.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.27 173.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.22 -53.05 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 C-N-CA 124.055 0.942 . . . . 10.0 109.788 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.86 75.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.275 0.63 . . . . 10.0 111.917 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.98 -56.13 25.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.88 0.872 . . . . 10.0 112.761 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.028 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.58 -49.52 46.19 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.337 0.655 . . . . 10.0 111.052 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.17 -48.4 78.82 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.636 1.347 . . . . 10.0 114.636 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.801 0.728 . . . . 10.0 110.506 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.164 0.801 . . . . 10.0 113.164 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.8 30.26 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.1 t -51.9 -49.1 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.044 0.937 . . . . 10.0 111.472 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.4 m -56.01 -63.95 1.01 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.62 2.768 . . . . 10.0 111.921 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.31 -49.51 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.488 1.115 . . . . 10.0 111.313 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.7 -62.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.172 0.989 . . . . 10.0 112.063 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.51 -47.17 85.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.974 0.806 . . . . 10.0 112.612 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -55.01 -50.31 69.35 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.683 0.793 . . . . 10.0 111.752 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -53.98 -32.18 53.14 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.902 1.075 . . . . 10.0 113.902 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.98 99.02 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.821 1.045 . . . . 10.0 113.821 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -48.37 -56.34 14.82 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 115.108 1.521 . . . . 10.0 115.108 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -58.84 -34.73 99.18 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.096 1.864 . . . . 10.0 113.318 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.81 -53.03 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.285 0.948 . . . . 10.0 110.636 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.77 -50.62 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.756 1.222 . . . . 10.0 111.596 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -56.39 -51.01 69.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.46 1.104 . . . . 10.0 112.53 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.2 tp -54.44 -45.53 73.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.59 1.156 . . . . 10.0 112.22 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -86.54 -5.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.15 1.537 . . . . 10.0 115.15 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.54 -169.29 32.79 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 122.602 1.112 . . . . 10.0 113.806 -168.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.75 65.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.868 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -67.29 -16.13 64.1 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.487 1.662 . . . . 10.0 115.487 -175.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.77 -105.99 1.04 Allowed Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.494 1.497 . . . . 10.0 114.104 -173.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.11 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.35 168.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 CA-C-N 117.878 0.308 . . . . 10.0 113.862 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.59 -42.73 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.73 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.416 1.886 . . . . 10.0 109.366 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.79 153.79 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.19 -39.78 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.18 171.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.38 21.9 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.682 1.364 . . . . 10.0 114.682 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.27 -49.83 41.77 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.603 0.638 . . . . 10.0 111.991 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.66 -47.06 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.999 1.72 . . . . 10.0 113.026 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.32 -52.29 62.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.974 0.91 . . . . 10.0 112.093 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.61 -59.0 4.99 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 109.975 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.83 -44.65 66.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.793 -1.098 . . . . 10.0 112.657 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -54.16 -52.64 60.51 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.579 1.536 . . . . 10.0 112.689 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.2 t -60.86 -46.26 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.69 1.196 . . . . 10.0 111.353 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -59.15 -52.44 65.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.364 1.466 . . . . 10.0 112.122 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -55.46 -54.64 41.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.507 1.923 . . . . 10.0 111.062 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t -49.49 -50.33 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.071 -1.018 . . . . 10.0 111.635 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 34.9 m -59.81 -53.43 57.99 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.269 1.028 . . . . 10.0 112.035 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.92 -25.45 66.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.709 2.003 . . . . 10.0 114.596 -176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -97.28 -70.81 0.71 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.454 1.102 . . . . 10.0 111.704 173.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.3 t -73.49 -50.32 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.575 1.15 . . . . 10.0 111.51 -171.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.34 -55.07 30.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.244 0.926 . . . . 10.0 112.758 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -43.47 -57.08 3.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.79 2.036 . . . . 10.0 112.488 166.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.98 -41.26 76.54 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.326 0.965 . . . . 10.0 113.993 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.79 -26.99 64.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.911 1.819 . . . . 10.0 115.911 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.5 -57.47 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.88 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.908 0.883 . . . . 10.0 113.187 -172.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.15 2.56 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.197 0.999 . . . . 10.0 113.296 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.05 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.983 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.13 1.82 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.771 0.828 . . . . 10.0 110.961 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.88 76.97 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.857 0.863 . . . . 10.0 112.094 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.862 2.865 . . . . 10.0 116.505 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.79 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.731 1.212 . . . . 10.0 110.698 -175.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.49 39.98 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.591 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.789 -2.053 . . . . 10.0 105.817 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.638 3.175 . . . . 10.0 117.211 160.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.69 65.0 0.11 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.306 2.642 . . . . 10.0 114.49 155.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.84 41.28 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.483 2.468 . . . . 10.0 111.523 168.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.667 -168.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -64.0 -60.6 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.519 2.292 . . . . 10.0 113.212 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.19 4.33 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.847 2.459 . . . . 10.0 115.787 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.46 -0.775 . . . . 10.0 112.619 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.57 84.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.859 0.863 . . . . 10.0 109.315 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.37 -52.66 62.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.426 0.69 . . . . 10.0 111.898 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.34 -53.64 55.84 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.221 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.81 51.95 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.366 1.466 . . . . 10.0 113.307 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.63 -45.0 84.75 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 10.0 113.026 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.41 -56.69 10.41 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.526 1.06 . . . . 10.0 111.465 166.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -49.7 -52.48 30.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.836 1.255 . . . . 10.0 112.19 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 -58.9 5.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.174 0.99 . . . . 10.0 112.207 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.31 -48.46 78.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.577 0.751 . . . . 10.0 112.825 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.0 mtt -58.89 -47.46 84.88 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.223 1.009 . . . . 10.0 111.523 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.85 -58.76 12.88 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.267 0.937 . . . . 10.0 113.66 174.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.18 -46.06 79.52 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.728 1.264 . . . . 10.0 112.1 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.33 75.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.76 1.172 . . . . 10.0 113.244 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -61.93 -58.49 7.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.742 0.817 . . . . 10.0 111.419 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.97 62.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.8 -58.07 9.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.986 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.63 81.86 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.236 0.828 . . . . 10.0 113.236 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.46 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.654 1.182 . . . . 10.0 113.581 169.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.44 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.781 1.753 . . . . 10.0 110.846 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.83 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.906 2.483 . . . . 10.0 109.366 171.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.98 93.05 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.143 2.177 . . . . 10.0 113.584 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.37 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.387 2.675 . . . . 10.0 116.975 166.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.65 -50.87 10.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.891 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.94 117.59 6.51 Favored Pre-proline 0 CA--C 1.536 0.432 0 O-C-N 124.741 1.275 . . . . 10.0 110.916 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.67 -29.6 89.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.695 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.04 22.82 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.114 1.366 . . . . 10.0 113.551 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.6 -47.44 19.94 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.242 1.417 . . . . 10.0 113.384 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.08 62.22 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.535 0.734 . . . . 10.0 110.935 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -57.02 -50.21 73.43 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.115 0.566 . . . . 10.0 112.348 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.26 65.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.903 -0.57 . . . . 10.0 112.378 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.01 1.91 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.412 0.893 . . . . 10.0 113.412 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.53 -58.07 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.918 1.287 . . . . 10.0 110.121 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 m -68.16 -16.99 64.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.297 1.439 . . . . 10.0 113.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -88.35 -39.78 14.08 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.571 1.078 . . . . 10.0 112.146 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -59.8 -42.18 92.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.939 0.791 . . . . 10.0 112.372 170.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -41.44 -60.7 1.69 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 126.094 1.758 . . . . 10.0 113.807 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.98 -25.67 16.07 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.158 2.572 . . . . 10.0 114.372 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.7 -45.07 84.2 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.674 1.579 . . . . 10.0 113.502 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -54.02 -52.81 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.01 0.924 . . . . 10.0 109.447 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.19 -45.9 72.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.465 1.106 . . . . 10.0 113.428 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -51.1 -57.58 8.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.058 1.343 . . . . 10.0 112.15 171.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 m -49.36 -52.63 26.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.302 1.441 . . . . 10.0 110.699 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.5 mmt -69.14 -48.13 63.2 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.895 0.878 . . . . 10.0 113.044 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -57.09 -39.95 76.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.927 -1.511 . . . . 10.0 113.218 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.35 -54.56 34.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.266 1.394 . . . . 10.0 111.281 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.64 -41.13 61.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.197 1.555 . . . . 10.0 115.197 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.85 -50.78 61.47 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.545 0.738 . . . . 10.0 110.511 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.64 -52.67 21.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.864 0.865 . . . . 10.0 112.908 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.91 -5.54 48.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.343 1.057 . . . . 10.0 113.835 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.544 0.978 . . . . 10.0 115.544 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.246 1.572 . . . . 10.0 115.246 -175.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.57 61.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.39 26.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.049 2.14 . . . . 10.0 109.041 171.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.1 15.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.004 166.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.02 53.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.703 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.52 129.6 23.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 125.048 1.339 . . . . 10.0 110.995 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.74 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.469 -1.012 . . . . 10.0 109.469 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.48 38.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.31 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.735 -0.946 . . . . 10.0 110.735 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.83 -3.35 0.69 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 118.656 2.223 . . . . 10.0 118.656 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.317 1.559 . . . . 10.0 112.21 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.85 9.04 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.491 1.516 . . . . 10.0 111.137 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -61.54 131.95 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.23 3.287 . . . . 10.0 112.145 171.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.35 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.043 1.737 . . . . 10.0 111.66 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.65 85.01 4.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.295 1.521 . . . . 10.0 113.037 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.587 -1.321 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.19 -35.99 62.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.998 1.11 . . . . 10.0 113.998 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.5 ptp180 -64.4 -23.32 67.25 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.589 -1.319 . . . . 10.0 114.169 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -77.69 -42.77 33.34 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.148 -0.97 . . . . 10.0 111.763 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.95 44.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.355 1.462 . . . . 10.0 111.726 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -51.8 -71.88 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.551 1.941 . . . . 10.0 111.805 169.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.417 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.0 m0 -56.48 -31.96 64.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 117.507 -1.235 . . . . 10.0 113.536 -172.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 tp -48.59 -45.56 38.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.004 1.722 . . . . 10.0 112.077 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.91 -43.78 6.59 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.059 0.944 . . . . 10.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.0 m -51.45 -48.86 62.63 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.58 1.552 . . . . 10.0 113.444 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 41.5 p -69.41 -46.62 27.48 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.57 1.322 . . . . 10.0 114.57 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.53 -42.41 49.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.143 2.562 . . . . 10.0 115.185 169.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.41 -48.36 81.92 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.555 -0.716 . . . . 10.0 112.245 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -36.55 82.52 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.523 1.056 . . . . 10.0 112.555 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.66 -49.03 76.25 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.097 -1.002 . . . . 10.0 111.674 165.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.82 -38.25 78.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.823 0.849 . . . . 10.0 112.874 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -52.36 -53.97 37.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.298 0.954 . . . . 10.0 111.173 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.676 0.79 . . . . 10.0 112.131 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.72 38.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.94 0.896 . . . . 10.0 112.039 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.22 79.25 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.778 0.831 . . . . 10.0 112.692 174.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.75 -38.6 91.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.399 1.259 . . . . 10.0 114.399 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.81 1.37 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.236 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.55 11.94 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.33 145.89 47.49 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.95 -1.719 . . . . 10.0 112.458 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.9 54.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.8 -39.72 2.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.316 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.44 -52.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.088 1.355 . . . . 10.0 111.101 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.26 67.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.543 0.571 . . . . 10.0 112.543 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.441 0.696 . . . . 10.0 110.943 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.8 4.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.849 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.12 -46.31 96.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.706 0.802 . . . . 10.0 111.374 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.31 64.04 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.701 0.667 . . . . 10.0 112.624 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.36 75.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.358 0.873 . . . . 10.0 113.358 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -53.22 -51.41 62.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.699 1.2 . . . . 10.0 110.641 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.42 -54.29 4.78 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.092 1.329 . . . . 10.0 113.276 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.53 -54.76 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 118.068 -0.968 . . . . 10.0 112.395 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . 0.309 3.1 ppp? -61.45 -42.64 99.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.605 1.548 . . . . 10.0 113.552 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.0 mm -65.52 -47.38 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 120.214 1.37 . . . . 10.0 111.702 170.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.76 -55.25 24.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.049 1.309 . . . . 10.0 113.406 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 32.4 p -60.72 -35.58 76.69 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.134 -1.215 . . . . 10.0 112.689 173.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.68 -59.07 8.29 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.239 0.923 . . . . 10.0 113.125 164.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.92 -47.71 43.22 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.768 2.827 . . . . 10.0 111.663 174.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.33 -49.53 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.551 1.14 . . . . 10.0 111.701 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.18 -58.69 11.07 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.058 1.79 . . . . 10.0 112.379 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.57 -43.4 2.71 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.209 2.604 . . . . 10.0 113.304 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.9 mt -101.19 -6.41 24.29 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.485 1.661 . . . . 10.0 115.485 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.75 10.47 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.165 -1.584 . . . . 10.0 110.366 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.61 72.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.248 2.619 . . . . 10.0 113.275 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.69 106.34 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.79 0.836 . . . . 10.0 110.05 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.82 -59.63 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.051 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.42 -42.11 14.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.513 1.525 . . . . 10.0 113.496 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.63 63.2 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.19 -41.58 68.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.855 0.752 . . . . 10.0 110.826 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.21 -32.64 72.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.771 1.228 . . . . 10.0 114.216 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.79 -51.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.073 0.851 . . . . 10.0 109.638 169.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -62.33 -46.23 89.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -52.22 -47.68 65.54 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.088 0.955 . . . . 10.0 112.686 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.37 -53.88 53.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.099 0.96 . . . . 10.0 111.804 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.13 -53.16 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.905 1.282 . . . . 10.0 111.509 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.1 t -53.34 -51.31 62.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.343 1.457 . . . . 10.0 111.908 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.9 m -61.0 -42.97 99.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.459 1.504 . . . . 10.0 112.401 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.78 -51.74 68.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.407 1.003 . . . . 10.0 112.452 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.79 77.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.925 0.89 . . . . 10.0 112.89 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 32.5 ttp -60.7 -50.67 72.55 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.062 -1.023 . . . . 10.0 112.403 169.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.1 -47.51 71.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.632 1.573 . . . . 10.0 111.626 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -47.07 -54.37 10.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 10.0 112.261 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.2 mt -53.43 -55.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.814 0.846 . . . . 10.0 110.692 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -57.04 -36.15 70.13 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.121 0.785 . . . . 10.0 113.121 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.25 -58.2 9.25 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.077 0.951 . . . . 10.0 113.017 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.278 -0.867 . . . . 10.0 111.44 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.78 -49.44 75.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.897 1.226 . . . . 10.0 112.106 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.38 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.856 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.65 -21.93 60.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.607 1.163 . . . . 10.0 113.467 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.11 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.629 0.633 . . . . 10.0 113.548 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.44 51.0 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.262 1.825 . . . . 10.0 113.067 -166.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.02 1.118 . . . . 10.0 114.02 172.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.74 -50.45 65.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.05 0.929 . . . . 10.0 112.285 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.21 -46.01 83.28 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.181 0.993 . . . . 10.0 112.088 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.47 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.078 1.751 . . . . 10.0 114.268 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.6 29.1 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.428 1.891 . . . . 10.0 114.907 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.59 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.536 1.636 . . . . 10.0 114.195 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.77 -46.28 34.7 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.308 2.005 . . . . 10.0 113.066 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.03 67.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.968 2.907 . . . . 10.0 113.33 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.23 -53.03 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.086 0.954 . . . . 10.0 109.794 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.254 0.622 . . . . 10.0 111.926 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -60.03 -56.15 25.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.919 0.887 . . . . 10.0 112.709 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 10.0 113.036 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.52 46.16 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.284 0.634 . . . . 10.0 111.068 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.11 -48.4 78.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.04 -49.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.791 0.723 . . . . 10.0 110.428 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.56 -51.65 68.98 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.76 30.28 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.817 2.047 . . . . 10.0 111.044 174.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.53 -58.26 9.34 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.757 0.423 . . . . 10.0 111.314 174.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.09 -45.01 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.054 0.942 . . . . 10.0 111.504 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -56.74 -67.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.281 2.633 . . . . 10.0 110.918 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.92 -48.15 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.005 1.322 . . . . 10.0 110.915 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -62.11 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.755 0.822 . . . . 10.0 112.484 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.75 -48.08 80.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.211 0.914 . . . . 10.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -51.75 -51.08 58.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.301 1.04 . . . . 10.0 112.193 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.0 m -55.28 -32.84 62.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.793 1.034 . . . . 10.0 113.793 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.66 -44.64 93.2 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.581 0.956 . . . . 10.0 113.581 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -46.28 -55.74 12.86 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 115.623 1.712 . . . . 10.0 115.623 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.17 -34.06 94.49 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.26 1.973 . . . . 10.0 113.216 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.5 t -64.46 -51.57 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.948 0.899 . . . . 10.0 110.589 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t -53.64 -50.58 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.592 1.157 . . . . 10.0 111.445 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.2 t90 -55.47 -51.81 65.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.287 1.035 . . . . 10.0 112.501 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 35.5 tp -54.04 -45.22 71.54 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.77 1.228 . . . . 10.0 112.281 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.49 -4.98 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.17 1.545 . . . . 10.0 115.17 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.3 32.95 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.576 1.098 . . . . 10.0 113.886 -168.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.871 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.66 -17.08 64.47 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.661 1.726 . . . . 10.0 115.661 -175.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.32 -106.07 1.14 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.339 1.427 . . . . 10.0 113.714 -172.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.637 -1.508 . . . . 10.0 109.353 168.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 113.905 0.322 . . . . 10.0 113.905 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.771 166.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.366 -174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -68.82 153.84 72.19 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.752 2.968 . . . . 10.0 111.424 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.81 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.329 1.052 . . . . 10.0 112.221 171.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.31 -52.4 21.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.95 -40.47 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.646 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.29 -49.85 41.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.586 0.63 . . . . 10.0 111.964 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.08 83.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.092 1.757 . . . . 10.0 112.983 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.3 -52.32 62.44 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.931 0.892 . . . . 10.0 112.141 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.59 -59.29 4.64 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.362 1.065 . . . . 10.0 109.944 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -52.9 -46.54 68.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.417 -1.278 . . . . 10.0 112.241 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -51.36 -53.38 36.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.687 1.585 . . . . 10.0 112.723 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.12 -49.68 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.202 1.401 . . . . 10.0 111.562 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -56.17 -50.9 69.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.141 1.376 . . . . 10.0 111.458 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -57.06 -62.66 1.6 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.195 1.798 . . . . 10.0 110.954 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 23.7 m -56.16 -36.81 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 120.49 1.495 . . . . 10.0 112.793 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 43.2 m -59.94 -56.88 16.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.256 1.022 . . . . 10.0 111.525 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.06 -22.64 67.0 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.424 1.489 . . . . 10.0 114.513 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -71.7 0.55 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.884 1.273 . . . . 10.0 109.493 176.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.4 t -83.63 -55.29 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.176 1.39 . . . . 10.0 110.728 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -51.19 -48.04 48.07 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.996 0.808 . . . . 10.0 113.228 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -54.73 -57.04 13.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.192 1.797 . . . . 10.0 112.656 172.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -53.02 -37.16 53.42 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.063 0.839 . . . . 10.0 113.596 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.58 -28.01 65.6 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 115.989 1.848 . . . . 10.0 115.989 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.62 -57.49 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 119.319 0.963 . . . . 10.0 108.445 165.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.848 0.859 . . . . 10.0 113.186 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.317 1.599 . . . . 10.0 115.317 -171.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.141 0.976 . . . . 10.0 113.292 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.049 0.94 . . . . 10.0 111.019 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.744 0.818 . . . . 10.0 110.957 170.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.92 77.0 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.896 0.879 . . . . 10.0 112.1 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.461 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.82 -55.45 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.731 1.212 . . . . 10.0 110.686 -175.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.44 40.12 Favored Glycine 0 C--O 1.239 0.451 0 C-N-CA 129.755 3.55 . . . . 10.0 119.677 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.484 2.714 . . . . 10.0 113.438 166.603 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.822 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.29 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.576 3.15 . . . . 10.0 117.276 160.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.67 65.05 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.331 2.652 . . . . 10.0 114.448 155.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.03 2.79 41.14 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.44 2.447 . . . . 10.0 111.488 168.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.684 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.477 2.277 . . . . 10.0 113.201 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.14 4.32 0.94 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.736 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.473 -0.767 . . . . 10.0 112.619 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.6 83.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.887 0.875 . . . . 10.0 109.3 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.43 -52.56 63.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.399 0.68 . . . . 10.0 111.882 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.41 -53.59 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.141 0.576 . . . . 10.0 112.247 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.85 -46.83 51.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.381 1.472 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -44.93 84.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.88 -56.2 12.58 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.346 0.974 . . . . 10.0 111.567 166.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.4 m -49.8 -52.47 31.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.844 1.257 . . . . 10.0 112.209 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.177 0.991 . . . . 10.0 112.139 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.31 -48.56 78.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.663 0.785 . . . . 10.0 112.809 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.417 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 46.8 mtt -59.22 -46.62 87.97 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.293 1.037 . . . . 10.0 111.606 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.49 -58.6 13.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.232 0.92 . . . . 10.0 113.735 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -46.12 79.6 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.64 1.22 . . . . 10.0 112.127 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.56 -41.74 74.3 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.755 1.169 . . . . 10.0 113.242 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -63.12 -57.83 9.26 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 118.297 -0.859 . . . . 10.0 111.412 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.49 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.81 -57.99 9.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.571 1.148 . . . . 10.0 112.973 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.05 -67.5 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.662 1.185 . . . . 10.0 113.611 169.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.756 1.741 . . . . 10.0 110.866 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.863 2.465 . . . . 10.0 109.319 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.93 93.06 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.143 2.177 . . . . 10.0 113.619 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.73 -84.38 1.19 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.732 0.682 . . . . 10.0 112.477 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.404 2.681 . . . . 10.0 116.922 166.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.66 -50.84 10.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.902 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.53 6.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.737 1.273 . . . . 10.0 110.967 -172.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.59 -29.63 89.61 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.724 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.52 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.106 1.362 . . . . 10.0 113.551 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.58 -47.4 19.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.231 1.413 . . . . 10.0 113.441 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.09 62.12 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.513 0.725 . . . . 10.0 110.939 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.1 m-85 -56.97 -50.21 73.35 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.044 0.538 . . . . 10.0 112.334 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.38 -51.27 65.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.356 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.384 0.883 . . . . 10.0 113.384 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.55 -58.11 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.914 1.286 . . . . 10.0 110.228 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -68.09 -18.03 64.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.368 . . . . 10.0 113.745 -172.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -86.6 -40.36 15.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.397 1.079 . . . . 10.0 112.059 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.3 mt -60.37 -41.55 93.95 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.387 -0.82 . . . . 10.0 112.525 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.8 t -41.2 -60.45 1.74 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.719 1.607 . . . . 10.0 113.769 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.95 -26.72 10.76 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.721 2.947 . . . . 10.0 114.262 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.85 97.72 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.938 1.699 . . . . 10.0 113.01 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -52.12 -54.86 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.14 1.376 . . . . 10.0 109.345 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -55.77 -45.21 78.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.629 1.171 . . . . 10.0 113.131 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.43 -57.3 9.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.422 1.465 . . . . 10.0 112.209 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -50.15 -52.4 35.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.164 1.386 . . . . 10.0 110.434 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.15 -48.02 63.44 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.805 0.842 . . . . 10.0 113.089 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.16 -40.08 76.56 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.845 -1.55 . . . . 10.0 113.085 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.407 1.458 . . . . 10.0 111.281 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.65 -41.06 61.05 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.7 mtm -66.88 -50.85 61.16 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.484 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.54 -52.69 21.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.826 0.851 . . . . 10.0 112.975 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.5 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.857 1.058 . . . . 10.0 113.857 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.09 43.02 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.252 1.575 . . . . 10.0 115.252 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.55 61.04 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.332 0.893 . . . . 10.0 115.332 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.43 26.41 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.042 2.137 . . . . 10.0 108.957 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.49 171.14 15.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.053 0.941 . . . . 10.0 111.0 166.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 136.0 53.43 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.9 0.88 . . . . 10.0 109.691 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.52 129.6 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.039 1.336 . . . . 10.0 110.959 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.36 38.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.826 0.676 . . . . 10.0 112.826 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -82.0 0.15 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.41 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.6 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.338 1.569 . . . . 10.0 112.217 -165.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.91 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.46 1.504 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.45 120.76 69.66 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.6 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.36 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.046 1.738 . . . . 10.0 111.71 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.69 85.05 4.74 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 123.058 1.409 . . . . 10.0 113.037 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.864 -1.147 . . . . 10.0 113.951 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.82 52.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.292 1.037 . . . . 10.0 113.147 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -50.68 -55.51 16.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.858 0.863 . . . . 10.0 111.515 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -64.02 -39.11 93.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.69 1.596 . . . . 10.0 112.182 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.69 65.36 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.48 1.112 . . . . 10.0 110.916 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -61.96 2.23 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.18 1.792 . . . . 10.0 112.764 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -53.65 -38.12 63.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.368 2.267 . . . . 10.0 113.177 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.46 -44.01 62.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.493 1.517 . . . . 10.0 112.183 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -99.4 -47.99 4.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 113.254 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.0 t -60.02 -37.6 80.24 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.454 -0.779 . . . . 10.0 113.058 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 4.5 m -68.38 -48.55 34.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.753 -1.217 . . . . 10.0 112.638 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 82.6 Cg_exo -49.62 -42.9 41.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.585 2.856 . . . . 10.0 115.278 164.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.58 -49.28 78.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.889 0.768 . . . . 10.0 112.076 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tt -53.01 -44.68 67.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.678 1.191 . . . . 10.0 112.679 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.62 -47.71 81.43 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.038 -1.039 . . . . 10.0 112.413 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.838 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.3 -54.04 36.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.298 0.954 . . . . 10.0 111.187 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.1 88.63 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.656 0.782 . . . . 10.0 112.099 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.69 38.43 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.94 0.896 . . . . 10.0 112.078 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.16 79.38 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.704 0.801 . . . . 10.0 112.731 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.71 -38.59 91.68 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.065 1.346 . . . . 10.0 112.313 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.56 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.829 1.652 . . . . 10.0 112.113 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.981 -1.699 . . . . 10.0 112.458 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.92 54.27 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.67 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.888 1.675 . . . . 10.0 113.465 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.26 5.29 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.139 1.352 . . . . 10.0 115.26 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.01 -46.74 87.86 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.158 -1.401 . . . . 10.0 111.354 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.97 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.087 1.355 . . . . 10.0 111.072 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.57 -51.33 67.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.82 43.16 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.424 0.689 . . . . 10.0 110.985 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.399 2.28 . . . . 10.0 114.849 174.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.07 -46.35 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 123.725 0.81 . . . . 10.0 111.349 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.31 64.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.659 0.647 . . . . 10.0 112.624 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.27 74.91 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.13 -45.32 87.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.583 0.753 . . . . 10.0 111.946 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.55 -56.47 4.87 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.455 1.502 . . . . 10.0 113.037 167.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 83.6 mt -56.45 -55.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.757 0.823 . . . . 10.0 110.322 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -48.98 -56.71 8.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.609 1.095 . . . . 10.0 113.115 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 123.116 0.566 . . . . 10.0 112.203 178.36 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 112.033 0.383 . . . . 10.0 112.033 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.98 -59.46 8.72 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.704 1.621 . . . . 10.0 112.096 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.79 -37.76 20.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.209 2.204 . . . . 10.0 113.434 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.7 -6.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.398 1.629 . . . . 10.0 115.398 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.67 116.72 10.4 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.207 -1.558 . . . . 10.0 110.356 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.248 2.619 . . . . 10.0 113.289 177.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.65 106.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.816 0.847 . . . . 10.0 110.128 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.764 1.226 . . . . 10.0 114.019 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.54 -42.01 15.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.458 1.503 . . . . 10.0 113.498 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.22 -24.59 63.13 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.897 1.443 . . . . 10.0 114.897 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.83 -41.87 67.86 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 118.901 0.773 . . . . 10.0 110.82 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.64 -31.88 70.23 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.854 1.262 . . . . 10.0 114.241 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.29 -52.26 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.152 0.887 . . . . 10.0 109.625 168.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -60.47 -45.24 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -52.64 -49.54 64.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.713 1.142 . . . . 10.0 112.71 173.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -53.92 48.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.139 . . . . 10.0 111.915 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.2 mt -54.62 -47.59 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.625 1.17 . . . . 10.0 111.481 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -57.57 -53.34 59.26 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.07 1.348 . . . . 10.0 112.394 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.6 t -67.82 -33.48 74.86 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.766 0.826 . . . . 10.0 112.308 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.63 73.34 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.258 0.935 . . . . 10.0 112.347 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.55 80.62 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.468 -0.77 . . . . 10.0 112.535 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.65 -52.99 62.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.267 1.027 . . . . 10.0 111.913 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.77 -49.62 65.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.069 1.748 . . . . 10.0 111.665 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -49.5 -54.71 16.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.722 0.809 . . . . 10.0 112.184 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.0 mt -54.11 -54.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.592 0.757 . . . . 10.0 110.86 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.35 -36.62 69.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.709 0.804 . . . . 10.0 113.07 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -57.24 -58.19 9.3 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.035 0.934 . . . . 10.0 113.059 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -40.96 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.373 -0.823 . . . . 10.0 111.468 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.76 -49.39 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.831 1.196 . . . . 10.0 112.169 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.26 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.075 -1.641 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.69 -21.98 60.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 10.0 113.477 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.588 0.614 . . . . 10.0 113.548 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.271 1.828 . . . . 10.0 113.067 -166.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.09 -56.44 14.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.032 1.123 . . . . 10.0 114.032 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.69 -50.58 65.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.115 0.959 . . . . 10.0 112.303 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.11 -46.02 82.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.136 0.975 . . . . 10.0 112.143 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.51 80.02 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.27 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.043 1.737 . . . . 10.0 114.235 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.477 1.911 . . . . 10.0 114.876 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.94 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.536 1.636 . . . . 10.0 114.171 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.24 35.04 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.277 1.984 . . . . 10.0 113.079 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.1 67.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.288 173.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.14 -53.07 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.83 75.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.246 0.618 . . . . 10.0 111.905 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -56.18 24.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.917 0.887 . . . . 10.0 112.709 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.211 1.004 . . . . 10.0 113.05 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.61 -49.44 46.85 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.253 0.621 . . . . 10.0 111.101 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.43 78.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.67 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.797 0.726 . . . . 10.0 110.487 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.57 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.83 30.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.86 2.064 . . . . 10.0 111.026 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.45 -58.36 8.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.796 0.438 . . . . 10.0 111.266 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.6 t -52.14 -46.64 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.112 0.965 . . . . 10.0 112.296 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.9 m -58.83 -64.85 0.79 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.971 2.509 . . . . 10.0 111.484 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.6 -49.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.928 1.291 . . . . 10.0 111.241 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.9 -64.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.844 0.858 . . . . 10.0 112.28 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.12 -43.02 81.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.037 0.835 . . . . 10.0 112.174 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -52.14 -54.29 32.43 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.128 0.971 . . . . 10.0 112.459 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 114.029 1.122 . . . . 10.0 114.029 -179.366 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 119.504 -0.284 . . . . 10.0 111.315 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -55.32 -52.34 63.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.894 1.277 . . . . 10.0 112.498 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 56.0 tp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.971 1.308 . . . . 10.0 112.449 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -88.15 -5.08 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 115.222 1.564 . . . . 10.0 115.222 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.47 -169.3 32.89 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-O 122.576 1.098 . . . . 10.0 113.873 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -40.85 64.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.828 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -54.94 -31.49 60.51 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.524 2.73 . . . . 10.0 115.154 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.62 -103.88 0.95 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.366 0.985 . . . . 10.0 113.623 -167.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.19 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.331 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.884 0.314 . . . . 10.0 113.884 173.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.64 -42.74 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.055 1.742 . . . . 10.0 108.716 166.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.27 133.38 24.9 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.448 1.899 . . . . 10.0 109.392 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.7 153.77 72.61 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.754 2.969 . . . . 10.0 111.468 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.34 -52.38 21.89 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.93 -40.48 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.668 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.35 -49.77 42.87 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.517 0.599 . . . . 10.0 111.946 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.68 -47.08 83.31 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.07 1.748 . . . . 10.0 113.002 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -58.8 5.62 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.335 1.054 . . . . 10.0 109.989 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -53.42 -43.88 68.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.876 -1.059 . . . . 10.0 112.956 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -54.53 -52.55 61.68 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.3 1.409 . . . . 10.0 112.492 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.18 -48.97 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.49 1.116 . . . . 10.0 110.939 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.0 mp -57.09 -53.53 57.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.747 1.619 . . . . 10.0 112.152 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -54.68 -56.04 23.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.065 1.746 . . . . 10.0 111.807 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.476 0.852 0 O-C-N 121.398 -0.814 . . . . 10.0 111.264 177.376 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.347 0 CA-C-O 120.997 0.22 . . . . 10.0 112.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.4 -57.28 3.14 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.549 1.939 . . . . 10.0 112.687 167.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.56 -38.92 89.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.582 1.087 . . . . 10.0 113.642 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -69.47 -27.56 65.33 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 115.614 1.709 . . . . 10.0 115.614 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.36 -57.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 165.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.87 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.877 0.871 . . . . 10.0 113.174 -172.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.61 5.23 2.54 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.28 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.89 4.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.113 0.965 . . . . 10.0 111.03 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.19 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.771 0.829 . . . . 10.0 110.957 170.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.94 77.05 7.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.874 0.87 . . . . 10.0 112.084 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.897 2.879 . . . . 10.0 116.462 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.81 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.75 1.22 . . . . 10.0 110.642 -175.308 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.72 3.533 . . . . 10.0 119.677 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.516 2.727 . . . . 10.0 113.457 166.652 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.87 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.569 3.148 . . . . 10.0 117.225 160.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.306 2.643 . . . . 10.0 114.448 155.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.45 137.93 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.41 1.884 . . . . 10.0 113.372 -158.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.015 -174.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.83 41.48 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.487 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.649 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.304 . . . . 10.0 113.21 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.28 4.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.732 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.507 -0.746 . . . . 10.0 112.625 176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.84 -49.64 83.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.892 0.877 . . . . 10.0 109.3 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.537 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.36 -52.66 62.8 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.379 0.672 . . . . 10.0 111.867 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.3 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.224 0.61 . . . . 10.0 112.276 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.8 51.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.332 1.453 . . . . 10.0 113.335 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.95 84.75 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.289 1.435 . . . . 10.0 112.997 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.6 -56.54 11.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.526 1.06 . . . . 10.0 111.511 166.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.59 -52.51 29.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.904 1.282 . . . . 10.0 112.248 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.5 -58.81 6.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.172 0.989 . . . . 10.0 112.161 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt -57.47 -48.62 78.71 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 10.0 112.836 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.14 -49.09 78.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.008 0.923 . . . . 10.0 111.281 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.53 -58.66 13.26 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.273 0.939 . . . . 10.0 113.931 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.18 -45.63 79.68 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.748 1.274 . . . . 10.0 112.175 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.85 -39.87 88.81 Favored Glycine 0 CA--C 1.533 1.205 0 O-C-N 120.779 -1.2 . . . . 10.0 113.588 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.3 m -60.21 -60.71 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 10.0 110.801 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.06 9.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 112.972 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.61 -38.67 81.92 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.254 0.835 . . . . 10.0 113.254 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.621 1.168 . . . . 10.0 113.589 169.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.813 1.768 . . . . 10.0 110.859 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.04 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.628 1.011 . . . . 10.0 115.628 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.2 mmm -59.47 -45.05 92.73 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.4 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.743 0.687 . . . . 10.0 112.511 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.07 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.401 2.68 . . . . 10.0 116.959 166.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 m -79.68 -50.83 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.168 -1.378 . . . . 10.0 113.892 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.5 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.66 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.67 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.111 0.565 . . . . 10.0 111.476 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.06 22.84 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.078 1.351 . . . . 10.0 113.566 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.57 -47.41 19.74 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.455 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.78 -53.1 61.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.933 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.9 -50.27 73.04 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.107 0.563 . . . . 10.0 112.353 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.27 65.25 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.99 1.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.85 -56.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.825 1.25 . . . . 10.0 110.736 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -69.81 -18.61 63.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.935 1.294 . . . . 10.0 113.498 -172.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.4 m -84.98 -42.52 14.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.478 1.111 . . . . 10.0 111.913 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.6 mt -57.49 -41.56 80.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.211 0.819 . . . . 10.0 113.211 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.4 t -50.17 -61.79 3.33 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.092 -0.956 . . . . 10.0 112.457 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -46.76 -47.27 16.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.627 3.551 . . . . 10.0 115.925 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.49 90.16 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.858 1.208 . . . . 10.0 113.811 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.25 -51.52 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.592 1.157 . . . . 10.0 109.326 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.24 76.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.093 0.957 . . . . 10.0 113.165 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -50.13 -56.23 11.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.681 1.592 . . . . 10.0 112.179 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.77 -52.82 29.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.3 1.44 . . . . 10.0 110.733 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.84 -48.13 64.27 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.976 0.91 . . . . 10.0 113.013 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -56.49 -40.75 75.47 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.195 1.362 . . . . 10.0 113.447 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.53 34.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.752 1.16 . . . . 10.0 111.292 170.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.14 61.12 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.174 1.546 . . . . 10.0 115.174 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.85 -50.82 61.34 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.594 0.758 . . . . 10.0 110.469 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.72 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.887 0.875 . . . . 10.0 112.92 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.86 -5.6 49.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 10.0 113.831 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.67 5.58 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.564 0.986 . . . . 10.0 115.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.01 43.5 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.53 61.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.339 0.896 . . . . 10.0 115.339 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.4 26.46 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.081 2.153 . . . . 10.0 109.031 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.711 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.64 129.62 23.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.028 1.331 . . . . 10.0 110.909 -176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.23 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.72 164.4 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.79 -3.28 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.669 2.228 . . . . 10.0 118.669 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.358 1.579 . . . . 10.0 112.194 -165.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.444 1.498 . . . . 10.0 111.081 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.45 120.78 69.66 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.651 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.5 131.91 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.184 3.256 . . . . 10.0 112.137 171.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.29 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.075 1.75 . . . . 10.0 111.763 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -93.63 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.063 1.411 . . . . 10.0 113.106 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.27 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.847 -1.158 . . . . 10.0 113.905 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.72 -26.61 35.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.271 1.029 . . . . 10.0 112.532 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -55.08 -48.31 73.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.01 1.324 . . . . 10.0 112.927 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -71.2 -38.87 72.04 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.955 0.902 . . . . 10.0 111.122 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.39 -48.95 65.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.32 1.048 . . . . 10.0 112.228 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.514 1.526 . . . . 10.0 111.558 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -55.27 -34.28 63.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.357 1.463 . . . . 10.0 112.503 -170.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.7 tp -48.82 -43.74 38.71 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.114 1.766 . . . . 10.0 112.141 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -101.9 -38.15 7.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.493 0.717 . . . . 10.0 112.764 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.7 p -64.72 -43.69 92.58 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.283 1.402 . . . . 10.0 113.92 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.277 74.8 p -65.04 -42.56 62.45 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 114.72 1.378 . . . . 10.0 114.72 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.89 -43.04 60.83 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.428 2.752 . . . . 10.0 115.247 167.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.23 -47.28 86.67 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.447 -0.783 . . . . 10.0 111.704 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.61 -50.01 55.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.414 1.485 . . . . 10.0 111.51 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mp -56.24 -47.52 78.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.111 0.965 . . . . 10.0 112.956 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.22 78.29 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.777 0.831 . . . . 10.0 112.903 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.02 36.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.285 0.948 . . . . 10.0 111.214 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.09 88.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.093 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.75 37.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.017 0.927 . . . . 10.0 111.974 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.25 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.67 53.41 12.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.838 1.655 . . . . 10.0 112.126 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.95 47.51 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.935 -1.728 . . . . 10.0 112.405 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.85 54.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.77 -39.72 2.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.93 1.692 . . . . 10.0 113.467 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.2 5.34 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.304 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.46 -52.93 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.154 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.57 -51.37 67.61 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.522 0.564 . . . . 10.0 112.522 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.05 -44.93 42.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.469 0.708 . . . . 10.0 110.959 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.814 175.005 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.393 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.14 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.614 0.626 . . . . 10.0 112.675 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.63 -46.92 73.97 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.187 0.81 . . . . 10.0 113.187 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -57.13 -45.54 83.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.023 0.929 . . . . 10.0 111.974 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.02 -55.58 5.59 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.201 1.382 . . . . 10.0 113.082 167.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.4 mt -56.77 -49.47 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.626 0.77 . . . . 10.0 111.893 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 64.4 ttp -49.39 -57.82 6.23 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 10.0 112.184 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.475 0.803 0 O-C-N 121.659 -0.651 . . . . 10.0 111.058 177.953 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 110.35 -0.241 . . . . 10.0 110.35 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.03 -60.84 5.78 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.833 1.682 . . . . 10.0 112.212 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.01 -37.66 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.484 1.913 . . . . 10.0 113.86 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.0 mt -99.27 -6.41 28.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -69.66 116.73 10.4 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.19 -1.569 . . . . 10.0 110.409 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.53 -49.55 72.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.186 2.594 . . . . 10.0 113.255 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.66 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.86 -59.52 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.72 1.208 . . . . 10.0 114.087 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.12 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.451 1.5 . . . . 10.0 113.485 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.64 63.25 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.956 1.465 . . . . 10.0 114.956 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.82 -41.94 67.91 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.848 0.749 . . . . 10.0 110.712 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.51 -32.01 70.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.903 1.281 . . . . 10.0 114.249 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.1 -51.77 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.59 168.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -62.46 -43.15 99.52 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -53.93 -48.38 70.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.48 1.112 . . . . 10.0 112.617 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.68 -53.14 61.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.693 0.797 . . . . 10.0 111.681 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.14 -54.33 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.809 1.244 . . . . 10.0 112.009 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 p -58.01 -43.15 86.53 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.252 -0.905 . . . . 10.0 112.852 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.2 m -61.73 -41.31 97.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.568 1.147 . . . . 10.0 112.56 174.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.41 -46.75 87.82 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.345 0.975 . . . . 10.0 112.343 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.74 79.81 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.668 0.787 . . . . 10.0 112.393 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.8 ttp -54.54 -54.54 39.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.037 0.935 . . . . 10.0 112.085 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.1 -50.4 61.71 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.314 1.446 . . . . 10.0 111.572 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.39 -54.66 20.14 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.048 0.939 . . . . 10.0 112.562 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.1 mt -53.52 -55.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.831 0.853 . . . . 10.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.8 mt -57.48 -35.6 70.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.2 -0.905 . . . . 10.0 112.902 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.31 -58.14 9.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.251 0.932 . . . . 10.0 113.047 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.92 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 118.342 -0.837 . . . . 10.0 111.441 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.44 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.83 1.195 . . . . 10.0 112.115 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.92 -70.4 0.46 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.866 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.73 -21.86 60.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.587 1.155 . . . . 10.0 113.468 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.37 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.14 -56.49 14.22 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.955 1.094 . . . . 10.0 113.955 172.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.64 -50.55 65.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.112 0.958 . . . . 10.0 112.299 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.16 -45.97 83.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.192 0.997 . . . . 10.0 112.149 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.42 80.59 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.54 -11.23 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.044 1.738 . . . . 10.0 114.225 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.62 29.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.427 1.891 . . . . 10.0 114.865 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.95 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.451 1.596 . . . . 10.0 114.14 -170.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.841 3.256 . . . . 10.0 105.549 170.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.86 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.27 1.98 . . . . 10.0 113.032 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.11 67.96 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.17 -53.01 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.274 0.63 . . . . 10.0 111.902 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.06 -56.14 25.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.933 0.893 . . . . 10.0 112.687 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.26 -53.21 60.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.019 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.55 -49.48 46.08 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.36 78.91 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.691 1.367 . . . . 10.0 114.691 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.62 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.815 0.734 . . . . 10.0 110.487 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.64 -51.61 69.18 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.82 -47.73 31.03 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.796 2.039 . . . . 10.0 111.047 174.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.57 -58.33 9.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.798 0.439 . . . . 10.0 111.253 174.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.09 -47.03 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.109 0.963 . . . . 10.0 112.298 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.9 m -58.76 -64.22 1.01 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.034 2.534 . . . . 10.0 111.53 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -50.19 -49.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.613 1.165 . . . . 10.0 111.288 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.46 -63.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.002 0.921 . . . . 10.0 112.269 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.9 -43.41 98.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.505 0.593 . . . . 10.0 112.529 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -55.05 -51.01 67.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.478 0.711 . . . . 10.0 111.757 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 114.134 1.161 . . . . 10.0 114.134 178.603 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.0 t . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 119.6 -0.238 . . . . 10.0 111.525 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -55.26 -54.26 45.68 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.964 1.306 . . . . 10.0 112.251 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.0 tp -52.86 -46.67 67.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.182 1.393 . . . . 10.0 112.514 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.6 pt -85.8 -4.92 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.62 -169.33 32.7 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-O 122.551 1.084 . . . . 10.0 113.789 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.07 -39.65 63.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.157 -1.021 . . . . 10.0 111.908 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.43 -32.87 65.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.377 2.671 . . . . 10.0 115.271 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.44 -104.34 1.11 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-O 122.142 0.857 . . . . 10.0 112.698 -167.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.19 35.82 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.285 170.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.34 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.93 0.332 . . . . 10.0 113.93 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.775 166.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.33 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.464 1.906 . . . . 10.0 109.351 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.76 153.84 72.32 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.438 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.25 -39.75 3.13 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.299 1.039 . . . . 10.0 112.223 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.28 -52.43 21.33 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.54 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.651 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.83 41.93 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.564 0.62 . . . . 10.0 111.907 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.0 83.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.038 1.735 . . . . 10.0 113.017 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.33 62.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.016 0.926 . . . . 10.0 112.06 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.63 -59.66 4.2 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.361 1.064 . . . . 10.0 109.913 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -52.82 -47.13 67.89 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.986 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.32 -52.72 34.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 121.283 1.856 . . . . 10.0 113.258 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.3 t -60.81 -48.12 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.817 1.247 . . . . 10.0 111.479 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.49 -50.17 74.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.319 1.448 . . . . 10.0 111.907 175.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.35 -57.41 11.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.469 2.308 . . . . 10.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.478 0.958 0 O-C-N 121.221 -0.924 . . . . 10.0 111.844 177.024 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.305 0 CA-C-O 121.104 0.28 . . . . 10.0 112.614 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -42.44 -56.54 2.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.824 2.049 . . . . 10.0 112.36 166.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.16 -39.89 82.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.649 1.119 . . . . 10.0 113.997 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.3 -27.14 65.13 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 115.75 1.759 . . . . 10.0 115.75 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.38 -57.56 11.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.604 -0.887 . . . . 10.0 108.604 165.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.68 0.85 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.949 0.899 . . . . 10.0 113.145 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.37 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.273 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.1 178.02 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.04 0.936 . . . . 10.0 110.995 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.68 98.15 1.87 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 10.0 110.921 170.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.93 77.04 7.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 10.0 112.107 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.06 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.892 2.877 . . . . 10.0 116.451 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.4 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.738 1.215 . . . . 10.0 110.622 -175.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.35 169.46 40.29 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.631 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.446 0 C-N-CA 128.524 2.73 . . . . 10.0 113.492 166.576 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.82 -2.038 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.34 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.588 3.155 . . . . 10.0 117.251 160.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.302 2.641 . . . . 10.0 114.511 155.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.4 137.96 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.344 -158.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.7 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.1 2.75 41.49 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.473 2.463 . . . . 10.0 111.463 167.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.3 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.668 -168.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.547 2.302 . . . . 10.0 113.252 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.25 4.34 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.732 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.13 61.76 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.615 176.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.42 -52.59 63.09 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 10.0 111.902 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.41 -53.6 56.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.234 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.78 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.2 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -56.1 12.46 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.655 1.122 . . . . 10.0 111.583 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -50.16 -52.35 36.07 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.895 1.278 . . . . 10.0 112.288 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.207 1.003 . . . . 10.0 112.161 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.77 -49.18 77.45 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 10.0 112.541 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.9 mmt -56.08 -49.95 72.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.603 0.761 . . . . 10.0 111.306 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.04 -58.47 14.44 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.312 0.958 . . . . 10.0 113.63 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.22 -45.59 79.85 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.656 1.228 . . . . 10.0 112.142 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.0 74.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.026 1.298 . . . . 10.0 113.273 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -59.79 -60.57 3.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.24 1.016 . . . . 10.0 111.14 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.96 62.5 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.955 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.84 -58.03 9.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.593 1.157 . . . . 10.0 112.929 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.63 81.94 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.621 1.168 . . . . 10.0 113.62 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.87 -44.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.332 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.16 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.04 92.92 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.154 2.182 . . . . 10.0 113.587 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.35 1.19 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.756 0.693 . . . . 10.0 112.497 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.96 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.396 2.678 . . . . 10.0 116.95 166.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.198 -1.365 . . . . 10.0 113.866 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.52 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.765 1.291 . . . . 10.0 110.957 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.65 89.48 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.708 2.939 . . . . 10.0 113.735 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -60.65 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.5 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.281 1.432 . . . . 10.0 113.444 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 110.967 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.28 65.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.891 -0.576 . . . . 10.0 112.321 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.7 -57.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.865 1.266 . . . . 10.0 110.417 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -69.28 -17.08 63.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.071 1.348 . . . . 10.0 113.693 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -86.91 -42.98 12.76 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.64 1.109 . . . . 10.0 112.018 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -56.75 -41.45 77.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.885 0.698 . . . . 10.0 112.885 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.3 t -49.97 -61.45 3.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.629 1.172 . . . . 10.0 112.569 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.95 -46.53 24.73 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.598 3.532 . . . . 10.0 116.029 164.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.2 93.39 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.973 1.26 . . . . 10.0 113.922 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mt -58.13 -52.23 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.496 1.118 . . . . 10.0 109.48 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.49 -43.97 72.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.006 0.922 . . . . 10.0 113.185 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -52.2 -57.96 8.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.137 1.375 . . . . 10.0 111.871 171.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.59 -52.91 20.57 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.507 1.523 . . . . 10.0 110.886 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.3 mmt -68.64 -48.21 64.6 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.966 0.906 . . . . 10.0 112.981 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -55.64 -41.71 73.96 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.163 1.347 . . . . 10.0 113.283 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.56 34.36 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.475 1.034 . . . . 10.0 111.317 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.05 61.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.91 -50.83 61.17 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.442 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.55 -52.67 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.883 0.873 . . . . 10.0 112.963 172.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.58 49.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.3 -34.73 5.53 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.575 0.99 . . . . 10.0 115.575 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.13 42.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.56 61.17 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.326 0.89 . . . . 10.0 115.326 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.45 26.4 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.021 2.129 . . . . 10.0 109.034 171.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.14 15.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.045 166.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.84 0.856 . . . . 10.0 109.745 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.56 129.57 23.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 125.071 1.348 . . . . 10.0 110.971 -176.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.69 116.17 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.67 164.41 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.647 -0.981 . . . . 10.0 110.647 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.354 1.577 . . . . 10.0 112.231 -165.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.86 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.45 120.73 69.66 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.4 Cg_exo -61.42 131.91 38.41 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.253 3.302 . . . . 10.0 112.167 171.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.16 126.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.044 1.738 . . . . 10.0 111.716 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.262 1.506 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.44 -28.23 66.78 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.641 -1.287 . . . . 10.0 113.881 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.14 62.2 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.225 1.194 . . . . 10.0 114.225 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -65.93 -22.98 66.53 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 120.112 -1.618 . . . . 10.0 113.821 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -77.26 -42.1 38.41 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.55 -1.344 . . . . 10.0 111.691 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.22 -47.91 54.7 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.444 1.498 . . . . 10.0 111.211 166.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -52.56 -70.76 0.08 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.626 1.97 . . . . 10.0 112.031 168.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -56.83 -32.76 66.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.26 1.024 . . . . 10.0 113.448 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.3 tp -50.17 -40.66 47.5 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.858 1.663 . . . . 10.0 111.871 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -105.29 -39.72 6.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.411 0.685 . . . . 10.0 112.521 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.3 p -61.6 -43.12 99.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.793 1.633 . . . . 10.0 113.794 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.299 68.0 p -69.94 -40.62 13.35 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 115.234 1.568 . . . . 10.0 115.234 -175.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.37 -42.98 62.93 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.208 2.605 . . . . 10.0 115.083 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.29 -47.43 86.04 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.484 -0.76 . . . . 10.0 111.684 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.11 -49.55 51.35 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.745 1.618 . . . . 10.0 111.527 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -57.11 -47.4 81.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.273 1.029 . . . . 10.0 113.146 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.24 78.11 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.843 0.857 . . . . 10.0 112.891 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.33 -54.02 37.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.179 169.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.14 88.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.65 -54.69 38.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.942 0.897 . . . . 10.0 112.063 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.13 79.42 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.682 0.793 . . . . 10.0 112.729 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.78 -38.54 91.49 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.42 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.269 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.46 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.845 1.658 . . . . 10.0 112.086 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.51 135.88 54.32 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.662 0.616 . . . . 10.0 112.662 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.84 -39.73 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.438 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.18 5.34 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.148 1.356 . . . . 10.0 115.25 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.08 -46.8 87.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.39 -52.91 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.161 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.66 -51.3 67.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.68 -59.82 4.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.366 2.266 . . . . 10.0 114.793 174.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.05 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 123.667 0.787 . . . . 10.0 111.398 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.17 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.617 0.627 . . . . 10.0 112.664 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.61 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.46 0.911 . . . . 10.0 113.46 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.02 -47.21 78.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.319 0.648 . . . . 10.0 111.684 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -54.23 5.95 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.825 1.203 . . . . 10.0 113.013 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.44 -51.22 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.744 0.818 . . . . 10.0 112.043 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 52.5 ttp -48.62 -57.15 6.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.019 1.327 . . . . 10.0 111.659 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.7 mm . . . . . 0 N--CA 1.472 0.626 0 C-N-CA 123.227 0.611 . . . . 10.0 111.907 178.004 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 111.697 0.258 . . . . 10.0 111.697 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.39 -59.21 8.63 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.713 1.625 . . . . 10.0 112.062 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.89 -37.84 20.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.913 2.085 . . . . 10.0 113.563 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.43 -6.63 27.35 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.7 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.199 -1.563 . . . . 10.0 110.398 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.65 71.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.255 2.622 . . . . 10.0 113.251 177.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.72 106.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.86 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.732 1.213 . . . . 10.0 114.101 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.02 15.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.7 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -53.7 -42.01 67.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.855 0.752 . . . . 10.0 110.807 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.35 -32.29 71.27 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.898 1.279 . . . . 10.0 114.213 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.97 -51.76 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.015 0.825 . . . . 10.0 109.608 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -61.96 -45.24 94.51 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 174.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -51.38 -49.24 61.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.35 1.06 . . . . 10.0 112.531 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.53 -52.63 64.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.191 0.996 . . . . 10.0 111.894 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.53 -52.0 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.831 1.252 . . . . 10.0 111.619 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -54.65 -47.06 73.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 10.0 111.99 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.8 m -60.49 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.53 1.532 . . . . 10.0 112.52 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.58 -48.43 80.95 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.19 0.905 . . . . 10.0 112.312 172.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.08 81.68 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.737 0.815 . . . . 10.0 112.484 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.05 -55.07 35.14 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.182 0.993 . . . . 10.0 112.101 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.13 -48.06 68.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.386 1.474 . . . . 10.0 111.947 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.07 -54.58 23.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 10.0 112.46 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.47 -55.17 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.787 0.835 . . . . 10.0 110.751 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.7 mt -57.42 -35.79 70.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.35 -0.833 . . . . 10.0 112.914 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.3 -58.23 9.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.042 0.937 . . . . 10.0 112.994 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.296 -0.859 . . . . 10.0 111.469 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.75 -49.42 75.3 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.873 1.215 . . . . 10.0 112.13 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.882 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.7 -21.95 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.671 1.188 . . . . 10.0 113.453 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.48 51.33 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.227 1.811 . . . . 10.0 113.037 -166.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.1 m -52.05 -56.42 14.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.64 -50.59 65.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.121 0.962 . . . . 10.0 112.314 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.03 82.89 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.161 0.984 . . . . 10.0 112.135 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.52 80.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.097 1.759 . . . . 10.0 114.195 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.61 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.432 1.893 . . . . 10.0 114.894 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.89 -92.61 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.521 1.629 . . . . 10.0 114.185 -170.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.99 72.63 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.767 3.227 . . . . 10.0 105.539 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.87 -46.23 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.269 1.979 . . . . 10.0 113.06 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.12 67.94 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.247 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.248 0.619 . . . . 10.0 111.937 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.93 -56.2 24.6 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.886 0.874 . . . . 10.0 112.765 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.16 -53.26 60.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 113.028 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.51 45.76 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.16 -48.43 78.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.99 -49.62 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.462 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.65 69.0 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.78 -47.78 30.53 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.816 2.046 . . . . 10.0 111.044 174.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.44 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.845 0.458 . . . . 10.0 111.274 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -52.23 -47.07 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.075 0.95 . . . . 10.0 111.989 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.0 m -58.62 -62.96 1.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.437 2.695 . . . . 10.0 111.822 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.33 -50.34 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.675 1.19 . . . . 10.0 111.071 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.85 -60.2 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.053 0.941 . . . . 10.0 112.068 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.54 -50.05 75.41 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.663 0.665 . . . . 10.0 112.743 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -53.39 -50.84 64.29 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.752 0.821 . . . . 10.0 111.382 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 178.611 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 118.945 -0.55 . . . . 10.0 112.161 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -56.33 -52.2 65.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.984 0.914 . . . . 10.0 112.321 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.4 tp -53.91 -45.42 71.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.513 1.125 . . . . 10.0 112.5 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -87.45 -5.28 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 115.248 1.573 . . . . 10.0 115.248 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.56 -169.3 32.76 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 122.611 1.117 . . . . 10.0 113.805 -168.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -40.73 64.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.165 -1.017 . . . . 10.0 111.838 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -54.56 -32.27 58.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.406 2.683 . . . . 10.0 115.379 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.92 0.99 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 10.0 113.38 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.18 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.318 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.45 65.28 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.29 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -68.73 153.79 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.15 -39.81 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.199 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.36 -52.38 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.681 1.363 . . . . 10.0 114.681 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.9 -40.5 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.674 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.31 -49.75 42.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.533 0.606 . . . . 10.0 111.974 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.72 -47.07 83.45 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.983 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.3 -52.33 62.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.016 0.926 . . . . 10.0 112.101 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 92.9 mt -52.51 -58.72 5.86 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 124.321 1.048 . . . . 10.0 110.003 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -52.08 -47.08 65.36 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.692 -1.147 . . . . 10.0 112.35 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.73 -52.14 57.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.308 1.413 . . . . 10.0 112.765 175.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.84 -49.64 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.461 1.104 . . . . 10.0 111.377 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mp -55.62 -52.86 62.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.56 . . . . 10.0 111.702 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -53.54 -56.41 17.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.957 2.103 . . . . 10.0 111.047 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.169 0.987 . . . . 10.0 111.374 176.289 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.313 0 CA-C-O 121.093 0.274 . . . . 10.0 113.083 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -43.06 -56.88 3.14 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.003 2.121 . . . . 10.0 112.382 166.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.97 -40.79 74.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.338 0.971 . . . . 10.0 114.095 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.75 -27.2 64.75 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 115.962 1.838 . . . . 10.0 115.962 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.52 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.78 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.92 0.888 . . . . 10.0 113.2 -172.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.5 5.12 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.308 1.596 . . . . 10.0 115.308 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.25 0.32 15.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.217 1.007 . . . . 10.0 113.292 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.026 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.21 1.87 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.812 0.845 . . . . 10.0 110.891 170.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.97 77.04 7.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.914 0.885 . . . . 10.0 112.03 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.464 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.48 0.3 OUTLIER 71.77 -55.37 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.765 1.226 . . . . 10.0 110.668 -175.275 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.781 3.562 . . . . 10.0 119.618 171.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.45 2.7 . . . . 10.0 113.408 166.649 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.305 2.642 . . . . 10.0 114.486 155.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.47 138.01 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.384 1.873 . . . . 10.0 113.344 -158.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.18 1.69 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 113.978 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.76 41.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 127.403 2.43 . . . . 10.0 111.491 168.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.57 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.634 -168.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.67 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.522 2.293 . . . . 10.0 113.212 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.15 4.32 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.782 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.41 -43.08 61.88 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.587 176.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.62 83.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.912 0.885 . . . . 10.0 109.315 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.35 -52.64 62.84 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.377 0.671 . . . . 10.0 111.928 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.187 0.595 . . . . 10.0 112.245 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.83 51.95 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.412 1.485 . . . . 10.0 113.287 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.98 84.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -57.06 10.07 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.247 0.927 . . . . 10.0 111.3 166.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -48.98 -52.46 24.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.642 1.177 . . . . 10.0 112.302 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.9 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.148 0.979 . . . . 10.0 112.166 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.66 -50.29 73.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.682 0.793 . . . . 10.0 112.579 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -53.69 -50.35 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.503 1.121 . . . . 10.0 111.348 175.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.36 -58.28 15.41 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.338 0.971 . . . . 10.0 113.471 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.91 79.79 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.539 1.17 . . . . 10.0 112.146 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.29 -42.53 73.99 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.956 1.265 . . . . 10.0 113.185 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.9 m -61.82 -58.75 6.75 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.852 0.861 . . . . 10.0 111.448 171.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.79 -58.04 9.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.974 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.7 82.13 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.176 0.806 . . . . 10.0 113.176 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.602 1.161 . . . . 10.0 113.64 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.718 1.723 . . . . 10.0 110.86 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.305 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 115.609 1.004 . . . . 10.0 115.609 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.02 92.93 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.46 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.798 0.713 . . . . 10.0 112.441 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.931 166.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.174 -1.375 . . . . 10.0 113.866 174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.769 1.293 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.58 -29.67 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.756 2.971 . . . . 10.0 113.682 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.17 -40.07 22.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.078 1.351 . . . . 10.0 113.534 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.43 19.58 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.434 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 111.015 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.94 -50.25 73.17 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.35 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.41 -51.26 65.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.353 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.2 mt -48.51 -58.0 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.892 1.277 . . . . 10.0 110.193 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -68.54 -16.48 63.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.218 1.407 . . . . 10.0 113.819 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -88.66 -39.72 13.83 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.624 1.102 . . . . 10.0 112.188 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.34 -42.17 90.89 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.457 -0.777 . . . . 10.0 112.29 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -41.13 -61.84 1.21 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 126.214 1.806 . . . . 10.0 113.782 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.13 -26.83 17.6 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.028 2.485 . . . . 10.0 114.436 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.69 89.49 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.504 1.502 . . . . 10.0 113.387 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -55.54 -53.81 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.426 1.09 . . . . 10.0 109.128 170.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -42.63 71.67 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.312 1.045 . . . . 10.0 113.751 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -52.93 -56.73 13.79 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.575 1.534 . . . . 10.0 111.915 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.96 -52.51 32.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.347 1.459 . . . . 10.0 110.735 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.21 62.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 118.168 -0.92 . . . . 10.0 112.982 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -56.3 -40.91 75.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.37 1.441 . . . . 10.0 113.013 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.23 -54.57 34.25 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.179 1.354 . . . . 10.0 111.333 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.66 -41.03 61.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.259 1.577 . . . . 10.0 115.259 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.91 -50.85 61.1 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.451 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.5 48.9 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.328 1.051 . . . . 10.0 113.835 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.01 43.21 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.26 1.578 . . . . 10.0 115.26 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.12 3.59 61.28 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.302 0.881 . . . . 10.0 115.302 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.4 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.035 2.134 . . . . 10.0 109.036 172.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.028 0.931 . . . . 10.0 111.0 166.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.887 0.875 . . . . 10.0 109.712 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.56 129.54 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.068 1.347 . . . . 10.0 110.976 -176.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.74 116.3 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.384 -1.044 . . . . 10.0 109.384 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.76 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.695 -0.962 . . . . 10.0 110.695 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.37 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.708 2.243 . . . . 10.0 118.708 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.54 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.263 -165.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.87 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.081 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.47 120.82 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.53 131.92 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.11 126.38 22.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.0 1.72 . . . . 10.0 111.684 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.746 1.26 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.3 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.54 -31.14 61.87 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.231 1.012 . . . . 10.0 112.305 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 82' ' ' ARG . 16.1 ttm-85 -46.97 -44.48 20.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.198 2.199 . . . . 10.0 113.104 167.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -82.12 -38.9 24.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.651 1.581 . . . . 10.0 111.794 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.17 -49.25 52.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.073 1.349 . . . . 10.0 111.629 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -53.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.038 1.735 . . . . 10.0 111.849 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -54.95 -33.23 62.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.936 -1.031 . . . . 10.0 113.549 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.13 -40.39 46.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.399 1.48 . . . . 10.0 112.051 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.28 -46.1 4.5 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.253 1.021 . . . . 10.0 112.303 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.1 m -52.32 -43.68 64.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.879 1.271 . . . . 10.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 m -72.87 -45.5 8.79 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 114.313 1.227 . . . . 10.0 114.313 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.88 -41.63 69.36 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.339 2.693 . . . . 10.0 115.1 167.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.0 mt -59.6 -47.14 86.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.285 0.634 . . . . 10.0 111.431 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.8 -51.45 22.5 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.349 1.86 . . . . 10.0 111.412 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.06 -47.28 83.64 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.92 1.288 . . . . 10.0 113.165 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.29 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.849 0.859 . . . . 10.0 112.889 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.34 -53.96 37.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.256 0.934 . . . . 10.0 111.2 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -42.05 88.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.62 0.768 . . . . 10.0 112.087 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 37.95 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.017 0.927 . . . . 10.0 112.024 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.29 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.752 0.821 . . . . 10.0 112.699 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.76 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.81 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.312 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.45 12.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.847 1.659 . . . . 10.0 112.159 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.92 54.38 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.69 2.61 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.523 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.79 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.46 -52.9 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.07 1.348 . . . . 10.0 111.128 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.61 -51.26 68.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.88 43.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.504 0.722 . . . . 10.0 110.923 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.357 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.82 -46.37 74.53 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.044 0.757 . . . . 10.0 113.044 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.52 -45.24 85.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.138 . . . . 10.0 112.08 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.99 -56.76 5.07 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.618 1.58 . . . . 10.0 112.797 166.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.46 -52.1 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 10.0 111.054 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 55.1 ttp -48.0 -59.79 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.855 1.262 . . . . 10.0 112.037 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 123.658 0.783 . . . . 10.0 111.889 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 111.967 0.358 . . . . 10.0 111.967 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.22 -59.25 9.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.911 1.719 . . . . 10.0 112.387 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.03 -42.94 3.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.313 2.645 . . . . 10.0 113.254 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.0 mt -101.42 -6.67 23.71 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.499 1.666 . . . . 10.0 115.499 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.7 10.36 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.19 -1.569 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.47 -49.62 72.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.187 2.595 . . . . 10.0 113.268 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.087 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.9 -59.53 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.07 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.501 1.52 . . . . 10.0 113.503 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.56 63.15 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.15 -41.26 68.24 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.89 0.768 . . . . 10.0 110.899 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.97 -31.98 69.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.837 1.255 . . . . 10.0 114.221 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.076 0.853 . . . . 10.0 109.713 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -60.03 -48.32 82.19 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -48.93 -49.61 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.575 1.079 . . . . 10.0 113.014 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.85 63.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 10.0 111.945 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.69 -51.28 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.983 1.313 . . . . 10.0 111.786 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.2 t -55.89 -46.24 78.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.615 1.166 . . . . 10.0 111.793 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.9 m -60.88 -42.64 98.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 10.0 112.557 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.78 79.17 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.228 0.922 . . . . 10.0 112.31 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.02 82.52 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.587 0.755 . . . . 10.0 112.607 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -55.38 -55.33 32.86 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.319 1.048 . . . . 10.0 112.142 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 tt -51.24 -50.54 58.98 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.949 1.7 . . . . 10.0 111.185 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -50.93 -54.9 20.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.021 0.928 . . . . 10.0 112.792 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.1 -54.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.592 0.757 . . . . 10.0 110.861 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.46 -36.58 69.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.692 0.797 . . . . 10.0 113.115 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.16 9.45 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.036 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.87 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.467 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.78 -49.44 75.29 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.115 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.087 -1.633 . . . . 10.0 112.871 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.68 -21.99 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 10.0 113.466 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.76 -79.06 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.621 0.629 . . . . 10.0 113.553 171.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.236 1.814 . . . . 10.0 113.045 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -50.55 65.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.057 0.932 . . . . 10.0 112.297 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.07 82.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.133 0.973 . . . . 10.0 112.167 173.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.45 80.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.532 1.308 . . . . 10.0 114.532 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.25 1.2 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.033 1.733 . . . . 10.0 114.254 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.65 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.391 1.876 . . . . 10.0 114.878 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.93 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.7 153.92 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.841 3.256 . . . . 10.0 105.592 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.82 -46.23 35.14 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.275 1.983 . . . . 10.0 113.06 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.15 68.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.236 173.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.1 -53.05 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.027 0.931 . . . . 10.0 109.832 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.8 75.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.274 0.63 . . . . 10.0 111.892 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.15 25.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.882 0.873 . . . . 10.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.25 -53.22 60.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 112.987 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.53 45.44 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.115 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.48 78.54 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.91 -49.63 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.843 0.747 . . . . 10.0 110.522 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.64 69.02 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.81 30.15 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.889 2.075 . . . . 10.0 111.037 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.836 0.454 . . . . 10.0 111.263 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.4 t -52.08 -47.39 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 112.209 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -65.29 0.66 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.209 2.604 . . . . 10.0 111.46 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.93 -48.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.783 1.233 . . . . 10.0 111.548 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.7 t -60.52 -61.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.945 0.898 . . . . 10.0 112.653 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.08 -48.78 73.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.766 0.712 . . . . 10.0 111.608 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -50.11 -53.03 30.14 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.647 1.179 . . . . 10.0 112.53 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.469 0.52 0 C-N-CA 124.278 1.031 . . . . 10.0 113.589 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 118.692 -0.671 . . . . 10.0 112.605 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -58.73 -56.1 26.59 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.547 1.139 . . . . 10.0 111.944 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.2 tt -58.36 -41.69 85.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.915 0.886 . . . . 10.0 112.697 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -81.27 -5.52 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.22 -169.29 33.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-O 122.587 1.104 . . . . 10.0 113.953 -169.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.43 65.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.847 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.46 -16.76 64.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.647 1.721 . . . . 10.0 115.647 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.05 -105.91 1.08 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.32 1.418 . . . . 10.0 113.799 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.17 35.81 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.617 -1.519 . . . . 10.0 109.325 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.894 0.318 . . . . 10.0 113.894 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.725 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.29 133.35 24.88 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.69 153.8 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.786 2.99 . . . . 10.0 111.433 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.77 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.307 1.043 . . . . 10.0 112.213 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.35 -52.35 22.07 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.712 1.375 . . . . 10.0 114.712 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.92 -40.5 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.476 1.11 . . . . 10.0 109.692 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.32 -49.78 42.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.513 0.597 . . . . 10.0 111.973 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.04 83.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.001 1.72 . . . . 10.0 112.993 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.35 62.14 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.02 0.928 . . . . 10.0 112.03 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -58.52 6.5 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.363 1.065 . . . . 10.0 109.975 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -53.44 -44.95 69.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.759 -1.115 . . . . 10.0 112.839 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.45 -53.0 57.66 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.66 -47.51 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.819 1.248 . . . . 10.0 111.678 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.12 -51.62 68.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.629 1.571 . . . . 10.0 111.815 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.21 -51.63 69.14 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.917 1.687 . . . . 10.0 111.788 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 124.669 1.188 . . . . 10.0 110.987 172.786 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.221 0 CA-C-O 121.028 0.238 . . . . 10.0 112.903 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -44.94 -58.02 3.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.542 1.937 . . . . 10.0 112.293 166.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.49 -38.5 70.62 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.005 0.812 . . . . 10.0 113.235 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -70.29 -27.65 64.57 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 116.215 1.932 . . . . 10.0 116.215 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.68 -57.49 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.63 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.921 0.889 . . . . 10.0 113.2 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.53 5.15 2.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.37 0.41 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.18 0.992 . . . . 10.0 113.272 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.08 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.011 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.98 7.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.874 0.87 . . . . 10.0 112.106 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.869 2.868 . . . . 10.0 116.475 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.719 1.208 . . . . 10.0 110.644 -175.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.21 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.666 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.483 2.713 . . . . 10.0 113.459 166.653 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.834 -2.032 . . . . 10.0 105.789 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 129.651 3.18 . . . . 10.0 117.196 160.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.65 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.306 2.642 . . . . 10.0 114.484 155.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.46 137.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.407 1.883 . . . . 10.0 113.345 -158.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.22 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.465 2.459 . . . . 10.0 111.487 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.62 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.25 -2.786 . . . . 10.0 116.634 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.543 2.301 . . . . 10.0 113.217 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.19 4.31 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.782 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.11 61.74 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.534 -0.729 . . . . 10.0 112.615 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.6 84.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.63 62.91 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.448 0.699 . . . . 10.0 111.882 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.59 56.42 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.183 0.593 . . . . 10.0 112.218 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 51.97 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.98 10.25 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.149 0.881 . . . . 10.0 111.202 166.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.27 -52.3 28.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.574 1.15 . . . . 10.0 112.187 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.122 0.969 . . . . 10.0 112.167 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.3 mt -57.86 -50.14 74.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.449 0.699 . . . . 10.0 112.751 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -49.7 68.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.442 1.097 . . . . 10.0 111.248 175.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.32 15.2 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.3 0.952 . . . . 10.0 113.608 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.02 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.485 1.142 . . . . 10.0 112.089 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -41.59 75.74 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.863 1.22 . . . . 10.0 113.232 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.55 -58.44 7.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.823 0.849 . . . . 10.0 111.421 171.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -40.98 62.49 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.045 0.938 . . . . 10.0 110.944 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.1 9.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.968 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.68 81.85 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.257 0.836 . . . . 10.0 113.257 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.46 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.586 1.154 . . . . 10.0 113.62 169.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.77 1.748 . . . . 10.0 110.892 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.013 . . . . 10.0 115.634 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.58 -44.96 93.16 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.162 2.185 . . . . 10.0 113.589 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.435 2.694 . . . . 10.0 116.939 166.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.64 -50.92 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.179 -1.373 . . . . 10.0 113.879 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.771 1.294 . . . . 10.0 110.957 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.59 -29.63 89.65 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.743 2.962 . . . . 10.0 113.69 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.09 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.108 1.363 . . . . 10.0 113.564 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.44 19.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.405 172.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.967 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.97 -50.23 73.29 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.334 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.29 65.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.337 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.53 -57.42 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.851 1.26 . . . . 10.0 110.533 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -67.99 -20.75 65.05 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.965 1.306 . . . . 10.0 113.552 -172.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -84.07 -40.92 17.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.414 1.086 . . . . 10.0 112.18 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.07 -41.52 88.15 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.469 -0.77 . . . . 10.0 112.983 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.37 -62.84 1.45 Allowed Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 124.603 1.161 . . . . 10.0 113.447 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.79 -26.34 32.56 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.001 2.467 . . . . 10.0 113.771 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.86 -45.94 83.92 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 120.547 1.522 . . . . 10.0 113.156 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.76 -51.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 120.982 -1.073 . . . . 10.0 109.302 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.82 72.84 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.42 0.896 . . . . 10.0 113.42 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -52.81 -56.42 15.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.119 1.368 . . . . 10.0 111.816 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.67 -52.78 28.58 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.263 1.425 . . . . 10.0 110.749 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.29 -47.97 62.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.99 0.916 . . . . 10.0 112.98 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.15 -41.2 75.04 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.365 1.439 . . . . 10.0 113.11 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.57 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.948 1.249 . . . . 10.0 111.297 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.61 -41.12 61.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.86 -50.85 61.22 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.525 0.73 . . . . 10.0 110.485 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.5 48.82 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.539 0.976 . . . . 10.0 115.539 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.55 61.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.42 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.042 2.137 . . . . 10.0 109.036 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.57 171.13 15.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.028 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.01 53.42 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.912 0.885 . . . . 10.0 109.712 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.51 129.62 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.079 1.352 . . . . 10.0 110.96 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.444 -1.022 . . . . 10.0 109.444 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.37 38.2 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.42 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.632 -0.987 . . . . 10.0 110.632 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.78 -3.35 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.317 1.558 . . . . 10.0 112.28 -165.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.93 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.52 120.74 69.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -165.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.2 Cg_exo -61.49 131.92 38.28 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.137 171.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.1 126.33 21.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.055 1.742 . . . . 10.0 111.752 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.63 85.01 4.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.958 1.361 . . . . 10.0 113.085 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.36 -28.28 66.71 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.898 -1.126 . . . . 10.0 113.928 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.8 38.3 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.26 1.024 . . . . 10.0 112.491 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -54.27 -48.3 71.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.032 1.333 . . . . 10.0 112.714 168.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -71.25 -38.49 71.91 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.485 1.114 . . . . 10.0 110.993 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.52 67.09 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.797 1.239 . . . . 10.0 112.367 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.15 -69.51 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.883 1.673 . . . . 10.0 111.624 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -56.84 -32.5 65.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.067 1.347 . . . . 10.0 112.836 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.35 -44.27 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.679 1.592 . . . . 10.0 111.876 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -100.14 -41.94 6.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 10.0 112.593 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.4 p -62.6 -42.72 99.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.836 1.198 . . . . 10.0 113.925 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 71.5 p -65.85 -44.01 60.98 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 114.663 1.357 . . . . 10.0 114.663 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -43.95 53.12 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.053 2.502 . . . . 10.0 115.637 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.46 -46.4 88.87 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.491 -0.756 . . . . 10.0 111.454 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 tp -50.76 -49.2 58.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.567 1.547 . . . . 10.0 112.038 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.09 -47.47 83.11 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.94 1.296 . . . . 10.0 112.513 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.22 78.28 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.78 0.832 . . . . 10.0 112.889 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.31 -54.04 36.64 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.309 0.959 . . . . 10.0 111.173 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.06 88.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 10.0 112.14 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 38.1 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 112.002 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.35 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.682 0.793 . . . . 10.0 112.704 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.76 -38.57 91.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.81 1.43 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.055 1.342 . . . . 10.0 112.296 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.9 47.62 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.443 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.93 54.46 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.664 0.616 . . . . 10.0 112.664 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.72 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.499 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.04 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.339 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.43 -52.9 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.075 1.35 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.27 67.89 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.87 43.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.429 0.692 . . . . 10.0 110.945 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.655 0.782 . . . . 10.0 111.375 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.9 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.78 -46.58 74.45 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -56.07 -48.3 76.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.896 0.879 . . . . 10.0 110.903 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.79 -54.57 4.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.951 1.263 . . . . 10.0 113.195 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.15 -51.01 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.903 0.881 . . . . 10.0 112.119 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -54.19 -51.96 62.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.866 1.212 . . . . 10.0 111.987 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 N--CA 1.471 0.576 0 O-C-N 121.801 -0.562 . . . . 10.0 111.034 177.406 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 112.139 0.422 . . . . 10.0 112.139 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.0 -58.98 9.34 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.919 1.723 . . . . 10.0 112.398 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.92 -43.3 3.03 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.057 2.543 . . . . 10.0 113.466 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.43 -6.33 24.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.461 1.652 . . . . 10.0 115.461 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.63 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.222 -1.549 . . . . 10.0 110.41 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.619 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.68 71.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.26 2.624 . . . . 10.0 113.251 177.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.61 106.3 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.52 3.03 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.771 1.229 . . . . 10.0 114.065 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.05 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.48 1.512 . . . . 10.0 113.519 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.63 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.907 1.447 . . . . 10.0 114.907 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -53.91 -41.81 68.05 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.914 0.779 . . . . 10.0 110.75 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.72 -31.49 69.52 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.355 1.243 . . . . 10.0 114.355 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.44 -52.01 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.041 0.837 . . . . 10.0 109.551 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -61.84 -42.56 99.19 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -53.67 -49.2 68.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.233 1.013 . . . . 10.0 112.759 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -52.58 64.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.636 0.774 . . . . 10.0 111.503 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.6 -55.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.987 1.315 . . . . 10.0 112.051 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 p -57.04 -43.63 82.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.905 0.882 . . . . 10.0 112.696 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -43.93 98.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.758 1.223 . . . . 10.0 112.157 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.41 81.7 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.229 0.922 . . . . 10.0 112.561 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.23 78.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.989 0.916 . . . . 10.0 112.43 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.8 ttp -56.56 -51.06 70.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.285 1.034 . . . . 10.0 112.382 171.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.02 -48.06 76.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.32 1.448 . . . . 10.0 112.681 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -48.53 -53.52 17.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.394 1.078 . . . . 10.0 111.794 169.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.72 -55.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.68 0.792 . . . . 10.0 110.899 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -56.52 -36.42 69.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.226 0.824 . . . . 10.0 113.226 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.28 -58.15 9.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.049 0.939 . . . . 10.0 113.059 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.5 -40.82 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.289 -0.863 . . . . 10.0 111.429 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.84 -49.4 75.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.909 1.231 . . . . 10.0 112.093 171.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.99 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.858 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.615 1.166 . . . . 10.0 113.447 -174.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.11 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.651 0.643 . . . . 10.0 113.554 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.242 1.817 . . . . 10.0 113.011 -166.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.06 -56.46 14.2 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.005 1.113 . . . . 10.0 114.005 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.69 -50.55 65.61 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.096 0.951 . . . . 10.0 112.272 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.14 -46.02 83.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.16 0.984 . . . . 10.0 112.151 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.51 80.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.43 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.124 1.77 . . . . 10.0 114.235 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.59 29.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.425 1.89 . . . . 10.0 114.851 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.5 1.619 . . . . 10.0 114.164 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.805 3.242 . . . . 10.0 105.562 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.84 -46.22 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.306 2.004 . . . . 10.0 113.069 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.11 68.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.057 2.943 . . . . 10.0 113.236 173.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.82 75.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.282 0.633 . . . . 10.0 111.917 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.19 24.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.913 0.885 . . . . 10.0 112.698 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.226 1.011 . . . . 10.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.55 -49.53 45.86 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.26 0.624 . . . . 10.0 111.115 174.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.15 -48.41 78.76 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.94 -49.7 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.801 0.728 . . . . 10.0 110.467 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.51 -51.63 69.07 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.8 -47.76 30.85 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 126.852 2.061 . . . . 10.0 111.04 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.48 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.862 0.465 . . . . 10.0 111.271 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.1 -47.33 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.078 0.951 . . . . 10.0 112.093 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.4 m -58.36 -64.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.126 2.57 . . . . 10.0 111.492 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -50.18 -49.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.676 1.19 . . . . 10.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.36 -63.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.974 0.91 . . . . 10.0 112.043 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.58 -45.45 81.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.142 0.883 . . . . 10.0 112.378 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -53.03 -51.88 60.27 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.107 0.963 . . . . 10.0 112.236 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 114.243 1.201 . . . . 10.0 114.243 179.724 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 112.77 0.655 . . . . 10.0 112.77 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -59.63 -55.18 37.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.563 1.145 . . . . 10.0 112.115 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.81 -41.68 82.67 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.764 0.826 . . . . 10.0 112.494 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -81.42 -5.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 115.003 1.483 . . . . 10.0 115.003 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.4 -169.31 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 122.576 1.098 . . . . 10.0 113.924 -168.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.56 65.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.822 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -67.92 -15.74 63.75 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.542 1.682 . . . . 10.0 115.542 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.53 -105.94 1.05 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 120.428 1.467 . . . . 10.0 114.03 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.304 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.32 1.35 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 113.855 0.302 . . . . 10.0 113.855 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.77 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.12 1.768 . . . . 10.0 108.692 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.7 t -126.26 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.368 -174.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.73 153.81 72.45 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.456 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.297 1.039 . . . . 10.0 112.199 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.3 -52.42 21.47 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 10.0 114.685 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.36 -49.77 42.93 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.563 0.62 . . . . 10.0 111.937 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.7 -47.05 83.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.979 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.28 -52.35 62.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.974 0.91 . . . . 10.0 112.123 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -58.96 5.1 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.303 1.041 . . . . 10.0 109.992 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -52.32 -44.57 65.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.679 -1.153 . . . . 10.0 112.6 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -55.26 -51.76 65.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.608 1.549 . . . . 10.0 112.511 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.43 -46.68 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.936 1.294 . . . . 10.0 111.629 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.91 -52.68 64.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.556 1.542 . . . . 10.0 111.601 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.57 -54.11 49.78 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.785 1.634 . . . . 10.0 111.933 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.475 0.778 0 O-C-N 121.22 -0.925 . . . . 10.0 112.456 -178.842 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.306 0 CA-C-O 120.909 0.172 . . . . 10.0 112.985 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -45.18 -56.3 4.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.414 1.886 . . . . 10.0 112.284 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.04 -40.03 71.93 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.072 0.844 . . . . 10.0 113.635 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.48 -27.69 64.4 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 115.774 1.768 . . . . 10.0 115.774 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.42 -57.52 11.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 165.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.65 0.86 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.907 0.883 . . . . 10.0 113.168 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.58 5.24 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.31 15.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.266 1.026 . . . . 10.0 113.28 172.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.038 0.935 . . . . 10.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.12 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.771 0.828 . . . . 10.0 110.973 170.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.85 76.99 7.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.87 0.868 . . . . 10.0 112.117 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.471 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.41 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.622 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.51 39.93 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.519 2.727 . . . . 10.0 113.439 166.61 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.782 -2.056 . . . . 10.0 105.826 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.51 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.615 3.166 . . . . 10.0 117.211 160.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.1 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.356 2.662 . . . . 10.0 114.417 155.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.365 1.866 . . . . 10.0 113.391 -158.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.13 1.69 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.306 1.842 . . . . 10.0 114.055 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.96 2.84 40.82 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 127.489 2.471 . . . . 10.0 111.487 168.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.55 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.96 -60.65 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.488 2.281 . . . . 10.0 113.191 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.23 4.37 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.8 2.44 . . . . 10.0 115.742 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.13 61.79 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.464 -0.772 . . . . 10.0 112.621 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.41 -52.65 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.422 0.689 . . . . 10.0 111.83 175.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.33 -53.59 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.174 0.59 . . . . 10.0 112.225 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 -46.81 52.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.368 1.467 . . . . 10.0 113.305 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.61 -45.04 84.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.83 -58.68 7.4 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.355 0.978 . . . . 10.0 110.765 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -48.4 -52.34 22.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.745 1.218 . . . . 10.0 112.072 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 -58.9 5.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.175 0.99 . . . . 10.0 112.15 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.74 -49.77 75.44 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.707 0.803 . . . . 10.0 112.207 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.2 mmm -57.78 -45.95 85.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.374 0.67 . . . . 10.0 111.603 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.47 -58.1 16.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.46 1.029 . . . . 10.0 113.895 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.21 -45.99 79.66 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.406 1.103 . . . . 10.0 112.077 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -42.02 75.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.821 1.2 . . . . 10.0 113.168 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 -58.58 7.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.676 0.79 . . . . 10.0 111.474 171.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.01 62.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.023 0.929 . . . . 10.0 110.974 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.78 -57.99 9.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.582 1.153 . . . . 10.0 113.011 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.68 82.0 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.621 1.168 . . . . 10.0 113.637 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.748 . . . . 10.0 110.878 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.937 2.495 . . . . 10.0 109.365 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.89 23.09 0.86 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.94 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.614 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.9 m -79.61 -50.87 10.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.231 -1.35 . . . . 10.0 113.902 174.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.52 6.44 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.794 1.309 . . . . 10.0 110.975 -172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.54 -29.69 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.705 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.66 2.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.111 0.565 . . . . 10.0 111.447 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.53 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.056 1.342 . . . . 10.0 113.588 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.49 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.249 1.42 . . . . 10.0 113.468 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.13 61.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.486 0.714 . . . . 10.0 110.946 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.91 -50.28 73.03 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.26 65.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.341 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.02 1.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.407 0.892 . . . . 10.0 113.407 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.36 -57.26 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.921 1.288 . . . . 10.0 110.645 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -68.39 -20.17 64.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.999 1.32 . . . . 10.0 113.508 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.9 m -84.92 -39.69 17.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.488 1.115 . . . . 10.0 112.303 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.59 -42.89 97.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.8 t -43.39 -63.77 0.93 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.898 1.279 . . . . 10.0 112.482 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.43 -27.56 33.52 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.94 2.426 . . . . 10.0 114.217 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.79 89.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.459 1.481 . . . . 10.0 113.033 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.2 mt -61.84 -46.97 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 120.86 -1.15 . . . . 10.0 109.908 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.61 71.14 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.027 0.751 . . . . 10.0 113.027 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -50.82 -56.87 10.12 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.193 1.397 . . . . 10.0 111.677 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -48.91 -53.39 19.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.237 1.415 . . . . 10.0 111.087 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.99 -48.34 63.33 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.034 0.933 . . . . 10.0 112.909 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -55.22 -41.94 72.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.309 1.413 . . . . 10.0 113.287 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.56 34.44 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.619 1.099 . . . . 10.0 111.356 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.64 -41.03 61.02 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.256 1.576 . . . . 10.0 115.256 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtm -66.95 -50.8 61.2 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 123.568 0.747 . . . . 10.0 110.456 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.67 -52.63 22.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.837 0.855 . . . . 10.0 112.91 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.93 -5.53 48.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.875 1.065 . . . . 10.0 113.875 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.22 -34.66 5.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 115.601 1.0 . . . . 10.0 115.601 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.38 -43.06 43.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.59 61.05 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.363 0.905 . . . . 10.0 115.363 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.39 26.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.072 2.149 . . . . 10.0 109.066 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.48 171.09 15.15 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.059 0.943 . . . . 10.0 111.048 166.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.1 53.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.862 0.865 . . . . 10.0 109.693 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.8 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.75 116.29 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.4 38.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 118.703 2.241 . . . . 10.0 118.703 170.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.9 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.302 1.551 . . . . 10.0 112.223 -165.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.78 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.544 1.537 . . . . 10.0 111.159 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.43 120.81 69.68 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 112.981 0.734 . . . . 10.0 112.981 -165.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.58 131.93 38.12 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.209 3.273 . . . . 10.0 112.144 171.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.12 126.32 21.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.054 1.742 . . . . 10.0 111.746 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.57 84.96 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.057 1.408 . . . . 10.0 113.065 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.31 -28.26 66.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.787 -1.195 . . . . 10.0 113.98 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.73 62.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.056 1.502 . . . . 10.0 115.056 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.409 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -63.86 -29.62 70.79 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 119.847 -1.783 . . . . 10.0 113.284 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -70.78 -43.99 67.57 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.254 -0.904 . . . . 10.0 112.012 171.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.1 -46.67 45.18 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.164 1.386 . . . . 10.0 111.669 167.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -56.92 -70.82 0.11 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.102 1.361 . . . . 10.0 111.675 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.409 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.2 m0 -53.4 -33.51 54.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.422 1.489 . . . . 10.0 112.835 -170.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.5 tp -46.29 -48.95 18.02 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.942 1.697 . . . . 10.0 111.913 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -90.8 -44.5 9.39 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.324 1.05 . . . . 10.0 112.311 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.2 p -78.91 -32.98 45.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.133 1.16 . . . . 10.0 114.133 -165.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.317 69.8 p -61.55 -44.98 93.66 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.594 -1.193 . . . . 10.0 112.767 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.52 -44.99 43.01 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.911 2.407 . . . . 10.0 115.892 166.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.41 -47.4 85.59 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.319 -0.863 . . . . 10.0 111.881 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.17 -49.51 60.79 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.898 1.679 . . . . 10.0 111.3 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.05 -48.06 76.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.237 1.015 . . . . 10.0 112.907 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.21 78.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.823 0.849 . . . . 10.0 112.863 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.37 -53.99 37.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.299 0.954 . . . . 10.0 111.163 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.12 88.8 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.151 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.71 38.29 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.951 0.9 . . . . 10.0 112.031 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.21 79.4 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.736 0.814 . . . . 10.0 112.669 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.75 -38.58 91.64 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.41 1.263 . . . . 10.0 114.41 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.269 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.89 47.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.966 -1.709 . . . . 10.0 112.437 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.87 54.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.79 -39.77 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.922 1.689 . . . . 10.0 113.452 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.74 87.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.382 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.49 -52.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.003 1.321 . . . . 10.0 111.16 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.28 67.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.516 0.562 . . . . 10.0 112.516 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.91 42.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.446 0.698 . . . . 10.0 110.932 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.9 4.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.429 2.292 . . . . 10.0 114.821 174.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -47.01 74.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -58.52 -44.28 89.48 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.703 0.801 . . . . 10.0 111.769 175.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -56.27 5.14 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.418 1.485 . . . . 10.0 113.384 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.59 -49.84 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 117.697 0.749 . . . . 10.0 111.245 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -53.85 -57.05 12.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.93 1.292 . . . . 10.0 112.587 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.479 0.978 0 CA-C-N 118.795 0.725 . . . . 10.0 111.625 173.406 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 110.23 -0.285 . . . . 10.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.88 -60.71 6.75 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.4 1.952 . . . . 10.0 112.533 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.61 -42.56 3.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.645 2.378 . . . . 10.0 113.219 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -100.77 -6.68 24.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.65 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 120.186 -1.571 . . . . 10.0 110.355 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.49 -49.6 72.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.154 2.582 . . . . 10.0 113.304 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.36 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.053 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.88 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.111 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.06 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.465 1.506 . . . . 10.0 113.56 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.74 63.26 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.03 -41.72 68.35 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.855 0.752 . . . . 10.0 110.768 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -69.33 -32.33 71.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.764 1.226 . . . . 10.0 114.25 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -52.15 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.051 0.841 . . . . 10.0 109.955 168.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -59.11 -51.71 68.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -48.24 -46.96 36.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.164 0.986 . . . . 10.0 113.388 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.44 -52.07 67.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 10.0 111.524 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.2 mt -54.22 -51.53 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.134 1.374 . . . . 10.0 111.514 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -54.45 -47.82 72.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.423 1.089 . . . . 10.0 112.13 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 73.6 m -63.0 -43.1 99.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.042 1.337 . . . . 10.0 111.663 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.46 73.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.238 1.015 . . . . 10.0 112.365 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.9 78.14 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.761 0.824 . . . . 10.0 112.497 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.97 -52.72 64.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.652 1.181 . . . . 10.0 111.959 172.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.08 -49.27 63.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.315 1.446 . . . . 10.0 111.414 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -49.33 -54.93 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.949 0.9 . . . . 10.0 112.681 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 42.0 mm -52.16 -55.88 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.852 0.751 . . . . 10.0 110.41 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.68 -35.22 72.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.463 -0.78 . . . . 10.0 111.735 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.36 -58.14 9.56 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.003 0.921 . . . . 10.0 113.008 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.85 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.438 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.4 75.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.857 1.208 . . . . 10.0 112.101 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -76.99 -70.32 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.119 -1.613 . . . . 10.0 112.851 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.89 60.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.634 1.174 . . . . 10.0 113.42 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.14 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.627 0.632 . . . . 10.0 113.514 171.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.41 51.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.26 1.824 . . . . 10.0 113.059 -166.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.54 13.8 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.96 1.096 . . . . 10.0 113.96 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.63 -50.54 65.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.084 0.945 . . . . 10.0 112.329 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.02 83.1 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.16 0.984 . . . . 10.0 112.117 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.47 80.12 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.32 1.23 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.124 1.77 . . . . 10.0 114.189 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.58 29.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.398 1.879 . . . . 10.0 114.917 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.86 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 123.48 1.61 . . . . 10.0 114.146 -170.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.66 153.96 72.74 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.798 3.239 . . . . 10.0 105.561 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.21 35.4 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.334 2.023 . . . . 10.0 113.008 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.032 2.933 . . . . 10.0 113.288 173.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.14 -53.08 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.059 0.943 . . . . 10.0 109.816 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.86 75.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.317 0.647 . . . . 10.0 111.907 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.96 -56.22 24.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.953 0.901 . . . . 10.0 112.675 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.18 -53.22 60.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.181 0.993 . . . . 10.0 113.059 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.53 -49.56 45.57 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.36 78.88 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.06 -49.58 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.832 0.742 . . . . 10.0 110.481 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.61 69.16 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.81 -47.74 30.95 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.883 2.073 . . . . 10.0 111.07 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.59 -58.33 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.815 0.446 . . . . 10.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.1 t -51.96 -47.94 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.091 0.956 . . . . 10.0 111.994 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.2 m -57.66 -63.41 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.397 2.679 . . . . 10.0 111.878 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.52 -49.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.526 1.131 . . . . 10.0 111.284 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.62 -60.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.1 0.96 . . . . 10.0 112.056 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.44 -48.08 83.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -52.26 -51.07 60.55 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.707 0.803 . . . . 10.0 111.597 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 114.028 1.121 . . . . 10.0 114.028 178.691 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 119.279 -0.391 . . . . 10.0 111.531 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -55.68 -52.91 62.24 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.412 1.085 . . . . 10.0 112.581 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -57.49 -43.15 83.92 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.854 0.861 . . . . 10.0 112.304 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -83.98 -5.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.097 1.517 . . . . 10.0 115.097 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.37 -169.35 33.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 122.559 1.088 . . . . 10.0 113.887 -168.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -41.23 64.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.889 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.7 -16.79 64.31 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.731 1.752 . . . . 10.0 115.731 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.89 -105.93 1.09 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.364 1.438 . . . . 10.0 113.711 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.4 127.13 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.368 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.52 65.4 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.081 1.753 . . . . 10.0 108.725 166.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.39 24.91 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.78 153.79 72.38 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.733 2.955 . . . . 10.0 111.463 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.09 -39.84 2.92 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.295 1.038 . . . . 10.0 112.232 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.31 -52.35 21.87 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.95 -40.45 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.388 1.075 . . . . 10.0 109.639 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.86 41.86 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.535 0.607 . . . . 10.0 111.946 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.4 m -57.71 -47.01 83.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.006 1.723 . . . . 10.0 112.995 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.33 62.29 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.938 0.895 . . . . 10.0 112.054 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.61 -59.07 4.91 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.307 1.043 . . . . 10.0 109.979 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.97 -46.99 68.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.479 -1.248 . . . . 10.0 112.297 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.98 -52.34 43.58 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.739 1.609 . . . . 10.0 113.035 174.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.32 -48.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.553 1.141 . . . . 10.0 111.636 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.98 -50.45 72.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.143 1.377 . . . . 10.0 111.763 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.14 -59.79 4.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.713 2.005 . . . . 10.0 110.198 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.477 0.909 0 C-N-CA 124.552 1.141 . . . . 10.0 111.989 175.282 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.294 0 N-CA-C 112.534 -0.226 . . . . 10.0 112.534 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -43.05 -57.39 2.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.759 2.024 . . . . 10.0 112.536 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.92 -41.59 84.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.388 0.994 . . . . 10.0 113.945 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.92 -27.18 64.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 115.703 1.742 . . . . 10.0 115.703 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.21 -57.65 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.947 0.899 . . . . 10.0 113.155 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.53 5.13 2.54 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.3 0.37 15.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.24 1.016 . . . . 10.0 113.324 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 110.972 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.95 77.07 7.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.824 0.849 . . . . 10.0 112.087 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.83 2.852 . . . . 10.0 116.458 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.91 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.721 1.209 . . . . 10.0 110.61 -175.352 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.77 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.656 171.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.468 2.707 . . . . 10.0 113.408 166.584 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.83 -2.033 . . . . 10.0 105.851 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.614 3.165 . . . . 10.0 117.211 160.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.272 2.629 . . . . 10.0 114.49 155.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.97 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.361 1.864 . . . . 10.0 113.378 -158.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.272 1.829 . . . . 10.0 113.99 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.16 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.58 -51.38 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.306 -2.759 . . . . 10.0 116.604 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.498 2.285 . . . . 10.0 113.205 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.31 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.737 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.39 -43.03 61.79 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.496 -0.752 . . . . 10.0 112.642 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.69 83.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.954 0.902 . . . . 10.0 109.305 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.872 175.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.33 -53.57 56.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.238 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.81 51.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.376 1.47 . . . . 10.0 113.354 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.99 84.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.294 1.438 . . . . 10.0 113.026 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.95 -55.68 14.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.575 1.084 . . . . 10.0 111.769 166.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -50.16 -52.5 34.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.916 1.286 . . . . 10.0 112.317 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.145 0.978 . . . . 10.0 112.204 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.2 mt -58.11 -49.31 77.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.451 0.7 . . . . 10.0 112.609 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.2 mmt -55.16 -50.27 69.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.686 0.794 . . . . 10.0 111.198 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.08 -58.57 13.9 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.388 0.994 . . . . 10.0 113.634 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.15 -45.65 79.56 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.593 1.196 . . . . 10.0 112.138 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.62 80.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.529 1.062 . . . . 10.0 113.389 172.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -60.17 -60.49 3.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.09 0.956 . . . . 10.0 110.984 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.96 62.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.939 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.09 9.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.654 1.181 . . . . 10.0 112.929 172.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.72 82.1 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.649 1.179 . . . . 10.0 113.619 169.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.698 1.713 . . . . 10.0 110.835 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.86 -44.8 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.878 2.471 . . . . 10.0 109.338 171.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.97 23.1 0.87 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.611 1.005 . . . . 10.0 115.611 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.48 -45.0 92.93 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.145 2.178 . . . . 10.0 113.605 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.765 0.698 . . . . 10.0 112.432 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.04 88.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.361 2.665 . . . . 10.0 116.933 166.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.67 -50.88 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.224 -1.353 . . . . 10.0 113.854 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.47 6.4 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.782 1.301 . . . . 10.0 110.957 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.57 -29.64 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.08 0.552 . . . . 10.0 111.442 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.15 22.67 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.142 1.377 . . . . 10.0 113.549 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.47 19.23 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.232 1.413 . . . . 10.0 113.46 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.11 61.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.952 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.95 -50.23 73.26 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.035 0.534 . . . . 10.0 112.351 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.36 -51.29 65.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.939 -0.553 . . . . 10.0 112.358 173.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.78 -56.88 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 10.0 110.489 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -69.23 -17.57 63.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.18 1.392 . . . . 10.0 113.6 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.6 m -86.6 -42.91 13.09 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.688 1.131 . . . . 10.0 111.953 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -57.13 -41.32 78.82 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -50.62 -61.35 3.95 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.985 1.314 . . . . 10.0 112.254 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.27 -46.78 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.393 3.395 . . . . 10.0 115.726 163.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.96 79.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.241 1.2 . . . . 10.0 114.241 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.09 -36.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 120.256 -1.528 . . . . 10.0 111.698 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.87 77.61 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.13 0.877 . . . . 10.0 112.603 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.8 -56.0 14.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 10.0 111.89 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -48.61 -53.21 19.37 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.498 1.519 . . . . 10.0 111.113 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.59 -48.14 64.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.142 0.977 . . . . 10.0 112.921 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -55.34 -42.16 73.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.009 1.277 . . . . 10.0 113.196 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.66 32.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.292 0.951 . . . . 10.0 111.25 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.55 -41.13 60.89 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.255 1.576 . . . . 10.0 115.255 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 47.0 mtm -66.91 -50.77 61.37 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.531 0.732 . . . . 10.0 110.459 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.7 -52.58 22.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.828 0.851 . . . . 10.0 112.924 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.46 48.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.23 -34.76 5.51 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.524 0.97 . . . . 10.0 115.524 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.26 -43.08 42.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.09 3.57 61.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.063 2.145 . . . . 10.0 109.001 171.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.13 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.03 166.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.726 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.6 129.63 23.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 125.069 1.348 . . . . 10.0 110.908 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.81 116.27 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 109.382 -1.045 . . . . 10.0 109.382 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.78 0.659 . . . . 10.0 112.78 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.718 -0.953 . . . . 10.0 110.718 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.43 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.664 2.225 . . . . 10.0 118.664 170.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.379 1.59 . . . . 10.0 112.202 -165.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.478 1.511 . . . . 10.0 111.059 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.9 Cg_exo -61.52 131.9 38.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.169 3.246 . . . . 10.0 112.166 171.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.7 85.01 4.72 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.717 1.246 . . . . 10.0 113.066 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.29 -28.31 66.64 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.26 -33.59 63.3 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.283 1.033 . . . . 10.0 112.155 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.478 ' HD2' ' CZ2' ' A' ' 86' ' ' TRP . 8.1 tpp180 -39.06 -54.23 1.73 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.24 2.616 . . . . 10.0 111.938 165.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.71 -38.11 48.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.047 1.739 . . . . 10.0 112.579 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.2 -47.35 62.29 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.72 1.146 . . . . 10.0 110.387 167.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -68.36 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.362 1.865 . . . . 10.0 111.485 168.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.478 ' CZ2' ' HD2' ' A' ' 82' ' ' ARG . 54.5 m0 -54.76 -35.83 64.19 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.608 0.966 . . . . 10.0 113.608 -172.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.14 -42.19 50.24 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.104 1.762 . . . . 10.0 111.825 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -103.5 -36.96 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.543 -0.741 . . . . 10.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.4 p -61.15 -46.22 91.43 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 121.155 1.798 . . . . 10.0 113.6 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.301 76.4 p -65.93 -43.89 59.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 -175.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.99 -43.14 62.34 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.429 2.753 . . . . 10.0 115.261 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.95 -47.78 84.85 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.318 -0.864 . . . . 10.0 111.698 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.411 HD21 ' HE1' ' A' ' 182' ' ' TRP . 17.5 tp -49.95 -49.59 49.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.136 1.374 . . . . 10.0 112.189 169.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.87 -47.93 76.46 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.111 -0.993 . . . . 10.0 112.658 170.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.26 78.28 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.781 0.832 . . . . 10.0 112.894 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -52.24 -54.05 35.98 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.31 0.959 . . . . 10.0 111.203 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.72 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.657 0.783 . . . . 10.0 112.158 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.74 -54.74 37.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.983 0.913 . . . . 10.0 112.016 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.15 79.17 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.677 174.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.82 -38.54 91.48 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.426 1.269 . . . . 10.0 114.426 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.018 1.327 . . . . 10.0 112.296 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.5 53.49 11.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.821 1.648 . . . . 10.0 112.175 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.92 47.52 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.938 -1.726 . . . . 10.0 112.392 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.89 54.27 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.7 2.63 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.861 1.664 . . . . 10.0 113.456 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.25 5.27 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.02 -46.8 87.62 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.88 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.997 1.319 . . . . 10.0 111.163 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.67 -51.28 67.84 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.55 0.574 . . . . 10.0 112.55 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.88 43.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.452 0.701 . . . . 10.0 110.908 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.52 -59.96 4.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.436 2.294 . . . . 10.0 114.815 174.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.99 -46.29 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 123.665 0.786 . . . . 10.0 111.428 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.71 -50.25 64.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.655 0.645 . . . . 10.0 112.63 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.71 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.234 0.827 . . . . 10.0 113.234 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -55.12 -48.3 73.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.591 1.156 . . . . 10.0 111.259 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -55.51 5.22 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.39 1.472 . . . . 10.0 113.246 168.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.61 -51.99 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.549 0.74 . . . . 10.0 111.735 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.2 tmm? -50.65 -56.38 12.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.969 1.707 . . . . 10.0 112.038 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm . . . . . 0 N--CA 1.473 0.692 0 O-C-N 121.652 -0.655 . . . . 10.0 112.423 175.457 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.0 t . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 119.683 -0.198 . . . . 10.0 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.26 6.3 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.714 1.626 . . . . 10.0 112.092 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.59 -37.55 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.387 1.875 . . . . 10.0 113.893 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.6 mt -99.14 -6.35 28.45 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.162 1.541 . . . . 10.0 115.162 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.68 116.69 10.37 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.128 -1.607 . . . . 10.0 110.365 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.221 2.608 . . . . 10.0 113.274 177.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.62 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.812 0.845 . . . . 10.0 110.066 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.95 -59.53 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.033 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.06 14.92 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.413 1.485 . . . . 10.0 113.52 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -70.2 -24.58 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.66 -42.2 67.64 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.917 0.78 . . . . 10.0 110.692 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.53 -31.54 69.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.853 1.261 . . . . 10.0 114.348 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.36 -51.86 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.0 0.818 . . . . 10.0 109.622 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -61.68 -43.03 99.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.387 1.255 . . . . 10.0 114.387 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.26 -49.03 67.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.545 1.138 . . . . 10.0 112.585 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.87 71.74 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.717 0.807 . . . . 10.0 111.675 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.4 mt -56.35 -54.33 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.924 1.289 . . . . 10.0 111.943 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -57.39 -42.04 81.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.451 0.7 . . . . 10.0 112.468 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.2 m -58.91 -46.73 87.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.89 1.276 . . . . 10.0 112.6 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.312 0.96 . . . . 10.0 112.371 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.99 83.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.982 0.913 . . . . 10.0 112.805 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.71 -53.61 56.19 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.468 1.107 . . . . 10.0 111.982 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.66 -47.61 70.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.422 1.489 . . . . 10.0 111.982 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -50.1 -54.56 19.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.001 0.92 . . . . 10.0 112.416 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.4 mt -53.78 -54.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.79 0.836 . . . . 10.0 110.728 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.56 -36.56 69.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.17 9.4 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -40.86 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.8 -49.43 75.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.883 1.22 . . . . 10.0 112.145 171.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.043 -1.66 . . . . 10.0 112.874 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.72 -21.91 60.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.607 1.163 . . . . 10.0 113.466 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.644 0.64 . . . . 10.0 113.522 171.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.43 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.037 -166.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.16 -56.42 14.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.953 1.094 . . . . 10.0 113.953 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.7 -50.51 65.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.145 0.974 . . . . 10.0 112.307 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.05 82.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.192 0.997 . . . . 10.0 112.152 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.53 80.03 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.42 -11.29 1.19 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.084 1.754 . . . . 10.0 114.223 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.411 1.884 . . . . 10.0 114.867 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.97 -92.62 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.501 1.619 . . . . 10.0 114.135 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.68 153.93 72.68 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.837 3.255 . . . . 10.0 105.604 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.345 2.03 . . . . 10.0 113.083 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.668 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.07 68.07 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.285 173.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.13 -53.05 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.105 0.962 . . . . 10.0 109.816 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.82 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.06 -56.11 25.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.864 0.865 . . . . 10.0 112.731 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.2 -53.24 60.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.229 1.012 . . . . 10.0 112.988 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.56 45.38 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.324 0.65 . . . . 10.0 111.097 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.14 -48.44 78.67 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.66 1.356 . . . . 10.0 114.66 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.97 -49.58 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.807 0.731 . . . . 10.0 110.482 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.14 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.169 0.803 . . . . 10.0 113.169 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.72 31.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.84 2.056 . . . . 10.0 111.068 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.61 -58.29 9.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.781 0.432 . . . . 10.0 111.245 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.85 -49.3 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.07 0.948 . . . . 10.0 111.497 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 29.7 m -56.19 -64.01 1.0 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.115 2.566 . . . . 10.0 111.952 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.02 -49.11 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.666 1.186 . . . . 10.0 111.347 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.31 -61.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.09 0.956 . . . . 10.0 112.372 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -58.04 -46.84 84.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.421 0.688 . . . . 10.0 111.932 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TRP . . . . . 0.411 ' HE1' HD21 ' A' ' 93' ' ' LEU . 9.0 m95 -51.29 -52.8 41.82 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.16 0.984 . . . . 10.0 112.101 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 113.789 1.033 . . . . 10.0 113.789 179.78 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 119.438 -0.315 . . . . 10.0 111.483 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -55.59 -53.3 58.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.697 1.199 . . . . 10.0 112.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -56.25 -44.51 79.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.936 0.894 . . . . 10.0 112.655 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -84.52 -5.81 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.08 1.511 . . . . 10.0 115.08 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.26 33.1 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-O 122.627 1.126 . . . . 10.0 113.94 -168.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -41.1 64.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.202 -0.999 . . . . 10.0 111.846 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -54.43 -31.66 55.77 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.503 2.721 . . . . 10.0 115.359 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.34 -103.85 0.96 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.433 1.015 . . . . 10.0 113.506 -167.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.15 35.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.653 -1.498 . . . . 10.0 109.357 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.4 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.69 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.721 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.33 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.388 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.72 153.8 72.51 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.792 2.995 . . . . 10.0 111.483 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.83 3.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.364 1.065 . . . . 10.0 112.19 171.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.28 -52.41 21.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.0 -40.42 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.363 1.065 . . . . 10.0 109.625 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.34 -49.81 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.61 0.641 . . . . 10.0 111.944 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.05 83.37 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.055 1.742 . . . . 10.0 112.976 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.4 -52.29 62.24 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.934 0.894 . . . . 10.0 112.054 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -58.73 5.84 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.338 1.055 . . . . 10.0 109.955 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -52.51 -45.36 66.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.604 -1.189 . . . . 10.0 112.684 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.8 -52.67 59.56 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.48 1.491 . . . . 10.0 112.856 174.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.51 -46.17 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.055 1.342 . . . . 10.0 111.551 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.28 -54.25 49.02 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.302 1.441 . . . . 10.0 111.589 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -54.03 -58.74 6.18 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.523 1.929 . . . . 10.0 111.278 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.474 0.746 0 O-C-N 121.153 -0.967 . . . . 10.0 112.185 -179.527 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.308 0 CA-C-O 121.11 0.284 . . . . 10.0 112.4 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -40.7 -60.13 1.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.904 2.081 . . . . 10.0 112.324 163.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.03 72.45 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.13 0.872 . . . . 10.0 113.745 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -69.94 -27.55 64.85 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 115.997 1.851 . . . . 10.0 115.997 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.73 -57.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.493 -0.929 . . . . 10.0 108.493 165.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.88 0.872 . . . . 10.0 113.171 -172.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.62 5.23 2.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 10.0 115.341 -171.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.4 15.7 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.174 0.99 . . . . 10.0 113.32 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.998 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.668 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.72 98.24 1.9 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.73 0.812 . . . . 10.0 110.953 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.04 7.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.87 0.868 . . . . 10.0 112.037 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.904 2.881 . . . . 10.0 116.466 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.48 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.765 1.226 . . . . 10.0 110.635 -175.284 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.74 Favored Glycine 0 C--O 1.238 0.388 0 C-N-CA 129.738 3.542 . . . . 10.0 119.647 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.476 2.711 . . . . 10.0 113.421 166.567 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.794 -2.05 . . . . 10.0 105.835 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.49 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.595 3.158 . . . . 10.0 117.209 160.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.1 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.306 2.642 . . . . 10.0 114.452 155.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.51 137.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.357 1.863 . . . . 10.0 113.393 -158.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.74 -165.2 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.76 40.74 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.412 2.434 . . . . 10.0 111.516 168.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.31 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.679 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.66 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.477 2.277 . . . . 10.0 113.238 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.37 0.95 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.751 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.42 -43.07 61.9 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.458 -0.776 . . . . 10.0 112.604 176.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.348 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.46 -52.62 63.01 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.386 0.675 . . . . 10.0 111.84 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.82 -46.8 51.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.353 1.461 . . . . 10.0 113.335 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.68 -44.93 84.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.267 1.427 . . . . 10.0 113.056 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.06 -55.78 14.31 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.373 0.987 . . . . 10.0 111.689 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.97 -52.41 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.874 1.27 . . . . 10.0 112.336 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.47 -58.89 5.72 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.172 0.989 . . . . 10.0 112.14 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -57.42 -48.79 78.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.619 0.768 . . . . 10.0 112.684 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.41 -47.1 85.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.221 1.008 . . . . 10.0 111.502 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.64 13.52 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.309 0.957 . . . . 10.0 113.721 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.21 -46.03 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.658 1.229 . . . . 10.0 112.112 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.18 -42.68 73.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.987 1.28 . . . . 10.0 113.175 172.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -62.05 -58.35 8.17 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.718 0.807 . . . . 10.0 111.534 172.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.32 -40.99 62.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.937 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.74 -58.07 9.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.616 1.166 . . . . 10.0 112.999 172.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.71 81.93 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.244 0.831 . . . . 10.0 113.244 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.625 1.17 . . . . 10.0 113.659 169.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.728 1.727 . . . . 10.0 110.868 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.875 2.47 . . . . 10.0 109.33 171.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.11 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.01 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.101 2.161 . . . . 10.0 113.623 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.175 -1.375 . . . . 10.0 113.841 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.84 117.52 6.35 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.745 1.278 . . . . 10.0 110.957 -172.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.63 -29.66 89.87 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.678 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.085 0.554 . . . . 10.0 111.448 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.22 -40.04 23.08 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.583 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.53 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.219 1.408 . . . . 10.0 113.446 172.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.81 -53.04 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.939 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.99 -50.27 73.21 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.316 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.29 -51.33 64.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.39 0.541 . . . . 10.0 112.395 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.44 -58.06 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 10.0 110.256 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -67.78 -18.71 64.95 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.234 1.414 . . . . 10.0 113.725 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -86.74 -40.64 14.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.381 1.072 . . . . 10.0 112.292 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.13 -42.92 91.77 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.44 -0.787 . . . . 10.0 112.708 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.2 t -42.2 -62.29 1.25 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.504 1.522 . . . . 10.0 113.285 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.17 -26.12 21.54 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.069 2.513 . . . . 10.0 114.24 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.94 80.63 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.855 1.662 . . . . 10.0 113.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.5 -49.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.026 -1.046 . . . . 10.0 109.778 169.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.56 -45.96 73.6 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 175.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -50.98 -56.32 13.04 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.758 1.623 . . . . 10.0 112.046 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -49.4 -52.76 26.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.303 1.441 . . . . 10.0 110.626 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.439 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.6 mmt -68.87 -47.97 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.005 0.922 . . . . 10.0 113.047 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -57.27 -40.13 77.08 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.201 -1.381 . . . . 10.0 113.346 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.3 -54.6 34.04 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.037 1.29 . . . . 10.0 111.301 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.04 61.0 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.211 1.56 . . . . 10.0 115.211 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.94 -50.78 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.476 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.65 21.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.883 . . . . 10.0 112.9 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.03 -5.51 49.06 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.34 1.056 . . . . 10.0 113.769 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.554 0.982 . . . . 10.0 115.554 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.04 43.04 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.28 1.585 . . . . 10.0 115.28 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.304 0.882 . . . . 10.0 115.304 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.26 143.37 26.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.082 2.153 . . . . 10.0 109.018 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.008 0.923 . . . . 10.0 111.021 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.01 53.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.751 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.56 129.58 23.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 125.12 1.368 . . . . 10.0 110.991 -176.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.28 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.379 -1.047 . . . . 10.0 109.379 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.41 -81.94 0.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.634 -0.986 . . . . 10.0 110.634 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.55 -171.82 4.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.23 -165.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.91 93.89 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.527 1.531 . . . . 10.0 111.056 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.45 120.79 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.989 0.737 . . . . 10.0 112.989 -165.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.6 Cg_exo -61.57 131.93 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.196 3.264 . . . . 10.0 112.129 171.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.004 1.721 . . . . 10.0 111.739 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.62 84.98 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.005 1.384 . . . . 10.0 113.035 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.32 -28.31 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.839 -1.163 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.92 45.45 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.259 1.023 . . . . 10.0 113.197 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -50.42 -60.96 2.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.706 1.202 . . . . 10.0 111.05 168.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -58.17 -42.44 86.01 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.32 2.248 . . . . 10.0 112.633 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.32 63.44 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.487 1.04 . . . . 10.0 112.418 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.439 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -62.39 -60.46 3.53 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.384 0.993 . . . . 10.0 111.759 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -52.96 -36.24 59.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 112.328 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.4 tp -50.49 -42.64 54.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.536 1.934 . . . . 10.0 112.14 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -102.35 -39.05 7.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.83 0.852 . . . . 10.0 112.842 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 71.2 p -63.08 -45.9 89.95 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 120.559 1.527 . . . . 10.0 113.308 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 72.6 p -62.86 -44.21 85.0 Favored Pre-proline 0 N--CA 1.478 0.944 0 N-CA-C 114.825 1.417 . . . . 10.0 114.825 -177.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.07 -43.29 60.73 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.521 2.814 . . . . 10.0 115.32 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.48 -47.5 85.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.803 0.729 . . . . 10.0 111.71 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.0 mt -53.6 -45.27 69.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.39 1.076 . . . . 10.0 112.204 172.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.81 -47.42 82.65 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.111 -0.993 . . . . 10.0 112.769 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.29 78.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.88 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.29 -54.06 36.2 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.258 0.936 . . . . 10.0 111.161 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.1 88.76 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.62 0.768 . . . . 10.0 112.146 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.75 37.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.986 0.914 . . . . 10.0 112.028 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.14 79.14 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.677 0.791 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.61 91.75 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.76 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.045 1.338 . . . . 10.0 112.313 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.844 1.658 . . . . 10.0 112.104 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.85 47.66 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.903 -1.748 . . . . 10.0 112.446 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 135.96 54.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.705 0.632 . . . . 10.0 112.705 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.71 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.856 1.663 . . . . 10.0 113.471 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.27 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.178 1.37 . . . . 10.0 115.262 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.04 -46.83 87.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.323 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.37 -52.95 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.02 1.328 . . . . 10.0 111.124 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.32 67.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.09 -44.92 42.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.49 0.716 . . . . 10.0 110.98 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.94 4.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.396 2.279 . . . . 10.0 114.8 174.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.93 -46.38 96.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.69 0.796 . . . . 10.0 111.423 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.29 64.24 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.674 0.654 . . . . 10.0 112.593 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.32 74.83 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.37 -45.72 84.13 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.164 0.986 . . . . 10.0 111.995 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.07 -55.62 5.61 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.332 1.444 . . . . 10.0 112.982 167.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.21 -53.57 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.02 -0.99 . . . . 10.0 110.768 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 57.4 ttp -46.02 -58.1 3.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.504 1.502 . . . . 10.0 112.653 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.1 mm . . . . . 0 N--CA 1.473 0.718 0 O-C-N 121.694 -0.629 . . . . 10.0 112.429 179.474 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 111.539 0.2 . . . . 10.0 111.539 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.27 -59.36 9.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.857 1.694 . . . . 10.0 112.448 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.07 -43.2 3.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.475 2.71 . . . . 10.0 113.272 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -101.26 -6.38 24.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.446 1.647 . . . . 10.0 115.446 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.76 10.48 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.222 -1.549 . . . . 10.0 110.397 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.217 2.607 . . . . 10.0 113.255 177.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.68 106.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.733 0.813 . . . . 10.0 110.065 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.94 -59.54 3.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.029 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.09 14.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.513 1.525 . . . . 10.0 113.486 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.23 -24.6 63.12 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.872 1.434 . . . . 10.0 114.872 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.95 -41.75 68.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.935 0.789 . . . . 10.0 110.776 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.86 70.22 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.356 1.243 . . . . 10.0 114.356 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.46 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.043 0.838 . . . . 10.0 109.621 168.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -60.51 -45.26 94.47 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.015 1.116 . . . . 10.0 114.015 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -52.23 -48.89 64.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.414 1.006 . . . . 10.0 112.895 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -54.45 45.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.092 0.957 . . . . 10.0 111.645 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.0 mt -53.28 -49.83 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.052 1.341 . . . . 10.0 111.592 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -54.84 -48.09 73.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.866 1.266 . . . . 10.0 111.852 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.7 m -65.19 -40.49 94.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.602 1.561 . . . . 10.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.07 -49.41 77.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.049 0.94 . . . . 10.0 112.286 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.45 79.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.746 0.818 . . . . 10.0 112.441 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.7 ttp -55.37 -54.04 48.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.12 0.968 . . . . 10.0 112.243 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -52.07 -50.38 61.66 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.83 1.652 . . . . 10.0 111.407 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -50.15 -54.71 18.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.14 0.976 . . . . 10.0 112.502 172.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.7 mt -53.49 -55.26 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.775 0.83 . . . . 10.0 110.736 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.32 -35.84 70.38 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.287 -0.863 . . . . 10.0 112.866 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.48 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.03 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.85 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.437 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.84 -49.37 75.63 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.866 1.212 . . . . 10.0 112.153 171.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.92 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.94 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.645 1.178 . . . . 10.0 113.412 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.75 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.676 0.655 . . . . 10.0 113.51 171.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.61 -32.43 51.12 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.23 1.812 . . . . 10.0 113.08 -166.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.9 m -52.04 -56.52 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.025 1.12 . . . . 10.0 114.025 172.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.58 -50.62 65.2 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.115 0.959 . . . . 10.0 112.32 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.08 -46.08 82.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.188 0.995 . . . . 10.0 112.105 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.54 79.8 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.516 1.302 . . . . 10.0 114.516 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.33 1.22 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.101 1.76 . . . . 10.0 114.235 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.07 6.67 29.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.433 1.893 . . . . 10.0 114.89 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.96 -92.68 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.473 1.606 . . . . 10.0 114.115 -170.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.68 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 129.805 3.242 . . . . 10.0 105.541 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.93 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.308 2.005 . . . . 10.0 113.052 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.06 68.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.977 2.911 . . . . 10.0 113.259 173.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.16 -53.05 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 124.014 0.925 . . . . 10.0 109.804 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.81 75.57 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.237 0.615 . . . . 10.0 111.952 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.02 -56.13 25.45 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.894 0.877 . . . . 10.0 112.734 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.1 m -57.3 -53.11 61.83 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.139 0.976 . . . . 10.0 113.02 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.6 -49.51 46.41 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.118 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.1 -48.4 78.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.6 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.774 0.715 . . . . 10.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.52 -51.68 68.84 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.77 30.14 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.822 2.049 . . . . 10.0 111.077 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.14 -47.0 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.015 0.926 . . . . 10.0 112.127 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 34.1 m -58.33 -64.16 1.02 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.276 2.631 . . . . 10.0 111.735 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.33 -50.15 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.68 1.192 . . . . 10.0 110.989 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.19 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.962 0.905 . . . . 10.0 111.915 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.07 -48.33 73.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.24 0.927 . . . . 10.0 112.69 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.76 -50.41 70.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.834 0.854 . . . . 10.0 111.66 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 114.397 1.258 . . . . 10.0 114.397 179.104 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 119.322 -0.37 . . . . 10.0 111.472 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -55.5 -52.63 63.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.408 1.083 . . . . 10.0 112.598 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -58.51 -42.97 88.87 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.686 0.794 . . . . 10.0 112.45 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -83.3 -5.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.915 1.45 . . . . 10.0 114.915 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.3 33.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 122.55 1.083 . . . . 10.0 113.964 -168.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.62 65.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.868 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.78 -15.87 63.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.568 1.692 . . . . 10.0 115.568 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.49 -106.06 1.06 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 120.452 1.478 . . . . 10.0 113.965 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.11 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.34 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.28 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.919 0.328 . . . . 10.0 113.919 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.55 -42.78 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.126 1.77 . . . . 10.0 108.725 166.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.4 t -126.29 133.38 24.9 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.419 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.7 153.77 72.6 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.816 3.011 . . . . 10.0 111.469 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.273 1.029 . . . . 10.0 112.251 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.32 -52.42 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.9 -40.52 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.618 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -49.28 -49.77 42.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.574 0.625 . . . . 10.0 111.991 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.07 83.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.086 1.755 . . . . 10.0 113.002 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.36 62.11 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.962 0.905 . . . . 10.0 112.063 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.5 -60.0 3.77 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.364 1.066 . . . . 10.0 109.974 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -52.51 -46.96 66.9 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.004 -1.474 . . . . 10.0 111.934 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.77 -53.03 35.16 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.376 1.898 . . . . 10.0 113.119 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.27 -48.55 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.083 1.353 . . . . 10.0 111.499 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.5 mp -57.48 -50.86 71.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.101 1.36 . . . . 10.0 111.577 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -56.96 -59.69 4.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.71 2.404 . . . . 10.0 111.089 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.481 1.116 0 O-C-N 120.563 -1.336 . . . . 10.0 112.379 -179.767 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.333 0 CA-C-O 120.768 0.093 . . . . 10.0 113.128 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -45.22 -56.21 5.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.448 1.899 . . . . 10.0 111.814 166.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.74 -40.5 71.64 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.327 0.965 . . . . 10.0 113.903 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -70.41 -27.77 64.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 115.843 1.794 . . . . 10.0 115.843 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.587 -0.894 . . . . 10.0 108.587 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.7 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.906 0.882 . . . . 10.0 113.193 -172.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.56 5.25 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.28 0.25 15.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.269 1.028 . . . . 10.0 113.301 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.93 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.078 0.951 . . . . 10.0 111.033 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.63 98.21 1.86 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.758 0.823 . . . . 10.0 110.92 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.04 7.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.866 0.866 . . . . 10.0 112.07 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.474 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.85 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.7 1.2 . . . . 10.0 110.674 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.31 169.51 40.05 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.534 . . . . 10.0 119.647 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.521 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.597 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.554 3.142 . . . . 10.0 117.276 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.64 . . . . 10.0 114.524 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.393 1.877 . . . . 10.0 113.338 -158.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.302 1.841 . . . . 10.0 114.018 -174.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.07 2.79 41.48 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.43 2.443 . . . . 10.0 111.48 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.6 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.649 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.04 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.559 2.307 . . . . 10.0 113.194 -175.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.23 4.31 0.98 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.842 2.457 . . . . 10.0 115.769 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.11 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.493 -0.754 . . . . 10.0 112.669 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.62 83.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.89 0.876 . . . . 10.0 109.272 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.41 -52.63 62.94 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.393 0.677 . . . . 10.0 111.885 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.34 -53.64 55.81 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.231 0.612 . . . . 10.0 112.18 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.77 51.99 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.413 1.485 . . . . 10.0 113.319 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.95 84.74 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.316 1.446 . . . . 10.0 112.998 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.56 -56.28 11.64 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.544 1.069 . . . . 10.0 111.549 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -50.18 -52.3 36.63 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.795 1.238 . . . . 10.0 112.171 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.86 5.8 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.154 0.981 . . . . 10.0 112.143 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.06 -48.9 77.43 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.67 0.788 . . . . 10.0 112.786 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 54.6 mtt -61.27 -44.48 97.17 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.905 0.882 . . . . 10.0 111.363 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.69 13.26 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.326 0.965 . . . . 10.0 113.967 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.22 -45.96 79.7 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.568 1.184 . . . . 10.0 112.131 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.6 -41.96 75.38 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.8 1.19 . . . . 10.0 113.191 173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.9 m -62.46 -58.36 7.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.717 0.807 . . . . 10.0 111.414 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.04 0.936 . . . . 10.0 110.917 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.07 9.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.599 1.16 . . . . 10.0 112.985 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.65 81.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.174 . . . . 10.0 113.585 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.33 40.88 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 123.745 1.736 . . . . 10.0 110.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.79 -44.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.367 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.88 23.09 0.86 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.656 1.023 . . . . 10.0 115.656 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.56 -44.98 93.12 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.178 2.191 . . . . 10.0 113.581 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.58 -84.45 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.787 0.708 . . . . 10.0 112.487 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.01 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.435 2.694 . . . . 10.0 116.933 166.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.64 -50.86 10.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.867 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.52 6.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.765 1.291 . . . . 10.0 110.975 -172.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.64 -29.53 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.702 2.935 . . . . 10.0 113.724 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -60.67 2.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.099 0.56 . . . . 10.0 111.407 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.5 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.097 1.359 . . . . 10.0 113.588 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.46 19.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.26 1.424 . . . . 10.0 113.396 172.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 61.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.459 0.704 . . . . 10.0 110.986 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.91 -50.27 73.05 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.29 65.31 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.321 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.44 -61.93 1.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.52 -57.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.897 1.279 . . . . 10.0 110.562 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 m -67.98 -20.91 65.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.952 1.301 . . . . 10.0 113.488 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.8 m -83.9 -40.68 18.28 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.401 1.08 . . . . 10.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -59.43 -41.87 90.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.393 -0.817 . . . . 10.0 113.182 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.1 t -45.07 -62.74 1.48 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.542 1.137 . . . . 10.0 113.081 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.33 -25.5 30.53 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.842 2.362 . . . . 10.0 113.871 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.41 -46.91 78.14 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.644 1.565 . . . . 10.0 113.188 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.76 -49.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.048 -1.033 . . . . 10.0 109.271 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.11 72.27 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.925 0.89 . . . . 10.0 113.238 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -50.83 -57.21 8.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.812 1.645 . . . . 10.0 111.768 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.49 -53.09 19.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.41 1.484 . . . . 10.0 110.787 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.69 -48.15 64.62 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.008 0.923 . . . . 10.0 113.05 -176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -56.58 -40.73 75.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.185 1.357 . . . . 10.0 113.347 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.58 34.28 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.789 1.177 . . . . 10.0 111.284 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.08 61.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.192 1.553 . . . . 10.0 115.192 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.86 -50.85 61.2 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.458 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.66 -52.63 22.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.873 0.869 . . . . 10.0 112.91 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.54 48.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.328 1.051 . . . . 10.0 113.833 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.69 5.57 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.06 43.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.213 1.561 . . . . 10.0 115.213 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.48 61.33 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.318 0.887 . . . . 10.0 115.318 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.049 2.14 . . . . 10.0 109.034 171.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.53 171.04 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.042 0.937 . . . . 10.0 111.024 166.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.11 53.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.9 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.21 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.474 -1.01 . . . . 10.0 109.474 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.7 164.4 38.18 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.38 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.68 -3.42 0.7 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 118.716 2.247 . . . . 10.0 118.716 170.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.57 -171.86 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.327 1.564 . . . . 10.0 112.223 -165.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.501 1.52 . . . . 10.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.8 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.18 126.34 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.992 1.717 . . . . 10.0 111.671 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.419 1.581 . . . . 10.0 113.087 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.28 -28.32 66.64 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.485 -1.385 . . . . 10.0 113.937 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.14 62.14 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.231 1.196 . . . . 10.0 114.231 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.424 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -65.12 -24.98 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.221 -1.549 . . . . 10.0 113.861 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -75.01 -42.6 57.07 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.577 -1.327 . . . . 10.0 112.189 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.82 -48.41 59.77 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.203 1.401 . . . . 10.0 111.693 167.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.95 -72.3 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.563 1.945 . . . . 10.0 111.819 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.424 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 49.8 m0 -55.43 -32.02 62.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.738 1.215 . . . . 10.0 112.952 -171.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.7 tp -50.66 -41.57 55.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.104 1.361 . . . . 10.0 111.932 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -103.84 -45.08 4.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.873 0.869 . . . . 10.0 112.626 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.7 p -59.51 -38.9 82.17 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.593 1.088 . . . . 10.0 113.373 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.0 m -66.61 -51.65 39.51 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 117.957 -1.021 . . . . 10.0 113.106 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 79.8 Cg_exo -51.56 -40.69 63.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.262 2.641 . . . . 10.0 114.631 171.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.5 mt -59.37 -48.31 82.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.619 0.767 . . . . 10.0 112.225 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.19 -39.45 86.55 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.584 1.084 . . . . 10.0 112.25 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.12 -49.05 74.99 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.081 -1.012 . . . . 10.0 111.348 167.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.29 78.27 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.852 0.861 . . . . 10.0 112.846 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.22 -54.1 35.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.301 0.955 . . . . 10.0 111.201 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.68 38.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.031 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.21 79.37 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.779 0.832 . . . . 10.0 112.669 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.81 -38.46 91.18 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.41 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.025 1.33 . . . . 10.0 112.298 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.873 1.669 . . . . 10.0 112.13 -173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.31 145.88 47.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.929 -1.732 . . . . 10.0 112.455 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.87 54.25 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.72 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.423 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.18 5.33 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.178 1.37 . . . . 10.0 115.276 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.8 p -62.13 -46.72 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.051 -1.452 . . . . 10.0 111.285 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.48 -52.89 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.036 1.334 . . . . 10.0 111.11 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.6 -51.32 67.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.87 42.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.496 0.718 . . . . 10.0 110.932 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.65 -59.85 4.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.354 2.262 . . . . 10.0 114.784 175.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.62 -46.64 73.9 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.573 0.749 . . . . 10.0 113.021 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -59.4 -43.7 92.95 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.847 0.859 . . . . 10.0 112.066 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -57.09 4.58 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.801 1.667 . . . . 10.0 113.123 165.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.1 mt -56.63 -49.81 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.94 0.896 . . . . 10.0 111.177 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -53.38 -58.62 6.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.427 1.012 . . . . 10.0 112.394 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.474 0.736 0 CA-C-N 118.417 0.553 . . . . 10.0 111.223 177.985 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 111.627 0.232 . . . . 10.0 111.627 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.02 -59.68 9.1 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.054 1.787 . . . . 10.0 112.541 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.09 3.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.181 2.592 . . . . 10.0 113.298 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.9 mt -100.83 -6.9 24.17 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.477 1.658 . . . . 10.0 115.477 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.182 -1.574 . . . . 10.0 110.409 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.619 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.52 -49.61 72.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.26 2.624 . . . . 10.0 113.239 177.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.58 106.29 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.783 0.833 . . . . 10.0 110.088 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.065 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.06 15.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.458 1.503 . . . . 10.0 113.49 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.65 63.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.884 1.439 . . . . 10.0 114.884 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.05 -41.38 68.04 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.902 0.774 . . . . 10.0 110.891 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -70.13 -31.26 68.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.837 1.255 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.49 -52.25 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.057 0.844 . . . . 10.0 109.629 168.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.26 -46.14 90.85 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.462 0.912 . . . . 10.0 113.462 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -50.95 -48.53 60.9 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.763 1.165 . . . . 10.0 113.213 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.87 -53.94 52.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.78 0.832 . . . . 10.0 111.79 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.72 -53.31 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.091 1.356 . . . . 10.0 111.859 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.6 p -58.67 -44.17 90.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.809 0.844 . . . . 10.0 112.697 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.66 -43.3 97.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.346 1.058 . . . . 10.0 112.346 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.1 78.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.295 0.952 . . . . 10.0 112.449 171.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.49 80.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.864 0.865 . . . . 10.0 112.524 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 35.8 ttp -55.74 -53.46 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.388 1.075 . . . . 10.0 112.024 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.74 -47.96 73.18 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.432 1.493 . . . . 10.0 112.446 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.6 -54.14 19.97 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 10.0 112.062 170.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.07 -54.86 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.593 0.757 . . . . 10.0 110.897 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.48 -36.45 69.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.441 -0.79 . . . . 10.0 113.116 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.35 -58.1 9.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.984 0.913 . . . . 10.0 113.077 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.93 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.344 -0.836 . . . . 10.0 111.461 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.77 -49.41 75.39 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.858 1.208 . . . . 10.0 112.163 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.908 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.9 60.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.624 1.169 . . . . 10.0 113.494 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.86 -79.03 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.601 0.619 . . . . 10.0 113.519 171.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.46 51.49 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.268 1.827 . . . . 10.0 113.067 -166.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.06 -56.45 14.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.022 1.119 . . . . 10.0 114.022 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.72 -50.5 65.79 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.06 0.934 . . . . 10.0 112.302 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.18 -45.98 83.23 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.197 0.999 . . . . 10.0 112.114 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.43 80.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.28 1.23 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.091 1.756 . . . . 10.0 114.194 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.11 6.66 29.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.374 1.87 . . . . 10.0 114.846 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.91 -92.64 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.522 1.63 . . . . 10.0 114.193 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.71 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 129.794 3.238 . . . . 10.0 105.571 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.19 35.55 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.263 1.976 . . . . 10.0 113.032 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.9 -46.13 67.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.04 2.936 . . . . 10.0 113.284 173.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.21 -52.95 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.17 -46.85 75.79 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.251 0.62 . . . . 10.0 111.9 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.19 24.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.9 m -57.19 -53.24 60.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 112.995 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.54 -49.56 45.62 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.292 0.637 . . . . 10.0 111.097 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.57 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.832 0.742 . . . . 10.0 110.54 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.56 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.87 30.11 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.839 2.056 . . . . 10.0 111.038 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.46 -58.35 8.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.769 0.428 . . . . 10.0 111.269 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.8 -48.73 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.116 0.967 . . . . 10.0 111.546 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.9 m -57.05 -63.99 1.03 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.056 2.542 . . . . 10.0 111.863 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.64 -49.15 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.847 1.259 . . . . 10.0 111.235 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.65 -62.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.89 0.876 . . . . 10.0 112.494 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.23 -45.26 84.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.748 0.704 . . . . 10.0 111.976 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -51.78 -53.08 43.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.929 0.892 . . . . 10.0 112.383 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 124.341 1.057 . . . . 10.0 113.65 -179.741 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 118.831 -0.605 . . . . 10.0 112.621 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -59.79 -54.9 40.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.529 1.132 . . . . 10.0 112.184 167.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.3 tp -52.9 -43.82 66.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.882 1.273 . . . . 10.0 112.254 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.75 -4.9 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 115.453 1.649 . . . . 10.0 115.453 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.45 -169.28 32.91 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.521 1.067 . . . . 10.0 113.898 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.23 -41.67 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.838 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.9 -14.16 62.87 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.364 1.616 . . . . 10.0 115.364 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.14 -106.14 1.02 Allowed Glycine 0 CA--C 1.535 1.284 0 CA-C-N 120.523 1.51 . . . . 10.0 114.218 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.08 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.666 -1.49 . . . . 10.0 109.314 168.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.38 65.31 1.34 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.7 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.36 24.89 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.66 153.8 72.64 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.814 3.009 . . . . 10.0 111.456 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.22 -39.77 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.193 171.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.34 -52.36 21.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.98 -40.45 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.429 1.092 . . . . 10.0 109.617 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.35 -49.76 42.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.603 0.638 . . . . 10.0 111.952 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.7 -47.06 83.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.004 1.721 . . . . 10.0 112.979 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.32 -52.32 62.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.957 0.903 . . . . 10.0 112.1 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.53 -58.93 5.2 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.362 1.065 . . . . 10.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.99 -47.21 65.0 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.641 -1.171 . . . . 10.0 112.359 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.52 -52.11 56.3 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.57 1.532 . . . . 10.0 112.846 175.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.91 -47.97 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.51 1.124 . . . . 10.0 111.189 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.9 mp -57.94 -51.33 70.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.74 1.616 . . . . 10.0 112.159 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -54.46 -56.01 23.05 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.292 2.237 . . . . 10.0 111.309 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.476 0.869 0 O-C-N 121.582 -0.699 . . . . 10.0 111.233 175.59 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.281 0 N-CA-C 112.602 -0.199 . . . . 10.0 112.602 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.7 -56.88 2.49 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.816 2.046 . . . . 10.0 112.554 166.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.48 -41.41 88.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.785 1.184 . . . . 10.0 114.256 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -69.31 -27.23 65.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 115.609 1.707 . . . . 10.0 115.609 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.2 -57.58 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 165.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.67 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.92 0.888 . . . . 10.0 113.167 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.54 5.21 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.324 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.09 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.028 0.931 . . . . 10.0 111.014 174.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.56 98.21 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.781 0.832 . . . . 10.0 110.949 170.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.95 76.99 7.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.908 0.883 . . . . 10.0 112.093 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.07 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 128.888 2.875 . . . . 10.0 116.499 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.87 -55.47 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.641 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.48 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.676 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.495 0 C-N-CA 128.527 2.731 . . . . 10.0 113.461 166.594 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.808 -2.044 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.657 3.183 . . . . 10.0 117.239 160.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.0 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.297 2.639 . . . . 10.0 114.49 155.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.427 1.891 . . . . 10.0 113.339 -158.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 114.015 -174.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.83 40.9 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.675 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.02 -60.65 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.502 2.286 . . . . 10.0 113.202 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.11 4.28 0.94 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.787 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.509 -0.744 . . . . 10.0 112.625 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.898 0.879 . . . . 10.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.537 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.42 -52.64 62.91 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.455 0.702 . . . . 10.0 111.84 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.39 -53.58 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.205 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.77 52.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.332 1.453 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.98 84.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.354 1.462 . . . . 10.0 112.997 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.66 -56.86 10.43 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.32 0.962 . . . . 10.0 111.3 165.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.47 -52.29 30.12 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.615 1.166 . . . . 10.0 112.199 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.92 5.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.159 0.984 . . . . 10.0 112.139 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -57.68 -50.31 73.6 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.599 0.76 . . . . 10.0 112.604 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -49.99 68.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.252 1.021 . . . . 10.0 111.071 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.92 -58.18 15.95 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.407 1.003 . . . . 10.0 113.673 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.19 -45.69 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.511 1.155 . . . . 10.0 112.086 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.7 -42.08 76.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.88 1.229 . . . . 10.0 113.302 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -60.51 -60.36 3.93 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.046 0.938 . . . . 10.0 111.071 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.97 62.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.0 9.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 113.004 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.71 -38.61 82.09 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.1 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.66 1.184 . . . . 10.0 113.628 169.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.759 1.742 . . . . 10.0 110.852 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.88 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.869 2.468 . . . . 10.0 109.286 171.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.12 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.594 0.998 . . . . 10.0 115.594 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.0 92.89 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.163 2.185 . . . . 10.0 113.605 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.43 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.742 0.687 . . . . 10.0 112.407 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.962 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.84 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.904 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.811 1.32 . . . . 10.0 110.972 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.54 -29.67 89.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.719 2.946 . . . . 10.0 113.716 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.23 -60.75 2.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.133 0.573 . . . . 10.0 111.441 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.07 -40.08 22.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.126 1.37 . . . . 10.0 113.58 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.59 -47.39 19.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.444 172.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.06 62.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.48 0.712 . . . . 10.0 110.955 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.97 -50.24 73.26 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.137 0.575 . . . . 10.0 112.313 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.22 65.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.868 -0.586 . . . . 10.0 112.362 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.77 -57.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.867 1.267 . . . . 10.0 110.329 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -69.27 -16.25 63.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.14 1.376 . . . . 10.0 113.69 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.1 m -87.87 -42.99 12.14 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.779 1.172 . . . . 10.0 111.96 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -56.56 -41.6 77.17 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 173.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -49.46 -61.61 3.31 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.804 1.242 . . . . 10.0 112.595 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.64 -47.62 20.14 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.593 3.529 . . . . 10.0 116.115 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.1 93.62 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.938 1.245 . . . . 10.0 113.966 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.9 mt -58.57 -51.76 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.398 1.079 . . . . 10.0 109.525 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -43.04 71.76 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 10.0 113.246 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -52.69 -57.95 8.42 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.131 1.332 . . . . 10.0 111.912 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -48.33 -52.89 19.48 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.57 1.548 . . . . 10.0 110.967 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.89 -48.12 64.16 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.916 0.886 . . . . 10.0 113.029 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -55.85 -41.44 74.31 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.27 1.395 . . . . 10.0 113.225 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.54 34.8 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.719 1.145 . . . . 10.0 111.292 170.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.23 1.567 . . . . 10.0 115.23 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.88 -50.82 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.519 0.728 . . . . 10.0 110.528 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.57 -52.69 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.835 0.854 . . . . 10.0 112.922 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.96 -5.53 48.97 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.65 5.6 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.527 0.971 . . . . 10.0 115.527 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.1 42.74 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.63 61.1 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.351 0.9 . . . . 10.0 115.351 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.35 26.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.034 2.133 . . . . 10.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.052 166.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.717 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.6 129.58 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.72 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.664 2.226 . . . . 10.0 118.664 170.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.343 1.571 . . . . 10.0 112.237 -165.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.85 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.096 -175.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.2 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.09 126.33 22.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.028 1.731 . . . . 10.0 111.682 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.61 85.06 4.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.384 1.564 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.42 -28.26 66.77 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.523 -1.361 . . . . 10.0 113.926 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.38 62.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -64.89 -24.45 67.54 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.232 -1.543 . . . . 10.0 113.876 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -75.87 -42.93 47.9 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.462 -1.399 . . . . 10.0 112.257 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.88 53.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.064 1.346 . . . . 10.0 111.368 168.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -52.41 -71.09 0.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.715 2.006 . . . . 10.0 111.836 168.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -56.17 -32.74 64.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.644 1.178 . . . . 10.0 113.153 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.88 -39.74 54.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.389 1.475 . . . . 10.0 112.084 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.72 -41.41 5.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.549 0.739 . . . . 10.0 112.95 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 p -59.31 -41.1 88.24 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 120.792 1.633 . . . . 10.0 113.347 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.402 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.6 m -68.47 -47.5 35.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 84.9 Cg_exo -53.99 -41.47 74.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.574 2.849 . . . . 10.0 114.872 168.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -47.66 85.08 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.586 0.755 . . . . 10.0 111.728 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.7 tt -50.47 -49.61 54.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 10.0 111.548 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.18 -47.83 77.53 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.129 -0.982 . . . . 10.0 112.848 170.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.26 78.42 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.829 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.27 -54.03 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.343 0.974 . . . . 10.0 111.165 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -42.09 88.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.641 0.776 . . . . 10.0 112.093 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.81 36.63 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.996 0.918 . . . . 10.0 112.021 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.1 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.875 1.67 . . . . 10.0 112.106 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.938 -1.726 . . . . 10.0 112.437 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.55 135.96 54.46 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.9 -39.66 2.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.474 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.18 5.36 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.15 1.357 . . . . 10.0 115.266 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -46.75 87.76 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.123 -1.418 . . . . 10.0 111.351 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.038 1.335 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.58 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.534 0.568 . . . . 10.0 112.534 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.86 43.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.716 . . . . 10.0 110.911 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.64 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.382 2.273 . . . . 10.0 114.814 174.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.04 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.647 0.779 . . . . 10.0 111.403 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.67 -46.76 74.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.24 0.83 . . . . 10.0 113.24 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.64 -44.11 89.94 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 10.0 112.217 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.87 -56.23 5.2 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.33 1.443 . . . . 10.0 113.072 166.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 90.0 mt -56.81 -51.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.674 0.789 . . . . 10.0 111.55 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -52.1 -57.61 9.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.268 1.027 . . . . 10.0 112.185 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 122.776 0.43 . . . . 10.0 111.81 177.621 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 110.328 -0.249 . . . . 10.0 110.328 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.39 -60.9 6.34 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.099 1.809 . . . . 10.0 112.704 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -44.22 -41.12 5.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.245 2.218 . . . . 10.0 113.585 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.26 -6.7 25.58 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.444 1.646 . . . . 10.0 115.444 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.74 116.75 10.49 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.375 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.58 72.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.66 106.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.043 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.62 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -53.99 -41.66 68.15 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.89 0.768 . . . . 10.0 110.807 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.78 -31.59 69.6 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.318 1.229 . . . . 10.0 114.318 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.22 -51.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.976 0.807 . . . . 10.0 109.636 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -61.92 -42.8 99.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.423 1.268 . . . . 10.0 114.423 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.65 -48.85 69.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.237 1.015 . . . . 10.0 112.758 171.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.24 70.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.534 0.734 . . . . 10.0 111.614 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.16 -55.03 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.079 1.352 . . . . 10.0 111.974 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.1 p -57.2 -40.83 78.21 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.432 -0.792 . . . . 10.0 112.706 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.4 m -61.92 -44.84 95.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.756 1.223 . . . . 10.0 112.326 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.6 80.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.314 0.961 . . . . 10.0 112.251 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.95 85.51 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.503 -0.748 . . . . 10.0 112.816 173.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.272 1.029 . . . . 10.0 112.26 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.88 -45.81 78.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.831 1.652 . . . . 10.0 112.231 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -54.81 -53.93 48.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 171.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 44.1 mt -54.21 -54.75 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.716 0.689 . . . . 10.0 110.856 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.27 1.0 OUTLIER -60.02 -32.71 71.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 117.467 -1.254 . . . . 10.0 112.904 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.25 -58.13 9.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.987 1.267 . . . . 10.0 113.071 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -40.89 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.312 -0.851 . . . . 10.0 111.446 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.78 -49.41 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.847 1.203 . . . . 10.0 112.145 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.05 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.046 -1.659 . . . . 10.0 112.833 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -73.79 -21.9 60.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.626 1.17 . . . . 10.0 113.398 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.588 0.614 . . . . 10.0 113.488 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.63 -32.45 51.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.62 -50.58 65.39 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.067 0.937 . . . . 10.0 112.286 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.17 -45.98 83.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.105 0.962 . . . . 10.0 112.15 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.46 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.506 1.299 . . . . 10.0 114.506 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.46 -11.34 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.078 1.751 . . . . 10.0 114.238 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.57 29.14 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.85 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.456 1.598 . . . . 10.0 114.171 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.77 153.88 72.49 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.834 3.254 . . . . 10.0 105.57 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.8 -46.21 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.329 2.019 . . . . 10.0 113.083 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.03 68.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.985 2.914 . . . . 10.0 113.27 173.575 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.19 -53.03 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.78 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.26 23.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.12 -53.23 60.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.164 0.986 . . . . 10.0 113.028 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.54 46.07 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.337 0.655 . . . . 10.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.06 -48.46 78.5 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.02 -49.61 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.767 0.712 . . . . 10.0 110.487 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.48 -51.69 68.77 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.74 30.88 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.818 2.047 . . . . 10.0 111.065 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.81 0.444 . . . . 10.0 111.269 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.99 -47.42 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.046 0.938 . . . . 10.0 112.238 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.9 m -58.19 -64.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.953 2.501 . . . . 10.0 111.482 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.27 -48.64 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.845 1.258 . . . . 10.0 111.373 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.27 -61.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.863 0.865 . . . . 10.0 112.606 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.19 -47.06 79.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.754 0.706 . . . . 10.0 111.934 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -50.11 -54.29 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.645 1.178 . . . . 10.0 112.149 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 m . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 124.509 1.123 . . . . 10.0 113.588 179.731 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.4 -56.63 19.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.544 1.138 . . . . 10.0 112.404 167.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.4 tt -57.59 -40.46 79.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.755 0.822 . . . . 10.0 112.355 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.18 -5.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 115.2 1.555 . . . . 10.0 115.2 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.35 32.95 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.573 1.096 . . . . 10.0 113.895 -168.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.93 65.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.176 -1.012 . . . . 10.0 111.88 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.88 -13.45 62.43 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.75 -106.13 0.98 Allowed Glycine 0 CA--C 1.535 1.311 0 CA-C-N 120.606 1.548 . . . . 10.0 114.45 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.12 35.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.595 -1.533 . . . . 10.0 109.368 168.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.904 0.321 . . . . 10.0 113.904 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.64 -42.7 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.687 166.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.34 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.382 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.69 153.79 72.59 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.774 2.983 . . . . 10.0 111.476 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.8 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.38 1.072 . . . . 10.0 112.169 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.43 -52.34 22.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.49 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.695 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.35 -49.78 42.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.515 0.598 . . . . 10.0 111.925 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.38 -52.26 62.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.923 0.889 . . . . 10.0 112.124 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.6 -58.82 5.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.319 1.048 . . . . 10.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -52.55 -46.14 66.68 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 117.629 -1.176 . . . . 10.0 112.506 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.01 -51.89 60.21 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.55 1.523 . . . . 10.0 112.789 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.68 -47.0 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.81 1.244 . . . . 10.0 111.598 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.73 -50.04 75.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 10.0 111.795 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -57.15 -57.4 12.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.879 2.072 . . . . 10.0 111.508 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.479 0.985 0 O-C-N 120.887 -1.133 . . . . 10.0 111.917 178.92 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 CA-C-O 121.129 0.294 . . . . 10.0 112.904 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -43.09 -56.91 3.14 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.999 2.12 . . . . 10.0 112.266 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.7 -40.43 71.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.303 0.954 . . . . 10.0 114.186 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -69.75 -27.32 64.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 115.882 1.808 . . . . 10.0 115.882 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -57.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.593 -0.892 . . . . 10.0 108.593 165.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.76 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.898 . . . . 10.0 113.193 -172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.17 2.53 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.23 0.3 15.74 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.22 1.008 . . . . 10.0 113.344 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.046 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.61 98.12 1.83 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.826 0.85 . . . . 10.0 110.941 170.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 77.04 7.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.824 0.85 . . . . 10.0 112.067 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.838 2.855 . . . . 10.0 116.491 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.738 1.215 . . . . 10.0 110.656 -175.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.44 39.92 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.757 3.551 . . . . 10.0 119.665 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.487 2.715 . . . . 10.0 113.44 166.597 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.75 -2.072 . . . . 10.0 105.863 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.62 65.01 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.252 2.621 . . . . 10.0 114.537 155.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.97 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.344 1.857 . . . . 10.0 113.339 -158.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.08 2.8 41.62 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.489 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.653 -168.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.92 -60.7 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.522 2.293 . . . . 10.0 113.196 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.19 4.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.726 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.29 -43.14 61.56 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.515 -0.741 . . . . 10.0 112.619 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.59 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.331 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.43 -52.63 62.96 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.455 0.702 . . . . 10.0 111.882 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.341 1.456 . . . . 10.0 113.315 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.12 -55.44 15.52 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.501 1.048 . . . . 10.0 111.801 166.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -50.26 -52.48 35.85 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.834 1.253 . . . . 10.0 112.284 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.87 5.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.16 0.984 . . . . 10.0 112.167 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.1 -48.86 77.57 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.615 0.766 . . . . 10.0 112.858 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -61.59 -43.94 97.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.649 0.78 . . . . 10.0 111.531 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.59 -58.75 12.93 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.145 0.879 . . . . 10.0 113.785 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -45.99 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.605 1.202 . . . . 10.0 112.119 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.08 -42.88 72.68 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.028 1.299 . . . . 10.0 113.132 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -62.1 -58.23 8.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.285 -0.864 . . . . 10.0 111.489 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.33 -40.99 62.62 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.041 0.936 . . . . 10.0 110.937 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.02 9.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.636 1.175 . . . . 10.0 112.968 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.71 82.15 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.45 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.632 1.173 . . . . 10.0 113.633 169.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.743 1.735 . . . . 10.0 110.88 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.9 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.839 2.455 . . . . 10.0 109.358 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.94 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.02 93.01 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.196 2.198 . . . . 10.0 113.546 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.39 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.437 2.695 . . . . 10.0 116.948 166.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.8 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.18 -1.373 . . . . 10.0 113.868 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.51 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.769 1.293 . . . . 10.0 110.981 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.55 -29.67 89.57 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.706 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.28 -60.69 2.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.111 0.565 . . . . 10.0 111.437 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.1 22.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.1 1.36 . . . . 10.0 113.549 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.44 19.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.199 1.4 . . . . 10.0 113.446 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.71 -53.07 62.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.48 0.712 . . . . 10.0 110.967 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.0 -50.22 73.37 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.297 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.2 65.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.34 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.99 1.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.8 mt -48.53 -57.93 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.865 1.266 . . . . 10.0 110.332 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -67.92 -19.03 64.95 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.105 1.362 . . . . 10.0 113.703 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -86.0 -40.87 15.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.45 1.1 . . . . 10.0 112.22 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.8 mt -59.17 -42.61 91.21 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.915 0.78 . . . . 10.0 112.921 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.9 t -44.03 -61.19 2.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.67 1.588 . . . . 10.0 113.154 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -70.74 -25.42 24.09 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.895 2.396 . . . . 10.0 114.041 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.11 -50.13 67.26 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 120.732 1.605 . . . . 10.0 113.795 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.28 -39.05 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 120.329 -1.482 . . . . 10.0 110.735 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.26 81.18 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 118.54 -0.743 . . . . 10.0 112.96 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -50.58 -55.71 15.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.581 1.553 . . . . 10.0 111.755 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.08 -53.19 21.58 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.363 1.465 . . . . 10.0 110.867 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.35 -48.19 65.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.102 0.961 . . . . 10.0 113.011 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.4 -41.1 75.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.241 1.382 . . . . 10.0 113.222 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.53 35.06 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.656 1.116 . . . . 10.0 111.313 170.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.15 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.9 mtm -66.78 -50.88 61.25 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.565 0.746 . . . . 10.0 110.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.54 -52.71 21.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 10.0 112.925 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.58 49.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.27 -34.66 5.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 115.542 0.977 . . . . 10.0 115.542 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.12 43.3 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.56 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.081 2.153 . . . . 10.0 109.056 171.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.062 166.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.883 0.873 . . . . 10.0 109.723 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.3 t -129.61 129.6 23.17 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.037 1.335 . . . . 10.0 110.927 -176.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.78 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -81.96 0.15 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.697 -0.961 . . . . 10.0 110.697 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.91 4.07 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.317 1.558 . . . . 10.0 112.27 -165.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.47 1.508 . . . . 10.0 111.107 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.46 120.76 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.52 131.92 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.198 3.265 . . . . 10.0 112.137 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.03 1.732 . . . . 10.0 111.69 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.04 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.865 1.317 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.4 -28.28 66.77 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.77 -26.47 46.07 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.296 1.038 . . . . 10.0 111.165 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -44.08 -63.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.374 1.47 . . . . 10.0 110.146 165.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -63.62 -39.73 95.1 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.223 2.209 . . . . 10.0 111.119 -172.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.26 -49.03 67.76 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.733 0.813 . . . . 10.0 112.024 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -63.67 1.21 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.96 1.304 . . . . 10.0 111.64 170.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -53.7 -36.95 62.75 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.805 1.642 . . . . 10.0 112.72 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.69 -42.17 56.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.036 1.734 . . . . 10.0 112.226 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -103.68 -35.29 8.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.932 0.716 . . . . 10.0 112.932 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.5 p -62.17 -49.04 77.42 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 121.387 1.903 . . . . 10.0 113.483 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.284 69.9 p -63.54 -41.73 68.4 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 114.722 1.379 . . . . 10.0 114.722 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.8 -43.24 51.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.481 2.787 . . . . 10.0 115.265 168.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 mt -60.62 -46.9 88.53 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.491 -0.756 . . . . 10.0 111.515 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.68 -49.83 56.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.646 1.578 . . . . 10.0 111.359 171.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.65 -47.46 79.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.247 1.019 . . . . 10.0 113.046 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.854 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.31 -54.01 36.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.173 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.11 88.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.69 0.796 . . . . 10.0 112.068 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.69 -54.75 37.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 111.974 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.725 0.81 . . . . 10.0 112.704 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.82 -38.56 91.57 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.78 1.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.062 1.345 . . . . 10.0 112.337 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.49 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.88 47.66 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.454 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.84 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.714 0.635 . . . . 10.0 112.714 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.8 -39.68 2.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.24 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.131 1.348 . . . . 10.0 115.235 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.06 -46.77 87.69 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.13 -1.414 . . . . 10.0 111.312 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.5 -52.91 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.029 1.332 . . . . 10.0 111.101 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.27 67.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.23 -44.85 43.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.424 0.69 . . . . 10.0 110.924 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.55 -59.88 4.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.419 2.288 . . . . 10.0 114.815 174.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.08 -46.29 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.667 0.787 . . . . 10.0 111.385 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.67 74.42 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 173.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.0 -45.99 82.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.851 0.86 . . . . 10.0 111.994 174.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -55.38 5.49 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.362 1.458 . . . . 10.0 113.142 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.73 -50.15 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.902 0.881 . . . . 10.0 111.74 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -50.99 -57.13 9.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.589 1.556 . . . . 10.0 111.873 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 123.121 0.568 . . . . 10.0 112.488 174.795 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 111.764 0.283 . . . . 10.0 111.764 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.55 -58.99 9.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.085 1.803 . . . . 10.0 112.338 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.49 -43.48 2.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.251 2.62 . . . . 10.0 113.294 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.3 mt -101.2 -6.4 24.3 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.423 1.638 . . . . 10.0 115.423 -174.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.67 116.73 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.165 -1.584 . . . . 10.0 110.419 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.59 72.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.217 2.607 . . . . 10.0 113.269 177.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.61 106.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.09 15.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 10.0 113.468 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.66 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -53.84 -41.91 67.92 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.902 0.774 . . . . 10.0 110.806 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.21 -32.57 71.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.817 1.247 . . . . 10.0 114.198 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.91 -52.12 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.022 0.828 . . . . 10.0 109.991 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -59.45 -51.76 68.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.491 0.922 . . . . 10.0 113.491 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.38 -46.59 37.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.428 1.091 . . . . 10.0 113.427 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.38 -52.55 65.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.945 0.898 . . . . 10.0 111.659 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.4 mt -54.07 -50.98 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.126 1.37 . . . . 10.0 111.49 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 m -53.84 -49.19 68.96 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.479 1.112 . . . . 10.0 112.108 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 76.5 m -61.34 -43.34 99.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.992 1.317 . . . . 10.0 111.618 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.45 -50.16 73.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.14 0.976 . . . . 10.0 112.477 170.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.87 82.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.736 0.814 . . . . 10.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.1 ttp -57.94 -53.13 61.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.496 1.118 . . . . 10.0 111.953 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -51.92 -50.01 61.95 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.772 1.629 . . . . 10.0 111.398 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -49.51 -54.89 15.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.06 0.944 . . . . 10.0 112.436 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -53.4 -55.29 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.829 0.852 . . . . 10.0 110.729 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.5 mt -57.49 -35.65 70.48 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.283 -0.865 . . . . 10.0 112.91 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.18 9.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.89 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.5 mt -56.77 -49.45 75.27 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.845 1.202 . . . . 10.0 112.099 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.877 -175.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.65 -21.99 60.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.635 1.174 . . . . 10.0 113.446 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.625 0.631 . . . . 10.0 113.527 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.55 -32.52 51.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.322 1.849 . . . . 10.0 113.019 -166.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.11 -56.4 14.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.56 65.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.121 0.962 . . . . 10.0 112.331 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.07 82.87 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.188 0.995 . . . . 10.0 112.134 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.77 -47.52 79.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.249 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.01 6.58 29.19 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.433 1.893 . . . . 10.0 114.907 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.65 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.535 1.636 . . . . 10.0 114.139 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.73 153.98 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.81 3.244 . . . . 10.0 105.572 170.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.85 -46.21 35.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.301 2.001 . . . . 10.0 113.052 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.96 -46.08 68.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.27 173.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.22 -53.05 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 C-N-CA 124.055 0.942 . . . . 10.0 109.788 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.86 75.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.275 0.63 . . . . 10.0 111.917 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.98 -56.13 25.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.88 0.872 . . . . 10.0 112.761 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.028 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.58 -49.52 46.19 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.337 0.655 . . . . 10.0 111.052 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.17 -48.4 78.82 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.636 1.347 . . . . 10.0 114.636 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.801 0.728 . . . . 10.0 110.506 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.164 0.801 . . . . 10.0 113.164 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.8 30.26 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.1 t -51.9 -49.1 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.044 0.937 . . . . 10.0 111.472 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.4 m -56.01 -63.95 1.01 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.62 2.768 . . . . 10.0 111.921 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.31 -49.51 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.488 1.115 . . . . 10.0 111.313 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.7 -62.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.172 0.989 . . . . 10.0 112.063 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.51 -47.17 85.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.974 0.806 . . . . 10.0 112.612 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -55.01 -50.31 69.35 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.683 0.793 . . . . 10.0 111.752 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.902 1.075 . . . . 10.0 113.902 179.256 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 119.43 -0.319 . . . . 10.0 111.596 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -56.39 -51.01 69.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.46 1.104 . . . . 10.0 112.53 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.2 tp -54.44 -45.53 73.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.59 1.156 . . . . 10.0 112.22 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -86.54 -5.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.15 1.537 . . . . 10.0 115.15 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.54 -169.29 32.79 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 122.602 1.112 . . . . 10.0 113.806 -168.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.75 65.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.868 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -67.29 -16.13 64.1 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.487 1.662 . . . . 10.0 115.487 -175.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.77 -105.99 1.04 Allowed Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.494 1.497 . . . . 10.0 114.104 -173.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.11 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.35 168.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 CA-C-N 117.878 0.308 . . . . 10.0 113.862 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.59 -42.73 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.73 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.1 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.416 1.886 . . . . 10.0 109.366 -174.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.79 153.79 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.19 -39.78 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.18 171.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.34 -52.38 21.9 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.682 1.364 . . . . 10.0 114.682 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.27 -49.83 41.77 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.603 0.638 . . . . 10.0 111.991 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.66 -47.06 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.999 1.72 . . . . 10.0 113.026 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.32 -52.29 62.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.974 0.91 . . . . 10.0 112.093 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.61 -59.0 4.99 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 109.975 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.83 -44.65 66.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.793 -1.098 . . . . 10.0 112.657 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -54.16 -52.64 60.51 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.579 1.536 . . . . 10.0 112.689 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.2 t -60.86 -46.26 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.69 1.196 . . . . 10.0 111.353 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -59.15 -52.44 65.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.364 1.466 . . . . 10.0 112.122 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -55.46 -54.64 41.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.507 1.923 . . . . 10.0 111.062 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.478 0.945 0 O-C-N 121.071 -1.018 . . . . 10.0 111.635 174.07 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.267 0 CA-C-O 121.036 0.242 . . . . 10.0 112.758 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -43.47 -57.08 3.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.79 2.036 . . . . 10.0 112.488 166.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.98 -41.26 76.54 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.326 0.965 . . . . 10.0 113.993 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.79 -26.99 64.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.911 1.819 . . . . 10.0 115.911 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.5 -57.47 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.88 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.908 0.883 . . . . 10.0 113.187 -172.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.15 2.56 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.197 0.999 . . . . 10.0 113.296 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.05 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.983 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.13 1.82 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.771 0.828 . . . . 10.0 110.961 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 76.97 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.857 0.863 . . . . 10.0 112.094 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.862 2.865 . . . . 10.0 116.505 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.79 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.731 1.212 . . . . 10.0 110.698 -175.224 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.49 39.98 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.591 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.789 -2.053 . . . . 10.0 105.817 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.638 3.175 . . . . 10.0 117.211 160.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.69 65.0 0.11 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.306 2.642 . . . . 10.0 114.49 155.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.84 41.28 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.483 2.468 . . . . 10.0 111.523 168.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.667 -168.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -64.0 -60.6 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.519 2.292 . . . . 10.0 113.212 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.33 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.847 2.459 . . . . 10.0 115.787 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.46 -0.775 . . . . 10.0 112.619 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.57 84.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.859 0.863 . . . . 10.0 109.315 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.37 -52.66 62.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.426 0.69 . . . . 10.0 111.898 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.34 -53.64 55.84 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.221 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.81 51.95 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.366 1.466 . . . . 10.0 113.307 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -45.0 84.75 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 10.0 113.026 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.41 -56.69 10.41 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.526 1.06 . . . . 10.0 111.465 166.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -49.7 -52.48 30.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.836 1.255 . . . . 10.0 112.19 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 -58.9 5.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.174 0.99 . . . . 10.0 112.207 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.31 -48.46 78.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.577 0.751 . . . . 10.0 112.825 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.418 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 52.0 mtt -58.89 -47.46 84.88 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.223 1.009 . . . . 10.0 111.523 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.85 -58.76 12.88 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.267 0.937 . . . . 10.0 113.66 174.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.18 -46.06 79.52 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.728 1.264 . . . . 10.0 112.1 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.33 75.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.76 1.172 . . . . 10.0 113.244 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -61.93 -58.49 7.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.742 0.817 . . . . 10.0 111.419 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.97 62.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.8 -58.07 9.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.986 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.63 81.86 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.236 0.828 . . . . 10.0 113.236 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.46 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.654 1.182 . . . . 10.0 113.581 169.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.44 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.781 1.753 . . . . 10.0 110.846 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.83 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.906 2.483 . . . . 10.0 109.366 171.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.98 93.05 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.143 2.177 . . . . 10.0 113.584 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.37 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.387 2.675 . . . . 10.0 116.975 166.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.65 -50.87 10.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.891 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.94 117.59 6.51 Favored Pre-proline 0 CA--C 1.536 0.432 0 O-C-N 124.741 1.275 . . . . 10.0 110.916 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.67 -29.6 89.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.695 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.04 22.82 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.114 1.366 . . . . 10.0 113.551 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.6 -47.44 19.94 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.242 1.417 . . . . 10.0 113.384 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.08 62.22 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.535 0.734 . . . . 10.0 110.935 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.02 -50.21 73.43 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.115 0.566 . . . . 10.0 112.348 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.26 65.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.903 -0.57 . . . . 10.0 112.378 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.01 1.91 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.412 0.893 . . . . 10.0 113.412 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.53 -58.07 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.918 1.287 . . . . 10.0 110.121 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 m -68.16 -16.99 64.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.297 1.439 . . . . 10.0 113.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -88.35 -39.78 14.08 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.571 1.078 . . . . 10.0 112.146 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -59.8 -42.18 92.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.939 0.791 . . . . 10.0 112.372 170.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -41.44 -60.7 1.69 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 126.094 1.758 . . . . 10.0 113.807 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.98 -25.67 16.07 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.158 2.572 . . . . 10.0 114.372 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.7 -45.07 84.2 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.674 1.579 . . . . 10.0 113.502 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -54.02 -52.81 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.01 0.924 . . . . 10.0 109.447 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.418 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -54.19 -45.9 72.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.465 1.106 . . . . 10.0 113.428 177.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -51.1 -57.58 8.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.058 1.343 . . . . 10.0 112.15 171.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 m -49.36 -52.63 26.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.302 1.441 . . . . 10.0 110.699 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.5 mmt -69.14 -48.13 63.2 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.895 0.878 . . . . 10.0 113.044 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -57.09 -39.95 76.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.927 -1.511 . . . . 10.0 113.218 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.35 -54.56 34.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.266 1.394 . . . . 10.0 111.281 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.64 -41.13 61.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.197 1.555 . . . . 10.0 115.197 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.85 -50.78 61.47 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.545 0.738 . . . . 10.0 110.511 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.64 -52.67 21.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.864 0.865 . . . . 10.0 112.908 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.91 -5.54 48.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.343 1.057 . . . . 10.0 113.835 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.544 0.978 . . . . 10.0 115.544 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.246 1.572 . . . . 10.0 115.246 -175.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.57 61.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.39 26.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.049 2.14 . . . . 10.0 109.041 171.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.1 15.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.004 166.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.02 53.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.703 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.52 129.6 23.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 125.048 1.339 . . . . 10.0 110.995 -176.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.74 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.469 -1.012 . . . . 10.0 109.469 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.48 38.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.31 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.735 -0.946 . . . . 10.0 110.735 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.83 -3.35 0.69 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 118.656 2.223 . . . . 10.0 118.656 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.317 1.559 . . . . 10.0 112.21 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.85 9.04 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.491 1.516 . . . . 10.0 111.137 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.54 131.95 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.23 3.287 . . . . 10.0 112.145 171.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.35 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.043 1.737 . . . . 10.0 111.66 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.65 85.01 4.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.295 1.521 . . . . 10.0 113.037 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.587 -1.321 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.19 -35.99 62.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.998 1.11 . . . . 10.0 113.998 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.417 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.5 ptp180 -64.4 -23.32 67.25 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.589 -1.319 . . . . 10.0 114.169 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -77.69 -42.77 33.34 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.148 -0.97 . . . . 10.0 111.763 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.95 44.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.355 1.462 . . . . 10.0 111.726 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -51.8 -71.88 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.551 1.941 . . . . 10.0 111.805 169.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.417 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.0 m0 -56.48 -31.96 64.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 117.507 -1.235 . . . . 10.0 113.536 -172.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 tp -48.59 -45.56 38.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.004 1.722 . . . . 10.0 112.077 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.91 -43.78 6.59 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.059 0.944 . . . . 10.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.0 m -51.45 -48.86 62.63 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.58 1.552 . . . . 10.0 113.444 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 41.5 p -69.41 -46.62 27.48 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.57 1.322 . . . . 10.0 114.57 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.53 -42.41 49.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.143 2.562 . . . . 10.0 115.185 169.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.41 -48.36 81.92 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.555 -0.716 . . . . 10.0 112.245 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -36.55 82.52 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.523 1.056 . . . . 10.0 112.555 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.66 -49.03 76.25 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.097 -1.002 . . . . 10.0 111.674 165.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.82 -38.25 78.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.823 0.849 . . . . 10.0 112.874 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -52.36 -53.97 37.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.298 0.954 . . . . 10.0 111.173 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.676 0.79 . . . . 10.0 112.131 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.72 38.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.94 0.896 . . . . 10.0 112.039 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.22 79.25 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.778 0.831 . . . . 10.0 112.692 174.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.75 -38.6 91.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.399 1.259 . . . . 10.0 114.399 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.81 1.37 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.236 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.55 11.94 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.33 145.89 47.49 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.95 -1.719 . . . . 10.0 112.458 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.9 54.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.8 -39.72 2.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.316 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.44 -52.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.088 1.355 . . . . 10.0 111.101 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.26 67.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.543 0.571 . . . . 10.0 112.543 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.441 0.696 . . . . 10.0 110.943 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.8 4.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.849 174.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.12 -46.31 96.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.706 0.802 . . . . 10.0 111.374 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.31 64.04 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.701 0.667 . . . . 10.0 112.624 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.36 75.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.358 0.873 . . . . 10.0 113.358 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -53.22 -51.41 62.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.699 1.2 . . . . 10.0 110.641 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.42 -54.29 4.78 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.092 1.329 . . . . 10.0 113.276 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.53 -54.76 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 118.068 -0.968 . . . . 10.0 112.395 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . 0.309 3.1 ppp? -61.45 -42.64 99.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.605 1.548 . . . . 10.0 113.552 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.0 mm . . . . . 0 N--CA 1.477 0.913 0 CA-C-N 120.214 1.37 . . . . 10.0 111.702 170.393 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 111.701 0.26 . . . . 10.0 111.701 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.18 -58.69 11.07 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.058 1.79 . . . . 10.0 112.379 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.57 -43.4 2.71 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.209 2.604 . . . . 10.0 113.304 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.9 mt -101.19 -6.41 24.29 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.485 1.661 . . . . 10.0 115.485 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.75 10.47 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.165 -1.584 . . . . 10.0 110.366 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.61 72.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.248 2.619 . . . . 10.0 113.275 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.69 106.34 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.79 0.836 . . . . 10.0 110.05 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.82 -59.63 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.051 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.42 -42.11 14.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.513 1.525 . . . . 10.0 113.496 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.63 63.2 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.19 -41.58 68.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.855 0.752 . . . . 10.0 110.826 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.21 -32.64 72.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.771 1.228 . . . . 10.0 114.216 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.79 -51.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.073 0.851 . . . . 10.0 109.638 169.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -62.33 -46.23 89.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -52.22 -47.68 65.54 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.088 0.955 . . . . 10.0 112.686 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.37 -53.88 53.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.099 0.96 . . . . 10.0 111.804 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.13 -53.16 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.905 1.282 . . . . 10.0 111.509 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.1 t -53.34 -51.31 62.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.343 1.457 . . . . 10.0 111.908 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.9 m -61.0 -42.97 99.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.459 1.504 . . . . 10.0 112.401 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.78 -51.74 68.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.407 1.003 . . . . 10.0 112.452 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.79 77.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.925 0.89 . . . . 10.0 112.89 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 32.5 ttp -60.7 -50.67 72.55 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.062 -1.023 . . . . 10.0 112.403 169.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.1 -47.51 71.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.632 1.573 . . . . 10.0 111.626 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -47.07 -54.37 10.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 10.0 112.261 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.2 mt -53.43 -55.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.814 0.846 . . . . 10.0 110.692 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -57.04 -36.15 70.13 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.121 0.785 . . . . 10.0 113.121 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.25 -58.2 9.25 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.077 0.951 . . . . 10.0 113.017 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.278 -0.867 . . . . 10.0 111.44 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.78 -49.44 75.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.897 1.226 . . . . 10.0 112.106 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.38 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.856 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.65 -21.93 60.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.607 1.163 . . . . 10.0 113.467 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.11 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.629 0.633 . . . . 10.0 113.548 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.44 51.0 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.262 1.825 . . . . 10.0 113.067 -166.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.02 1.118 . . . . 10.0 114.02 172.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.74 -50.45 65.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.05 0.929 . . . . 10.0 112.285 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.21 -46.01 83.28 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.181 0.993 . . . . 10.0 112.088 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.47 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.078 1.751 . . . . 10.0 114.268 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.6 29.1 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.428 1.891 . . . . 10.0 114.907 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.59 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.536 1.636 . . . . 10.0 114.195 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.77 -46.28 34.7 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.308 2.005 . . . . 10.0 113.066 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.03 67.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.968 2.907 . . . . 10.0 113.33 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.23 -53.03 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.086 0.954 . . . . 10.0 109.794 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.254 0.622 . . . . 10.0 111.926 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -60.03 -56.15 25.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.919 0.887 . . . . 10.0 112.709 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 10.0 113.036 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.52 46.16 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.284 0.634 . . . . 10.0 111.068 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.11 -48.4 78.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.04 -49.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.791 0.723 . . . . 10.0 110.428 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.56 -51.65 68.98 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.76 30.28 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.817 2.047 . . . . 10.0 111.044 174.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.53 -58.26 9.34 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.757 0.423 . . . . 10.0 111.314 174.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.09 -45.01 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.054 0.942 . . . . 10.0 111.504 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -56.74 -67.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.281 2.633 . . . . 10.0 110.918 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.92 -48.15 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.005 1.322 . . . . 10.0 110.915 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -62.11 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.755 0.822 . . . . 10.0 112.484 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.75 -48.08 80.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.211 0.914 . . . . 10.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -51.75 -51.08 58.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.301 1.04 . . . . 10.0 112.193 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 113.793 1.034 . . . . 10.0 113.793 178.908 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 119.308 -0.377 . . . . 10.0 111.445 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.2 t90 -55.47 -51.81 65.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.287 1.035 . . . . 10.0 112.501 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 35.5 tp -54.04 -45.22 71.54 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.77 1.228 . . . . 10.0 112.281 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.49 -4.98 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.17 1.545 . . . . 10.0 115.17 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.3 32.95 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.576 1.098 . . . . 10.0 113.886 -168.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.871 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.66 -17.08 64.47 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.661 1.726 . . . . 10.0 115.661 -175.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.32 -106.07 1.14 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.339 1.427 . . . . 10.0 113.714 -172.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.637 -1.508 . . . . 10.0 109.353 168.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 113.905 0.322 . . . . 10.0 113.905 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.771 166.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.7 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.366 -174.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -68.82 153.84 72.19 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.752 2.968 . . . . 10.0 111.424 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.81 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.329 1.052 . . . . 10.0 112.221 171.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.31 -52.4 21.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.95 -40.47 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.646 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.29 -49.85 41.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.586 0.63 . . . . 10.0 111.964 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.08 83.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.092 1.757 . . . . 10.0 112.983 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.3 -52.32 62.44 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.931 0.892 . . . . 10.0 112.141 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.59 -59.29 4.64 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.362 1.065 . . . . 10.0 109.944 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -52.9 -46.54 68.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.417 -1.278 . . . . 10.0 112.241 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -51.36 -53.38 36.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.687 1.585 . . . . 10.0 112.723 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.12 -49.68 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.202 1.401 . . . . 10.0 111.562 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -56.17 -50.9 69.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.141 1.376 . . . . 10.0 111.458 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -57.06 -62.66 1.6 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.195 1.798 . . . . 10.0 110.954 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.482 1.162 0 CA-C-N 120.49 1.495 . . . . 10.0 112.793 -178.343 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.333 0 CA-C-O 121.309 0.394 . . . . 10.0 113.228 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -54.73 -57.04 13.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.192 1.797 . . . . 10.0 112.656 172.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -53.02 -37.16 53.42 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.063 0.839 . . . . 10.0 113.596 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.58 -28.01 65.6 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 115.989 1.848 . . . . 10.0 115.989 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.62 -57.49 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 119.319 0.963 . . . . 10.0 108.445 165.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.848 0.859 . . . . 10.0 113.186 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.317 1.599 . . . . 10.0 115.317 -171.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.141 0.976 . . . . 10.0 113.292 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.049 0.94 . . . . 10.0 111.019 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.744 0.818 . . . . 10.0 110.957 170.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.0 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.896 0.879 . . . . 10.0 112.1 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.461 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.82 -55.45 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.731 1.212 . . . . 10.0 110.686 -175.278 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.44 40.12 Favored Glycine 0 C--O 1.239 0.451 0 C-N-CA 129.755 3.55 . . . . 10.0 119.677 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.484 2.714 . . . . 10.0 113.438 166.603 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.822 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.29 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.576 3.15 . . . . 10.0 117.276 160.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.67 65.05 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.331 2.652 . . . . 10.0 114.448 155.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.03 2.79 41.14 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.44 2.447 . . . . 10.0 111.488 168.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.684 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.477 2.277 . . . . 10.0 113.201 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.14 4.32 0.94 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.736 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.473 -0.767 . . . . 10.0 112.619 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.6 83.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.887 0.875 . . . . 10.0 109.3 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.43 -52.56 63.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.399 0.68 . . . . 10.0 111.882 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.41 -53.59 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.141 0.576 . . . . 10.0 112.247 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.85 -46.83 51.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.381 1.472 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -44.93 84.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.88 -56.2 12.58 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.346 0.974 . . . . 10.0 111.567 166.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.4 m -49.8 -52.47 31.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.844 1.257 . . . . 10.0 112.209 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.177 0.991 . . . . 10.0 112.139 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.31 -48.56 78.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.663 0.785 . . . . 10.0 112.809 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.417 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 46.8 mtt -59.22 -46.62 87.97 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.293 1.037 . . . . 10.0 111.606 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.49 -58.6 13.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.232 0.92 . . . . 10.0 113.735 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -46.12 79.6 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.64 1.22 . . . . 10.0 112.127 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.56 -41.74 74.3 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.755 1.169 . . . . 10.0 113.242 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -63.12 -57.83 9.26 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 118.297 -0.859 . . . . 10.0 111.412 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.49 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.81 -57.99 9.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.571 1.148 . . . . 10.0 112.973 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.05 -67.5 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.662 1.185 . . . . 10.0 113.611 169.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.756 1.741 . . . . 10.0 110.866 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.863 2.465 . . . . 10.0 109.319 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.93 93.06 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.143 2.177 . . . . 10.0 113.619 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.73 -84.38 1.19 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.732 0.682 . . . . 10.0 112.477 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.404 2.681 . . . . 10.0 116.922 166.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.66 -50.84 10.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.902 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.53 6.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.737 1.273 . . . . 10.0 110.967 -172.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.59 -29.63 89.61 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.724 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.52 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.106 1.362 . . . . 10.0 113.551 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.58 -47.4 19.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.231 1.413 . . . . 10.0 113.441 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.09 62.12 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.513 0.725 . . . . 10.0 110.939 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.1 m-85 -56.97 -50.21 73.35 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.044 0.538 . . . . 10.0 112.334 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.38 -51.27 65.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.356 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.384 0.883 . . . . 10.0 113.384 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.55 -58.11 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.914 1.286 . . . . 10.0 110.228 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -68.09 -18.03 64.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.368 . . . . 10.0 113.745 -172.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -86.6 -40.36 15.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.397 1.079 . . . . 10.0 112.059 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.3 mt -60.37 -41.55 93.95 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.387 -0.82 . . . . 10.0 112.525 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.8 t -41.2 -60.45 1.74 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.719 1.607 . . . . 10.0 113.769 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.95 -26.72 10.76 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.721 2.947 . . . . 10.0 114.262 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.85 97.72 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.938 1.699 . . . . 10.0 113.01 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -52.12 -54.86 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.14 1.376 . . . . 10.0 109.345 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -55.77 -45.21 78.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.629 1.171 . . . . 10.0 113.131 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.43 -57.3 9.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.422 1.465 . . . . 10.0 112.209 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -50.15 -52.4 35.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.164 1.386 . . . . 10.0 110.434 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.15 -48.02 63.44 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.805 0.842 . . . . 10.0 113.089 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.16 -40.08 76.56 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.845 -1.55 . . . . 10.0 113.085 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.407 1.458 . . . . 10.0 111.281 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.65 -41.06 61.05 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.7 mtm -66.88 -50.85 61.16 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.484 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.54 -52.69 21.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.826 0.851 . . . . 10.0 112.975 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.5 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.857 1.058 . . . . 10.0 113.857 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.09 43.02 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.252 1.575 . . . . 10.0 115.252 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.55 61.04 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.332 0.893 . . . . 10.0 115.332 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.43 26.41 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.042 2.137 . . . . 10.0 108.957 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.49 171.14 15.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.053 0.941 . . . . 10.0 111.0 166.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 136.0 53.43 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.9 0.88 . . . . 10.0 109.691 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.52 129.6 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.039 1.336 . . . . 10.0 110.959 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.36 38.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.826 0.676 . . . . 10.0 112.826 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -82.0 0.15 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.41 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.6 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.338 1.569 . . . . 10.0 112.217 -165.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.91 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.46 1.504 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.45 120.76 69.66 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.6 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.36 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.046 1.738 . . . . 10.0 111.71 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.69 85.05 4.74 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 123.058 1.409 . . . . 10.0 113.037 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.864 -1.147 . . . . 10.0 113.951 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.82 52.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.292 1.037 . . . . 10.0 113.147 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -50.68 -55.51 16.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.858 0.863 . . . . 10.0 111.515 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -64.02 -39.11 93.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.69 1.596 . . . . 10.0 112.182 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.69 65.36 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.48 1.112 . . . . 10.0 110.916 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -61.96 2.23 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.18 1.792 . . . . 10.0 112.764 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -53.65 -38.12 63.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.368 2.267 . . . . 10.0 113.177 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.46 -44.01 62.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.493 1.517 . . . . 10.0 112.183 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -99.4 -47.99 4.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 113.254 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.0 t -60.02 -37.6 80.24 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.454 -0.779 . . . . 10.0 113.058 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 4.5 m -68.38 -48.55 34.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.753 -1.217 . . . . 10.0 112.638 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 82.6 Cg_exo -49.62 -42.9 41.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.585 2.856 . . . . 10.0 115.278 164.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.58 -49.28 78.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.889 0.768 . . . . 10.0 112.076 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tt -53.01 -44.68 67.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.678 1.191 . . . . 10.0 112.679 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.62 -47.71 81.43 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.038 -1.039 . . . . 10.0 112.413 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.838 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.3 -54.04 36.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.298 0.954 . . . . 10.0 111.187 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.1 88.63 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.656 0.782 . . . . 10.0 112.099 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.69 38.43 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.94 0.896 . . . . 10.0 112.078 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.16 79.38 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.704 0.801 . . . . 10.0 112.731 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.71 -38.59 91.68 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.065 1.346 . . . . 10.0 112.313 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.56 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.829 1.652 . . . . 10.0 112.113 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.981 -1.699 . . . . 10.0 112.458 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.92 54.27 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.67 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.888 1.675 . . . . 10.0 113.465 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.26 5.29 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.139 1.352 . . . . 10.0 115.26 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.01 -46.74 87.86 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.158 -1.401 . . . . 10.0 111.354 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.97 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.087 1.355 . . . . 10.0 111.072 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.57 -51.33 67.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.82 43.16 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.424 0.689 . . . . 10.0 110.985 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.399 2.28 . . . . 10.0 114.849 174.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.07 -46.35 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 123.725 0.81 . . . . 10.0 111.349 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.31 64.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.659 0.647 . . . . 10.0 112.624 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.27 74.91 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.13 -45.32 87.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.583 0.753 . . . . 10.0 111.946 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.55 -56.47 4.87 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.455 1.502 . . . . 10.0 113.037 167.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 83.6 mt -56.45 -55.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.757 0.823 . . . . 10.0 110.322 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -48.98 -56.71 8.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.609 1.095 . . . . 10.0 113.115 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.3 mm -68.86 -46.42 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.116 0.566 . . . . 10.0 112.203 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.65 -44.71 79.46 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.388 0.994 . . . . 10.0 113.075 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.9 m -61.52 -44.21 97.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.404 1.482 . . . . 10.0 111.159 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.06 -51.42 19.58 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.244 0.925 . . . . 10.0 113.185 165.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.57 -50.19 66.1 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 127.931 2.492 . . . . 10.0 111.096 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t -59.65 -50.34 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 125.449 1.5 . . . . 10.0 112.033 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.98 -59.46 8.72 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.704 1.621 . . . . 10.0 112.096 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.79 -37.76 20.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.209 2.204 . . . . 10.0 113.434 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.7 -6.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.398 1.629 . . . . 10.0 115.398 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.67 116.72 10.4 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.207 -1.558 . . . . 10.0 110.356 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.248 2.619 . . . . 10.0 113.289 177.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.65 106.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.816 0.847 . . . . 10.0 110.128 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.764 1.226 . . . . 10.0 114.019 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.54 -42.01 15.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.458 1.503 . . . . 10.0 113.498 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.22 -24.59 63.13 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.897 1.443 . . . . 10.0 114.897 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.83 -41.87 67.86 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 118.901 0.773 . . . . 10.0 110.82 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.64 -31.88 70.23 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.854 1.262 . . . . 10.0 114.241 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.29 -52.26 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.152 0.887 . . . . 10.0 109.625 168.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -60.47 -45.24 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -52.64 -49.54 64.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.713 1.142 . . . . 10.0 112.71 173.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -53.92 48.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.139 . . . . 10.0 111.915 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.2 mt -54.62 -47.59 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.625 1.17 . . . . 10.0 111.481 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -57.57 -53.34 59.26 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.07 1.348 . . . . 10.0 112.394 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.6 t -67.82 -33.48 74.86 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.766 0.826 . . . . 10.0 112.308 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.63 73.34 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.258 0.935 . . . . 10.0 112.347 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.55 80.62 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.468 -0.77 . . . . 10.0 112.535 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.65 -52.99 62.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.267 1.027 . . . . 10.0 111.913 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.77 -49.62 65.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.069 1.748 . . . . 10.0 111.665 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -49.5 -54.71 16.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.722 0.809 . . . . 10.0 112.184 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.0 mt -54.11 -54.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.592 0.757 . . . . 10.0 110.86 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.35 -36.62 69.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.709 0.804 . . . . 10.0 113.07 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -57.24 -58.19 9.3 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.035 0.934 . . . . 10.0 113.059 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -40.96 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.373 -0.823 . . . . 10.0 111.468 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.76 -49.39 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.831 1.196 . . . . 10.0 112.169 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.26 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.075 -1.641 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.69 -21.98 60.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 10.0 113.477 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.588 0.614 . . . . 10.0 113.548 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.271 1.828 . . . . 10.0 113.067 -166.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.09 -56.44 14.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.032 1.123 . . . . 10.0 114.032 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.69 -50.58 65.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.115 0.959 . . . . 10.0 112.303 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.11 -46.02 82.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.136 0.975 . . . . 10.0 112.143 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.51 80.02 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.27 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.043 1.737 . . . . 10.0 114.235 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.477 1.911 . . . . 10.0 114.876 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.94 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.536 1.636 . . . . 10.0 114.171 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.24 35.04 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.277 1.984 . . . . 10.0 113.079 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.1 67.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.288 173.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.14 -53.07 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.83 75.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.246 0.618 . . . . 10.0 111.905 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -56.18 24.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.917 0.887 . . . . 10.0 112.709 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.211 1.004 . . . . 10.0 113.05 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.61 -49.44 46.85 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.253 0.621 . . . . 10.0 111.101 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.43 78.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.67 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.797 0.726 . . . . 10.0 110.487 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.57 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.83 30.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.86 2.064 . . . . 10.0 111.026 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.45 -58.36 8.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.796 0.438 . . . . 10.0 111.266 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.6 t -52.14 -46.64 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.112 0.965 . . . . 10.0 112.296 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.9 m -58.83 -64.85 0.79 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.971 2.509 . . . . 10.0 111.484 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.6 -49.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.928 1.291 . . . . 10.0 111.241 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.9 -64.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.844 0.858 . . . . 10.0 112.28 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.12 -43.02 81.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.037 0.835 . . . . 10.0 112.174 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -52.14 -54.29 32.43 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.128 0.971 . . . . 10.0 112.459 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.8 p -51.88 -33.13 35.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.029 1.122 . . . . 10.0 114.029 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.24 -43.44 94.92 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.92 1.082 . . . . 10.0 113.92 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -45.87 -57.35 8.17 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 115.151 1.537 . . . . 10.0 115.151 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.401 ' HB3' H183 ' A' ' 999' ' ' RET . 36.6 Cg_endo -61.09 -34.02 90.45 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.278 1.985 . . . . 10.0 113.01 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.1 t -64.02 -51.61 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.234 0.925 . . . . 10.0 110.821 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.1 t -53.55 -50.7 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.811 1.244 . . . . 10.0 111.315 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -55.32 -52.34 63.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.894 1.277 . . . . 10.0 112.498 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 56.0 tp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.971 1.308 . . . . 10.0 112.449 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -88.15 -5.08 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 115.222 1.564 . . . . 10.0 115.222 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.47 -169.3 32.89 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-O 122.576 1.098 . . . . 10.0 113.873 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -40.85 64.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.828 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -54.94 -31.49 60.51 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.524 2.73 . . . . 10.0 115.154 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.62 -103.88 0.95 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.366 0.985 . . . . 10.0 113.623 -167.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.19 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.331 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.884 0.314 . . . . 10.0 113.884 173.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.64 -42.74 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.055 1.742 . . . . 10.0 108.716 166.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.27 133.38 24.9 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.448 1.899 . . . . 10.0 109.392 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.7 153.77 72.61 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.754 2.969 . . . . 10.0 111.468 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.34 -52.38 21.89 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.93 -40.48 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.668 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.35 -49.77 42.87 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.517 0.599 . . . . 10.0 111.946 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.68 -47.08 83.31 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.07 1.748 . . . . 10.0 113.002 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -58.8 5.62 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.335 1.054 . . . . 10.0 109.989 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -53.42 -43.88 68.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.876 -1.059 . . . . 10.0 112.956 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -54.53 -52.55 61.68 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.3 1.409 . . . . 10.0 112.492 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.18 -48.97 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.49 1.116 . . . . 10.0 110.939 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.0 mp -57.09 -53.53 57.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.747 1.619 . . . . 10.0 112.152 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -54.68 -56.04 23.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.065 1.746 . . . . 10.0 111.807 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 66.0 t -57.1 -47.44 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.398 -0.814 . . . . 10.0 111.264 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 46.1 m -55.95 -50.51 70.56 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.901 0.88 . . . . 10.0 112.042 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -71.75 -0.93 12.24 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.424 1.889 . . . . 10.0 114.315 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -130.14 -68.76 0.69 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.476 1.11 . . . . 10.0 111.671 -175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.6 t -68.85 -51.91 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.186 0.994 . . . . 10.0 110.253 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.52 -56.45 23.55 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 123.999 0.809 . . . . 10.0 112.866 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.4 -57.28 3.14 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.549 1.939 . . . . 10.0 112.687 167.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.56 -38.92 89.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.582 1.087 . . . . 10.0 113.642 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -69.47 -27.56 65.33 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 115.614 1.709 . . . . 10.0 115.614 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.36 -57.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 165.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.87 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.877 0.871 . . . . 10.0 113.174 -172.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.61 5.23 2.54 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.28 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.89 4.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.113 0.965 . . . . 10.0 111.03 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.19 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.771 0.829 . . . . 10.0 110.957 170.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.94 77.05 7.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.874 0.87 . . . . 10.0 112.084 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.897 2.879 . . . . 10.0 116.462 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.81 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.75 1.22 . . . . 10.0 110.642 -175.308 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.72 3.533 . . . . 10.0 119.677 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.516 2.727 . . . . 10.0 113.457 166.652 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.498 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.87 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.569 3.148 . . . . 10.0 117.225 160.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.306 2.643 . . . . 10.0 114.448 155.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.45 137.93 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.41 1.884 . . . . 10.0 113.372 -158.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.015 -174.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.83 41.48 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.487 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.649 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.304 . . . . 10.0 113.21 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.28 4.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.732 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.507 -0.746 . . . . 10.0 112.625 176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.84 -49.64 83.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.892 0.877 . . . . 10.0 109.3 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.537 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.36 -52.66 62.8 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.379 0.672 . . . . 10.0 111.867 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.3 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.224 0.61 . . . . 10.0 112.276 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.8 51.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.332 1.453 . . . . 10.0 113.335 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.95 84.75 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.289 1.435 . . . . 10.0 112.997 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.6 -56.54 11.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.526 1.06 . . . . 10.0 111.511 166.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.59 -52.51 29.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.904 1.282 . . . . 10.0 112.248 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.5 -58.81 6.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.172 0.989 . . . . 10.0 112.161 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt -57.47 -48.62 78.71 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 10.0 112.836 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.14 -49.09 78.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.008 0.923 . . . . 10.0 111.281 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.53 -58.66 13.26 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.273 0.939 . . . . 10.0 113.931 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.18 -45.63 79.68 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.748 1.274 . . . . 10.0 112.175 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.85 -39.87 88.81 Favored Glycine 0 CA--C 1.533 1.205 0 O-C-N 120.779 -1.2 . . . . 10.0 113.588 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.3 m -60.21 -60.71 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 10.0 110.801 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.06 9.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 112.972 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.61 -38.67 81.92 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.254 0.835 . . . . 10.0 113.254 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.621 1.168 . . . . 10.0 113.589 169.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.813 1.768 . . . . 10.0 110.859 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.04 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.628 1.011 . . . . 10.0 115.628 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.2 mmm -59.47 -45.05 92.73 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.4 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.743 0.687 . . . . 10.0 112.511 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.07 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.401 2.68 . . . . 10.0 116.959 166.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 m -79.68 -50.83 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.168 -1.378 . . . . 10.0 113.892 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.5 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.66 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.67 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.111 0.565 . . . . 10.0 111.476 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.06 22.84 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.078 1.351 . . . . 10.0 113.566 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.57 -47.41 19.74 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.455 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.78 -53.1 61.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.933 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.9 -50.27 73.04 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.107 0.563 . . . . 10.0 112.353 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.27 65.25 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.99 1.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.85 -56.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.825 1.25 . . . . 10.0 110.736 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -69.81 -18.61 63.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.935 1.294 . . . . 10.0 113.498 -172.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.4 m -84.98 -42.52 14.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.478 1.111 . . . . 10.0 111.913 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.6 mt -57.49 -41.56 80.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.211 0.819 . . . . 10.0 113.211 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.4 t -50.17 -61.79 3.33 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.092 -0.956 . . . . 10.0 112.457 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -46.76 -47.27 16.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.627 3.551 . . . . 10.0 115.925 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.49 90.16 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.858 1.208 . . . . 10.0 113.811 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.25 -51.52 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.592 1.157 . . . . 10.0 109.326 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.24 76.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.093 0.957 . . . . 10.0 113.165 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -50.13 -56.23 11.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.681 1.592 . . . . 10.0 112.179 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.77 -52.82 29.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.3 1.44 . . . . 10.0 110.733 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.84 -48.13 64.27 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.976 0.91 . . . . 10.0 113.013 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -56.49 -40.75 75.47 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.195 1.362 . . . . 10.0 113.447 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.53 34.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.752 1.16 . . . . 10.0 111.292 170.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.14 61.12 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.174 1.546 . . . . 10.0 115.174 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.85 -50.82 61.34 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.594 0.758 . . . . 10.0 110.469 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.72 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.887 0.875 . . . . 10.0 112.92 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.86 -5.6 49.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 10.0 113.831 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.67 5.58 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.564 0.986 . . . . 10.0 115.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.01 43.5 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.53 61.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.339 0.896 . . . . 10.0 115.339 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.4 26.46 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.081 2.153 . . . . 10.0 109.031 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.711 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.64 129.62 23.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.028 1.331 . . . . 10.0 110.909 -176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.23 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.72 164.4 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.79 -3.28 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.669 2.228 . . . . 10.0 118.669 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.358 1.579 . . . . 10.0 112.194 -165.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.444 1.498 . . . . 10.0 111.081 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.45 120.78 69.66 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.651 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.5 131.91 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.184 3.256 . . . . 10.0 112.137 171.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.29 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.075 1.75 . . . . 10.0 111.763 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -93.63 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.063 1.411 . . . . 10.0 113.106 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.27 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.847 -1.158 . . . . 10.0 113.905 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.72 -26.61 35.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.271 1.029 . . . . 10.0 112.532 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -55.08 -48.31 73.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.01 1.324 . . . . 10.0 112.927 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -71.2 -38.87 72.04 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.955 0.902 . . . . 10.0 111.122 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.39 -48.95 65.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.32 1.048 . . . . 10.0 112.228 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.514 1.526 . . . . 10.0 111.558 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -55.27 -34.28 63.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.357 1.463 . . . . 10.0 112.503 -170.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.7 tp -48.82 -43.74 38.71 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.114 1.766 . . . . 10.0 112.141 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -101.9 -38.15 7.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.493 0.717 . . . . 10.0 112.764 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.7 p -64.72 -43.69 92.58 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.283 1.402 . . . . 10.0 113.92 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.277 74.8 p -65.04 -42.56 62.45 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 114.72 1.378 . . . . 10.0 114.72 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.89 -43.04 60.83 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.428 2.752 . . . . 10.0 115.247 167.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.23 -47.28 86.67 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.447 -0.783 . . . . 10.0 111.704 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.61 -50.01 55.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.414 1.485 . . . . 10.0 111.51 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mp -56.24 -47.52 78.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.111 0.965 . . . . 10.0 112.956 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.22 78.29 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.777 0.831 . . . . 10.0 112.903 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.02 36.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.285 0.948 . . . . 10.0 111.214 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.09 88.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.093 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.75 37.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.017 0.927 . . . . 10.0 111.974 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.25 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.67 53.41 12.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.838 1.655 . . . . 10.0 112.126 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.95 47.51 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.935 -1.728 . . . . 10.0 112.405 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.85 54.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.77 -39.72 2.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.93 1.692 . . . . 10.0 113.467 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.2 5.34 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.304 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.46 -52.93 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.154 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.57 -51.37 67.61 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.522 0.564 . . . . 10.0 112.522 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.05 -44.93 42.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.469 0.708 . . . . 10.0 110.959 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.814 175.005 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.393 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.14 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.614 0.626 . . . . 10.0 112.675 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.63 -46.92 73.97 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.187 0.81 . . . . 10.0 113.187 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -57.13 -45.54 83.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.023 0.929 . . . . 10.0 111.974 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.02 -55.58 5.59 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.201 1.382 . . . . 10.0 113.082 167.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.4 mt -56.77 -49.47 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.626 0.77 . . . . 10.0 111.893 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 64.4 ttp -49.39 -57.82 6.23 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 10.0 112.184 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.82 -47.12 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 O-C-N 121.659 -0.651 . . . . 10.0 111.058 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -50.71 -62.54 5.16 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.82 1.2 . . . . 10.0 112.563 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 p -59.07 -36.17 74.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.707 0.803 . . . . 10.0 112.817 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.36 -56.93 8.68 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.321 0.962 . . . . 10.0 113.88 165.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.87 -47.22 85.68 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.791 1.637 . . . . 10.0 111.644 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.7 t -52.81 -51.81 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.253 0.621 . . . . 10.0 110.35 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.03 -60.84 5.78 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.833 1.682 . . . . 10.0 112.212 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.01 -37.66 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.484 1.913 . . . . 10.0 113.86 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.0 mt -99.27 -6.41 28.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -69.66 116.73 10.4 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.19 -1.569 . . . . 10.0 110.409 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.53 -49.55 72.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.186 2.594 . . . . 10.0 113.255 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.66 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.86 -59.52 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.72 1.208 . . . . 10.0 114.087 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.12 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.451 1.5 . . . . 10.0 113.485 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.64 63.25 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.956 1.465 . . . . 10.0 114.956 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.82 -41.94 67.91 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.848 0.749 . . . . 10.0 110.712 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.51 -32.01 70.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.903 1.281 . . . . 10.0 114.249 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.1 -51.77 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.59 168.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -62.46 -43.15 99.52 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -53.93 -48.38 70.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.48 1.112 . . . . 10.0 112.617 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.68 -53.14 61.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.693 0.797 . . . . 10.0 111.681 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.14 -54.33 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.809 1.244 . . . . 10.0 112.009 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 p -58.01 -43.15 86.53 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.252 -0.905 . . . . 10.0 112.852 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.2 m -61.73 -41.31 97.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.568 1.147 . . . . 10.0 112.56 174.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.41 -46.75 87.82 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.345 0.975 . . . . 10.0 112.343 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.74 79.81 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.668 0.787 . . . . 10.0 112.393 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.8 ttp -54.54 -54.54 39.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.037 0.935 . . . . 10.0 112.085 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.1 -50.4 61.71 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.314 1.446 . . . . 10.0 111.572 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.39 -54.66 20.14 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.048 0.939 . . . . 10.0 112.562 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.1 mt -53.52 -55.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.831 0.853 . . . . 10.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.8 mt -57.48 -35.6 70.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.2 -0.905 . . . . 10.0 112.902 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.31 -58.14 9.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.251 0.932 . . . . 10.0 113.047 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.92 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 118.342 -0.837 . . . . 10.0 111.441 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.44 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.83 1.195 . . . . 10.0 112.115 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.92 -70.4 0.46 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.866 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.73 -21.86 60.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.587 1.155 . . . . 10.0 113.468 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.37 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.14 -56.49 14.22 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.955 1.094 . . . . 10.0 113.955 172.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.64 -50.55 65.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.112 0.958 . . . . 10.0 112.299 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.16 -45.97 83.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.192 0.997 . . . . 10.0 112.149 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.42 80.59 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.54 -11.23 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.044 1.738 . . . . 10.0 114.225 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.62 29.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.427 1.891 . . . . 10.0 114.865 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.95 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.451 1.596 . . . . 10.0 114.14 -170.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.841 3.256 . . . . 10.0 105.549 170.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.86 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.27 1.98 . . . . 10.0 113.032 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.11 67.96 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.17 -53.01 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.274 0.63 . . . . 10.0 111.902 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.06 -56.14 25.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.933 0.893 . . . . 10.0 112.687 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.26 -53.21 60.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.019 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.55 -49.48 46.08 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.36 78.91 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.691 1.367 . . . . 10.0 114.691 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.62 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.815 0.734 . . . . 10.0 110.487 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.64 -51.61 69.18 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.82 -47.73 31.03 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.796 2.039 . . . . 10.0 111.047 174.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.57 -58.33 9.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.798 0.439 . . . . 10.0 111.253 174.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.09 -47.03 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.109 0.963 . . . . 10.0 112.298 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.9 m -58.76 -64.22 1.01 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.034 2.534 . . . . 10.0 111.53 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -50.19 -49.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.613 1.165 . . . . 10.0 111.288 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.46 -63.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.002 0.921 . . . . 10.0 112.269 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.9 -43.41 98.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.505 0.593 . . . . 10.0 112.529 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -55.05 -51.01 67.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.478 0.711 . . . . 10.0 111.757 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.5 m -54.92 -29.97 57.5 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.134 1.161 . . . . 10.0 114.134 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.29 -41.94 96.64 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.62 0.97 . . . . 10.0 113.62 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -46.85 -56.27 12.28 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 115.325 1.602 . . . . 10.0 115.325 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -59.68 -35.31 95.25 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.264 1.976 . . . . 10.0 112.85 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.63 -53.07 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.132 0.973 . . . . 10.0 110.909 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.21 -48.79 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.023 1.329 . . . . 10.0 111.525 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -55.26 -54.26 45.68 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.964 1.306 . . . . 10.0 112.251 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.0 tp -52.86 -46.67 67.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.182 1.393 . . . . 10.0 112.514 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.6 pt -85.8 -4.92 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.62 -169.33 32.7 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-O 122.551 1.084 . . . . 10.0 113.789 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.07 -39.65 63.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.157 -1.021 . . . . 10.0 111.908 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.43 -32.87 65.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.377 2.671 . . . . 10.0 115.271 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.44 -104.34 1.11 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-O 122.142 0.857 . . . . 10.0 112.698 -167.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.19 35.82 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.285 170.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.34 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.93 0.332 . . . . 10.0 113.93 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.775 166.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.33 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.464 1.906 . . . . 10.0 109.351 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.76 153.84 72.32 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.438 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.25 -39.75 3.13 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.299 1.039 . . . . 10.0 112.223 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.28 -52.43 21.33 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.54 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.651 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.83 41.93 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.564 0.62 . . . . 10.0 111.907 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.0 83.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.038 1.735 . . . . 10.0 113.017 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.33 62.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.016 0.926 . . . . 10.0 112.06 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.63 -59.66 4.2 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.361 1.064 . . . . 10.0 109.913 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -52.82 -47.13 67.89 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.986 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.32 -52.72 34.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 121.283 1.856 . . . . 10.0 113.258 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.3 t -60.81 -48.12 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.817 1.247 . . . . 10.0 111.479 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.49 -50.17 74.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.319 1.448 . . . . 10.0 111.907 175.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.35 -57.41 11.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.469 2.308 . . . . 10.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.96 -45.44 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.221 -0.924 . . . . 10.0 111.844 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.9 m -56.95 -51.75 67.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.963 0.905 . . . . 10.0 112.025 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -77.73 5.9 8.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.68 1.592 . . . . 10.0 114.241 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -128.11 -74.16 0.58 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.767 1.227 . . . . 10.0 111.219 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.4 m -72.79 -41.64 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.268 -0.895 . . . . 10.0 111.972 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.23 -56.61 24.26 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 119.367 0.985 . . . . 10.0 112.614 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -42.44 -56.54 2.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.824 2.049 . . . . 10.0 112.36 166.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.16 -39.89 82.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.649 1.119 . . . . 10.0 113.997 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.3 -27.14 65.13 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 115.75 1.759 . . . . 10.0 115.75 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.38 -57.56 11.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.604 -0.887 . . . . 10.0 108.604 165.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.68 0.85 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.949 0.899 . . . . 10.0 113.145 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.37 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.273 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.1 178.02 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.04 0.936 . . . . 10.0 110.995 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.68 98.15 1.87 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 10.0 110.921 170.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.93 77.04 7.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 10.0 112.107 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.06 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.892 2.877 . . . . 10.0 116.451 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.4 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.738 1.215 . . . . 10.0 110.622 -175.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.35 169.46 40.29 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.631 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.446 0 C-N-CA 128.524 2.73 . . . . 10.0 113.492 166.576 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.505 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.82 -2.038 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.34 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.588 3.155 . . . . 10.0 117.251 160.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.302 2.641 . . . . 10.0 114.511 155.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.4 137.96 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.344 -158.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.7 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.1 2.75 41.49 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.473 2.463 . . . . 10.0 111.463 167.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.3 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.668 -168.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.547 2.302 . . . . 10.0 113.252 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.25 4.34 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.732 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.13 61.76 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.615 176.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.42 -52.59 63.09 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 10.0 111.902 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.41 -53.6 56.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.234 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.78 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.2 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -56.1 12.46 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.655 1.122 . . . . 10.0 111.583 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -50.16 -52.35 36.07 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.895 1.278 . . . . 10.0 112.288 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.207 1.003 . . . . 10.0 112.161 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.77 -49.18 77.45 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 10.0 112.541 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.9 mmt -56.08 -49.95 72.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.603 0.761 . . . . 10.0 111.306 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.04 -58.47 14.44 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.312 0.958 . . . . 10.0 113.63 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.22 -45.59 79.85 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.656 1.228 . . . . 10.0 112.142 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.0 74.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.026 1.298 . . . . 10.0 113.273 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -59.79 -60.57 3.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.24 1.016 . . . . 10.0 111.14 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.96 62.5 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.955 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.84 -58.03 9.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.593 1.157 . . . . 10.0 112.929 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.63 81.94 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.621 1.168 . . . . 10.0 113.62 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.87 -44.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.332 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.16 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.04 92.92 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.154 2.182 . . . . 10.0 113.587 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.35 1.19 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.756 0.693 . . . . 10.0 112.497 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.96 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.396 2.678 . . . . 10.0 116.95 166.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.198 -1.365 . . . . 10.0 113.866 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.52 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.765 1.291 . . . . 10.0 110.957 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.65 89.48 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.708 2.939 . . . . 10.0 113.735 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -60.65 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.5 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.281 1.432 . . . . 10.0 113.444 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 110.967 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.28 65.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.891 -0.576 . . . . 10.0 112.321 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.7 -57.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.865 1.266 . . . . 10.0 110.417 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -69.28 -17.08 63.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.071 1.348 . . . . 10.0 113.693 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -86.91 -42.98 12.76 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.64 1.109 . . . . 10.0 112.018 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -56.75 -41.45 77.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.885 0.698 . . . . 10.0 112.885 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.3 t -49.97 -61.45 3.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.629 1.172 . . . . 10.0 112.569 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.95 -46.53 24.73 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.598 3.532 . . . . 10.0 116.029 164.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.2 93.39 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.973 1.26 . . . . 10.0 113.922 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mt -58.13 -52.23 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.496 1.118 . . . . 10.0 109.48 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.49 -43.97 72.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.006 0.922 . . . . 10.0 113.185 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -52.2 -57.96 8.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.137 1.375 . . . . 10.0 111.871 171.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.59 -52.91 20.57 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.507 1.523 . . . . 10.0 110.886 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.3 mmt -68.64 -48.21 64.6 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.966 0.906 . . . . 10.0 112.981 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -55.64 -41.71 73.96 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.163 1.347 . . . . 10.0 113.283 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.56 34.36 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.475 1.034 . . . . 10.0 111.317 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.05 61.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.91 -50.83 61.17 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.442 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.55 -52.67 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.883 0.873 . . . . 10.0 112.963 172.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.58 49.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.3 -34.73 5.53 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.575 0.99 . . . . 10.0 115.575 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.13 42.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.56 61.17 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.326 0.89 . . . . 10.0 115.326 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.45 26.4 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.021 2.129 . . . . 10.0 109.034 171.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.14 15.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.045 166.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.84 0.856 . . . . 10.0 109.745 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.56 129.57 23.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 125.071 1.348 . . . . 10.0 110.971 -176.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.69 116.17 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.67 164.41 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.647 -0.981 . . . . 10.0 110.647 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.354 1.577 . . . . 10.0 112.231 -165.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.86 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.45 120.73 69.66 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.4 Cg_exo -61.42 131.91 38.41 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.253 3.302 . . . . 10.0 112.167 171.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.16 126.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.044 1.738 . . . . 10.0 111.716 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.262 1.506 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.44 -28.23 66.78 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.641 -1.287 . . . . 10.0 113.881 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.14 62.2 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.225 1.194 . . . . 10.0 114.225 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -65.93 -22.98 66.53 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 120.112 -1.618 . . . . 10.0 113.821 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -77.26 -42.1 38.41 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.55 -1.344 . . . . 10.0 111.691 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.22 -47.91 54.7 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.444 1.498 . . . . 10.0 111.211 166.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -52.56 -70.76 0.08 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.626 1.97 . . . . 10.0 112.031 168.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -56.83 -32.76 66.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.26 1.024 . . . . 10.0 113.448 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.3 tp -50.17 -40.66 47.5 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.858 1.663 . . . . 10.0 111.871 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -105.29 -39.72 6.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.411 0.685 . . . . 10.0 112.521 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.3 p -61.6 -43.12 99.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.793 1.633 . . . . 10.0 113.794 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.299 68.0 p -69.94 -40.62 13.35 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 115.234 1.568 . . . . 10.0 115.234 -175.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.37 -42.98 62.93 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.208 2.605 . . . . 10.0 115.083 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.29 -47.43 86.04 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.484 -0.76 . . . . 10.0 111.684 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.11 -49.55 51.35 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.745 1.618 . . . . 10.0 111.527 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -57.11 -47.4 81.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.273 1.029 . . . . 10.0 113.146 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.24 78.11 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.843 0.857 . . . . 10.0 112.891 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.33 -54.02 37.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.179 169.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.14 88.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.65 -54.69 38.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.942 0.897 . . . . 10.0 112.063 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.13 79.42 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.682 0.793 . . . . 10.0 112.729 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.78 -38.54 91.49 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.42 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.269 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.46 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.845 1.658 . . . . 10.0 112.086 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.51 135.88 54.32 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.662 0.616 . . . . 10.0 112.662 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.84 -39.73 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.438 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.18 5.34 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.148 1.356 . . . . 10.0 115.25 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.08 -46.8 87.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.39 -52.91 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.161 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.66 -51.3 67.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.68 -59.82 4.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.366 2.266 . . . . 10.0 114.793 174.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.05 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 123.667 0.787 . . . . 10.0 111.398 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.17 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.617 0.627 . . . . 10.0 112.664 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.61 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.46 0.911 . . . . 10.0 113.46 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.02 -47.21 78.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.319 0.648 . . . . 10.0 111.684 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -54.23 5.95 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.825 1.203 . . . . 10.0 113.013 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.44 -51.22 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.744 0.818 . . . . 10.0 112.043 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 52.5 ttp -48.62 -57.15 6.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.019 1.327 . . . . 10.0 111.659 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.7 mm -67.6 -46.24 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.227 0.611 . . . . 10.0 111.907 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.44 -55.06 21.42 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.122 1.344 . . . . 10.0 113.263 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.5 p -61.08 -36.13 78.82 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.235 -1.156 . . . . 10.0 112.693 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.66 -57.17 12.84 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-N 119.158 0.89 . . . . 10.0 113.727 165.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.28 -50.71 37.82 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.668 2.787 . . . . 10.0 111.124 173.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.35 -50.55 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.587 1.155 . . . . 10.0 111.697 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.39 -59.21 8.63 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.713 1.625 . . . . 10.0 112.062 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.89 -37.84 20.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.913 2.085 . . . . 10.0 113.563 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.43 -6.63 27.35 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.7 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.199 -1.563 . . . . 10.0 110.398 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.65 71.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.255 2.622 . . . . 10.0 113.251 177.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.72 106.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.86 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.732 1.213 . . . . 10.0 114.101 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.02 15.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.7 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -53.7 -42.01 67.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.855 0.752 . . . . 10.0 110.807 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.35 -32.29 71.27 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.898 1.279 . . . . 10.0 114.213 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.97 -51.76 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.015 0.825 . . . . 10.0 109.608 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -61.96 -45.24 94.51 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 174.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -51.38 -49.24 61.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.35 1.06 . . . . 10.0 112.531 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.53 -52.63 64.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.191 0.996 . . . . 10.0 111.894 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.53 -52.0 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.831 1.252 . . . . 10.0 111.619 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -54.65 -47.06 73.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 10.0 111.99 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.8 m -60.49 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.53 1.532 . . . . 10.0 112.52 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.58 -48.43 80.95 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.19 0.905 . . . . 10.0 112.312 172.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.08 81.68 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.737 0.815 . . . . 10.0 112.484 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.05 -55.07 35.14 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.182 0.993 . . . . 10.0 112.101 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.13 -48.06 68.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.386 1.474 . . . . 10.0 111.947 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.07 -54.58 23.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 10.0 112.46 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.47 -55.17 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.787 0.835 . . . . 10.0 110.751 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.7 mt -57.42 -35.79 70.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.35 -0.833 . . . . 10.0 112.914 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.3 -58.23 9.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.042 0.937 . . . . 10.0 112.994 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.296 -0.859 . . . . 10.0 111.469 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.75 -49.42 75.3 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.873 1.215 . . . . 10.0 112.13 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.882 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.7 -21.95 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.671 1.188 . . . . 10.0 113.453 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.48 51.33 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.227 1.811 . . . . 10.0 113.037 -166.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.1 m -52.05 -56.42 14.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.64 -50.59 65.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.121 0.962 . . . . 10.0 112.314 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.03 82.89 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.161 0.984 . . . . 10.0 112.135 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.52 80.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.097 1.759 . . . . 10.0 114.195 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.61 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.432 1.893 . . . . 10.0 114.894 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.89 -92.61 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.521 1.629 . . . . 10.0 114.185 -170.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.99 72.63 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.767 3.227 . . . . 10.0 105.539 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.87 -46.23 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.269 1.979 . . . . 10.0 113.06 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.12 67.94 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.247 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.248 0.619 . . . . 10.0 111.937 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.93 -56.2 24.6 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.886 0.874 . . . . 10.0 112.765 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.16 -53.26 60.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 113.028 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.51 45.76 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.16 -48.43 78.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.99 -49.62 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.462 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.65 69.0 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.78 -47.78 30.53 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.816 2.046 . . . . 10.0 111.044 174.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.44 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.845 0.458 . . . . 10.0 111.274 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -52.23 -47.07 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.075 0.95 . . . . 10.0 111.989 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.0 m -58.62 -62.96 1.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.437 2.695 . . . . 10.0 111.822 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.33 -50.34 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.675 1.19 . . . . 10.0 111.071 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.85 -60.2 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.053 0.941 . . . . 10.0 112.068 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.54 -50.05 75.41 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.663 0.665 . . . . 10.0 112.743 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -53.39 -50.84 64.29 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.752 0.821 . . . . 10.0 111.382 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -58.52 -21.07 50.98 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.11 73.76 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.684 1.129 . . . . 10.0 113.225 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -45.01 -53.71 15.46 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 115.18 1.548 . . . . 10.0 115.18 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.528 ' HB3' H183 ' A' ' 999' ' ' RET . 27.5 Cg_endo -59.39 -35.25 96.94 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.99 1.793 . . . . 10.0 113.188 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.4 t -67.22 -54.97 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.326 1.05 . . . . 10.0 111.066 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.77 -44.77 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.111 0.869 . . . . 10.0 112.161 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -56.33 -52.2 65.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.984 0.914 . . . . 10.0 112.321 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.4 tp -53.91 -45.42 71.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.513 1.125 . . . . 10.0 112.5 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -87.45 -5.28 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 115.248 1.573 . . . . 10.0 115.248 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.56 -169.3 32.76 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 122.611 1.117 . . . . 10.0 113.805 -168.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -40.73 64.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.165 -1.017 . . . . 10.0 111.838 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -54.56 -32.27 58.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.406 2.683 . . . . 10.0 115.379 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.92 0.99 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 10.0 113.38 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.18 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.318 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.45 65.28 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.29 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -68.73 153.79 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.15 -39.81 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.199 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.36 -52.38 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.681 1.363 . . . . 10.0 114.681 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.9 -40.5 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.674 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.31 -49.75 42.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.533 0.606 . . . . 10.0 111.974 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.72 -47.07 83.45 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.983 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.3 -52.33 62.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.016 0.926 . . . . 10.0 112.101 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 92.9 mt -52.51 -58.72 5.86 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 124.321 1.048 . . . . 10.0 110.003 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -52.08 -47.08 65.36 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.692 -1.147 . . . . 10.0 112.35 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.73 -52.14 57.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.308 1.413 . . . . 10.0 112.765 175.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.84 -49.64 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.461 1.104 . . . . 10.0 111.377 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mp -55.62 -52.86 62.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.56 . . . . 10.0 111.702 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -53.54 -56.41 17.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.957 2.103 . . . . 10.0 111.047 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 43.6 t -50.58 -51.58 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.169 0.987 . . . . 10.0 111.374 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.2 t -61.59 -43.65 98.46 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.603 0.594 . . . . 10.0 112.603 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.37 -24.61 61.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.108 1.763 . . . . 10.0 114.192 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -100.14 -71.74 0.69 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.716 1.206 . . . . 10.0 111.236 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.13 -50.65 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.465 1.106 . . . . 10.0 111.539 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.11 -55.92 25.78 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.134 0.873 . . . . 10.0 113.083 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -43.06 -56.88 3.14 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.003 2.121 . . . . 10.0 112.382 166.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.97 -40.79 74.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.338 0.971 . . . . 10.0 114.095 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.75 -27.2 64.75 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 115.962 1.838 . . . . 10.0 115.962 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.52 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.78 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.92 0.888 . . . . 10.0 113.2 -172.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.5 5.12 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.308 1.596 . . . . 10.0 115.308 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.25 0.32 15.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.217 1.007 . . . . 10.0 113.292 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.026 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.21 1.87 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.812 0.845 . . . . 10.0 110.891 170.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.97 77.04 7.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.914 0.885 . . . . 10.0 112.03 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.464 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.48 0.3 OUTLIER 71.77 -55.37 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.765 1.226 . . . . 10.0 110.668 -175.275 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.781 3.562 . . . . 10.0 119.618 171.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.45 2.7 . . . . 10.0 113.408 166.649 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.528 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.305 2.642 . . . . 10.0 114.486 155.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.47 138.01 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.384 1.873 . . . . 10.0 113.344 -158.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.18 1.69 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 113.978 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.76 41.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 127.403 2.43 . . . . 10.0 111.491 168.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.57 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.634 -168.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.67 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.522 2.293 . . . . 10.0 113.212 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.15 4.32 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.782 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.41 -43.08 61.88 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.587 176.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.62 83.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.912 0.885 . . . . 10.0 109.315 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.35 -52.64 62.84 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.377 0.671 . . . . 10.0 111.928 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.187 0.595 . . . . 10.0 112.245 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.83 51.95 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.412 1.485 . . . . 10.0 113.287 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.98 84.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -57.06 10.07 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.247 0.927 . . . . 10.0 111.3 166.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -48.98 -52.46 24.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.642 1.177 . . . . 10.0 112.302 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.9 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.148 0.979 . . . . 10.0 112.166 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.66 -50.29 73.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.682 0.793 . . . . 10.0 112.579 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -53.69 -50.35 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.503 1.121 . . . . 10.0 111.348 175.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.36 -58.28 15.41 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.338 0.971 . . . . 10.0 113.471 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.91 79.79 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.539 1.17 . . . . 10.0 112.146 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.29 -42.53 73.99 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.956 1.265 . . . . 10.0 113.185 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.9 m -61.82 -58.75 6.75 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.852 0.861 . . . . 10.0 111.448 171.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.79 -58.04 9.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.974 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.7 82.13 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.176 0.806 . . . . 10.0 113.176 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.602 1.161 . . . . 10.0 113.64 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.718 1.723 . . . . 10.0 110.86 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.305 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 115.609 1.004 . . . . 10.0 115.609 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.02 92.93 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.46 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.798 0.713 . . . . 10.0 112.441 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.931 166.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.174 -1.375 . . . . 10.0 113.866 174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.769 1.293 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.58 -29.67 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.756 2.971 . . . . 10.0 113.682 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.17 -40.07 22.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.078 1.351 . . . . 10.0 113.534 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.43 19.58 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.434 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 111.015 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.94 -50.25 73.17 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.35 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.41 -51.26 65.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.353 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.2 mt -48.51 -58.0 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.892 1.277 . . . . 10.0 110.193 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -68.54 -16.48 63.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.218 1.407 . . . . 10.0 113.819 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -88.66 -39.72 13.83 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.624 1.102 . . . . 10.0 112.188 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.34 -42.17 90.89 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.457 -0.777 . . . . 10.0 112.29 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -41.13 -61.84 1.21 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 126.214 1.806 . . . . 10.0 113.782 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.13 -26.83 17.6 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.028 2.485 . . . . 10.0 114.436 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.69 89.49 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.504 1.502 . . . . 10.0 113.387 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -55.54 -53.81 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.426 1.09 . . . . 10.0 109.128 170.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -42.63 71.67 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.312 1.045 . . . . 10.0 113.751 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -52.93 -56.73 13.79 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.575 1.534 . . . . 10.0 111.915 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.96 -52.51 32.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.347 1.459 . . . . 10.0 110.735 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.21 62.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 118.168 -0.92 . . . . 10.0 112.982 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -56.3 -40.91 75.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.37 1.441 . . . . 10.0 113.013 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.23 -54.57 34.25 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.179 1.354 . . . . 10.0 111.333 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.66 -41.03 61.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.259 1.577 . . . . 10.0 115.259 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.91 -50.85 61.1 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.451 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.5 48.9 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.328 1.051 . . . . 10.0 113.835 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.01 43.21 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.26 1.578 . . . . 10.0 115.26 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.12 3.59 61.28 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.302 0.881 . . . . 10.0 115.302 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.4 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.035 2.134 . . . . 10.0 109.036 172.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.028 0.931 . . . . 10.0 111.0 166.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.887 0.875 . . . . 10.0 109.712 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.56 129.54 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.068 1.347 . . . . 10.0 110.976 -176.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.74 116.3 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.384 -1.044 . . . . 10.0 109.384 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.76 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.695 -0.962 . . . . 10.0 110.695 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.37 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.708 2.243 . . . . 10.0 118.708 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.54 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.263 -165.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.87 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.081 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.47 120.82 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.53 131.92 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.11 126.38 22.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.0 1.72 . . . . 10.0 111.684 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.746 1.26 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.3 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.54 -31.14 61.87 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.231 1.012 . . . . 10.0 112.305 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 82' ' ' ARG . 16.1 ttm-85 -46.97 -44.48 20.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.198 2.199 . . . . 10.0 113.104 167.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -82.12 -38.9 24.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.651 1.581 . . . . 10.0 111.794 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.17 -49.25 52.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.073 1.349 . . . . 10.0 111.629 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -53.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.038 1.735 . . . . 10.0 111.849 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -54.95 -33.23 62.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.936 -1.031 . . . . 10.0 113.549 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.13 -40.39 46.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.399 1.48 . . . . 10.0 112.051 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.28 -46.1 4.5 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.253 1.021 . . . . 10.0 112.303 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.1 m -52.32 -43.68 64.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.879 1.271 . . . . 10.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 m -72.87 -45.5 8.79 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 114.313 1.227 . . . . 10.0 114.313 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.88 -41.63 69.36 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.339 2.693 . . . . 10.0 115.1 167.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.0 mt -59.6 -47.14 86.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.285 0.634 . . . . 10.0 111.431 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.8 -51.45 22.5 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.349 1.86 . . . . 10.0 111.412 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.06 -47.28 83.64 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.92 1.288 . . . . 10.0 113.165 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.29 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.849 0.859 . . . . 10.0 112.889 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.34 -53.96 37.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.256 0.934 . . . . 10.0 111.2 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -42.05 88.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.62 0.768 . . . . 10.0 112.087 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 37.95 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.017 0.927 . . . . 10.0 112.024 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.29 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.752 0.821 . . . . 10.0 112.699 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.76 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.81 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.312 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.45 12.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.847 1.659 . . . . 10.0 112.159 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.92 54.38 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.69 2.61 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.523 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.79 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.46 -52.9 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.07 1.348 . . . . 10.0 111.128 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.61 -51.26 68.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.88 43.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.504 0.722 . . . . 10.0 110.923 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.357 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.82 -46.37 74.53 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.044 0.757 . . . . 10.0 113.044 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.52 -45.24 85.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.138 . . . . 10.0 112.08 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.99 -56.76 5.07 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.618 1.58 . . . . 10.0 112.797 166.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.46 -52.1 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 10.0 111.054 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 55.1 ttp -48.0 -59.79 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.855 1.262 . . . . 10.0 112.037 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.4 -48.42 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.658 0.783 . . . . 10.0 111.889 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.36 -46.75 57.45 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.631 1.11 . . . . 10.0 113.016 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 63.0 m -59.26 -45.36 91.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.686 1.195 . . . . 10.0 111.779 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.29 -51.7 20.23 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.856 0.741 . . . . 10.0 112.768 167.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.4 -48.36 68.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.077 2.551 . . . . 10.0 111.693 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.71 -49.15 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.397 1.479 . . . . 10.0 111.967 172.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.22 -59.25 9.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.911 1.719 . . . . 10.0 112.387 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.03 -42.94 3.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.313 2.645 . . . . 10.0 113.254 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.0 mt -101.42 -6.67 23.71 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.499 1.666 . . . . 10.0 115.499 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.7 10.36 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.19 -1.569 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.47 -49.62 72.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.187 2.595 . . . . 10.0 113.268 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.087 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.9 -59.53 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.07 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.501 1.52 . . . . 10.0 113.503 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.56 63.15 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.15 -41.26 68.24 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.89 0.768 . . . . 10.0 110.899 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.97 -31.98 69.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.837 1.255 . . . . 10.0 114.221 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.076 0.853 . . . . 10.0 109.713 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -60.03 -48.32 82.19 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -48.93 -49.61 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.575 1.079 . . . . 10.0 113.014 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.85 63.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 10.0 111.945 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.69 -51.28 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.983 1.313 . . . . 10.0 111.786 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.2 t -55.89 -46.24 78.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.615 1.166 . . . . 10.0 111.793 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.9 m -60.88 -42.64 98.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 10.0 112.557 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.78 79.17 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.228 0.922 . . . . 10.0 112.31 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.02 82.52 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.587 0.755 . . . . 10.0 112.607 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -55.38 -55.33 32.86 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.319 1.048 . . . . 10.0 112.142 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 tt -51.24 -50.54 58.98 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.949 1.7 . . . . 10.0 111.185 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -50.93 -54.9 20.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.021 0.928 . . . . 10.0 112.792 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.1 -54.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.592 0.757 . . . . 10.0 110.861 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.46 -36.58 69.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.692 0.797 . . . . 10.0 113.115 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.16 9.45 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.036 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.87 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.467 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.78 -49.44 75.29 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.115 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.087 -1.633 . . . . 10.0 112.871 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.68 -21.99 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 10.0 113.466 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.76 -79.06 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.621 0.629 . . . . 10.0 113.553 171.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.236 1.814 . . . . 10.0 113.045 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -50.55 65.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.057 0.932 . . . . 10.0 112.297 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.07 82.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.133 0.973 . . . . 10.0 112.167 173.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.45 80.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.532 1.308 . . . . 10.0 114.532 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.25 1.2 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.033 1.733 . . . . 10.0 114.254 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.65 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.391 1.876 . . . . 10.0 114.878 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.93 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.7 153.92 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.841 3.256 . . . . 10.0 105.592 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.82 -46.23 35.14 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.275 1.983 . . . . 10.0 113.06 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.15 68.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.236 173.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.1 -53.05 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.027 0.931 . . . . 10.0 109.832 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.8 75.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.274 0.63 . . . . 10.0 111.892 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.15 25.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.882 0.873 . . . . 10.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.25 -53.22 60.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 112.987 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.53 45.44 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.115 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.48 78.54 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.91 -49.63 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.843 0.747 . . . . 10.0 110.522 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.64 69.02 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.81 30.15 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.889 2.075 . . . . 10.0 111.037 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.836 0.454 . . . . 10.0 111.263 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.4 t -52.08 -47.39 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 112.209 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -65.29 0.66 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.209 2.604 . . . . 10.0 111.46 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.93 -48.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.783 1.233 . . . . 10.0 111.548 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.7 t -60.52 -61.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.945 0.898 . . . . 10.0 112.653 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.08 -48.78 73.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.766 0.712 . . . . 10.0 111.608 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -50.11 -53.03 30.14 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.647 1.179 . . . . 10.0 112.53 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m -53.14 -32.02 45.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.278 1.031 . . . . 10.0 113.589 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.85 94.83 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.03 1.122 . . . . 10.0 114.03 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -46.87 -56.67 11.0 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 115.098 1.518 . . . . 10.0 115.098 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.528 ' HB3' H183 ' A' ' 999' ' ' RET . 29.1 Cg_endo -59.59 -36.7 91.89 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.526 2.151 . . . . 10.0 113.056 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.85 -57.94 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.393 1.077 . . . . 10.0 110.745 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.73 -34.66 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 118.692 -0.671 . . . . 10.0 112.605 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -58.73 -56.1 26.59 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.547 1.139 . . . . 10.0 111.944 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.2 tt -58.36 -41.69 85.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.915 0.886 . . . . 10.0 112.697 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -81.27 -5.52 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.22 -169.29 33.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-O 122.587 1.104 . . . . 10.0 113.953 -169.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.43 65.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.847 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.46 -16.76 64.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.647 1.721 . . . . 10.0 115.647 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.05 -105.91 1.08 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.32 1.418 . . . . 10.0 113.799 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.17 35.81 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.617 -1.519 . . . . 10.0 109.325 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.894 0.318 . . . . 10.0 113.894 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.725 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.29 133.35 24.88 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.69 153.8 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.786 2.99 . . . . 10.0 111.433 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.77 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.307 1.043 . . . . 10.0 112.213 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.35 -52.35 22.07 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.712 1.375 . . . . 10.0 114.712 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.92 -40.5 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.476 1.11 . . . . 10.0 109.692 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.32 -49.78 42.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.513 0.597 . . . . 10.0 111.973 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.04 83.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.001 1.72 . . . . 10.0 112.993 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.35 62.14 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.02 0.928 . . . . 10.0 112.03 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -58.52 6.5 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.363 1.065 . . . . 10.0 109.975 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -53.44 -44.95 69.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.759 -1.115 . . . . 10.0 112.839 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.45 -53.0 57.66 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.66 -47.51 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.819 1.248 . . . . 10.0 111.678 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.12 -51.62 68.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.629 1.571 . . . . 10.0 111.815 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.21 -51.63 69.14 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.917 1.687 . . . . 10.0 111.788 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.1 t -48.83 -51.52 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.669 1.188 . . . . 10.0 110.987 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.5 m -58.81 -50.71 72.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.461 1.104 . . . . 10.0 111.823 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.91 -28.23 64.37 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.594 1.558 . . . . 10.0 114.459 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.75 -72.16 0.5 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.753 1.221 . . . . 10.0 110.017 173.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.35 -49.88 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.084 1.354 . . . . 10.0 111.575 -167.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.82 -53.66 35.18 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.163 0.887 . . . . 10.0 112.903 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -44.94 -58.02 3.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.542 1.937 . . . . 10.0 112.293 166.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.49 -38.5 70.62 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.005 0.812 . . . . 10.0 113.235 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -70.29 -27.65 64.57 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 116.215 1.932 . . . . 10.0 116.215 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.68 -57.49 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.63 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.921 0.889 . . . . 10.0 113.2 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.53 5.15 2.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.37 0.41 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.18 0.992 . . . . 10.0 113.272 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.08 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.011 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.98 7.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.874 0.87 . . . . 10.0 112.106 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.869 2.868 . . . . 10.0 116.475 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.719 1.208 . . . . 10.0 110.644 -175.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.21 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.666 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.483 2.713 . . . . 10.0 113.459 166.653 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.528 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.834 -2.032 . . . . 10.0 105.789 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 129.651 3.18 . . . . 10.0 117.196 160.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.65 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.306 2.642 . . . . 10.0 114.484 155.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.46 137.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.407 1.883 . . . . 10.0 113.345 -158.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.22 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.465 2.459 . . . . 10.0 111.487 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.62 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.25 -2.786 . . . . 10.0 116.634 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.543 2.301 . . . . 10.0 113.217 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.19 4.31 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.782 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.11 61.74 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.534 -0.729 . . . . 10.0 112.615 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.6 84.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.63 62.91 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.448 0.699 . . . . 10.0 111.882 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.59 56.42 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.183 0.593 . . . . 10.0 112.218 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 51.97 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.98 10.25 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.149 0.881 . . . . 10.0 111.202 166.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.27 -52.3 28.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.574 1.15 . . . . 10.0 112.187 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.122 0.969 . . . . 10.0 112.167 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.3 mt -57.86 -50.14 74.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.449 0.699 . . . . 10.0 112.751 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -49.7 68.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.442 1.097 . . . . 10.0 111.248 175.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.32 15.2 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.3 0.952 . . . . 10.0 113.608 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.02 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.485 1.142 . . . . 10.0 112.089 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -41.59 75.74 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.863 1.22 . . . . 10.0 113.232 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.55 -58.44 7.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.823 0.849 . . . . 10.0 111.421 171.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -40.98 62.49 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.045 0.938 . . . . 10.0 110.944 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.1 9.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.968 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.68 81.85 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.257 0.836 . . . . 10.0 113.257 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.46 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.586 1.154 . . . . 10.0 113.62 169.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.77 1.748 . . . . 10.0 110.892 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.013 . . . . 10.0 115.634 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.58 -44.96 93.16 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.162 2.185 . . . . 10.0 113.589 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.435 2.694 . . . . 10.0 116.939 166.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.64 -50.92 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.179 -1.373 . . . . 10.0 113.879 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.771 1.294 . . . . 10.0 110.957 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.59 -29.63 89.65 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.743 2.962 . . . . 10.0 113.69 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.09 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.108 1.363 . . . . 10.0 113.564 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.44 19.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.405 172.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.967 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.97 -50.23 73.29 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.334 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.29 65.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.337 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.53 -57.42 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.851 1.26 . . . . 10.0 110.533 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -67.99 -20.75 65.05 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.965 1.306 . . . . 10.0 113.552 -172.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -84.07 -40.92 17.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.414 1.086 . . . . 10.0 112.18 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.07 -41.52 88.15 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.469 -0.77 . . . . 10.0 112.983 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.37 -62.84 1.45 Allowed Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 124.603 1.161 . . . . 10.0 113.447 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.79 -26.34 32.56 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.001 2.467 . . . . 10.0 113.771 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.86 -45.94 83.92 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 120.547 1.522 . . . . 10.0 113.156 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.76 -51.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 120.982 -1.073 . . . . 10.0 109.302 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.82 72.84 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.42 0.896 . . . . 10.0 113.42 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -52.81 -56.42 15.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.119 1.368 . . . . 10.0 111.816 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.67 -52.78 28.58 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.263 1.425 . . . . 10.0 110.749 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.29 -47.97 62.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.99 0.916 . . . . 10.0 112.98 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.15 -41.2 75.04 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.365 1.439 . . . . 10.0 113.11 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.57 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.948 1.249 . . . . 10.0 111.297 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.61 -41.12 61.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.86 -50.85 61.22 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.525 0.73 . . . . 10.0 110.485 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.5 48.82 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.539 0.976 . . . . 10.0 115.539 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.55 61.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.42 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.042 2.137 . . . . 10.0 109.036 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.57 171.13 15.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.028 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.01 53.42 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.912 0.885 . . . . 10.0 109.712 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.51 129.62 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.079 1.352 . . . . 10.0 110.96 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.444 -1.022 . . . . 10.0 109.444 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.37 38.2 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.42 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.632 -0.987 . . . . 10.0 110.632 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.78 -3.35 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.317 1.558 . . . . 10.0 112.28 -165.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.93 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.52 120.74 69.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -165.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.2 Cg_exo -61.49 131.92 38.28 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.137 171.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.1 126.33 21.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.055 1.742 . . . . 10.0 111.752 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.63 85.01 4.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.958 1.361 . . . . 10.0 113.085 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.36 -28.28 66.71 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.898 -1.126 . . . . 10.0 113.928 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.8 38.3 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.26 1.024 . . . . 10.0 112.491 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -54.27 -48.3 71.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.032 1.333 . . . . 10.0 112.714 168.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -71.25 -38.49 71.91 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.485 1.114 . . . . 10.0 110.993 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.52 67.09 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.797 1.239 . . . . 10.0 112.367 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.15 -69.51 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.883 1.673 . . . . 10.0 111.624 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -56.84 -32.5 65.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.067 1.347 . . . . 10.0 112.836 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.35 -44.27 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.679 1.592 . . . . 10.0 111.876 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -100.14 -41.94 6.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 10.0 112.593 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.4 p -62.6 -42.72 99.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.836 1.198 . . . . 10.0 113.925 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 71.5 p -65.85 -44.01 60.98 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 114.663 1.357 . . . . 10.0 114.663 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -43.95 53.12 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.053 2.502 . . . . 10.0 115.637 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.46 -46.4 88.87 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.491 -0.756 . . . . 10.0 111.454 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 tp -50.76 -49.2 58.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.567 1.547 . . . . 10.0 112.038 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.09 -47.47 83.11 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.94 1.296 . . . . 10.0 112.513 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.22 78.28 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.78 0.832 . . . . 10.0 112.889 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.31 -54.04 36.64 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.309 0.959 . . . . 10.0 111.173 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.06 88.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 10.0 112.14 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 38.1 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 112.002 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.35 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.682 0.793 . . . . 10.0 112.704 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.76 -38.57 91.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.81 1.43 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.055 1.342 . . . . 10.0 112.296 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.9 47.62 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.443 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.93 54.46 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.664 0.616 . . . . 10.0 112.664 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.72 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.499 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.04 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.339 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.43 -52.9 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.075 1.35 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.27 67.89 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.87 43.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.429 0.692 . . . . 10.0 110.945 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.655 0.782 . . . . 10.0 111.375 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.9 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.78 -46.58 74.45 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -56.07 -48.3 76.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.896 0.879 . . . . 10.0 110.903 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.79 -54.57 4.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.951 1.263 . . . . 10.0 113.195 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.15 -51.01 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.903 0.881 . . . . 10.0 112.119 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -54.19 -51.96 62.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.866 1.212 . . . . 10.0 111.987 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.1 mm -69.87 -45.53 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.801 -0.562 . . . . 10.0 111.034 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.2 -58.21 11.36 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.21 1.386 . . . . 10.0 113.345 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.0 p -61.31 -33.71 74.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.234 -1.156 . . . . 10.0 112.735 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.95 -55.29 19.01 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 119.395 0.998 . . . . 10.0 113.659 162.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tt -52.78 -45.37 67.11 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.921 2.889 . . . . 10.0 110.881 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.14 -50.4 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.55 1.54 . . . . 10.0 112.139 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.0 -58.98 9.34 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.919 1.723 . . . . 10.0 112.398 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.92 -43.3 3.03 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.057 2.543 . . . . 10.0 113.466 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.43 -6.33 24.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.461 1.652 . . . . 10.0 115.461 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.63 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.222 -1.549 . . . . 10.0 110.41 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.619 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.68 71.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.26 2.624 . . . . 10.0 113.251 177.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.61 106.3 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.52 3.03 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.771 1.229 . . . . 10.0 114.065 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.05 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.48 1.512 . . . . 10.0 113.519 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.63 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.907 1.447 . . . . 10.0 114.907 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -53.91 -41.81 68.05 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.914 0.779 . . . . 10.0 110.75 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.72 -31.49 69.52 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.355 1.243 . . . . 10.0 114.355 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.44 -52.01 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.041 0.837 . . . . 10.0 109.551 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -61.84 -42.56 99.19 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -53.67 -49.2 68.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.233 1.013 . . . . 10.0 112.759 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -52.58 64.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.636 0.774 . . . . 10.0 111.503 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.6 -55.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.987 1.315 . . . . 10.0 112.051 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 p -57.04 -43.63 82.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.905 0.882 . . . . 10.0 112.696 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -43.93 98.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.758 1.223 . . . . 10.0 112.157 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.41 81.7 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.229 0.922 . . . . 10.0 112.561 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.23 78.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.989 0.916 . . . . 10.0 112.43 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.8 ttp -56.56 -51.06 70.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.285 1.034 . . . . 10.0 112.382 171.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.02 -48.06 76.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.32 1.448 . . . . 10.0 112.681 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -48.53 -53.52 17.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.394 1.078 . . . . 10.0 111.794 169.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.72 -55.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.68 0.792 . . . . 10.0 110.899 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -56.52 -36.42 69.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.226 0.824 . . . . 10.0 113.226 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.28 -58.15 9.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.049 0.939 . . . . 10.0 113.059 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.5 -40.82 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.289 -0.863 . . . . 10.0 111.429 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.84 -49.4 75.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.909 1.231 . . . . 10.0 112.093 171.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.99 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.858 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.615 1.166 . . . . 10.0 113.447 -174.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.11 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.651 0.643 . . . . 10.0 113.554 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.242 1.817 . . . . 10.0 113.011 -166.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.06 -56.46 14.2 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.005 1.113 . . . . 10.0 114.005 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.69 -50.55 65.61 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.096 0.951 . . . . 10.0 112.272 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.14 -46.02 83.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.16 0.984 . . . . 10.0 112.151 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.51 80.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.43 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.124 1.77 . . . . 10.0 114.235 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.59 29.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.425 1.89 . . . . 10.0 114.851 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.5 1.619 . . . . 10.0 114.164 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.805 3.242 . . . . 10.0 105.562 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.84 -46.22 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.306 2.004 . . . . 10.0 113.069 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.11 68.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.057 2.943 . . . . 10.0 113.236 173.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.82 75.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.282 0.633 . . . . 10.0 111.917 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.19 24.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.913 0.885 . . . . 10.0 112.698 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.226 1.011 . . . . 10.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.55 -49.53 45.86 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.26 0.624 . . . . 10.0 111.115 174.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.15 -48.41 78.76 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.94 -49.7 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.801 0.728 . . . . 10.0 110.467 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.51 -51.63 69.07 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.8 -47.76 30.85 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 126.852 2.061 . . . . 10.0 111.04 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.48 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.862 0.465 . . . . 10.0 111.271 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.1 -47.33 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.078 0.951 . . . . 10.0 112.093 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.4 m -58.36 -64.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.126 2.57 . . . . 10.0 111.492 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -50.18 -49.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.676 1.19 . . . . 10.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.36 -63.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.974 0.91 . . . . 10.0 112.043 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.58 -45.45 81.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.142 0.883 . . . . 10.0 112.378 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -53.03 -51.88 60.27 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.107 0.963 . . . . 10.0 112.236 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 52.6 p -52.39 -33.19 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.243 1.201 . . . . 10.0 114.243 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.32 97.43 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.973 1.101 . . . . 10.0 113.973 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -46.87 -58.07 7.75 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 114.769 1.396 . . . . 10.0 114.769 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.404 ' HB3' H183 ' A' ' 999' ' ' RET . 32.3 Cg_endo -60.55 -33.5 93.64 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.174 1.916 . . . . 10.0 113.429 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.1 t -64.23 -58.02 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.143 0.883 . . . . 10.0 110.659 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.69 -35.06 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.46 0.704 . . . . 10.0 112.77 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -59.63 -55.18 37.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.563 1.145 . . . . 10.0 112.115 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.81 -41.68 82.67 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.764 0.826 . . . . 10.0 112.494 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -81.42 -5.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 115.003 1.483 . . . . 10.0 115.003 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.4 -169.31 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 122.576 1.098 . . . . 10.0 113.924 -168.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.56 65.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.822 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -67.92 -15.74 63.75 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.542 1.682 . . . . 10.0 115.542 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.53 -105.94 1.05 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 120.428 1.467 . . . . 10.0 114.03 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.304 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.32 1.35 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 113.855 0.302 . . . . 10.0 113.855 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.77 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.12 1.768 . . . . 10.0 108.692 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.7 t -126.26 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.368 -174.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.73 153.81 72.45 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.456 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.297 1.039 . . . . 10.0 112.199 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.3 -52.42 21.47 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 10.0 114.685 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.36 -49.77 42.93 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.563 0.62 . . . . 10.0 111.937 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.7 -47.05 83.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.979 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.28 -52.35 62.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.974 0.91 . . . . 10.0 112.123 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -58.96 5.1 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.303 1.041 . . . . 10.0 109.992 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -52.32 -44.57 65.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.679 -1.153 . . . . 10.0 112.6 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -55.26 -51.76 65.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.608 1.549 . . . . 10.0 112.511 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.43 -46.68 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.936 1.294 . . . . 10.0 111.629 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.91 -52.68 64.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.556 1.542 . . . . 10.0 111.601 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.57 -54.11 49.78 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.785 1.634 . . . . 10.0 111.933 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.94 -43.88 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.22 -0.925 . . . . 10.0 112.456 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 55.4 p -62.96 -44.84 94.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.74 0.7 . . . . 10.0 112.061 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.05 -28.22 69.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.405 1.482 . . . . 10.0 114.279 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.65 -74.16 0.53 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.507 1.123 . . . . 10.0 110.898 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.05 -48.26 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.675 1.59 . . . . 10.0 111.245 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.54 -55.69 27.36 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.094 0.854 . . . . 10.0 112.985 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -45.18 -56.3 4.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.414 1.886 . . . . 10.0 112.284 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.04 -40.03 71.93 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.072 0.844 . . . . 10.0 113.635 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.48 -27.69 64.4 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 115.774 1.768 . . . . 10.0 115.774 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.42 -57.52 11.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 165.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.65 0.86 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.907 0.883 . . . . 10.0 113.168 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.58 5.24 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.31 15.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.266 1.026 . . . . 10.0 113.28 172.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.038 0.935 . . . . 10.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.12 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.771 0.828 . . . . 10.0 110.973 170.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.85 76.99 7.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.87 0.868 . . . . 10.0 112.117 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.471 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.41 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.622 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.51 39.93 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.519 2.727 . . . . 10.0 113.439 166.61 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.522 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.782 -2.056 . . . . 10.0 105.826 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.51 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.615 3.166 . . . . 10.0 117.211 160.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.1 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.356 2.662 . . . . 10.0 114.417 155.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.365 1.866 . . . . 10.0 113.391 -158.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.13 1.69 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.306 1.842 . . . . 10.0 114.055 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.96 2.84 40.82 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 127.489 2.471 . . . . 10.0 111.487 168.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.55 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.96 -60.65 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.488 2.281 . . . . 10.0 113.191 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.23 4.37 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.8 2.44 . . . . 10.0 115.742 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.13 61.79 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.464 -0.772 . . . . 10.0 112.621 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.41 -52.65 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.422 0.689 . . . . 10.0 111.83 175.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.33 -53.59 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.174 0.59 . . . . 10.0 112.225 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 -46.81 52.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.368 1.467 . . . . 10.0 113.305 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.61 -45.04 84.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.83 -58.68 7.4 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.355 0.978 . . . . 10.0 110.765 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -48.4 -52.34 22.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.745 1.218 . . . . 10.0 112.072 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 -58.9 5.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.175 0.99 . . . . 10.0 112.15 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.74 -49.77 75.44 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.707 0.803 . . . . 10.0 112.207 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.2 mmm -57.78 -45.95 85.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.374 0.67 . . . . 10.0 111.603 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.47 -58.1 16.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.46 1.029 . . . . 10.0 113.895 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.21 -45.99 79.66 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.406 1.103 . . . . 10.0 112.077 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -42.02 75.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.821 1.2 . . . . 10.0 113.168 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 -58.58 7.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.676 0.79 . . . . 10.0 111.474 171.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.01 62.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.023 0.929 . . . . 10.0 110.974 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.78 -57.99 9.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.582 1.153 . . . . 10.0 113.011 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.68 82.0 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.621 1.168 . . . . 10.0 113.637 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.748 . . . . 10.0 110.878 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.937 2.495 . . . . 10.0 109.365 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.89 23.09 0.86 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.94 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.614 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.9 m -79.61 -50.87 10.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.231 -1.35 . . . . 10.0 113.902 174.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.52 6.44 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.794 1.309 . . . . 10.0 110.975 -172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.54 -29.69 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.705 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.66 2.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.111 0.565 . . . . 10.0 111.447 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.53 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.056 1.342 . . . . 10.0 113.588 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.49 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.249 1.42 . . . . 10.0 113.468 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.13 61.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.486 0.714 . . . . 10.0 110.946 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.91 -50.28 73.03 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.26 65.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.341 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.02 1.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.407 0.892 . . . . 10.0 113.407 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.36 -57.26 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.921 1.288 . . . . 10.0 110.645 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -68.39 -20.17 64.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.999 1.32 . . . . 10.0 113.508 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.9 m -84.92 -39.69 17.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.488 1.115 . . . . 10.0 112.303 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.59 -42.89 97.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.8 t -43.39 -63.77 0.93 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.898 1.279 . . . . 10.0 112.482 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.43 -27.56 33.52 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.94 2.426 . . . . 10.0 114.217 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.79 89.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.459 1.481 . . . . 10.0 113.033 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.2 mt -61.84 -46.97 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 120.86 -1.15 . . . . 10.0 109.908 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.61 71.14 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.027 0.751 . . . . 10.0 113.027 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -50.82 -56.87 10.12 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.193 1.397 . . . . 10.0 111.677 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -48.91 -53.39 19.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.237 1.415 . . . . 10.0 111.087 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.99 -48.34 63.33 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.034 0.933 . . . . 10.0 112.909 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -55.22 -41.94 72.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.309 1.413 . . . . 10.0 113.287 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.56 34.44 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.619 1.099 . . . . 10.0 111.356 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.64 -41.03 61.02 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.256 1.576 . . . . 10.0 115.256 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtm -66.95 -50.8 61.2 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 123.568 0.747 . . . . 10.0 110.456 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.67 -52.63 22.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.837 0.855 . . . . 10.0 112.91 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.93 -5.53 48.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.875 1.065 . . . . 10.0 113.875 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.22 -34.66 5.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 115.601 1.0 . . . . 10.0 115.601 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.38 -43.06 43.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.59 61.05 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.363 0.905 . . . . 10.0 115.363 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.39 26.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.072 2.149 . . . . 10.0 109.066 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.48 171.09 15.15 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.059 0.943 . . . . 10.0 111.048 166.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.1 53.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.862 0.865 . . . . 10.0 109.693 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.8 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.75 116.29 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.4 38.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 118.703 2.241 . . . . 10.0 118.703 170.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.9 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.302 1.551 . . . . 10.0 112.223 -165.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.78 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.544 1.537 . . . . 10.0 111.159 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.43 120.81 69.68 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 112.981 0.734 . . . . 10.0 112.981 -165.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.58 131.93 38.12 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.209 3.273 . . . . 10.0 112.144 171.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.12 126.32 21.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.054 1.742 . . . . 10.0 111.746 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.57 84.96 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.057 1.408 . . . . 10.0 113.065 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.31 -28.26 66.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.787 -1.195 . . . . 10.0 113.98 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.73 62.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.056 1.502 . . . . 10.0 115.056 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.409 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -63.86 -29.62 70.79 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 119.847 -1.783 . . . . 10.0 113.284 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -70.78 -43.99 67.57 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.254 -0.904 . . . . 10.0 112.012 171.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.1 -46.67 45.18 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.164 1.386 . . . . 10.0 111.669 167.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -56.92 -70.82 0.11 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.102 1.361 . . . . 10.0 111.675 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.409 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.2 m0 -53.4 -33.51 54.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.422 1.489 . . . . 10.0 112.835 -170.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.5 tp -46.29 -48.95 18.02 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.942 1.697 . . . . 10.0 111.913 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -90.8 -44.5 9.39 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.324 1.05 . . . . 10.0 112.311 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.2 p -78.91 -32.98 45.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.133 1.16 . . . . 10.0 114.133 -165.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.317 69.8 p -61.55 -44.98 93.66 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.594 -1.193 . . . . 10.0 112.767 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.52 -44.99 43.01 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.911 2.407 . . . . 10.0 115.892 166.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.41 -47.4 85.59 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.319 -0.863 . . . . 10.0 111.881 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.17 -49.51 60.79 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.898 1.679 . . . . 10.0 111.3 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.05 -48.06 76.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.237 1.015 . . . . 10.0 112.907 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.21 78.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.823 0.849 . . . . 10.0 112.863 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.37 -53.99 37.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.299 0.954 . . . . 10.0 111.163 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.12 88.8 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.151 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.71 38.29 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.951 0.9 . . . . 10.0 112.031 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.21 79.4 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.736 0.814 . . . . 10.0 112.669 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.75 -38.58 91.64 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.41 1.263 . . . . 10.0 114.41 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.269 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.89 47.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.966 -1.709 . . . . 10.0 112.437 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.87 54.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.79 -39.77 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.922 1.689 . . . . 10.0 113.452 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.74 87.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.382 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.49 -52.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.003 1.321 . . . . 10.0 111.16 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.28 67.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.516 0.562 . . . . 10.0 112.516 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.91 42.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.446 0.698 . . . . 10.0 110.932 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.9 4.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.429 2.292 . . . . 10.0 114.821 174.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -47.01 74.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -58.52 -44.28 89.48 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.703 0.801 . . . . 10.0 111.769 175.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -56.27 5.14 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.418 1.485 . . . . 10.0 113.384 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.59 -49.84 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 117.697 0.749 . . . . 10.0 111.245 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -53.85 -57.05 12.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.93 1.292 . . . . 10.0 112.587 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.64 -45.99 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.795 0.725 . . . . 10.0 111.625 173.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.24 -59.92 8.33 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.526 1.06 . . . . 10.0 112.805 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.2 p -55.79 -39.45 71.3 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.824 1.25 . . . . 10.0 112.41 172.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.85 -56.11 10.42 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.385 0.993 . . . . 10.0 113.222 167.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.72 -45.69 91.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.403 1.481 . . . . 10.0 112.206 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t -54.07 -50.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.376 -0.827 . . . . 10.0 110.23 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.88 -60.71 6.75 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.4 1.952 . . . . 10.0 112.533 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.61 -42.56 3.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.645 2.378 . . . . 10.0 113.219 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -100.77 -6.68 24.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.65 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 120.186 -1.571 . . . . 10.0 110.355 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.49 -49.6 72.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.154 2.582 . . . . 10.0 113.304 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.36 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.053 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.88 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.111 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.06 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.465 1.506 . . . . 10.0 113.56 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.74 63.26 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.03 -41.72 68.35 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.855 0.752 . . . . 10.0 110.768 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -69.33 -32.33 71.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.764 1.226 . . . . 10.0 114.25 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -52.15 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.051 0.841 . . . . 10.0 109.955 168.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -59.11 -51.71 68.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -48.24 -46.96 36.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.164 0.986 . . . . 10.0 113.388 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.44 -52.07 67.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 10.0 111.524 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.2 mt -54.22 -51.53 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.134 1.374 . . . . 10.0 111.514 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -54.45 -47.82 72.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.423 1.089 . . . . 10.0 112.13 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 73.6 m -63.0 -43.1 99.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.042 1.337 . . . . 10.0 111.663 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.46 73.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.238 1.015 . . . . 10.0 112.365 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.9 78.14 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.761 0.824 . . . . 10.0 112.497 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.97 -52.72 64.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.652 1.181 . . . . 10.0 111.959 172.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.08 -49.27 63.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.315 1.446 . . . . 10.0 111.414 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -49.33 -54.93 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.949 0.9 . . . . 10.0 112.681 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 42.0 mm -52.16 -55.88 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.852 0.751 . . . . 10.0 110.41 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.68 -35.22 72.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.463 -0.78 . . . . 10.0 111.735 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.36 -58.14 9.56 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.003 0.921 . . . . 10.0 113.008 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.85 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.438 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.4 75.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.857 1.208 . . . . 10.0 112.101 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -76.99 -70.32 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.119 -1.613 . . . . 10.0 112.851 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.89 60.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.634 1.174 . . . . 10.0 113.42 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.14 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.627 0.632 . . . . 10.0 113.514 171.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.41 51.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.26 1.824 . . . . 10.0 113.059 -166.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.54 13.8 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.96 1.096 . . . . 10.0 113.96 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.63 -50.54 65.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.084 0.945 . . . . 10.0 112.329 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.02 83.1 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.16 0.984 . . . . 10.0 112.117 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.47 80.12 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.32 1.23 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.124 1.77 . . . . 10.0 114.189 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.58 29.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.398 1.879 . . . . 10.0 114.917 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.86 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 123.48 1.61 . . . . 10.0 114.146 -170.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.66 153.96 72.74 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.798 3.239 . . . . 10.0 105.561 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.21 35.4 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.334 2.023 . . . . 10.0 113.008 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.032 2.933 . . . . 10.0 113.288 173.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.14 -53.08 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.059 0.943 . . . . 10.0 109.816 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.86 75.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.317 0.647 . . . . 10.0 111.907 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.96 -56.22 24.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.953 0.901 . . . . 10.0 112.675 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.18 -53.22 60.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.181 0.993 . . . . 10.0 113.059 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.53 -49.56 45.57 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.36 78.88 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.06 -49.58 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.832 0.742 . . . . 10.0 110.481 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.61 69.16 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.81 -47.74 30.95 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.883 2.073 . . . . 10.0 111.07 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.59 -58.33 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.815 0.446 . . . . 10.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.1 t -51.96 -47.94 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.091 0.956 . . . . 10.0 111.994 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.2 m -57.66 -63.41 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.397 2.679 . . . . 10.0 111.878 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.52 -49.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.526 1.131 . . . . 10.0 111.284 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.62 -60.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.1 0.96 . . . . 10.0 112.056 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.44 -48.08 83.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -52.26 -51.07 60.55 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.707 0.803 . . . . 10.0 111.597 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -53.5 -33.51 54.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.028 1.121 . . . . 10.0 114.028 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.1 97.8 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.006 1.113 . . . . 10.0 114.006 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -48.18 -55.78 16.9 Favored Pre-proline 0 N--CA 1.476 0.851 0 N-CA-C 115.374 1.62 . . . . 10.0 115.374 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HB3' H183 ' A' ' 999' ' ' RET . 26.1 Cg_endo -59.63 -33.14 96.79 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.262 1.975 . . . . 10.0 113.441 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.0 -54.71 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.917 0.887 . . . . 10.0 110.324 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.9 t -53.23 -50.11 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.005 1.322 . . . . 10.0 111.531 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -55.68 -52.91 62.24 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.412 1.085 . . . . 10.0 112.581 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -57.49 -43.15 83.92 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.854 0.861 . . . . 10.0 112.304 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -83.98 -5.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.097 1.517 . . . . 10.0 115.097 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.37 -169.35 33.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 122.559 1.088 . . . . 10.0 113.887 -168.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -41.23 64.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.889 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.7 -16.79 64.31 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.731 1.752 . . . . 10.0 115.731 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.89 -105.93 1.09 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.364 1.438 . . . . 10.0 113.711 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.4 127.13 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.368 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.52 65.4 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.081 1.753 . . . . 10.0 108.725 166.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.39 24.91 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.78 153.79 72.38 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.733 2.955 . . . . 10.0 111.463 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.09 -39.84 2.92 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.295 1.038 . . . . 10.0 112.232 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.31 -52.35 21.87 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.95 -40.45 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.388 1.075 . . . . 10.0 109.639 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.86 41.86 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.535 0.607 . . . . 10.0 111.946 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.4 m -57.71 -47.01 83.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.006 1.723 . . . . 10.0 112.995 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.33 62.29 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.938 0.895 . . . . 10.0 112.054 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.61 -59.07 4.91 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.307 1.043 . . . . 10.0 109.979 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.97 -46.99 68.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.479 -1.248 . . . . 10.0 112.297 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.98 -52.34 43.58 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.739 1.609 . . . . 10.0 113.035 174.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.32 -48.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.553 1.141 . . . . 10.0 111.636 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.98 -50.45 72.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.143 1.377 . . . . 10.0 111.763 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.14 -59.79 4.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.713 2.005 . . . . 10.0 110.198 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 42.4 t -46.18 -51.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.552 1.141 . . . . 10.0 111.989 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 5.9 t -61.75 -52.6 63.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.888 0.875 . . . . 10.0 112.501 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.24 -21.72 65.73 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.413 1.885 . . . . 10.0 114.41 -176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -101.3 -69.21 0.79 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.924 1.29 . . . . 10.0 111.547 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.8 t -72.54 -50.76 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.507 1.123 . . . . 10.0 111.475 -173.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.07 -55.63 27.18 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.297 0.951 . . . . 10.0 112.534 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -43.05 -57.39 2.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.759 2.024 . . . . 10.0 112.536 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.92 -41.59 84.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.388 0.994 . . . . 10.0 113.945 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.92 -27.18 64.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 115.703 1.742 . . . . 10.0 115.703 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.21 -57.65 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.947 0.899 . . . . 10.0 113.155 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.53 5.13 2.54 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.3 0.37 15.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.24 1.016 . . . . 10.0 113.324 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 110.972 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.95 77.07 7.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.824 0.849 . . . . 10.0 112.087 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.83 2.852 . . . . 10.0 116.458 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.91 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.721 1.209 . . . . 10.0 110.61 -175.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.77 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.656 171.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.468 2.707 . . . . 10.0 113.408 166.584 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.517 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.83 -2.033 . . . . 10.0 105.851 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.614 3.165 . . . . 10.0 117.211 160.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.272 2.629 . . . . 10.0 114.49 155.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.97 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.361 1.864 . . . . 10.0 113.378 -158.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.272 1.829 . . . . 10.0 113.99 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.16 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.58 -51.38 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.306 -2.759 . . . . 10.0 116.604 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.498 2.285 . . . . 10.0 113.205 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.31 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.737 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.39 -43.03 61.79 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.496 -0.752 . . . . 10.0 112.642 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.69 83.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.954 0.902 . . . . 10.0 109.305 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.872 175.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.33 -53.57 56.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.238 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.81 51.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.376 1.47 . . . . 10.0 113.354 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.99 84.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.294 1.438 . . . . 10.0 113.026 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.95 -55.68 14.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.575 1.084 . . . . 10.0 111.769 166.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -50.16 -52.5 34.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.916 1.286 . . . . 10.0 112.317 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.145 0.978 . . . . 10.0 112.204 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.2 mt -58.11 -49.31 77.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.451 0.7 . . . . 10.0 112.609 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.2 mmt -55.16 -50.27 69.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.686 0.794 . . . . 10.0 111.198 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.08 -58.57 13.9 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.388 0.994 . . . . 10.0 113.634 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.15 -45.65 79.56 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.593 1.196 . . . . 10.0 112.138 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.62 80.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.529 1.062 . . . . 10.0 113.389 172.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -60.17 -60.49 3.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.09 0.956 . . . . 10.0 110.984 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.96 62.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.939 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.09 9.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.654 1.181 . . . . 10.0 112.929 172.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.72 82.1 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.649 1.179 . . . . 10.0 113.619 169.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.698 1.713 . . . . 10.0 110.835 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.86 -44.8 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.878 2.471 . . . . 10.0 109.338 171.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.97 23.1 0.87 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.611 1.005 . . . . 10.0 115.611 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.48 -45.0 92.93 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.145 2.178 . . . . 10.0 113.605 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.765 0.698 . . . . 10.0 112.432 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.04 88.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.361 2.665 . . . . 10.0 116.933 166.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.67 -50.88 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.224 -1.353 . . . . 10.0 113.854 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.47 6.4 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.782 1.301 . . . . 10.0 110.957 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.57 -29.64 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.08 0.552 . . . . 10.0 111.442 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.15 22.67 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.142 1.377 . . . . 10.0 113.549 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.47 19.23 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.232 1.413 . . . . 10.0 113.46 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.11 61.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.952 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.95 -50.23 73.26 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.035 0.534 . . . . 10.0 112.351 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.36 -51.29 65.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.939 -0.553 . . . . 10.0 112.358 173.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.78 -56.88 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 10.0 110.489 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -69.23 -17.57 63.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.18 1.392 . . . . 10.0 113.6 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.6 m -86.6 -42.91 13.09 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.688 1.131 . . . . 10.0 111.953 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -57.13 -41.32 78.82 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -50.62 -61.35 3.95 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.985 1.314 . . . . 10.0 112.254 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.27 -46.78 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.393 3.395 . . . . 10.0 115.726 163.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.96 79.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.241 1.2 . . . . 10.0 114.241 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.09 -36.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 120.256 -1.528 . . . . 10.0 111.698 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.87 77.61 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.13 0.877 . . . . 10.0 112.603 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.8 -56.0 14.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 10.0 111.89 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -48.61 -53.21 19.37 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.498 1.519 . . . . 10.0 111.113 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.59 -48.14 64.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.142 0.977 . . . . 10.0 112.921 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -55.34 -42.16 73.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.009 1.277 . . . . 10.0 113.196 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.66 32.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.292 0.951 . . . . 10.0 111.25 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.55 -41.13 60.89 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.255 1.576 . . . . 10.0 115.255 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 47.0 mtm -66.91 -50.77 61.37 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.531 0.732 . . . . 10.0 110.459 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.7 -52.58 22.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.828 0.851 . . . . 10.0 112.924 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.46 48.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.23 -34.76 5.51 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.524 0.97 . . . . 10.0 115.524 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.26 -43.08 42.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.09 3.57 61.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.063 2.145 . . . . 10.0 109.001 171.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.13 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.03 166.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.726 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.6 129.63 23.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 125.069 1.348 . . . . 10.0 110.908 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.81 116.27 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 109.382 -1.045 . . . . 10.0 109.382 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.78 0.659 . . . . 10.0 112.78 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.718 -0.953 . . . . 10.0 110.718 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.43 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.664 2.225 . . . . 10.0 118.664 170.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.379 1.59 . . . . 10.0 112.202 -165.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.478 1.511 . . . . 10.0 111.059 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.9 Cg_exo -61.52 131.9 38.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.169 3.246 . . . . 10.0 112.166 171.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.7 85.01 4.72 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.717 1.246 . . . . 10.0 113.066 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.29 -28.31 66.64 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.26 -33.59 63.3 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.283 1.033 . . . . 10.0 112.155 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.478 ' HD2' ' CZ2' ' A' ' 86' ' ' TRP . 8.1 tpp180 -39.06 -54.23 1.73 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.24 2.616 . . . . 10.0 111.938 165.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.71 -38.11 48.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.047 1.739 . . . . 10.0 112.579 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.2 -47.35 62.29 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.72 1.146 . . . . 10.0 110.387 167.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -68.36 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.362 1.865 . . . . 10.0 111.485 168.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.478 ' CZ2' ' HD2' ' A' ' 82' ' ' ARG . 54.5 m0 -54.76 -35.83 64.19 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.608 0.966 . . . . 10.0 113.608 -172.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.14 -42.19 50.24 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.104 1.762 . . . . 10.0 111.825 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -103.5 -36.96 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.543 -0.741 . . . . 10.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.4 p -61.15 -46.22 91.43 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 121.155 1.798 . . . . 10.0 113.6 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.301 76.4 p -65.93 -43.89 59.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 -175.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.99 -43.14 62.34 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.429 2.753 . . . . 10.0 115.261 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.95 -47.78 84.85 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.318 -0.864 . . . . 10.0 111.698 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.411 HD21 ' HE1' ' A' ' 182' ' ' TRP . 17.5 tp -49.95 -49.59 49.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.136 1.374 . . . . 10.0 112.189 169.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.87 -47.93 76.46 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.111 -0.993 . . . . 10.0 112.658 170.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.26 78.28 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.781 0.832 . . . . 10.0 112.894 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -52.24 -54.05 35.98 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.31 0.959 . . . . 10.0 111.203 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.72 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.657 0.783 . . . . 10.0 112.158 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.74 -54.74 37.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.983 0.913 . . . . 10.0 112.016 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.15 79.17 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.677 174.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.82 -38.54 91.48 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.426 1.269 . . . . 10.0 114.426 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.018 1.327 . . . . 10.0 112.296 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.5 53.49 11.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.821 1.648 . . . . 10.0 112.175 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.92 47.52 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.938 -1.726 . . . . 10.0 112.392 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.89 54.27 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.7 2.63 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.861 1.664 . . . . 10.0 113.456 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.25 5.27 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.02 -46.8 87.62 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.88 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.997 1.319 . . . . 10.0 111.163 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.67 -51.28 67.84 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.55 0.574 . . . . 10.0 112.55 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.88 43.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.452 0.701 . . . . 10.0 110.908 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.52 -59.96 4.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.436 2.294 . . . . 10.0 114.815 174.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.99 -46.29 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 123.665 0.786 . . . . 10.0 111.428 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.71 -50.25 64.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.655 0.645 . . . . 10.0 112.63 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.71 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.234 0.827 . . . . 10.0 113.234 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -55.12 -48.3 73.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.591 1.156 . . . . 10.0 111.259 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -55.51 5.22 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.39 1.472 . . . . 10.0 113.246 168.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.61 -51.99 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.549 0.74 . . . . 10.0 111.735 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.2 tmm? -50.65 -56.38 12.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.969 1.707 . . . . 10.0 112.038 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.08 -45.44 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.652 -0.655 . . . . 10.0 112.423 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.16 -58.39 12.0 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.948 1.261 . . . . 10.0 113.257 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.4 p -59.46 -35.82 74.78 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.984 0.914 . . . . 10.0 112.513 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.45 -56.86 7.81 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.293 0.949 . . . . 10.0 113.825 164.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.9 tp -58.34 -47.47 83.68 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.266 1.426 . . . . 10.0 112.149 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.0 t -52.75 -51.71 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.583 -0.698 . . . . 10.0 110.518 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.26 6.3 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.714 1.626 . . . . 10.0 112.092 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.59 -37.55 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.387 1.875 . . . . 10.0 113.893 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.6 mt -99.14 -6.35 28.45 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.162 1.541 . . . . 10.0 115.162 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.68 116.69 10.37 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.128 -1.607 . . . . 10.0 110.365 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.221 2.608 . . . . 10.0 113.274 177.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.62 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.812 0.845 . . . . 10.0 110.066 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.95 -59.53 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.033 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.06 14.92 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.413 1.485 . . . . 10.0 113.52 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -70.2 -24.58 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.66 -42.2 67.64 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.917 0.78 . . . . 10.0 110.692 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.53 -31.54 69.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.853 1.261 . . . . 10.0 114.348 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.36 -51.86 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.0 0.818 . . . . 10.0 109.622 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -61.68 -43.03 99.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.387 1.255 . . . . 10.0 114.387 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.26 -49.03 67.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.545 1.138 . . . . 10.0 112.585 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.87 71.74 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.717 0.807 . . . . 10.0 111.675 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.4 mt -56.35 -54.33 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.924 1.289 . . . . 10.0 111.943 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -57.39 -42.04 81.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.451 0.7 . . . . 10.0 112.468 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.2 m -58.91 -46.73 87.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.89 1.276 . . . . 10.0 112.6 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.312 0.96 . . . . 10.0 112.371 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.99 83.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.982 0.913 . . . . 10.0 112.805 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.71 -53.61 56.19 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.468 1.107 . . . . 10.0 111.982 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.66 -47.61 70.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.422 1.489 . . . . 10.0 111.982 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -50.1 -54.56 19.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.001 0.92 . . . . 10.0 112.416 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.4 mt -53.78 -54.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.79 0.836 . . . . 10.0 110.728 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.56 -36.56 69.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.17 9.4 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -40.86 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.8 -49.43 75.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.883 1.22 . . . . 10.0 112.145 171.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.043 -1.66 . . . . 10.0 112.874 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.72 -21.91 60.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.607 1.163 . . . . 10.0 113.466 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.644 0.64 . . . . 10.0 113.522 171.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.43 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.037 -166.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.16 -56.42 14.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.953 1.094 . . . . 10.0 113.953 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.7 -50.51 65.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.145 0.974 . . . . 10.0 112.307 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.05 82.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.192 0.997 . . . . 10.0 112.152 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.53 80.03 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.42 -11.29 1.19 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.084 1.754 . . . . 10.0 114.223 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.411 1.884 . . . . 10.0 114.867 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.97 -92.62 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.501 1.619 . . . . 10.0 114.135 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.68 153.93 72.68 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.837 3.255 . . . . 10.0 105.604 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.345 2.03 . . . . 10.0 113.083 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.668 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.07 68.07 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.285 173.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.13 -53.05 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.105 0.962 . . . . 10.0 109.816 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.82 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.06 -56.11 25.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.864 0.865 . . . . 10.0 112.731 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.2 -53.24 60.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.229 1.012 . . . . 10.0 112.988 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.56 45.38 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.324 0.65 . . . . 10.0 111.097 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.14 -48.44 78.67 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.66 1.356 . . . . 10.0 114.66 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.97 -49.58 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.807 0.731 . . . . 10.0 110.482 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.14 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.169 0.803 . . . . 10.0 113.169 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.72 31.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.84 2.056 . . . . 10.0 111.068 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.61 -58.29 9.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.781 0.432 . . . . 10.0 111.245 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.85 -49.3 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.07 0.948 . . . . 10.0 111.497 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 29.7 m -56.19 -64.01 1.0 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.115 2.566 . . . . 10.0 111.952 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.02 -49.11 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.666 1.186 . . . . 10.0 111.347 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.31 -61.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.09 0.956 . . . . 10.0 112.372 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -58.04 -46.84 84.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.421 0.688 . . . . 10.0 111.932 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TRP . . . . . 0.411 ' HE1' HD21 ' A' ' 93' ' ' LEU . 9.0 m95 -51.29 -52.8 41.82 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.16 0.984 . . . . 10.0 112.101 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.6 m -54.46 -31.01 54.76 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.789 1.033 . . . . 10.0 113.789 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.91 93.82 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.816 1.043 . . . . 10.0 113.816 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -47.3 -55.28 16.6 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 115.712 1.745 . . . . 10.0 115.712 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.545 ' HB3' H183 ' A' ' 999' ' ' RET . 19.2 Cg_endo -58.05 -36.88 97.66 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.552 2.168 . . . . 10.0 112.952 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.97 -54.31 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.429 1.092 . . . . 10.0 110.666 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.4 t -53.51 -49.23 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.758 1.223 . . . . 10.0 111.483 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -55.59 -53.3 58.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.697 1.199 . . . . 10.0 112.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -56.25 -44.51 79.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.936 0.894 . . . . 10.0 112.655 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -84.52 -5.81 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.08 1.511 . . . . 10.0 115.08 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.26 33.1 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-O 122.627 1.126 . . . . 10.0 113.94 -168.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -41.1 64.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.202 -0.999 . . . . 10.0 111.846 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -54.43 -31.66 55.77 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.503 2.721 . . . . 10.0 115.359 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.34 -103.85 0.96 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.433 1.015 . . . . 10.0 113.506 -167.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.15 35.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.653 -1.498 . . . . 10.0 109.357 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.4 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.69 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.721 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.33 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.388 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.72 153.8 72.51 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.792 2.995 . . . . 10.0 111.483 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.83 3.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.364 1.065 . . . . 10.0 112.19 171.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.28 -52.41 21.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.0 -40.42 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.363 1.065 . . . . 10.0 109.625 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.34 -49.81 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.61 0.641 . . . . 10.0 111.944 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.05 83.37 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.055 1.742 . . . . 10.0 112.976 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.4 -52.29 62.24 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.934 0.894 . . . . 10.0 112.054 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -58.73 5.84 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.338 1.055 . . . . 10.0 109.955 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -52.51 -45.36 66.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.604 -1.189 . . . . 10.0 112.684 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.8 -52.67 59.56 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.48 1.491 . . . . 10.0 112.856 174.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.51 -46.17 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.055 1.342 . . . . 10.0 111.551 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.28 -54.25 49.02 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.302 1.441 . . . . 10.0 111.589 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -54.03 -58.74 6.18 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.523 1.929 . . . . 10.0 111.278 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.86 -42.94 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.153 -0.967 . . . . 10.0 112.185 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 20.0 m -59.94 -48.57 81.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.755 0.822 . . . . 10.0 112.088 172.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.93 -18.69 64.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.653 1.981 . . . . 10.0 114.536 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -106.4 -74.14 0.66 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.021 1.328 . . . . 10.0 111.812 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.19 -42.31 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 120.629 -1.294 . . . . 10.0 111.785 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -57.84 -55.26 31.49 Favored Glycine 0 N--CA 1.476 1.308 0 C-N-CA 124.06 0.838 . . . . 10.0 112.4 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -40.7 -60.13 1.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.904 2.081 . . . . 10.0 112.324 163.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.03 72.45 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.13 0.872 . . . . 10.0 113.745 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -69.94 -27.55 64.85 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 115.997 1.851 . . . . 10.0 115.997 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.73 -57.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.493 -0.929 . . . . 10.0 108.493 165.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.88 0.872 . . . . 10.0 113.171 -172.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.62 5.23 2.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 10.0 115.341 -171.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.4 15.7 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.174 0.99 . . . . 10.0 113.32 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.998 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.668 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.72 98.24 1.9 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.73 0.812 . . . . 10.0 110.953 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.04 7.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.87 0.868 . . . . 10.0 112.037 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.904 2.881 . . . . 10.0 116.466 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.48 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.765 1.226 . . . . 10.0 110.635 -175.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.74 Favored Glycine 0 C--O 1.238 0.388 0 C-N-CA 129.738 3.542 . . . . 10.0 119.647 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.476 2.711 . . . . 10.0 113.421 166.567 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.545 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.794 -2.05 . . . . 10.0 105.835 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.49 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.595 3.158 . . . . 10.0 117.209 160.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.1 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.306 2.642 . . . . 10.0 114.452 155.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.51 137.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.357 1.863 . . . . 10.0 113.393 -158.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.74 -165.2 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.76 40.74 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.412 2.434 . . . . 10.0 111.516 168.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.31 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.679 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.66 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.477 2.277 . . . . 10.0 113.238 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.37 0.95 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.751 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.42 -43.07 61.9 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.458 -0.776 . . . . 10.0 112.604 176.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.348 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.46 -52.62 63.01 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.386 0.675 . . . . 10.0 111.84 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.82 -46.8 51.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.353 1.461 . . . . 10.0 113.335 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.68 -44.93 84.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.267 1.427 . . . . 10.0 113.056 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.06 -55.78 14.31 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.373 0.987 . . . . 10.0 111.689 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.97 -52.41 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.874 1.27 . . . . 10.0 112.336 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.47 -58.89 5.72 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.172 0.989 . . . . 10.0 112.14 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -57.42 -48.79 78.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.619 0.768 . . . . 10.0 112.684 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.41 -47.1 85.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.221 1.008 . . . . 10.0 111.502 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.64 13.52 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.309 0.957 . . . . 10.0 113.721 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.21 -46.03 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.658 1.229 . . . . 10.0 112.112 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.18 -42.68 73.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.987 1.28 . . . . 10.0 113.175 172.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -62.05 -58.35 8.17 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.718 0.807 . . . . 10.0 111.534 172.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.32 -40.99 62.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.937 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.74 -58.07 9.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.616 1.166 . . . . 10.0 112.999 172.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.71 81.93 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.244 0.831 . . . . 10.0 113.244 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.625 1.17 . . . . 10.0 113.659 169.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.728 1.727 . . . . 10.0 110.868 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.875 2.47 . . . . 10.0 109.33 171.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.11 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.01 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.101 2.161 . . . . 10.0 113.623 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.175 -1.375 . . . . 10.0 113.841 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.84 117.52 6.35 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.745 1.278 . . . . 10.0 110.957 -172.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.63 -29.66 89.87 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.678 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.085 0.554 . . . . 10.0 111.448 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.22 -40.04 23.08 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.583 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.53 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.219 1.408 . . . . 10.0 113.446 172.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.81 -53.04 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.939 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.99 -50.27 73.21 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.316 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.29 -51.33 64.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.39 0.541 . . . . 10.0 112.395 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.44 -58.06 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 10.0 110.256 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -67.78 -18.71 64.95 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.234 1.414 . . . . 10.0 113.725 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -86.74 -40.64 14.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.381 1.072 . . . . 10.0 112.292 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.13 -42.92 91.77 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.44 -0.787 . . . . 10.0 112.708 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.2 t -42.2 -62.29 1.25 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.504 1.522 . . . . 10.0 113.285 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.17 -26.12 21.54 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.069 2.513 . . . . 10.0 114.24 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.94 80.63 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.855 1.662 . . . . 10.0 113.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.5 -49.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.026 -1.046 . . . . 10.0 109.778 169.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.56 -45.96 73.6 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 175.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -50.98 -56.32 13.04 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.758 1.623 . . . . 10.0 112.046 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -49.4 -52.76 26.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.303 1.441 . . . . 10.0 110.626 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.439 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.6 mmt -68.87 -47.97 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.005 0.922 . . . . 10.0 113.047 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -57.27 -40.13 77.08 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.201 -1.381 . . . . 10.0 113.346 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.3 -54.6 34.04 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.037 1.29 . . . . 10.0 111.301 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.04 61.0 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.211 1.56 . . . . 10.0 115.211 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.94 -50.78 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.476 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.65 21.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.883 . . . . 10.0 112.9 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.03 -5.51 49.06 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.34 1.056 . . . . 10.0 113.769 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.554 0.982 . . . . 10.0 115.554 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.04 43.04 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.28 1.585 . . . . 10.0 115.28 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.304 0.882 . . . . 10.0 115.304 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.26 143.37 26.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.082 2.153 . . . . 10.0 109.018 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.008 0.923 . . . . 10.0 111.021 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.01 53.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.751 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.56 129.58 23.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 125.12 1.368 . . . . 10.0 110.991 -176.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.28 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.379 -1.047 . . . . 10.0 109.379 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.41 -81.94 0.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.634 -0.986 . . . . 10.0 110.634 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.55 -171.82 4.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.23 -165.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.91 93.89 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.527 1.531 . . . . 10.0 111.056 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.45 120.79 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.989 0.737 . . . . 10.0 112.989 -165.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.6 Cg_exo -61.57 131.93 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.196 3.264 . . . . 10.0 112.129 171.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.004 1.721 . . . . 10.0 111.739 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.62 84.98 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.005 1.384 . . . . 10.0 113.035 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.32 -28.31 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.839 -1.163 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.92 45.45 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.259 1.023 . . . . 10.0 113.197 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -50.42 -60.96 2.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.706 1.202 . . . . 10.0 111.05 168.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -58.17 -42.44 86.01 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.32 2.248 . . . . 10.0 112.633 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.32 63.44 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.487 1.04 . . . . 10.0 112.418 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.439 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -62.39 -60.46 3.53 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.384 0.993 . . . . 10.0 111.759 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -52.96 -36.24 59.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 112.328 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.4 tp -50.49 -42.64 54.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.536 1.934 . . . . 10.0 112.14 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -102.35 -39.05 7.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.83 0.852 . . . . 10.0 112.842 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 71.2 p -63.08 -45.9 89.95 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 120.559 1.527 . . . . 10.0 113.308 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 72.6 p -62.86 -44.21 85.0 Favored Pre-proline 0 N--CA 1.478 0.944 0 N-CA-C 114.825 1.417 . . . . 10.0 114.825 -177.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.07 -43.29 60.73 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.521 2.814 . . . . 10.0 115.32 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.48 -47.5 85.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.803 0.729 . . . . 10.0 111.71 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.0 mt -53.6 -45.27 69.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.39 1.076 . . . . 10.0 112.204 172.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.81 -47.42 82.65 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.111 -0.993 . . . . 10.0 112.769 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.29 78.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.88 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.29 -54.06 36.2 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.258 0.936 . . . . 10.0 111.161 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.1 88.76 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.62 0.768 . . . . 10.0 112.146 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.75 37.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.986 0.914 . . . . 10.0 112.028 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.14 79.14 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.677 0.791 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.61 91.75 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.76 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.045 1.338 . . . . 10.0 112.313 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.844 1.658 . . . . 10.0 112.104 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.85 47.66 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.903 -1.748 . . . . 10.0 112.446 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 135.96 54.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.705 0.632 . . . . 10.0 112.705 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.71 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.856 1.663 . . . . 10.0 113.471 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.27 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.178 1.37 . . . . 10.0 115.262 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.04 -46.83 87.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.323 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.37 -52.95 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.02 1.328 . . . . 10.0 111.124 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.32 67.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.09 -44.92 42.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.49 0.716 . . . . 10.0 110.98 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.94 4.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.396 2.279 . . . . 10.0 114.8 174.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.93 -46.38 96.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.69 0.796 . . . . 10.0 111.423 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.29 64.24 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.674 0.654 . . . . 10.0 112.593 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.32 74.83 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.37 -45.72 84.13 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.164 0.986 . . . . 10.0 111.995 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.07 -55.62 5.61 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.332 1.444 . . . . 10.0 112.982 167.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.21 -53.57 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.02 -0.99 . . . . 10.0 110.768 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 57.4 ttp -46.02 -58.1 3.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.504 1.502 . . . . 10.0 112.653 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.1 mm -71.58 -45.08 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.694 -0.629 . . . . 10.0 112.429 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.5 -47.4 63.31 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.593 1.092 . . . . 10.0 112.884 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.3 m -60.88 -44.85 96.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.313 1.445 . . . . 10.0 111.384 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.49 -55.01 11.46 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.474 1.035 . . . . 10.0 113.402 168.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.85 -48.23 51.23 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.498 2.719 . . . . 10.0 111.636 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.61 -49.1 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 120.951 -1.093 . . . . 10.0 111.539 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.27 -59.36 9.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.857 1.694 . . . . 10.0 112.448 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.07 -43.2 3.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.475 2.71 . . . . 10.0 113.272 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -101.26 -6.38 24.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.446 1.647 . . . . 10.0 115.446 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.76 10.48 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.222 -1.549 . . . . 10.0 110.397 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.217 2.607 . . . . 10.0 113.255 177.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.68 106.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.733 0.813 . . . . 10.0 110.065 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.94 -59.54 3.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.029 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.09 14.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.513 1.525 . . . . 10.0 113.486 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.23 -24.6 63.12 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.872 1.434 . . . . 10.0 114.872 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.95 -41.75 68.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.935 0.789 . . . . 10.0 110.776 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.86 70.22 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.356 1.243 . . . . 10.0 114.356 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.46 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.043 0.838 . . . . 10.0 109.621 168.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -60.51 -45.26 94.47 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.015 1.116 . . . . 10.0 114.015 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -52.23 -48.89 64.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.414 1.006 . . . . 10.0 112.895 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -54.45 45.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.092 0.957 . . . . 10.0 111.645 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.0 mt -53.28 -49.83 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.052 1.341 . . . . 10.0 111.592 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -54.84 -48.09 73.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.866 1.266 . . . . 10.0 111.852 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.7 m -65.19 -40.49 94.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.602 1.561 . . . . 10.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.07 -49.41 77.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.049 0.94 . . . . 10.0 112.286 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.45 79.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.746 0.818 . . . . 10.0 112.441 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.7 ttp -55.37 -54.04 48.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.12 0.968 . . . . 10.0 112.243 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -52.07 -50.38 61.66 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.83 1.652 . . . . 10.0 111.407 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -50.15 -54.71 18.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.14 0.976 . . . . 10.0 112.502 172.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.7 mt -53.49 -55.26 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.775 0.83 . . . . 10.0 110.736 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.32 -35.84 70.38 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.287 -0.863 . . . . 10.0 112.866 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.48 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.03 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.85 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.437 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.84 -49.37 75.63 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.866 1.212 . . . . 10.0 112.153 171.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.92 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.94 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.645 1.178 . . . . 10.0 113.412 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.75 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.676 0.655 . . . . 10.0 113.51 171.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.61 -32.43 51.12 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.23 1.812 . . . . 10.0 113.08 -166.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.9 m -52.04 -56.52 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.025 1.12 . . . . 10.0 114.025 172.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.58 -50.62 65.2 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.115 0.959 . . . . 10.0 112.32 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.08 -46.08 82.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.188 0.995 . . . . 10.0 112.105 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.54 79.8 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.516 1.302 . . . . 10.0 114.516 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.33 1.22 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.101 1.76 . . . . 10.0 114.235 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.07 6.67 29.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.433 1.893 . . . . 10.0 114.89 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.96 -92.68 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.473 1.606 . . . . 10.0 114.115 -170.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.68 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 129.805 3.242 . . . . 10.0 105.541 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.93 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.308 2.005 . . . . 10.0 113.052 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.06 68.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.977 2.911 . . . . 10.0 113.259 173.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.16 -53.05 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 124.014 0.925 . . . . 10.0 109.804 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.81 75.57 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.237 0.615 . . . . 10.0 111.952 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.02 -56.13 25.45 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.894 0.877 . . . . 10.0 112.734 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.1 m -57.3 -53.11 61.83 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.139 0.976 . . . . 10.0 113.02 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.6 -49.51 46.41 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.118 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.1 -48.4 78.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.6 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.774 0.715 . . . . 10.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.52 -51.68 68.84 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.77 30.14 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.822 2.049 . . . . 10.0 111.077 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.14 -47.0 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.015 0.926 . . . . 10.0 112.127 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 34.1 m -58.33 -64.16 1.02 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.276 2.631 . . . . 10.0 111.735 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.33 -50.15 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.68 1.192 . . . . 10.0 110.989 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.19 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.962 0.905 . . . . 10.0 111.915 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.07 -48.33 73.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.24 0.927 . . . . 10.0 112.69 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.76 -50.41 70.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.834 0.854 . . . . 10.0 111.66 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.0 p -52.27 -33.37 41.56 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.397 1.258 . . . . 10.0 114.397 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.69 -40.16 94.9 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -47.72 -56.12 14.5 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 114.991 1.478 . . . . 10.0 114.991 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.429 ' HB3' H183 ' A' ' 999' ' ' RET . 28.6 Cg_endo -60.0 -33.36 95.55 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.249 1.966 . . . . 10.0 113.625 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.74 -54.67 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.17 0.895 . . . . 10.0 110.395 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.06 -50.54 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.236 1.415 . . . . 10.0 111.472 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -55.5 -52.63 63.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.408 1.083 . . . . 10.0 112.598 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -58.51 -42.97 88.87 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.686 0.794 . . . . 10.0 112.45 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -83.3 -5.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.915 1.45 . . . . 10.0 114.915 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.3 33.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 122.55 1.083 . . . . 10.0 113.964 -168.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.62 65.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.868 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.78 -15.87 63.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.568 1.692 . . . . 10.0 115.568 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.49 -106.06 1.06 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 120.452 1.478 . . . . 10.0 113.965 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.11 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.34 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.28 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.919 0.328 . . . . 10.0 113.919 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.55 -42.78 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.126 1.77 . . . . 10.0 108.725 166.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.4 t -126.29 133.38 24.9 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.419 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.7 153.77 72.6 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.816 3.011 . . . . 10.0 111.469 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.273 1.029 . . . . 10.0 112.251 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.32 -52.42 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.9 -40.52 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.618 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -49.28 -49.77 42.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.574 0.625 . . . . 10.0 111.991 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.07 83.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.086 1.755 . . . . 10.0 113.002 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.36 62.11 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.962 0.905 . . . . 10.0 112.063 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.5 -60.0 3.77 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.364 1.066 . . . . 10.0 109.974 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -52.51 -46.96 66.9 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.004 -1.474 . . . . 10.0 111.934 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.77 -53.03 35.16 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.376 1.898 . . . . 10.0 113.119 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.27 -48.55 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.083 1.353 . . . . 10.0 111.499 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.5 mp -57.48 -50.86 71.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.101 1.36 . . . . 10.0 111.577 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -56.96 -59.69 4.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.71 2.404 . . . . 10.0 111.089 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.9 m -57.27 -38.83 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 120.563 -1.336 . . . . 10.0 112.379 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.6 t -62.86 -54.51 37.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.091 0.956 . . . . 10.0 112.024 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.66 -28.7 69.57 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.006 1.722 . . . . 10.0 114.386 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -90.77 -70.66 0.67 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.37 1.068 . . . . 10.0 111.605 173.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 16.9 t -76.59 -48.73 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.506 1.122 . . . . 10.0 111.797 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -54.87 -54.11 35.54 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.409 1.004 . . . . 10.0 113.128 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -45.22 -56.21 5.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.448 1.899 . . . . 10.0 111.814 166.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.74 -40.5 71.64 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.327 0.965 . . . . 10.0 113.903 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -70.41 -27.77 64.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 115.843 1.794 . . . . 10.0 115.843 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.587 -0.894 . . . . 10.0 108.587 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.7 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.906 0.882 . . . . 10.0 113.193 -172.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.56 5.25 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.28 0.25 15.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.269 1.028 . . . . 10.0 113.301 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.93 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.078 0.951 . . . . 10.0 111.033 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.63 98.21 1.86 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.758 0.823 . . . . 10.0 110.92 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.04 7.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.866 0.866 . . . . 10.0 112.07 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.474 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.85 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.7 1.2 . . . . 10.0 110.674 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.31 169.51 40.05 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.534 . . . . 10.0 119.647 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.521 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.597 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.52 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.554 3.142 . . . . 10.0 117.276 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.64 . . . . 10.0 114.524 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.393 1.877 . . . . 10.0 113.338 -158.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.302 1.841 . . . . 10.0 114.018 -174.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.07 2.79 41.48 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.43 2.443 . . . . 10.0 111.48 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.6 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.649 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.04 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.559 2.307 . . . . 10.0 113.194 -175.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.23 4.31 0.98 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.842 2.457 . . . . 10.0 115.769 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.11 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.493 -0.754 . . . . 10.0 112.669 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.62 83.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.89 0.876 . . . . 10.0 109.272 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.41 -52.63 62.94 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.393 0.677 . . . . 10.0 111.885 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.34 -53.64 55.81 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.231 0.612 . . . . 10.0 112.18 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.77 51.99 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.413 1.485 . . . . 10.0 113.319 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.95 84.74 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.316 1.446 . . . . 10.0 112.998 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.56 -56.28 11.64 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.544 1.069 . . . . 10.0 111.549 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -50.18 -52.3 36.63 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.795 1.238 . . . . 10.0 112.171 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.86 5.8 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.154 0.981 . . . . 10.0 112.143 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.06 -48.9 77.43 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.67 0.788 . . . . 10.0 112.786 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 54.6 mtt -61.27 -44.48 97.17 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.905 0.882 . . . . 10.0 111.363 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.69 13.26 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.326 0.965 . . . . 10.0 113.967 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.22 -45.96 79.7 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.568 1.184 . . . . 10.0 112.131 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.6 -41.96 75.38 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.8 1.19 . . . . 10.0 113.191 173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.9 m -62.46 -58.36 7.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.717 0.807 . . . . 10.0 111.414 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.04 0.936 . . . . 10.0 110.917 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.07 9.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.599 1.16 . . . . 10.0 112.985 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.65 81.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.174 . . . . 10.0 113.585 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.33 40.88 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 123.745 1.736 . . . . 10.0 110.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.79 -44.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.367 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.88 23.09 0.86 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.656 1.023 . . . . 10.0 115.656 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.56 -44.98 93.12 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.178 2.191 . . . . 10.0 113.581 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.58 -84.45 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.787 0.708 . . . . 10.0 112.487 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.01 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.435 2.694 . . . . 10.0 116.933 166.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.64 -50.86 10.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.867 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.52 6.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.765 1.291 . . . . 10.0 110.975 -172.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.64 -29.53 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.702 2.935 . . . . 10.0 113.724 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -60.67 2.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.099 0.56 . . . . 10.0 111.407 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.5 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.097 1.359 . . . . 10.0 113.588 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.46 19.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.26 1.424 . . . . 10.0 113.396 172.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 61.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.459 0.704 . . . . 10.0 110.986 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.91 -50.27 73.05 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.29 65.31 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.321 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.44 -61.93 1.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.52 -57.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.897 1.279 . . . . 10.0 110.562 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 m -67.98 -20.91 65.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.952 1.301 . . . . 10.0 113.488 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.8 m -83.9 -40.68 18.28 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.401 1.08 . . . . 10.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -59.43 -41.87 90.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.393 -0.817 . . . . 10.0 113.182 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.1 t -45.07 -62.74 1.48 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.542 1.137 . . . . 10.0 113.081 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.33 -25.5 30.53 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.842 2.362 . . . . 10.0 113.871 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.41 -46.91 78.14 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.644 1.565 . . . . 10.0 113.188 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.76 -49.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.048 -1.033 . . . . 10.0 109.271 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.11 72.27 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.925 0.89 . . . . 10.0 113.238 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -50.83 -57.21 8.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.812 1.645 . . . . 10.0 111.768 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.49 -53.09 19.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.41 1.484 . . . . 10.0 110.787 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.69 -48.15 64.62 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.008 0.923 . . . . 10.0 113.05 -176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -56.58 -40.73 75.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.185 1.357 . . . . 10.0 113.347 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.58 34.28 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.789 1.177 . . . . 10.0 111.284 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.08 61.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.192 1.553 . . . . 10.0 115.192 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.86 -50.85 61.2 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.458 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.66 -52.63 22.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.873 0.869 . . . . 10.0 112.91 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.54 48.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.328 1.051 . . . . 10.0 113.833 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.69 5.57 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.06 43.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.213 1.561 . . . . 10.0 115.213 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.48 61.33 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.318 0.887 . . . . 10.0 115.318 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.049 2.14 . . . . 10.0 109.034 171.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.53 171.04 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.042 0.937 . . . . 10.0 111.024 166.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.11 53.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.9 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.21 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.474 -1.01 . . . . 10.0 109.474 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.7 164.4 38.18 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.38 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.68 -3.42 0.7 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 118.716 2.247 . . . . 10.0 118.716 170.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.57 -171.86 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.327 1.564 . . . . 10.0 112.223 -165.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.501 1.52 . . . . 10.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.8 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.18 126.34 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.992 1.717 . . . . 10.0 111.671 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.419 1.581 . . . . 10.0 113.087 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.28 -28.32 66.64 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.485 -1.385 . . . . 10.0 113.937 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.14 62.14 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.231 1.196 . . . . 10.0 114.231 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.424 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -65.12 -24.98 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.221 -1.549 . . . . 10.0 113.861 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -75.01 -42.6 57.07 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.577 -1.327 . . . . 10.0 112.189 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.82 -48.41 59.77 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.203 1.401 . . . . 10.0 111.693 167.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.95 -72.3 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.563 1.945 . . . . 10.0 111.819 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.424 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 49.8 m0 -55.43 -32.02 62.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.738 1.215 . . . . 10.0 112.952 -171.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.7 tp -50.66 -41.57 55.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.104 1.361 . . . . 10.0 111.932 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -103.84 -45.08 4.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.873 0.869 . . . . 10.0 112.626 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.7 p -59.51 -38.9 82.17 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.593 1.088 . . . . 10.0 113.373 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.0 m -66.61 -51.65 39.51 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 117.957 -1.021 . . . . 10.0 113.106 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 79.8 Cg_exo -51.56 -40.69 63.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.262 2.641 . . . . 10.0 114.631 171.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.5 mt -59.37 -48.31 82.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.619 0.767 . . . . 10.0 112.225 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.19 -39.45 86.55 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.584 1.084 . . . . 10.0 112.25 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.12 -49.05 74.99 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.081 -1.012 . . . . 10.0 111.348 167.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.29 78.27 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.852 0.861 . . . . 10.0 112.846 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.22 -54.1 35.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.301 0.955 . . . . 10.0 111.201 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.68 38.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.031 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.21 79.37 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.779 0.832 . . . . 10.0 112.669 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.81 -38.46 91.18 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.41 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.025 1.33 . . . . 10.0 112.298 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.873 1.669 . . . . 10.0 112.13 -173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.31 145.88 47.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.929 -1.732 . . . . 10.0 112.455 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.87 54.25 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.72 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.423 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.18 5.33 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.178 1.37 . . . . 10.0 115.276 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.8 p -62.13 -46.72 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.051 -1.452 . . . . 10.0 111.285 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.48 -52.89 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.036 1.334 . . . . 10.0 111.11 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.6 -51.32 67.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.87 42.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.496 0.718 . . . . 10.0 110.932 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.65 -59.85 4.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.354 2.262 . . . . 10.0 114.784 175.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.62 -46.64 73.9 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.573 0.749 . . . . 10.0 113.021 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -59.4 -43.7 92.95 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.847 0.859 . . . . 10.0 112.066 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -57.09 4.58 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.801 1.667 . . . . 10.0 113.123 165.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.1 mt -56.63 -49.81 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.94 0.896 . . . . 10.0 111.177 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -53.38 -58.62 6.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.427 1.012 . . . . 10.0 112.394 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.9 mp -64.96 -48.36 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.417 0.553 . . . . 10.0 111.223 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.61 -47.81 57.02 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.804 1.193 . . . . 10.0 112.888 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 97.7 m -60.27 -45.76 92.18 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.965 1.306 . . . . 10.0 111.882 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.2 -54.27 12.97 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.115 0.864 . . . . 10.0 112.904 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.55 -49.6 45.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.504 2.722 . . . . 10.0 111.7 173.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.94 -49.09 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 120.922 -1.111 . . . . 10.0 111.627 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.02 -59.68 9.1 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.054 1.787 . . . . 10.0 112.541 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.09 3.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.181 2.592 . . . . 10.0 113.298 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.9 mt -100.83 -6.9 24.17 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.477 1.658 . . . . 10.0 115.477 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.182 -1.574 . . . . 10.0 110.409 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.619 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.52 -49.61 72.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.26 2.624 . . . . 10.0 113.239 177.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.58 106.29 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.783 0.833 . . . . 10.0 110.088 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.065 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.06 15.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.458 1.503 . . . . 10.0 113.49 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.65 63.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.884 1.439 . . . . 10.0 114.884 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.05 -41.38 68.04 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.902 0.774 . . . . 10.0 110.891 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -70.13 -31.26 68.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.837 1.255 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.49 -52.25 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.057 0.844 . . . . 10.0 109.629 168.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.26 -46.14 90.85 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.462 0.912 . . . . 10.0 113.462 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -50.95 -48.53 60.9 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.763 1.165 . . . . 10.0 113.213 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.87 -53.94 52.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.78 0.832 . . . . 10.0 111.79 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.72 -53.31 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.091 1.356 . . . . 10.0 111.859 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.6 p -58.67 -44.17 90.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.809 0.844 . . . . 10.0 112.697 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.66 -43.3 97.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.346 1.058 . . . . 10.0 112.346 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.1 78.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.295 0.952 . . . . 10.0 112.449 171.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.49 80.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.864 0.865 . . . . 10.0 112.524 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 35.8 ttp -55.74 -53.46 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.388 1.075 . . . . 10.0 112.024 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.74 -47.96 73.18 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.432 1.493 . . . . 10.0 112.446 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.6 -54.14 19.97 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 10.0 112.062 170.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.07 -54.86 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.593 0.757 . . . . 10.0 110.897 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.48 -36.45 69.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.441 -0.79 . . . . 10.0 113.116 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.35 -58.1 9.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.984 0.913 . . . . 10.0 113.077 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.93 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.344 -0.836 . . . . 10.0 111.461 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.77 -49.41 75.39 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.858 1.208 . . . . 10.0 112.163 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.908 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.9 60.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.624 1.169 . . . . 10.0 113.494 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.86 -79.03 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.601 0.619 . . . . 10.0 113.519 171.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.46 51.49 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.268 1.827 . . . . 10.0 113.067 -166.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.06 -56.45 14.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.022 1.119 . . . . 10.0 114.022 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.72 -50.5 65.79 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.06 0.934 . . . . 10.0 112.302 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.18 -45.98 83.23 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.197 0.999 . . . . 10.0 112.114 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.43 80.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.28 1.23 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.091 1.756 . . . . 10.0 114.194 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.11 6.66 29.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.374 1.87 . . . . 10.0 114.846 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.91 -92.64 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.522 1.63 . . . . 10.0 114.193 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.71 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 129.794 3.238 . . . . 10.0 105.571 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.19 35.55 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.263 1.976 . . . . 10.0 113.032 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.9 -46.13 67.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.04 2.936 . . . . 10.0 113.284 173.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.21 -52.95 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.17 -46.85 75.79 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.251 0.62 . . . . 10.0 111.9 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.19 24.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.9 m -57.19 -53.24 60.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 112.995 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.54 -49.56 45.62 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.292 0.637 . . . . 10.0 111.097 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.57 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.832 0.742 . . . . 10.0 110.54 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.56 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.87 30.11 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.839 2.056 . . . . 10.0 111.038 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.46 -58.35 8.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.769 0.428 . . . . 10.0 111.269 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.8 -48.73 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.116 0.967 . . . . 10.0 111.546 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.9 m -57.05 -63.99 1.03 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.056 2.542 . . . . 10.0 111.863 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.64 -49.15 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.847 1.259 . . . . 10.0 111.235 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.65 -62.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.89 0.876 . . . . 10.0 112.494 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.23 -45.26 84.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.748 0.704 . . . . 10.0 111.976 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -51.78 -53.08 43.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.929 0.892 . . . . 10.0 112.383 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.2 m -53.14 -31.68 43.62 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.341 1.057 . . . . 10.0 113.65 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.83 96.14 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.833 1.049 . . . . 10.0 113.833 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -47.04 -57.38 9.37 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 115.241 1.571 . . . . 10.0 115.241 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.469 ' HB3' H183 ' A' ' 999' ' ' RET . 32.2 Cg_endo -59.89 -35.13 94.73 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.23 1.953 . . . . 10.0 112.917 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.23 -56.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.991 0.916 . . . . 10.0 110.926 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.9 m -62.97 -34.17 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 118.831 -0.605 . . . . 10.0 112.621 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -59.79 -54.9 40.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.529 1.132 . . . . 10.0 112.184 167.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.3 tp -52.9 -43.82 66.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.882 1.273 . . . . 10.0 112.254 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.75 -4.9 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 115.453 1.649 . . . . 10.0 115.453 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.45 -169.28 32.91 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.521 1.067 . . . . 10.0 113.898 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.23 -41.67 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.838 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.9 -14.16 62.87 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.364 1.616 . . . . 10.0 115.364 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.14 -106.14 1.02 Allowed Glycine 0 CA--C 1.535 1.284 0 CA-C-N 120.523 1.51 . . . . 10.0 114.218 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.08 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.666 -1.49 . . . . 10.0 109.314 168.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.38 65.31 1.34 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.7 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.36 24.89 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.66 153.8 72.64 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.814 3.009 . . . . 10.0 111.456 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.22 -39.77 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.193 171.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.34 -52.36 21.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.98 -40.45 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.429 1.092 . . . . 10.0 109.617 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.35 -49.76 42.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.603 0.638 . . . . 10.0 111.952 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.7 -47.06 83.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.004 1.721 . . . . 10.0 112.979 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.32 -52.32 62.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.957 0.903 . . . . 10.0 112.1 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.53 -58.93 5.2 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.362 1.065 . . . . 10.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.99 -47.21 65.0 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.641 -1.171 . . . . 10.0 112.359 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.52 -52.11 56.3 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.57 1.532 . . . . 10.0 112.846 175.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.91 -47.97 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.51 1.124 . . . . 10.0 111.189 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.9 mp -57.94 -51.33 70.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.74 1.616 . . . . 10.0 112.159 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -54.46 -56.01 23.05 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.292 2.237 . . . . 10.0 111.309 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.75 -49.36 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.582 -0.699 . . . . 10.0 111.233 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.8 m -56.2 -55.01 38.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.254 1.022 . . . . 10.0 112.33 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.43 1.11 8.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.373 1.869 . . . . 10.0 114.913 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -128.87 -68.83 0.73 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.921 1.288 . . . . 10.0 111.594 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.11 -50.93 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.595 1.158 . . . . 10.0 110.813 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -56.66 -55.87 27.66 Favored Glycine 0 N--CA 1.475 1.281 0 C-N-CA 124.118 0.866 . . . . 10.0 112.602 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.7 -56.88 2.49 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.816 2.046 . . . . 10.0 112.554 166.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.48 -41.41 88.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.785 1.184 . . . . 10.0 114.256 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -69.31 -27.23 65.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 115.609 1.707 . . . . 10.0 115.609 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.2 -57.58 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 165.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.67 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.92 0.888 . . . . 10.0 113.167 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.54 5.21 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.324 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.09 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.028 0.931 . . . . 10.0 111.014 174.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.56 98.21 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.781 0.832 . . . . 10.0 110.949 170.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.95 76.99 7.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.908 0.883 . . . . 10.0 112.093 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.07 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 128.888 2.875 . . . . 10.0 116.499 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.87 -55.47 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.641 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.48 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.676 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.495 0 C-N-CA 128.527 2.731 . . . . 10.0 113.461 166.594 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.475 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.808 -2.044 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.657 3.183 . . . . 10.0 117.239 160.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.0 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.297 2.639 . . . . 10.0 114.49 155.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.427 1.891 . . . . 10.0 113.339 -158.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 114.015 -174.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.83 40.9 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.675 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.02 -60.65 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.502 2.286 . . . . 10.0 113.202 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.11 4.28 0.94 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.787 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.509 -0.744 . . . . 10.0 112.625 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.898 0.879 . . . . 10.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.537 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.42 -52.64 62.91 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.455 0.702 . . . . 10.0 111.84 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.39 -53.58 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.205 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.77 52.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.332 1.453 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.98 84.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.354 1.462 . . . . 10.0 112.997 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.66 -56.86 10.43 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.32 0.962 . . . . 10.0 111.3 165.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.47 -52.29 30.12 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.615 1.166 . . . . 10.0 112.199 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.92 5.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.159 0.984 . . . . 10.0 112.139 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -57.68 -50.31 73.6 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.599 0.76 . . . . 10.0 112.604 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -49.99 68.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.252 1.021 . . . . 10.0 111.071 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.92 -58.18 15.95 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.407 1.003 . . . . 10.0 113.673 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.19 -45.69 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.511 1.155 . . . . 10.0 112.086 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.7 -42.08 76.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.88 1.229 . . . . 10.0 113.302 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -60.51 -60.36 3.93 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.046 0.938 . . . . 10.0 111.071 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.97 62.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.0 9.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 113.004 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.71 -38.61 82.09 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.1 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.66 1.184 . . . . 10.0 113.628 169.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.759 1.742 . . . . 10.0 110.852 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.88 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.869 2.468 . . . . 10.0 109.286 171.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.12 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.594 0.998 . . . . 10.0 115.594 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.0 92.89 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.163 2.185 . . . . 10.0 113.605 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.43 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.742 0.687 . . . . 10.0 112.407 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.962 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.84 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.904 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.811 1.32 . . . . 10.0 110.972 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.54 -29.67 89.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.719 2.946 . . . . 10.0 113.716 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.23 -60.75 2.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.133 0.573 . . . . 10.0 111.441 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.07 -40.08 22.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.126 1.37 . . . . 10.0 113.58 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.59 -47.39 19.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.444 172.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.06 62.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.48 0.712 . . . . 10.0 110.955 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.97 -50.24 73.26 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.137 0.575 . . . . 10.0 112.313 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.22 65.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.868 -0.586 . . . . 10.0 112.362 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.77 -57.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.867 1.267 . . . . 10.0 110.329 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -69.27 -16.25 63.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.14 1.376 . . . . 10.0 113.69 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.1 m -87.87 -42.99 12.14 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.779 1.172 . . . . 10.0 111.96 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -56.56 -41.6 77.17 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 173.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -49.46 -61.61 3.31 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.804 1.242 . . . . 10.0 112.595 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.64 -47.62 20.14 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.593 3.529 . . . . 10.0 116.115 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.1 93.62 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.938 1.245 . . . . 10.0 113.966 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.9 mt -58.57 -51.76 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.398 1.079 . . . . 10.0 109.525 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -43.04 71.76 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 10.0 113.246 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -52.69 -57.95 8.42 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.131 1.332 . . . . 10.0 111.912 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -48.33 -52.89 19.48 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.57 1.548 . . . . 10.0 110.967 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.89 -48.12 64.16 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.916 0.886 . . . . 10.0 113.029 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -55.85 -41.44 74.31 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.27 1.395 . . . . 10.0 113.225 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.54 34.8 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.719 1.145 . . . . 10.0 111.292 170.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.23 1.567 . . . . 10.0 115.23 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.88 -50.82 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.519 0.728 . . . . 10.0 110.528 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.57 -52.69 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.835 0.854 . . . . 10.0 112.922 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.96 -5.53 48.97 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.65 5.6 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.527 0.971 . . . . 10.0 115.527 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.1 42.74 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.63 61.1 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.351 0.9 . . . . 10.0 115.351 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.35 26.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.034 2.133 . . . . 10.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.052 166.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.717 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.6 129.58 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.72 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.664 2.226 . . . . 10.0 118.664 170.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.343 1.571 . . . . 10.0 112.237 -165.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.85 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.096 -175.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.2 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.09 126.33 22.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.028 1.731 . . . . 10.0 111.682 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.61 85.06 4.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.384 1.564 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.42 -28.26 66.77 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.523 -1.361 . . . . 10.0 113.926 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.38 62.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -64.89 -24.45 67.54 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.232 -1.543 . . . . 10.0 113.876 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -75.87 -42.93 47.9 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.462 -1.399 . . . . 10.0 112.257 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.88 53.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.064 1.346 . . . . 10.0 111.368 168.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -52.41 -71.09 0.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.715 2.006 . . . . 10.0 111.836 168.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -56.17 -32.74 64.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.644 1.178 . . . . 10.0 113.153 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.88 -39.74 54.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.389 1.475 . . . . 10.0 112.084 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.72 -41.41 5.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.549 0.739 . . . . 10.0 112.95 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 p -59.31 -41.1 88.24 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 120.792 1.633 . . . . 10.0 113.347 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.402 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.6 m -68.47 -47.5 35.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 84.9 Cg_exo -53.99 -41.47 74.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.574 2.849 . . . . 10.0 114.872 168.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -47.66 85.08 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.586 0.755 . . . . 10.0 111.728 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.7 tt -50.47 -49.61 54.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 10.0 111.548 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.18 -47.83 77.53 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.129 -0.982 . . . . 10.0 112.848 170.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.26 78.42 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.829 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.27 -54.03 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.343 0.974 . . . . 10.0 111.165 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -42.09 88.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.641 0.776 . . . . 10.0 112.093 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.81 36.63 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.996 0.918 . . . . 10.0 112.021 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.1 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.875 1.67 . . . . 10.0 112.106 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.938 -1.726 . . . . 10.0 112.437 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.55 135.96 54.46 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.9 -39.66 2.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.474 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.18 5.36 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.15 1.357 . . . . 10.0 115.266 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -46.75 87.76 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.123 -1.418 . . . . 10.0 111.351 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.038 1.335 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.58 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.534 0.568 . . . . 10.0 112.534 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.86 43.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.716 . . . . 10.0 110.911 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.64 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.382 2.273 . . . . 10.0 114.814 174.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.04 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.647 0.779 . . . . 10.0 111.403 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.67 -46.76 74.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.24 0.83 . . . . 10.0 113.24 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.64 -44.11 89.94 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 10.0 112.217 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.87 -56.23 5.2 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.33 1.443 . . . . 10.0 113.072 166.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 90.0 mt -56.81 -51.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.674 0.789 . . . . 10.0 111.55 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -52.1 -57.61 9.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.268 1.027 . . . . 10.0 112.185 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.0 mm -66.59 -43.83 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.776 0.43 . . . . 10.0 111.81 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.88 -59.95 9.09 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.823 1.201 . . . . 10.0 113.316 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.6 p -59.45 -35.87 74.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.893 0.877 . . . . 10.0 112.52 173.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -46.27 -58.92 5.49 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.351 0.977 . . . . 10.0 113.543 163.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.9 tp -57.53 -46.28 84.05 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.318 1.447 . . . . 10.0 112.101 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.3 t -53.08 -50.67 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.709 -0.62 . . . . 10.0 110.328 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.39 -60.9 6.34 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.099 1.809 . . . . 10.0 112.704 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -44.22 -41.12 5.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.245 2.218 . . . . 10.0 113.585 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.26 -6.7 25.58 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.444 1.646 . . . . 10.0 115.444 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.74 116.75 10.49 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.375 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.58 72.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.66 106.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.043 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.62 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -53.99 -41.66 68.15 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.89 0.768 . . . . 10.0 110.807 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.78 -31.59 69.6 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.318 1.229 . . . . 10.0 114.318 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.22 -51.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.976 0.807 . . . . 10.0 109.636 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -61.92 -42.8 99.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.423 1.268 . . . . 10.0 114.423 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.65 -48.85 69.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.237 1.015 . . . . 10.0 112.758 171.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.24 70.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.534 0.734 . . . . 10.0 111.614 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.16 -55.03 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.079 1.352 . . . . 10.0 111.974 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.1 p -57.2 -40.83 78.21 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.432 -0.792 . . . . 10.0 112.706 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.4 m -61.92 -44.84 95.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.756 1.223 . . . . 10.0 112.326 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.6 80.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.314 0.961 . . . . 10.0 112.251 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.95 85.51 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.503 -0.748 . . . . 10.0 112.816 173.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.272 1.029 . . . . 10.0 112.26 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.88 -45.81 78.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.831 1.652 . . . . 10.0 112.231 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -54.81 -53.93 48.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 171.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 44.1 mt -54.21 -54.75 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.716 0.689 . . . . 10.0 110.856 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.27 1.0 OUTLIER -60.02 -32.71 71.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 117.467 -1.254 . . . . 10.0 112.904 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.25 -58.13 9.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.987 1.267 . . . . 10.0 113.071 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -40.89 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.312 -0.851 . . . . 10.0 111.446 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.78 -49.41 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.847 1.203 . . . . 10.0 112.145 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.05 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.046 -1.659 . . . . 10.0 112.833 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -73.79 -21.9 60.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.626 1.17 . . . . 10.0 113.398 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.588 0.614 . . . . 10.0 113.488 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.63 -32.45 51.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.62 -50.58 65.39 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.067 0.937 . . . . 10.0 112.286 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.17 -45.98 83.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.105 0.962 . . . . 10.0 112.15 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.46 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.506 1.299 . . . . 10.0 114.506 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.46 -11.34 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.078 1.751 . . . . 10.0 114.238 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.57 29.14 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.85 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.456 1.598 . . . . 10.0 114.171 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.77 153.88 72.49 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.834 3.254 . . . . 10.0 105.57 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.8 -46.21 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.329 2.019 . . . . 10.0 113.083 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.03 68.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.985 2.914 . . . . 10.0 113.27 173.575 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.19 -53.03 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.78 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.26 23.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.12 -53.23 60.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.164 0.986 . . . . 10.0 113.028 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.54 46.07 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.337 0.655 . . . . 10.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.06 -48.46 78.5 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.02 -49.61 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.767 0.712 . . . . 10.0 110.487 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.48 -51.69 68.77 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.74 30.88 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.818 2.047 . . . . 10.0 111.065 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.81 0.444 . . . . 10.0 111.269 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.99 -47.42 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.046 0.938 . . . . 10.0 112.238 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.9 m -58.19 -64.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.953 2.501 . . . . 10.0 111.482 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.27 -48.64 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.845 1.258 . . . . 10.0 111.373 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.27 -61.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.863 0.865 . . . . 10.0 112.606 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.19 -47.06 79.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.754 0.706 . . . . 10.0 111.934 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -50.11 -54.29 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.645 1.178 . . . . 10.0 112.149 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 m -52.31 -33.88 44.44 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.509 1.123 . . . . 10.0 113.588 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.97 96.81 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.017 1.117 . . . . 10.0 114.017 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -46.37 -58.08 7.3 Favored Pre-proline 0 N--CA 1.479 0.986 0 N-CA-C 114.908 1.447 . . . . 10.0 114.908 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.93 -32.79 92.89 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.376 2.051 . . . . 10.0 113.492 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.75 -57.89 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.991 0.916 . . . . 10.0 110.417 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.0 m -61.86 -34.08 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.4 -56.63 19.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.544 1.138 . . . . 10.0 112.404 167.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.4 tt -57.59 -40.46 79.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.755 0.822 . . . . 10.0 112.355 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.18 -5.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 115.2 1.555 . . . . 10.0 115.2 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.35 32.95 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.573 1.096 . . . . 10.0 113.895 -168.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.93 65.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.176 -1.012 . . . . 10.0 111.88 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.88 -13.45 62.43 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.75 -106.13 0.98 Allowed Glycine 0 CA--C 1.535 1.311 0 CA-C-N 120.606 1.548 . . . . 10.0 114.45 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.12 35.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.595 -1.533 . . . . 10.0 109.368 168.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.904 0.321 . . . . 10.0 113.904 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.64 -42.7 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.687 166.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.34 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.382 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.69 153.79 72.59 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.774 2.983 . . . . 10.0 111.476 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.8 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.38 1.072 . . . . 10.0 112.169 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.43 -52.34 22.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.49 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.695 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.35 -49.78 42.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.515 0.598 . . . . 10.0 111.925 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.38 -52.26 62.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.923 0.889 . . . . 10.0 112.124 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.6 -58.82 5.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.319 1.048 . . . . 10.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -52.55 -46.14 66.68 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 117.629 -1.176 . . . . 10.0 112.506 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.01 -51.89 60.21 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.55 1.523 . . . . 10.0 112.789 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.68 -47.0 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.81 1.244 . . . . 10.0 111.598 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.73 -50.04 75.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 10.0 111.795 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -57.15 -57.4 12.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.879 2.072 . . . . 10.0 111.508 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.53 -40.31 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.887 -1.133 . . . . 10.0 111.917 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 28.0 m -59.45 -51.87 68.03 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.952 0.901 . . . . 10.0 111.867 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.09 -25.8 66.4 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.313 1.845 . . . . 10.0 114.42 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -98.65 -71.66 0.68 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.485 1.114 . . . . 10.0 111.685 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.86 -49.77 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.604 1.162 . . . . 10.0 111.567 -172.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.2 -55.44 28.25 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.254 0.93 . . . . 10.0 112.904 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -43.09 -56.91 3.14 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.999 2.12 . . . . 10.0 112.266 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.7 -40.43 71.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.303 0.954 . . . . 10.0 114.186 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -69.75 -27.32 64.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 115.882 1.808 . . . . 10.0 115.882 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -57.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.593 -0.892 . . . . 10.0 108.593 165.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.76 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.898 . . . . 10.0 113.193 -172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.17 2.53 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.23 0.3 15.74 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.22 1.008 . . . . 10.0 113.344 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.046 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.61 98.12 1.83 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.826 0.85 . . . . 10.0 110.941 170.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 77.04 7.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.824 0.85 . . . . 10.0 112.067 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.838 2.855 . . . . 10.0 116.491 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.738 1.215 . . . . 10.0 110.656 -175.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.44 39.92 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.757 3.551 . . . . 10.0 119.665 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.487 2.715 . . . . 10.0 113.44 166.597 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.491 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.75 -2.072 . . . . 10.0 105.863 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.62 65.01 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.252 2.621 . . . . 10.0 114.537 155.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.97 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.344 1.857 . . . . 10.0 113.339 -158.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.08 2.8 41.62 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.489 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.653 -168.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.92 -60.7 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.522 2.293 . . . . 10.0 113.196 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.19 4.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.726 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.29 -43.14 61.56 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.515 -0.741 . . . . 10.0 112.619 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.59 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.331 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.43 -52.63 62.96 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.455 0.702 . . . . 10.0 111.882 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.341 1.456 . . . . 10.0 113.315 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.12 -55.44 15.52 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.501 1.048 . . . . 10.0 111.801 166.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -50.26 -52.48 35.85 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.834 1.253 . . . . 10.0 112.284 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.87 5.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.16 0.984 . . . . 10.0 112.167 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.1 -48.86 77.57 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.615 0.766 . . . . 10.0 112.858 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -61.59 -43.94 97.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.649 0.78 . . . . 10.0 111.531 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.59 -58.75 12.93 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.145 0.879 . . . . 10.0 113.785 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -45.99 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.605 1.202 . . . . 10.0 112.119 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.08 -42.88 72.68 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.028 1.299 . . . . 10.0 113.132 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -62.1 -58.23 8.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.285 -0.864 . . . . 10.0 111.489 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.33 -40.99 62.62 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.041 0.936 . . . . 10.0 110.937 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.02 9.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.636 1.175 . . . . 10.0 112.968 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.71 82.15 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.45 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.632 1.173 . . . . 10.0 113.633 169.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.743 1.735 . . . . 10.0 110.88 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.9 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.839 2.455 . . . . 10.0 109.358 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.94 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.02 93.01 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.196 2.198 . . . . 10.0 113.546 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.39 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.437 2.695 . . . . 10.0 116.948 166.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.8 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.18 -1.373 . . . . 10.0 113.868 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.51 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.769 1.293 . . . . 10.0 110.981 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.55 -29.67 89.57 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.706 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.28 -60.69 2.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.111 0.565 . . . . 10.0 111.437 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.1 22.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.1 1.36 . . . . 10.0 113.549 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.44 19.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.199 1.4 . . . . 10.0 113.446 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.71 -53.07 62.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.48 0.712 . . . . 10.0 110.967 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.0 -50.22 73.37 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.297 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.2 65.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.34 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.99 1.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.8 mt -48.53 -57.93 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.865 1.266 . . . . 10.0 110.332 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -67.92 -19.03 64.95 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.105 1.362 . . . . 10.0 113.703 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -86.0 -40.87 15.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.45 1.1 . . . . 10.0 112.22 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.8 mt -59.17 -42.61 91.21 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.915 0.78 . . . . 10.0 112.921 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.9 t -44.03 -61.19 2.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.67 1.588 . . . . 10.0 113.154 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -70.74 -25.42 24.09 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.895 2.396 . . . . 10.0 114.041 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.11 -50.13 67.26 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 120.732 1.605 . . . . 10.0 113.795 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.28 -39.05 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 120.329 -1.482 . . . . 10.0 110.735 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.26 81.18 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 118.54 -0.743 . . . . 10.0 112.96 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -50.58 -55.71 15.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.581 1.553 . . . . 10.0 111.755 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.08 -53.19 21.58 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.363 1.465 . . . . 10.0 110.867 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.35 -48.19 65.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.102 0.961 . . . . 10.0 113.011 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.4 -41.1 75.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.241 1.382 . . . . 10.0 113.222 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.53 35.06 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.656 1.116 . . . . 10.0 111.313 170.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.15 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.9 mtm -66.78 -50.88 61.25 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.565 0.746 . . . . 10.0 110.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.54 -52.71 21.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 10.0 112.925 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.58 49.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.27 -34.66 5.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 115.542 0.977 . . . . 10.0 115.542 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.12 43.3 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.56 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.081 2.153 . . . . 10.0 109.056 171.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.062 166.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.883 0.873 . . . . 10.0 109.723 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.3 t -129.61 129.6 23.17 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.037 1.335 . . . . 10.0 110.927 -176.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.78 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -81.96 0.15 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.697 -0.961 . . . . 10.0 110.697 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.91 4.07 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.317 1.558 . . . . 10.0 112.27 -165.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.47 1.508 . . . . 10.0 111.107 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.46 120.76 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.52 131.92 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.198 3.265 . . . . 10.0 112.137 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.03 1.732 . . . . 10.0 111.69 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.04 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.865 1.317 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.4 -28.28 66.77 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.77 -26.47 46.07 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.296 1.038 . . . . 10.0 111.165 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -44.08 -63.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.374 1.47 . . . . 10.0 110.146 165.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -63.62 -39.73 95.1 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.223 2.209 . . . . 10.0 111.119 -172.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.26 -49.03 67.76 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.733 0.813 . . . . 10.0 112.024 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -63.67 1.21 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.96 1.304 . . . . 10.0 111.64 170.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -53.7 -36.95 62.75 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.805 1.642 . . . . 10.0 112.72 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.69 -42.17 56.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.036 1.734 . . . . 10.0 112.226 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -103.68 -35.29 8.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.932 0.716 . . . . 10.0 112.932 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.5 p -62.17 -49.04 77.42 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 121.387 1.903 . . . . 10.0 113.483 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.284 69.9 p -63.54 -41.73 68.4 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 114.722 1.379 . . . . 10.0 114.722 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.8 -43.24 51.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.481 2.787 . . . . 10.0 115.265 168.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 mt -60.62 -46.9 88.53 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.491 -0.756 . . . . 10.0 111.515 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.68 -49.83 56.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.646 1.578 . . . . 10.0 111.359 171.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.65 -47.46 79.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.247 1.019 . . . . 10.0 113.046 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.854 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.31 -54.01 36.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.173 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.11 88.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.69 0.796 . . . . 10.0 112.068 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.69 -54.75 37.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 111.974 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.725 0.81 . . . . 10.0 112.704 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.82 -38.56 91.57 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.78 1.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.062 1.345 . . . . 10.0 112.337 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.49 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.88 47.66 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.454 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.84 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.714 0.635 . . . . 10.0 112.714 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.8 -39.68 2.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.24 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.131 1.348 . . . . 10.0 115.235 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.06 -46.77 87.69 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.13 -1.414 . . . . 10.0 111.312 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.5 -52.91 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.029 1.332 . . . . 10.0 111.101 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.27 67.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.23 -44.85 43.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.424 0.69 . . . . 10.0 110.924 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.55 -59.88 4.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.419 2.288 . . . . 10.0 114.815 174.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.08 -46.29 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.667 0.787 . . . . 10.0 111.385 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.67 74.42 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 173.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.0 -45.99 82.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.851 0.86 . . . . 10.0 111.994 174.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -55.38 5.49 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.362 1.458 . . . . 10.0 113.142 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.73 -50.15 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.902 0.881 . . . . 10.0 111.74 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -50.99 -57.13 9.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.589 1.556 . . . . 10.0 111.873 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm -68.66 -42.85 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.121 0.568 . . . . 10.0 112.488 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.2 -53.1 39.57 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.04 1.305 . . . . 10.0 113.501 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.5 p -61.05 -36.52 79.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.208 -1.172 . . . . 10.0 112.307 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.23 -56.77 13.32 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.148 0.88 . . . . 10.0 113.294 165.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.52 -47.29 49.0 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.498 2.719 . . . . 10.0 111.321 174.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.05 -49.68 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.488 1.115 . . . . 10.0 111.764 174.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.55 -58.99 9.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.085 1.803 . . . . 10.0 112.338 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.49 -43.48 2.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.251 2.62 . . . . 10.0 113.294 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.3 mt -101.2 -6.4 24.3 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.423 1.638 . . . . 10.0 115.423 -174.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.67 116.73 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.165 -1.584 . . . . 10.0 110.419 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.59 72.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.217 2.607 . . . . 10.0 113.269 177.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.61 106.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.09 15.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 10.0 113.468 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.66 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -53.84 -41.91 67.92 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.902 0.774 . . . . 10.0 110.806 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.21 -32.57 71.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.817 1.247 . . . . 10.0 114.198 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.91 -52.12 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.022 0.828 . . . . 10.0 109.991 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -59.45 -51.76 68.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.491 0.922 . . . . 10.0 113.491 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.38 -46.59 37.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.428 1.091 . . . . 10.0 113.427 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.38 -52.55 65.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.945 0.898 . . . . 10.0 111.659 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.4 mt -54.07 -50.98 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.126 1.37 . . . . 10.0 111.49 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 m -53.84 -49.19 68.96 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.479 1.112 . . . . 10.0 112.108 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 76.5 m -61.34 -43.34 99.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.992 1.317 . . . . 10.0 111.618 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.45 -50.16 73.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.14 0.976 . . . . 10.0 112.477 170.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.87 82.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.736 0.814 . . . . 10.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.1 ttp -57.94 -53.13 61.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.496 1.118 . . . . 10.0 111.953 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -51.92 -50.01 61.95 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.772 1.629 . . . . 10.0 111.398 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -49.51 -54.89 15.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.06 0.944 . . . . 10.0 112.436 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -53.4 -55.29 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.829 0.852 . . . . 10.0 110.729 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.5 mt -57.49 -35.65 70.48 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.283 -0.865 . . . . 10.0 112.91 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.18 9.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.89 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.5 mt -56.77 -49.45 75.27 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.845 1.202 . . . . 10.0 112.099 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.877 -175.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.65 -21.99 60.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.635 1.174 . . . . 10.0 113.446 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.625 0.631 . . . . 10.0 113.527 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.55 -32.52 51.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.322 1.849 . . . . 10.0 113.019 -166.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.11 -56.4 14.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.56 65.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.121 0.962 . . . . 10.0 112.331 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.07 82.87 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.188 0.995 . . . . 10.0 112.134 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.77 -47.52 79.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.249 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.01 6.58 29.19 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.433 1.893 . . . . 10.0 114.907 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.65 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.535 1.636 . . . . 10.0 114.139 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.73 153.98 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.81 3.244 . . . . 10.0 105.572 170.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.85 -46.21 35.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.301 2.001 . . . . 10.0 113.052 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.96 -46.08 68.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.27 173.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.22 -53.05 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 C-N-CA 124.055 0.942 . . . . 10.0 109.788 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.86 75.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.275 0.63 . . . . 10.0 111.917 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.98 -56.13 25.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.88 0.872 . . . . 10.0 112.761 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.028 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.58 -49.52 46.19 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.337 0.655 . . . . 10.0 111.052 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.17 -48.4 78.82 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.636 1.347 . . . . 10.0 114.636 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.801 0.728 . . . . 10.0 110.506 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.164 0.801 . . . . 10.0 113.164 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.8 30.26 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.1 t -51.9 -49.1 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.044 0.937 . . . . 10.0 111.472 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.4 m -56.01 -63.95 1.01 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.62 2.768 . . . . 10.0 111.921 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.31 -49.51 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.488 1.115 . . . . 10.0 111.313 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.7 -62.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.172 0.989 . . . . 10.0 112.063 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.51 -47.17 85.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.974 0.806 . . . . 10.0 112.612 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -55.01 -50.31 69.35 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.683 0.793 . . . . 10.0 111.752 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -53.98 -32.18 53.14 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.902 1.075 . . . . 10.0 113.902 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.98 99.02 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.821 1.045 . . . . 10.0 113.821 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -48.37 -56.34 14.82 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 115.108 1.521 . . . . 10.0 115.108 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.458 ' HB3' H183 ' A' ' 999' ' ' RET . 22.3 Cg_endo -58.84 -34.73 99.18 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.096 1.864 . . . . 10.0 113.318 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.81 -53.03 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.285 0.948 . . . . 10.0 110.636 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.77 -50.62 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.756 1.222 . . . . 10.0 111.596 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -56.39 -51.01 69.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.46 1.104 . . . . 10.0 112.53 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.2 tp -54.44 -45.53 73.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.59 1.156 . . . . 10.0 112.22 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -86.54 -5.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.15 1.537 . . . . 10.0 115.15 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.54 -169.29 32.79 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 122.602 1.112 . . . . 10.0 113.806 -168.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.75 65.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.868 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -67.29 -16.13 64.1 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.487 1.662 . . . . 10.0 115.487 -175.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.77 -105.99 1.04 Allowed Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.494 1.497 . . . . 10.0 114.104 -173.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.11 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.35 168.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 CA-C-N 117.878 0.308 . . . . 10.0 113.862 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.59 -42.73 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.73 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.1 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.416 1.886 . . . . 10.0 109.366 -174.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.79 153.79 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.19 -39.78 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.18 171.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.34 -52.38 21.9 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.682 1.364 . . . . 10.0 114.682 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.27 -49.83 41.77 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.603 0.638 . . . . 10.0 111.991 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.66 -47.06 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.999 1.72 . . . . 10.0 113.026 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.32 -52.29 62.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.974 0.91 . . . . 10.0 112.093 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.61 -59.0 4.99 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 109.975 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.83 -44.65 66.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.793 -1.098 . . . . 10.0 112.657 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -54.16 -52.64 60.51 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.579 1.536 . . . . 10.0 112.689 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.2 t -60.86 -46.26 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.69 1.196 . . . . 10.0 111.353 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -59.15 -52.44 65.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.364 1.466 . . . . 10.0 112.122 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -55.46 -54.64 41.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.507 1.923 . . . . 10.0 111.062 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t -49.49 -50.33 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.071 -1.018 . . . . 10.0 111.635 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 34.9 m -59.81 -53.43 57.99 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.269 1.028 . . . . 10.0 112.035 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.92 -25.45 66.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.709 2.003 . . . . 10.0 114.596 -176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -97.28 -70.81 0.71 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.454 1.102 . . . . 10.0 111.704 173.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.3 t -73.49 -50.32 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.575 1.15 . . . . 10.0 111.51 -171.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.34 -55.07 30.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.244 0.926 . . . . 10.0 112.758 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -43.47 -57.08 3.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.79 2.036 . . . . 10.0 112.488 166.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.98 -41.26 76.54 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.326 0.965 . . . . 10.0 113.993 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.79 -26.99 64.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.911 1.819 . . . . 10.0 115.911 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.5 -57.47 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.88 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.908 0.883 . . . . 10.0 113.187 -172.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.15 2.56 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.197 0.999 . . . . 10.0 113.296 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.05 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.983 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.13 1.82 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.771 0.828 . . . . 10.0 110.961 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 76.97 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.857 0.863 . . . . 10.0 112.094 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.862 2.865 . . . . 10.0 116.505 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.79 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.731 1.212 . . . . 10.0 110.698 -175.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.49 39.98 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.591 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.521 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.789 -2.053 . . . . 10.0 105.817 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.638 3.175 . . . . 10.0 117.211 160.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.69 65.0 0.11 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.306 2.642 . . . . 10.0 114.49 155.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.84 41.28 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.483 2.468 . . . . 10.0 111.523 168.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.667 -168.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -64.0 -60.6 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.519 2.292 . . . . 10.0 113.212 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.33 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.847 2.459 . . . . 10.0 115.787 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.46 -0.775 . . . . 10.0 112.619 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.57 84.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.859 0.863 . . . . 10.0 109.315 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.37 -52.66 62.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.426 0.69 . . . . 10.0 111.898 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.34 -53.64 55.84 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.221 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.81 51.95 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.366 1.466 . . . . 10.0 113.307 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -45.0 84.75 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 10.0 113.026 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.41 -56.69 10.41 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.526 1.06 . . . . 10.0 111.465 166.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -49.7 -52.48 30.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.836 1.255 . . . . 10.0 112.19 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 -58.9 5.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.174 0.99 . . . . 10.0 112.207 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.31 -48.46 78.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.577 0.751 . . . . 10.0 112.825 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.418 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 52.0 mtt -58.89 -47.46 84.88 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.223 1.009 . . . . 10.0 111.523 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.85 -58.76 12.88 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.267 0.937 . . . . 10.0 113.66 174.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.18 -46.06 79.52 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.728 1.264 . . . . 10.0 112.1 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.33 75.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.76 1.172 . . . . 10.0 113.244 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -61.93 -58.49 7.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.742 0.817 . . . . 10.0 111.419 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.97 62.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.8 -58.07 9.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.986 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.63 81.86 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.236 0.828 . . . . 10.0 113.236 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.46 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.654 1.182 . . . . 10.0 113.581 169.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.44 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.781 1.753 . . . . 10.0 110.846 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.83 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.906 2.483 . . . . 10.0 109.366 171.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.98 93.05 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.143 2.177 . . . . 10.0 113.584 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.37 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.387 2.675 . . . . 10.0 116.975 166.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.65 -50.87 10.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.891 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.94 117.59 6.51 Favored Pre-proline 0 CA--C 1.536 0.432 0 O-C-N 124.741 1.275 . . . . 10.0 110.916 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.67 -29.6 89.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.695 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.04 22.82 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.114 1.366 . . . . 10.0 113.551 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.6 -47.44 19.94 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.242 1.417 . . . . 10.0 113.384 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.08 62.22 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.535 0.734 . . . . 10.0 110.935 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.02 -50.21 73.43 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.115 0.566 . . . . 10.0 112.348 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.26 65.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.903 -0.57 . . . . 10.0 112.378 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.01 1.91 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.412 0.893 . . . . 10.0 113.412 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.53 -58.07 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.918 1.287 . . . . 10.0 110.121 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 m -68.16 -16.99 64.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.297 1.439 . . . . 10.0 113.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -88.35 -39.78 14.08 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.571 1.078 . . . . 10.0 112.146 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -59.8 -42.18 92.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.939 0.791 . . . . 10.0 112.372 170.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -41.44 -60.7 1.69 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 126.094 1.758 . . . . 10.0 113.807 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.98 -25.67 16.07 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.158 2.572 . . . . 10.0 114.372 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.7 -45.07 84.2 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.674 1.579 . . . . 10.0 113.502 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -54.02 -52.81 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.01 0.924 . . . . 10.0 109.447 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.418 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -54.19 -45.9 72.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.465 1.106 . . . . 10.0 113.428 177.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -51.1 -57.58 8.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.058 1.343 . . . . 10.0 112.15 171.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 m -49.36 -52.63 26.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.302 1.441 . . . . 10.0 110.699 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.5 mmt -69.14 -48.13 63.2 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.895 0.878 . . . . 10.0 113.044 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -57.09 -39.95 76.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.927 -1.511 . . . . 10.0 113.218 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.35 -54.56 34.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.266 1.394 . . . . 10.0 111.281 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.64 -41.13 61.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.197 1.555 . . . . 10.0 115.197 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.85 -50.78 61.47 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.545 0.738 . . . . 10.0 110.511 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.64 -52.67 21.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.864 0.865 . . . . 10.0 112.908 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.91 -5.54 48.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.343 1.057 . . . . 10.0 113.835 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.544 0.978 . . . . 10.0 115.544 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.246 1.572 . . . . 10.0 115.246 -175.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.57 61.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.39 26.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.049 2.14 . . . . 10.0 109.041 171.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.1 15.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.004 166.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.02 53.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.703 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.52 129.6 23.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 125.048 1.339 . . . . 10.0 110.995 -176.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.74 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.469 -1.012 . . . . 10.0 109.469 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.48 38.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.31 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.735 -0.946 . . . . 10.0 110.735 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.83 -3.35 0.69 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 118.656 2.223 . . . . 10.0 118.656 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.317 1.559 . . . . 10.0 112.21 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.85 9.04 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.491 1.516 . . . . 10.0 111.137 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.54 131.95 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.23 3.287 . . . . 10.0 112.145 171.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.35 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.043 1.737 . . . . 10.0 111.66 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.65 85.01 4.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.295 1.521 . . . . 10.0 113.037 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.587 -1.321 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.19 -35.99 62.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.998 1.11 . . . . 10.0 113.998 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.5 ptp180 -64.4 -23.32 67.25 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.589 -1.319 . . . . 10.0 114.169 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -77.69 -42.77 33.34 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.148 -0.97 . . . . 10.0 111.763 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.95 44.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.355 1.462 . . . . 10.0 111.726 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -51.8 -71.88 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.551 1.941 . . . . 10.0 111.805 169.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.417 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.0 m0 -56.48 -31.96 64.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 117.507 -1.235 . . . . 10.0 113.536 -172.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 tp -48.59 -45.56 38.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.004 1.722 . . . . 10.0 112.077 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.91 -43.78 6.59 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.059 0.944 . . . . 10.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.0 m -51.45 -48.86 62.63 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.58 1.552 . . . . 10.0 113.444 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 41.5 p -69.41 -46.62 27.48 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.57 1.322 . . . . 10.0 114.57 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.53 -42.41 49.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.143 2.562 . . . . 10.0 115.185 169.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.41 -48.36 81.92 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.555 -0.716 . . . . 10.0 112.245 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -36.55 82.52 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.523 1.056 . . . . 10.0 112.555 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.66 -49.03 76.25 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.097 -1.002 . . . . 10.0 111.674 165.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.82 -38.25 78.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.823 0.849 . . . . 10.0 112.874 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -52.36 -53.97 37.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.298 0.954 . . . . 10.0 111.173 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.676 0.79 . . . . 10.0 112.131 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.72 38.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.94 0.896 . . . . 10.0 112.039 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.22 79.25 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.778 0.831 . . . . 10.0 112.692 174.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.75 -38.6 91.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.399 1.259 . . . . 10.0 114.399 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.81 1.37 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.236 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.55 11.94 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.33 145.89 47.49 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.95 -1.719 . . . . 10.0 112.458 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.9 54.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.8 -39.72 2.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.316 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.44 -52.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.088 1.355 . . . . 10.0 111.101 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.26 67.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.543 0.571 . . . . 10.0 112.543 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.441 0.696 . . . . 10.0 110.943 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.8 4.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.849 174.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.12 -46.31 96.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.706 0.802 . . . . 10.0 111.374 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.31 64.04 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.701 0.667 . . . . 10.0 112.624 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.36 75.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.358 0.873 . . . . 10.0 113.358 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -53.22 -51.41 62.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.699 1.2 . . . . 10.0 110.641 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.42 -54.29 4.78 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.092 1.329 . . . . 10.0 113.276 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.53 -54.76 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 118.068 -0.968 . . . . 10.0 112.395 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . 0.309 3.1 ppp? -61.45 -42.64 99.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.605 1.548 . . . . 10.0 113.552 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.0 mm -65.52 -47.38 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 120.214 1.37 . . . . 10.0 111.702 170.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.76 -55.25 24.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.049 1.309 . . . . 10.0 113.406 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 32.4 p -60.72 -35.58 76.69 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.134 -1.215 . . . . 10.0 112.689 173.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.68 -59.07 8.29 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.239 0.923 . . . . 10.0 113.125 164.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.92 -47.71 43.22 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.768 2.827 . . . . 10.0 111.663 174.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.33 -49.53 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.551 1.14 . . . . 10.0 111.701 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.18 -58.69 11.07 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.058 1.79 . . . . 10.0 112.379 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.57 -43.4 2.71 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.209 2.604 . . . . 10.0 113.304 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.9 mt -101.19 -6.41 24.29 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.485 1.661 . . . . 10.0 115.485 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.75 10.47 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.165 -1.584 . . . . 10.0 110.366 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.61 72.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.248 2.619 . . . . 10.0 113.275 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.69 106.34 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.79 0.836 . . . . 10.0 110.05 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.82 -59.63 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.051 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.42 -42.11 14.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.513 1.525 . . . . 10.0 113.496 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.63 63.2 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.19 -41.58 68.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.855 0.752 . . . . 10.0 110.826 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.21 -32.64 72.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.771 1.228 . . . . 10.0 114.216 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.79 -51.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.073 0.851 . . . . 10.0 109.638 169.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -62.33 -46.23 89.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -52.22 -47.68 65.54 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.088 0.955 . . . . 10.0 112.686 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.37 -53.88 53.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.099 0.96 . . . . 10.0 111.804 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.13 -53.16 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.905 1.282 . . . . 10.0 111.509 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.1 t -53.34 -51.31 62.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.343 1.457 . . . . 10.0 111.908 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.9 m -61.0 -42.97 99.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.459 1.504 . . . . 10.0 112.401 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.78 -51.74 68.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.407 1.003 . . . . 10.0 112.452 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.79 77.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.925 0.89 . . . . 10.0 112.89 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 32.5 ttp -60.7 -50.67 72.55 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.062 -1.023 . . . . 10.0 112.403 169.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.1 -47.51 71.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.632 1.573 . . . . 10.0 111.626 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -47.07 -54.37 10.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 10.0 112.261 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.2 mt -53.43 -55.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.814 0.846 . . . . 10.0 110.692 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -57.04 -36.15 70.13 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.121 0.785 . . . . 10.0 113.121 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.25 -58.2 9.25 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.077 0.951 . . . . 10.0 113.017 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.278 -0.867 . . . . 10.0 111.44 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.78 -49.44 75.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.897 1.226 . . . . 10.0 112.106 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.38 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.856 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.65 -21.93 60.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.607 1.163 . . . . 10.0 113.467 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.11 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.629 0.633 . . . . 10.0 113.548 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.44 51.0 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.262 1.825 . . . . 10.0 113.067 -166.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.02 1.118 . . . . 10.0 114.02 172.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.74 -50.45 65.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.05 0.929 . . . . 10.0 112.285 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.21 -46.01 83.28 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.181 0.993 . . . . 10.0 112.088 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.47 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.078 1.751 . . . . 10.0 114.268 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.6 29.1 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.428 1.891 . . . . 10.0 114.907 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.59 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.536 1.636 . . . . 10.0 114.195 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.77 -46.28 34.7 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.308 2.005 . . . . 10.0 113.066 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.03 67.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.968 2.907 . . . . 10.0 113.33 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.23 -53.03 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.086 0.954 . . . . 10.0 109.794 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.254 0.622 . . . . 10.0 111.926 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -60.03 -56.15 25.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.919 0.887 . . . . 10.0 112.709 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 10.0 113.036 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.52 46.16 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.284 0.634 . . . . 10.0 111.068 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.11 -48.4 78.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.04 -49.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.791 0.723 . . . . 10.0 110.428 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.56 -51.65 68.98 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.76 30.28 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.817 2.047 . . . . 10.0 111.044 174.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.53 -58.26 9.34 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.757 0.423 . . . . 10.0 111.314 174.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.09 -45.01 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.054 0.942 . . . . 10.0 111.504 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -56.74 -67.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.281 2.633 . . . . 10.0 110.918 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.92 -48.15 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.005 1.322 . . . . 10.0 110.915 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -62.11 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.755 0.822 . . . . 10.0 112.484 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.75 -48.08 80.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.211 0.914 . . . . 10.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -51.75 -51.08 58.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.301 1.04 . . . . 10.0 112.193 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.0 m -55.28 -32.84 62.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.793 1.034 . . . . 10.0 113.793 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.66 -44.64 93.2 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.581 0.956 . . . . 10.0 113.581 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -46.28 -55.74 12.86 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 115.623 1.712 . . . . 10.0 115.623 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.455 ' HB3' H183 ' A' ' 999' ' ' RET . 29.2 Cg_endo -60.17 -34.06 94.49 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.26 1.973 . . . . 10.0 113.216 177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.5 t -64.46 -51.57 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.948 0.899 . . . . 10.0 110.589 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t -53.64 -50.58 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.592 1.157 . . . . 10.0 111.445 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.2 t90 -55.47 -51.81 65.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.287 1.035 . . . . 10.0 112.501 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 35.5 tp -54.04 -45.22 71.54 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.77 1.228 . . . . 10.0 112.281 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.49 -4.98 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.17 1.545 . . . . 10.0 115.17 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.3 32.95 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.576 1.098 . . . . 10.0 113.886 -168.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.871 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.66 -17.08 64.47 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.661 1.726 . . . . 10.0 115.661 -175.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.32 -106.07 1.14 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.339 1.427 . . . . 10.0 113.714 -172.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.637 -1.508 . . . . 10.0 109.353 168.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 113.905 0.322 . . . . 10.0 113.905 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.771 166.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.7 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.366 -174.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -68.82 153.84 72.19 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.752 2.968 . . . . 10.0 111.424 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.81 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.329 1.052 . . . . 10.0 112.221 171.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.31 -52.4 21.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.95 -40.47 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.646 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.29 -49.85 41.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.586 0.63 . . . . 10.0 111.964 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.08 83.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.092 1.757 . . . . 10.0 112.983 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.3 -52.32 62.44 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.931 0.892 . . . . 10.0 112.141 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.59 -59.29 4.64 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.362 1.065 . . . . 10.0 109.944 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -52.9 -46.54 68.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.417 -1.278 . . . . 10.0 112.241 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -51.36 -53.38 36.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.687 1.585 . . . . 10.0 112.723 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.12 -49.68 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.202 1.401 . . . . 10.0 111.562 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -56.17 -50.9 69.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.141 1.376 . . . . 10.0 111.458 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -57.06 -62.66 1.6 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.195 1.798 . . . . 10.0 110.954 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 23.7 m -56.16 -36.81 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 120.49 1.495 . . . . 10.0 112.793 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 43.2 m -59.94 -56.88 16.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.256 1.022 . . . . 10.0 111.525 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.06 -22.64 67.0 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.424 1.489 . . . . 10.0 114.513 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -71.7 0.55 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.884 1.273 . . . . 10.0 109.493 176.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.4 t -83.63 -55.29 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.176 1.39 . . . . 10.0 110.728 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -51.19 -48.04 48.07 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.996 0.808 . . . . 10.0 113.228 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -54.73 -57.04 13.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.192 1.797 . . . . 10.0 112.656 172.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -53.02 -37.16 53.42 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.063 0.839 . . . . 10.0 113.596 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.58 -28.01 65.6 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 115.989 1.848 . . . . 10.0 115.989 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.62 -57.49 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 119.319 0.963 . . . . 10.0 108.445 165.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.848 0.859 . . . . 10.0 113.186 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.317 1.599 . . . . 10.0 115.317 -171.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.141 0.976 . . . . 10.0 113.292 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.049 0.94 . . . . 10.0 111.019 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.744 0.818 . . . . 10.0 110.957 170.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.0 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.896 0.879 . . . . 10.0 112.1 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.461 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.82 -55.45 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.731 1.212 . . . . 10.0 110.686 -175.278 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.44 40.12 Favored Glycine 0 C--O 1.239 0.451 0 C-N-CA 129.755 3.55 . . . . 10.0 119.677 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.484 2.714 . . . . 10.0 113.438 166.603 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.487 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.822 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.29 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.576 3.15 . . . . 10.0 117.276 160.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.67 65.05 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.331 2.652 . . . . 10.0 114.448 155.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.03 2.79 41.14 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.44 2.447 . . . . 10.0 111.488 168.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.684 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.477 2.277 . . . . 10.0 113.201 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.14 4.32 0.94 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.736 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.473 -0.767 . . . . 10.0 112.619 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.6 83.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.887 0.875 . . . . 10.0 109.3 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.43 -52.56 63.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.399 0.68 . . . . 10.0 111.882 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.41 -53.59 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.141 0.576 . . . . 10.0 112.247 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.85 -46.83 51.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.381 1.472 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -44.93 84.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.88 -56.2 12.58 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.346 0.974 . . . . 10.0 111.567 166.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.4 m -49.8 -52.47 31.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.844 1.257 . . . . 10.0 112.209 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.177 0.991 . . . . 10.0 112.139 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.31 -48.56 78.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.663 0.785 . . . . 10.0 112.809 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.417 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 46.8 mtt -59.22 -46.62 87.97 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.293 1.037 . . . . 10.0 111.606 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.49 -58.6 13.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.232 0.92 . . . . 10.0 113.735 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -46.12 79.6 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.64 1.22 . . . . 10.0 112.127 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.56 -41.74 74.3 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.755 1.169 . . . . 10.0 113.242 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -63.12 -57.83 9.26 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 118.297 -0.859 . . . . 10.0 111.412 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.49 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.81 -57.99 9.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.571 1.148 . . . . 10.0 112.973 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.05 -67.5 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.662 1.185 . . . . 10.0 113.611 169.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.756 1.741 . . . . 10.0 110.866 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.863 2.465 . . . . 10.0 109.319 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.93 93.06 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.143 2.177 . . . . 10.0 113.619 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.73 -84.38 1.19 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.732 0.682 . . . . 10.0 112.477 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.404 2.681 . . . . 10.0 116.922 166.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.66 -50.84 10.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.902 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.53 6.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.737 1.273 . . . . 10.0 110.967 -172.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.59 -29.63 89.61 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.724 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.52 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.106 1.362 . . . . 10.0 113.551 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.58 -47.4 19.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.231 1.413 . . . . 10.0 113.441 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.09 62.12 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.513 0.725 . . . . 10.0 110.939 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.1 m-85 -56.97 -50.21 73.35 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.044 0.538 . . . . 10.0 112.334 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.38 -51.27 65.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.356 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.384 0.883 . . . . 10.0 113.384 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.55 -58.11 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.914 1.286 . . . . 10.0 110.228 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -68.09 -18.03 64.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.368 . . . . 10.0 113.745 -172.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -86.6 -40.36 15.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.397 1.079 . . . . 10.0 112.059 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.3 mt -60.37 -41.55 93.95 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.387 -0.82 . . . . 10.0 112.525 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.8 t -41.2 -60.45 1.74 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.719 1.607 . . . . 10.0 113.769 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.95 -26.72 10.76 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.721 2.947 . . . . 10.0 114.262 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.85 97.72 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.938 1.699 . . . . 10.0 113.01 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -52.12 -54.86 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.14 1.376 . . . . 10.0 109.345 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -55.77 -45.21 78.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.629 1.171 . . . . 10.0 113.131 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.43 -57.3 9.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.422 1.465 . . . . 10.0 112.209 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -50.15 -52.4 35.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.164 1.386 . . . . 10.0 110.434 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.15 -48.02 63.44 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.805 0.842 . . . . 10.0 113.089 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.16 -40.08 76.56 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.845 -1.55 . . . . 10.0 113.085 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.407 1.458 . . . . 10.0 111.281 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.65 -41.06 61.05 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.7 mtm -66.88 -50.85 61.16 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.484 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.54 -52.69 21.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.826 0.851 . . . . 10.0 112.975 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.5 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.857 1.058 . . . . 10.0 113.857 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.09 43.02 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.252 1.575 . . . . 10.0 115.252 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.55 61.04 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.332 0.893 . . . . 10.0 115.332 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.43 26.41 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.042 2.137 . . . . 10.0 108.957 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.49 171.14 15.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.053 0.941 . . . . 10.0 111.0 166.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 136.0 53.43 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.9 0.88 . . . . 10.0 109.691 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.52 129.6 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.039 1.336 . . . . 10.0 110.959 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.36 38.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.826 0.676 . . . . 10.0 112.826 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -82.0 0.15 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.41 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.6 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.338 1.569 . . . . 10.0 112.217 -165.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.91 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.46 1.504 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.45 120.76 69.66 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.6 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.36 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.046 1.738 . . . . 10.0 111.71 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.69 85.05 4.74 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 123.058 1.409 . . . . 10.0 113.037 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.864 -1.147 . . . . 10.0 113.951 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.82 52.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.292 1.037 . . . . 10.0 113.147 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -50.68 -55.51 16.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.858 0.863 . . . . 10.0 111.515 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -64.02 -39.11 93.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.69 1.596 . . . . 10.0 112.182 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.69 65.36 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.48 1.112 . . . . 10.0 110.916 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -61.96 2.23 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.18 1.792 . . . . 10.0 112.764 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -53.65 -38.12 63.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.368 2.267 . . . . 10.0 113.177 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.46 -44.01 62.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.493 1.517 . . . . 10.0 112.183 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -99.4 -47.99 4.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 113.254 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.0 t -60.02 -37.6 80.24 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.454 -0.779 . . . . 10.0 113.058 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 4.5 m -68.38 -48.55 34.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.753 -1.217 . . . . 10.0 112.638 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 82.6 Cg_exo -49.62 -42.9 41.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.585 2.856 . . . . 10.0 115.278 164.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.58 -49.28 78.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.889 0.768 . . . . 10.0 112.076 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tt -53.01 -44.68 67.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.678 1.191 . . . . 10.0 112.679 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.62 -47.71 81.43 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.038 -1.039 . . . . 10.0 112.413 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.838 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.3 -54.04 36.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.298 0.954 . . . . 10.0 111.187 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.1 88.63 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.656 0.782 . . . . 10.0 112.099 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.69 38.43 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.94 0.896 . . . . 10.0 112.078 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.16 79.38 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.704 0.801 . . . . 10.0 112.731 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.71 -38.59 91.68 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.065 1.346 . . . . 10.0 112.313 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.56 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.829 1.652 . . . . 10.0 112.113 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.981 -1.699 . . . . 10.0 112.458 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.92 54.27 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.67 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.888 1.675 . . . . 10.0 113.465 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.26 5.29 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.139 1.352 . . . . 10.0 115.26 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.01 -46.74 87.86 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.158 -1.401 . . . . 10.0 111.354 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.97 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.087 1.355 . . . . 10.0 111.072 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.57 -51.33 67.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.82 43.16 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.424 0.689 . . . . 10.0 110.985 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.399 2.28 . . . . 10.0 114.849 174.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.07 -46.35 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 123.725 0.81 . . . . 10.0 111.349 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.31 64.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.659 0.647 . . . . 10.0 112.624 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.27 74.91 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.13 -45.32 87.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.583 0.753 . . . . 10.0 111.946 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.55 -56.47 4.87 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.455 1.502 . . . . 10.0 113.037 167.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 83.6 mt -56.45 -55.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.757 0.823 . . . . 10.0 110.322 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -48.98 -56.71 8.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.609 1.095 . . . . 10.0 113.115 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 123.116 0.566 . . . . 10.0 112.203 178.36 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 112.033 0.383 . . . . 10.0 112.033 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.98 -59.46 8.72 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.704 1.621 . . . . 10.0 112.096 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.79 -37.76 20.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.209 2.204 . . . . 10.0 113.434 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.7 -6.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.398 1.629 . . . . 10.0 115.398 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.67 116.72 10.4 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.207 -1.558 . . . . 10.0 110.356 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.248 2.619 . . . . 10.0 113.289 177.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.65 106.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.816 0.847 . . . . 10.0 110.128 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.764 1.226 . . . . 10.0 114.019 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.54 -42.01 15.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.458 1.503 . . . . 10.0 113.498 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.22 -24.59 63.13 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.897 1.443 . . . . 10.0 114.897 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.83 -41.87 67.86 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 118.901 0.773 . . . . 10.0 110.82 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.64 -31.88 70.23 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.854 1.262 . . . . 10.0 114.241 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.29 -52.26 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.152 0.887 . . . . 10.0 109.625 168.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -60.47 -45.24 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -52.64 -49.54 64.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.713 1.142 . . . . 10.0 112.71 173.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -53.92 48.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.139 . . . . 10.0 111.915 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.2 mt -54.62 -47.59 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.625 1.17 . . . . 10.0 111.481 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -57.57 -53.34 59.26 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.07 1.348 . . . . 10.0 112.394 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.6 t -67.82 -33.48 74.86 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.766 0.826 . . . . 10.0 112.308 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.63 73.34 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.258 0.935 . . . . 10.0 112.347 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.55 80.62 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.468 -0.77 . . . . 10.0 112.535 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.65 -52.99 62.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.267 1.027 . . . . 10.0 111.913 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.77 -49.62 65.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.069 1.748 . . . . 10.0 111.665 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -49.5 -54.71 16.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.722 0.809 . . . . 10.0 112.184 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.0 mt -54.11 -54.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.592 0.757 . . . . 10.0 110.86 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.35 -36.62 69.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.709 0.804 . . . . 10.0 113.07 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -57.24 -58.19 9.3 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.035 0.934 . . . . 10.0 113.059 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -40.96 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.373 -0.823 . . . . 10.0 111.468 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.76 -49.39 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.831 1.196 . . . . 10.0 112.169 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.26 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.075 -1.641 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.69 -21.98 60.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 10.0 113.477 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.588 0.614 . . . . 10.0 113.548 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.271 1.828 . . . . 10.0 113.067 -166.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.09 -56.44 14.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.032 1.123 . . . . 10.0 114.032 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.69 -50.58 65.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.115 0.959 . . . . 10.0 112.303 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.11 -46.02 82.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.136 0.975 . . . . 10.0 112.143 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.51 80.02 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.27 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.043 1.737 . . . . 10.0 114.235 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.477 1.911 . . . . 10.0 114.876 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.94 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.536 1.636 . . . . 10.0 114.171 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.24 35.04 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.277 1.984 . . . . 10.0 113.079 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.1 67.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.288 173.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.14 -53.07 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.83 75.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.246 0.618 . . . . 10.0 111.905 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -56.18 24.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.917 0.887 . . . . 10.0 112.709 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.211 1.004 . . . . 10.0 113.05 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.61 -49.44 46.85 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.253 0.621 . . . . 10.0 111.101 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.43 78.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.67 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.797 0.726 . . . . 10.0 110.487 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.57 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.83 30.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.86 2.064 . . . . 10.0 111.026 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.45 -58.36 8.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.796 0.438 . . . . 10.0 111.266 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.6 t -52.14 -46.64 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.112 0.965 . . . . 10.0 112.296 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.9 m -58.83 -64.85 0.79 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.971 2.509 . . . . 10.0 111.484 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.6 -49.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.928 1.291 . . . . 10.0 111.241 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.9 -64.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.844 0.858 . . . . 10.0 112.28 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.12 -43.02 81.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.037 0.835 . . . . 10.0 112.174 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -52.14 -54.29 32.43 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.128 0.971 . . . . 10.0 112.459 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 114.029 1.122 . . . . 10.0 114.029 -179.366 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 119.504 -0.284 . . . . 10.0 111.315 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -55.32 -52.34 63.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.894 1.277 . . . . 10.0 112.498 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 56.0 tp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.971 1.308 . . . . 10.0 112.449 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -88.15 -5.08 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 115.222 1.564 . . . . 10.0 115.222 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.47 -169.3 32.89 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-O 122.576 1.098 . . . . 10.0 113.873 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -40.85 64.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.828 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -54.94 -31.49 60.51 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.524 2.73 . . . . 10.0 115.154 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.62 -103.88 0.95 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.366 0.985 . . . . 10.0 113.623 -167.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.19 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.331 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.884 0.314 . . . . 10.0 113.884 173.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.64 -42.74 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.055 1.742 . . . . 10.0 108.716 166.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.27 133.38 24.9 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.448 1.899 . . . . 10.0 109.392 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.7 153.77 72.61 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.754 2.969 . . . . 10.0 111.468 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.38 21.89 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.93 -40.48 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.668 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.35 -49.77 42.87 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.517 0.599 . . . . 10.0 111.946 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.68 -47.08 83.31 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.07 1.748 . . . . 10.0 113.002 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -58.8 5.62 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.335 1.054 . . . . 10.0 109.989 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -53.42 -43.88 68.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.876 -1.059 . . . . 10.0 112.956 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -54.53 -52.55 61.68 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.3 1.409 . . . . 10.0 112.492 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.18 -48.97 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.49 1.116 . . . . 10.0 110.939 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.0 mp -57.09 -53.53 57.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.747 1.619 . . . . 10.0 112.152 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -54.68 -56.04 23.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.065 1.746 . . . . 10.0 111.807 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.476 0.852 0 O-C-N 121.398 -0.814 . . . . 10.0 111.264 177.376 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.347 0 CA-C-O 120.997 0.22 . . . . 10.0 112.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.4 -57.28 3.14 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.549 1.939 . . . . 10.0 112.687 167.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.56 -38.92 89.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.582 1.087 . . . . 10.0 113.642 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -69.47 -27.56 65.33 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 115.614 1.709 . . . . 10.0 115.614 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.36 -57.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 165.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.87 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.877 0.871 . . . . 10.0 113.174 -172.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.61 5.23 2.54 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.28 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.89 4.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.113 0.965 . . . . 10.0 111.03 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.19 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.771 0.829 . . . . 10.0 110.957 170.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.94 77.05 7.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.874 0.87 . . . . 10.0 112.084 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.897 2.879 . . . . 10.0 116.462 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.81 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.75 1.22 . . . . 10.0 110.642 -175.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.72 3.533 . . . . 10.0 119.677 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.516 2.727 . . . . 10.0 113.457 166.652 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.87 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.569 3.148 . . . . 10.0 117.225 160.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.306 2.643 . . . . 10.0 114.448 155.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.45 137.93 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.41 1.884 . . . . 10.0 113.372 -158.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.015 -174.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.83 41.48 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.487 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.649 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.304 . . . . 10.0 113.21 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.28 4.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.732 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.507 -0.746 . . . . 10.0 112.625 176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.84 -49.64 83.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.892 0.877 . . . . 10.0 109.3 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.537 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.36 -52.66 62.8 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.379 0.672 . . . . 10.0 111.867 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.3 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.224 0.61 . . . . 10.0 112.276 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.8 51.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.332 1.453 . . . . 10.0 113.335 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.95 84.75 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.289 1.435 . . . . 10.0 112.997 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.6 -56.54 11.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.526 1.06 . . . . 10.0 111.511 166.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.59 -52.51 29.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.904 1.282 . . . . 10.0 112.248 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.5 -58.81 6.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.172 0.989 . . . . 10.0 112.161 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt -57.47 -48.62 78.71 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 10.0 112.836 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.14 -49.09 78.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.008 0.923 . . . . 10.0 111.281 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.53 -58.66 13.26 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.273 0.939 . . . . 10.0 113.931 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.18 -45.63 79.68 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.748 1.274 . . . . 10.0 112.175 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.85 -39.87 88.81 Favored Glycine 0 CA--C 1.533 1.205 0 O-C-N 120.779 -1.2 . . . . 10.0 113.588 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.3 m -60.21 -60.71 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 10.0 110.801 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.06 9.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 112.972 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.61 -38.67 81.92 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.254 0.835 . . . . 10.0 113.254 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.621 1.168 . . . . 10.0 113.589 169.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.813 1.768 . . . . 10.0 110.859 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.04 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.628 1.011 . . . . 10.0 115.628 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.2 mmm -59.47 -45.05 92.73 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.4 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.743 0.687 . . . . 10.0 112.511 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.07 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.401 2.68 . . . . 10.0 116.959 166.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 m -79.68 -50.83 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.168 -1.378 . . . . 10.0 113.892 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.5 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.66 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.67 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.111 0.565 . . . . 10.0 111.476 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.06 22.84 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.078 1.351 . . . . 10.0 113.566 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.57 -47.41 19.74 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.455 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.78 -53.1 61.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.933 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.9 -50.27 73.04 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.107 0.563 . . . . 10.0 112.353 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.27 65.25 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.99 1.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.85 -56.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.825 1.25 . . . . 10.0 110.736 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -69.81 -18.61 63.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.935 1.294 . . . . 10.0 113.498 -172.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.4 m -84.98 -42.52 14.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.478 1.111 . . . . 10.0 111.913 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.6 mt -57.49 -41.56 80.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.211 0.819 . . . . 10.0 113.211 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.4 t -50.17 -61.79 3.33 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.092 -0.956 . . . . 10.0 112.457 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -46.76 -47.27 16.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.627 3.551 . . . . 10.0 115.925 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.49 90.16 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.858 1.208 . . . . 10.0 113.811 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.25 -51.52 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.592 1.157 . . . . 10.0 109.326 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.24 76.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.093 0.957 . . . . 10.0 113.165 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -50.13 -56.23 11.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.681 1.592 . . . . 10.0 112.179 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.77 -52.82 29.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.3 1.44 . . . . 10.0 110.733 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.84 -48.13 64.27 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.976 0.91 . . . . 10.0 113.013 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -56.49 -40.75 75.47 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.195 1.362 . . . . 10.0 113.447 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.53 34.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.752 1.16 . . . . 10.0 111.292 170.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.14 61.12 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.174 1.546 . . . . 10.0 115.174 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.85 -50.82 61.34 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.594 0.758 . . . . 10.0 110.469 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.72 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.887 0.875 . . . . 10.0 112.92 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.86 -5.6 49.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 10.0 113.831 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.67 5.58 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.564 0.986 . . . . 10.0 115.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.01 43.5 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.53 61.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.339 0.896 . . . . 10.0 115.339 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.4 26.46 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.081 2.153 . . . . 10.0 109.031 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.711 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.64 129.62 23.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.028 1.331 . . . . 10.0 110.909 -176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.23 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.72 164.4 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.79 -3.28 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.669 2.228 . . . . 10.0 118.669 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.358 1.579 . . . . 10.0 112.194 -165.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.444 1.498 . . . . 10.0 111.081 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.45 120.78 69.66 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.651 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.5 131.91 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.184 3.256 . . . . 10.0 112.137 171.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.29 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.075 1.75 . . . . 10.0 111.763 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -93.63 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.063 1.411 . . . . 10.0 113.106 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.27 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.847 -1.158 . . . . 10.0 113.905 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.72 -26.61 35.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.271 1.029 . . . . 10.0 112.532 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -55.08 -48.31 73.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.01 1.324 . . . . 10.0 112.927 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -71.2 -38.87 72.04 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.955 0.902 . . . . 10.0 111.122 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.39 -48.95 65.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.32 1.048 . . . . 10.0 112.228 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.514 1.526 . . . . 10.0 111.558 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -55.27 -34.28 63.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.357 1.463 . . . . 10.0 112.503 -170.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.7 tp -48.82 -43.74 38.71 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.114 1.766 . . . . 10.0 112.141 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -101.9 -38.15 7.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.493 0.717 . . . . 10.0 112.764 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.7 p -64.72 -43.69 92.58 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.283 1.402 . . . . 10.0 113.92 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.277 74.8 p -65.04 -42.56 62.45 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 114.72 1.378 . . . . 10.0 114.72 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.89 -43.04 60.83 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.428 2.752 . . . . 10.0 115.247 167.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.23 -47.28 86.67 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.447 -0.783 . . . . 10.0 111.704 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.61 -50.01 55.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.414 1.485 . . . . 10.0 111.51 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mp -56.24 -47.52 78.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.111 0.965 . . . . 10.0 112.956 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.22 78.29 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.777 0.831 . . . . 10.0 112.903 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.02 36.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.285 0.948 . . . . 10.0 111.214 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.09 88.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.093 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.75 37.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.017 0.927 . . . . 10.0 111.974 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.25 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.67 53.41 12.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.838 1.655 . . . . 10.0 112.126 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.95 47.51 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.935 -1.728 . . . . 10.0 112.405 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.85 54.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.77 -39.72 2.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.93 1.692 . . . . 10.0 113.467 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.2 5.34 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.304 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.46 -52.93 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.154 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.57 -51.37 67.61 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.522 0.564 . . . . 10.0 112.522 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.05 -44.93 42.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.469 0.708 . . . . 10.0 110.959 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.814 175.005 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.393 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.14 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.614 0.626 . . . . 10.0 112.675 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.63 -46.92 73.97 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.187 0.81 . . . . 10.0 113.187 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -57.13 -45.54 83.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.023 0.929 . . . . 10.0 111.974 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.02 -55.58 5.59 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.201 1.382 . . . . 10.0 113.082 167.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.4 mt -56.77 -49.47 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.626 0.77 . . . . 10.0 111.893 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 64.4 ttp -49.39 -57.82 6.23 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 10.0 112.184 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.475 0.803 0 O-C-N 121.659 -0.651 . . . . 10.0 111.058 177.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 110.35 -0.241 . . . . 10.0 110.35 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.03 -60.84 5.78 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.833 1.682 . . . . 10.0 112.212 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.01 -37.66 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.484 1.913 . . . . 10.0 113.86 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.0 mt -99.27 -6.41 28.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -69.66 116.73 10.4 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.19 -1.569 . . . . 10.0 110.409 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.53 -49.55 72.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.186 2.594 . . . . 10.0 113.255 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.66 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.86 -59.52 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.72 1.208 . . . . 10.0 114.087 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.12 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.451 1.5 . . . . 10.0 113.485 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.64 63.25 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.956 1.465 . . . . 10.0 114.956 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.82 -41.94 67.91 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.848 0.749 . . . . 10.0 110.712 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.51 -32.01 70.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.903 1.281 . . . . 10.0 114.249 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.1 -51.77 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.59 168.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -62.46 -43.15 99.52 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -53.93 -48.38 70.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.48 1.112 . . . . 10.0 112.617 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.68 -53.14 61.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.693 0.797 . . . . 10.0 111.681 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.14 -54.33 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.809 1.244 . . . . 10.0 112.009 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 p -58.01 -43.15 86.53 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.252 -0.905 . . . . 10.0 112.852 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.2 m -61.73 -41.31 97.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.568 1.147 . . . . 10.0 112.56 174.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.41 -46.75 87.82 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.345 0.975 . . . . 10.0 112.343 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.74 79.81 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.668 0.787 . . . . 10.0 112.393 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.8 ttp -54.54 -54.54 39.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.037 0.935 . . . . 10.0 112.085 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.1 -50.4 61.71 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.314 1.446 . . . . 10.0 111.572 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.39 -54.66 20.14 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.048 0.939 . . . . 10.0 112.562 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.1 mt -53.52 -55.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.831 0.853 . . . . 10.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.8 mt -57.48 -35.6 70.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.2 -0.905 . . . . 10.0 112.902 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.31 -58.14 9.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.251 0.932 . . . . 10.0 113.047 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.92 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 118.342 -0.837 . . . . 10.0 111.441 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.44 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.83 1.195 . . . . 10.0 112.115 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.92 -70.4 0.46 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.866 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.73 -21.86 60.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.587 1.155 . . . . 10.0 113.468 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.37 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.14 -56.49 14.22 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.955 1.094 . . . . 10.0 113.955 172.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.64 -50.55 65.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.112 0.958 . . . . 10.0 112.299 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.16 -45.97 83.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.192 0.997 . . . . 10.0 112.149 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.42 80.59 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.54 -11.23 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.044 1.738 . . . . 10.0 114.225 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.62 29.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.427 1.891 . . . . 10.0 114.865 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.95 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.451 1.596 . . . . 10.0 114.14 -170.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.841 3.256 . . . . 10.0 105.549 170.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.86 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.27 1.98 . . . . 10.0 113.032 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.11 67.96 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.17 -53.01 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.274 0.63 . . . . 10.0 111.902 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.06 -56.14 25.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.933 0.893 . . . . 10.0 112.687 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.26 -53.21 60.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.019 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.55 -49.48 46.08 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.36 78.91 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.691 1.367 . . . . 10.0 114.691 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.62 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.815 0.734 . . . . 10.0 110.487 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.64 -51.61 69.18 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.82 -47.73 31.03 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.796 2.039 . . . . 10.0 111.047 174.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.57 -58.33 9.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.798 0.439 . . . . 10.0 111.253 174.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.09 -47.03 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.109 0.963 . . . . 10.0 112.298 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.9 m -58.76 -64.22 1.01 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.034 2.534 . . . . 10.0 111.53 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -50.19 -49.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.613 1.165 . . . . 10.0 111.288 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.46 -63.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.002 0.921 . . . . 10.0 112.269 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.9 -43.41 98.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.505 0.593 . . . . 10.0 112.529 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -55.05 -51.01 67.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.478 0.711 . . . . 10.0 111.757 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 114.134 1.161 . . . . 10.0 114.134 178.603 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.0 t . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 119.6 -0.238 . . . . 10.0 111.525 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -55.26 -54.26 45.68 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.964 1.306 . . . . 10.0 112.251 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.0 tp -52.86 -46.67 67.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.182 1.393 . . . . 10.0 112.514 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.6 pt -85.8 -4.92 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.62 -169.33 32.7 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-O 122.551 1.084 . . . . 10.0 113.789 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.07 -39.65 63.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.157 -1.021 . . . . 10.0 111.908 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.43 -32.87 65.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.377 2.671 . . . . 10.0 115.271 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.44 -104.34 1.11 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-O 122.142 0.857 . . . . 10.0 112.698 -167.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.19 35.82 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.285 170.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.34 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.93 0.332 . . . . 10.0 113.93 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.775 166.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.33 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.464 1.906 . . . . 10.0 109.351 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.76 153.84 72.32 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.438 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.25 -39.75 3.13 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.299 1.039 . . . . 10.0 112.223 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.43 21.33 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.54 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.651 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.83 41.93 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.564 0.62 . . . . 10.0 111.907 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.0 83.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.038 1.735 . . . . 10.0 113.017 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.33 62.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.016 0.926 . . . . 10.0 112.06 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.63 -59.66 4.2 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.361 1.064 . . . . 10.0 109.913 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -52.82 -47.13 67.89 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.986 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.32 -52.72 34.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 121.283 1.856 . . . . 10.0 113.258 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.3 t -60.81 -48.12 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.817 1.247 . . . . 10.0 111.479 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.49 -50.17 74.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.319 1.448 . . . . 10.0 111.907 175.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.35 -57.41 11.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.469 2.308 . . . . 10.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.478 0.958 0 O-C-N 121.221 -0.924 . . . . 10.0 111.844 177.024 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.305 0 CA-C-O 121.104 0.28 . . . . 10.0 112.614 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -42.44 -56.54 2.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.824 2.049 . . . . 10.0 112.36 166.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.16 -39.89 82.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.649 1.119 . . . . 10.0 113.997 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.3 -27.14 65.13 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 115.75 1.759 . . . . 10.0 115.75 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.38 -57.56 11.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.604 -0.887 . . . . 10.0 108.604 165.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.68 0.85 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.949 0.899 . . . . 10.0 113.145 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.37 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.273 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.1 178.02 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.04 0.936 . . . . 10.0 110.995 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.68 98.15 1.87 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 10.0 110.921 170.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.93 77.04 7.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 10.0 112.107 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.06 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.892 2.877 . . . . 10.0 116.451 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.4 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.738 1.215 . . . . 10.0 110.622 -175.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.35 169.46 40.29 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.631 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.446 0 C-N-CA 128.524 2.73 . . . . 10.0 113.492 166.576 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.82 -2.038 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.34 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.588 3.155 . . . . 10.0 117.251 160.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.302 2.641 . . . . 10.0 114.511 155.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.4 137.96 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.344 -158.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.7 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.1 2.75 41.49 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.473 2.463 . . . . 10.0 111.463 167.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.3 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.668 -168.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.547 2.302 . . . . 10.0 113.252 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.25 4.34 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.732 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.13 61.76 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.615 176.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.42 -52.59 63.09 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 10.0 111.902 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.41 -53.6 56.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.234 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.78 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.2 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -56.1 12.46 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.655 1.122 . . . . 10.0 111.583 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -50.16 -52.35 36.07 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.895 1.278 . . . . 10.0 112.288 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.207 1.003 . . . . 10.0 112.161 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.77 -49.18 77.45 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 10.0 112.541 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.9 mmt -56.08 -49.95 72.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.603 0.761 . . . . 10.0 111.306 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.04 -58.47 14.44 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.312 0.958 . . . . 10.0 113.63 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.22 -45.59 79.85 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.656 1.228 . . . . 10.0 112.142 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.0 74.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.026 1.298 . . . . 10.0 113.273 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -59.79 -60.57 3.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.24 1.016 . . . . 10.0 111.14 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.96 62.5 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.955 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.84 -58.03 9.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.593 1.157 . . . . 10.0 112.929 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.63 81.94 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.621 1.168 . . . . 10.0 113.62 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.87 -44.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.332 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.16 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.04 92.92 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.154 2.182 . . . . 10.0 113.587 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.35 1.19 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.756 0.693 . . . . 10.0 112.497 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.96 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.396 2.678 . . . . 10.0 116.95 166.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.198 -1.365 . . . . 10.0 113.866 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.52 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.765 1.291 . . . . 10.0 110.957 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.65 89.48 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.708 2.939 . . . . 10.0 113.735 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -60.65 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.5 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.281 1.432 . . . . 10.0 113.444 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 110.967 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.28 65.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.891 -0.576 . . . . 10.0 112.321 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.7 -57.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.865 1.266 . . . . 10.0 110.417 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -69.28 -17.08 63.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.071 1.348 . . . . 10.0 113.693 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -86.91 -42.98 12.76 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.64 1.109 . . . . 10.0 112.018 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -56.75 -41.45 77.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.885 0.698 . . . . 10.0 112.885 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.3 t -49.97 -61.45 3.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.629 1.172 . . . . 10.0 112.569 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.95 -46.53 24.73 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.598 3.532 . . . . 10.0 116.029 164.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.2 93.39 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.973 1.26 . . . . 10.0 113.922 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mt -58.13 -52.23 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.496 1.118 . . . . 10.0 109.48 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.49 -43.97 72.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.006 0.922 . . . . 10.0 113.185 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -52.2 -57.96 8.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.137 1.375 . . . . 10.0 111.871 171.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.59 -52.91 20.57 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.507 1.523 . . . . 10.0 110.886 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.3 mmt -68.64 -48.21 64.6 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.966 0.906 . . . . 10.0 112.981 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -55.64 -41.71 73.96 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.163 1.347 . . . . 10.0 113.283 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.56 34.36 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.475 1.034 . . . . 10.0 111.317 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.05 61.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.91 -50.83 61.17 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.442 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.55 -52.67 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.883 0.873 . . . . 10.0 112.963 172.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.58 49.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.3 -34.73 5.53 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.575 0.99 . . . . 10.0 115.575 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.13 42.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.56 61.17 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.326 0.89 . . . . 10.0 115.326 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.45 26.4 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.021 2.129 . . . . 10.0 109.034 171.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.14 15.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.045 166.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.84 0.856 . . . . 10.0 109.745 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.56 129.57 23.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 125.071 1.348 . . . . 10.0 110.971 -176.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.69 116.17 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.67 164.41 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.647 -0.981 . . . . 10.0 110.647 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.354 1.577 . . . . 10.0 112.231 -165.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.86 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.45 120.73 69.66 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.4 Cg_exo -61.42 131.91 38.41 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.253 3.302 . . . . 10.0 112.167 171.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.16 126.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.044 1.738 . . . . 10.0 111.716 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.262 1.506 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.44 -28.23 66.78 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.641 -1.287 . . . . 10.0 113.881 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.14 62.2 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.225 1.194 . . . . 10.0 114.225 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -65.93 -22.98 66.53 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 120.112 -1.618 . . . . 10.0 113.821 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -77.26 -42.1 38.41 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.55 -1.344 . . . . 10.0 111.691 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.22 -47.91 54.7 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.444 1.498 . . . . 10.0 111.211 166.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -52.56 -70.76 0.08 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.626 1.97 . . . . 10.0 112.031 168.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -56.83 -32.76 66.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.26 1.024 . . . . 10.0 113.448 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.3 tp -50.17 -40.66 47.5 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.858 1.663 . . . . 10.0 111.871 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -105.29 -39.72 6.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.411 0.685 . . . . 10.0 112.521 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.3 p -61.6 -43.12 99.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.793 1.633 . . . . 10.0 113.794 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.299 68.0 p -69.94 -40.62 13.35 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 115.234 1.568 . . . . 10.0 115.234 -175.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.37 -42.98 62.93 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.208 2.605 . . . . 10.0 115.083 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.29 -47.43 86.04 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.484 -0.76 . . . . 10.0 111.684 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.11 -49.55 51.35 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.745 1.618 . . . . 10.0 111.527 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -57.11 -47.4 81.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.273 1.029 . . . . 10.0 113.146 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.24 78.11 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.843 0.857 . . . . 10.0 112.891 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.33 -54.02 37.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.179 169.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.14 88.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.65 -54.69 38.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.942 0.897 . . . . 10.0 112.063 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.13 79.42 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.682 0.793 . . . . 10.0 112.729 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.78 -38.54 91.49 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.42 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.269 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.46 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.845 1.658 . . . . 10.0 112.086 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.51 135.88 54.32 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.662 0.616 . . . . 10.0 112.662 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.84 -39.73 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.438 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.18 5.34 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.148 1.356 . . . . 10.0 115.25 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.08 -46.8 87.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.39 -52.91 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.161 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.66 -51.3 67.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.68 -59.82 4.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.366 2.266 . . . . 10.0 114.793 174.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.05 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 123.667 0.787 . . . . 10.0 111.398 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.17 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.617 0.627 . . . . 10.0 112.664 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.61 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.46 0.911 . . . . 10.0 113.46 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.02 -47.21 78.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.319 0.648 . . . . 10.0 111.684 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -54.23 5.95 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.825 1.203 . . . . 10.0 113.013 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.44 -51.22 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.744 0.818 . . . . 10.0 112.043 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 52.5 ttp -48.62 -57.15 6.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.019 1.327 . . . . 10.0 111.659 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.7 mm . . . . . 0 N--CA 1.472 0.626 0 C-N-CA 123.227 0.611 . . . . 10.0 111.907 178.004 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 111.697 0.258 . . . . 10.0 111.697 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.39 -59.21 8.63 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.713 1.625 . . . . 10.0 112.062 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.89 -37.84 20.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.913 2.085 . . . . 10.0 113.563 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.43 -6.63 27.35 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.7 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.199 -1.563 . . . . 10.0 110.398 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.65 71.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.255 2.622 . . . . 10.0 113.251 177.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.72 106.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.86 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.732 1.213 . . . . 10.0 114.101 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.02 15.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.7 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -53.7 -42.01 67.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.855 0.752 . . . . 10.0 110.807 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.35 -32.29 71.27 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.898 1.279 . . . . 10.0 114.213 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.97 -51.76 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.015 0.825 . . . . 10.0 109.608 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -61.96 -45.24 94.51 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 174.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -51.38 -49.24 61.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.35 1.06 . . . . 10.0 112.531 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.53 -52.63 64.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.191 0.996 . . . . 10.0 111.894 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.53 -52.0 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.831 1.252 . . . . 10.0 111.619 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -54.65 -47.06 73.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 10.0 111.99 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.8 m -60.49 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.53 1.532 . . . . 10.0 112.52 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.58 -48.43 80.95 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.19 0.905 . . . . 10.0 112.312 172.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.08 81.68 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.737 0.815 . . . . 10.0 112.484 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.05 -55.07 35.14 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.182 0.993 . . . . 10.0 112.101 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.13 -48.06 68.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.386 1.474 . . . . 10.0 111.947 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.07 -54.58 23.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 10.0 112.46 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.47 -55.17 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.787 0.835 . . . . 10.0 110.751 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.7 mt -57.42 -35.79 70.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.35 -0.833 . . . . 10.0 112.914 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.3 -58.23 9.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.042 0.937 . . . . 10.0 112.994 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.296 -0.859 . . . . 10.0 111.469 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.75 -49.42 75.3 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.873 1.215 . . . . 10.0 112.13 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.882 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.7 -21.95 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.671 1.188 . . . . 10.0 113.453 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.48 51.33 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.227 1.811 . . . . 10.0 113.037 -166.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.1 m -52.05 -56.42 14.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.64 -50.59 65.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.121 0.962 . . . . 10.0 112.314 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.03 82.89 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.161 0.984 . . . . 10.0 112.135 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.52 80.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.097 1.759 . . . . 10.0 114.195 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.61 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.432 1.893 . . . . 10.0 114.894 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.89 -92.61 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.521 1.629 . . . . 10.0 114.185 -170.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.99 72.63 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.767 3.227 . . . . 10.0 105.539 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.87 -46.23 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.269 1.979 . . . . 10.0 113.06 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.12 67.94 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.247 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.248 0.619 . . . . 10.0 111.937 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.93 -56.2 24.6 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.886 0.874 . . . . 10.0 112.765 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.16 -53.26 60.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 113.028 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.51 45.76 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.16 -48.43 78.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.99 -49.62 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.462 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.65 69.0 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.78 -47.78 30.53 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.816 2.046 . . . . 10.0 111.044 174.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.44 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.845 0.458 . . . . 10.0 111.274 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -52.23 -47.07 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.075 0.95 . . . . 10.0 111.989 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.0 m -58.62 -62.96 1.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.437 2.695 . . . . 10.0 111.822 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.33 -50.34 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.675 1.19 . . . . 10.0 111.071 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.85 -60.2 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.053 0.941 . . . . 10.0 112.068 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.54 -50.05 75.41 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.663 0.665 . . . . 10.0 112.743 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -53.39 -50.84 64.29 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.752 0.821 . . . . 10.0 111.382 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 178.611 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 118.945 -0.55 . . . . 10.0 112.161 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -56.33 -52.2 65.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.984 0.914 . . . . 10.0 112.321 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.4 tp -53.91 -45.42 71.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.513 1.125 . . . . 10.0 112.5 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -87.45 -5.28 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 115.248 1.573 . . . . 10.0 115.248 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.56 -169.3 32.76 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 122.611 1.117 . . . . 10.0 113.805 -168.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -40.73 64.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.165 -1.017 . . . . 10.0 111.838 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -54.56 -32.27 58.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.406 2.683 . . . . 10.0 115.379 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.92 0.99 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 10.0 113.38 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.18 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.318 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.45 65.28 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.29 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -68.73 153.79 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.15 -39.81 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.199 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.36 -52.38 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.681 1.363 . . . . 10.0 114.681 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.9 -40.5 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.674 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.31 -49.75 42.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.533 0.606 . . . . 10.0 111.974 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.72 -47.07 83.45 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.983 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.3 -52.33 62.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.016 0.926 . . . . 10.0 112.101 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 92.9 mt -52.51 -58.72 5.86 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 124.321 1.048 . . . . 10.0 110.003 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -52.08 -47.08 65.36 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.692 -1.147 . . . . 10.0 112.35 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.73 -52.14 57.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.308 1.413 . . . . 10.0 112.765 175.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.84 -49.64 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.461 1.104 . . . . 10.0 111.377 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mp -55.62 -52.86 62.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.56 . . . . 10.0 111.702 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -53.54 -56.41 17.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.957 2.103 . . . . 10.0 111.047 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 124.169 0.987 . . . . 10.0 111.374 176.289 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.313 0 CA-C-O 121.093 0.274 . . . . 10.0 113.083 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -43.06 -56.88 3.14 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.003 2.121 . . . . 10.0 112.382 166.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.97 -40.79 74.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.338 0.971 . . . . 10.0 114.095 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.75 -27.2 64.75 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 115.962 1.838 . . . . 10.0 115.962 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.52 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.78 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.92 0.888 . . . . 10.0 113.2 -172.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.5 5.12 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.308 1.596 . . . . 10.0 115.308 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.25 0.32 15.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.217 1.007 . . . . 10.0 113.292 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.026 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.21 1.87 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.812 0.845 . . . . 10.0 110.891 170.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.97 77.04 7.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.914 0.885 . . . . 10.0 112.03 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.464 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.48 0.3 OUTLIER 71.77 -55.37 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.765 1.226 . . . . 10.0 110.668 -175.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.781 3.562 . . . . 10.0 119.618 171.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.45 2.7 . . . . 10.0 113.408 166.649 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.305 2.642 . . . . 10.0 114.486 155.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.47 138.01 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.384 1.873 . . . . 10.0 113.344 -158.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.18 1.69 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 113.978 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.76 41.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 127.403 2.43 . . . . 10.0 111.491 168.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.57 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.634 -168.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.67 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.522 2.293 . . . . 10.0 113.212 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.15 4.32 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.782 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.41 -43.08 61.88 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.587 176.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.62 83.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.912 0.885 . . . . 10.0 109.315 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.35 -52.64 62.84 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.377 0.671 . . . . 10.0 111.928 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.187 0.595 . . . . 10.0 112.245 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.83 51.95 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.412 1.485 . . . . 10.0 113.287 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.98 84.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -57.06 10.07 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.247 0.927 . . . . 10.0 111.3 166.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -48.98 -52.46 24.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.642 1.177 . . . . 10.0 112.302 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.9 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.148 0.979 . . . . 10.0 112.166 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.66 -50.29 73.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.682 0.793 . . . . 10.0 112.579 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -53.69 -50.35 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.503 1.121 . . . . 10.0 111.348 175.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.36 -58.28 15.41 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.338 0.971 . . . . 10.0 113.471 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.91 79.79 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.539 1.17 . . . . 10.0 112.146 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.29 -42.53 73.99 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.956 1.265 . . . . 10.0 113.185 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.9 m -61.82 -58.75 6.75 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.852 0.861 . . . . 10.0 111.448 171.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.79 -58.04 9.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.974 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.7 82.13 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.176 0.806 . . . . 10.0 113.176 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.602 1.161 . . . . 10.0 113.64 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.718 1.723 . . . . 10.0 110.86 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.305 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 115.609 1.004 . . . . 10.0 115.609 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.02 92.93 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.46 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.798 0.713 . . . . 10.0 112.441 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.931 166.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.174 -1.375 . . . . 10.0 113.866 174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.769 1.293 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.58 -29.67 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.756 2.971 . . . . 10.0 113.682 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.17 -40.07 22.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.078 1.351 . . . . 10.0 113.534 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.43 19.58 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.434 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 111.015 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.94 -50.25 73.17 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.35 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.41 -51.26 65.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.353 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.2 mt -48.51 -58.0 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.892 1.277 . . . . 10.0 110.193 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -68.54 -16.48 63.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.218 1.407 . . . . 10.0 113.819 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -88.66 -39.72 13.83 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.624 1.102 . . . . 10.0 112.188 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.34 -42.17 90.89 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.457 -0.777 . . . . 10.0 112.29 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -41.13 -61.84 1.21 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 126.214 1.806 . . . . 10.0 113.782 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.13 -26.83 17.6 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.028 2.485 . . . . 10.0 114.436 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.69 89.49 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.504 1.502 . . . . 10.0 113.387 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -55.54 -53.81 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.426 1.09 . . . . 10.0 109.128 170.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -42.63 71.67 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.312 1.045 . . . . 10.0 113.751 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -52.93 -56.73 13.79 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.575 1.534 . . . . 10.0 111.915 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.96 -52.51 32.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.347 1.459 . . . . 10.0 110.735 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.21 62.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 118.168 -0.92 . . . . 10.0 112.982 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -56.3 -40.91 75.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.37 1.441 . . . . 10.0 113.013 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.23 -54.57 34.25 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.179 1.354 . . . . 10.0 111.333 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.66 -41.03 61.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.259 1.577 . . . . 10.0 115.259 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.91 -50.85 61.1 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.451 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.5 48.9 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.328 1.051 . . . . 10.0 113.835 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.01 43.21 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.26 1.578 . . . . 10.0 115.26 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.12 3.59 61.28 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.302 0.881 . . . . 10.0 115.302 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.4 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.035 2.134 . . . . 10.0 109.036 172.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.028 0.931 . . . . 10.0 111.0 166.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.887 0.875 . . . . 10.0 109.712 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.56 129.54 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.068 1.347 . . . . 10.0 110.976 -176.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.74 116.3 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.384 -1.044 . . . . 10.0 109.384 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.76 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.695 -0.962 . . . . 10.0 110.695 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.37 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.708 2.243 . . . . 10.0 118.708 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.54 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.263 -165.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.87 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.081 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.47 120.82 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.53 131.92 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.11 126.38 22.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.0 1.72 . . . . 10.0 111.684 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.746 1.26 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.3 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.54 -31.14 61.87 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.231 1.012 . . . . 10.0 112.305 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 82' ' ' ARG . 16.1 ttm-85 -46.97 -44.48 20.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.198 2.199 . . . . 10.0 113.104 167.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -82.12 -38.9 24.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.651 1.581 . . . . 10.0 111.794 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.17 -49.25 52.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.073 1.349 . . . . 10.0 111.629 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -53.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.038 1.735 . . . . 10.0 111.849 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -54.95 -33.23 62.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.936 -1.031 . . . . 10.0 113.549 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.13 -40.39 46.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.399 1.48 . . . . 10.0 112.051 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.28 -46.1 4.5 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.253 1.021 . . . . 10.0 112.303 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.1 m -52.32 -43.68 64.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.879 1.271 . . . . 10.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 m -72.87 -45.5 8.79 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 114.313 1.227 . . . . 10.0 114.313 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.88 -41.63 69.36 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.339 2.693 . . . . 10.0 115.1 167.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.0 mt -59.6 -47.14 86.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.285 0.634 . . . . 10.0 111.431 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.8 -51.45 22.5 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.349 1.86 . . . . 10.0 111.412 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.06 -47.28 83.64 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.92 1.288 . . . . 10.0 113.165 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.29 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.849 0.859 . . . . 10.0 112.889 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.34 -53.96 37.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.256 0.934 . . . . 10.0 111.2 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -42.05 88.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.62 0.768 . . . . 10.0 112.087 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 37.95 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.017 0.927 . . . . 10.0 112.024 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.29 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.752 0.821 . . . . 10.0 112.699 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.76 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.81 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.312 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.45 12.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.847 1.659 . . . . 10.0 112.159 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.92 54.38 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.69 2.61 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.523 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.79 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.46 -52.9 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.07 1.348 . . . . 10.0 111.128 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.61 -51.26 68.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.88 43.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.504 0.722 . . . . 10.0 110.923 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.357 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.82 -46.37 74.53 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.044 0.757 . . . . 10.0 113.044 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.52 -45.24 85.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.138 . . . . 10.0 112.08 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.99 -56.76 5.07 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.618 1.58 . . . . 10.0 112.797 166.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.46 -52.1 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 10.0 111.054 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 55.1 ttp -48.0 -59.79 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.855 1.262 . . . . 10.0 112.037 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.5 mm . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 123.658 0.783 . . . . 10.0 111.889 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 111.967 0.358 . . . . 10.0 111.967 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.22 -59.25 9.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.911 1.719 . . . . 10.0 112.387 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.03 -42.94 3.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.313 2.645 . . . . 10.0 113.254 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.0 mt -101.42 -6.67 23.71 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.499 1.666 . . . . 10.0 115.499 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.7 10.36 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.19 -1.569 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.47 -49.62 72.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.187 2.595 . . . . 10.0 113.268 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.087 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.9 -59.53 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.07 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.501 1.52 . . . . 10.0 113.503 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.56 63.15 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.15 -41.26 68.24 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.89 0.768 . . . . 10.0 110.899 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.97 -31.98 69.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.837 1.255 . . . . 10.0 114.221 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.076 0.853 . . . . 10.0 109.713 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -60.03 -48.32 82.19 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -48.93 -49.61 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.575 1.079 . . . . 10.0 113.014 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.85 63.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 10.0 111.945 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.69 -51.28 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.983 1.313 . . . . 10.0 111.786 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.2 t -55.89 -46.24 78.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.615 1.166 . . . . 10.0 111.793 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.9 m -60.88 -42.64 98.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 10.0 112.557 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.78 79.17 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.228 0.922 . . . . 10.0 112.31 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.02 82.52 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.587 0.755 . . . . 10.0 112.607 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -55.38 -55.33 32.86 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.319 1.048 . . . . 10.0 112.142 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 tt -51.24 -50.54 58.98 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.949 1.7 . . . . 10.0 111.185 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -50.93 -54.9 20.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.021 0.928 . . . . 10.0 112.792 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.1 -54.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.592 0.757 . . . . 10.0 110.861 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.46 -36.58 69.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.692 0.797 . . . . 10.0 113.115 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.16 9.45 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.036 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.87 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.467 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.78 -49.44 75.29 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.115 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.087 -1.633 . . . . 10.0 112.871 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.68 -21.99 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 10.0 113.466 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.76 -79.06 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.621 0.629 . . . . 10.0 113.553 171.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.236 1.814 . . . . 10.0 113.045 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -50.55 65.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.057 0.932 . . . . 10.0 112.297 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.07 82.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.133 0.973 . . . . 10.0 112.167 173.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.45 80.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.532 1.308 . . . . 10.0 114.532 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.25 1.2 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.033 1.733 . . . . 10.0 114.254 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.65 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.391 1.876 . . . . 10.0 114.878 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.93 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.7 153.92 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.841 3.256 . . . . 10.0 105.592 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.82 -46.23 35.14 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.275 1.983 . . . . 10.0 113.06 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.15 68.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.236 173.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.1 -53.05 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.027 0.931 . . . . 10.0 109.832 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.8 75.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.274 0.63 . . . . 10.0 111.892 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.15 25.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.882 0.873 . . . . 10.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.25 -53.22 60.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 112.987 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.53 45.44 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.115 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.48 78.54 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.91 -49.63 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.843 0.747 . . . . 10.0 110.522 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.64 69.02 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.81 30.15 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.889 2.075 . . . . 10.0 111.037 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.836 0.454 . . . . 10.0 111.263 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.4 t -52.08 -47.39 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 112.209 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -65.29 0.66 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.209 2.604 . . . . 10.0 111.46 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.93 -48.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.783 1.233 . . . . 10.0 111.548 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.7 t -60.52 -61.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.945 0.898 . . . . 10.0 112.653 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.08 -48.78 73.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.766 0.712 . . . . 10.0 111.608 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -50.11 -53.03 30.14 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.647 1.179 . . . . 10.0 112.53 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.469 0.52 0 C-N-CA 124.278 1.031 . . . . 10.0 113.589 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 118.692 -0.671 . . . . 10.0 112.605 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -58.73 -56.1 26.59 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.547 1.139 . . . . 10.0 111.944 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.2 tt -58.36 -41.69 85.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.915 0.886 . . . . 10.0 112.697 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -81.27 -5.52 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.22 -169.29 33.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-O 122.587 1.104 . . . . 10.0 113.953 -169.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.43 65.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.847 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.46 -16.76 64.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.647 1.721 . . . . 10.0 115.647 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.05 -105.91 1.08 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.32 1.418 . . . . 10.0 113.799 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.17 35.81 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.617 -1.519 . . . . 10.0 109.325 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.894 0.318 . . . . 10.0 113.894 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.725 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.29 133.35 24.88 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.69 153.8 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.786 2.99 . . . . 10.0 111.433 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.77 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.307 1.043 . . . . 10.0 112.213 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.35 -52.35 22.07 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.712 1.375 . . . . 10.0 114.712 176.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.92 -40.5 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.476 1.11 . . . . 10.0 109.692 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.32 -49.78 42.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.513 0.597 . . . . 10.0 111.973 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.04 83.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.001 1.72 . . . . 10.0 112.993 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.35 62.14 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.02 0.928 . . . . 10.0 112.03 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -58.52 6.5 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.363 1.065 . . . . 10.0 109.975 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -53.44 -44.95 69.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.759 -1.115 . . . . 10.0 112.839 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.45 -53.0 57.66 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.66 -47.51 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.819 1.248 . . . . 10.0 111.678 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.12 -51.62 68.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.629 1.571 . . . . 10.0 111.815 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.21 -51.63 69.14 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.917 1.687 . . . . 10.0 111.788 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 124.669 1.188 . . . . 10.0 110.987 172.786 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.221 0 CA-C-O 121.028 0.238 . . . . 10.0 112.903 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -44.94 -58.02 3.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.542 1.937 . . . . 10.0 112.293 166.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.49 -38.5 70.62 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.005 0.812 . . . . 10.0 113.235 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -70.29 -27.65 64.57 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 116.215 1.932 . . . . 10.0 116.215 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.68 -57.49 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.63 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.921 0.889 . . . . 10.0 113.2 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.53 5.15 2.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.37 0.41 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.18 0.992 . . . . 10.0 113.272 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.08 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.011 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.98 7.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.874 0.87 . . . . 10.0 112.106 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.869 2.868 . . . . 10.0 116.475 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.719 1.208 . . . . 10.0 110.644 -175.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.21 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.666 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.483 2.713 . . . . 10.0 113.459 166.653 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.834 -2.032 . . . . 10.0 105.789 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 129.651 3.18 . . . . 10.0 117.196 160.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.65 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.306 2.642 . . . . 10.0 114.484 155.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.46 137.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.407 1.883 . . . . 10.0 113.345 -158.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.22 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.465 2.459 . . . . 10.0 111.487 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.62 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.25 -2.786 . . . . 10.0 116.634 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.543 2.301 . . . . 10.0 113.217 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.19 4.31 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.782 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.11 61.74 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.534 -0.729 . . . . 10.0 112.615 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.6 84.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.63 62.91 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.448 0.699 . . . . 10.0 111.882 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.59 56.42 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.183 0.593 . . . . 10.0 112.218 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 51.97 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.98 10.25 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.149 0.881 . . . . 10.0 111.202 166.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.27 -52.3 28.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.574 1.15 . . . . 10.0 112.187 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.122 0.969 . . . . 10.0 112.167 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.3 mt -57.86 -50.14 74.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.449 0.699 . . . . 10.0 112.751 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -49.7 68.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.442 1.097 . . . . 10.0 111.248 175.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.32 15.2 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.3 0.952 . . . . 10.0 113.608 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.02 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.485 1.142 . . . . 10.0 112.089 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -41.59 75.74 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.863 1.22 . . . . 10.0 113.232 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.55 -58.44 7.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.823 0.849 . . . . 10.0 111.421 171.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -40.98 62.49 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.045 0.938 . . . . 10.0 110.944 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.1 9.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.968 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.68 81.85 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.257 0.836 . . . . 10.0 113.257 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.46 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.586 1.154 . . . . 10.0 113.62 169.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.77 1.748 . . . . 10.0 110.892 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.013 . . . . 10.0 115.634 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.58 -44.96 93.16 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.162 2.185 . . . . 10.0 113.589 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.435 2.694 . . . . 10.0 116.939 166.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.64 -50.92 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.179 -1.373 . . . . 10.0 113.879 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.771 1.294 . . . . 10.0 110.957 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.59 -29.63 89.65 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.743 2.962 . . . . 10.0 113.69 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.09 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.108 1.363 . . . . 10.0 113.564 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.44 19.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.405 172.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.967 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.97 -50.23 73.29 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.334 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.29 65.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.337 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.53 -57.42 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.851 1.26 . . . . 10.0 110.533 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -67.99 -20.75 65.05 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.965 1.306 . . . . 10.0 113.552 -172.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -84.07 -40.92 17.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.414 1.086 . . . . 10.0 112.18 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.07 -41.52 88.15 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.469 -0.77 . . . . 10.0 112.983 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.37 -62.84 1.45 Allowed Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 124.603 1.161 . . . . 10.0 113.447 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.79 -26.34 32.56 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.001 2.467 . . . . 10.0 113.771 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.86 -45.94 83.92 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 120.547 1.522 . . . . 10.0 113.156 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.76 -51.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 120.982 -1.073 . . . . 10.0 109.302 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.82 72.84 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.42 0.896 . . . . 10.0 113.42 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -52.81 -56.42 15.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.119 1.368 . . . . 10.0 111.816 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.67 -52.78 28.58 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.263 1.425 . . . . 10.0 110.749 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.29 -47.97 62.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.99 0.916 . . . . 10.0 112.98 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.15 -41.2 75.04 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.365 1.439 . . . . 10.0 113.11 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.57 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.948 1.249 . . . . 10.0 111.297 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.61 -41.12 61.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.86 -50.85 61.22 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.525 0.73 . . . . 10.0 110.485 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.5 48.82 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.539 0.976 . . . . 10.0 115.539 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.55 61.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.42 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.042 2.137 . . . . 10.0 109.036 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.57 171.13 15.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.028 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.01 53.42 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.912 0.885 . . . . 10.0 109.712 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.51 129.62 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.079 1.352 . . . . 10.0 110.96 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.444 -1.022 . . . . 10.0 109.444 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.37 38.2 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.42 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.632 -0.987 . . . . 10.0 110.632 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.78 -3.35 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.317 1.558 . . . . 10.0 112.28 -165.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.93 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.52 120.74 69.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -165.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.2 Cg_exo -61.49 131.92 38.28 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.137 171.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.1 126.33 21.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.055 1.742 . . . . 10.0 111.752 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.63 85.01 4.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.958 1.361 . . . . 10.0 113.085 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.36 -28.28 66.71 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.898 -1.126 . . . . 10.0 113.928 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.8 38.3 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.26 1.024 . . . . 10.0 112.491 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -54.27 -48.3 71.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.032 1.333 . . . . 10.0 112.714 168.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -71.25 -38.49 71.91 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.485 1.114 . . . . 10.0 110.993 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.52 67.09 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.797 1.239 . . . . 10.0 112.367 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.15 -69.51 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.883 1.673 . . . . 10.0 111.624 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -56.84 -32.5 65.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.067 1.347 . . . . 10.0 112.836 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.35 -44.27 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.679 1.592 . . . . 10.0 111.876 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -100.14 -41.94 6.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 10.0 112.593 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.4 p -62.6 -42.72 99.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.836 1.198 . . . . 10.0 113.925 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 71.5 p -65.85 -44.01 60.98 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 114.663 1.357 . . . . 10.0 114.663 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -43.95 53.12 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.053 2.502 . . . . 10.0 115.637 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.46 -46.4 88.87 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.491 -0.756 . . . . 10.0 111.454 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 tp -50.76 -49.2 58.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.567 1.547 . . . . 10.0 112.038 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.09 -47.47 83.11 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.94 1.296 . . . . 10.0 112.513 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.22 78.28 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.78 0.832 . . . . 10.0 112.889 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.31 -54.04 36.64 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.309 0.959 . . . . 10.0 111.173 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.06 88.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 10.0 112.14 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 38.1 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 112.002 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.35 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.682 0.793 . . . . 10.0 112.704 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.76 -38.57 91.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.81 1.43 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.055 1.342 . . . . 10.0 112.296 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.9 47.62 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.443 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.93 54.46 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.664 0.616 . . . . 10.0 112.664 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.72 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.499 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.04 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.339 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.43 -52.9 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.075 1.35 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.27 67.89 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.87 43.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.429 0.692 . . . . 10.0 110.945 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.655 0.782 . . . . 10.0 111.375 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.9 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.78 -46.58 74.45 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -56.07 -48.3 76.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.896 0.879 . . . . 10.0 110.903 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.79 -54.57 4.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.951 1.263 . . . . 10.0 113.195 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.15 -51.01 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.903 0.881 . . . . 10.0 112.119 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -54.19 -51.96 62.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.866 1.212 . . . . 10.0 111.987 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 N--CA 1.471 0.576 0 O-C-N 121.801 -0.562 . . . . 10.0 111.034 177.406 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 112.139 0.422 . . . . 10.0 112.139 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.0 -58.98 9.34 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.919 1.723 . . . . 10.0 112.398 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.92 -43.3 3.03 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.057 2.543 . . . . 10.0 113.466 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.43 -6.33 24.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.461 1.652 . . . . 10.0 115.461 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.63 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.222 -1.549 . . . . 10.0 110.41 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.619 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.68 71.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.26 2.624 . . . . 10.0 113.251 177.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.61 106.3 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.52 3.03 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.771 1.229 . . . . 10.0 114.065 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.05 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.48 1.512 . . . . 10.0 113.519 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.63 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.907 1.447 . . . . 10.0 114.907 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -53.91 -41.81 68.05 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.914 0.779 . . . . 10.0 110.75 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.72 -31.49 69.52 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.355 1.243 . . . . 10.0 114.355 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.44 -52.01 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.041 0.837 . . . . 10.0 109.551 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -61.84 -42.56 99.19 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -53.67 -49.2 68.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.233 1.013 . . . . 10.0 112.759 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -52.58 64.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.636 0.774 . . . . 10.0 111.503 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.6 -55.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.987 1.315 . . . . 10.0 112.051 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 p -57.04 -43.63 82.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.905 0.882 . . . . 10.0 112.696 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -43.93 98.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.758 1.223 . . . . 10.0 112.157 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.41 81.7 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.229 0.922 . . . . 10.0 112.561 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.23 78.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.989 0.916 . . . . 10.0 112.43 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.8 ttp -56.56 -51.06 70.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.285 1.034 . . . . 10.0 112.382 171.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.02 -48.06 76.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.32 1.448 . . . . 10.0 112.681 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -48.53 -53.52 17.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.394 1.078 . . . . 10.0 111.794 169.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.72 -55.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.68 0.792 . . . . 10.0 110.899 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -56.52 -36.42 69.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.226 0.824 . . . . 10.0 113.226 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.28 -58.15 9.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.049 0.939 . . . . 10.0 113.059 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.5 -40.82 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.289 -0.863 . . . . 10.0 111.429 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.84 -49.4 75.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.909 1.231 . . . . 10.0 112.093 171.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.99 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.858 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.615 1.166 . . . . 10.0 113.447 -174.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.11 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.651 0.643 . . . . 10.0 113.554 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.242 1.817 . . . . 10.0 113.011 -166.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.06 -56.46 14.2 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.005 1.113 . . . . 10.0 114.005 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.69 -50.55 65.61 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.096 0.951 . . . . 10.0 112.272 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.14 -46.02 83.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.16 0.984 . . . . 10.0 112.151 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.51 80.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.43 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.124 1.77 . . . . 10.0 114.235 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.59 29.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.425 1.89 . . . . 10.0 114.851 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.5 1.619 . . . . 10.0 114.164 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.805 3.242 . . . . 10.0 105.562 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.84 -46.22 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.306 2.004 . . . . 10.0 113.069 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.11 68.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.057 2.943 . . . . 10.0 113.236 173.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.82 75.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.282 0.633 . . . . 10.0 111.917 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.19 24.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.913 0.885 . . . . 10.0 112.698 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.226 1.011 . . . . 10.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.55 -49.53 45.86 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.26 0.624 . . . . 10.0 111.115 174.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.15 -48.41 78.76 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.94 -49.7 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.801 0.728 . . . . 10.0 110.467 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.51 -51.63 69.07 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.8 -47.76 30.85 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 126.852 2.061 . . . . 10.0 111.04 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.48 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.862 0.465 . . . . 10.0 111.271 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.1 -47.33 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.078 0.951 . . . . 10.0 112.093 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.4 m -58.36 -64.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.126 2.57 . . . . 10.0 111.492 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -50.18 -49.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.676 1.19 . . . . 10.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.36 -63.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.974 0.91 . . . . 10.0 112.043 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.58 -45.45 81.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.142 0.883 . . . . 10.0 112.378 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -53.03 -51.88 60.27 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.107 0.963 . . . . 10.0 112.236 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 114.243 1.201 . . . . 10.0 114.243 179.724 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 112.77 0.655 . . . . 10.0 112.77 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -59.63 -55.18 37.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.563 1.145 . . . . 10.0 112.115 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.81 -41.68 82.67 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.764 0.826 . . . . 10.0 112.494 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -81.42 -5.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 115.003 1.483 . . . . 10.0 115.003 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.4 -169.31 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 122.576 1.098 . . . . 10.0 113.924 -168.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.56 65.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.822 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -67.92 -15.74 63.75 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.542 1.682 . . . . 10.0 115.542 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.53 -105.94 1.05 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 120.428 1.467 . . . . 10.0 114.03 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.304 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.32 1.35 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 113.855 0.302 . . . . 10.0 113.855 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.77 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.12 1.768 . . . . 10.0 108.692 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.7 t -126.26 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.368 -174.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.73 153.81 72.45 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.456 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.297 1.039 . . . . 10.0 112.199 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.3 -52.42 21.47 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 10.0 114.685 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.36 -49.77 42.93 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.563 0.62 . . . . 10.0 111.937 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.7 -47.05 83.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.979 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.28 -52.35 62.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.974 0.91 . . . . 10.0 112.123 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -58.96 5.1 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.303 1.041 . . . . 10.0 109.992 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -52.32 -44.57 65.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.679 -1.153 . . . . 10.0 112.6 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -55.26 -51.76 65.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.608 1.549 . . . . 10.0 112.511 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.43 -46.68 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.936 1.294 . . . . 10.0 111.629 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.91 -52.68 64.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.556 1.542 . . . . 10.0 111.601 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.57 -54.11 49.78 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.785 1.634 . . . . 10.0 111.933 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.475 0.778 0 O-C-N 121.22 -0.925 . . . . 10.0 112.456 -178.842 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.306 0 CA-C-O 120.909 0.172 . . . . 10.0 112.985 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -45.18 -56.3 4.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.414 1.886 . . . . 10.0 112.284 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.04 -40.03 71.93 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.072 0.844 . . . . 10.0 113.635 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.48 -27.69 64.4 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 115.774 1.768 . . . . 10.0 115.774 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.42 -57.52 11.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 165.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.65 0.86 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.907 0.883 . . . . 10.0 113.168 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.58 5.24 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.31 15.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.266 1.026 . . . . 10.0 113.28 172.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.038 0.935 . . . . 10.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.12 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.771 0.828 . . . . 10.0 110.973 170.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.85 76.99 7.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.87 0.868 . . . . 10.0 112.117 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.471 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.41 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.622 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.51 39.93 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.519 2.727 . . . . 10.0 113.439 166.61 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.782 -2.056 . . . . 10.0 105.826 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.51 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.615 3.166 . . . . 10.0 117.211 160.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.1 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.356 2.662 . . . . 10.0 114.417 155.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.365 1.866 . . . . 10.0 113.391 -158.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.13 1.69 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.306 1.842 . . . . 10.0 114.055 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.96 2.84 40.82 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 127.489 2.471 . . . . 10.0 111.487 168.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.55 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.96 -60.65 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.488 2.281 . . . . 10.0 113.191 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.23 4.37 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.8 2.44 . . . . 10.0 115.742 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.13 61.79 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.464 -0.772 . . . . 10.0 112.621 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.41 -52.65 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.422 0.689 . . . . 10.0 111.83 175.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.33 -53.59 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.174 0.59 . . . . 10.0 112.225 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 -46.81 52.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.368 1.467 . . . . 10.0 113.305 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.61 -45.04 84.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.83 -58.68 7.4 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.355 0.978 . . . . 10.0 110.765 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -48.4 -52.34 22.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.745 1.218 . . . . 10.0 112.072 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 -58.9 5.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.175 0.99 . . . . 10.0 112.15 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.74 -49.77 75.44 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.707 0.803 . . . . 10.0 112.207 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.2 mmm -57.78 -45.95 85.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.374 0.67 . . . . 10.0 111.603 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.47 -58.1 16.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.46 1.029 . . . . 10.0 113.895 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.21 -45.99 79.66 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.406 1.103 . . . . 10.0 112.077 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -42.02 75.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.821 1.2 . . . . 10.0 113.168 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 -58.58 7.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.676 0.79 . . . . 10.0 111.474 171.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.01 62.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.023 0.929 . . . . 10.0 110.974 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.78 -57.99 9.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.582 1.153 . . . . 10.0 113.011 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.68 82.0 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.621 1.168 . . . . 10.0 113.637 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.748 . . . . 10.0 110.878 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.937 2.495 . . . . 10.0 109.365 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.89 23.09 0.86 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.94 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.614 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.9 m -79.61 -50.87 10.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.231 -1.35 . . . . 10.0 113.902 174.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.52 6.44 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.794 1.309 . . . . 10.0 110.975 -172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.54 -29.69 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.705 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.66 2.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.111 0.565 . . . . 10.0 111.447 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.53 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.056 1.342 . . . . 10.0 113.588 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.49 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.249 1.42 . . . . 10.0 113.468 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.13 61.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.486 0.714 . . . . 10.0 110.946 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.91 -50.28 73.03 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.26 65.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.341 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.02 1.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.407 0.892 . . . . 10.0 113.407 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.36 -57.26 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.921 1.288 . . . . 10.0 110.645 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -68.39 -20.17 64.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.999 1.32 . . . . 10.0 113.508 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.9 m -84.92 -39.69 17.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.488 1.115 . . . . 10.0 112.303 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.59 -42.89 97.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.8 t -43.39 -63.77 0.93 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.898 1.279 . . . . 10.0 112.482 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.43 -27.56 33.52 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.94 2.426 . . . . 10.0 114.217 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.79 89.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.459 1.481 . . . . 10.0 113.033 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.2 mt -61.84 -46.97 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 120.86 -1.15 . . . . 10.0 109.908 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.61 71.14 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.027 0.751 . . . . 10.0 113.027 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -50.82 -56.87 10.12 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.193 1.397 . . . . 10.0 111.677 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -48.91 -53.39 19.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.237 1.415 . . . . 10.0 111.087 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.99 -48.34 63.33 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.034 0.933 . . . . 10.0 112.909 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -55.22 -41.94 72.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.309 1.413 . . . . 10.0 113.287 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.56 34.44 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.619 1.099 . . . . 10.0 111.356 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.64 -41.03 61.02 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.256 1.576 . . . . 10.0 115.256 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtm -66.95 -50.8 61.2 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 123.568 0.747 . . . . 10.0 110.456 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.67 -52.63 22.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.837 0.855 . . . . 10.0 112.91 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.93 -5.53 48.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.875 1.065 . . . . 10.0 113.875 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.22 -34.66 5.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 115.601 1.0 . . . . 10.0 115.601 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.38 -43.06 43.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.59 61.05 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.363 0.905 . . . . 10.0 115.363 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.39 26.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.072 2.149 . . . . 10.0 109.066 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.48 171.09 15.15 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.059 0.943 . . . . 10.0 111.048 166.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.1 53.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.862 0.865 . . . . 10.0 109.693 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.8 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.75 116.29 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.4 38.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 118.703 2.241 . . . . 10.0 118.703 170.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.9 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.302 1.551 . . . . 10.0 112.223 -165.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.78 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.544 1.537 . . . . 10.0 111.159 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.43 120.81 69.68 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 112.981 0.734 . . . . 10.0 112.981 -165.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.58 131.93 38.12 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.209 3.273 . . . . 10.0 112.144 171.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.12 126.32 21.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.054 1.742 . . . . 10.0 111.746 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.57 84.96 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.057 1.408 . . . . 10.0 113.065 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.31 -28.26 66.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.787 -1.195 . . . . 10.0 113.98 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.73 62.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.056 1.502 . . . . 10.0 115.056 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.409 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -63.86 -29.62 70.79 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 119.847 -1.783 . . . . 10.0 113.284 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -70.78 -43.99 67.57 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.254 -0.904 . . . . 10.0 112.012 171.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.1 -46.67 45.18 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.164 1.386 . . . . 10.0 111.669 167.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -56.92 -70.82 0.11 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.102 1.361 . . . . 10.0 111.675 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.409 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.2 m0 -53.4 -33.51 54.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.422 1.489 . . . . 10.0 112.835 -170.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.5 tp -46.29 -48.95 18.02 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.942 1.697 . . . . 10.0 111.913 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -90.8 -44.5 9.39 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.324 1.05 . . . . 10.0 112.311 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.2 p -78.91 -32.98 45.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.133 1.16 . . . . 10.0 114.133 -165.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.317 69.8 p -61.55 -44.98 93.66 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.594 -1.193 . . . . 10.0 112.767 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.52 -44.99 43.01 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.911 2.407 . . . . 10.0 115.892 166.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.41 -47.4 85.59 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.319 -0.863 . . . . 10.0 111.881 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.17 -49.51 60.79 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.898 1.679 . . . . 10.0 111.3 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.05 -48.06 76.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.237 1.015 . . . . 10.0 112.907 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.21 78.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.823 0.849 . . . . 10.0 112.863 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.37 -53.99 37.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.299 0.954 . . . . 10.0 111.163 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.12 88.8 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.151 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.71 38.29 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.951 0.9 . . . . 10.0 112.031 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.21 79.4 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.736 0.814 . . . . 10.0 112.669 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.75 -38.58 91.64 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.41 1.263 . . . . 10.0 114.41 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.269 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.89 47.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.966 -1.709 . . . . 10.0 112.437 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.87 54.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.79 -39.77 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.922 1.689 . . . . 10.0 113.452 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.74 87.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.382 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.49 -52.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.003 1.321 . . . . 10.0 111.16 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.28 67.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.516 0.562 . . . . 10.0 112.516 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.91 42.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.446 0.698 . . . . 10.0 110.932 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.9 4.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.429 2.292 . . . . 10.0 114.821 174.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -47.01 74.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -58.52 -44.28 89.48 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.703 0.801 . . . . 10.0 111.769 175.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -56.27 5.14 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.418 1.485 . . . . 10.0 113.384 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.59 -49.84 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 117.697 0.749 . . . . 10.0 111.245 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -53.85 -57.05 12.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.93 1.292 . . . . 10.0 112.587 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.479 0.978 0 CA-C-N 118.795 0.725 . . . . 10.0 111.625 173.406 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 110.23 -0.285 . . . . 10.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.88 -60.71 6.75 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.4 1.952 . . . . 10.0 112.533 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.61 -42.56 3.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.645 2.378 . . . . 10.0 113.219 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -100.77 -6.68 24.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.65 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 120.186 -1.571 . . . . 10.0 110.355 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.49 -49.6 72.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.154 2.582 . . . . 10.0 113.304 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.36 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.053 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.88 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.111 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.06 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.465 1.506 . . . . 10.0 113.56 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.74 63.26 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.03 -41.72 68.35 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.855 0.752 . . . . 10.0 110.768 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -69.33 -32.33 71.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.764 1.226 . . . . 10.0 114.25 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -52.15 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.051 0.841 . . . . 10.0 109.955 168.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -59.11 -51.71 68.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -48.24 -46.96 36.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.164 0.986 . . . . 10.0 113.388 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.44 -52.07 67.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 10.0 111.524 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.2 mt -54.22 -51.53 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.134 1.374 . . . . 10.0 111.514 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -54.45 -47.82 72.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.423 1.089 . . . . 10.0 112.13 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 73.6 m -63.0 -43.1 99.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.042 1.337 . . . . 10.0 111.663 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.46 73.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.238 1.015 . . . . 10.0 112.365 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.9 78.14 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.761 0.824 . . . . 10.0 112.497 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.97 -52.72 64.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.652 1.181 . . . . 10.0 111.959 172.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.08 -49.27 63.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.315 1.446 . . . . 10.0 111.414 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -49.33 -54.93 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.949 0.9 . . . . 10.0 112.681 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 42.0 mm -52.16 -55.88 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.852 0.751 . . . . 10.0 110.41 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.68 -35.22 72.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.463 -0.78 . . . . 10.0 111.735 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.36 -58.14 9.56 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.003 0.921 . . . . 10.0 113.008 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.85 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.438 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.4 75.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.857 1.208 . . . . 10.0 112.101 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -76.99 -70.32 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.119 -1.613 . . . . 10.0 112.851 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.89 60.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.634 1.174 . . . . 10.0 113.42 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.14 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.627 0.632 . . . . 10.0 113.514 171.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.41 51.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.26 1.824 . . . . 10.0 113.059 -166.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.54 13.8 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.96 1.096 . . . . 10.0 113.96 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.63 -50.54 65.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.084 0.945 . . . . 10.0 112.329 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.02 83.1 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.16 0.984 . . . . 10.0 112.117 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.47 80.12 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.32 1.23 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.124 1.77 . . . . 10.0 114.189 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.58 29.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.398 1.879 . . . . 10.0 114.917 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.86 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 123.48 1.61 . . . . 10.0 114.146 -170.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.66 153.96 72.74 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.798 3.239 . . . . 10.0 105.561 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.21 35.4 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.334 2.023 . . . . 10.0 113.008 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.032 2.933 . . . . 10.0 113.288 173.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.14 -53.08 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.059 0.943 . . . . 10.0 109.816 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.86 75.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.317 0.647 . . . . 10.0 111.907 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.96 -56.22 24.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.953 0.901 . . . . 10.0 112.675 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.18 -53.22 60.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.181 0.993 . . . . 10.0 113.059 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.53 -49.56 45.57 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.36 78.88 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.06 -49.58 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.832 0.742 . . . . 10.0 110.481 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.61 69.16 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.81 -47.74 30.95 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.883 2.073 . . . . 10.0 111.07 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.59 -58.33 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.815 0.446 . . . . 10.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.1 t -51.96 -47.94 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.091 0.956 . . . . 10.0 111.994 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.2 m -57.66 -63.41 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.397 2.679 . . . . 10.0 111.878 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.52 -49.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.526 1.131 . . . . 10.0 111.284 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.62 -60.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.1 0.96 . . . . 10.0 112.056 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.44 -48.08 83.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -52.26 -51.07 60.55 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.707 0.803 . . . . 10.0 111.597 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 114.028 1.121 . . . . 10.0 114.028 178.691 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 119.279 -0.391 . . . . 10.0 111.531 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -55.68 -52.91 62.24 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.412 1.085 . . . . 10.0 112.581 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -57.49 -43.15 83.92 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.854 0.861 . . . . 10.0 112.304 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -83.98 -5.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.097 1.517 . . . . 10.0 115.097 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.37 -169.35 33.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 122.559 1.088 . . . . 10.0 113.887 -168.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -41.23 64.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.889 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.7 -16.79 64.31 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.731 1.752 . . . . 10.0 115.731 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.89 -105.93 1.09 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.364 1.438 . . . . 10.0 113.711 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.4 127.13 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.368 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.52 65.4 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.081 1.753 . . . . 10.0 108.725 166.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.39 24.91 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.78 153.79 72.38 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.733 2.955 . . . . 10.0 111.463 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.09 -39.84 2.92 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.295 1.038 . . . . 10.0 112.232 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.31 -52.35 21.87 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.95 -40.45 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.388 1.075 . . . . 10.0 109.639 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.86 41.86 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.535 0.607 . . . . 10.0 111.946 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.4 m -57.71 -47.01 83.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.006 1.723 . . . . 10.0 112.995 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.33 62.29 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.938 0.895 . . . . 10.0 112.054 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.61 -59.07 4.91 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.307 1.043 . . . . 10.0 109.979 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.97 -46.99 68.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.479 -1.248 . . . . 10.0 112.297 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.98 -52.34 43.58 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.739 1.609 . . . . 10.0 113.035 174.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.32 -48.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.553 1.141 . . . . 10.0 111.636 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.98 -50.45 72.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.143 1.377 . . . . 10.0 111.763 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.14 -59.79 4.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.713 2.005 . . . . 10.0 110.198 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.477 0.909 0 C-N-CA 124.552 1.141 . . . . 10.0 111.989 175.282 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.294 0 N-CA-C 112.534 -0.226 . . . . 10.0 112.534 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -43.05 -57.39 2.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.759 2.024 . . . . 10.0 112.536 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.92 -41.59 84.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.388 0.994 . . . . 10.0 113.945 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.92 -27.18 64.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 115.703 1.742 . . . . 10.0 115.703 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.21 -57.65 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.947 0.899 . . . . 10.0 113.155 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.53 5.13 2.54 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.3 0.37 15.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.24 1.016 . . . . 10.0 113.324 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 110.972 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.95 77.07 7.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.824 0.849 . . . . 10.0 112.087 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.83 2.852 . . . . 10.0 116.458 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.91 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.721 1.209 . . . . 10.0 110.61 -175.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.77 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.656 171.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.468 2.707 . . . . 10.0 113.408 166.584 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.83 -2.033 . . . . 10.0 105.851 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.614 3.165 . . . . 10.0 117.211 160.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.272 2.629 . . . . 10.0 114.49 155.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.97 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.361 1.864 . . . . 10.0 113.378 -158.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.272 1.829 . . . . 10.0 113.99 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.16 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.58 -51.38 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.306 -2.759 . . . . 10.0 116.604 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.498 2.285 . . . . 10.0 113.205 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.31 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.737 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.39 -43.03 61.79 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.496 -0.752 . . . . 10.0 112.642 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.69 83.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.954 0.902 . . . . 10.0 109.305 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.872 175.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.33 -53.57 56.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.238 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.81 51.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.376 1.47 . . . . 10.0 113.354 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.99 84.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.294 1.438 . . . . 10.0 113.026 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.95 -55.68 14.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.575 1.084 . . . . 10.0 111.769 166.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -50.16 -52.5 34.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.916 1.286 . . . . 10.0 112.317 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.145 0.978 . . . . 10.0 112.204 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.2 mt -58.11 -49.31 77.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.451 0.7 . . . . 10.0 112.609 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.2 mmt -55.16 -50.27 69.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.686 0.794 . . . . 10.0 111.198 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.08 -58.57 13.9 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.388 0.994 . . . . 10.0 113.634 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.15 -45.65 79.56 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.593 1.196 . . . . 10.0 112.138 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.62 80.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.529 1.062 . . . . 10.0 113.389 172.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -60.17 -60.49 3.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.09 0.956 . . . . 10.0 110.984 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.96 62.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.939 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.09 9.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.654 1.181 . . . . 10.0 112.929 172.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.72 82.1 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.649 1.179 . . . . 10.0 113.619 169.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.698 1.713 . . . . 10.0 110.835 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.86 -44.8 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.878 2.471 . . . . 10.0 109.338 171.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.97 23.1 0.87 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.611 1.005 . . . . 10.0 115.611 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.48 -45.0 92.93 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.145 2.178 . . . . 10.0 113.605 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.765 0.698 . . . . 10.0 112.432 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.04 88.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.361 2.665 . . . . 10.0 116.933 166.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.67 -50.88 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.224 -1.353 . . . . 10.0 113.854 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.47 6.4 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.782 1.301 . . . . 10.0 110.957 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.57 -29.64 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.08 0.552 . . . . 10.0 111.442 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.15 22.67 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.142 1.377 . . . . 10.0 113.549 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.47 19.23 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.232 1.413 . . . . 10.0 113.46 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.11 61.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.952 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.95 -50.23 73.26 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.035 0.534 . . . . 10.0 112.351 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.36 -51.29 65.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.939 -0.553 . . . . 10.0 112.358 173.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.78 -56.88 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 10.0 110.489 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -69.23 -17.57 63.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.18 1.392 . . . . 10.0 113.6 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.6 m -86.6 -42.91 13.09 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.688 1.131 . . . . 10.0 111.953 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -57.13 -41.32 78.82 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -50.62 -61.35 3.95 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.985 1.314 . . . . 10.0 112.254 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.27 -46.78 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.393 3.395 . . . . 10.0 115.726 163.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.96 79.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.241 1.2 . . . . 10.0 114.241 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.09 -36.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 120.256 -1.528 . . . . 10.0 111.698 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.87 77.61 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.13 0.877 . . . . 10.0 112.603 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.8 -56.0 14.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 10.0 111.89 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -48.61 -53.21 19.37 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.498 1.519 . . . . 10.0 111.113 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.59 -48.14 64.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.142 0.977 . . . . 10.0 112.921 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -55.34 -42.16 73.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.009 1.277 . . . . 10.0 113.196 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.66 32.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.292 0.951 . . . . 10.0 111.25 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.55 -41.13 60.89 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.255 1.576 . . . . 10.0 115.255 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 47.0 mtm -66.91 -50.77 61.37 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.531 0.732 . . . . 10.0 110.459 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.7 -52.58 22.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.828 0.851 . . . . 10.0 112.924 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.46 48.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.23 -34.76 5.51 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.524 0.97 . . . . 10.0 115.524 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.26 -43.08 42.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.09 3.57 61.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.063 2.145 . . . . 10.0 109.001 171.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.13 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.03 166.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.726 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.6 129.63 23.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 125.069 1.348 . . . . 10.0 110.908 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.81 116.27 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 109.382 -1.045 . . . . 10.0 109.382 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.78 0.659 . . . . 10.0 112.78 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.718 -0.953 . . . . 10.0 110.718 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.43 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.664 2.225 . . . . 10.0 118.664 170.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.379 1.59 . . . . 10.0 112.202 -165.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.478 1.511 . . . . 10.0 111.059 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.9 Cg_exo -61.52 131.9 38.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.169 3.246 . . . . 10.0 112.166 171.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.7 85.01 4.72 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.717 1.246 . . . . 10.0 113.066 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.29 -28.31 66.64 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.26 -33.59 63.3 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.283 1.033 . . . . 10.0 112.155 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.478 ' HD2' ' CZ2' ' A' ' 86' ' ' TRP . 8.1 tpp180 -39.06 -54.23 1.73 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.24 2.616 . . . . 10.0 111.938 165.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.71 -38.11 48.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.047 1.739 . . . . 10.0 112.579 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.2 -47.35 62.29 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.72 1.146 . . . . 10.0 110.387 167.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -68.36 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.362 1.865 . . . . 10.0 111.485 168.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.478 ' CZ2' ' HD2' ' A' ' 82' ' ' ARG . 54.5 m0 -54.76 -35.83 64.19 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.608 0.966 . . . . 10.0 113.608 -172.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.14 -42.19 50.24 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.104 1.762 . . . . 10.0 111.825 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -103.5 -36.96 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.543 -0.741 . . . . 10.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.4 p -61.15 -46.22 91.43 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 121.155 1.798 . . . . 10.0 113.6 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.301 76.4 p -65.93 -43.89 59.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 -175.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.99 -43.14 62.34 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.429 2.753 . . . . 10.0 115.261 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.95 -47.78 84.85 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.318 -0.864 . . . . 10.0 111.698 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.411 HD21 ' HE1' ' A' ' 182' ' ' TRP . 17.5 tp -49.95 -49.59 49.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.136 1.374 . . . . 10.0 112.189 169.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.87 -47.93 76.46 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.111 -0.993 . . . . 10.0 112.658 170.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.26 78.28 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.781 0.832 . . . . 10.0 112.894 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -52.24 -54.05 35.98 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.31 0.959 . . . . 10.0 111.203 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.72 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.657 0.783 . . . . 10.0 112.158 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.74 -54.74 37.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.983 0.913 . . . . 10.0 112.016 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.15 79.17 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.677 174.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.82 -38.54 91.48 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.426 1.269 . . . . 10.0 114.426 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.018 1.327 . . . . 10.0 112.296 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.5 53.49 11.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.821 1.648 . . . . 10.0 112.175 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.92 47.52 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.938 -1.726 . . . . 10.0 112.392 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.89 54.27 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.7 2.63 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.861 1.664 . . . . 10.0 113.456 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.25 5.27 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.02 -46.8 87.62 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.88 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.997 1.319 . . . . 10.0 111.163 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.67 -51.28 67.84 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.55 0.574 . . . . 10.0 112.55 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.88 43.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.452 0.701 . . . . 10.0 110.908 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.52 -59.96 4.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.436 2.294 . . . . 10.0 114.815 174.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.99 -46.29 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 123.665 0.786 . . . . 10.0 111.428 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.71 -50.25 64.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.655 0.645 . . . . 10.0 112.63 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.71 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.234 0.827 . . . . 10.0 113.234 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -55.12 -48.3 73.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.591 1.156 . . . . 10.0 111.259 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -55.51 5.22 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.39 1.472 . . . . 10.0 113.246 168.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.61 -51.99 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.549 0.74 . . . . 10.0 111.735 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.2 tmm? -50.65 -56.38 12.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.969 1.707 . . . . 10.0 112.038 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm . . . . . 0 N--CA 1.473 0.692 0 O-C-N 121.652 -0.655 . . . . 10.0 112.423 175.457 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.0 t . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 119.683 -0.198 . . . . 10.0 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.26 6.3 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.714 1.626 . . . . 10.0 112.092 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.59 -37.55 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.387 1.875 . . . . 10.0 113.893 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.6 mt -99.14 -6.35 28.45 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.162 1.541 . . . . 10.0 115.162 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.68 116.69 10.37 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.128 -1.607 . . . . 10.0 110.365 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.221 2.608 . . . . 10.0 113.274 177.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.62 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.812 0.845 . . . . 10.0 110.066 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.95 -59.53 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.033 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.06 14.92 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.413 1.485 . . . . 10.0 113.52 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -70.2 -24.58 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.66 -42.2 67.64 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.917 0.78 . . . . 10.0 110.692 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.53 -31.54 69.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.853 1.261 . . . . 10.0 114.348 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.36 -51.86 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.0 0.818 . . . . 10.0 109.622 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -61.68 -43.03 99.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.387 1.255 . . . . 10.0 114.387 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.26 -49.03 67.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.545 1.138 . . . . 10.0 112.585 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.87 71.74 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.717 0.807 . . . . 10.0 111.675 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.4 mt -56.35 -54.33 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.924 1.289 . . . . 10.0 111.943 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -57.39 -42.04 81.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.451 0.7 . . . . 10.0 112.468 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.2 m -58.91 -46.73 87.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.89 1.276 . . . . 10.0 112.6 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.312 0.96 . . . . 10.0 112.371 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.99 83.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.982 0.913 . . . . 10.0 112.805 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.71 -53.61 56.19 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.468 1.107 . . . . 10.0 111.982 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.66 -47.61 70.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.422 1.489 . . . . 10.0 111.982 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -50.1 -54.56 19.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.001 0.92 . . . . 10.0 112.416 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.4 mt -53.78 -54.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.79 0.836 . . . . 10.0 110.728 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.56 -36.56 69.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.17 9.4 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -40.86 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.8 -49.43 75.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.883 1.22 . . . . 10.0 112.145 171.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.043 -1.66 . . . . 10.0 112.874 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.72 -21.91 60.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.607 1.163 . . . . 10.0 113.466 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.644 0.64 . . . . 10.0 113.522 171.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.43 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.037 -166.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.16 -56.42 14.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.953 1.094 . . . . 10.0 113.953 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.7 -50.51 65.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.145 0.974 . . . . 10.0 112.307 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.05 82.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.192 0.997 . . . . 10.0 112.152 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.53 80.03 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.42 -11.29 1.19 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.084 1.754 . . . . 10.0 114.223 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.411 1.884 . . . . 10.0 114.867 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.97 -92.62 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.501 1.619 . . . . 10.0 114.135 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.68 153.93 72.68 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.837 3.255 . . . . 10.0 105.604 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.345 2.03 . . . . 10.0 113.083 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.668 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.07 68.07 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.285 173.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.13 -53.05 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.105 0.962 . . . . 10.0 109.816 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.82 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.06 -56.11 25.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.864 0.865 . . . . 10.0 112.731 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.2 -53.24 60.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.229 1.012 . . . . 10.0 112.988 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.56 45.38 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.324 0.65 . . . . 10.0 111.097 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.14 -48.44 78.67 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.66 1.356 . . . . 10.0 114.66 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.97 -49.58 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.807 0.731 . . . . 10.0 110.482 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.14 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.169 0.803 . . . . 10.0 113.169 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.72 31.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.84 2.056 . . . . 10.0 111.068 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.61 -58.29 9.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.781 0.432 . . . . 10.0 111.245 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.85 -49.3 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.07 0.948 . . . . 10.0 111.497 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 29.7 m -56.19 -64.01 1.0 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.115 2.566 . . . . 10.0 111.952 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.02 -49.11 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.666 1.186 . . . . 10.0 111.347 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.31 -61.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.09 0.956 . . . . 10.0 112.372 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -58.04 -46.84 84.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.421 0.688 . . . . 10.0 111.932 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . 0.411 ' HE1' HD21 ' A' ' 93' ' ' LEU . 9.0 m95 -51.29 -52.8 41.82 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.16 0.984 . . . . 10.0 112.101 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 113.789 1.033 . . . . 10.0 113.789 179.78 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 119.438 -0.315 . . . . 10.0 111.483 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -55.59 -53.3 58.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.697 1.199 . . . . 10.0 112.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -56.25 -44.51 79.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.936 0.894 . . . . 10.0 112.655 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -84.52 -5.81 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.08 1.511 . . . . 10.0 115.08 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.26 33.1 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-O 122.627 1.126 . . . . 10.0 113.94 -168.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -41.1 64.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.202 -0.999 . . . . 10.0 111.846 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -54.43 -31.66 55.77 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.503 2.721 . . . . 10.0 115.359 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.34 -103.85 0.96 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.433 1.015 . . . . 10.0 113.506 -167.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.15 35.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.653 -1.498 . . . . 10.0 109.357 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.4 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.69 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.721 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.33 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.388 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.72 153.8 72.51 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.792 2.995 . . . . 10.0 111.483 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.83 3.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.364 1.065 . . . . 10.0 112.19 171.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.41 21.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.0 -40.42 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.363 1.065 . . . . 10.0 109.625 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.34 -49.81 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.61 0.641 . . . . 10.0 111.944 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.05 83.37 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.055 1.742 . . . . 10.0 112.976 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.4 -52.29 62.24 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.934 0.894 . . . . 10.0 112.054 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -58.73 5.84 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.338 1.055 . . . . 10.0 109.955 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -52.51 -45.36 66.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.604 -1.189 . . . . 10.0 112.684 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.8 -52.67 59.56 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.48 1.491 . . . . 10.0 112.856 174.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.51 -46.17 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.055 1.342 . . . . 10.0 111.551 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.28 -54.25 49.02 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.302 1.441 . . . . 10.0 111.589 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -54.03 -58.74 6.18 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.523 1.929 . . . . 10.0 111.278 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.474 0.746 0 O-C-N 121.153 -0.967 . . . . 10.0 112.185 -179.527 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.308 0 CA-C-O 121.11 0.284 . . . . 10.0 112.4 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -40.7 -60.13 1.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.904 2.081 . . . . 10.0 112.324 163.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.03 72.45 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.13 0.872 . . . . 10.0 113.745 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -69.94 -27.55 64.85 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 115.997 1.851 . . . . 10.0 115.997 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.73 -57.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.493 -0.929 . . . . 10.0 108.493 165.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.88 0.872 . . . . 10.0 113.171 -172.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.62 5.23 2.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 10.0 115.341 -171.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.4 15.7 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.174 0.99 . . . . 10.0 113.32 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.998 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.668 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.72 98.24 1.9 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.73 0.812 . . . . 10.0 110.953 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.04 7.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.87 0.868 . . . . 10.0 112.037 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.904 2.881 . . . . 10.0 116.466 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.48 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.765 1.226 . . . . 10.0 110.635 -175.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.74 Favored Glycine 0 C--O 1.238 0.388 0 C-N-CA 129.738 3.542 . . . . 10.0 119.647 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.476 2.711 . . . . 10.0 113.421 166.567 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.794 -2.05 . . . . 10.0 105.835 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.49 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.595 3.158 . . . . 10.0 117.209 160.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.1 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.306 2.642 . . . . 10.0 114.452 155.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.51 137.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.357 1.863 . . . . 10.0 113.393 -158.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.74 -165.2 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.76 40.74 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.412 2.434 . . . . 10.0 111.516 168.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.31 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.679 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.66 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.477 2.277 . . . . 10.0 113.238 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.37 0.95 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.751 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.42 -43.07 61.9 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.458 -0.776 . . . . 10.0 112.604 176.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.348 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.46 -52.62 63.01 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.386 0.675 . . . . 10.0 111.84 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.82 -46.8 51.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.353 1.461 . . . . 10.0 113.335 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.68 -44.93 84.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.267 1.427 . . . . 10.0 113.056 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.06 -55.78 14.31 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.373 0.987 . . . . 10.0 111.689 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.97 -52.41 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.874 1.27 . . . . 10.0 112.336 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.47 -58.89 5.72 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.172 0.989 . . . . 10.0 112.14 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -57.42 -48.79 78.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.619 0.768 . . . . 10.0 112.684 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.41 -47.1 85.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.221 1.008 . . . . 10.0 111.502 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.64 13.52 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.309 0.957 . . . . 10.0 113.721 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.21 -46.03 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.658 1.229 . . . . 10.0 112.112 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.18 -42.68 73.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.987 1.28 . . . . 10.0 113.175 172.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -62.05 -58.35 8.17 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.718 0.807 . . . . 10.0 111.534 172.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.32 -40.99 62.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.937 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.74 -58.07 9.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.616 1.166 . . . . 10.0 112.999 172.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.71 81.93 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.244 0.831 . . . . 10.0 113.244 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.625 1.17 . . . . 10.0 113.659 169.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.728 1.727 . . . . 10.0 110.868 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.875 2.47 . . . . 10.0 109.33 171.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.11 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.01 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.101 2.161 . . . . 10.0 113.623 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.175 -1.375 . . . . 10.0 113.841 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.84 117.52 6.35 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.745 1.278 . . . . 10.0 110.957 -172.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.63 -29.66 89.87 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.678 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.085 0.554 . . . . 10.0 111.448 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.22 -40.04 23.08 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.583 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.53 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.219 1.408 . . . . 10.0 113.446 172.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.81 -53.04 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.939 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.99 -50.27 73.21 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.316 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.29 -51.33 64.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.39 0.541 . . . . 10.0 112.395 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.44 -58.06 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 10.0 110.256 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -67.78 -18.71 64.95 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.234 1.414 . . . . 10.0 113.725 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -86.74 -40.64 14.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.381 1.072 . . . . 10.0 112.292 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.13 -42.92 91.77 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.44 -0.787 . . . . 10.0 112.708 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.2 t -42.2 -62.29 1.25 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.504 1.522 . . . . 10.0 113.285 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.17 -26.12 21.54 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.069 2.513 . . . . 10.0 114.24 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.94 80.63 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.855 1.662 . . . . 10.0 113.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.5 -49.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.026 -1.046 . . . . 10.0 109.778 169.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.56 -45.96 73.6 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 175.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -50.98 -56.32 13.04 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.758 1.623 . . . . 10.0 112.046 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -49.4 -52.76 26.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.303 1.441 . . . . 10.0 110.626 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.439 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.6 mmt -68.87 -47.97 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.005 0.922 . . . . 10.0 113.047 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -57.27 -40.13 77.08 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.201 -1.381 . . . . 10.0 113.346 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.3 -54.6 34.04 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.037 1.29 . . . . 10.0 111.301 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.04 61.0 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.211 1.56 . . . . 10.0 115.211 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.94 -50.78 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.476 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.65 21.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.883 . . . . 10.0 112.9 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.03 -5.51 49.06 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.34 1.056 . . . . 10.0 113.769 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.554 0.982 . . . . 10.0 115.554 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.04 43.04 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.28 1.585 . . . . 10.0 115.28 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.304 0.882 . . . . 10.0 115.304 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.26 143.37 26.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.082 2.153 . . . . 10.0 109.018 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.008 0.923 . . . . 10.0 111.021 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.01 53.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.751 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.56 129.58 23.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 125.12 1.368 . . . . 10.0 110.991 -176.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.28 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.379 -1.047 . . . . 10.0 109.379 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.41 -81.94 0.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.634 -0.986 . . . . 10.0 110.634 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.55 -171.82 4.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.23 -165.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.91 93.89 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.527 1.531 . . . . 10.0 111.056 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.45 120.79 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.989 0.737 . . . . 10.0 112.989 -165.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.6 Cg_exo -61.57 131.93 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.196 3.264 . . . . 10.0 112.129 171.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.004 1.721 . . . . 10.0 111.739 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.62 84.98 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.005 1.384 . . . . 10.0 113.035 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.32 -28.31 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.839 -1.163 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.92 45.45 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.259 1.023 . . . . 10.0 113.197 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -50.42 -60.96 2.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.706 1.202 . . . . 10.0 111.05 168.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -58.17 -42.44 86.01 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.32 2.248 . . . . 10.0 112.633 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.32 63.44 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.487 1.04 . . . . 10.0 112.418 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.439 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -62.39 -60.46 3.53 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.384 0.993 . . . . 10.0 111.759 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -52.96 -36.24 59.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 112.328 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.4 tp -50.49 -42.64 54.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.536 1.934 . . . . 10.0 112.14 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -102.35 -39.05 7.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.83 0.852 . . . . 10.0 112.842 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 71.2 p -63.08 -45.9 89.95 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 120.559 1.527 . . . . 10.0 113.308 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 72.6 p -62.86 -44.21 85.0 Favored Pre-proline 0 N--CA 1.478 0.944 0 N-CA-C 114.825 1.417 . . . . 10.0 114.825 -177.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.07 -43.29 60.73 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.521 2.814 . . . . 10.0 115.32 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.48 -47.5 85.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.803 0.729 . . . . 10.0 111.71 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.0 mt -53.6 -45.27 69.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.39 1.076 . . . . 10.0 112.204 172.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.81 -47.42 82.65 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.111 -0.993 . . . . 10.0 112.769 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.29 78.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.88 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.29 -54.06 36.2 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.258 0.936 . . . . 10.0 111.161 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.1 88.76 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.62 0.768 . . . . 10.0 112.146 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.75 37.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.986 0.914 . . . . 10.0 112.028 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.14 79.14 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.677 0.791 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.61 91.75 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.76 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.045 1.338 . . . . 10.0 112.313 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.844 1.658 . . . . 10.0 112.104 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.85 47.66 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.903 -1.748 . . . . 10.0 112.446 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 135.96 54.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.705 0.632 . . . . 10.0 112.705 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.71 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.856 1.663 . . . . 10.0 113.471 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.27 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.178 1.37 . . . . 10.0 115.262 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.04 -46.83 87.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.323 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.37 -52.95 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.02 1.328 . . . . 10.0 111.124 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.32 67.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.09 -44.92 42.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.49 0.716 . . . . 10.0 110.98 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.94 4.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.396 2.279 . . . . 10.0 114.8 174.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.93 -46.38 96.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.69 0.796 . . . . 10.0 111.423 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.29 64.24 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.674 0.654 . . . . 10.0 112.593 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.32 74.83 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.37 -45.72 84.13 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.164 0.986 . . . . 10.0 111.995 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.07 -55.62 5.61 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.332 1.444 . . . . 10.0 112.982 167.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.21 -53.57 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.02 -0.99 . . . . 10.0 110.768 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 57.4 ttp -46.02 -58.1 3.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.504 1.502 . . . . 10.0 112.653 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.1 mm . . . . . 0 N--CA 1.473 0.718 0 O-C-N 121.694 -0.629 . . . . 10.0 112.429 179.474 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 111.539 0.2 . . . . 10.0 111.539 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.27 -59.36 9.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.857 1.694 . . . . 10.0 112.448 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.07 -43.2 3.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.475 2.71 . . . . 10.0 113.272 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -101.26 -6.38 24.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.446 1.647 . . . . 10.0 115.446 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.76 10.48 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.222 -1.549 . . . . 10.0 110.397 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.217 2.607 . . . . 10.0 113.255 177.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.68 106.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.733 0.813 . . . . 10.0 110.065 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.94 -59.54 3.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.029 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.09 14.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.513 1.525 . . . . 10.0 113.486 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.23 -24.6 63.12 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.872 1.434 . . . . 10.0 114.872 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.95 -41.75 68.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.935 0.789 . . . . 10.0 110.776 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.86 70.22 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.356 1.243 . . . . 10.0 114.356 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.46 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.043 0.838 . . . . 10.0 109.621 168.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -60.51 -45.26 94.47 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.015 1.116 . . . . 10.0 114.015 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -52.23 -48.89 64.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.414 1.006 . . . . 10.0 112.895 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -54.45 45.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.092 0.957 . . . . 10.0 111.645 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.0 mt -53.28 -49.83 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.052 1.341 . . . . 10.0 111.592 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -54.84 -48.09 73.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.866 1.266 . . . . 10.0 111.852 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.7 m -65.19 -40.49 94.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.602 1.561 . . . . 10.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.07 -49.41 77.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.049 0.94 . . . . 10.0 112.286 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.45 79.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.746 0.818 . . . . 10.0 112.441 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.7 ttp -55.37 -54.04 48.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.12 0.968 . . . . 10.0 112.243 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -52.07 -50.38 61.66 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.83 1.652 . . . . 10.0 111.407 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -50.15 -54.71 18.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.14 0.976 . . . . 10.0 112.502 172.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.7 mt -53.49 -55.26 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.775 0.83 . . . . 10.0 110.736 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.32 -35.84 70.38 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.287 -0.863 . . . . 10.0 112.866 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.48 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.03 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.85 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.437 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.84 -49.37 75.63 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.866 1.212 . . . . 10.0 112.153 171.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.92 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.94 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.645 1.178 . . . . 10.0 113.412 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.75 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.676 0.655 . . . . 10.0 113.51 171.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.61 -32.43 51.12 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.23 1.812 . . . . 10.0 113.08 -166.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.9 m -52.04 -56.52 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.025 1.12 . . . . 10.0 114.025 172.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.58 -50.62 65.2 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.115 0.959 . . . . 10.0 112.32 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.08 -46.08 82.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.188 0.995 . . . . 10.0 112.105 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.54 79.8 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.516 1.302 . . . . 10.0 114.516 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.33 1.22 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.101 1.76 . . . . 10.0 114.235 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.07 6.67 29.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.433 1.893 . . . . 10.0 114.89 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.96 -92.68 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.473 1.606 . . . . 10.0 114.115 -170.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.68 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 129.805 3.242 . . . . 10.0 105.541 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.93 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.308 2.005 . . . . 10.0 113.052 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.06 68.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.977 2.911 . . . . 10.0 113.259 173.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.16 -53.05 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 124.014 0.925 . . . . 10.0 109.804 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.81 75.57 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.237 0.615 . . . . 10.0 111.952 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.02 -56.13 25.45 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.894 0.877 . . . . 10.0 112.734 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.1 m -57.3 -53.11 61.83 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.139 0.976 . . . . 10.0 113.02 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.6 -49.51 46.41 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.118 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.1 -48.4 78.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.6 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.774 0.715 . . . . 10.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.52 -51.68 68.84 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.77 30.14 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.822 2.049 . . . . 10.0 111.077 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.14 -47.0 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.015 0.926 . . . . 10.0 112.127 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 34.1 m -58.33 -64.16 1.02 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.276 2.631 . . . . 10.0 111.735 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.33 -50.15 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.68 1.192 . . . . 10.0 110.989 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.19 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.962 0.905 . . . . 10.0 111.915 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.07 -48.33 73.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.24 0.927 . . . . 10.0 112.69 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.76 -50.41 70.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.834 0.854 . . . . 10.0 111.66 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.0 p . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 114.397 1.258 . . . . 10.0 114.397 179.104 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.7 t . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 119.322 -0.37 . . . . 10.0 111.472 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -55.5 -52.63 63.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.408 1.083 . . . . 10.0 112.598 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -58.51 -42.97 88.87 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.686 0.794 . . . . 10.0 112.45 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -83.3 -5.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.915 1.45 . . . . 10.0 114.915 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.3 33.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 122.55 1.083 . . . . 10.0 113.964 -168.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.62 65.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.868 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.78 -15.87 63.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.568 1.692 . . . . 10.0 115.568 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.49 -106.06 1.06 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 120.452 1.478 . . . . 10.0 113.965 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.11 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.34 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.28 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.919 0.328 . . . . 10.0 113.919 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.55 -42.78 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.126 1.77 . . . . 10.0 108.725 166.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.4 t -126.29 133.38 24.9 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.419 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.7 153.77 72.6 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.816 3.011 . . . . 10.0 111.469 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.273 1.029 . . . . 10.0 112.251 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.32 -52.42 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.9 -40.52 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.618 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -49.28 -49.77 42.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.574 0.625 . . . . 10.0 111.991 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.07 83.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.086 1.755 . . . . 10.0 113.002 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.36 62.11 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.962 0.905 . . . . 10.0 112.063 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.5 -60.0 3.77 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.364 1.066 . . . . 10.0 109.974 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -52.51 -46.96 66.9 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.004 -1.474 . . . . 10.0 111.934 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.77 -53.03 35.16 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.376 1.898 . . . . 10.0 113.119 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.27 -48.55 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.083 1.353 . . . . 10.0 111.499 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.5 mp -57.48 -50.86 71.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.101 1.36 . . . . 10.0 111.577 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -56.96 -59.69 4.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.71 2.404 . . . . 10.0 111.089 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.481 1.116 0 O-C-N 120.563 -1.336 . . . . 10.0 112.379 -179.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.333 0 CA-C-O 120.768 0.093 . . . . 10.0 113.128 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -45.22 -56.21 5.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.448 1.899 . . . . 10.0 111.814 166.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.74 -40.5 71.64 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.327 0.965 . . . . 10.0 113.903 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -70.41 -27.77 64.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 115.843 1.794 . . . . 10.0 115.843 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.587 -0.894 . . . . 10.0 108.587 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.7 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.906 0.882 . . . . 10.0 113.193 -172.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.56 5.25 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.28 0.25 15.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.269 1.028 . . . . 10.0 113.301 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.93 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.078 0.951 . . . . 10.0 111.033 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.63 98.21 1.86 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.758 0.823 . . . . 10.0 110.92 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.04 7.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.866 0.866 . . . . 10.0 112.07 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.474 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.85 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.7 1.2 . . . . 10.0 110.674 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.31 169.51 40.05 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.534 . . . . 10.0 119.647 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.521 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.597 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.554 3.142 . . . . 10.0 117.276 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.64 . . . . 10.0 114.524 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.393 1.877 . . . . 10.0 113.338 -158.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.302 1.841 . . . . 10.0 114.018 -174.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.07 2.79 41.48 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.43 2.443 . . . . 10.0 111.48 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.6 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.649 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.04 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.559 2.307 . . . . 10.0 113.194 -175.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.23 4.31 0.98 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.842 2.457 . . . . 10.0 115.769 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.11 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.493 -0.754 . . . . 10.0 112.669 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.62 83.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.89 0.876 . . . . 10.0 109.272 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.41 -52.63 62.94 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.393 0.677 . . . . 10.0 111.885 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.34 -53.64 55.81 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.231 0.612 . . . . 10.0 112.18 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.77 51.99 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.413 1.485 . . . . 10.0 113.319 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.95 84.74 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.316 1.446 . . . . 10.0 112.998 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.56 -56.28 11.64 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.544 1.069 . . . . 10.0 111.549 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -50.18 -52.3 36.63 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.795 1.238 . . . . 10.0 112.171 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.86 5.8 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.154 0.981 . . . . 10.0 112.143 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.06 -48.9 77.43 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.67 0.788 . . . . 10.0 112.786 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 54.6 mtt -61.27 -44.48 97.17 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.905 0.882 . . . . 10.0 111.363 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.69 13.26 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.326 0.965 . . . . 10.0 113.967 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.22 -45.96 79.7 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.568 1.184 . . . . 10.0 112.131 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.6 -41.96 75.38 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.8 1.19 . . . . 10.0 113.191 173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.9 m -62.46 -58.36 7.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.717 0.807 . . . . 10.0 111.414 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.04 0.936 . . . . 10.0 110.917 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.07 9.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.599 1.16 . . . . 10.0 112.985 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.65 81.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.174 . . . . 10.0 113.585 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.33 40.88 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 123.745 1.736 . . . . 10.0 110.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.79 -44.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.367 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.88 23.09 0.86 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.656 1.023 . . . . 10.0 115.656 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.56 -44.98 93.12 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.178 2.191 . . . . 10.0 113.581 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.58 -84.45 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.787 0.708 . . . . 10.0 112.487 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.01 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.435 2.694 . . . . 10.0 116.933 166.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.64 -50.86 10.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.867 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.52 6.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.765 1.291 . . . . 10.0 110.975 -172.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.64 -29.53 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.702 2.935 . . . . 10.0 113.724 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -60.67 2.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.099 0.56 . . . . 10.0 111.407 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.5 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.097 1.359 . . . . 10.0 113.588 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.46 19.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.26 1.424 . . . . 10.0 113.396 172.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 61.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.459 0.704 . . . . 10.0 110.986 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.91 -50.27 73.05 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.29 65.31 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.321 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.44 -61.93 1.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.52 -57.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.897 1.279 . . . . 10.0 110.562 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 m -67.98 -20.91 65.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.952 1.301 . . . . 10.0 113.488 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.8 m -83.9 -40.68 18.28 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.401 1.08 . . . . 10.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -59.43 -41.87 90.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.393 -0.817 . . . . 10.0 113.182 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.1 t -45.07 -62.74 1.48 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.542 1.137 . . . . 10.0 113.081 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.33 -25.5 30.53 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.842 2.362 . . . . 10.0 113.871 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.41 -46.91 78.14 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.644 1.565 . . . . 10.0 113.188 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.76 -49.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.048 -1.033 . . . . 10.0 109.271 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.11 72.27 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.925 0.89 . . . . 10.0 113.238 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -50.83 -57.21 8.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.812 1.645 . . . . 10.0 111.768 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.49 -53.09 19.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.41 1.484 . . . . 10.0 110.787 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.69 -48.15 64.62 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.008 0.923 . . . . 10.0 113.05 -176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -56.58 -40.73 75.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.185 1.357 . . . . 10.0 113.347 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.58 34.28 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.789 1.177 . . . . 10.0 111.284 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.08 61.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.192 1.553 . . . . 10.0 115.192 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.86 -50.85 61.2 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.458 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.66 -52.63 22.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.873 0.869 . . . . 10.0 112.91 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.54 48.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.328 1.051 . . . . 10.0 113.833 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.69 5.57 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.06 43.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.213 1.561 . . . . 10.0 115.213 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.48 61.33 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.318 0.887 . . . . 10.0 115.318 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.049 2.14 . . . . 10.0 109.034 171.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.53 171.04 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.042 0.937 . . . . 10.0 111.024 166.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.11 53.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.9 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.21 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.474 -1.01 . . . . 10.0 109.474 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.7 164.4 38.18 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.38 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.68 -3.42 0.7 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 118.716 2.247 . . . . 10.0 118.716 170.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.57 -171.86 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.327 1.564 . . . . 10.0 112.223 -165.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.501 1.52 . . . . 10.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.8 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.18 126.34 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.992 1.717 . . . . 10.0 111.671 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.419 1.581 . . . . 10.0 113.087 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.28 -28.32 66.64 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.485 -1.385 . . . . 10.0 113.937 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.14 62.14 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.231 1.196 . . . . 10.0 114.231 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.424 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -65.12 -24.98 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.221 -1.549 . . . . 10.0 113.861 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -75.01 -42.6 57.07 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.577 -1.327 . . . . 10.0 112.189 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.82 -48.41 59.77 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.203 1.401 . . . . 10.0 111.693 167.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.95 -72.3 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.563 1.945 . . . . 10.0 111.819 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.424 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 49.8 m0 -55.43 -32.02 62.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.738 1.215 . . . . 10.0 112.952 -171.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.7 tp -50.66 -41.57 55.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.104 1.361 . . . . 10.0 111.932 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -103.84 -45.08 4.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.873 0.869 . . . . 10.0 112.626 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.7 p -59.51 -38.9 82.17 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.593 1.088 . . . . 10.0 113.373 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.0 m -66.61 -51.65 39.51 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 117.957 -1.021 . . . . 10.0 113.106 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 79.8 Cg_exo -51.56 -40.69 63.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.262 2.641 . . . . 10.0 114.631 171.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.5 mt -59.37 -48.31 82.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.619 0.767 . . . . 10.0 112.225 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.19 -39.45 86.55 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.584 1.084 . . . . 10.0 112.25 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.12 -49.05 74.99 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.081 -1.012 . . . . 10.0 111.348 167.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.29 78.27 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.852 0.861 . . . . 10.0 112.846 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.22 -54.1 35.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.301 0.955 . . . . 10.0 111.201 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.68 38.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.031 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.21 79.37 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.779 0.832 . . . . 10.0 112.669 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.81 -38.46 91.18 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.41 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.025 1.33 . . . . 10.0 112.298 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.873 1.669 . . . . 10.0 112.13 -173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.31 145.88 47.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.929 -1.732 . . . . 10.0 112.455 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.87 54.25 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.72 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.423 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.18 5.33 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.178 1.37 . . . . 10.0 115.276 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.8 p -62.13 -46.72 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.051 -1.452 . . . . 10.0 111.285 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.48 -52.89 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.036 1.334 . . . . 10.0 111.11 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.6 -51.32 67.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.87 42.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.496 0.718 . . . . 10.0 110.932 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.65 -59.85 4.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.354 2.262 . . . . 10.0 114.784 175.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.62 -46.64 73.9 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.573 0.749 . . . . 10.0 113.021 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -59.4 -43.7 92.95 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.847 0.859 . . . . 10.0 112.066 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -57.09 4.58 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.801 1.667 . . . . 10.0 113.123 165.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.1 mt -56.63 -49.81 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.94 0.896 . . . . 10.0 111.177 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -53.38 -58.62 6.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.427 1.012 . . . . 10.0 112.394 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.474 0.736 0 CA-C-N 118.417 0.553 . . . . 10.0 111.223 177.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 111.627 0.232 . . . . 10.0 111.627 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.02 -59.68 9.1 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.054 1.787 . . . . 10.0 112.541 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.09 3.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.181 2.592 . . . . 10.0 113.298 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.9 mt -100.83 -6.9 24.17 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.477 1.658 . . . . 10.0 115.477 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.182 -1.574 . . . . 10.0 110.409 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.619 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.52 -49.61 72.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.26 2.624 . . . . 10.0 113.239 177.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.58 106.29 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.783 0.833 . . . . 10.0 110.088 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.065 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.06 15.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.458 1.503 . . . . 10.0 113.49 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.65 63.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.884 1.439 . . . . 10.0 114.884 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.05 -41.38 68.04 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.902 0.774 . . . . 10.0 110.891 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -70.13 -31.26 68.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.837 1.255 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.49 -52.25 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.057 0.844 . . . . 10.0 109.629 168.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.26 -46.14 90.85 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.462 0.912 . . . . 10.0 113.462 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -50.95 -48.53 60.9 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.763 1.165 . . . . 10.0 113.213 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.87 -53.94 52.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.78 0.832 . . . . 10.0 111.79 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.72 -53.31 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.091 1.356 . . . . 10.0 111.859 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.6 p -58.67 -44.17 90.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.809 0.844 . . . . 10.0 112.697 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.66 -43.3 97.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.346 1.058 . . . . 10.0 112.346 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.1 78.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.295 0.952 . . . . 10.0 112.449 171.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.49 80.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.864 0.865 . . . . 10.0 112.524 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 35.8 ttp -55.74 -53.46 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.388 1.075 . . . . 10.0 112.024 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.74 -47.96 73.18 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.432 1.493 . . . . 10.0 112.446 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.6 -54.14 19.97 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 10.0 112.062 170.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.07 -54.86 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.593 0.757 . . . . 10.0 110.897 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.48 -36.45 69.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.441 -0.79 . . . . 10.0 113.116 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.35 -58.1 9.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.984 0.913 . . . . 10.0 113.077 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.93 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.344 -0.836 . . . . 10.0 111.461 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.77 -49.41 75.39 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.858 1.208 . . . . 10.0 112.163 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.908 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.9 60.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.624 1.169 . . . . 10.0 113.494 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.86 -79.03 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.601 0.619 . . . . 10.0 113.519 171.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.46 51.49 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.268 1.827 . . . . 10.0 113.067 -166.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.06 -56.45 14.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.022 1.119 . . . . 10.0 114.022 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.72 -50.5 65.79 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.06 0.934 . . . . 10.0 112.302 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.18 -45.98 83.23 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.197 0.999 . . . . 10.0 112.114 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.43 80.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.28 1.23 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.091 1.756 . . . . 10.0 114.194 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.11 6.66 29.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.374 1.87 . . . . 10.0 114.846 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.91 -92.64 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.522 1.63 . . . . 10.0 114.193 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.71 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 129.794 3.238 . . . . 10.0 105.571 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.19 35.55 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.263 1.976 . . . . 10.0 113.032 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.9 -46.13 67.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.04 2.936 . . . . 10.0 113.284 173.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.21 -52.95 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.17 -46.85 75.79 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.251 0.62 . . . . 10.0 111.9 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.19 24.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.9 m -57.19 -53.24 60.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 112.995 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.54 -49.56 45.62 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.292 0.637 . . . . 10.0 111.097 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.57 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.832 0.742 . . . . 10.0 110.54 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.56 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.87 30.11 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.839 2.056 . . . . 10.0 111.038 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.46 -58.35 8.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.769 0.428 . . . . 10.0 111.269 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.8 -48.73 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.116 0.967 . . . . 10.0 111.546 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.9 m -57.05 -63.99 1.03 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.056 2.542 . . . . 10.0 111.863 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.64 -49.15 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.847 1.259 . . . . 10.0 111.235 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.65 -62.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.89 0.876 . . . . 10.0 112.494 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.23 -45.26 84.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.748 0.704 . . . . 10.0 111.976 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -51.78 -53.08 43.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.929 0.892 . . . . 10.0 112.383 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 124.341 1.057 . . . . 10.0 113.65 -179.741 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 118.831 -0.605 . . . . 10.0 112.621 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -59.79 -54.9 40.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.529 1.132 . . . . 10.0 112.184 167.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.3 tp -52.9 -43.82 66.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.882 1.273 . . . . 10.0 112.254 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.75 -4.9 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 115.453 1.649 . . . . 10.0 115.453 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.45 -169.28 32.91 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.521 1.067 . . . . 10.0 113.898 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.23 -41.67 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.838 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.9 -14.16 62.87 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.364 1.616 . . . . 10.0 115.364 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.14 -106.14 1.02 Allowed Glycine 0 CA--C 1.535 1.284 0 CA-C-N 120.523 1.51 . . . . 10.0 114.218 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.08 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.666 -1.49 . . . . 10.0 109.314 168.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.38 65.31 1.34 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.7 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.36 24.89 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.66 153.8 72.64 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.814 3.009 . . . . 10.0 111.456 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.22 -39.77 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.193 171.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.36 21.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.98 -40.45 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.429 1.092 . . . . 10.0 109.617 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.35 -49.76 42.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.603 0.638 . . . . 10.0 111.952 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.7 -47.06 83.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.004 1.721 . . . . 10.0 112.979 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.32 -52.32 62.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.957 0.903 . . . . 10.0 112.1 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.53 -58.93 5.2 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.362 1.065 . . . . 10.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.99 -47.21 65.0 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.641 -1.171 . . . . 10.0 112.359 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.52 -52.11 56.3 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.57 1.532 . . . . 10.0 112.846 175.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.91 -47.97 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.51 1.124 . . . . 10.0 111.189 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.9 mp -57.94 -51.33 70.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.74 1.616 . . . . 10.0 112.159 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -54.46 -56.01 23.05 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.292 2.237 . . . . 10.0 111.309 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.476 0.869 0 O-C-N 121.582 -0.699 . . . . 10.0 111.233 175.59 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.281 0 N-CA-C 112.602 -0.199 . . . . 10.0 112.602 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.7 -56.88 2.49 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.816 2.046 . . . . 10.0 112.554 166.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.48 -41.41 88.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.785 1.184 . . . . 10.0 114.256 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -69.31 -27.23 65.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 115.609 1.707 . . . . 10.0 115.609 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.2 -57.58 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 165.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.67 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.92 0.888 . . . . 10.0 113.167 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.54 5.21 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.324 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.09 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.028 0.931 . . . . 10.0 111.014 174.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.56 98.21 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.781 0.832 . . . . 10.0 110.949 170.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.95 76.99 7.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.908 0.883 . . . . 10.0 112.093 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.07 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 128.888 2.875 . . . . 10.0 116.499 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.87 -55.47 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.641 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.48 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.676 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.495 0 C-N-CA 128.527 2.731 . . . . 10.0 113.461 166.594 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.808 -2.044 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.657 3.183 . . . . 10.0 117.239 160.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.0 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.297 2.639 . . . . 10.0 114.49 155.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.427 1.891 . . . . 10.0 113.339 -158.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 114.015 -174.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.83 40.9 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.675 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.02 -60.65 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.502 2.286 . . . . 10.0 113.202 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.11 4.28 0.94 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.787 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.509 -0.744 . . . . 10.0 112.625 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.898 0.879 . . . . 10.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.537 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.42 -52.64 62.91 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.455 0.702 . . . . 10.0 111.84 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.39 -53.58 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.205 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.77 52.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.332 1.453 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.98 84.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.354 1.462 . . . . 10.0 112.997 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.66 -56.86 10.43 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.32 0.962 . . . . 10.0 111.3 165.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.47 -52.29 30.12 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.615 1.166 . . . . 10.0 112.199 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.92 5.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.159 0.984 . . . . 10.0 112.139 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -57.68 -50.31 73.6 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.599 0.76 . . . . 10.0 112.604 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -49.99 68.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.252 1.021 . . . . 10.0 111.071 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.92 -58.18 15.95 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.407 1.003 . . . . 10.0 113.673 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.19 -45.69 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.511 1.155 . . . . 10.0 112.086 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.7 -42.08 76.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.88 1.229 . . . . 10.0 113.302 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -60.51 -60.36 3.93 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.046 0.938 . . . . 10.0 111.071 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.97 62.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.0 9.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 113.004 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.71 -38.61 82.09 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.1 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.66 1.184 . . . . 10.0 113.628 169.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.759 1.742 . . . . 10.0 110.852 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.88 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.869 2.468 . . . . 10.0 109.286 171.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.12 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.594 0.998 . . . . 10.0 115.594 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.0 92.89 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.163 2.185 . . . . 10.0 113.605 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.43 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.742 0.687 . . . . 10.0 112.407 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.962 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.84 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.904 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.811 1.32 . . . . 10.0 110.972 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.54 -29.67 89.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.719 2.946 . . . . 10.0 113.716 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.23 -60.75 2.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.133 0.573 . . . . 10.0 111.441 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.07 -40.08 22.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.126 1.37 . . . . 10.0 113.58 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.59 -47.39 19.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.444 172.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.06 62.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.48 0.712 . . . . 10.0 110.955 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.97 -50.24 73.26 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.137 0.575 . . . . 10.0 112.313 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.22 65.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.868 -0.586 . . . . 10.0 112.362 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.77 -57.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.867 1.267 . . . . 10.0 110.329 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -69.27 -16.25 63.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.14 1.376 . . . . 10.0 113.69 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.1 m -87.87 -42.99 12.14 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.779 1.172 . . . . 10.0 111.96 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -56.56 -41.6 77.17 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 173.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -49.46 -61.61 3.31 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.804 1.242 . . . . 10.0 112.595 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.64 -47.62 20.14 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.593 3.529 . . . . 10.0 116.115 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.1 93.62 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.938 1.245 . . . . 10.0 113.966 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.9 mt -58.57 -51.76 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.398 1.079 . . . . 10.0 109.525 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -43.04 71.76 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 10.0 113.246 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -52.69 -57.95 8.42 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.131 1.332 . . . . 10.0 111.912 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -48.33 -52.89 19.48 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.57 1.548 . . . . 10.0 110.967 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.89 -48.12 64.16 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.916 0.886 . . . . 10.0 113.029 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -55.85 -41.44 74.31 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.27 1.395 . . . . 10.0 113.225 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.54 34.8 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.719 1.145 . . . . 10.0 111.292 170.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.23 1.567 . . . . 10.0 115.23 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.88 -50.82 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.519 0.728 . . . . 10.0 110.528 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.57 -52.69 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.835 0.854 . . . . 10.0 112.922 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.96 -5.53 48.97 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.65 5.6 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.527 0.971 . . . . 10.0 115.527 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.1 42.74 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.63 61.1 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.351 0.9 . . . . 10.0 115.351 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.35 26.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.034 2.133 . . . . 10.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.052 166.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.717 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.6 129.58 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.72 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.664 2.226 . . . . 10.0 118.664 170.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.343 1.571 . . . . 10.0 112.237 -165.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.85 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.096 -175.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.2 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.09 126.33 22.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.028 1.731 . . . . 10.0 111.682 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.61 85.06 4.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.384 1.564 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.42 -28.26 66.77 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.523 -1.361 . . . . 10.0 113.926 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.38 62.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -64.89 -24.45 67.54 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.232 -1.543 . . . . 10.0 113.876 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -75.87 -42.93 47.9 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.462 -1.399 . . . . 10.0 112.257 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.88 53.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.064 1.346 . . . . 10.0 111.368 168.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -52.41 -71.09 0.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.715 2.006 . . . . 10.0 111.836 168.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -56.17 -32.74 64.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.644 1.178 . . . . 10.0 113.153 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.88 -39.74 54.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.389 1.475 . . . . 10.0 112.084 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.72 -41.41 5.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.549 0.739 . . . . 10.0 112.95 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 p -59.31 -41.1 88.24 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 120.792 1.633 . . . . 10.0 113.347 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.402 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.6 m -68.47 -47.5 35.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 84.9 Cg_exo -53.99 -41.47 74.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.574 2.849 . . . . 10.0 114.872 168.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -47.66 85.08 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.586 0.755 . . . . 10.0 111.728 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.7 tt -50.47 -49.61 54.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 10.0 111.548 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.18 -47.83 77.53 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.129 -0.982 . . . . 10.0 112.848 170.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.26 78.42 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.829 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.27 -54.03 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.343 0.974 . . . . 10.0 111.165 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -42.09 88.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.641 0.776 . . . . 10.0 112.093 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.81 36.63 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.996 0.918 . . . . 10.0 112.021 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.1 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.875 1.67 . . . . 10.0 112.106 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.938 -1.726 . . . . 10.0 112.437 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.55 135.96 54.46 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.9 -39.66 2.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.474 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.18 5.36 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.15 1.357 . . . . 10.0 115.266 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -46.75 87.76 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.123 -1.418 . . . . 10.0 111.351 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.038 1.335 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.58 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.534 0.568 . . . . 10.0 112.534 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.86 43.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.716 . . . . 10.0 110.911 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.64 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.382 2.273 . . . . 10.0 114.814 174.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.04 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.647 0.779 . . . . 10.0 111.403 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.67 -46.76 74.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.24 0.83 . . . . 10.0 113.24 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.64 -44.11 89.94 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 10.0 112.217 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.87 -56.23 5.2 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.33 1.443 . . . . 10.0 113.072 166.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 90.0 mt -56.81 -51.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.674 0.789 . . . . 10.0 111.55 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -52.1 -57.61 9.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.268 1.027 . . . . 10.0 112.185 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 122.776 0.43 . . . . 10.0 111.81 177.621 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 110.328 -0.249 . . . . 10.0 110.328 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.39 -60.9 6.34 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.099 1.809 . . . . 10.0 112.704 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -44.22 -41.12 5.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.245 2.218 . . . . 10.0 113.585 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.26 -6.7 25.58 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.444 1.646 . . . . 10.0 115.444 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.74 116.75 10.49 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.375 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.58 72.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.66 106.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.043 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.62 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -53.99 -41.66 68.15 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.89 0.768 . . . . 10.0 110.807 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.78 -31.59 69.6 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.318 1.229 . . . . 10.0 114.318 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.22 -51.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.976 0.807 . . . . 10.0 109.636 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -61.92 -42.8 99.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.423 1.268 . . . . 10.0 114.423 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.65 -48.85 69.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.237 1.015 . . . . 10.0 112.758 171.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.24 70.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.534 0.734 . . . . 10.0 111.614 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.16 -55.03 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.079 1.352 . . . . 10.0 111.974 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.1 p -57.2 -40.83 78.21 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.432 -0.792 . . . . 10.0 112.706 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.4 m -61.92 -44.84 95.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.756 1.223 . . . . 10.0 112.326 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.6 80.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.314 0.961 . . . . 10.0 112.251 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.95 85.51 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.503 -0.748 . . . . 10.0 112.816 173.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.272 1.029 . . . . 10.0 112.26 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.88 -45.81 78.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.831 1.652 . . . . 10.0 112.231 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -54.81 -53.93 48.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 171.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 44.1 mt -54.21 -54.75 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.716 0.689 . . . . 10.0 110.856 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.27 1.0 OUTLIER -60.02 -32.71 71.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 117.467 -1.254 . . . . 10.0 112.904 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.25 -58.13 9.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.987 1.267 . . . . 10.0 113.071 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -40.89 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.312 -0.851 . . . . 10.0 111.446 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.78 -49.41 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.847 1.203 . . . . 10.0 112.145 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.05 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.046 -1.659 . . . . 10.0 112.833 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -73.79 -21.9 60.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.626 1.17 . . . . 10.0 113.398 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.588 0.614 . . . . 10.0 113.488 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.63 -32.45 51.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.62 -50.58 65.39 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.067 0.937 . . . . 10.0 112.286 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.17 -45.98 83.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.105 0.962 . . . . 10.0 112.15 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.46 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.506 1.299 . . . . 10.0 114.506 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.46 -11.34 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.078 1.751 . . . . 10.0 114.238 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.57 29.14 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.85 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.456 1.598 . . . . 10.0 114.171 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.77 153.88 72.49 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.834 3.254 . . . . 10.0 105.57 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.8 -46.21 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.329 2.019 . . . . 10.0 113.083 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.03 68.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.985 2.914 . . . . 10.0 113.27 173.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.19 -53.03 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.78 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.26 23.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.12 -53.23 60.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.164 0.986 . . . . 10.0 113.028 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.54 46.07 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.337 0.655 . . . . 10.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.06 -48.46 78.5 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.02 -49.61 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.767 0.712 . . . . 10.0 110.487 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.48 -51.69 68.77 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.74 30.88 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.818 2.047 . . . . 10.0 111.065 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.81 0.444 . . . . 10.0 111.269 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.99 -47.42 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.046 0.938 . . . . 10.0 112.238 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.9 m -58.19 -64.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.953 2.501 . . . . 10.0 111.482 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.27 -48.64 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.845 1.258 . . . . 10.0 111.373 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.27 -61.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.863 0.865 . . . . 10.0 112.606 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.19 -47.06 79.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.754 0.706 . . . . 10.0 111.934 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -50.11 -54.29 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.645 1.178 . . . . 10.0 112.149 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 m . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 124.509 1.123 . . . . 10.0 113.588 179.731 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.4 -56.63 19.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.544 1.138 . . . . 10.0 112.404 167.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.4 tt -57.59 -40.46 79.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.755 0.822 . . . . 10.0 112.355 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.18 -5.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 115.2 1.555 . . . . 10.0 115.2 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.35 32.95 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.573 1.096 . . . . 10.0 113.895 -168.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.93 65.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.176 -1.012 . . . . 10.0 111.88 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.88 -13.45 62.43 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.75 -106.13 0.98 Allowed Glycine 0 CA--C 1.535 1.311 0 CA-C-N 120.606 1.548 . . . . 10.0 114.45 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.12 35.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.595 -1.533 . . . . 10.0 109.368 168.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.904 0.321 . . . . 10.0 113.904 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.64 -42.7 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.687 166.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.34 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.382 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.69 153.79 72.59 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.774 2.983 . . . . 10.0 111.476 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.8 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.38 1.072 . . . . 10.0 112.169 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -52.34 22.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.49 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.695 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.35 -49.78 42.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.515 0.598 . . . . 10.0 111.925 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.38 -52.26 62.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.923 0.889 . . . . 10.0 112.124 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.6 -58.82 5.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.319 1.048 . . . . 10.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -52.55 -46.14 66.68 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 117.629 -1.176 . . . . 10.0 112.506 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.01 -51.89 60.21 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.55 1.523 . . . . 10.0 112.789 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.68 -47.0 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.81 1.244 . . . . 10.0 111.598 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.73 -50.04 75.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 10.0 111.795 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -57.15 -57.4 12.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.879 2.072 . . . . 10.0 111.508 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.479 0.985 0 O-C-N 120.887 -1.133 . . . . 10.0 111.917 178.92 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.283 0 CA-C-O 121.129 0.294 . . . . 10.0 112.904 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -43.09 -56.91 3.14 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.999 2.12 . . . . 10.0 112.266 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.7 -40.43 71.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.303 0.954 . . . . 10.0 114.186 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -69.75 -27.32 64.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 115.882 1.808 . . . . 10.0 115.882 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -57.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.593 -0.892 . . . . 10.0 108.593 165.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.76 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.898 . . . . 10.0 113.193 -172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.17 2.53 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.23 0.3 15.74 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.22 1.008 . . . . 10.0 113.344 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.046 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.61 98.12 1.83 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.826 0.85 . . . . 10.0 110.941 170.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 77.04 7.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.824 0.85 . . . . 10.0 112.067 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.838 2.855 . . . . 10.0 116.491 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.738 1.215 . . . . 10.0 110.656 -175.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.44 39.92 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.757 3.551 . . . . 10.0 119.665 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.487 2.715 . . . . 10.0 113.44 166.597 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.75 -2.072 . . . . 10.0 105.863 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.62 65.01 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.252 2.621 . . . . 10.0 114.537 155.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.97 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.344 1.857 . . . . 10.0 113.339 -158.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.08 2.8 41.62 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.489 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.653 -168.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.92 -60.7 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.522 2.293 . . . . 10.0 113.196 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.19 4.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.726 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.29 -43.14 61.56 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.515 -0.741 . . . . 10.0 112.619 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.59 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.331 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.43 -52.63 62.96 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.455 0.702 . . . . 10.0 111.882 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.341 1.456 . . . . 10.0 113.315 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.12 -55.44 15.52 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.501 1.048 . . . . 10.0 111.801 166.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -50.26 -52.48 35.85 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.834 1.253 . . . . 10.0 112.284 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.87 5.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.16 0.984 . . . . 10.0 112.167 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.1 -48.86 77.57 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.615 0.766 . . . . 10.0 112.858 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -61.59 -43.94 97.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.649 0.78 . . . . 10.0 111.531 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.59 -58.75 12.93 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.145 0.879 . . . . 10.0 113.785 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -45.99 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.605 1.202 . . . . 10.0 112.119 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.08 -42.88 72.68 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.028 1.299 . . . . 10.0 113.132 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -62.1 -58.23 8.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.285 -0.864 . . . . 10.0 111.489 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.33 -40.99 62.62 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.041 0.936 . . . . 10.0 110.937 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.02 9.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.636 1.175 . . . . 10.0 112.968 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.71 82.15 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.45 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.632 1.173 . . . . 10.0 113.633 169.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.743 1.735 . . . . 10.0 110.88 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.9 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.839 2.455 . . . . 10.0 109.358 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.94 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.02 93.01 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.196 2.198 . . . . 10.0 113.546 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.39 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.437 2.695 . . . . 10.0 116.948 166.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.8 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.18 -1.373 . . . . 10.0 113.868 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.51 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.769 1.293 . . . . 10.0 110.981 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.55 -29.67 89.57 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.706 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.28 -60.69 2.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.111 0.565 . . . . 10.0 111.437 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.1 22.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.1 1.36 . . . . 10.0 113.549 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.44 19.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.199 1.4 . . . . 10.0 113.446 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.71 -53.07 62.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.48 0.712 . . . . 10.0 110.967 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.0 -50.22 73.37 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.297 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.2 65.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.34 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.99 1.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.8 mt -48.53 -57.93 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.865 1.266 . . . . 10.0 110.332 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -67.92 -19.03 64.95 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.105 1.362 . . . . 10.0 113.703 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -86.0 -40.87 15.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.45 1.1 . . . . 10.0 112.22 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.8 mt -59.17 -42.61 91.21 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.915 0.78 . . . . 10.0 112.921 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.9 t -44.03 -61.19 2.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.67 1.588 . . . . 10.0 113.154 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -70.74 -25.42 24.09 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.895 2.396 . . . . 10.0 114.041 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.11 -50.13 67.26 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 120.732 1.605 . . . . 10.0 113.795 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.28 -39.05 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 120.329 -1.482 . . . . 10.0 110.735 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.26 81.18 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 118.54 -0.743 . . . . 10.0 112.96 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -50.58 -55.71 15.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.581 1.553 . . . . 10.0 111.755 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.08 -53.19 21.58 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.363 1.465 . . . . 10.0 110.867 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.35 -48.19 65.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.102 0.961 . . . . 10.0 113.011 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.4 -41.1 75.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.241 1.382 . . . . 10.0 113.222 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.53 35.06 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.656 1.116 . . . . 10.0 111.313 170.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.15 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.9 mtm -66.78 -50.88 61.25 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.565 0.746 . . . . 10.0 110.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.54 -52.71 21.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 10.0 112.925 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.58 49.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.27 -34.66 5.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 115.542 0.977 . . . . 10.0 115.542 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.12 43.3 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.56 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.081 2.153 . . . . 10.0 109.056 171.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.062 166.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.883 0.873 . . . . 10.0 109.723 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.3 t -129.61 129.6 23.17 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.037 1.335 . . . . 10.0 110.927 -176.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.78 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -81.96 0.15 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.697 -0.961 . . . . 10.0 110.697 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.91 4.07 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.317 1.558 . . . . 10.0 112.27 -165.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.47 1.508 . . . . 10.0 111.107 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.46 120.76 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.52 131.92 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.198 3.265 . . . . 10.0 112.137 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.03 1.732 . . . . 10.0 111.69 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.04 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.865 1.317 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.4 -28.28 66.77 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.77 -26.47 46.07 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.296 1.038 . . . . 10.0 111.165 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -44.08 -63.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.374 1.47 . . . . 10.0 110.146 165.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -63.62 -39.73 95.1 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.223 2.209 . . . . 10.0 111.119 -172.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.26 -49.03 67.76 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.733 0.813 . . . . 10.0 112.024 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -63.67 1.21 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.96 1.304 . . . . 10.0 111.64 170.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -53.7 -36.95 62.75 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.805 1.642 . . . . 10.0 112.72 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.69 -42.17 56.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.036 1.734 . . . . 10.0 112.226 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -103.68 -35.29 8.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.932 0.716 . . . . 10.0 112.932 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.5 p -62.17 -49.04 77.42 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 121.387 1.903 . . . . 10.0 113.483 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.284 69.9 p -63.54 -41.73 68.4 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 114.722 1.379 . . . . 10.0 114.722 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.8 -43.24 51.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.481 2.787 . . . . 10.0 115.265 168.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 mt -60.62 -46.9 88.53 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.491 -0.756 . . . . 10.0 111.515 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.68 -49.83 56.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.646 1.578 . . . . 10.0 111.359 171.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.65 -47.46 79.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.247 1.019 . . . . 10.0 113.046 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.854 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.31 -54.01 36.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.173 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.11 88.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.69 0.796 . . . . 10.0 112.068 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.69 -54.75 37.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 111.974 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.725 0.81 . . . . 10.0 112.704 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.82 -38.56 91.57 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.78 1.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.062 1.345 . . . . 10.0 112.337 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.49 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.88 47.66 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.454 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.84 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.714 0.635 . . . . 10.0 112.714 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.8 -39.68 2.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.24 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.131 1.348 . . . . 10.0 115.235 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.06 -46.77 87.69 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.13 -1.414 . . . . 10.0 111.312 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.5 -52.91 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.029 1.332 . . . . 10.0 111.101 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.27 67.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.23 -44.85 43.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.424 0.69 . . . . 10.0 110.924 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.55 -59.88 4.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.419 2.288 . . . . 10.0 114.815 174.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.08 -46.29 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.667 0.787 . . . . 10.0 111.385 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.67 74.42 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 173.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.0 -45.99 82.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.851 0.86 . . . . 10.0 111.994 174.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -55.38 5.49 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.362 1.458 . . . . 10.0 113.142 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.73 -50.15 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.902 0.881 . . . . 10.0 111.74 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -50.99 -57.13 9.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.589 1.556 . . . . 10.0 111.873 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 123.121 0.568 . . . . 10.0 112.488 174.795 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 111.764 0.283 . . . . 10.0 111.764 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.55 -58.99 9.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.085 1.803 . . . . 10.0 112.338 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.49 -43.48 2.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.251 2.62 . . . . 10.0 113.294 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.3 mt -101.2 -6.4 24.3 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.423 1.638 . . . . 10.0 115.423 -174.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.67 116.73 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.165 -1.584 . . . . 10.0 110.419 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.59 72.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.217 2.607 . . . . 10.0 113.269 177.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.61 106.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.09 15.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 10.0 113.468 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.66 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -53.84 -41.91 67.92 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.902 0.774 . . . . 10.0 110.806 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.21 -32.57 71.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.817 1.247 . . . . 10.0 114.198 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.91 -52.12 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.022 0.828 . . . . 10.0 109.991 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -59.45 -51.76 68.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.491 0.922 . . . . 10.0 113.491 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.38 -46.59 37.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.428 1.091 . . . . 10.0 113.427 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.38 -52.55 65.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.945 0.898 . . . . 10.0 111.659 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.4 mt -54.07 -50.98 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.126 1.37 . . . . 10.0 111.49 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 m -53.84 -49.19 68.96 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.479 1.112 . . . . 10.0 112.108 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 76.5 m -61.34 -43.34 99.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.992 1.317 . . . . 10.0 111.618 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.45 -50.16 73.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.14 0.976 . . . . 10.0 112.477 170.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.87 82.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.736 0.814 . . . . 10.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.1 ttp -57.94 -53.13 61.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.496 1.118 . . . . 10.0 111.953 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -51.92 -50.01 61.95 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.772 1.629 . . . . 10.0 111.398 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -49.51 -54.89 15.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.06 0.944 . . . . 10.0 112.436 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -53.4 -55.29 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.829 0.852 . . . . 10.0 110.729 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.5 mt -57.49 -35.65 70.48 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.283 -0.865 . . . . 10.0 112.91 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.18 9.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.89 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.5 mt -56.77 -49.45 75.27 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.845 1.202 . . . . 10.0 112.099 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.877 -175.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.65 -21.99 60.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.635 1.174 . . . . 10.0 113.446 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.625 0.631 . . . . 10.0 113.527 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.55 -32.52 51.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.322 1.849 . . . . 10.0 113.019 -166.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.11 -56.4 14.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.56 65.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.121 0.962 . . . . 10.0 112.331 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.07 82.87 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.188 0.995 . . . . 10.0 112.134 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.77 -47.52 79.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.249 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.01 6.58 29.19 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.433 1.893 . . . . 10.0 114.907 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.65 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.535 1.636 . . . . 10.0 114.139 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.73 153.98 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.81 3.244 . . . . 10.0 105.572 170.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.85 -46.21 35.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.301 2.001 . . . . 10.0 113.052 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.96 -46.08 68.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.27 173.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.22 -53.05 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 C-N-CA 124.055 0.942 . . . . 10.0 109.788 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.86 75.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.275 0.63 . . . . 10.0 111.917 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.98 -56.13 25.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.88 0.872 . . . . 10.0 112.761 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.028 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.58 -49.52 46.19 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.337 0.655 . . . . 10.0 111.052 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.17 -48.4 78.82 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.636 1.347 . . . . 10.0 114.636 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.801 0.728 . . . . 10.0 110.506 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.164 0.801 . . . . 10.0 113.164 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.8 30.26 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.1 t -51.9 -49.1 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.044 0.937 . . . . 10.0 111.472 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.4 m -56.01 -63.95 1.01 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.62 2.768 . . . . 10.0 111.921 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.31 -49.51 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.488 1.115 . . . . 10.0 111.313 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.7 -62.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.172 0.989 . . . . 10.0 112.063 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.51 -47.17 85.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.974 0.806 . . . . 10.0 112.612 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -55.01 -50.31 69.35 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.683 0.793 . . . . 10.0 111.752 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.902 1.075 . . . . 10.0 113.902 179.256 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 119.43 -0.319 . . . . 10.0 111.596 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -56.39 -51.01 69.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.46 1.104 . . . . 10.0 112.53 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.2 tp -54.44 -45.53 73.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.59 1.156 . . . . 10.0 112.22 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -86.54 -5.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.15 1.537 . . . . 10.0 115.15 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.54 -169.29 32.79 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 122.602 1.112 . . . . 10.0 113.806 -168.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.75 65.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.868 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -67.29 -16.13 64.1 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.487 1.662 . . . . 10.0 115.487 -175.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.77 -105.99 1.04 Allowed Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.494 1.497 . . . . 10.0 114.104 -173.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.11 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.35 168.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 CA-C-N 117.878 0.308 . . . . 10.0 113.862 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.59 -42.73 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.73 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.1 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.416 1.886 . . . . 10.0 109.366 -174.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.79 153.79 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.19 -39.78 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.18 171.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.38 21.9 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.682 1.364 . . . . 10.0 114.682 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.27 -49.83 41.77 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.603 0.638 . . . . 10.0 111.991 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.66 -47.06 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.999 1.72 . . . . 10.0 113.026 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.32 -52.29 62.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.974 0.91 . . . . 10.0 112.093 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.61 -59.0 4.99 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 109.975 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.83 -44.65 66.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.793 -1.098 . . . . 10.0 112.657 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -54.16 -52.64 60.51 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.579 1.536 . . . . 10.0 112.689 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.2 t -60.86 -46.26 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.69 1.196 . . . . 10.0 111.353 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -59.15 -52.44 65.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.364 1.466 . . . . 10.0 112.122 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -55.46 -54.64 41.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.507 1.923 . . . . 10.0 111.062 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.478 0.945 0 O-C-N 121.071 -1.018 . . . . 10.0 111.635 174.07 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.267 0 CA-C-O 121.036 0.242 . . . . 10.0 112.758 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -43.47 -57.08 3.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.79 2.036 . . . . 10.0 112.488 166.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.98 -41.26 76.54 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.326 0.965 . . . . 10.0 113.993 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.79 -26.99 64.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.911 1.819 . . . . 10.0 115.911 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.5 -57.47 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.88 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.908 0.883 . . . . 10.0 113.187 -172.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.15 2.56 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.197 0.999 . . . . 10.0 113.296 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.05 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.983 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.13 1.82 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.771 0.828 . . . . 10.0 110.961 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 76.97 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.857 0.863 . . . . 10.0 112.094 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.862 2.865 . . . . 10.0 116.505 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.79 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.731 1.212 . . . . 10.0 110.698 -175.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.49 39.98 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.591 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.789 -2.053 . . . . 10.0 105.817 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.638 3.175 . . . . 10.0 117.211 160.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.69 65.0 0.11 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.306 2.642 . . . . 10.0 114.49 155.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.84 41.28 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.483 2.468 . . . . 10.0 111.523 168.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.667 -168.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -64.0 -60.6 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.519 2.292 . . . . 10.0 113.212 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.33 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.847 2.459 . . . . 10.0 115.787 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.46 -0.775 . . . . 10.0 112.619 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.57 84.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.859 0.863 . . . . 10.0 109.315 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.37 -52.66 62.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.426 0.69 . . . . 10.0 111.898 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.34 -53.64 55.84 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.221 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.81 51.95 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.366 1.466 . . . . 10.0 113.307 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -45.0 84.75 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 10.0 113.026 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.41 -56.69 10.41 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.526 1.06 . . . . 10.0 111.465 166.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -49.7 -52.48 30.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.836 1.255 . . . . 10.0 112.19 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 -58.9 5.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.174 0.99 . . . . 10.0 112.207 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.31 -48.46 78.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.577 0.751 . . . . 10.0 112.825 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.418 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 52.0 mtt -58.89 -47.46 84.88 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.223 1.009 . . . . 10.0 111.523 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.85 -58.76 12.88 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.267 0.937 . . . . 10.0 113.66 174.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.18 -46.06 79.52 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.728 1.264 . . . . 10.0 112.1 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.33 75.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.76 1.172 . . . . 10.0 113.244 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -61.93 -58.49 7.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.742 0.817 . . . . 10.0 111.419 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.97 62.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.8 -58.07 9.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.986 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.63 81.86 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.236 0.828 . . . . 10.0 113.236 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.46 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.654 1.182 . . . . 10.0 113.581 169.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.44 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.781 1.753 . . . . 10.0 110.846 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.83 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.906 2.483 . . . . 10.0 109.366 171.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.98 93.05 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.143 2.177 . . . . 10.0 113.584 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.37 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.387 2.675 . . . . 10.0 116.975 166.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.65 -50.87 10.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.891 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.94 117.59 6.51 Favored Pre-proline 0 CA--C 1.536 0.432 0 O-C-N 124.741 1.275 . . . . 10.0 110.916 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.67 -29.6 89.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.695 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.04 22.82 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.114 1.366 . . . . 10.0 113.551 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.6 -47.44 19.94 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.242 1.417 . . . . 10.0 113.384 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.08 62.22 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.535 0.734 . . . . 10.0 110.935 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.02 -50.21 73.43 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.115 0.566 . . . . 10.0 112.348 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.26 65.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.903 -0.57 . . . . 10.0 112.378 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.01 1.91 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.412 0.893 . . . . 10.0 113.412 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.53 -58.07 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.918 1.287 . . . . 10.0 110.121 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 m -68.16 -16.99 64.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.297 1.439 . . . . 10.0 113.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -88.35 -39.78 14.08 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.571 1.078 . . . . 10.0 112.146 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -59.8 -42.18 92.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.939 0.791 . . . . 10.0 112.372 170.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -41.44 -60.7 1.69 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 126.094 1.758 . . . . 10.0 113.807 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.98 -25.67 16.07 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.158 2.572 . . . . 10.0 114.372 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.7 -45.07 84.2 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.674 1.579 . . . . 10.0 113.502 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -54.02 -52.81 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.01 0.924 . . . . 10.0 109.447 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.418 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -54.19 -45.9 72.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.465 1.106 . . . . 10.0 113.428 177.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -51.1 -57.58 8.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.058 1.343 . . . . 10.0 112.15 171.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 m -49.36 -52.63 26.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.302 1.441 . . . . 10.0 110.699 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.5 mmt -69.14 -48.13 63.2 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.895 0.878 . . . . 10.0 113.044 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -57.09 -39.95 76.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.927 -1.511 . . . . 10.0 113.218 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.35 -54.56 34.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.266 1.394 . . . . 10.0 111.281 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.64 -41.13 61.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.197 1.555 . . . . 10.0 115.197 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.85 -50.78 61.47 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.545 0.738 . . . . 10.0 110.511 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.64 -52.67 21.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.864 0.865 . . . . 10.0 112.908 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.91 -5.54 48.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.343 1.057 . . . . 10.0 113.835 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.544 0.978 . . . . 10.0 115.544 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.246 1.572 . . . . 10.0 115.246 -175.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.57 61.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.39 26.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.049 2.14 . . . . 10.0 109.041 171.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.1 15.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.004 166.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.02 53.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.703 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.52 129.6 23.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 125.048 1.339 . . . . 10.0 110.995 -176.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.74 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.469 -1.012 . . . . 10.0 109.469 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.48 38.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.31 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.735 -0.946 . . . . 10.0 110.735 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.83 -3.35 0.69 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 118.656 2.223 . . . . 10.0 118.656 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.317 1.559 . . . . 10.0 112.21 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.85 9.04 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.491 1.516 . . . . 10.0 111.137 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.54 131.95 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.23 3.287 . . . . 10.0 112.145 171.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.35 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.043 1.737 . . . . 10.0 111.66 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.65 85.01 4.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.295 1.521 . . . . 10.0 113.037 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.587 -1.321 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.19 -35.99 62.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.998 1.11 . . . . 10.0 113.998 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.417 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.5 ptp180 -64.4 -23.32 67.25 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.589 -1.319 . . . . 10.0 114.169 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -77.69 -42.77 33.34 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.148 -0.97 . . . . 10.0 111.763 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.95 44.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.355 1.462 . . . . 10.0 111.726 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -51.8 -71.88 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.551 1.941 . . . . 10.0 111.805 169.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.417 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.0 m0 -56.48 -31.96 64.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 117.507 -1.235 . . . . 10.0 113.536 -172.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 tp -48.59 -45.56 38.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.004 1.722 . . . . 10.0 112.077 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.91 -43.78 6.59 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.059 0.944 . . . . 10.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.0 m -51.45 -48.86 62.63 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.58 1.552 . . . . 10.0 113.444 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 41.5 p -69.41 -46.62 27.48 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.57 1.322 . . . . 10.0 114.57 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.53 -42.41 49.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.143 2.562 . . . . 10.0 115.185 169.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.41 -48.36 81.92 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.555 -0.716 . . . . 10.0 112.245 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -36.55 82.52 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.523 1.056 . . . . 10.0 112.555 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.66 -49.03 76.25 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.097 -1.002 . . . . 10.0 111.674 165.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.82 -38.25 78.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.823 0.849 . . . . 10.0 112.874 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -52.36 -53.97 37.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.298 0.954 . . . . 10.0 111.173 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.676 0.79 . . . . 10.0 112.131 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.72 38.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.94 0.896 . . . . 10.0 112.039 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.22 79.25 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.778 0.831 . . . . 10.0 112.692 174.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.75 -38.6 91.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.399 1.259 . . . . 10.0 114.399 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.81 1.37 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.236 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.55 11.94 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.33 145.89 47.49 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.95 -1.719 . . . . 10.0 112.458 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.9 54.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.8 -39.72 2.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.316 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.44 -52.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.088 1.355 . . . . 10.0 111.101 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.26 67.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.543 0.571 . . . . 10.0 112.543 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.441 0.696 . . . . 10.0 110.943 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.8 4.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.849 174.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.12 -46.31 96.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.706 0.802 . . . . 10.0 111.374 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.31 64.04 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.701 0.667 . . . . 10.0 112.624 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.36 75.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.358 0.873 . . . . 10.0 113.358 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -53.22 -51.41 62.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.699 1.2 . . . . 10.0 110.641 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.42 -54.29 4.78 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.092 1.329 . . . . 10.0 113.276 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.53 -54.76 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 118.068 -0.968 . . . . 10.0 112.395 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . 0.309 3.1 ppp? -61.45 -42.64 99.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.605 1.548 . . . . 10.0 113.552 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.0 mm . . . . . 0 N--CA 1.477 0.913 0 CA-C-N 120.214 1.37 . . . . 10.0 111.702 170.393 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 111.701 0.26 . . . . 10.0 111.701 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.18 -58.69 11.07 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.058 1.79 . . . . 10.0 112.379 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.57 -43.4 2.71 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.209 2.604 . . . . 10.0 113.304 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.9 mt -101.19 -6.41 24.29 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.485 1.661 . . . . 10.0 115.485 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.75 10.47 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.165 -1.584 . . . . 10.0 110.366 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.61 72.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.248 2.619 . . . . 10.0 113.275 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.69 106.34 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.79 0.836 . . . . 10.0 110.05 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.82 -59.63 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.051 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.42 -42.11 14.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.513 1.525 . . . . 10.0 113.496 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.63 63.2 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.19 -41.58 68.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.855 0.752 . . . . 10.0 110.826 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.21 -32.64 72.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.771 1.228 . . . . 10.0 114.216 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.79 -51.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.073 0.851 . . . . 10.0 109.638 169.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -62.33 -46.23 89.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -52.22 -47.68 65.54 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.088 0.955 . . . . 10.0 112.686 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.37 -53.88 53.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.099 0.96 . . . . 10.0 111.804 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.13 -53.16 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.905 1.282 . . . . 10.0 111.509 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.1 t -53.34 -51.31 62.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.343 1.457 . . . . 10.0 111.908 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.9 m -61.0 -42.97 99.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.459 1.504 . . . . 10.0 112.401 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.78 -51.74 68.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.407 1.003 . . . . 10.0 112.452 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.79 77.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.925 0.89 . . . . 10.0 112.89 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 32.5 ttp -60.7 -50.67 72.55 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.062 -1.023 . . . . 10.0 112.403 169.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.1 -47.51 71.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.632 1.573 . . . . 10.0 111.626 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -47.07 -54.37 10.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 10.0 112.261 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.2 mt -53.43 -55.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.814 0.846 . . . . 10.0 110.692 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -57.04 -36.15 70.13 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.121 0.785 . . . . 10.0 113.121 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.25 -58.2 9.25 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.077 0.951 . . . . 10.0 113.017 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.278 -0.867 . . . . 10.0 111.44 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.78 -49.44 75.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.897 1.226 . . . . 10.0 112.106 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.38 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.856 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.65 -21.93 60.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.607 1.163 . . . . 10.0 113.467 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.11 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.629 0.633 . . . . 10.0 113.548 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.44 51.0 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.262 1.825 . . . . 10.0 113.067 -166.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.02 1.118 . . . . 10.0 114.02 172.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.74 -50.45 65.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.05 0.929 . . . . 10.0 112.285 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.21 -46.01 83.28 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.181 0.993 . . . . 10.0 112.088 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.47 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.078 1.751 . . . . 10.0 114.268 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.6 29.1 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.428 1.891 . . . . 10.0 114.907 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.59 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.536 1.636 . . . . 10.0 114.195 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.77 -46.28 34.7 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.308 2.005 . . . . 10.0 113.066 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.03 67.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.968 2.907 . . . . 10.0 113.33 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.23 -53.03 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.086 0.954 . . . . 10.0 109.794 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.254 0.622 . . . . 10.0 111.926 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -60.03 -56.15 25.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.919 0.887 . . . . 10.0 112.709 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 10.0 113.036 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.52 46.16 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.284 0.634 . . . . 10.0 111.068 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.11 -48.4 78.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.04 -49.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.791 0.723 . . . . 10.0 110.428 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.56 -51.65 68.98 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.76 30.28 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.817 2.047 . . . . 10.0 111.044 174.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.53 -58.26 9.34 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.757 0.423 . . . . 10.0 111.314 174.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.09 -45.01 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.054 0.942 . . . . 10.0 111.504 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -56.74 -67.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.281 2.633 . . . . 10.0 110.918 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.92 -48.15 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.005 1.322 . . . . 10.0 110.915 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -62.11 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.755 0.822 . . . . 10.0 112.484 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.75 -48.08 80.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.211 0.914 . . . . 10.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -51.75 -51.08 58.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.301 1.04 . . . . 10.0 112.193 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 113.793 1.034 . . . . 10.0 113.793 178.908 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.479 1.013 0 CA-C-O 119.308 -0.377 . . . . 10.0 111.445 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.2 t90 -55.47 -51.81 65.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.287 1.035 . . . . 10.0 112.501 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 35.5 tp -54.04 -45.22 71.54 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.77 1.228 . . . . 10.0 112.281 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.49 -4.98 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.17 1.545 . . . . 10.0 115.17 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.3 32.95 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.576 1.098 . . . . 10.0 113.886 -168.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.871 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.66 -17.08 64.47 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.661 1.726 . . . . 10.0 115.661 -175.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.32 -106.07 1.14 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.339 1.427 . . . . 10.0 113.714 -172.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.637 -1.508 . . . . 10.0 109.353 168.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 113.905 0.322 . . . . 10.0 113.905 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.771 166.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.7 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.366 -174.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -68.82 153.84 72.19 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.752 2.968 . . . . 10.0 111.424 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.81 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.329 1.052 . . . . 10.0 112.221 171.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.31 -52.4 21.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.95 -40.47 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.646 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.29 -49.85 41.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.586 0.63 . . . . 10.0 111.964 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.08 83.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.092 1.757 . . . . 10.0 112.983 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.3 -52.32 62.44 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.931 0.892 . . . . 10.0 112.141 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.59 -59.29 4.64 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.362 1.065 . . . . 10.0 109.944 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -52.9 -46.54 68.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.417 -1.278 . . . . 10.0 112.241 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -51.36 -53.38 36.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.687 1.585 . . . . 10.0 112.723 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.12 -49.68 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.202 1.401 . . . . 10.0 111.562 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -56.17 -50.9 69.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.141 1.376 . . . . 10.0 111.458 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -57.06 -62.66 1.6 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.195 1.798 . . . . 10.0 110.954 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.482 1.162 0 CA-C-N 120.49 1.495 . . . . 10.0 112.793 -178.343 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.333 0 CA-C-O 121.309 0.394 . . . . 10.0 113.228 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -54.73 -57.04 13.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.192 1.797 . . . . 10.0 112.656 172.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -53.02 -37.16 53.42 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.063 0.839 . . . . 10.0 113.596 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.58 -28.01 65.6 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 115.989 1.848 . . . . 10.0 115.989 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.62 -57.49 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 119.319 0.963 . . . . 10.0 108.445 165.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.848 0.859 . . . . 10.0 113.186 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.317 1.599 . . . . 10.0 115.317 -171.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.141 0.976 . . . . 10.0 113.292 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.049 0.94 . . . . 10.0 111.019 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.744 0.818 . . . . 10.0 110.957 170.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.0 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.896 0.879 . . . . 10.0 112.1 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.461 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.82 -55.45 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.731 1.212 . . . . 10.0 110.686 -175.278 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.44 40.12 Favored Glycine 0 C--O 1.239 0.451 0 C-N-CA 129.755 3.55 . . . . 10.0 119.677 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.484 2.714 . . . . 10.0 113.438 166.603 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.822 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.29 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.576 3.15 . . . . 10.0 117.276 160.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.67 65.05 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.331 2.652 . . . . 10.0 114.448 155.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.03 2.79 41.14 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.44 2.447 . . . . 10.0 111.488 168.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.684 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.477 2.277 . . . . 10.0 113.201 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.14 4.32 0.94 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.736 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.473 -0.767 . . . . 10.0 112.619 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.6 83.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.887 0.875 . . . . 10.0 109.3 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.43 -52.56 63.19 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 123.399 0.68 . . . . 10.0 111.882 175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.41 -53.59 56.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.141 0.576 . . . . 10.0 112.247 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.85 -46.83 51.74 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.381 1.472 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -44.93 84.98 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.88 -56.2 12.58 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.346 0.974 . . . . 10.0 111.567 166.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.4 m -49.8 -52.47 31.93 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.844 1.257 . . . . 10.0 112.209 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.177 0.991 . . . . 10.0 112.139 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.31 -48.56 78.64 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.663 0.785 . . . . 10.0 112.809 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.417 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 46.8 mtt -59.22 -46.62 87.97 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.293 1.037 . . . . 10.0 111.606 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.49 -58.6 13.69 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.232 0.92 . . . . 10.0 113.735 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -46.12 79.6 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.64 1.22 . . . . 10.0 112.127 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.56 -41.74 74.3 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.755 1.169 . . . . 10.0 113.242 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.8 m -63.12 -57.83 9.26 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 118.297 -0.859 . . . . 10.0 111.412 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.49 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.81 -57.99 9.73 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.571 1.148 . . . . 10.0 112.973 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.05 -67.5 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.662 1.185 . . . . 10.0 113.611 169.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.756 1.741 . . . . 10.0 110.866 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.863 2.465 . . . . 10.0 109.319 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.93 93.06 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.143 2.177 . . . . 10.0 113.619 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.73 -84.38 1.19 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.732 0.682 . . . . 10.0 112.477 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.404 2.681 . . . . 10.0 116.922 166.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.66 -50.84 10.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.902 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.53 6.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.737 1.273 . . . . 10.0 110.967 -172.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.59 -29.63 89.61 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.724 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.05 22.52 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.106 1.362 . . . . 10.0 113.551 171.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.58 -47.4 19.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.231 1.413 . . . . 10.0 113.441 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.09 62.12 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.513 0.725 . . . . 10.0 110.939 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.1 m-85 -56.97 -50.21 73.35 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.044 0.538 . . . . 10.0 112.334 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.38 -51.27 65.36 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.356 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.384 0.883 . . . . 10.0 113.384 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.55 -58.11 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.914 1.286 . . . . 10.0 110.228 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -68.09 -18.03 64.54 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.119 1.368 . . . . 10.0 113.745 -172.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.7 m -86.6 -40.36 15.24 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.397 1.079 . . . . 10.0 112.059 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.3 mt -60.37 -41.55 93.95 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.387 -0.82 . . . . 10.0 112.525 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.8 t -41.2 -60.45 1.74 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.719 1.607 . . . . 10.0 113.769 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.95 -26.72 10.76 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.721 2.947 . . . . 10.0 114.262 174.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.85 97.72 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 120.938 1.699 . . . . 10.0 113.01 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.7 mt -52.12 -54.86 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.14 1.376 . . . . 10.0 109.345 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -55.77 -45.21 78.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.629 1.171 . . . . 10.0 113.131 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -51.43 -57.3 9.37 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 120.422 1.465 . . . . 10.0 112.209 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -50.15 -52.4 35.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.164 1.386 . . . . 10.0 110.434 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.15 -48.02 63.44 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.805 0.842 . . . . 10.0 113.089 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.16 -40.08 76.56 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 116.845 -1.55 . . . . 10.0 113.085 173.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.407 1.458 . . . . 10.0 111.281 170.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.65 -41.06 61.05 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.7 mtm -66.88 -50.85 61.16 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.484 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.54 -52.69 21.4 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.826 0.851 . . . . 10.0 112.975 172.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.5 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.857 1.058 . . . . 10.0 113.857 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.09 43.02 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.252 1.575 . . . . 10.0 115.252 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.55 61.04 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.332 0.893 . . . . 10.0 115.332 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.43 26.41 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.042 2.137 . . . . 10.0 108.957 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.49 171.14 15.08 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.053 0.941 . . . . 10.0 111.0 166.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.06 136.0 53.43 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.9 0.88 . . . . 10.0 109.691 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.52 129.6 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.039 1.336 . . . . 10.0 110.959 -176.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.36 38.21 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.826 0.676 . . . . 10.0 112.826 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -82.0 0.15 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.652 -0.979 . . . . 10.0 110.652 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.41 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.6 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.338 1.569 . . . . 10.0 112.217 -165.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.91 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.46 1.504 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.45 120.76 69.66 Favored Pre-proline 0 N--CA 1.451 -0.393 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.6 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.36 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.046 1.738 . . . . 10.0 111.71 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.69 85.05 4.74 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 123.058 1.409 . . . . 10.0 113.037 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.864 -1.147 . . . . 10.0 113.951 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.61 -29.82 52.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.292 1.037 . . . . 10.0 113.147 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.0 mtt-85 -50.68 -55.51 16.2 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.858 0.863 . . . . 10.0 111.515 169.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -64.02 -39.11 93.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.69 1.596 . . . . 10.0 112.182 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.88 -49.69 65.36 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 124.48 1.112 . . . . 10.0 110.916 166.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -61.96 2.23 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.18 1.792 . . . . 10.0 112.764 174.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -53.65 -38.12 63.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.368 2.267 . . . . 10.0 113.177 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.5 tp -51.46 -44.01 62.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.493 1.517 . . . . 10.0 112.183 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -99.4 -47.99 4.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 113.254 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.0 t -60.02 -37.6 80.24 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.454 -0.779 . . . . 10.0 113.058 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 4.5 m -68.38 -48.55 34.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 120.753 -1.217 . . . . 10.0 112.638 -176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 82.6 Cg_exo -49.62 -42.9 41.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.585 2.856 . . . . 10.0 115.278 164.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.58 -49.28 78.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.889 0.768 . . . . 10.0 112.076 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tt -53.01 -44.68 67.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.678 1.191 . . . . 10.0 112.679 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.62 -47.71 81.43 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.038 -1.039 . . . . 10.0 112.413 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.838 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.3 -54.04 36.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.298 0.954 . . . . 10.0 111.187 169.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.1 88.63 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.656 0.782 . . . . 10.0 112.099 -178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.69 38.43 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.94 0.896 . . . . 10.0 112.078 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.16 79.38 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.704 0.801 . . . . 10.0 112.731 174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.71 -38.59 91.68 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.47 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.065 1.346 . . . . 10.0 112.313 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.56 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.829 1.652 . . . . 10.0 112.113 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.981 -1.699 . . . . 10.0 112.458 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.92 54.27 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.67 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.888 1.675 . . . . 10.0 113.465 175.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.26 5.29 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.139 1.352 . . . . 10.0 115.26 169.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.01 -46.74 87.86 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.158 -1.401 . . . . 10.0 111.354 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.97 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.087 1.355 . . . . 10.0 111.072 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.57 -51.33 67.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.16 -44.82 43.16 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.424 0.689 . . . . 10.0 110.985 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.399 2.28 . . . . 10.0 114.849 174.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.07 -46.35 96.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 123.725 0.81 . . . . 10.0 111.349 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.31 64.02 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.659 0.647 . . . . 10.0 112.624 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.27 74.91 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.13 -45.32 87.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.583 0.753 . . . . 10.0 111.946 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.55 -56.47 4.87 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.455 1.502 . . . . 10.0 113.037 167.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 83.6 mt -56.45 -55.99 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.757 0.823 . . . . 10.0 110.322 173.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -48.98 -56.71 8.07 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.609 1.095 . . . . 10.0 113.115 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.3 mm -68.86 -46.42 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.116 0.566 . . . . 10.0 112.203 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.65 -44.71 79.46 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.388 0.994 . . . . 10.0 113.075 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.9 m -61.52 -44.21 97.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.404 1.482 . . . . 10.0 111.159 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.06 -51.42 19.58 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.244 0.925 . . . . 10.0 113.185 165.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.57 -50.19 66.1 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 127.931 2.492 . . . . 10.0 111.096 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t -59.65 -50.34 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 125.449 1.5 . . . . 10.0 112.033 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.98 -59.46 8.72 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.704 1.621 . . . . 10.0 112.096 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.79 -37.76 20.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.209 2.204 . . . . 10.0 113.434 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.7 -6.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.398 1.629 . . . . 10.0 115.398 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.67 116.72 10.4 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.207 -1.558 . . . . 10.0 110.356 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.248 2.619 . . . . 10.0 113.289 177.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.65 106.3 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.816 0.847 . . . . 10.0 110.128 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.764 1.226 . . . . 10.0 114.019 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.54 -42.01 15.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.458 1.503 . . . . 10.0 113.498 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.22 -24.59 63.13 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.897 1.443 . . . . 10.0 114.897 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.83 -41.87 67.86 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 118.901 0.773 . . . . 10.0 110.82 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.64 -31.88 70.23 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.854 1.262 . . . . 10.0 114.241 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.29 -52.26 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.152 0.887 . . . . 10.0 109.625 168.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -60.47 -45.24 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.827 1.047 . . . . 10.0 113.827 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.7 t90 -52.64 -49.54 64.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.713 1.142 . . . . 10.0 112.71 173.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -53.92 48.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.546 1.139 . . . . 10.0 111.915 176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.2 mt -54.62 -47.59 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.625 1.17 . . . . 10.0 111.481 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -57.57 -53.34 59.26 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.07 1.348 . . . . 10.0 112.394 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.6 t -67.82 -33.48 74.86 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.766 0.826 . . . . 10.0 112.308 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.63 73.34 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.258 0.935 . . . . 10.0 112.347 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.02 -42.55 80.62 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.468 -0.77 . . . . 10.0 112.535 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.65 -52.99 62.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.267 1.027 . . . . 10.0 111.913 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.77 -49.62 65.16 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.069 1.748 . . . . 10.0 111.665 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -49.5 -54.71 16.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.722 0.809 . . . . 10.0 112.184 171.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.0 mt -54.11 -54.87 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.592 0.757 . . . . 10.0 110.86 177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.35 -36.62 69.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.709 0.804 . . . . 10.0 113.07 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -57.24 -58.19 9.3 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.035 0.934 . . . . 10.0 113.059 173.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -40.96 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.373 -0.823 . . . . 10.0 111.468 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.76 -49.39 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.831 1.196 . . . . 10.0 112.169 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.26 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.075 -1.641 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.69 -21.98 60.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 10.0 113.477 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.588 0.614 . . . . 10.0 113.548 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.271 1.828 . . . . 10.0 113.067 -166.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.09 -56.44 14.4 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.032 1.123 . . . . 10.0 114.032 172.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.69 -50.58 65.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.115 0.959 . . . . 10.0 112.303 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.11 -46.02 82.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.136 0.975 . . . . 10.0 112.143 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.51 80.02 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.27 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.043 1.737 . . . . 10.0 114.235 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.477 1.911 . . . . 10.0 114.876 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.94 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.536 1.636 . . . . 10.0 114.171 -170.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.24 35.04 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.277 1.984 . . . . 10.0 113.079 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.1 67.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.288 173.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.14 -53.07 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.83 75.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.246 0.618 . . . . 10.0 111.905 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -59.99 -56.18 24.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.917 0.887 . . . . 10.0 112.709 174.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.211 1.004 . . . . 10.0 113.05 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.61 -49.44 46.85 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.253 0.621 . . . . 10.0 111.101 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.43 78.73 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.67 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.797 0.726 . . . . 10.0 110.487 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.57 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.83 30.13 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.86 2.064 . . . . 10.0 111.026 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.45 -58.36 8.85 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.796 0.438 . . . . 10.0 111.266 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.6 t -52.14 -46.64 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 124.112 0.965 . . . . 10.0 112.296 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.9 m -58.83 -64.85 0.79 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.971 2.509 . . . . 10.0 111.484 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.6 -49.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.928 1.291 . . . . 10.0 111.241 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.9 -64.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.844 0.858 . . . . 10.0 112.28 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.12 -43.02 81.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.037 0.835 . . . . 10.0 112.174 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -52.14 -54.29 32.43 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.128 0.971 . . . . 10.0 112.459 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.8 p -51.88 -33.13 35.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.029 1.122 . . . . 10.0 114.029 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.24 -43.44 94.92 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.92 1.082 . . . . 10.0 113.92 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -45.87 -57.35 8.17 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 115.151 1.537 . . . . 10.0 115.151 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.401 ' HB3' H183 ' A' ' 999' ' ' RET . 36.6 Cg_endo -61.09 -34.02 90.45 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.278 1.985 . . . . 10.0 113.01 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.1 t -64.02 -51.61 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.234 0.925 . . . . 10.0 110.821 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.1 t -53.55 -50.7 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 124.811 1.244 . . . . 10.0 111.315 175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -55.32 -52.34 63.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.894 1.277 . . . . 10.0 112.498 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 56.0 tp -53.16 -45.59 68.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.971 1.308 . . . . 10.0 112.449 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -88.15 -5.08 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 115.222 1.564 . . . . 10.0 115.222 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.47 -169.3 32.89 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-O 122.576 1.098 . . . . 10.0 113.873 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -40.85 64.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.828 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -54.94 -31.49 60.51 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 128.524 2.73 . . . . 10.0 115.154 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.62 -103.88 0.95 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 119.366 0.985 . . . . 10.0 113.623 -167.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.19 35.81 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.331 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.884 0.314 . . . . 10.0 113.884 173.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.64 -42.74 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.055 1.742 . . . . 10.0 108.716 166.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.27 133.38 24.9 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.448 1.899 . . . . 10.0 109.392 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.7 153.77 72.61 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 123.754 2.969 . . . . 10.0 111.468 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.38 21.89 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.93 -40.48 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.668 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.35 -49.77 42.87 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.517 0.599 . . . . 10.0 111.946 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.68 -47.08 83.31 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.07 1.748 . . . . 10.0 113.002 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -58.8 5.62 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.335 1.054 . . . . 10.0 109.989 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -53.42 -43.88 68.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.876 -1.059 . . . . 10.0 112.956 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -54.53 -52.55 61.68 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.3 1.409 . . . . 10.0 112.492 174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.18 -48.97 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.49 1.116 . . . . 10.0 110.939 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.0 mp -57.09 -53.53 57.03 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.747 1.619 . . . . 10.0 112.152 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -54.68 -56.04 23.33 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.065 1.746 . . . . 10.0 111.807 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 66.0 t -57.1 -47.44 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 121.398 -0.814 . . . . 10.0 111.264 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 46.1 m -55.95 -50.51 70.56 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.901 0.88 . . . . 10.0 112.042 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -71.75 -0.93 12.24 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.424 1.889 . . . . 10.0 114.315 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -130.14 -68.76 0.69 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.476 1.11 . . . . 10.0 111.671 -175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 25.6 t -68.85 -51.91 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.186 0.994 . . . . 10.0 110.253 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.52 -56.45 23.55 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 123.999 0.809 . . . . 10.0 112.866 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -43.4 -57.28 3.14 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.549 1.939 . . . . 10.0 112.687 167.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.56 -38.92 89.81 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.582 1.087 . . . . 10.0 113.642 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -69.47 -27.56 65.33 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 115.614 1.709 . . . . 10.0 115.614 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.5 mt -63.36 -57.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 165.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.87 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.877 0.871 . . . . 10.0 113.174 -172.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.61 5.23 2.54 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.28 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.89 4.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.113 0.965 . . . . 10.0 111.03 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.19 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.771 0.829 . . . . 10.0 110.957 170.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.94 77.05 7.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.874 0.87 . . . . 10.0 112.084 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.897 2.879 . . . . 10.0 116.462 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.81 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.75 1.22 . . . . 10.0 110.642 -175.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.72 3.533 . . . . 10.0 119.677 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.516 2.727 . . . . 10.0 113.457 166.652 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.498 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.87 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.569 3.148 . . . . 10.0 117.225 160.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 128.306 2.643 . . . . 10.0 114.448 155.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.45 137.93 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.41 1.884 . . . . 10.0 113.372 -158.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.015 -174.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.83 41.48 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.487 168.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.649 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.304 . . . . 10.0 113.21 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.28 4.34 0.99 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.732 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.507 -0.746 . . . . 10.0 112.625 176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.84 -49.64 83.76 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.892 0.877 . . . . 10.0 109.3 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.537 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.36 -52.66 62.8 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.379 0.672 . . . . 10.0 111.867 175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.1 mt -57.3 -53.62 56.04 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.224 0.61 . . . . 10.0 112.276 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.8 51.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.332 1.453 . . . . 10.0 113.335 173.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.95 84.75 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.289 1.435 . . . . 10.0 112.997 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.6 -56.54 11.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.526 1.06 . . . . 10.0 111.511 166.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.59 -52.51 29.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.904 1.282 . . . . 10.0 112.248 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.5 -58.81 6.01 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.172 0.989 . . . . 10.0 112.161 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt -57.47 -48.62 78.71 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 10.0 112.836 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.14 -49.09 78.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.008 0.923 . . . . 10.0 111.281 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.53 -58.66 13.26 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.273 0.939 . . . . 10.0 113.931 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.18 -45.63 79.68 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.748 1.274 . . . . 10.0 112.175 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.85 -39.87 88.81 Favored Glycine 0 CA--C 1.533 1.205 0 O-C-N 120.779 -1.2 . . . . 10.0 113.588 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.3 m -60.21 -60.71 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 10.0 110.801 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.06 9.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 112.972 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.61 -38.67 81.92 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.254 0.835 . . . . 10.0 113.254 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.621 1.168 . . . . 10.0 113.589 169.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.813 1.768 . . . . 10.0 110.859 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.04 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.628 1.011 . . . . 10.0 115.628 173.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.2 mmm -59.47 -45.05 92.73 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.4 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.743 0.687 . . . . 10.0 112.511 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.07 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.401 2.68 . . . . 10.0 116.959 166.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 m -79.68 -50.83 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.168 -1.378 . . . . 10.0 113.892 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.5 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.66 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.67 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.111 0.565 . . . . 10.0 111.476 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.06 22.84 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.078 1.351 . . . . 10.0 113.566 171.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.57 -47.41 19.74 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.455 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.78 -53.1 61.97 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.933 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.9 -50.27 73.04 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 123.107 0.563 . . . . 10.0 112.353 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.27 65.25 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.963 -0.541 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.99 1.93 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.85 -56.35 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.825 1.25 . . . . 10.0 110.736 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -69.81 -18.61 63.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.935 1.294 . . . . 10.0 113.498 -172.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.4 m -84.98 -42.52 14.83 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.478 1.111 . . . . 10.0 111.913 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.6 mt -57.49 -41.56 80.99 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.211 0.819 . . . . 10.0 113.211 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.4 t -50.17 -61.79 3.33 Favored Pre-proline 0 CA--C 1.55 0.975 0 CA-C-O 118.092 -0.956 . . . . 10.0 112.457 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -46.76 -47.27 16.43 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 124.627 3.551 . . . . 10.0 115.925 165.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.49 90.16 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.858 1.208 . . . . 10.0 113.811 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.25 -51.52 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.592 1.157 . . . . 10.0 109.326 171.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.24 76.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.093 0.957 . . . . 10.0 113.165 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -50.13 -56.23 11.79 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.681 1.592 . . . . 10.0 112.179 171.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.77 -52.82 29.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.3 1.44 . . . . 10.0 110.733 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.84 -48.13 64.27 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.976 0.91 . . . . 10.0 113.013 -176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -56.49 -40.75 75.47 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.195 1.362 . . . . 10.0 113.447 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.53 34.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.752 1.16 . . . . 10.0 111.292 170.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.14 61.12 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.174 1.546 . . . . 10.0 115.174 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.85 -50.82 61.34 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.594 0.758 . . . . 10.0 110.469 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.72 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.887 0.875 . . . . 10.0 112.92 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.86 -5.6 49.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 10.0 113.831 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.67 5.58 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.564 0.986 . . . . 10.0 115.564 174.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.01 43.5 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.53 61.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.339 0.896 . . . . 10.0 115.339 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.4 26.46 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.081 2.153 . . . . 10.0 109.031 171.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.711 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.64 129.62 23.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.028 1.331 . . . . 10.0 110.909 -176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.23 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.72 164.4 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.79 -3.28 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.669 2.228 . . . . 10.0 118.669 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.358 1.579 . . . . 10.0 112.194 -165.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.444 1.498 . . . . 10.0 111.081 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.45 120.78 69.66 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.651 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.5 131.91 38.22 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.184 3.256 . . . . 10.0 112.137 171.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.29 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.075 1.75 . . . . 10.0 111.763 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -93.63 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.063 1.411 . . . . 10.0 113.106 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.27 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.847 -1.158 . . . . 10.0 113.905 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.72 -26.61 35.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.271 1.029 . . . . 10.0 112.532 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.4 mtt-85 -55.08 -48.31 73.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.01 1.324 . . . . 10.0 112.927 169.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -71.2 -38.87 72.04 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.955 0.902 . . . . 10.0 111.122 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.39 -48.95 65.33 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.32 1.048 . . . . 10.0 112.228 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -54.85 -69.49 0.13 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.514 1.526 . . . . 10.0 111.558 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.1 m0 -55.27 -34.28 63.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.357 1.463 . . . . 10.0 112.503 -170.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.7 tp -48.82 -43.74 38.71 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.114 1.766 . . . . 10.0 112.141 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -101.9 -38.15 7.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.493 0.717 . . . . 10.0 112.764 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.7 p -64.72 -43.69 92.58 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.283 1.402 . . . . 10.0 113.92 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.277 74.8 p -65.04 -42.56 62.45 Favored Pre-proline 0 N--CA 1.478 0.929 0 N-CA-C 114.72 1.378 . . . . 10.0 114.72 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.89 -43.04 60.83 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.428 2.752 . . . . 10.0 115.247 167.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.23 -47.28 86.67 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.447 -0.783 . . . . 10.0 111.704 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.61 -50.01 55.15 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.414 1.485 . . . . 10.0 111.51 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mp -56.24 -47.52 78.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.111 0.965 . . . . 10.0 112.956 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.22 78.29 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.777 0.831 . . . . 10.0 112.903 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.02 36.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.285 0.948 . . . . 10.0 111.214 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.09 88.53 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.093 -178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.75 37.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.017 0.927 . . . . 10.0 111.974 173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.25 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.67 53.41 12.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.838 1.655 . . . . 10.0 112.126 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.95 47.51 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.935 -1.728 . . . . 10.0 112.405 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.85 54.39 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.77 -39.72 2.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.93 1.692 . . . . 10.0 113.467 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.2 5.34 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.304 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.46 -52.93 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.154 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.57 -51.37 67.61 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.522 0.564 . . . . 10.0 112.522 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.05 -44.93 42.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.469 0.708 . . . . 10.0 110.959 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.82 4.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.814 175.005 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.393 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.14 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.614 0.626 . . . . 10.0 112.675 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.63 -46.92 73.97 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.187 0.81 . . . . 10.0 113.187 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -57.13 -45.54 83.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.023 0.929 . . . . 10.0 111.974 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.02 -55.58 5.59 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.201 1.382 . . . . 10.0 113.082 167.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.4 mt -56.77 -49.47 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.626 0.77 . . . . 10.0 111.893 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 64.4 ttp -49.39 -57.82 6.23 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.151 1.381 . . . . 10.0 112.184 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.82 -47.12 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 O-C-N 121.659 -0.651 . . . . 10.0 111.058 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -50.71 -62.54 5.16 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.82 1.2 . . . . 10.0 112.563 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 p -59.07 -36.17 74.62 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.707 0.803 . . . . 10.0 112.817 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.36 -56.93 8.68 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 124.321 0.962 . . . . 10.0 113.88 165.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.87 -47.22 85.68 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.791 1.637 . . . . 10.0 111.644 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.7 t -52.81 -51.81 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.253 0.621 . . . . 10.0 110.35 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.03 -60.84 5.78 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.833 1.682 . . . . 10.0 112.212 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.01 -37.66 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.484 1.913 . . . . 10.0 113.86 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.0 mt -99.27 -6.41 28.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.168 1.544 . . . . 10.0 115.168 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.1 m -69.66 116.73 10.4 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.19 -1.569 . . . . 10.0 110.409 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.53 -49.55 72.34 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.186 2.594 . . . . 10.0 113.255 177.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.66 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.86 -59.52 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.72 1.208 . . . . 10.0 114.087 -173.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.12 15.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.451 1.5 . . . . 10.0 113.485 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.64 63.25 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.956 1.465 . . . . 10.0 114.956 -178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.82 -41.94 67.91 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.848 0.749 . . . . 10.0 110.712 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.51 -32.01 70.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.903 1.281 . . . . 10.0 114.249 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.1 -51.77 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.59 168.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -62.46 -43.15 99.52 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -53.93 -48.38 70.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.48 1.112 . . . . 10.0 112.617 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.68 -53.14 61.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.693 0.797 . . . . 10.0 111.681 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.14 -54.33 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.809 1.244 . . . . 10.0 112.009 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 p -58.01 -43.15 86.53 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.252 -0.905 . . . . 10.0 112.852 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 56.2 m -61.73 -41.31 97.48 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.568 1.147 . . . . 10.0 112.56 174.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.41 -46.75 87.82 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.345 0.975 . . . . 10.0 112.343 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.74 79.81 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.668 0.787 . . . . 10.0 112.393 172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 37.8 ttp -54.54 -54.54 39.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.037 0.935 . . . . 10.0 112.085 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.1 -50.4 61.71 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.314 1.446 . . . . 10.0 111.572 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -50.39 -54.66 20.14 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.048 0.939 . . . . 10.0 112.562 172.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.1 mt -53.52 -55.3 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.831 0.853 . . . . 10.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.8 mt -57.48 -35.6 70.4 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.2 -0.905 . . . . 10.0 112.902 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.31 -58.14 9.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 119.251 0.932 . . . . 10.0 113.047 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.92 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 118.342 -0.837 . . . . 10.0 111.441 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.44 75.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.83 1.195 . . . . 10.0 112.115 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.92 -70.4 0.46 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.866 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.73 -21.86 60.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.587 1.155 . . . . 10.0 113.468 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.37 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.14 -56.49 14.22 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.955 1.094 . . . . 10.0 113.955 172.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.64 -50.55 65.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.112 0.958 . . . . 10.0 112.299 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.16 -45.97 83.16 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.192 0.997 . . . . 10.0 112.149 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.42 80.59 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.54 -11.23 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.044 1.738 . . . . 10.0 114.225 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.62 29.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.427 1.891 . . . . 10.0 114.865 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.95 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.451 1.596 . . . . 10.0 114.14 -170.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.841 3.256 . . . . 10.0 105.549 170.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.86 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.27 1.98 . . . . 10.0 113.032 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.11 67.96 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.17 -53.01 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.044 0.938 . . . . 10.0 109.822 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.274 0.63 . . . . 10.0 111.902 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.06 -56.14 25.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.933 0.893 . . . . 10.0 112.687 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.26 -53.21 60.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.019 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.55 -49.48 46.08 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.36 78.91 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.691 1.367 . . . . 10.0 114.691 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.62 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.815 0.734 . . . . 10.0 110.487 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.64 -51.61 69.18 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.15 0.796 . . . . 10.0 113.15 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.82 -47.73 31.03 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.796 2.039 . . . . 10.0 111.047 174.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.57 -58.33 9.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.798 0.439 . . . . 10.0 111.253 174.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.09 -47.03 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.109 0.963 . . . . 10.0 112.298 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.9 m -58.76 -64.22 1.01 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 128.034 2.534 . . . . 10.0 111.53 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -50.19 -49.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.613 1.165 . . . . 10.0 111.288 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.46 -63.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.002 0.921 . . . . 10.0 112.269 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.9 -43.41 98.55 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.505 0.593 . . . . 10.0 112.529 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -55.05 -51.01 67.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.478 0.711 . . . . 10.0 111.757 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.5 m -54.92 -29.97 57.5 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.134 1.161 . . . . 10.0 114.134 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.29 -41.94 96.64 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.62 0.97 . . . . 10.0 113.62 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -46.85 -56.27 12.28 Favored Pre-proline 0 N--CA 1.478 0.934 0 N-CA-C 115.325 1.602 . . . . 10.0 115.325 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -59.68 -35.31 95.25 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.264 1.976 . . . . 10.0 112.85 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.63 -53.07 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.132 0.973 . . . . 10.0 110.909 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.21 -48.79 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.023 1.329 . . . . 10.0 111.525 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -55.26 -54.26 45.68 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.964 1.306 . . . . 10.0 112.251 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.0 tp -52.86 -46.67 67.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.182 1.393 . . . . 10.0 112.514 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.6 pt -85.8 -4.92 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.62 -169.33 32.7 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-O 122.551 1.084 . . . . 10.0 113.789 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.07 -39.65 63.45 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.157 -1.021 . . . . 10.0 111.908 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -56.43 -32.87 65.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.377 2.671 . . . . 10.0 115.271 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.44 -104.34 1.11 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-O 122.142 0.857 . . . . 10.0 112.698 -167.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.19 35.82 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.285 170.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.34 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.93 0.332 . . . . 10.0 113.93 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.66 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.775 166.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.33 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.464 1.906 . . . . 10.0 109.351 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.76 153.84 72.32 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.438 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.25 -39.75 3.13 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.299 1.039 . . . . 10.0 112.223 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.43 21.33 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.54 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.651 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.83 41.93 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.564 0.62 . . . . 10.0 111.907 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.0 83.57 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.038 1.735 . . . . 10.0 113.017 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.33 62.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.016 0.926 . . . . 10.0 112.06 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.63 -59.66 4.2 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.361 1.064 . . . . 10.0 109.913 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -52.82 -47.13 67.89 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.986 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.32 -52.72 34.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 121.283 1.856 . . . . 10.0 113.258 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.3 t -60.81 -48.12 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.817 1.247 . . . . 10.0 111.479 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.49 -50.17 74.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.319 1.448 . . . . 10.0 111.907 175.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.35 -57.41 11.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.469 2.308 . . . . 10.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.96 -45.44 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.221 -0.924 . . . . 10.0 111.844 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.9 m -56.95 -51.75 67.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.963 0.905 . . . . 10.0 112.025 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -77.73 5.9 8.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.68 1.592 . . . . 10.0 114.241 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -128.11 -74.16 0.58 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.767 1.227 . . . . 10.0 111.219 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.4 m -72.79 -41.64 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.268 -0.895 . . . . 10.0 111.972 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.23 -56.61 24.26 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 119.367 0.985 . . . . 10.0 112.614 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -42.44 -56.54 2.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.824 2.049 . . . . 10.0 112.36 166.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.16 -39.89 82.14 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.649 1.119 . . . . 10.0 113.997 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.3 -27.14 65.13 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 115.75 1.759 . . . . 10.0 115.75 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.38 -57.56 11.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.604 -0.887 . . . . 10.0 108.604 165.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.68 0.85 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.949 0.899 . . . . 10.0 113.145 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.37 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.183 0.993 . . . . 10.0 113.273 172.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.1 178.02 4.63 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.04 0.936 . . . . 10.0 110.995 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.68 98.15 1.87 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.834 . . . . 10.0 110.921 170.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.93 77.04 7.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.86 0.864 . . . . 10.0 112.107 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.06 102.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.892 2.877 . . . . 10.0 116.451 177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.4 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.738 1.215 . . . . 10.0 110.622 -175.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.35 169.46 40.29 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.631 171.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.446 0 C-N-CA 128.524 2.73 . . . . 10.0 113.492 166.576 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.505 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.82 -2.038 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.34 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.588 3.155 . . . . 10.0 117.251 160.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.302 2.641 . . . . 10.0 114.511 155.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.4 137.96 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.344 -158.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.7 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.1 2.75 41.49 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.473 2.463 . . . . 10.0 111.463 167.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.3 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.668 -168.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.547 2.302 . . . . 10.0 113.252 -175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.25 4.34 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.732 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.13 61.76 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.615 176.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.42 -52.59 63.09 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 10.0 111.902 175.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.41 -53.6 56.3 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.234 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.78 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.2 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -56.1 12.46 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.655 1.122 . . . . 10.0 111.583 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -50.16 -52.35 36.07 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.895 1.278 . . . . 10.0 112.288 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.207 1.003 . . . . 10.0 112.161 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.77 -49.18 77.45 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 10.0 112.541 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.9 mmt -56.08 -49.95 72.36 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.603 0.761 . . . . 10.0 111.306 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.04 -58.47 14.44 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.312 0.958 . . . . 10.0 113.63 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.22 -45.59 79.85 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.656 1.228 . . . . 10.0 112.142 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.25 -43.0 74.85 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.026 1.298 . . . . 10.0 113.273 172.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -59.79 -60.57 3.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.24 1.016 . . . . 10.0 111.14 171.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.96 62.5 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.955 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.84 -58.03 9.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.593 1.157 . . . . 10.0 112.929 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.63 81.94 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.621 1.168 . . . . 10.0 113.62 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.87 -44.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.332 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.16 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.04 92.92 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.154 2.182 . . . . 10.0 113.587 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.35 1.19 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.756 0.693 . . . . 10.0 112.497 -170.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.96 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.396 2.678 . . . . 10.0 116.95 166.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.198 -1.365 . . . . 10.0 113.866 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.52 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.765 1.291 . . . . 10.0 110.957 -172.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.65 89.48 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.708 2.939 . . . . 10.0 113.735 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -60.65 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.5 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.281 1.432 . . . . 10.0 113.444 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 110.967 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.28 65.34 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.891 -0.576 . . . . 10.0 112.321 173.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.7 -57.13 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.865 1.266 . . . . 10.0 110.417 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -69.28 -17.08 63.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.071 1.348 . . . . 10.0 113.693 -172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -86.91 -42.98 12.76 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.64 1.109 . . . . 10.0 112.018 174.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -56.75 -41.45 77.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.885 0.698 . . . . 10.0 112.885 173.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.3 t -49.97 -61.45 3.63 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 124.629 1.172 . . . . 10.0 112.569 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -48.95 -46.53 24.73 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.598 3.532 . . . . 10.0 116.029 164.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.2 93.39 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.973 1.26 . . . . 10.0 113.922 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 mt -58.13 -52.23 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.496 1.118 . . . . 10.0 109.48 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.49 -43.97 72.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.006 0.922 . . . . 10.0 113.185 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -52.2 -57.96 8.08 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.137 1.375 . . . . 10.0 111.871 171.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.59 -52.91 20.57 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.507 1.523 . . . . 10.0 110.886 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.3 mmt -68.64 -48.21 64.6 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.966 0.906 . . . . 10.0 112.981 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -55.64 -41.71 73.96 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.163 1.347 . . . . 10.0 113.283 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.56 34.36 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.475 1.034 . . . . 10.0 111.317 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.05 61.14 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.91 -50.83 61.17 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.442 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.55 -52.67 21.56 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.883 0.873 . . . . 10.0 112.963 172.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.92 -5.58 49.09 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.3 -34.73 5.53 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.575 0.99 . . . . 10.0 115.575 174.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.13 42.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.56 61.17 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.326 0.89 . . . . 10.0 115.326 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.45 26.4 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.021 2.129 . . . . 10.0 109.034 171.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.14 15.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.045 166.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.84 0.856 . . . . 10.0 109.745 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.56 129.57 23.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 125.071 1.348 . . . . 10.0 110.971 -176.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.69 116.17 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.67 164.41 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.647 -0.981 . . . . 10.0 110.647 175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.354 1.577 . . . . 10.0 112.231 -165.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.86 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.45 120.73 69.66 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.4 Cg_exo -61.42 131.91 38.41 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.253 3.302 . . . . 10.0 112.167 171.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.16 126.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.044 1.738 . . . . 10.0 111.716 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 123.262 1.506 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.44 -28.23 66.78 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.641 -1.287 . . . . 10.0 113.881 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.14 62.2 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.225 1.194 . . . . 10.0 114.225 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -65.93 -22.98 66.53 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 120.112 -1.618 . . . . 10.0 113.821 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -77.26 -42.1 38.41 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.55 -1.344 . . . . 10.0 111.691 171.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.22 -47.91 54.7 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 125.444 1.498 . . . . 10.0 111.211 166.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -52.56 -70.76 0.08 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.626 1.97 . . . . 10.0 112.031 168.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -56.83 -32.76 66.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.26 1.024 . . . . 10.0 113.448 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.3 tp -50.17 -40.66 47.5 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.858 1.663 . . . . 10.0 111.871 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -105.29 -39.72 6.08 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.411 0.685 . . . . 10.0 112.521 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.3 p -61.6 -43.12 99.45 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.793 1.633 . . . . 10.0 113.794 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.299 68.0 p -69.94 -40.62 13.35 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 115.234 1.568 . . . . 10.0 115.234 -175.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.37 -42.98 62.93 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.208 2.605 . . . . 10.0 115.083 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.29 -47.43 86.04 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.484 -0.76 . . . . 10.0 111.684 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.11 -49.55 51.35 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.745 1.618 . . . . 10.0 111.527 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -57.11 -47.4 81.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.273 1.029 . . . . 10.0 113.146 170.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.24 78.11 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.843 0.857 . . . . 10.0 112.891 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.33 -54.02 37.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.179 169.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.14 88.6 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.65 -54.69 38.29 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.942 0.897 . . . . 10.0 112.063 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.13 79.42 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.682 0.793 . . . . 10.0 112.729 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.78 -38.54 91.49 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.42 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.269 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.46 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.845 1.658 . . . . 10.0 112.086 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.51 135.88 54.32 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.662 0.616 . . . . 10.0 112.662 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.84 -39.73 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.438 175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.18 5.34 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.148 1.356 . . . . 10.0 115.25 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.08 -46.8 87.5 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.39 -52.91 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.161 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.66 -51.3 67.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.68 -59.82 4.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.366 2.266 . . . . 10.0 114.793 174.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.05 -46.35 96.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 123.667 0.787 . . . . 10.0 111.398 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.29 64.17 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.617 0.627 . . . . 10.0 112.664 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.61 75.23 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.46 0.911 . . . . 10.0 113.46 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -56.02 -47.21 78.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.319 0.648 . . . . 10.0 111.684 173.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -54.23 5.95 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.825 1.203 . . . . 10.0 113.013 169.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.44 -51.22 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.744 0.818 . . . . 10.0 112.043 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 52.5 ttp -48.62 -57.15 6.68 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.019 1.327 . . . . 10.0 111.659 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 35.7 mm -67.6 -46.24 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.227 0.611 . . . . 10.0 111.907 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.44 -55.06 21.42 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.122 1.344 . . . . 10.0 113.263 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 36.5 p -61.08 -36.13 78.82 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.235 -1.156 . . . . 10.0 112.693 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.66 -57.17 12.84 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-N 119.158 0.89 . . . . 10.0 113.727 165.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.28 -50.71 37.82 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.668 2.787 . . . . 10.0 111.124 173.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.35 -50.55 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.587 1.155 . . . . 10.0 111.697 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.39 -59.21 8.63 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.713 1.625 . . . . 10.0 112.062 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.89 -37.84 20.92 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.913 2.085 . . . . 10.0 113.563 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.6 mt -99.43 -6.63 27.35 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.7 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.199 -1.563 . . . . 10.0 110.398 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.65 71.84 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.255 2.622 . . . . 10.0 113.251 177.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.72 106.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.86 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.732 1.213 . . . . 10.0 114.101 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.02 15.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.7 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -53.7 -42.01 67.55 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.855 0.752 . . . . 10.0 110.807 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.35 -32.29 71.27 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.898 1.279 . . . . 10.0 114.213 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.97 -51.76 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.015 0.825 . . . . 10.0 109.608 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -61.96 -45.24 94.51 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 174.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -51.38 -49.24 61.9 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.35 1.06 . . . . 10.0 112.531 172.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.53 -52.63 64.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.191 0.996 . . . . 10.0 111.894 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.53 -52.0 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.831 1.252 . . . . 10.0 111.619 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.1 t -54.65 -47.06 73.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.022 1.329 . . . . 10.0 111.99 175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 48.8 m -60.49 -42.97 97.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.53 1.532 . . . . 10.0 112.52 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.58 -48.43 80.95 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.19 0.905 . . . . 10.0 112.312 172.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.08 81.68 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.737 0.815 . . . . 10.0 112.484 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 36.3 ttp -55.05 -55.07 35.14 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.182 0.993 . . . . 10.0 112.101 171.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.13 -48.06 68.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.386 1.474 . . . . 10.0 111.947 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.07 -54.58 23.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 10.0 112.46 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.47 -55.17 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.787 0.835 . . . . 10.0 110.751 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.7 mt -57.42 -35.79 70.5 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 118.35 -0.833 . . . . 10.0 112.914 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.3 -58.23 9.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.042 0.937 . . . . 10.0 112.994 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.89 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.296 -0.859 . . . . 10.0 111.469 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.75 -49.42 75.3 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.873 1.215 . . . . 10.0 112.13 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.882 -175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.7 -21.95 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.671 1.188 . . . . 10.0 113.453 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.48 51.33 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.227 1.811 . . . . 10.0 113.037 -166.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.1 m -52.05 -56.42 14.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.64 -50.59 65.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.121 0.962 . . . . 10.0 112.314 -177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.03 82.89 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.161 0.984 . . . . 10.0 112.135 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.52 80.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.097 1.759 . . . . 10.0 114.195 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.61 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.432 1.893 . . . . 10.0 114.894 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.89 -92.61 0.15 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 123.521 1.629 . . . . 10.0 114.185 -170.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.99 72.63 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.767 3.227 . . . . 10.0 105.539 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.87 -46.23 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.269 1.979 . . . . 10.0 113.06 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.92 -46.12 67.94 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.247 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.8 75.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.248 0.619 . . . . 10.0 111.937 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.93 -56.2 24.6 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.886 0.874 . . . . 10.0 112.765 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.16 -53.26 60.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 113.028 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.51 45.76 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.16 -48.43 78.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.99 -49.62 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.462 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.65 69.0 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.78 -47.78 30.53 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.816 2.046 . . . . 10.0 111.044 174.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.44 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.845 0.458 . . . . 10.0 111.274 174.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.7 t -52.23 -47.07 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.075 0.95 . . . . 10.0 111.989 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.0 m -58.62 -62.96 1.47 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 128.437 2.695 . . . . 10.0 111.822 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.33 -50.34 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.675 1.19 . . . . 10.0 111.071 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.5 t -58.85 -60.2 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.053 0.941 . . . . 10.0 112.068 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.54 -50.05 75.41 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.663 0.665 . . . . 10.0 112.743 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -53.39 -50.84 64.29 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.752 0.821 . . . . 10.0 111.382 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -58.52 -21.07 50.98 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.11 73.76 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 119.684 1.129 . . . . 10.0 113.225 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -45.01 -53.71 15.46 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 115.18 1.548 . . . . 10.0 115.18 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.528 ' HB3' H183 ' A' ' 999' ' ' RET . 27.5 Cg_endo -59.39 -35.25 96.94 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.99 1.793 . . . . 10.0 113.188 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.4 t -67.22 -54.97 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.326 1.05 . . . . 10.0 111.066 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.77 -44.77 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.111 0.869 . . . . 10.0 112.161 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -56.33 -52.2 65.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.984 0.914 . . . . 10.0 112.321 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.4 tp -53.91 -45.42 71.16 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.513 1.125 . . . . 10.0 112.5 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -87.45 -5.28 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 115.248 1.573 . . . . 10.0 115.248 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.56 -169.3 32.76 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 122.611 1.117 . . . . 10.0 113.805 -168.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -40.73 64.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.165 -1.017 . . . . 10.0 111.838 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -54.56 -32.27 58.12 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.406 2.683 . . . . 10.0 115.379 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.96 -103.92 0.99 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 10.0 113.38 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.18 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.702 -1.469 . . . . 10.0 109.318 169.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.45 65.28 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.29 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -68.73 153.79 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.15 -39.81 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.199 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.36 -52.38 21.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.681 1.363 . . . . 10.0 114.681 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.9 -40.5 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.674 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.31 -49.75 42.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.533 0.606 . . . . 10.0 111.974 173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.72 -47.07 83.45 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.983 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.3 -52.33 62.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.016 0.926 . . . . 10.0 112.101 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 92.9 mt -52.51 -58.72 5.86 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 124.321 1.048 . . . . 10.0 110.003 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -52.08 -47.08 65.36 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.692 -1.147 . . . . 10.0 112.35 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.73 -52.14 57.55 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.308 1.413 . . . . 10.0 112.765 175.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.84 -49.64 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.461 1.104 . . . . 10.0 111.377 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 mp -55.62 -52.86 62.36 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.601 1.56 . . . . 10.0 111.702 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -53.54 -56.41 17.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.957 2.103 . . . . 10.0 111.047 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 43.6 t -50.58 -51.58 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.169 0.987 . . . . 10.0 111.374 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.2 t -61.59 -43.65 98.46 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.603 0.594 . . . . 10.0 112.603 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.37 -24.61 61.3 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.108 1.763 . . . . 10.0 114.192 -177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -100.14 -71.74 0.69 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.716 1.206 . . . . 10.0 111.236 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.13 -50.65 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.465 1.106 . . . . 10.0 111.539 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.11 -55.92 25.78 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.134 0.873 . . . . 10.0 113.083 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -43.06 -56.88 3.14 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.003 2.121 . . . . 10.0 112.382 166.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.97 -40.79 74.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.338 0.971 . . . . 10.0 114.095 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.4 mt -69.75 -27.2 64.75 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 115.962 1.838 . . . . 10.0 115.962 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.52 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.78 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.92 0.888 . . . . 10.0 113.2 -172.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.5 5.12 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.308 1.596 . . . . 10.0 115.308 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.25 0.32 15.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.217 1.007 . . . . 10.0 113.292 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.026 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.21 1.87 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.812 0.845 . . . . 10.0 110.891 170.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.97 77.04 7.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.914 0.885 . . . . 10.0 112.03 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.464 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.48 0.3 OUTLIER 71.77 -55.37 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.765 1.226 . . . . 10.0 110.668 -175.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.781 3.562 . . . . 10.0 119.618 171.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.45 2.7 . . . . 10.0 113.408 166.649 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.528 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.305 2.642 . . . . 10.0 114.486 155.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.47 138.01 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.384 1.873 . . . . 10.0 113.344 -158.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.18 1.69 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 113.978 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.76 41.15 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 127.403 2.43 . . . . 10.0 111.491 168.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.57 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.634 -168.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.98 -60.67 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.522 2.293 . . . . 10.0 113.212 -175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.15 4.32 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.782 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.41 -43.08 61.88 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.587 176.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.62 83.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.912 0.885 . . . . 10.0 109.315 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.35 -52.64 62.84 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.377 0.671 . . . . 10.0 111.928 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 123.187 0.595 . . . . 10.0 112.245 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.83 51.95 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.412 1.485 . . . . 10.0 113.287 173.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.98 84.73 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.72 -57.06 10.07 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.247 0.927 . . . . 10.0 111.3 166.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -48.98 -52.46 24.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.642 1.177 . . . . 10.0 112.302 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.9 5.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.148 0.979 . . . . 10.0 112.166 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.66 -50.29 73.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.682 0.793 . . . . 10.0 112.579 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -53.69 -50.35 66.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.503 1.121 . . . . 10.0 111.348 175.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.36 -58.28 15.41 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.338 0.971 . . . . 10.0 113.471 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.91 79.79 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.539 1.17 . . . . 10.0 112.146 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.29 -42.53 73.99 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.956 1.265 . . . . 10.0 113.185 172.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.9 m -61.82 -58.75 6.75 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.852 0.861 . . . . 10.0 111.448 171.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.79 -58.04 9.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.974 172.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.7 82.13 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.176 0.806 . . . . 10.0 113.176 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.602 1.161 . . . . 10.0 113.64 169.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.718 1.723 . . . . 10.0 110.86 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.847 2.459 . . . . 10.0 109.305 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.53 0.975 0 N-CA-C 115.609 1.004 . . . . 10.0 115.609 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.02 92.93 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.46 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.798 0.713 . . . . 10.0 112.441 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.931 166.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.62 -50.93 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.174 -1.375 . . . . 10.0 113.866 174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.769 1.293 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.58 -29.67 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.756 2.971 . . . . 10.0 113.682 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.17 -40.07 22.86 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.078 1.351 . . . . 10.0 113.534 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.43 19.58 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.434 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 111.015 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.94 -50.25 73.17 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.35 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.41 -51.26 65.44 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.353 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.02 1.91 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.376 0.88 . . . . 10.0 113.376 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.2 mt -48.51 -58.0 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 124.892 1.277 . . . . 10.0 110.193 178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -68.54 -16.48 63.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.218 1.407 . . . . 10.0 113.819 -172.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -88.66 -39.72 13.83 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.624 1.102 . . . . 10.0 112.188 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.34 -42.17 90.89 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.457 -0.777 . . . . 10.0 112.29 170.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -41.13 -61.84 1.21 Allowed Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 126.214 1.806 . . . . 10.0 113.782 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.13 -26.83 17.6 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.028 2.485 . . . . 10.0 114.436 174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.69 89.49 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.504 1.502 . . . . 10.0 113.387 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.4 mt -55.54 -53.81 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.426 1.09 . . . . 10.0 109.128 170.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -42.63 71.67 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.312 1.045 . . . . 10.0 113.751 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -52.93 -56.73 13.79 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.575 1.534 . . . . 10.0 111.915 171.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.96 -52.51 32.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.347 1.459 . . . . 10.0 110.735 177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.21 62.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 118.168 -0.92 . . . . 10.0 112.982 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -56.3 -40.91 75.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.37 1.441 . . . . 10.0 113.013 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.23 -54.57 34.25 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.179 1.354 . . . . 10.0 111.333 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.66 -41.03 61.07 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.259 1.577 . . . . 10.0 115.259 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.91 -50.85 61.1 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.451 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.5 48.9 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.328 1.051 . . . . 10.0 113.835 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.01 43.21 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.26 1.578 . . . . 10.0 115.26 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.12 3.59 61.28 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.302 0.881 . . . . 10.0 115.302 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.4 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.035 2.134 . . . . 10.0 109.036 172.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.028 0.931 . . . . 10.0 111.0 166.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.887 0.875 . . . . 10.0 109.712 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.56 129.54 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.068 1.347 . . . . 10.0 110.976 -176.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.74 116.3 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.384 -1.044 . . . . 10.0 109.384 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.76 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.695 -0.962 . . . . 10.0 110.695 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.37 0.7 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.708 2.243 . . . . 10.0 118.708 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.54 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.263 -165.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.87 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.081 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.47 120.82 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.53 131.92 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.11 126.38 22.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.0 1.72 . . . . 10.0 111.684 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.746 1.26 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.3 66.75 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.54 -31.14 61.87 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.231 1.012 . . . . 10.0 112.305 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.437 ' HG3' HH11 ' A' ' 82' ' ' ARG . 16.1 ttm-85 -46.97 -44.48 20.14 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.198 2.199 . . . . 10.0 113.104 167.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -82.12 -38.9 24.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.651 1.581 . . . . 10.0 111.794 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.17 -49.25 52.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.073 1.349 . . . . 10.0 111.629 167.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -53.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.038 1.735 . . . . 10.0 111.849 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.9 m0 -54.95 -33.23 62.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.936 -1.031 . . . . 10.0 113.549 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.13 -40.39 46.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.399 1.48 . . . . 10.0 112.051 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -104.28 -46.1 4.5 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.253 1.021 . . . . 10.0 112.303 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.1 m -52.32 -43.68 64.69 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.879 1.271 . . . . 10.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 m -72.87 -45.5 8.79 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 114.313 1.227 . . . . 10.0 114.313 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.88 -41.63 69.36 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.339 2.693 . . . . 10.0 115.1 167.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.0 mt -59.6 -47.14 86.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.285 0.634 . . . . 10.0 111.431 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.8 -51.45 22.5 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.349 1.86 . . . . 10.0 111.412 170.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.06 -47.28 83.64 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.92 1.288 . . . . 10.0 113.165 171.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.29 78.22 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.849 0.859 . . . . 10.0 112.889 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.34 -53.96 37.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.256 0.934 . . . . 10.0 111.2 169.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -42.05 88.36 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.62 0.768 . . . . 10.0 112.087 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 37.95 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.017 0.927 . . . . 10.0 112.024 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.29 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.752 0.821 . . . . 10.0 112.699 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.76 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.81 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.312 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.45 12.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.847 1.659 . . . . 10.0 112.159 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.24 145.9 47.64 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.969 -1.707 . . . . 10.0 112.425 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.52 135.92 54.38 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.84 -39.69 2.61 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.523 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.79 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.297 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.46 -52.9 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.07 1.348 . . . . 10.0 111.128 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.61 -51.26 68.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.602 0.593 . . . . 10.0 112.602 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.88 43.62 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.504 0.722 . . . . 10.0 110.923 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.07 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.357 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.82 -46.37 74.53 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.044 0.757 . . . . 10.0 113.044 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -57.52 -45.24 85.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.544 1.138 . . . . 10.0 112.08 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.99 -56.76 5.07 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.618 1.58 . . . . 10.0 112.797 166.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.9 mt -57.46 -52.1 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.936 0.894 . . . . 10.0 111.054 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 55.1 ttp -48.0 -59.79 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.855 1.262 . . . . 10.0 112.037 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.4 -48.42 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.658 0.783 . . . . 10.0 111.889 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.36 -46.75 57.45 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.631 1.11 . . . . 10.0 113.016 176.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 63.0 m -59.26 -45.36 91.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.686 1.195 . . . . 10.0 111.779 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.29 -51.7 20.23 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.856 0.741 . . . . 10.0 112.768 167.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.1 tt -53.4 -48.36 68.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.077 2.551 . . . . 10.0 111.693 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.71 -49.15 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 125.397 1.479 . . . . 10.0 111.967 172.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.22 -59.25 9.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.911 1.719 . . . . 10.0 112.387 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.03 -42.94 3.02 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.313 2.645 . . . . 10.0 113.254 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.0 mt -101.42 -6.67 23.71 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.499 1.666 . . . . 10.0 115.499 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.7 10.36 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.19 -1.569 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.47 -49.62 72.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.187 2.595 . . . . 10.0 113.268 177.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.65 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.087 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.9 -59.53 3.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.07 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.501 1.52 . . . . 10.0 113.503 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.56 63.15 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.15 -41.26 68.24 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 118.89 0.768 . . . . 10.0 110.899 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.97 -31.98 69.96 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.837 1.255 . . . . 10.0 114.221 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.076 0.853 . . . . 10.0 109.713 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -60.03 -48.32 82.19 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -48.93 -49.61 39.36 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.575 1.079 . . . . 10.0 113.014 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.04 -52.85 63.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 10.0 111.945 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.0 mt -54.69 -51.28 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.983 1.313 . . . . 10.0 111.786 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.2 t -55.89 -46.24 78.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.615 1.166 . . . . 10.0 111.793 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 47.9 m -60.88 -42.64 98.35 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 10.0 112.557 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.78 79.17 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.228 0.922 . . . . 10.0 112.31 171.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.81 -45.02 82.52 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.587 0.755 . . . . 10.0 112.607 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -55.38 -55.33 32.86 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.319 1.048 . . . . 10.0 112.142 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.0 tt -51.24 -50.54 58.98 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.949 1.7 . . . . 10.0 111.185 178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -50.93 -54.9 20.21 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.021 0.928 . . . . 10.0 112.792 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.1 -54.76 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.592 0.757 . . . . 10.0 110.861 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.46 -36.58 69.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.692 0.797 . . . . 10.0 113.115 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.16 9.45 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.036 173.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.87 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.467 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.7 mt -56.78 -49.44 75.29 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.115 171.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.087 -1.633 . . . . 10.0 112.871 -175.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.68 -21.99 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 10.0 113.466 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.76 -79.06 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.621 0.629 . . . . 10.0 113.553 171.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.43 51.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.236 1.814 . . . . 10.0 113.045 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.68 -50.55 65.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.057 0.932 . . . . 10.0 112.297 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.07 82.92 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.133 0.973 . . . . 10.0 112.167 173.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.45 80.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.532 1.308 . . . . 10.0 114.532 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.25 1.2 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.033 1.733 . . . . 10.0 114.254 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.65 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.391 1.876 . . . . 10.0 114.878 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.93 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.7 153.92 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.841 3.256 . . . . 10.0 105.592 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.82 -46.23 35.14 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.275 1.983 . . . . 10.0 113.06 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.15 68.02 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.236 173.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.1 -53.05 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.027 0.931 . . . . 10.0 109.832 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.8 75.84 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.274 0.63 . . . . 10.0 111.892 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.15 25.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.882 0.873 . . . . 10.0 112.727 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.25 -53.22 60.55 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 112.987 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.53 45.44 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.115 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.48 78.54 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.65 1.352 . . . . 10.0 114.65 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.91 -49.63 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.843 0.747 . . . . 10.0 110.522 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.64 69.02 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.81 30.15 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.889 2.075 . . . . 10.0 111.037 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.836 0.454 . . . . 10.0 111.263 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.4 t -52.08 -47.39 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 112.209 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -65.29 0.66 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.209 2.604 . . . . 10.0 111.46 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -49.93 -48.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.783 1.233 . . . . 10.0 111.548 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.7 t -60.52 -61.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.945 0.898 . . . . 10.0 112.653 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.08 -48.78 73.07 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.766 0.712 . . . . 10.0 111.608 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -50.11 -53.03 30.14 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.647 1.179 . . . . 10.0 112.53 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.4 m -53.14 -32.02 45.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.278 1.031 . . . . 10.0 113.589 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.85 94.83 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.03 1.122 . . . . 10.0 114.03 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -46.87 -56.67 11.0 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 115.098 1.518 . . . . 10.0 115.098 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.528 ' HB3' H183 ' A' ' 999' ' ' RET . 29.1 Cg_endo -59.59 -36.7 91.89 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.526 2.151 . . . . 10.0 113.056 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.85 -57.94 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.393 1.077 . . . . 10.0 110.745 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.73 -34.66 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 118.692 -0.671 . . . . 10.0 112.605 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -58.73 -56.1 26.59 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.547 1.139 . . . . 10.0 111.944 168.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.2 tt -58.36 -41.69 85.27 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.915 0.886 . . . . 10.0 112.697 -175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -81.27 -5.52 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.22 -169.29 33.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-O 122.587 1.104 . . . . 10.0 113.953 -169.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.43 65.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.847 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -67.46 -16.76 64.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.647 1.721 . . . . 10.0 115.647 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.05 -105.91 1.08 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.32 1.418 . . . . 10.0 113.799 -173.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.17 35.81 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.617 -1.519 . . . . 10.0 109.325 168.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.894 0.318 . . . . 10.0 113.894 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.61 -42.69 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.725 166.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.29 133.35 24.88 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.385 -174.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.69 153.8 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.786 2.99 . . . . 10.0 111.433 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.77 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.307 1.043 . . . . 10.0 112.213 171.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.35 -52.35 22.07 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.712 1.375 . . . . 10.0 114.712 176.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.92 -40.5 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.476 1.11 . . . . 10.0 109.692 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.32 -49.78 42.46 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.513 0.597 . . . . 10.0 111.973 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.69 -47.04 83.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.001 1.72 . . . . 10.0 112.993 174.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.35 62.14 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.02 0.928 . . . . 10.0 112.03 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -58.52 6.5 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.363 1.065 . . . . 10.0 109.975 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -53.44 -44.95 69.25 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.759 -1.115 . . . . 10.0 112.839 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.45 -53.0 57.66 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.66 -47.51 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.819 1.248 . . . . 10.0 111.678 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.12 -51.62 68.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.629 1.571 . . . . 10.0 111.815 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.21 -51.63 69.14 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.917 1.687 . . . . 10.0 111.788 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.1 t -48.83 -51.52 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.669 1.188 . . . . 10.0 110.987 172.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.5 m -58.81 -50.71 72.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.461 1.104 . . . . 10.0 111.823 177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.91 -28.23 64.37 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.594 1.558 . . . . 10.0 114.459 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.75 -72.16 0.5 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.753 1.221 . . . . 10.0 110.017 173.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.35 -49.88 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.084 1.354 . . . . 10.0 111.575 -167.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.82 -53.66 35.18 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.163 0.887 . . . . 10.0 112.903 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -44.94 -58.02 3.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.542 1.937 . . . . 10.0 112.293 166.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.49 -38.5 70.62 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.005 0.812 . . . . 10.0 113.235 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -70.29 -27.65 64.57 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 116.215 1.932 . . . . 10.0 116.215 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.68 -57.49 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.63 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.921 0.889 . . . . 10.0 113.2 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.53 5.15 2.53 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.37 0.41 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.18 0.992 . . . . 10.0 113.272 172.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.08 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.011 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.98 7.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.874 0.87 . . . . 10.0 112.106 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.869 2.868 . . . . 10.0 116.475 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.719 1.208 . . . . 10.0 110.644 -175.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.33 169.47 40.21 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.666 171.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.483 2.713 . . . . 10.0 113.459 166.653 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.528 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.834 -2.032 . . . . 10.0 105.789 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 129.651 3.18 . . . . 10.0 117.196 160.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.65 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.306 2.642 . . . . 10.0 114.484 155.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.46 137.96 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.407 1.883 . . . . 10.0 113.345 -158.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.22 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.465 2.459 . . . . 10.0 111.487 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.62 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.25 -2.786 . . . . 10.0 116.634 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.05 -60.59 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.543 2.301 . . . . 10.0 113.217 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.19 4.31 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.782 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.11 61.74 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.534 -0.729 . . . . 10.0 112.615 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.6 84.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.63 62.91 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.448 0.699 . . . . 10.0 111.882 175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.59 56.42 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.183 0.593 . . . . 10.0 112.218 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 51.97 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.378 1.471 . . . . 10.0 113.352 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.76 -56.98 10.25 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.149 0.881 . . . . 10.0 111.202 166.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.27 -52.3 28.27 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.574 1.15 . . . . 10.0 112.187 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.77 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.122 0.969 . . . . 10.0 112.167 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.3 mt -57.86 -50.14 74.33 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.449 0.699 . . . . 10.0 112.751 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -49.7 68.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.442 1.097 . . . . 10.0 111.248 175.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.32 15.2 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.3 0.952 . . . . 10.0 113.608 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.02 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.485 1.142 . . . . 10.0 112.089 176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -41.59 75.74 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.863 1.22 . . . . 10.0 113.232 173.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.55 -58.44 7.54 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.823 0.849 . . . . 10.0 111.421 171.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -40.98 62.49 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.045 0.938 . . . . 10.0 110.944 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.1 9.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.594 1.158 . . . . 10.0 112.968 172.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.68 81.85 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.257 0.836 . . . . 10.0 113.257 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.46 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.586 1.154 . . . . 10.0 113.62 169.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.99 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.77 1.748 . . . . 10.0 110.892 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.9 -44.85 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.338 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.14 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.013 . . . . 10.0 115.634 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.58 -44.96 93.16 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.162 2.185 . . . . 10.0 113.589 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.98 88.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.435 2.694 . . . . 10.0 116.939 166.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.64 -50.92 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.179 -1.373 . . . . 10.0 113.879 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.52 6.38 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.771 1.294 . . . . 10.0 110.957 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.59 -29.63 89.65 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.743 2.962 . . . . 10.0 113.69 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.111 0.565 . . . . 10.0 111.473 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.14 -40.09 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.108 1.363 . . . . 10.0 113.564 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.44 19.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.405 172.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.967 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.97 -50.23 73.29 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.088 0.555 . . . . 10.0 112.334 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.29 65.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.337 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.53 -57.42 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.851 1.26 . . . . 10.0 110.533 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -67.99 -20.75 65.05 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.965 1.306 . . . . 10.0 113.552 -172.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -84.07 -40.92 17.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.414 1.086 . . . . 10.0 112.18 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.07 -41.52 88.15 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.469 -0.77 . . . . 10.0 112.983 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.37 -62.84 1.45 Allowed Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 124.603 1.161 . . . . 10.0 113.447 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -68.79 -26.34 32.56 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.001 2.467 . . . . 10.0 113.771 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.86 -45.94 83.92 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 120.547 1.522 . . . . 10.0 113.156 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.76 -51.33 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 120.982 -1.073 . . . . 10.0 109.302 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.82 72.84 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.42 0.896 . . . . 10.0 113.42 175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -52.81 -56.42 15.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.119 1.368 . . . . 10.0 111.816 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.67 -52.78 28.58 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.263 1.425 . . . . 10.0 110.749 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.29 -47.97 62.99 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.99 0.916 . . . . 10.0 112.98 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.15 -41.2 75.04 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.365 1.439 . . . . 10.0 113.11 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.57 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.948 1.249 . . . . 10.0 111.297 170.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.61 -41.12 61.01 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.238 1.57 . . . . 10.0 115.238 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.7 mtm -66.86 -50.85 61.22 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.525 0.73 . . . . 10.0 110.485 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.68 21.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.896 0.878 . . . . 10.0 112.931 172.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.5 48.82 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 115.539 0.976 . . . . 10.0 115.539 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.244 1.572 . . . . 10.0 115.244 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.55 61.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.42 26.44 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.042 2.137 . . . . 10.0 109.036 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.57 171.13 15.13 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.028 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.01 53.42 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.912 0.885 . . . . 10.0 109.712 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.51 129.62 23.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 C-N-CA 125.079 1.352 . . . . 10.0 110.96 -176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.444 -1.022 . . . . 10.0 109.444 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.37 38.2 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.798 0.666 . . . . 10.0 112.798 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.42 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.632 -0.987 . . . . 10.0 110.632 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.78 -3.35 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.665 2.226 . . . . 10.0 118.665 170.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.88 4.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.317 1.558 . . . . 10.0 112.28 -165.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.93 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.107 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.52 120.74 69.62 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 -165.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.2 Cg_exo -61.49 131.92 38.28 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.137 171.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.1 126.33 21.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.055 1.742 . . . . 10.0 111.752 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.63 85.01 4.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.958 1.361 . . . . 10.0 113.085 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.36 -28.28 66.71 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.898 -1.126 . . . . 10.0 113.928 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.8 38.3 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.26 1.024 . . . . 10.0 112.491 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -54.27 -48.3 71.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.032 1.333 . . . . 10.0 112.714 168.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -71.25 -38.49 71.91 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.485 1.114 . . . . 10.0 110.993 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.52 67.09 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.797 1.239 . . . . 10.0 112.367 168.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.15 -69.51 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.883 1.673 . . . . 10.0 111.624 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -56.84 -32.5 65.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.067 1.347 . . . . 10.0 112.836 -170.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.3 tp -49.35 -44.27 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.679 1.592 . . . . 10.0 111.876 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -100.14 -41.94 6.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.688 0.795 . . . . 10.0 112.593 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.4 p -62.6 -42.72 99.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.836 1.198 . . . . 10.0 113.925 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 71.5 p -65.85 -44.01 60.98 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 114.663 1.357 . . . . 10.0 114.663 -178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -43.95 53.12 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.053 2.502 . . . . 10.0 115.637 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.46 -46.4 88.87 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.491 -0.756 . . . . 10.0 111.454 175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.1 tp -50.76 -49.2 58.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.567 1.547 . . . . 10.0 112.038 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 mp -58.09 -47.47 83.11 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.94 1.296 . . . . 10.0 112.513 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.22 78.28 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.78 0.832 . . . . 10.0 112.889 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.31 -54.04 36.64 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.309 0.959 . . . . 10.0 111.173 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.06 88.67 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 10.0 112.14 -178.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.73 38.1 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 112.002 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.35 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.682 0.793 . . . . 10.0 112.704 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.76 -38.57 91.59 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.81 1.43 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.055 1.342 . . . . 10.0 112.296 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.9 47.62 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.443 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.93 54.46 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.664 0.616 . . . . 10.0 112.664 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.72 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.871 1.669 . . . . 10.0 113.499 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.04 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.339 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.43 -52.9 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.075 1.35 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.27 67.89 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.87 43.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.429 0.692 . . . . 10.0 110.945 174.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.85 4.78 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.355 2.262 . . . . 10.0 114.835 174.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.32 96.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.655 0.782 . . . . 10.0 111.375 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.9 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.78 -46.58 74.45 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.241 0.83 . . . . 10.0 113.241 173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -56.07 -48.3 76.33 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.896 0.879 . . . . 10.0 110.903 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.79 -54.57 4.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.951 1.263 . . . . 10.0 113.195 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -58.15 -51.01 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.903 0.881 . . . . 10.0 112.119 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -54.19 -51.96 62.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.866 1.212 . . . . 10.0 111.987 -177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.1 mm -69.87 -45.53 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.801 -0.562 . . . . 10.0 111.034 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.2 -58.21 11.36 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.21 1.386 . . . . 10.0 113.345 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.0 p -61.31 -33.71 74.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.234 -1.156 . . . . 10.0 112.735 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.95 -55.29 19.01 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 119.395 0.998 . . . . 10.0 113.659 162.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tt -52.78 -45.37 67.11 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.921 2.889 . . . . 10.0 110.881 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.14 -50.4 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.55 1.54 . . . . 10.0 112.139 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.0 -58.98 9.34 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.919 1.723 . . . . 10.0 112.398 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.92 -43.3 3.03 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 128.057 2.543 . . . . 10.0 113.466 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.43 -6.33 24.15 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.461 1.652 . . . . 10.0 115.461 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.63 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.222 -1.549 . . . . 10.0 110.41 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.619 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.68 71.85 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.26 2.624 . . . . 10.0 113.251 177.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.61 106.3 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.52 3.03 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.771 1.229 . . . . 10.0 114.065 -173.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.51 -42.05 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.48 1.512 . . . . 10.0 113.519 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.63 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.907 1.447 . . . . 10.0 114.907 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -53.91 -41.81 68.05 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.914 0.779 . . . . 10.0 110.75 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.72 -31.49 69.52 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.355 1.243 . . . . 10.0 114.355 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.44 -52.01 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.041 0.837 . . . . 10.0 109.551 168.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -61.84 -42.56 99.19 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.9 t90 -53.67 -49.2 68.49 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.233 1.013 . . . . 10.0 112.759 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -52.58 64.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.636 0.774 . . . . 10.0 111.503 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.6 -55.26 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.987 1.315 . . . . 10.0 112.051 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.6 p -57.04 -43.63 82.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.905 0.882 . . . . 10.0 112.696 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.98 -43.93 98.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.758 1.223 . . . . 10.0 112.157 174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.41 81.7 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.229 0.922 . . . . 10.0 112.561 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.23 78.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.989 0.916 . . . . 10.0 112.43 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.8 ttp -56.56 -51.06 70.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.285 1.034 . . . . 10.0 112.382 171.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.02 -48.06 76.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.32 1.448 . . . . 10.0 112.681 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -48.53 -53.52 17.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.394 1.078 . . . . 10.0 111.794 169.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.72 -55.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.68 0.792 . . . . 10.0 110.899 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -56.52 -36.42 69.2 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.226 0.824 . . . . 10.0 113.226 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.28 -58.15 9.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.049 0.939 . . . . 10.0 113.059 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.5 -40.82 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.289 -0.863 . . . . 10.0 111.429 177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.8 mt -56.84 -49.4 75.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.909 1.231 . . . . 10.0 112.093 171.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.99 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.858 -175.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.615 1.166 . . . . 10.0 113.447 -174.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.11 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.651 0.643 . . . . 10.0 113.554 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.62 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.242 1.817 . . . . 10.0 113.011 -166.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.06 -56.46 14.2 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.005 1.113 . . . . 10.0 114.005 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.69 -50.55 65.61 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.096 0.951 . . . . 10.0 112.272 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.14 -46.02 83.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.16 0.984 . . . . 10.0 112.151 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.51 80.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.43 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.124 1.77 . . . . 10.0 114.235 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.09 6.59 29.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.425 1.89 . . . . 10.0 114.851 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.5 1.619 . . . . 10.0 114.164 -170.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.805 3.242 . . . . 10.0 105.562 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.84 -46.22 35.23 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.306 2.004 . . . . 10.0 113.069 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.11 68.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.057 2.943 . . . . 10.0 113.236 173.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -53.05 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.085 0.954 . . . . 10.0 109.788 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.82 75.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.282 0.633 . . . . 10.0 111.917 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.19 24.7 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.913 0.885 . . . . 10.0 112.698 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.226 1.011 . . . . 10.0 113.028 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.55 -49.53 45.86 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.26 0.624 . . . . 10.0 111.115 174.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.15 -48.41 78.76 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.94 -49.7 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.801 0.728 . . . . 10.0 110.467 176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.51 -51.63 69.07 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.8 -47.76 30.85 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 126.852 2.061 . . . . 10.0 111.04 174.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.48 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.862 0.465 . . . . 10.0 111.271 174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.1 -47.33 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.078 0.951 . . . . 10.0 112.093 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 31.4 m -58.36 -64.29 0.97 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.126 2.57 . . . . 10.0 111.492 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -50.18 -49.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.676 1.19 . . . . 10.0 111.24 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.36 -63.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.974 0.91 . . . . 10.0 112.043 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.58 -45.45 81.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.142 0.883 . . . . 10.0 112.378 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -53.03 -51.88 60.27 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.107 0.963 . . . . 10.0 112.236 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 52.6 p -52.39 -33.19 42.35 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.243 1.201 . . . . 10.0 114.243 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.05 -41.32 97.43 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.973 1.101 . . . . 10.0 113.973 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -46.87 -58.07 7.75 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 114.769 1.396 . . . . 10.0 114.769 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.404 ' HB3' H183 ' A' ' 999' ' ' RET . 32.3 Cg_endo -60.55 -33.5 93.64 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.174 1.916 . . . . 10.0 113.429 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.1 t -64.23 -58.02 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.143 0.883 . . . . 10.0 110.659 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.69 -35.06 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.46 0.704 . . . . 10.0 112.77 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -59.63 -55.18 37.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.563 1.145 . . . . 10.0 112.115 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.81 -41.68 82.67 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.764 0.826 . . . . 10.0 112.494 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -81.42 -5.55 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 115.003 1.483 . . . . 10.0 115.003 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.4 -169.31 32.99 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-O 122.576 1.098 . . . . 10.0 113.924 -168.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.56 65.46 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.822 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -67.92 -15.74 63.75 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.542 1.682 . . . . 10.0 115.542 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.53 -105.94 1.05 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 120.428 1.467 . . . . 10.0 114.03 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.304 168.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.32 1.35 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 113.855 0.302 . . . . 10.0 113.855 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.77 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.12 1.768 . . . . 10.0 108.692 166.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.7 t -126.26 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.368 -174.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.73 153.81 72.45 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.456 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.05 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.297 1.039 . . . . 10.0 112.199 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.3 -52.42 21.47 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.685 1.365 . . . . 10.0 114.685 176.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.36 -49.77 42.93 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.563 0.62 . . . . 10.0 111.937 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.7 -47.05 83.46 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.979 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.28 -52.35 62.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.974 0.91 . . . . 10.0 112.123 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -58.96 5.1 Favored 'General case' 0 C--O 1.228 -0.066 0 C-N-CA 124.303 1.041 . . . . 10.0 109.992 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -52.32 -44.57 65.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.679 -1.153 . . . . 10.0 112.6 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -55.26 -51.76 65.6 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.608 1.549 . . . . 10.0 112.511 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.43 -46.68 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.936 1.294 . . . . 10.0 111.629 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.9 mp -58.91 -52.68 64.69 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.556 1.542 . . . . 10.0 111.601 174.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.57 -54.11 49.78 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.785 1.634 . . . . 10.0 111.933 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.94 -43.88 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 O-C-N 121.22 -0.925 . . . . 10.0 112.456 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 55.4 p -62.96 -44.84 94.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.74 0.7 . . . . 10.0 112.061 174.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.05 -28.22 69.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.405 1.482 . . . . 10.0 114.279 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.65 -74.16 0.53 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.507 1.123 . . . . 10.0 110.898 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.6 t -73.05 -48.26 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.675 1.59 . . . . 10.0 111.245 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.54 -55.69 27.36 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.094 0.854 . . . . 10.0 112.985 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -45.18 -56.3 4.93 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.414 1.886 . . . . 10.0 112.284 166.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.04 -40.03 71.93 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.072 0.844 . . . . 10.0 113.635 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.8 mt -70.48 -27.69 64.4 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 115.774 1.768 . . . . 10.0 115.774 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.42 -57.52 11.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 165.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.65 0.86 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.907 0.883 . . . . 10.0 113.168 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.58 5.24 2.52 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.31 15.66 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.266 1.026 . . . . 10.0 113.28 172.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.038 0.935 . . . . 10.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.12 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.771 0.828 . . . . 10.0 110.973 170.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.85 76.99 7.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.87 0.868 . . . . 10.0 112.117 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.471 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.82 -55.41 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.622 -175.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.51 39.93 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.519 2.727 . . . . 10.0 113.439 166.61 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.522 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.782 -2.056 . . . . 10.0 105.826 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.51 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.615 3.166 . . . . 10.0 117.211 160.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.1 0.11 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.356 2.662 . . . . 10.0 114.417 155.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.96 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.365 1.866 . . . . 10.0 113.391 -158.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.13 1.69 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.306 1.842 . . . . 10.0 114.055 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.96 2.84 40.82 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 127.489 2.471 . . . . 10.0 111.487 168.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.55 -51.36 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -63.96 -60.65 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.488 2.281 . . . . 10.0 113.191 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.23 4.37 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.8 2.44 . . . . 10.0 115.742 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.13 61.79 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.464 -0.772 . . . . 10.0 112.621 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.41 -52.65 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.422 0.689 . . . . 10.0 111.83 175.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.33 -53.59 56.35 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.174 0.59 . . . . 10.0 112.225 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.89 -46.81 52.09 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.368 1.467 . . . . 10.0 113.305 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.61 -45.04 84.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.339 1.456 . . . . 10.0 112.997 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -48.83 -58.68 7.4 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.355 0.978 . . . . 10.0 110.765 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.8 m -48.4 -52.34 22.4 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.745 1.218 . . . . 10.0 112.072 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 -58.9 5.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.175 0.99 . . . . 10.0 112.15 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.74 -49.77 75.44 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.707 0.803 . . . . 10.0 112.207 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 53.2 mmm -57.78 -45.95 85.29 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.374 0.67 . . . . 10.0 111.603 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.47 -58.1 16.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.46 1.029 . . . . 10.0 113.895 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.21 -45.99 79.66 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.406 1.103 . . . . 10.0 112.077 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.57 -42.02 75.22 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.821 1.2 . . . . 10.0 113.168 173.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -62.16 -58.58 7.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.676 0.79 . . . . 10.0 111.474 171.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.01 62.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.023 0.929 . . . . 10.0 110.974 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.78 -57.99 9.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.582 1.153 . . . . 10.0 113.011 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.68 82.0 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.224 0.824 . . . . 10.0 113.224 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.621 1.168 . . . . 10.0 113.637 169.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.748 . . . . 10.0 110.878 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.92 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.937 2.495 . . . . 10.0 109.365 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.89 23.09 0.86 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.94 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.614 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.9 m -79.61 -50.87 10.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.231 -1.35 . . . . 10.0 113.902 174.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.52 6.44 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.794 1.309 . . . . 10.0 110.975 -172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.54 -29.69 89.62 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.705 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.66 2.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.111 0.565 . . . . 10.0 111.447 176.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.53 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.056 1.342 . . . . 10.0 113.588 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.49 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.249 1.42 . . . . 10.0 113.468 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.13 61.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.486 0.714 . . . . 10.0 110.946 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.91 -50.28 73.03 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.26 65.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.341 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.02 1.91 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.407 0.892 . . . . 10.0 113.407 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.36 -57.26 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.921 1.288 . . . . 10.0 110.645 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -68.39 -20.17 64.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.999 1.32 . . . . 10.0 113.508 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.9 m -84.92 -39.69 17.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.488 1.115 . . . . 10.0 112.303 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.59 -42.89 97.63 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.8 t -43.39 -63.77 0.93 Allowed Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.898 1.279 . . . . 10.0 112.482 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.43 -27.56 33.52 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.94 2.426 . . . . 10.0 114.217 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.79 89.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 120.459 1.481 . . . . 10.0 113.033 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.2 mt -61.84 -46.97 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 120.86 -1.15 . . . . 10.0 109.908 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.81 -46.61 71.14 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.027 0.751 . . . . 10.0 113.027 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -50.82 -56.87 10.12 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.193 1.397 . . . . 10.0 111.677 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -48.91 -53.39 19.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.237 1.415 . . . . 10.0 111.087 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -68.99 -48.34 63.33 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.034 0.933 . . . . 10.0 112.909 -176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -55.22 -41.94 72.72 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.309 1.413 . . . . 10.0 113.287 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.56 34.44 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.619 1.099 . . . . 10.0 111.356 171.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.8 p -51.64 -41.03 61.02 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.256 1.576 . . . . 10.0 115.256 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtm -66.95 -50.8 61.2 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 123.568 0.747 . . . . 10.0 110.456 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.67 -52.63 22.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.837 0.855 . . . . 10.0 112.91 172.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.93 -5.53 48.88 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.875 1.065 . . . . 10.0 113.875 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.22 -34.66 5.59 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 115.601 1.0 . . . . 10.0 115.601 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.38 -43.06 43.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.59 61.05 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.363 0.905 . . . . 10.0 115.363 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.39 26.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.072 2.149 . . . . 10.0 109.066 171.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.48 171.09 15.15 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.059 0.943 . . . . 10.0 111.048 166.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.1 53.35 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.862 0.865 . . . . 10.0 109.693 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.8 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.75 116.29 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.4 38.17 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.821 0.674 . . . . 10.0 112.821 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.33 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 118.703 2.241 . . . . 10.0 118.703 170.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.9 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.302 1.551 . . . . 10.0 112.223 -165.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.78 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.544 1.537 . . . . 10.0 111.159 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.43 120.81 69.68 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 112.981 0.734 . . . . 10.0 112.981 -165.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.58 131.93 38.12 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.209 3.273 . . . . 10.0 112.144 171.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.12 126.32 21.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.054 1.742 . . . . 10.0 111.746 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.57 84.96 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.057 1.408 . . . . 10.0 113.065 174.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.31 -28.26 66.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.787 -1.195 . . . . 10.0 113.98 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.25 -35.73 62.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.056 1.502 . . . . 10.0 115.056 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.409 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -63.86 -29.62 70.79 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 119.847 -1.783 . . . . 10.0 113.284 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -70.78 -43.99 67.57 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.254 -0.904 . . . . 10.0 112.012 171.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.1 -46.67 45.18 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 125.164 1.386 . . . . 10.0 111.669 167.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -56.92 -70.82 0.11 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.102 1.361 . . . . 10.0 111.675 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.409 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.2 m0 -53.4 -33.51 54.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.422 1.489 . . . . 10.0 112.835 -170.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.5 tp -46.29 -48.95 18.02 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.942 1.697 . . . . 10.0 111.913 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -90.8 -44.5 9.39 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.324 1.05 . . . . 10.0 112.311 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.2 p -78.91 -32.98 45.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.133 1.16 . . . . 10.0 114.133 -165.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.317 69.8 p -61.55 -44.98 93.66 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 117.594 -1.193 . . . . 10.0 112.767 170.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.52 -44.99 43.01 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.911 2.407 . . . . 10.0 115.892 166.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.41 -47.4 85.59 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.319 -0.863 . . . . 10.0 111.881 175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -51.17 -49.51 60.79 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.898 1.679 . . . . 10.0 111.3 171.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.05 -48.06 76.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.237 1.015 . . . . 10.0 112.907 169.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.21 78.31 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.823 0.849 . . . . 10.0 112.863 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.37 -53.99 37.58 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.299 0.954 . . . . 10.0 111.163 169.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.12 88.8 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.151 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.71 38.29 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.951 0.9 . . . . 10.0 112.031 173.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.21 79.4 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.736 0.814 . . . . 10.0 112.669 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.75 -38.58 91.64 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.41 1.263 . . . . 10.0 114.41 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.269 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.46 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.854 1.662 . . . . 10.0 112.137 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.89 47.66 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.966 -1.709 . . . . 10.0 112.437 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.87 54.0 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.79 -39.77 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.922 1.689 . . . . 10.0 113.452 175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.31 -60.22 5.31 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.106 1.336 . . . . 10.0 115.25 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.74 87.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.382 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.49 -52.8 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.003 1.321 . . . . 10.0 111.16 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.28 67.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.516 0.562 . . . . 10.0 112.516 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.91 42.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.446 0.698 . . . . 10.0 110.932 174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.9 4.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.429 2.292 . . . . 10.0 114.821 174.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -47.01 74.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -58.52 -44.28 89.48 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.703 0.801 . . . . 10.0 111.769 175.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -56.27 5.14 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.418 1.485 . . . . 10.0 113.384 166.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 91.3 mt -56.59 -49.84 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 117.697 0.749 . . . . 10.0 111.245 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -53.85 -57.05 12.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.93 1.292 . . . . 10.0 112.587 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.64 -45.99 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.795 0.725 . . . . 10.0 111.625 173.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.24 -59.92 8.33 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.526 1.06 . . . . 10.0 112.805 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.2 p -55.79 -39.45 71.3 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.824 1.25 . . . . 10.0 112.41 172.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.85 -56.11 10.42 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.385 0.993 . . . . 10.0 113.222 167.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.1 tp -59.72 -45.69 91.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.403 1.481 . . . . 10.0 112.206 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t -54.07 -50.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 121.376 -0.827 . . . . 10.0 110.23 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.88 -60.71 6.75 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.4 1.952 . . . . 10.0 112.533 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.61 -42.56 3.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.645 2.378 . . . . 10.0 113.219 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -100.77 -6.68 24.57 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.65 116.75 10.4 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 120.186 -1.571 . . . . 10.0 110.355 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.49 -49.6 72.13 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.154 2.582 . . . . 10.0 113.304 177.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.36 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.053 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.88 -59.51 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.111 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.06 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.465 1.506 . . . . 10.0 113.56 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.74 63.26 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -54.03 -41.72 68.35 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.855 0.752 . . . . 10.0 110.768 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -69.33 -32.33 71.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.764 1.226 . . . . 10.0 114.25 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -52.15 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.051 0.841 . . . . 10.0 109.955 168.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -59.11 -51.71 68.84 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.5 t90 -48.24 -46.96 36.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.164 0.986 . . . . 10.0 113.388 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.44 -52.07 67.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.98 0.912 . . . . 10.0 111.524 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.2 mt -54.22 -51.53 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.134 1.374 . . . . 10.0 111.514 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.5 m -54.45 -47.82 72.44 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.423 1.089 . . . . 10.0 112.13 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 73.6 m -63.0 -43.1 99.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.042 1.337 . . . . 10.0 111.663 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.46 73.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.238 1.015 . . . . 10.0 112.365 170.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.9 78.14 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.761 0.824 . . . . 10.0 112.497 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.5 ttp -56.97 -52.72 64.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.652 1.181 . . . . 10.0 111.959 172.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.08 -49.27 63.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.315 1.446 . . . . 10.0 111.414 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -49.33 -54.93 14.67 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.949 0.9 . . . . 10.0 112.681 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 42.0 mm -52.16 -55.88 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 118.852 0.751 . . . . 10.0 110.41 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.7 mt -58.68 -35.22 72.25 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.463 -0.78 . . . . 10.0 111.735 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.36 -58.14 9.56 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.003 0.921 . . . . 10.0 113.008 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.85 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.438 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 mt -56.82 -49.4 75.51 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.857 1.208 . . . . 10.0 112.101 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -76.99 -70.32 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.119 -1.613 . . . . 10.0 112.851 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.89 60.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.634 1.174 . . . . 10.0 113.42 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.14 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.627 0.632 . . . . 10.0 113.514 171.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.41 51.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.26 1.824 . . . . 10.0 113.059 -166.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.54 13.8 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.96 1.096 . . . . 10.0 113.96 172.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.63 -50.54 65.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.084 0.945 . . . . 10.0 112.329 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.02 83.1 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.16 0.984 . . . . 10.0 112.117 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.47 80.12 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.524 1.305 . . . . 10.0 114.524 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.32 1.23 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.124 1.77 . . . . 10.0 114.189 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.58 29.1 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.398 1.879 . . . . 10.0 114.917 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.86 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 123.48 1.61 . . . . 10.0 114.146 -170.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.66 153.96 72.74 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.798 3.239 . . . . 10.0 105.561 170.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.21 35.4 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.334 2.023 . . . . 10.0 113.008 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.032 2.933 . . . . 10.0 113.288 173.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -69.14 -53.08 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.059 0.943 . . . . 10.0 109.816 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.86 75.59 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.317 0.647 . . . . 10.0 111.907 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.96 -56.22 24.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.953 0.901 . . . . 10.0 112.675 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.18 -53.22 60.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.181 0.993 . . . . 10.0 113.059 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.53 -49.56 45.57 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.332 0.653 . . . . 10.0 111.097 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.36 78.88 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.667 1.358 . . . . 10.0 114.667 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.06 -49.58 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.832 0.742 . . . . 10.0 110.481 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.61 69.16 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.2 0.815 . . . . 10.0 113.2 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.81 -47.74 30.95 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.883 2.073 . . . . 10.0 111.07 174.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.59 -58.33 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.815 0.446 . . . . 10.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.1 t -51.96 -47.94 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.091 0.956 . . . . 10.0 111.994 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 37.2 m -57.66 -63.41 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.397 2.679 . . . . 10.0 111.878 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.0 t -51.52 -49.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.526 1.131 . . . . 10.0 111.284 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 71.9 t -58.62 -60.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.1 0.96 . . . . 10.0 112.056 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.2 mt -60.44 -48.08 83.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -52.26 -51.07 60.55 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.707 0.803 . . . . 10.0 111.597 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -53.5 -33.51 54.65 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.028 1.121 . . . . 10.0 114.028 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.1 97.8 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.006 1.113 . . . . 10.0 114.006 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -48.18 -55.78 16.9 Favored Pre-proline 0 N--CA 1.476 0.851 0 N-CA-C 115.374 1.62 . . . . 10.0 115.374 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HB3' H183 ' A' ' 999' ' ' RET . 26.1 Cg_endo -59.63 -33.14 96.79 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.262 1.975 . . . . 10.0 113.441 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.7 t -64.0 -54.71 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.917 0.887 . . . . 10.0 110.324 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.9 t -53.23 -50.11 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.005 1.322 . . . . 10.0 111.531 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -55.68 -52.91 62.24 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.412 1.085 . . . . 10.0 112.581 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -57.49 -43.15 83.92 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.854 0.861 . . . . 10.0 112.304 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -83.98 -5.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.097 1.517 . . . . 10.0 115.097 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.37 -169.35 33.04 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-O 122.559 1.088 . . . . 10.0 113.887 -168.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -41.23 64.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.889 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -67.7 -16.79 64.31 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.731 1.752 . . . . 10.0 115.731 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.89 -105.93 1.09 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-N 120.364 1.438 . . . . 10.0 113.711 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.4 127.13 35.79 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.644 -1.504 . . . . 10.0 109.368 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.52 65.4 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.74 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.081 1.753 . . . . 10.0 108.725 166.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.39 24.91 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -68.78 153.79 72.38 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.733 2.955 . . . . 10.0 111.463 -176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.09 -39.84 2.92 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.295 1.038 . . . . 10.0 112.232 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.31 -52.35 21.87 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.95 -40.45 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.388 1.075 . . . . 10.0 109.639 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.86 41.86 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.535 0.607 . . . . 10.0 111.946 173.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.4 m -57.71 -47.01 83.6 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.006 1.723 . . . . 10.0 112.995 174.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.33 62.29 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.938 0.895 . . . . 10.0 112.054 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.61 -59.07 4.91 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.307 1.043 . . . . 10.0 109.979 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -52.97 -46.99 68.5 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.479 -1.248 . . . . 10.0 112.297 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.98 -52.34 43.58 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.739 1.609 . . . . 10.0 113.035 174.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.32 -48.52 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.553 1.141 . . . . 10.0 111.636 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.98 -50.45 72.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.143 1.377 . . . . 10.0 111.763 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.14 -59.79 4.28 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.713 2.005 . . . . 10.0 110.198 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 42.4 t -46.18 -51.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.552 1.141 . . . . 10.0 111.989 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 5.9 t -61.75 -52.6 63.6 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.888 0.875 . . . . 10.0 112.501 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.24 -21.72 65.73 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.413 1.885 . . . . 10.0 114.41 -176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -101.3 -69.21 0.79 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.924 1.29 . . . . 10.0 111.547 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.8 t -72.54 -50.76 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.507 1.123 . . . . 10.0 111.475 -173.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.07 -55.63 27.18 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.297 0.951 . . . . 10.0 112.534 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -43.05 -57.39 2.91 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.759 2.024 . . . . 10.0 112.536 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.92 -41.59 84.57 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.388 0.994 . . . . 10.0 113.945 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.92 -27.18 64.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 115.703 1.742 . . . . 10.0 115.703 176.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.21 -57.65 11.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.645 -0.872 . . . . 10.0 108.645 165.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.947 0.899 . . . . 10.0 113.155 -172.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.53 5.13 2.54 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.3 0.37 15.69 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.24 1.016 . . . . 10.0 113.324 172.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 110.972 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.69 98.21 1.88 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.725 0.81 . . . . 10.0 110.891 170.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.95 77.07 7.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.824 0.849 . . . . 10.0 112.087 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.83 2.852 . . . . 10.0 116.458 177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.91 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.721 1.209 . . . . 10.0 110.61 -175.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.77 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.656 171.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.468 2.707 . . . . 10.0 113.408 166.584 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.517 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 115.83 -2.033 . . . . 10.0 105.851 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.614 3.165 . . . . 10.0 117.211 160.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.63 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.272 2.629 . . . . 10.0 114.49 155.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.45 137.97 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.361 1.864 . . . . 10.0 113.378 -158.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.2 1.7 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.272 1.829 . . . . 10.0 113.99 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.88 41.16 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.58 -51.38 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.306 -2.759 . . . . 10.0 116.604 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.66 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.498 2.285 . . . . 10.0 113.205 -175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.31 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.868 2.467 . . . . 10.0 115.737 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.39 -43.03 61.79 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.496 -0.752 . . . . 10.0 112.642 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.69 83.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.954 0.902 . . . . 10.0 109.305 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.872 175.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.33 -53.57 56.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.238 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.81 51.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.376 1.47 . . . . 10.0 113.354 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.99 84.7 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.294 1.438 . . . . 10.0 113.026 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.95 -55.68 14.26 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.575 1.084 . . . . 10.0 111.769 166.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -50.16 -52.5 34.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.916 1.286 . . . . 10.0 112.317 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.145 0.978 . . . . 10.0 112.204 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.2 mt -58.11 -49.31 77.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.451 0.7 . . . . 10.0 112.609 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.2 mmt -55.16 -50.27 69.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.686 0.794 . . . . 10.0 111.198 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.08 -58.57 13.9 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.388 0.994 . . . . 10.0 113.634 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.15 -45.65 79.56 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.593 1.196 . . . . 10.0 112.138 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -41.62 80.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.529 1.062 . . . . 10.0 113.389 172.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -60.17 -60.49 3.74 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.09 0.956 . . . . 10.0 110.984 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.96 62.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.939 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.09 9.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.654 1.181 . . . . 10.0 112.929 172.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.72 82.1 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.649 1.179 . . . . 10.0 113.619 169.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.43 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.698 1.713 . . . . 10.0 110.835 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.86 -44.8 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.878 2.471 . . . . 10.0 109.338 171.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.97 23.1 0.87 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 115.611 1.005 . . . . 10.0 115.611 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.48 -45.0 92.93 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.145 2.178 . . . . 10.0 113.605 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.765 0.698 . . . . 10.0 112.432 -170.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.04 88.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.361 2.665 . . . . 10.0 116.933 166.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.67 -50.88 9.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.224 -1.353 . . . . 10.0 113.854 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.47 6.4 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.782 1.301 . . . . 10.0 110.957 -172.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.57 -29.64 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.08 0.552 . . . . 10.0 111.442 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.15 22.67 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.142 1.377 . . . . 10.0 113.549 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.47 -47.47 19.23 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.232 1.413 . . . . 10.0 113.46 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.11 61.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.952 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.95 -50.23 73.26 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.035 0.534 . . . . 10.0 112.351 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.36 -51.29 65.24 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.939 -0.553 . . . . 10.0 112.358 173.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.78 -56.88 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.835 1.254 . . . . 10.0 110.489 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -69.23 -17.57 63.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.18 1.392 . . . . 10.0 113.6 -172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.6 m -86.6 -42.91 13.09 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.688 1.131 . . . . 10.0 111.953 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.6 mt -57.13 -41.32 78.82 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.212 0.819 . . . . 10.0 113.212 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -50.62 -61.35 3.95 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.985 1.314 . . . . 10.0 112.254 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.27 -46.78 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.393 3.395 . . . . 10.0 115.726 163.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.96 79.67 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.241 1.2 . . . . 10.0 114.241 -175.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.2 tt -69.09 -36.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 120.256 -1.528 . . . . 10.0 111.698 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.87 77.61 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.13 0.877 . . . . 10.0 112.603 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.8 -56.0 14.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 10.0 111.89 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -48.61 -53.21 19.37 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.498 1.519 . . . . 10.0 111.113 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.59 -48.14 64.96 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.142 0.977 . . . . 10.0 112.921 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -55.34 -42.16 73.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.009 1.277 . . . . 10.0 113.196 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.66 32.89 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.292 0.951 . . . . 10.0 111.25 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.55 -41.13 60.89 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 115.255 1.576 . . . . 10.0 115.255 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 47.0 mtm -66.91 -50.77 61.37 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.531 0.732 . . . . 10.0 110.459 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.7 -52.58 22.73 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.828 0.851 . . . . 10.0 112.924 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.98 -5.46 48.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.23 -34.76 5.51 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.524 0.97 . . . . 10.0 115.524 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.26 -43.08 42.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.09 3.57 61.24 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.063 2.145 . . . . 10.0 109.001 171.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.13 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.03 166.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.09 53.36 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.726 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.6 129.63 23.18 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 125.069 1.348 . . . . 10.0 110.908 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.81 116.27 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 N-CA-C 109.382 -1.045 . . . . 10.0 109.382 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.75 164.4 38.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.78 0.659 . . . . 10.0 112.78 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.718 -0.953 . . . . 10.0 110.718 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.43 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.664 2.225 . . . . 10.0 118.664 170.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.379 1.59 . . . . 10.0 112.202 -165.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.478 1.511 . . . . 10.0 111.059 -175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.983 0.734 . . . . 10.0 112.983 -165.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.9 Cg_exo -61.52 131.9 38.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.169 3.246 . . . . 10.0 112.166 171.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.7 85.01 4.72 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.717 1.246 . . . . 10.0 113.066 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.29 -28.31 66.64 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.26 -33.59 63.3 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.283 1.033 . . . . 10.0 112.155 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.478 ' HD2' ' CZ2' ' A' ' 86' ' ' TRP . 8.1 tpp180 -39.06 -54.23 1.73 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 128.24 2.616 . . . . 10.0 111.938 165.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -77.71 -38.11 48.02 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.047 1.739 . . . . 10.0 112.579 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.2 -47.35 62.29 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.72 1.146 . . . . 10.0 110.387 167.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.46 -68.36 0.19 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.362 1.865 . . . . 10.0 111.485 168.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.478 ' CZ2' ' HD2' ' A' ' 82' ' ' ARG . 54.5 m0 -54.76 -35.83 64.19 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.608 0.966 . . . . 10.0 113.608 -172.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.6 tp -50.14 -42.19 50.24 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.104 1.762 . . . . 10.0 111.825 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -103.5 -36.96 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.543 -0.741 . . . . 10.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.4 p -61.15 -46.22 91.43 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 121.155 1.798 . . . . 10.0 113.6 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.301 76.4 p -65.93 -43.89 59.78 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 114.734 1.383 . . . . 10.0 114.734 -175.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -54.99 -43.14 62.34 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.429 2.753 . . . . 10.0 115.261 168.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.95 -47.78 84.85 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.318 -0.864 . . . . 10.0 111.698 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.411 HD21 ' HE1' ' A' ' 182' ' ' TRP . 17.5 tp -49.95 -49.59 49.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.136 1.374 . . . . 10.0 112.189 169.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -55.87 -47.93 76.46 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 121.111 -0.993 . . . . 10.0 112.658 170.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.26 78.28 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.781 0.832 . . . . 10.0 112.894 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -52.24 -54.05 35.98 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.31 0.959 . . . . 10.0 111.203 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.72 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.657 0.783 . . . . 10.0 112.158 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.74 -54.74 37.98 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.983 0.913 . . . . 10.0 112.016 173.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.15 79.17 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.677 174.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.7 tp -63.82 -38.54 91.48 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.426 1.269 . . . . 10.0 114.426 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.018 1.327 . . . . 10.0 112.296 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.5 53.49 11.99 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.821 1.648 . . . . 10.0 112.175 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.92 47.52 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.938 -1.726 . . . . 10.0 112.392 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.89 54.27 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.7 2.63 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.861 1.664 . . . . 10.0 113.456 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.25 5.27 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.02 -46.8 87.62 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.88 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.997 1.319 . . . . 10.0 111.163 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.67 -51.28 67.84 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.55 0.574 . . . . 10.0 112.55 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.88 43.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.452 0.701 . . . . 10.0 110.908 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.52 -59.96 4.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.436 2.294 . . . . 10.0 114.815 174.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.99 -46.29 96.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 123.665 0.786 . . . . 10.0 111.428 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.71 -50.25 64.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.655 0.645 . . . . 10.0 112.63 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.71 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.234 0.827 . . . . 10.0 113.234 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -55.12 -48.3 73.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.591 1.156 . . . . 10.0 111.259 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -55.51 5.22 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.39 1.472 . . . . 10.0 113.246 168.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.61 -51.99 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.549 0.74 . . . . 10.0 111.735 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.2 tmm? -50.65 -56.38 12.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.969 1.707 . . . . 10.0 112.038 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.08 -45.44 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.652 -0.655 . . . . 10.0 112.423 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.16 -58.39 12.0 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.948 1.261 . . . . 10.0 113.257 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.4 p -59.46 -35.82 74.78 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.984 0.914 . . . . 10.0 112.513 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.45 -56.86 7.81 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.293 0.949 . . . . 10.0 113.825 164.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.9 tp -58.34 -47.47 83.68 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.266 1.426 . . . . 10.0 112.149 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 72.0 t -52.75 -51.71 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.583 -0.698 . . . . 10.0 110.518 173.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.26 6.3 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.714 1.626 . . . . 10.0 112.092 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.59 -37.55 28.09 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.387 1.875 . . . . 10.0 113.893 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.6 mt -99.14 -6.35 28.45 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.162 1.541 . . . . 10.0 115.162 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.68 116.69 10.37 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.128 -1.607 . . . . 10.0 110.365 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.45 -49.61 72.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.221 2.608 . . . . 10.0 113.274 177.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.62 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.812 0.845 . . . . 10.0 110.066 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.95 -59.53 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.033 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.48 -42.06 14.92 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.413 1.485 . . . . 10.0 113.52 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -70.2 -24.58 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.66 -42.2 67.64 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 118.917 0.78 . . . . 10.0 110.692 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.53 -31.54 69.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.853 1.261 . . . . 10.0 114.348 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.36 -51.86 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.0 0.818 . . . . 10.0 109.622 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -61.68 -43.03 99.63 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.387 1.255 . . . . 10.0 114.387 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.26 -49.03 67.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.545 1.138 . . . . 10.0 112.585 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.87 71.74 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.717 0.807 . . . . 10.0 111.675 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.4 mt -56.35 -54.33 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.924 1.289 . . . . 10.0 111.943 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 p -57.39 -42.04 81.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.451 0.7 . . . . 10.0 112.468 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 67.2 m -58.91 -46.73 87.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.89 1.276 . . . . 10.0 112.6 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.36 76.28 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.312 0.96 . . . . 10.0 112.371 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.17 -43.99 83.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.982 0.913 . . . . 10.0 112.805 174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.9 ttp -57.71 -53.61 56.19 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.468 1.107 . . . . 10.0 111.982 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.9 tp -53.66 -47.61 70.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.422 1.489 . . . . 10.0 111.982 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -50.1 -54.56 19.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.001 0.92 . . . . 10.0 112.416 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.4 mt -53.78 -54.98 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.79 0.836 . . . . 10.0 110.728 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.56 -36.56 69.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.179 0.807 . . . . 10.0 113.179 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.17 9.4 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.46 -40.86 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.8 -49.43 75.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.883 1.22 . . . . 10.0 112.145 171.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.043 -1.66 . . . . 10.0 112.874 -175.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.72 -21.91 60.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.607 1.163 . . . . 10.0 113.466 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.644 0.64 . . . . 10.0 113.522 171.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.43 51.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.037 -166.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.5 m -52.16 -56.42 14.67 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.953 1.094 . . . . 10.0 113.953 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.7 -50.51 65.72 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.145 0.974 . . . . 10.0 112.307 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.05 82.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.192 0.997 . . . . 10.0 112.152 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.53 80.03 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.502 1.297 . . . . 10.0 114.502 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.42 -11.29 1.19 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.084 1.754 . . . . 10.0 114.223 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.1 6.64 29.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.411 1.884 . . . . 10.0 114.867 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.97 -92.62 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.501 1.619 . . . . 10.0 114.135 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.68 153.93 72.68 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.837 3.255 . . . . 10.0 105.604 170.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.345 2.03 . . . . 10.0 113.083 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.668 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.07 68.07 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.285 173.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.13 -53.05 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.105 0.962 . . . . 10.0 109.816 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.82 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.06 -56.11 25.63 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.864 0.865 . . . . 10.0 112.731 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.2 -53.24 60.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.229 1.012 . . . . 10.0 112.988 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.51 -49.56 45.38 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.324 0.65 . . . . 10.0 111.097 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.14 -48.44 78.67 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.66 1.356 . . . . 10.0 114.66 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.97 -49.58 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.807 0.731 . . . . 10.0 110.482 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.14 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.169 0.803 . . . . 10.0 113.169 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.72 31.05 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 126.84 2.056 . . . . 10.0 111.068 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.61 -58.29 9.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.781 0.432 . . . . 10.0 111.245 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.85 -49.3 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.07 0.948 . . . . 10.0 111.497 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 29.7 m -56.19 -64.01 1.0 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.115 2.566 . . . . 10.0 111.952 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.02 -49.11 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.666 1.186 . . . . 10.0 111.347 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.31 -61.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.09 0.956 . . . . 10.0 112.372 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.6 mp -58.04 -46.84 84.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.421 0.688 . . . . 10.0 111.932 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . 0.411 ' HE1' HD21 ' A' ' 93' ' ' LEU . 9.0 m95 -51.29 -52.8 41.82 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.16 0.984 . . . . 10.0 112.101 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.6 m -54.46 -31.01 54.76 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.789 1.033 . . . . 10.0 113.789 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.91 93.82 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.816 1.043 . . . . 10.0 113.816 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -47.3 -55.28 16.6 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 115.712 1.745 . . . . 10.0 115.712 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.545 ' HB3' H183 ' A' ' 999' ' ' RET . 19.2 Cg_endo -58.05 -36.88 97.66 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.552 2.168 . . . . 10.0 112.952 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.97 -54.31 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.429 1.092 . . . . 10.0 110.666 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.4 t -53.51 -49.23 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.758 1.223 . . . . 10.0 111.483 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -55.59 -53.3 58.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.697 1.199 . . . . 10.0 112.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -56.25 -44.51 79.72 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.936 0.894 . . . . 10.0 112.655 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -84.52 -5.81 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.08 1.511 . . . . 10.0 115.08 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.26 33.1 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-O 122.627 1.126 . . . . 10.0 113.94 -168.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.18 -41.1 64.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.202 -0.999 . . . . 10.0 111.846 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -54.43 -31.66 55.77 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.503 2.721 . . . . 10.0 115.359 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.34 -103.85 0.96 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.433 1.015 . . . . 10.0 113.506 -167.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.15 35.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.653 -1.498 . . . . 10.0 109.357 169.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.4 1.36 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.69 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.721 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.33 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.388 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.72 153.8 72.51 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.792 2.995 . . . . 10.0 111.483 -176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.83 3.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.364 1.065 . . . . 10.0 112.19 171.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.41 21.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.0 -40.42 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.363 1.065 . . . . 10.0 109.625 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.34 -49.81 42.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.61 0.641 . . . . 10.0 111.944 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.05 83.37 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.055 1.742 . . . . 10.0 112.976 174.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.4 -52.29 62.24 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.934 0.894 . . . . 10.0 112.054 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -58.73 5.84 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.338 1.055 . . . . 10.0 109.955 176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -52.51 -45.36 66.2 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.604 -1.189 . . . . 10.0 112.684 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.8 -52.67 59.56 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.48 1.491 . . . . 10.0 112.856 174.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.51 -46.17 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.055 1.342 . . . . 10.0 111.551 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.28 -54.25 49.02 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.302 1.441 . . . . 10.0 111.589 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -54.03 -58.74 6.18 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.523 1.929 . . . . 10.0 111.278 178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.86 -42.94 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.153 -0.967 . . . . 10.0 112.185 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 20.0 m -59.94 -48.57 81.18 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.755 0.822 . . . . 10.0 112.088 172.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.93 -18.69 64.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.653 1.981 . . . . 10.0 114.536 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -106.4 -74.14 0.66 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.021 1.328 . . . . 10.0 111.812 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 1.4 m -75.19 -42.31 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 O-C-N 120.629 -1.294 . . . . 10.0 111.785 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -57.84 -55.26 31.49 Favored Glycine 0 N--CA 1.476 1.308 0 C-N-CA 124.06 0.838 . . . . 10.0 112.4 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -40.7 -60.13 1.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.904 2.081 . . . . 10.0 112.324 163.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.87 -38.03 72.45 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.13 0.872 . . . . 10.0 113.745 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.2 mt -69.94 -27.55 64.85 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 115.997 1.851 . . . . 10.0 115.997 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.73 -57.37 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.493 -0.929 . . . . 10.0 108.493 165.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.88 0.872 . . . . 10.0 113.171 -172.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.62 5.23 2.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 115.341 1.608 . . . . 10.0 115.341 -171.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.4 15.7 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.174 0.99 . . . . 10.0 113.32 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.998 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.668 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.72 98.24 1.9 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.73 0.812 . . . . 10.0 110.953 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.04 7.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.87 0.868 . . . . 10.0 112.037 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.904 2.881 . . . . 10.0 116.466 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.85 -55.48 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.765 1.226 . . . . 10.0 110.635 -175.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.22 169.49 39.74 Favored Glycine 0 C--O 1.238 0.388 0 C-N-CA 129.738 3.542 . . . . 10.0 119.647 171.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.476 2.711 . . . . 10.0 113.421 166.567 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.545 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.794 -2.05 . . . . 10.0 105.835 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.49 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.595 3.158 . . . . 10.0 117.209 160.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.66 65.1 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.306 2.642 . . . . 10.0 114.452 155.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.51 137.99 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.357 1.863 . . . . 10.0 113.393 -158.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.74 -165.2 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.76 40.74 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.412 2.434 . . . . 10.0 111.516 168.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.31 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.281 -2.771 . . . . 10.0 116.679 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.96 -60.66 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.477 2.277 . . . . 10.0 113.238 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.37 0.95 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.834 2.453 . . . . 10.0 115.751 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.42 -43.07 61.9 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.458 -0.776 . . . . 10.0 112.604 176.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.348 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.46 -52.62 63.01 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.386 0.675 . . . . 10.0 111.84 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.82 -46.8 51.53 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.353 1.461 . . . . 10.0 113.335 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.68 -44.93 84.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.267 1.427 . . . . 10.0 113.056 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.06 -55.78 14.31 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.373 0.987 . . . . 10.0 111.689 166.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.97 -52.41 33.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.874 1.27 . . . . 10.0 112.336 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.47 -58.89 5.72 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.172 0.989 . . . . 10.0 112.14 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.8 mt -57.42 -48.79 78.19 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.619 0.768 . . . . 10.0 112.684 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.41 -47.1 85.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.221 1.008 . . . . 10.0 111.502 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.4 -58.64 13.52 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.309 0.957 . . . . 10.0 113.721 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.21 -46.03 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.658 1.229 . . . . 10.0 112.112 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.18 -42.68 73.23 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.987 1.28 . . . . 10.0 113.175 172.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -62.05 -58.35 8.17 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.718 0.807 . . . . 10.0 111.534 172.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.32 -40.99 62.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.937 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.74 -58.07 9.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.616 1.166 . . . . 10.0 112.999 172.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.58 -38.71 81.93 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.244 0.831 . . . . 10.0 113.244 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.09 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.625 1.17 . . . . 10.0 113.659 169.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.728 1.727 . . . . 10.0 110.868 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.88 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.875 2.47 . . . . 10.0 109.33 171.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.11 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.01 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.101 2.161 . . . . 10.0 113.623 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.175 -1.375 . . . . 10.0 113.841 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.84 117.52 6.35 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.745 1.278 . . . . 10.0 110.957 -172.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.63 -29.66 89.87 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.678 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.085 0.554 . . . . 10.0 111.448 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.22 -40.04 23.08 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.583 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.53 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.219 1.408 . . . . 10.0 113.446 172.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.81 -53.04 62.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.939 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.99 -50.27 73.21 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.316 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.29 -51.33 64.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.39 0.541 . . . . 10.0 112.395 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.399 0.889 . . . . 10.0 113.399 177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.44 -58.06 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 10.0 110.256 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 m -67.78 -18.71 64.95 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.234 1.414 . . . . 10.0 113.725 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -86.74 -40.64 14.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.381 1.072 . . . . 10.0 112.292 175.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.13 -42.92 91.77 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.44 -0.787 . . . . 10.0 112.708 172.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.2 t -42.2 -62.29 1.25 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.504 1.522 . . . . 10.0 113.285 177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.17 -26.12 21.54 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.069 2.513 . . . . 10.0 114.24 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.94 80.63 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 120.855 1.662 . . . . 10.0 113.293 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.5 -49.83 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.026 -1.046 . . . . 10.0 109.778 169.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.56 -45.96 73.6 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 175.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -50.98 -56.32 13.04 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.758 1.623 . . . . 10.0 112.046 171.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 m -49.4 -52.76 26.46 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.303 1.441 . . . . 10.0 110.626 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.439 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.6 mmt -68.87 -47.97 64.59 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.005 0.922 . . . . 10.0 113.047 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -57.27 -40.13 77.08 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.201 -1.381 . . . . 10.0 113.346 173.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.3 -54.6 34.04 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.037 1.29 . . . . 10.0 111.301 170.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.04 61.0 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.211 1.56 . . . . 10.0 115.211 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.94 -50.78 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.566 0.746 . . . . 10.0 110.476 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.6 -52.65 21.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.883 . . . . 10.0 112.9 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -77.03 -5.51 49.06 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.34 1.056 . . . . 10.0 113.769 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.554 0.982 . . . . 10.0 115.554 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.04 43.04 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.28 1.585 . . . . 10.0 115.28 -176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.304 0.882 . . . . 10.0 115.304 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.26 143.37 26.48 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.082 2.153 . . . . 10.0 109.018 172.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.008 0.923 . . . . 10.0 111.021 166.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.01 53.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.751 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.56 129.58 23.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 125.12 1.368 . . . . 10.0 110.991 -176.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.28 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.379 -1.047 . . . . 10.0 109.379 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.73 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.41 -81.94 0.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.634 -0.986 . . . . 10.0 110.634 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.45 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.55 -171.82 4.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.306 1.553 . . . . 10.0 112.23 -165.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.91 93.89 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.527 1.531 . . . . 10.0 111.056 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.45 120.79 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.989 0.737 . . . . 10.0 112.989 -165.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.6 Cg_exo -61.57 131.93 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.196 3.264 . . . . 10.0 112.129 171.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 126.004 1.721 . . . . 10.0 111.739 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.62 84.98 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 123.005 1.384 . . . . 10.0 113.035 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.32 -28.31 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.839 -1.163 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.93 -25.92 45.45 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.259 1.023 . . . . 10.0 113.197 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -50.42 -60.96 2.48 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.706 1.202 . . . . 10.0 111.05 168.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -58.17 -42.44 86.01 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.32 2.248 . . . . 10.0 112.633 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.32 63.44 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 119.487 1.04 . . . . 10.0 112.418 169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.439 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -62.39 -60.46 3.53 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.384 0.993 . . . . 10.0 111.759 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -52.96 -36.24 59.78 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 112.328 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.4 tp -50.49 -42.64 54.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.536 1.934 . . . . 10.0 112.14 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -102.35 -39.05 7.35 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.83 0.852 . . . . 10.0 112.842 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 71.2 p -63.08 -45.9 89.95 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 120.559 1.527 . . . . 10.0 113.308 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 72.6 p -62.86 -44.21 85.0 Favored Pre-proline 0 N--CA 1.478 0.944 0 N-CA-C 114.825 1.417 . . . . 10.0 114.825 -177.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.07 -43.29 60.73 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.521 2.814 . . . . 10.0 115.32 167.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.48 -47.5 85.86 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.803 0.729 . . . . 10.0 111.71 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.0 mt -53.6 -45.27 69.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.39 1.076 . . . . 10.0 112.204 172.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.81 -47.42 82.65 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.111 -0.993 . . . . 10.0 112.769 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.29 78.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.846 0.858 . . . . 10.0 112.88 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.29 -54.06 36.2 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.258 0.936 . . . . 10.0 111.161 169.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.1 88.76 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.62 0.768 . . . . 10.0 112.146 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.75 37.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.986 0.914 . . . . 10.0 112.028 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.14 79.14 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.677 0.791 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.61 91.75 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.76 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.045 1.338 . . . . 10.0 112.313 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.844 1.658 . . . . 10.0 112.104 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.85 47.66 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.903 -1.748 . . . . 10.0 112.446 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.46 135.96 54.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.705 0.632 . . . . 10.0 112.705 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.71 2.64 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.856 1.663 . . . . 10.0 113.471 175.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.27 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.178 1.37 . . . . 10.0 115.262 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.04 -46.83 87.45 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.153 -1.403 . . . . 10.0 111.323 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.7 mt -48.37 -52.95 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.02 1.328 . . . . 10.0 111.124 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.32 67.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.09 -44.92 42.5 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.49 0.716 . . . . 10.0 110.98 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.94 4.65 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.396 2.279 . . . . 10.0 114.8 174.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.93 -46.38 96.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.69 0.796 . . . . 10.0 111.423 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.29 64.24 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.674 0.654 . . . . 10.0 112.593 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.32 74.83 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -57.37 -45.72 84.13 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.164 0.986 . . . . 10.0 111.995 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -44.07 -55.62 5.61 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.332 1.444 . . . . 10.0 112.982 167.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.21 -53.57 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.02 -0.99 . . . . 10.0 110.768 172.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 57.4 ttp -46.02 -58.1 3.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.504 1.502 . . . . 10.0 112.653 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.1 mm -71.58 -45.08 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.694 -0.629 . . . . 10.0 112.429 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.5 -47.4 63.31 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.593 1.092 . . . . 10.0 112.884 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.3 m -60.88 -44.85 96.52 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.313 1.445 . . . . 10.0 111.384 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.49 -55.01 11.46 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.474 1.035 . . . . 10.0 113.402 168.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.85 -48.23 51.23 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.498 2.719 . . . . 10.0 111.636 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.61 -49.1 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 120.951 -1.093 . . . . 10.0 111.539 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.27 -59.36 9.03 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.857 1.694 . . . . 10.0 112.448 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.07 -43.2 3.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.475 2.71 . . . . 10.0 113.272 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -101.26 -6.38 24.25 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.446 1.647 . . . . 10.0 115.446 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.76 10.48 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.222 -1.549 . . . . 10.0 110.397 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.217 2.607 . . . . 10.0 113.255 177.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.68 106.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.733 0.813 . . . . 10.0 110.065 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.94 -59.54 3.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.029 -173.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.09 14.87 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.513 1.525 . . . . 10.0 113.486 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.23 -24.6 63.12 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.872 1.434 . . . . 10.0 114.872 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.95 -41.75 68.14 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.935 0.789 . . . . 10.0 110.776 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.86 70.22 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.356 1.243 . . . . 10.0 114.356 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.05 -52.46 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.043 0.838 . . . . 10.0 109.621 168.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -60.51 -45.26 94.47 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.015 1.116 . . . . 10.0 114.015 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -52.23 -48.89 64.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.414 1.006 . . . . 10.0 112.895 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.57 -54.45 45.78 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.092 0.957 . . . . 10.0 111.645 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.0 mt -53.28 -49.83 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.052 1.341 . . . . 10.0 111.592 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -54.84 -48.09 73.31 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.866 1.266 . . . . 10.0 111.852 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.7 m -65.19 -40.49 94.28 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.602 1.561 . . . . 10.0 111.665 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.07 -49.41 77.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.049 0.94 . . . . 10.0 112.286 170.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.45 79.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.746 0.818 . . . . 10.0 112.441 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.7 ttp -55.37 -54.04 48.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.12 0.968 . . . . 10.0 112.243 171.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -52.07 -50.38 61.66 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.83 1.652 . . . . 10.0 111.407 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -50.15 -54.71 18.89 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.14 0.976 . . . . 10.0 112.502 172.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.7 mt -53.49 -55.26 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.775 0.83 . . . . 10.0 110.736 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.32 -35.84 70.38 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.287 -0.863 . . . . 10.0 112.866 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.48 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.03 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.85 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.352 -0.832 . . . . 10.0 111.437 178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.4 mt -56.84 -49.37 75.63 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.866 1.212 . . . . 10.0 112.153 171.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.92 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.94 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.645 1.178 . . . . 10.0 113.412 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.75 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.676 0.655 . . . . 10.0 113.51 171.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.61 -32.43 51.12 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.23 1.812 . . . . 10.0 113.08 -166.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 30.9 m -52.04 -56.52 13.84 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.025 1.12 . . . . 10.0 114.025 172.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.58 -50.62 65.2 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.115 0.959 . . . . 10.0 112.32 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.08 -46.08 82.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.188 0.995 . . . . 10.0 112.105 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.54 79.8 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.516 1.302 . . . . 10.0 114.516 174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.47 -11.33 1.22 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.101 1.76 . . . . 10.0 114.235 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.07 6.67 29.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.433 1.893 . . . . 10.0 114.89 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.96 -92.68 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.473 1.606 . . . . 10.0 114.115 -170.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.68 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 129.805 3.242 . . . . 10.0 105.541 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.8 -46.25 34.93 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.308 2.005 . . . . 10.0 113.052 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.06 68.11 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.977 2.911 . . . . 10.0 113.259 173.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.16 -53.05 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 C-N-CA 124.014 0.925 . . . . 10.0 109.804 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.81 75.57 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.237 0.615 . . . . 10.0 111.952 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -60.02 -56.13 25.45 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.894 0.877 . . . . 10.0 112.734 174.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.1 m -57.3 -53.11 61.83 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.139 0.976 . . . . 10.0 113.02 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.6 -49.51 46.41 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.287 0.635 . . . . 10.0 111.118 174.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.1 -48.4 78.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.6 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 118.774 0.715 . . . . 10.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.52 -51.68 68.84 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.74 -47.77 30.14 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.822 2.049 . . . . 10.0 111.077 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.14 -47.0 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.015 0.926 . . . . 10.0 112.127 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 34.1 m -58.33 -64.16 1.02 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.276 2.631 . . . . 10.0 111.735 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.33 -50.15 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.68 1.192 . . . . 10.0 110.989 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.19 -63.79 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.962 0.905 . . . . 10.0 111.915 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.07 -48.33 73.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.24 0.927 . . . . 10.0 112.69 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.76 -50.41 70.5 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.834 0.854 . . . . 10.0 111.66 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 53.0 p -52.27 -33.37 41.56 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.397 1.258 . . . . 10.0 114.397 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.69 -40.16 94.9 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -47.72 -56.12 14.5 Favored Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 114.991 1.478 . . . . 10.0 114.991 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.429 ' HB3' H183 ' A' ' 999' ' ' RET . 28.6 Cg_endo -60.0 -33.36 95.55 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.249 1.966 . . . . 10.0 113.625 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.74 -54.67 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.17 0.895 . . . . 10.0 110.395 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.06 -50.54 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.236 1.415 . . . . 10.0 111.472 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -55.5 -52.63 63.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.408 1.083 . . . . 10.0 112.598 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -58.51 -42.97 88.87 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.686 0.794 . . . . 10.0 112.45 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -83.3 -5.86 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.915 1.45 . . . . 10.0 114.915 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.3 33.13 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 122.55 1.083 . . . . 10.0 113.964 -168.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.62 65.2 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.868 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.78 -15.87 63.84 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 115.568 1.692 . . . . 10.0 115.568 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.49 -106.06 1.06 Allowed Glycine 0 CA--C 1.533 1.176 0 CA-C-N 120.452 1.478 . . . . 10.0 113.965 -173.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.11 35.81 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.34 168.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.28 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.919 0.328 . . . . 10.0 113.919 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.55 -42.78 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 126.126 1.77 . . . . 10.0 108.725 166.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.4 t -126.29 133.38 24.9 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.419 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -68.7 153.77 72.6 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.816 3.011 . . . . 10.0 111.469 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.79 2.99 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.273 1.029 . . . . 10.0 112.251 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.32 -52.42 21.57 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.9 -40.52 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.618 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -49.28 -49.77 42.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.574 0.625 . . . . 10.0 111.991 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.07 83.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.086 1.755 . . . . 10.0 113.002 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.36 62.11 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.962 0.905 . . . . 10.0 112.063 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.5 -60.0 3.77 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.364 1.066 . . . . 10.0 109.974 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -52.51 -46.96 66.9 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 117.004 -1.474 . . . . 10.0 111.934 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.77 -53.03 35.16 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 121.376 1.898 . . . . 10.0 113.119 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.27 -48.55 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.083 1.353 . . . . 10.0 111.499 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.5 mp -57.48 -50.86 71.68 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.101 1.36 . . . . 10.0 111.577 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -56.96 -59.69 4.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.71 2.404 . . . . 10.0 111.089 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.9 m -57.27 -38.83 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 120.563 -1.336 . . . . 10.0 112.379 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 8.6 t -62.86 -54.51 37.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.091 0.956 . . . . 10.0 112.024 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.66 -28.7 69.57 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.006 1.722 . . . . 10.0 114.386 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -90.77 -70.66 0.67 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.37 1.068 . . . . 10.0 111.605 173.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 16.9 t -76.59 -48.73 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.506 1.122 . . . . 10.0 111.797 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -54.87 -54.11 35.54 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.409 1.004 . . . . 10.0 113.128 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -45.22 -56.21 5.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.448 1.899 . . . . 10.0 111.814 166.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.74 -40.5 71.64 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.327 0.965 . . . . 10.0 113.903 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -70.41 -27.77 64.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 115.843 1.794 . . . . 10.0 115.843 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.49 -57.44 11.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.587 -0.894 . . . . 10.0 108.587 165.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.7 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.906 0.882 . . . . 10.0 113.193 -172.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.56 5.25 2.49 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.28 0.25 15.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.269 1.028 . . . . 10.0 113.301 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -107.99 177.93 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.078 0.951 . . . . 10.0 111.033 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.63 98.21 1.86 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.758 0.823 . . . . 10.0 110.92 170.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.04 7.89 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.866 0.866 . . . . 10.0 112.07 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.474 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.85 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.7 1.2 . . . . 10.0 110.674 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.31 169.51 40.05 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.534 . . . . 10.0 119.647 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.521 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.597 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.52 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.554 3.142 . . . . 10.0 117.276 160.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.64 . . . . 10.0 114.524 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.393 1.877 . . . . 10.0 113.338 -158.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.302 1.841 . . . . 10.0 114.018 -174.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.07 2.79 41.48 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.43 2.443 . . . . 10.0 111.48 168.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.6 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.235 -2.793 . . . . 10.0 116.649 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.04 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.559 2.307 . . . . 10.0 113.194 -175.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.23 4.31 0.98 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.842 2.457 . . . . 10.0 115.769 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.11 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.493 -0.754 . . . . 10.0 112.669 176.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.62 83.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.89 0.876 . . . . 10.0 109.272 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.41 -52.63 62.94 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.393 0.677 . . . . 10.0 111.885 175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.34 -53.64 55.81 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.231 0.612 . . . . 10.0 112.18 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.77 51.99 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.413 1.485 . . . . 10.0 113.319 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.95 84.74 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.316 1.446 . . . . 10.0 112.998 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.56 -56.28 11.64 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.544 1.069 . . . . 10.0 111.549 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -50.18 -52.3 36.63 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.795 1.238 . . . . 10.0 112.171 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.86 5.8 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.154 0.981 . . . . 10.0 112.143 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.06 -48.9 77.43 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.67 0.788 . . . . 10.0 112.786 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 54.6 mtt -61.27 -44.48 97.17 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.905 0.882 . . . . 10.0 111.363 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.69 13.26 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.326 0.965 . . . . 10.0 113.967 172.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.22 -45.96 79.7 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 118.568 1.184 . . . . 10.0 112.131 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.6 -41.96 75.38 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.8 1.19 . . . . 10.0 113.191 173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.9 m -62.46 -58.36 7.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.717 0.807 . . . . 10.0 111.414 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.98 62.53 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.04 0.936 . . . . 10.0 110.917 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.07 9.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.599 1.16 . . . . 10.0 112.985 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.65 81.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.174 . . . . 10.0 113.585 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.33 40.88 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 123.745 1.736 . . . . 10.0 110.868 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.79 -44.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.367 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.88 23.09 0.86 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.656 1.023 . . . . 10.0 115.656 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.56 -44.98 93.12 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.178 2.191 . . . . 10.0 113.581 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.58 -84.45 1.18 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.787 0.708 . . . . 10.0 112.487 -170.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.01 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.435 2.694 . . . . 10.0 116.933 166.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 m -79.64 -50.86 10.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.867 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.52 6.45 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.765 1.291 . . . . 10.0 110.975 -172.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.64 -29.53 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.702 2.935 . . . . 10.0 113.724 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.36 -60.67 2.27 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.099 0.56 . . . . 10.0 111.407 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.07 22.5 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.097 1.359 . . . . 10.0 113.588 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.46 19.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.26 1.424 . . . . 10.0 113.396 172.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 61.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.459 0.704 . . . . 10.0 110.986 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.91 -50.27 73.05 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.128 0.571 . . . . 10.0 112.321 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.29 65.31 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.888 -0.577 . . . . 10.0 112.321 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.44 -61.93 1.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 177.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.52 -57.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.897 1.279 . . . . 10.0 110.562 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 m -67.98 -20.91 65.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.952 1.301 . . . . 10.0 113.488 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.8 m -83.9 -40.68 18.28 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.401 1.08 . . . . 10.0 112.263 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.7 mt -59.43 -41.87 90.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.393 -0.817 . . . . 10.0 113.182 173.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.1 t -45.07 -62.74 1.48 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.542 1.137 . . . . 10.0 113.081 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.33 -25.5 30.53 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.842 2.362 . . . . 10.0 113.871 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.41 -46.91 78.14 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 120.644 1.565 . . . . 10.0 113.188 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.76 -49.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.048 -1.033 . . . . 10.0 109.271 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.11 72.27 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.925 0.89 . . . . 10.0 113.238 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -50.83 -57.21 8.99 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.812 1.645 . . . . 10.0 111.768 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.1 m -48.49 -53.09 19.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.41 1.484 . . . . 10.0 110.787 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.69 -48.15 64.62 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.008 0.923 . . . . 10.0 113.05 -176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -56.58 -40.73 75.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.185 1.357 . . . . 10.0 113.347 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.28 -54.58 34.28 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.789 1.177 . . . . 10.0 111.284 170.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.08 61.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.192 1.553 . . . . 10.0 115.192 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.86 -50.85 61.2 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.581 0.752 . . . . 10.0 110.458 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.66 -52.63 22.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.873 0.869 . . . . 10.0 112.91 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.96 -5.54 48.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.328 1.051 . . . . 10.0 113.833 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.69 5.57 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.06 43.35 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.213 1.561 . . . . 10.0 115.213 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.48 61.33 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.318 0.887 . . . . 10.0 115.318 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.21 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.049 2.14 . . . . 10.0 109.034 171.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.53 171.04 15.24 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.042 0.937 . . . . 10.0 111.024 166.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.11 53.34 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.719 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.9 t -129.56 129.54 23.19 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.103 1.361 . . . . 10.0 110.994 -176.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.73 116.21 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.474 -1.01 . . . . 10.0 109.474 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.7 164.4 38.18 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.38 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.68 -3.42 0.7 Allowed Glycine 0 CA--C 1.527 0.786 0 N-CA-C 118.716 2.247 . . . . 10.0 118.716 170.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.57 -171.86 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.327 1.564 . . . . 10.0 112.223 -165.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.91 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.501 1.52 . . . . 10.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.8 Cg_exo -61.45 131.93 38.44 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.201 171.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.18 126.34 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 125.992 1.717 . . . . 10.0 111.671 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.64 85.02 4.75 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 123.419 1.581 . . . . 10.0 113.087 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.28 -28.32 66.64 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.485 -1.385 . . . . 10.0 113.937 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.14 62.14 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.231 1.196 . . . . 10.0 114.231 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.424 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.8 ptp180 -65.12 -24.98 67.57 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.221 -1.549 . . . . 10.0 113.861 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -75.01 -42.6 57.07 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.577 -1.327 . . . . 10.0 112.189 170.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.82 -48.41 59.77 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.203 1.401 . . . . 10.0 111.693 167.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.95 -72.3 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.563 1.945 . . . . 10.0 111.819 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.424 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 49.8 m0 -55.43 -32.02 62.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.738 1.215 . . . . 10.0 112.952 -171.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.7 tp -50.66 -41.57 55.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.104 1.361 . . . . 10.0 111.932 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -103.84 -45.08 4.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.873 0.869 . . . . 10.0 112.626 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 65.7 p -59.51 -38.9 82.17 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.593 1.088 . . . . 10.0 113.373 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.0 m -66.61 -51.65 39.51 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 117.957 -1.021 . . . . 10.0 113.106 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 79.8 Cg_exo -51.56 -40.69 63.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.262 2.641 . . . . 10.0 114.631 171.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.5 mt -59.37 -48.31 82.14 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.619 0.767 . . . . 10.0 112.225 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.19 -39.45 86.55 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.584 1.084 . . . . 10.0 112.25 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.12 -49.05 74.99 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.081 -1.012 . . . . 10.0 111.348 167.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.29 78.27 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.852 0.861 . . . . 10.0 112.846 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.22 -54.1 35.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.301 0.955 . . . . 10.0 111.201 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.07 88.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.093 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.68 38.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.031 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.21 79.37 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.779 0.832 . . . . 10.0 112.669 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.81 -38.46 91.18 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.86 1.41 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.025 1.33 . . . . 10.0 112.298 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.58 53.49 12.08 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.873 1.669 . . . . 10.0 112.13 -173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.31 145.88 47.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.929 -1.732 . . . . 10.0 112.455 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.87 54.25 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.7 0.63 . . . . 10.0 112.7 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.86 -39.72 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.866 1.666 . . . . 10.0 113.423 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.18 5.33 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.178 1.37 . . . . 10.0 115.276 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.8 p -62.13 -46.72 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.051 -1.452 . . . . 10.0 111.285 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.48 -52.89 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.036 1.334 . . . . 10.0 111.11 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.6 -51.32 67.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.552 0.575 . . . . 10.0 112.552 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.87 42.72 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.496 0.718 . . . . 10.0 110.932 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.65 -59.85 4.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.354 2.262 . . . . 10.0 114.784 175.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.691 0.796 . . . . 10.0 111.442 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.28 64.2 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.666 0.65 . . . . 10.0 112.668 174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.62 -46.64 73.9 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.573 0.749 . . . . 10.0 113.021 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -59.4 -43.7 92.95 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.847 0.859 . . . . 10.0 112.066 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.49 -57.09 4.58 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.801 1.667 . . . . 10.0 113.123 165.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.1 mt -56.63 -49.81 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.94 0.896 . . . . 10.0 111.177 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -53.38 -58.62 6.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.427 1.012 . . . . 10.0 112.394 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.9 mp -64.96 -48.36 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.417 0.553 . . . . 10.0 111.223 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.61 -47.81 57.02 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.804 1.193 . . . . 10.0 112.888 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 97.7 m -60.27 -45.76 92.18 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.965 1.306 . . . . 10.0 111.882 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.2 -54.27 12.97 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.115 0.864 . . . . 10.0 112.904 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.55 -49.6 45.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.504 2.722 . . . . 10.0 111.7 173.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.94 -49.09 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 O-C-N 120.922 -1.111 . . . . 10.0 111.627 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.02 -59.68 9.1 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.054 1.787 . . . . 10.0 112.541 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.09 3.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.181 2.592 . . . . 10.0 113.298 175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.9 mt -100.83 -6.9 24.17 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.477 1.658 . . . . 10.0 115.477 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.182 -1.574 . . . . 10.0 110.409 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.619 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.52 -49.61 72.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.26 2.624 . . . . 10.0 113.239 177.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.58 106.29 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.783 0.833 . . . . 10.0 110.088 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.065 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.06 15.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.458 1.503 . . . . 10.0 113.49 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.19 -24.65 63.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 114.884 1.439 . . . . 10.0 114.884 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.05 -41.38 68.04 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.902 0.774 . . . . 10.0 110.891 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -70.13 -31.26 68.71 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.837 1.255 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.49 -52.25 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.057 0.844 . . . . 10.0 109.629 168.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -60.26 -46.14 90.85 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.462 0.912 . . . . 10.0 113.462 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.1 t90 -50.95 -48.53 60.9 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.763 1.165 . . . . 10.0 113.213 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.87 -53.94 52.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.78 0.832 . . . . 10.0 111.79 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.72 -53.31 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.091 1.356 . . . . 10.0 111.859 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.6 p -58.67 -44.17 90.1 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.809 0.844 . . . . 10.0 112.697 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.4 m -60.66 -43.3 97.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.346 1.058 . . . . 10.0 112.346 174.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.51 -49.1 78.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.295 0.952 . . . . 10.0 112.449 171.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.39 -44.49 80.28 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.864 0.865 . . . . 10.0 112.524 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 35.8 ttp -55.74 -53.46 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.388 1.075 . . . . 10.0 112.024 171.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.74 -47.96 73.18 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.432 1.493 . . . . 10.0 112.446 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.6 -54.14 19.97 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.027 0.931 . . . . 10.0 112.062 170.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.0 mt -54.07 -54.86 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.593 0.757 . . . . 10.0 110.897 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.48 -36.45 69.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 118.441 -0.79 . . . . 10.0 113.116 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.35 -58.1 9.72 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.984 0.913 . . . . 10.0 113.077 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.93 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.344 -0.836 . . . . 10.0 111.461 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.9 mt -56.77 -49.41 75.39 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.858 1.208 . . . . 10.0 112.163 171.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.908 -175.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.9 60.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.624 1.169 . . . . 10.0 113.494 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.86 -79.03 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.601 0.619 . . . . 10.0 113.519 171.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.64 -32.46 51.49 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.268 1.827 . . . . 10.0 113.067 -166.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.06 -56.45 14.32 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.022 1.119 . . . . 10.0 114.022 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.72 -50.5 65.79 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.06 0.934 . . . . 10.0 112.302 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.18 -45.98 83.23 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.197 0.999 . . . . 10.0 112.114 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.43 80.42 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.28 1.23 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.091 1.756 . . . . 10.0 114.194 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.11 6.66 29.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.374 1.87 . . . . 10.0 114.846 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.4 mmm -91.91 -92.64 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.522 1.63 . . . . 10.0 114.193 -170.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.71 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 129.794 3.238 . . . . 10.0 105.571 170.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.91 -46.19 35.55 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.263 1.976 . . . . 10.0 113.032 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.9 -46.13 67.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 129.04 2.936 . . . . 10.0 113.284 173.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.21 -52.95 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.17 -46.85 75.79 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.251 0.62 . . . . 10.0 111.9 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.19 24.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.9 m -57.19 -53.24 60.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 112.995 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.54 -49.56 45.62 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.292 0.637 . . . . 10.0 111.097 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.98 -49.57 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.832 0.742 . . . . 10.0 110.54 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.56 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.18 0.807 . . . . 10.0 113.18 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.74 -47.87 30.11 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.839 2.056 . . . . 10.0 111.038 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.46 -58.35 8.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.769 0.428 . . . . 10.0 111.269 174.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.0 t -51.8 -48.73 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.116 0.967 . . . . 10.0 111.546 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.9 m -57.05 -63.99 1.03 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.056 2.542 . . . . 10.0 111.863 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.64 -49.15 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.847 1.259 . . . . 10.0 111.235 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.65 -62.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.89 0.876 . . . . 10.0 112.494 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.23 -45.26 84.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.748 0.704 . . . . 10.0 111.976 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -51.78 -53.08 43.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.929 0.892 . . . . 10.0 112.383 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.2 m -53.14 -31.68 43.62 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.341 1.057 . . . . 10.0 113.65 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.83 96.14 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.833 1.049 . . . . 10.0 113.833 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -47.04 -57.38 9.37 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 115.241 1.571 . . . . 10.0 115.241 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.469 ' HB3' H183 ' A' ' 999' ' ' RET . 32.2 Cg_endo -59.89 -35.13 94.73 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.23 1.953 . . . . 10.0 112.917 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.23 -56.04 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.991 0.916 . . . . 10.0 110.926 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 14.9 m -62.97 -34.17 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 118.831 -0.605 . . . . 10.0 112.621 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.7 t90 -59.79 -54.9 40.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.529 1.132 . . . . 10.0 112.184 167.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 31.3 tp -52.9 -43.82 66.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.882 1.273 . . . . 10.0 112.254 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.75 -4.9 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 115.453 1.649 . . . . 10.0 115.453 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.45 -169.28 32.91 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.521 1.067 . . . . 10.0 113.898 -168.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.23 -41.67 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.838 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -68.9 -14.16 62.87 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.364 1.616 . . . . 10.0 115.364 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.14 -106.14 1.02 Allowed Glycine 0 CA--C 1.535 1.284 0 CA-C-N 120.523 1.51 . . . . 10.0 114.218 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.08 35.8 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.666 -1.49 . . . . 10.0 109.314 168.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.38 65.31 1.34 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 113.892 0.317 . . . . 10.0 113.892 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.7 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.3 133.36 24.89 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 126.479 1.912 . . . . 10.0 109.399 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.66 153.8 72.64 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.814 3.009 . . . . 10.0 111.456 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.22 -39.77 3.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.193 171.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.36 21.97 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.98 -40.45 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.429 1.092 . . . . 10.0 109.617 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.35 -49.76 42.84 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 118.603 0.638 . . . . 10.0 111.952 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.0 m -57.7 -47.06 83.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.004 1.721 . . . . 10.0 112.979 174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.32 -52.32 62.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.957 0.903 . . . . 10.0 112.1 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.53 -58.93 5.2 Favored 'General case' 0 C--N 1.335 -0.054 0 C-N-CA 124.362 1.065 . . . . 10.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -51.99 -47.21 65.0 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.641 -1.171 . . . . 10.0 112.359 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.52 -52.11 56.3 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 120.57 1.532 . . . . 10.0 112.846 175.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.91 -47.97 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.51 1.124 . . . . 10.0 111.189 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.9 mp -57.94 -51.33 70.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.74 1.616 . . . . 10.0 112.159 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -54.46 -56.01 23.05 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.292 2.237 . . . . 10.0 111.309 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.75 -49.36 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.582 -0.699 . . . . 10.0 111.233 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 50.8 m -56.2 -55.01 38.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.254 1.022 . . . . 10.0 112.33 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -72.43 1.11 8.55 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.373 1.869 . . . . 10.0 114.913 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -128.87 -68.83 0.73 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.921 1.288 . . . . 10.0 111.594 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.11 -50.93 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.595 1.158 . . . . 10.0 110.813 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -56.66 -55.87 27.66 Favored Glycine 0 N--CA 1.475 1.281 0 C-N-CA 124.118 0.866 . . . . 10.0 112.602 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -41.7 -56.88 2.49 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.816 2.046 . . . . 10.0 112.554 166.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.48 -41.41 88.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.785 1.184 . . . . 10.0 114.256 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -69.31 -27.23 65.2 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 115.609 1.707 . . . . 10.0 115.609 176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.2 -57.58 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 165.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.67 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.92 0.888 . . . . 10.0 113.167 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.54 5.21 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.37 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.324 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.09 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.028 0.931 . . . . 10.0 111.014 174.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.56 98.21 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.781 0.832 . . . . 10.0 110.949 170.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.95 76.99 7.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.908 0.883 . . . . 10.0 112.093 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.07 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 128.888 2.875 . . . . 10.0 116.499 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.87 -55.47 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.641 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.48 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.722 3.535 . . . . 10.0 119.676 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.495 0 C-N-CA 128.527 2.731 . . . . 10.0 113.461 166.594 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.475 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.808 -2.044 . . . . 10.0 105.804 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.37 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.657 3.183 . . . . 10.0 117.239 160.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.0 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.297 2.639 . . . . 10.0 114.49 155.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.427 1.891 . . . . 10.0 113.339 -158.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.289 1.836 . . . . 10.0 114.015 -174.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.83 40.9 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.486 2.469 . . . . 10.0 111.521 168.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.675 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.02 -60.65 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.502 2.286 . . . . 10.0 113.202 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.11 4.28 0.94 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.852 2.461 . . . . 10.0 115.787 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.35 -43.14 61.73 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.509 -0.744 . . . . 10.0 112.625 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.898 0.879 . . . . 10.0 109.321 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.537 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.42 -52.64 62.91 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.455 0.702 . . . . 10.0 111.84 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.39 -53.58 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.148 0.579 . . . . 10.0 112.205 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.77 52.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.332 1.453 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.66 -44.98 84.69 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.354 1.462 . . . . 10.0 112.997 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.66 -56.86 10.43 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.32 0.962 . . . . 10.0 111.3 165.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.7 m -49.47 -52.29 30.12 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.615 1.166 . . . . 10.0 112.199 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.92 5.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.159 0.984 . . . . 10.0 112.139 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt -57.68 -50.31 73.6 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.599 0.76 . . . . 10.0 112.604 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -49.99 68.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.252 1.021 . . . . 10.0 111.071 175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.92 -58.18 15.95 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.407 1.003 . . . . 10.0 113.673 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.19 -45.69 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.511 1.155 . . . . 10.0 112.086 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.7 -42.08 76.67 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.88 1.229 . . . . 10.0 113.302 172.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.8 m -60.51 -60.36 3.93 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.046 0.938 . . . . 10.0 111.071 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.97 62.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.0 9.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.62 1.168 . . . . 10.0 113.004 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.71 -38.61 82.09 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.245 0.832 . . . . 10.0 113.245 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.1 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.66 1.184 . . . . 10.0 113.628 169.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.759 1.742 . . . . 10.0 110.852 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.88 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.869 2.468 . . . . 10.0 109.286 171.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.12 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.594 0.998 . . . . 10.0 115.594 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.0 92.89 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.163 2.185 . . . . 10.0 113.605 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.43 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.742 0.687 . . . . 10.0 112.407 -170.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.4 2.68 . . . . 10.0 116.962 166.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.62 -50.84 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.169 -1.378 . . . . 10.0 113.904 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.811 1.32 . . . . 10.0 110.972 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.54 -29.67 89.55 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.719 2.946 . . . . 10.0 113.716 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.23 -60.75 2.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.133 0.573 . . . . 10.0 111.441 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.07 -40.08 22.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.126 1.37 . . . . 10.0 113.58 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.59 -47.39 19.87 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.201 1.4 . . . . 10.0 113.444 172.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.06 62.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.48 0.712 . . . . 10.0 110.955 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.97 -50.24 73.26 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.137 0.575 . . . . 10.0 112.313 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.22 65.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.868 -0.586 . . . . 10.0 112.362 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.77 -57.25 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.867 1.267 . . . . 10.0 110.329 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -69.27 -16.25 63.53 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.14 1.376 . . . . 10.0 113.69 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.1 m -87.87 -42.99 12.14 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.779 1.172 . . . . 10.0 111.96 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.2 mt -56.56 -41.6 77.17 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 173.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.5 t -49.46 -61.61 3.31 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.804 1.242 . . . . 10.0 112.595 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.64 -47.62 20.14 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.593 3.529 . . . . 10.0 116.115 164.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.1 93.62 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 119.938 1.245 . . . . 10.0 113.966 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.9 mt -58.57 -51.76 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.398 1.079 . . . . 10.0 109.525 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -43.04 71.76 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 10.0 113.246 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -52.69 -57.95 8.42 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.131 1.332 . . . . 10.0 111.912 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -48.33 -52.89 19.48 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.57 1.548 . . . . 10.0 110.967 177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.89 -48.12 64.16 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.916 0.886 . . . . 10.0 113.029 -176.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -55.85 -41.44 74.31 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.27 1.395 . . . . 10.0 113.225 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.54 34.8 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 119.719 1.145 . . . . 10.0 111.292 170.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.23 1.567 . . . . 10.0 115.23 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.88 -50.82 61.28 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.519 0.728 . . . . 10.0 110.528 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.57 -52.69 21.55 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.835 0.854 . . . . 10.0 112.922 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.96 -5.53 48.97 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.805 1.039 . . . . 10.0 113.805 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.65 5.6 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.527 0.971 . . . . 10.0 115.527 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.1 42.74 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.11 3.63 61.1 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.351 0.9 . . . . 10.0 115.351 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.35 26.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.034 2.133 . . . . 10.0 109.056 171.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.052 166.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.902 0.881 . . . . 10.0 109.717 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.6 129.58 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.26 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.72 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.75 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.664 2.226 . . . . 10.0 118.664 170.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.343 1.571 . . . . 10.0 112.237 -165.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.85 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.096 -175.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.2 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.09 126.33 22.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 126.028 1.731 . . . . 10.0 111.682 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -93.61 85.06 4.77 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.384 1.564 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.42 -28.26 66.77 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.523 -1.361 . . . . 10.0 113.926 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.38 62.38 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -64.89 -24.45 67.54 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 120.232 -1.543 . . . . 10.0 113.876 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -75.87 -42.93 47.9 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.462 -1.399 . . . . 10.0 112.257 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.1 -47.88 53.6 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.064 1.346 . . . . 10.0 111.368 168.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -52.41 -71.09 0.07 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.715 2.006 . . . . 10.0 111.836 168.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -56.17 -32.74 64.61 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.644 1.178 . . . . 10.0 113.153 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.88 -39.74 54.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.389 1.475 . . . . 10.0 112.084 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.72 -41.41 5.24 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.549 0.739 . . . . 10.0 112.95 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.6 p -59.31 -41.1 88.24 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 120.792 1.633 . . . . 10.0 113.347 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.402 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.6 m -68.47 -47.5 35.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 84.9 Cg_exo -53.99 -41.47 74.89 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.574 2.849 . . . . 10.0 114.872 168.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.1 mt -60.32 -47.66 85.08 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.586 0.755 . . . . 10.0 111.728 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.7 tt -50.47 -49.61 54.75 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.502 1.521 . . . . 10.0 111.548 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -56.18 -47.83 77.53 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 121.129 -0.982 . . . . 10.0 112.848 170.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.26 78.42 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.829 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.27 -54.03 36.45 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.343 0.974 . . . . 10.0 111.165 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.38 -42.09 88.45 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.641 0.776 . . . . 10.0 112.093 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.81 36.63 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.996 0.918 . . . . 10.0 112.021 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.1 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.58 91.62 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.78 1.39 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.27 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.875 1.67 . . . . 10.0 112.106 -174.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.938 -1.726 . . . . 10.0 112.437 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.55 135.96 54.46 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.689 -0.632 . . . . 10.0 112.697 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.9 -39.66 2.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.474 175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.18 5.36 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.15 1.357 . . . . 10.0 115.266 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.1 p -62.05 -46.75 87.76 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.123 -1.418 . . . . 10.0 111.351 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.038 1.335 . . . . 10.0 111.148 178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.58 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.534 0.568 . . . . 10.0 112.534 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.86 43.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.716 . . . . 10.0 110.911 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.64 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.382 2.273 . . . . 10.0 114.814 174.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.04 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.647 0.779 . . . . 10.0 111.403 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.67 -46.76 74.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.24 0.83 . . . . 10.0 113.24 173.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.64 -44.11 89.94 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.198 0.599 . . . . 10.0 112.217 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.87 -56.23 5.2 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.33 1.443 . . . . 10.0 113.072 166.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 90.0 mt -56.81 -51.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.674 0.789 . . . . 10.0 111.55 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -52.1 -57.61 9.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.268 1.027 . . . . 10.0 112.185 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.0 mm -66.59 -43.83 90.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.776 0.43 . . . . 10.0 111.81 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.88 -59.95 9.09 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.823 1.201 . . . . 10.0 113.316 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.6 p -59.45 -35.87 74.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.893 0.877 . . . . 10.0 112.52 173.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -46.27 -58.92 5.49 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.351 0.977 . . . . 10.0 113.543 163.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.9 tp -57.53 -46.28 84.05 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.318 1.447 . . . . 10.0 112.101 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.3 t -53.08 -50.67 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.709 -0.62 . . . . 10.0 110.328 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.39 -60.9 6.34 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.099 1.809 . . . . 10.0 112.704 171.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -44.22 -41.12 5.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.245 2.218 . . . . 10.0 113.585 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.26 -6.7 25.58 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.444 1.646 . . . . 10.0 115.444 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.74 116.75 10.49 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.375 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.58 72.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.66 106.37 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.767 0.827 . . . . 10.0 110.103 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.813 1.245 . . . . 10.0 114.043 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.62 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -53.99 -41.66 68.15 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 118.89 0.768 . . . . 10.0 110.807 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.78 -31.59 69.6 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.318 1.229 . . . . 10.0 114.318 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.22 -51.81 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.976 0.807 . . . . 10.0 109.636 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -61.92 -42.8 99.52 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.423 1.268 . . . . 10.0 114.423 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.5 t90 -53.65 -48.85 69.0 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.237 1.015 . . . . 10.0 112.758 171.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.12 -51.24 70.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.534 0.734 . . . . 10.0 111.614 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.16 -55.03 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.079 1.352 . . . . 10.0 111.974 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.1 p -57.2 -40.83 78.21 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.432 -0.792 . . . . 10.0 112.706 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.4 m -61.92 -44.84 95.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.756 1.223 . . . . 10.0 112.326 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.6 80.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.314 0.961 . . . . 10.0 112.251 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.53 -44.95 85.51 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.503 -0.748 . . . . 10.0 112.816 173.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -56.79 -50.86 71.06 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.272 1.029 . . . . 10.0 112.26 172.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.88 -45.81 78.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.831 1.652 . . . . 10.0 112.231 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -54.81 -53.93 48.76 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 171.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 44.1 mt -54.21 -54.75 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 118.716 0.689 . . . . 10.0 110.856 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.27 1.0 OUTLIER -60.02 -32.71 71.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 117.467 -1.254 . . . . 10.0 112.904 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.25 -58.13 9.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.987 1.267 . . . . 10.0 113.071 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -40.89 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.312 -0.851 . . . . 10.0 111.446 177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.78 -49.41 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.847 1.203 . . . . 10.0 112.145 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.05 -70.27 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.046 -1.659 . . . . 10.0 112.833 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -73.79 -21.9 60.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.626 1.17 . . . . 10.0 113.398 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.588 0.614 . . . . 10.0 113.488 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.63 -32.45 51.34 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.62 -50.58 65.39 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.067 0.937 . . . . 10.0 112.286 -177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.17 -45.98 83.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.105 0.962 . . . . 10.0 112.15 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.46 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.506 1.299 . . . . 10.0 114.506 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.46 -11.34 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.078 1.751 . . . . 10.0 114.238 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.57 29.14 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.85 -92.62 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.456 1.598 . . . . 10.0 114.171 -170.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.77 153.88 72.49 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.834 3.254 . . . . 10.0 105.57 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.8 -46.21 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.329 2.019 . . . . 10.0 113.083 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.03 68.22 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 128.985 2.914 . . . . 10.0 113.27 173.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.3 t -69.19 -53.03 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.045 0.938 . . . . 10.0 109.822 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.78 75.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.274 0.63 . . . . 10.0 111.938 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.26 23.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.922 0.889 . . . . 10.0 112.685 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.12 -53.23 60.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.164 0.986 . . . . 10.0 113.028 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.54 46.07 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.337 0.655 . . . . 10.0 111.082 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.06 -48.46 78.5 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.6 t -56.02 -49.61 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.767 0.712 . . . . 10.0 110.487 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.48 -51.69 68.77 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.74 30.88 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.818 2.047 . . . . 10.0 111.065 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.39 8.72 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.81 0.444 . . . . 10.0 111.269 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.99 -47.42 42.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.046 0.938 . . . . 10.0 112.238 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.9 m -58.19 -64.67 0.83 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.953 2.501 . . . . 10.0 111.482 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.27 -48.64 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.845 1.258 . . . . 10.0 111.373 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.1 t -60.27 -61.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.863 0.865 . . . . 10.0 112.606 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.19 -47.06 79.1 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.754 0.706 . . . . 10.0 111.934 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -50.11 -54.29 21.58 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.645 1.178 . . . . 10.0 112.149 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 m -52.31 -33.88 44.44 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.509 1.123 . . . . 10.0 113.588 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.97 96.81 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.017 1.117 . . . . 10.0 114.017 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -46.37 -58.08 7.3 Favored Pre-proline 0 N--CA 1.479 0.986 0 N-CA-C 114.908 1.447 . . . . 10.0 114.908 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.93 -32.79 92.89 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.376 2.051 . . . . 10.0 113.492 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.75 -57.89 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.991 0.916 . . . . 10.0 110.417 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 15.0 m -61.86 -34.08 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.639 0.607 . . . . 10.0 112.639 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.4 -56.63 19.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.544 1.138 . . . . 10.0 112.404 167.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.4 tt -57.59 -40.46 79.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.755 0.822 . . . . 10.0 112.355 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.18 -5.48 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 115.2 1.555 . . . . 10.0 115.2 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.35 32.95 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 122.573 1.096 . . . . 10.0 113.895 -168.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.15 -41.93 65.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.176 -1.012 . . . . 10.0 111.88 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -68.88 -13.45 62.43 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 115.242 1.571 . . . . 10.0 115.242 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.75 -106.13 0.98 Allowed Glycine 0 CA--C 1.535 1.311 0 CA-C-N 120.606 1.548 . . . . 10.0 114.45 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.12 35.77 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.595 -1.533 . . . . 10.0 109.368 168.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.904 0.321 . . . . 10.0 113.904 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.64 -42.7 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 126.091 1.756 . . . . 10.0 108.687 166.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.34 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.382 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -68.69 153.79 72.59 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.774 2.983 . . . . 10.0 111.476 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.8 2.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.38 1.072 . . . . 10.0 112.169 171.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -52.34 22.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.87 -40.49 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.695 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.35 -49.78 42.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.515 0.598 . . . . 10.0 111.925 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.537 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.38 -52.26 62.42 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.923 0.889 . . . . 10.0 112.124 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.6 -58.82 5.58 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.319 1.048 . . . . 10.0 109.931 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -52.55 -46.14 66.68 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 117.629 -1.176 . . . . 10.0 112.506 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.01 -51.89 60.21 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.55 1.523 . . . . 10.0 112.789 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 83.7 t -61.68 -47.0 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.81 1.244 . . . . 10.0 111.598 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.7 mp -58.73 -50.04 75.37 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 10.0 111.795 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -57.15 -57.4 12.77 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.879 2.072 . . . . 10.0 111.508 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.53 -40.31 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 120.887 -1.133 . . . . 10.0 111.917 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 28.0 m -59.45 -51.87 68.03 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.952 0.901 . . . . 10.0 111.867 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.09 -25.8 66.4 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.313 1.845 . . . . 10.0 114.42 -177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -98.65 -71.66 0.68 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.485 1.114 . . . . 10.0 111.685 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.86 -49.77 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.604 1.162 . . . . 10.0 111.567 -172.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.2 -55.44 28.25 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.254 0.93 . . . . 10.0 112.904 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -43.09 -56.91 3.14 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.999 2.12 . . . . 10.0 112.266 165.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.7 -40.43 71.08 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.303 0.954 . . . . 10.0 114.186 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.3 mt -69.75 -27.32 64.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 115.882 1.808 . . . . 10.0 115.882 177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -57.53 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.593 -0.892 . . . . 10.0 108.593 165.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.76 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.946 0.898 . . . . 10.0 113.193 -172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.17 2.53 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.23 0.3 15.74 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.22 1.008 . . . . 10.0 113.344 172.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.046 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.61 98.12 1.83 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.826 0.85 . . . . 10.0 110.941 170.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 77.04 7.79 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.824 0.85 . . . . 10.0 112.067 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.838 2.855 . . . . 10.0 116.491 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.738 1.215 . . . . 10.0 110.656 -175.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.44 39.92 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.757 3.551 . . . . 10.0 119.665 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.487 2.715 . . . . 10.0 113.44 166.597 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.491 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 115.75 -2.072 . . . . 10.0 105.863 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.42 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.579 3.152 . . . . 10.0 117.26 160.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.62 65.01 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.252 2.621 . . . . 10.0 114.537 155.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.97 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.344 1.857 . . . . 10.0 113.339 -158.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.77 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.315 1.846 . . . . 10.0 113.982 -174.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.08 2.8 41.62 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.492 2.473 . . . . 10.0 111.489 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.653 -168.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.92 -60.7 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.18 0 CA-C-N 123.522 2.293 . . . . 10.0 113.196 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.8 pm0 -67.19 4.28 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.726 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.29 -43.14 61.56 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.515 -0.741 . . . . 10.0 112.619 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.89 -49.59 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.899 0.879 . . . . 10.0 109.331 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.43 -52.63 62.96 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.455 0.702 . . . . 10.0 111.882 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.32 -53.67 55.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.223 177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.341 1.456 . . . . 10.0 113.315 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.97 84.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.319 1.448 . . . . 10.0 113.027 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.12 -55.44 15.52 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.501 1.048 . . . . 10.0 111.801 166.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -50.26 -52.48 35.85 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.834 1.253 . . . . 10.0 112.284 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.87 5.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.16 0.984 . . . . 10.0 112.167 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.1 -48.86 77.57 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.615 0.766 . . . . 10.0 112.858 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 59.6 mtt -61.59 -43.94 97.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.649 0.78 . . . . 10.0 111.531 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.59 -58.75 12.93 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.145 0.879 . . . . 10.0 113.785 172.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.21 -45.99 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.605 1.202 . . . . 10.0 112.119 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.08 -42.88 72.68 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.028 1.299 . . . . 10.0 113.132 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.5 m -62.1 -58.23 8.61 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.285 -0.864 . . . . 10.0 111.489 172.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.33 -40.99 62.62 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.041 0.936 . . . . 10.0 110.937 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.76 -58.02 9.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.636 1.175 . . . . 10.0 112.968 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.65 -38.71 82.15 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.213 0.82 . . . . 10.0 113.213 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.45 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.632 1.173 . . . . 10.0 113.633 169.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.39 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.743 1.735 . . . . 10.0 110.88 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.9 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.839 2.455 . . . . 10.0 109.358 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.94 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.671 1.029 . . . . 10.0 115.671 173.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -45.02 93.01 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.196 2.198 . . . . 10.0 113.546 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.7 -84.39 1.19 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.777 0.703 . . . . 10.0 112.435 -170.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.437 2.695 . . . . 10.0 116.948 166.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.8 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.18 -1.373 . . . . 10.0 113.868 174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.94 117.51 6.43 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.769 1.293 . . . . 10.0 110.981 -172.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.55 -29.67 89.57 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.706 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.28 -60.69 2.27 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.111 0.565 . . . . 10.0 111.437 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.1 22.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.1 1.36 . . . . 10.0 113.549 171.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.54 -47.44 19.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.199 1.4 . . . . 10.0 113.446 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.71 -53.07 62.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.48 0.712 . . . . 10.0 110.967 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.0 -50.22 73.37 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.097 0.559 . . . . 10.0 112.297 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.45 -51.2 65.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 118.895 -0.574 . . . . 10.0 112.34 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.43 -61.99 1.93 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.8 mt -48.53 -57.93 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.865 1.266 . . . . 10.0 110.332 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -67.92 -19.03 64.95 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.105 1.362 . . . . 10.0 113.703 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -86.0 -40.87 15.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.45 1.1 . . . . 10.0 112.22 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.8 mt -59.17 -42.61 91.21 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.915 0.78 . . . . 10.0 112.921 172.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.9 t -44.03 -61.19 2.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.67 1.588 . . . . 10.0 113.154 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -70.74 -25.42 24.09 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.895 2.396 . . . . 10.0 114.041 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.11 -50.13 67.26 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 120.732 1.605 . . . . 10.0 113.795 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.28 -39.05 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 120.329 -1.482 . . . . 10.0 110.735 171.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.26 81.18 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 118.54 -0.743 . . . . 10.0 112.96 172.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -50.58 -55.71 15.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.581 1.553 . . . . 10.0 111.755 169.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -49.08 -53.19 21.58 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.363 1.465 . . . . 10.0 110.867 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -68.35 -48.19 65.48 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.102 0.961 . . . . 10.0 113.011 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -56.4 -41.1 75.73 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.241 1.382 . . . . 10.0 113.222 173.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.53 35.06 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.656 1.116 . . . . 10.0 111.313 170.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.15 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 53.9 mtm -66.78 -50.88 61.25 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.565 0.746 . . . . 10.0 110.485 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.54 -52.71 21.27 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 10.0 112.925 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.58 49.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.27 -34.66 5.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 115.542 0.977 . . . . 10.0 115.542 174.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.32 -43.12 43.3 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.56 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.41 26.45 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.081 2.153 . . . . 10.0 109.056 171.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.048 0.939 . . . . 10.0 111.062 166.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.883 0.873 . . . . 10.0 109.723 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.3 t -129.61 129.6 23.17 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.037 1.335 . . . . 10.0 110.927 -176.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.78 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.34 38.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.44 -81.96 0.15 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.697 -0.961 . . . . 10.0 110.697 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 118.694 2.238 . . . . 10.0 118.694 170.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.91 4.07 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.317 1.558 . . . . 10.0 112.27 -165.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.47 1.508 . . . . 10.0 111.107 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.46 120.76 69.66 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.52 131.92 38.21 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.198 3.265 . . . . 10.0 112.137 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.03 1.732 . . . . 10.0 111.69 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.04 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.865 1.317 . . . . 10.0 113.032 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.4 -28.28 66.77 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.77 -26.47 46.07 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.296 1.038 . . . . 10.0 111.165 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -44.08 -63.43 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.374 1.47 . . . . 10.0 110.146 165.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -63.62 -39.73 95.1 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.223 2.209 . . . . 10.0 111.119 -172.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.26 -49.03 67.76 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.733 0.813 . . . . 10.0 112.024 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.83 -63.67 1.21 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.96 1.304 . . . . 10.0 111.64 170.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.8 m0 -53.7 -36.95 62.75 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.805 1.642 . . . . 10.0 112.72 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.9 tp -50.69 -42.17 56.6 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.036 1.734 . . . . 10.0 112.226 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -103.68 -35.29 8.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.932 0.716 . . . . 10.0 112.932 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 49.5 p -62.17 -49.04 77.42 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 121.387 1.903 . . . . 10.0 113.483 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.284 69.9 p -63.54 -41.73 68.4 Favored Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 114.722 1.379 . . . . 10.0 114.722 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -57.8 -43.24 51.31 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.481 2.787 . . . . 10.0 115.265 168.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.4 mt -60.62 -46.9 88.53 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.491 -0.756 . . . . 10.0 111.515 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tt -50.68 -49.83 56.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.646 1.578 . . . . 10.0 111.359 171.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.65 -47.46 79.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.247 1.019 . . . . 10.0 113.046 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.823 0.849 . . . . 10.0 112.854 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -52.31 -54.01 36.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.324 0.966 . . . . 10.0 111.173 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.11 88.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.69 0.796 . . . . 10.0 112.068 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.69 -54.75 37.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.979 0.912 . . . . 10.0 111.974 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.12 79.23 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.725 0.81 . . . . 10.0 112.704 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.82 -38.56 91.57 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.4 t -94.78 1.42 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.062 1.345 . . . . 10.0 112.337 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.49 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.23 145.88 47.66 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 119.916 -1.74 . . . . 10.0 112.454 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.84 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.714 0.635 . . . . 10.0 112.714 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.8 -39.68 2.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.24 5.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.131 1.348 . . . . 10.0 115.235 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -62.06 -46.77 87.69 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.13 -1.414 . . . . 10.0 111.312 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.5 -52.91 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.029 1.332 . . . . 10.0 111.101 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.27 67.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.536 0.569 . . . . 10.0 112.536 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.23 -44.85 43.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.424 0.69 . . . . 10.0 110.924 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.55 -59.88 4.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.419 2.288 . . . . 10.0 114.815 174.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.08 -46.29 96.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.667 0.787 . . . . 10.0 111.385 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.33 63.89 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.77 -46.67 74.42 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 173.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.0 -45.99 82.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.851 0.86 . . . . 10.0 111.994 174.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -55.38 5.49 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.362 1.458 . . . . 10.0 113.142 167.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.3 mt -58.73 -50.15 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.902 0.881 . . . . 10.0 111.74 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -50.99 -57.13 9.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.589 1.556 . . . . 10.0 111.873 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.1 mm -68.66 -42.85 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.121 0.568 . . . . 10.0 112.488 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.2 -53.1 39.57 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.04 1.305 . . . . 10.0 113.501 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.5 p -61.05 -36.52 79.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.208 -1.172 . . . . 10.0 112.307 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -51.23 -56.77 13.32 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.148 0.88 . . . . 10.0 113.294 165.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.52 -47.29 49.0 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 128.498 2.719 . . . . 10.0 111.321 174.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.05 -49.68 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.488 1.115 . . . . 10.0 111.764 174.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.55 -58.99 9.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.085 1.803 . . . . 10.0 112.338 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.49 -43.48 2.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.251 2.62 . . . . 10.0 113.294 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.3 mt -101.2 -6.4 24.3 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.423 1.638 . . . . 10.0 115.423 -174.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.67 116.73 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.165 -1.584 . . . . 10.0 110.419 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.59 72.17 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.217 2.607 . . . . 10.0 113.269 177.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.61 106.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.81 0.844 . . . . 10.0 110.109 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.776 1.231 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.09 15.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.451 1.5 . . . . 10.0 113.468 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.66 63.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.904 1.446 . . . . 10.0 114.904 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -53.84 -41.91 67.92 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.902 0.774 . . . . 10.0 110.806 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.21 -32.57 71.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.817 1.247 . . . . 10.0 114.198 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.91 -52.12 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.022 0.828 . . . . 10.0 109.991 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -59.45 -51.76 68.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.491 0.922 . . . . 10.0 113.491 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -48.38 -46.59 37.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.428 1.091 . . . . 10.0 113.427 174.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.38 -52.55 65.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.945 0.898 . . . . 10.0 111.659 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.4 mt -54.07 -50.98 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.126 1.37 . . . . 10.0 111.49 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 m -53.84 -49.19 68.96 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.479 1.112 . . . . 10.0 112.108 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 76.5 m -61.34 -43.34 99.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.992 1.317 . . . . 10.0 111.618 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.45 -50.16 73.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.14 0.976 . . . . 10.0 112.477 170.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.13 -43.87 82.82 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.736 0.814 . . . . 10.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.1 ttp -57.94 -53.13 61.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.496 1.118 . . . . 10.0 111.953 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.3 tt -51.92 -50.01 61.95 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.772 1.629 . . . . 10.0 111.398 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -49.51 -54.89 15.45 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.06 0.944 . . . . 10.0 112.436 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 58.4 mt -53.4 -55.29 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.829 0.852 . . . . 10.0 110.729 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.5 mt -57.49 -35.65 70.48 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.283 -0.865 . . . . 10.0 112.91 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.23 -58.18 9.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.04 0.936 . . . . 10.0 113.052 173.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.89 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.5 mt -56.77 -49.45 75.27 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.845 1.202 . . . . 10.0 112.099 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.877 -175.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.65 -21.99 60.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.635 1.174 . . . . 10.0 113.446 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.1 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.625 0.631 . . . . 10.0 113.527 171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.55 -32.52 51.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.322 1.849 . . . . 10.0 113.019 -166.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.11 -56.4 14.73 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.56 65.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 122.121 0.962 . . . . 10.0 112.331 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.07 82.87 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.188 0.995 . . . . 10.0 112.134 173.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.77 -47.52 79.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.249 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.01 6.58 29.19 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.433 1.893 . . . . 10.0 114.907 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.65 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.535 1.636 . . . . 10.0 114.139 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.73 153.98 72.64 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.81 3.244 . . . . 10.0 105.572 170.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.85 -46.21 35.34 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.301 2.001 . . . . 10.0 113.052 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.96 -46.08 68.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.27 173.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.22 -53.05 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 C-N-CA 124.055 0.942 . . . . 10.0 109.788 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.86 75.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.275 0.63 . . . . 10.0 111.917 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.98 -56.13 25.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.88 0.872 . . . . 10.0 112.761 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.6 m -57.2 -53.2 60.75 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.028 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.58 -49.52 46.19 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.337 0.655 . . . . 10.0 111.052 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.17 -48.4 78.82 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.636 1.347 . . . . 10.0 114.636 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.6 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.801 0.728 . . . . 10.0 110.506 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.59 -51.62 69.15 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.164 0.801 . . . . 10.0 113.164 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.8 30.26 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.55 -58.34 8.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.785 0.434 . . . . 10.0 111.236 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.1 t -51.9 -49.1 38.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.044 0.937 . . . . 10.0 111.472 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.4 m -56.01 -63.95 1.01 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.62 2.768 . . . . 10.0 111.921 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.31 -49.51 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.488 1.115 . . . . 10.0 111.313 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.7 -62.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.172 0.989 . . . . 10.0 112.063 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.51 -47.17 85.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.974 0.806 . . . . 10.0 112.612 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -55.01 -50.31 69.35 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.683 0.793 . . . . 10.0 111.752 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -53.98 -32.18 53.14 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.902 1.075 . . . . 10.0 113.902 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.98 99.02 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.821 1.045 . . . . 10.0 113.821 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -48.37 -56.34 14.82 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 115.108 1.521 . . . . 10.0 115.108 -175.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.458 ' HB3' H183 ' A' ' 999' ' ' RET . 22.3 Cg_endo -58.84 -34.73 99.18 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.096 1.864 . . . . 10.0 113.318 176.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.81 -53.03 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.285 0.948 . . . . 10.0 110.636 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.77 -50.62 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.756 1.222 . . . . 10.0 111.596 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -56.39 -51.01 69.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.46 1.104 . . . . 10.0 112.53 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 29.2 tp -54.44 -45.53 73.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.59 1.156 . . . . 10.0 112.22 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.1 pt -86.54 -5.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.15 1.537 . . . . 10.0 115.15 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.54 -169.29 32.79 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 122.602 1.112 . . . . 10.0 113.806 -168.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.75 65.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.196 -1.002 . . . . 10.0 111.868 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -67.29 -16.13 64.1 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.487 1.662 . . . . 10.0 115.487 -175.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.77 -105.99 1.04 Allowed Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.494 1.497 . . . . 10.0 114.104 -173.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.11 35.8 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.668 -1.49 . . . . 10.0 109.35 168.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.35 1.36 Allowed Glycine 0 CA--C 1.532 1.138 0 CA-C-N 117.878 0.308 . . . . 10.0 113.862 173.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.59 -42.73 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.73 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.1 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.416 1.886 . . . . 10.0 109.366 -174.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.79 153.79 72.34 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.3 tp -43.19 -39.78 3.06 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.336 1.054 . . . . 10.0 112.18 171.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.38 21.9 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.682 1.364 . . . . 10.0 114.682 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.92 -40.48 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.412 1.085 . . . . 10.0 109.66 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.27 -49.83 41.77 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.603 0.638 . . . . 10.0 111.991 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.66 -47.06 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.999 1.72 . . . . 10.0 113.026 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.32 -52.29 62.49 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.974 0.91 . . . . 10.0 112.093 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.61 -59.0 4.99 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 109.975 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -52.83 -44.65 66.87 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 117.793 -1.098 . . . . 10.0 112.657 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -54.16 -52.64 60.51 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.579 1.536 . . . . 10.0 112.689 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.2 t -60.86 -46.26 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.69 1.196 . . . . 10.0 111.353 178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -59.15 -52.44 65.7 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.364 1.466 . . . . 10.0 112.122 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -55.46 -54.64 41.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.507 1.923 . . . . 10.0 111.062 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t -49.49 -50.33 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.071 -1.018 . . . . 10.0 111.635 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 34.9 m -59.81 -53.43 57.99 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.269 1.028 . . . . 10.0 112.035 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.92 -25.45 66.37 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.709 2.003 . . . . 10.0 114.596 -176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -97.28 -70.81 0.71 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.454 1.102 . . . . 10.0 111.704 173.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.3 t -73.49 -50.32 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.575 1.15 . . . . 10.0 111.51 -171.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.34 -55.07 30.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.244 0.926 . . . . 10.0 112.758 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -43.47 -57.08 3.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.79 2.036 . . . . 10.0 112.488 166.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.98 -41.26 76.54 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.326 0.965 . . . . 10.0 113.993 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.1 mt -69.79 -26.99 64.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.911 1.819 . . . . 10.0 115.911 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.5 -57.47 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.88 -64.61 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.908 0.883 . . . . 10.0 113.187 -172.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.15 2.56 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.3 1.592 . . . . 10.0 115.3 -171.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.197 0.999 . . . . 10.0 113.296 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.05 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 110.983 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.58 98.13 1.82 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.771 0.828 . . . . 10.0 110.961 170.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 76.97 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.857 0.863 . . . . 10.0 112.094 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.862 2.865 . . . . 10.0 116.505 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.79 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.731 1.212 . . . . 10.0 110.698 -175.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.49 39.98 Favored Glycine 0 C--O 1.239 0.463 0 C-N-CA 129.754 3.55 . . . . 10.0 119.646 171.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.506 2.722 . . . . 10.0 113.406 166.591 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.521 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.789 -2.053 . . . . 10.0 105.817 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.638 3.175 . . . . 10.0 117.211 160.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.69 65.0 0.11 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 128.306 2.642 . . . . 10.0 114.49 155.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.46 137.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.393 1.877 . . . . 10.0 113.334 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.317 1.847 . . . . 10.0 114.012 -174.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.84 41.28 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.483 2.468 . . . . 10.0 111.523 168.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.333 -2.746 . . . . 10.0 116.667 -168.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -64.0 -60.6 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.519 2.292 . . . . 10.0 113.212 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.33 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.847 2.459 . . . . 10.0 115.787 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.36 -43.15 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.46 -0.775 . . . . 10.0 112.619 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.9 -49.57 84.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.859 0.863 . . . . 10.0 109.315 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.37 -52.66 62.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.426 0.69 . . . . 10.0 111.898 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.34 -53.64 55.84 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.221 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.81 51.95 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.366 1.466 . . . . 10.0 113.307 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -45.0 84.75 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 10.0 113.026 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.41 -56.69 10.41 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.526 1.06 . . . . 10.0 111.465 166.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -49.7 -52.48 30.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.836 1.255 . . . . 10.0 112.19 174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.32 -58.9 5.65 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.174 0.99 . . . . 10.0 112.207 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.31 -48.46 78.89 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.577 0.751 . . . . 10.0 112.825 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.418 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 52.0 mtt -58.89 -47.46 84.88 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.223 1.009 . . . . 10.0 111.523 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.85 -58.76 12.88 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.267 0.937 . . . . 10.0 113.66 174.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.18 -46.06 79.52 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.728 1.264 . . . . 10.0 112.1 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.5 -42.33 75.55 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.76 1.172 . . . . 10.0 113.244 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -61.93 -58.49 7.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.742 0.817 . . . . 10.0 111.419 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.97 62.45 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.034 0.934 . . . . 10.0 110.96 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.8 -58.07 9.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.986 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.63 81.86 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.236 0.828 . . . . 10.0 113.236 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.46 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.654 1.182 . . . . 10.0 113.581 169.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.44 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.781 1.753 . . . . 10.0 110.846 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.83 -44.86 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.906 2.483 . . . . 10.0 109.366 171.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.93 23.13 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.632 1.013 . . . . 10.0 115.632 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.98 93.05 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.143 2.177 . . . . 10.0 113.584 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.37 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.387 2.675 . . . . 10.0 116.975 166.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.65 -50.87 10.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.891 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.94 117.59 6.51 Favored Pre-proline 0 CA--C 1.536 0.432 0 O-C-N 124.741 1.275 . . . . 10.0 110.916 -172.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.67 -29.6 89.86 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.697 2.931 . . . . 10.0 113.695 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.099 0.56 . . . . 10.0 111.429 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.18 -40.04 22.82 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.114 1.366 . . . . 10.0 113.551 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.6 -47.44 19.94 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.242 1.417 . . . . 10.0 113.384 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.08 62.22 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.535 0.734 . . . . 10.0 110.935 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.02 -50.21 73.43 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.115 0.566 . . . . 10.0 112.348 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.26 65.35 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.903 -0.57 . . . . 10.0 112.378 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.4 -62.01 1.91 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.412 0.893 . . . . 10.0 113.412 177.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.53 -58.07 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.918 1.287 . . . . 10.0 110.121 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 m -68.16 -16.99 64.22 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.297 1.439 . . . . 10.0 113.851 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -88.35 -39.78 14.08 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.571 1.078 . . . . 10.0 112.146 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.6 mt -59.8 -42.18 92.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.939 0.791 . . . . 10.0 112.372 170.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -41.44 -60.7 1.69 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 126.094 1.758 . . . . 10.0 113.807 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.98 -25.67 16.07 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.158 2.572 . . . . 10.0 114.372 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.7 -45.07 84.2 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 120.674 1.579 . . . . 10.0 113.502 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -54.02 -52.81 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.01 0.924 . . . . 10.0 109.447 168.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.418 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -54.19 -45.9 72.28 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.465 1.106 . . . . 10.0 113.428 177.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -51.1 -57.58 8.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.058 1.343 . . . . 10.0 112.15 171.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 m -49.36 -52.63 26.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.302 1.441 . . . . 10.0 110.699 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.5 mmt -69.14 -48.13 63.2 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.895 0.878 . . . . 10.0 113.044 -176.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -57.09 -39.95 76.03 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 116.927 -1.511 . . . . 10.0 113.218 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.35 -54.56 34.85 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.266 1.394 . . . . 10.0 111.281 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.64 -41.13 61.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.197 1.555 . . . . 10.0 115.197 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.3 mtm -66.85 -50.78 61.47 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 123.545 0.738 . . . . 10.0 110.511 176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.1 tp -48.64 -52.67 21.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.864 0.865 . . . . 10.0 112.908 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.91 -5.54 48.89 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.343 1.057 . . . . 10.0 113.835 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 115.544 0.978 . . . . 10.0 115.544 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.33 -43.05 43.38 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.246 1.572 . . . . 10.0 115.246 -175.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.57 61.09 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.27 143.39 26.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.049 2.14 . . . . 10.0 109.041 171.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.1 15.15 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.044 0.938 . . . . 10.0 111.004 166.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.02 53.42 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.703 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.52 129.6 23.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 125.048 1.339 . . . . 10.0 110.995 -176.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.74 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 N-CA-C 109.469 -1.012 . . . . 10.0 109.469 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.48 38.1 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.31 -81.9 0.14 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.735 -0.946 . . . . 10.0 110.735 175.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.83 -3.35 0.69 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 118.656 2.223 . . . . 10.0 118.656 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.317 1.559 . . . . 10.0 112.21 -165.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.83 93.85 9.04 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.491 1.516 . . . . 10.0 111.137 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.43 120.82 69.68 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 -165.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.654 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.8 Cg_exo -61.54 131.95 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.23 3.287 . . . . 10.0 112.145 171.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.35 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.043 1.737 . . . . 10.0 111.66 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.65 85.01 4.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.295 1.521 . . . . 10.0 113.037 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.34 -28.28 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.587 -1.321 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.19 -35.99 62.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.998 1.11 . . . . 10.0 113.998 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 1.5 ptp180 -64.4 -23.32 67.25 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.589 -1.319 . . . . 10.0 114.169 173.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -77.69 -42.77 33.34 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.148 -0.97 . . . . 10.0 111.763 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.95 44.92 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.355 1.462 . . . . 10.0 111.726 167.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -51.8 -71.88 0.06 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.551 1.941 . . . . 10.0 111.805 169.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.417 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 50.0 m0 -56.48 -31.96 64.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 117.507 -1.235 . . . . 10.0 113.536 -172.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.5 tp -48.59 -45.56 38.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.004 1.722 . . . . 10.0 112.077 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.91 -43.78 6.59 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.059 0.944 . . . . 10.0 112.111 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.0 m -51.45 -48.86 62.63 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.58 1.552 . . . . 10.0 113.444 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.306 41.5 p -69.41 -46.62 27.48 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.57 1.322 . . . . 10.0 114.57 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -50.53 -42.41 49.3 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.143 2.562 . . . . 10.0 115.185 169.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.41 -48.36 81.92 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.555 -0.716 . . . . 10.0 112.245 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -36.55 82.52 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.523 1.056 . . . . 10.0 112.555 175.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.66 -49.03 76.25 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.097 -1.002 . . . . 10.0 111.674 165.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.82 -38.25 78.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.823 0.849 . . . . 10.0 112.874 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -52.36 -53.97 37.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.298 0.954 . . . . 10.0 111.173 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.676 0.79 . . . . 10.0 112.131 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.72 38.01 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.94 0.896 . . . . 10.0 112.039 173.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.22 79.25 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.778 0.831 . . . . 10.0 112.692 174.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.1 tp -63.75 -38.6 91.7 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.399 1.259 . . . . 10.0 114.399 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.81 1.37 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.236 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.54 53.55 11.94 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.892 1.677 . . . . 10.0 112.104 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.33 145.89 47.49 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 119.95 -1.719 . . . . 10.0 112.458 -174.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.9 54.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.8 -39.72 2.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.489 175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.03 -46.78 87.67 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.316 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.44 -52.88 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.088 1.355 . . . . 10.0 111.101 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.7 -51.26 67.88 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.543 0.571 . . . . 10.0 112.543 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.441 0.696 . . . . 10.0 110.943 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.8 4.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.849 174.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.3 t -61.12 -46.31 96.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.706 0.802 . . . . 10.0 111.374 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.31 64.04 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.701 0.667 . . . . 10.0 112.624 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.08 -46.36 75.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.358 0.873 . . . . 10.0 113.358 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -53.22 -51.41 62.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.699 1.2 . . . . 10.0 110.641 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.42 -54.29 4.78 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.092 1.329 . . . . 10.0 113.276 170.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 84.8 mt -57.53 -54.76 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 118.068 -0.968 . . . . 10.0 112.395 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . 0.309 3.1 ppp? -61.45 -42.64 99.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.605 1.548 . . . . 10.0 113.552 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.0 mm -65.52 -47.38 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 120.214 1.37 . . . . 10.0 111.702 170.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.76 -55.25 24.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.049 1.309 . . . . 10.0 113.406 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 32.4 p -60.72 -35.58 76.69 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.134 -1.215 . . . . 10.0 112.689 173.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.68 -59.07 8.29 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.239 0.923 . . . . 10.0 113.125 164.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.92 -47.71 43.22 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.768 2.827 . . . . 10.0 111.663 174.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.33 -49.53 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.551 1.14 . . . . 10.0 111.701 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -53.18 -58.69 11.07 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 126.058 1.79 . . . . 10.0 112.379 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -41.57 -43.4 2.71 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.209 2.604 . . . . 10.0 113.304 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.9 mt -101.19 -6.41 24.29 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.485 1.661 . . . . 10.0 115.485 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.71 116.75 10.47 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.165 -1.584 . . . . 10.0 110.366 -178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.46 -49.61 72.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.248 2.619 . . . . 10.0 113.275 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.69 106.34 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 123.79 0.836 . . . . 10.0 110.05 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.82 -59.63 2.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.051 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.42 -42.11 14.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.513 1.525 . . . . 10.0 113.496 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.63 63.2 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.929 1.455 . . . . 10.0 114.929 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -54.19 -41.58 68.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.855 0.752 . . . . 10.0 110.826 176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -69.21 -32.64 72.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.771 1.228 . . . . 10.0 114.216 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.79 -51.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.073 0.851 . . . . 10.0 109.638 169.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -62.33 -46.23 89.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.49 1.293 . . . . 10.0 114.49 174.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -52.22 -47.68 65.54 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.088 0.955 . . . . 10.0 112.686 173.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.37 -53.88 53.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.099 0.96 . . . . 10.0 111.804 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.13 -53.16 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.905 1.282 . . . . 10.0 111.509 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.1 t -53.34 -51.31 62.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.343 1.457 . . . . 10.0 111.908 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.9 m -61.0 -42.97 99.46 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.459 1.504 . . . . 10.0 112.401 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.78 -51.74 68.44 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.407 1.003 . . . . 10.0 112.452 173.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.84 -37.79 77.25 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.925 0.89 . . . . 10.0 112.89 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 32.5 ttp -60.7 -50.67 72.55 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.062 -1.023 . . . . 10.0 112.403 169.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.7 tt -54.1 -47.51 71.7 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.632 1.573 . . . . 10.0 111.626 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -47.07 -54.37 10.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.364 1.066 . . . . 10.0 112.261 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 66.2 mt -53.43 -55.1 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.814 0.846 . . . . 10.0 110.692 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -57.04 -36.15 70.13 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.121 0.785 . . . . 10.0 113.121 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.25 -58.2 9.25 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.077 0.951 . . . . 10.0 113.017 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.278 -0.867 . . . . 10.0 111.44 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.78 -49.44 75.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.897 1.226 . . . . 10.0 112.106 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.38 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.856 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.65 -21.93 60.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.607 1.163 . . . . 10.0 113.467 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.11 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.629 0.633 . . . . 10.0 113.548 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.44 51.0 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.262 1.825 . . . . 10.0 113.067 -166.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.46 14.27 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.02 1.118 . . . . 10.0 114.02 172.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.2 p -53.74 -50.45 65.93 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.05 0.929 . . . . 10.0 112.285 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.21 -46.01 83.28 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.181 0.993 . . . . 10.0 112.088 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.83 -47.47 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.29 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.078 1.751 . . . . 10.0 114.268 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.06 6.6 29.1 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.428 1.891 . . . . 10.0 114.907 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.59 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.536 1.636 . . . . 10.0 114.195 -170.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.79 153.91 72.48 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 129.778 3.231 . . . . 10.0 105.519 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.77 -46.28 34.7 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.308 2.005 . . . . 10.0 113.066 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.93 -46.03 67.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.968 2.907 . . . . 10.0 113.33 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.9 t -69.23 -53.03 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 124.086 0.954 . . . . 10.0 109.794 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.254 0.622 . . . . 10.0 111.926 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -60.03 -56.15 25.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.919 0.887 . . . . 10.0 112.709 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.18 0.992 . . . . 10.0 113.036 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.58 -49.52 46.16 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.284 0.634 . . . . 10.0 111.068 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.11 -48.4 78.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.04 -49.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.791 0.723 . . . . 10.0 110.428 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.56 -51.65 68.98 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.76 30.28 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.817 2.047 . . . . 10.0 111.044 174.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.53 -58.26 9.34 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.757 0.423 . . . . 10.0 111.314 174.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.09 -45.01 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.054 0.942 . . . . 10.0 111.504 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -56.74 -67.51 0.3 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.281 2.633 . . . . 10.0 110.918 176.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 53.5 t -50.92 -48.15 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.005 1.322 . . . . 10.0 110.915 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.36 -62.11 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.755 0.822 . . . . 10.0 112.484 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.75 -48.08 80.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.211 0.914 . . . . 10.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -51.75 -51.08 58.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.301 1.04 . . . . 10.0 112.193 175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.0 m -55.28 -32.84 62.71 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.793 1.034 . . . . 10.0 113.793 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.66 -44.64 93.2 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.581 0.956 . . . . 10.0 113.581 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -46.28 -55.74 12.86 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 115.623 1.712 . . . . 10.0 115.623 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.455 ' HB3' H183 ' A' ' 999' ' ' RET . 29.2 Cg_endo -60.17 -34.06 94.49 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.26 1.973 . . . . 10.0 113.216 177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.5 t -64.46 -51.57 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.948 0.899 . . . . 10.0 110.589 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t -53.64 -50.58 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.592 1.157 . . . . 10.0 111.445 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.2 t90 -55.47 -51.81 65.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.287 1.035 . . . . 10.0 112.501 174.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 35.5 tp -54.04 -45.22 71.54 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.77 1.228 . . . . 10.0 112.281 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.49 -4.98 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.17 1.545 . . . . 10.0 115.17 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.43 -169.3 32.95 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.576 1.098 . . . . 10.0 113.886 -168.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -41.29 65.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.871 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.66 -17.08 64.47 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.661 1.726 . . . . 10.0 115.661 -175.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.32 -106.07 1.14 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.339 1.427 . . . . 10.0 113.714 -172.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.13 35.8 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.637 -1.508 . . . . 10.0 109.353 168.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 113.905 0.322 . . . . 10.0 113.905 173.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.042 1.737 . . . . 10.0 108.771 166.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.7 t -126.3 133.45 24.98 Favored Pre-proline 0 N--CA 1.454 -0.266 0 C-N-CA 126.477 1.911 . . . . 10.0 109.366 -174.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -68.82 153.84 72.19 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.752 2.968 . . . . 10.0 111.424 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.81 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.329 1.052 . . . . 10.0 112.221 171.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.31 -52.4 21.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.401 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.95 -40.47 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.441 1.097 . . . . 10.0 109.646 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.29 -49.85 41.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.586 0.63 . . . . 10.0 111.964 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.08 83.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.092 1.757 . . . . 10.0 112.983 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.3 -52.32 62.44 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.931 0.892 . . . . 10.0 112.141 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.59 -59.29 4.64 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 124.362 1.065 . . . . 10.0 109.944 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -52.9 -46.54 68.04 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 117.417 -1.278 . . . . 10.0 112.241 176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -51.36 -53.38 36.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.687 1.585 . . . . 10.0 112.723 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.0 t -60.12 -49.68 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.202 1.401 . . . . 10.0 111.562 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -56.17 -50.9 69.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.141 1.376 . . . . 10.0 111.458 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -57.06 -62.66 1.6 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.195 1.798 . . . . 10.0 110.954 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 23.7 m -56.16 -36.81 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 120.49 1.495 . . . . 10.0 112.793 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 43.2 m -59.94 -56.88 16.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.256 1.022 . . . . 10.0 111.525 170.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.06 -22.64 67.0 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.424 1.489 . . . . 10.0 114.513 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -71.7 0.55 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.884 1.273 . . . . 10.0 109.493 176.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.4 t -83.63 -55.29 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.176 1.39 . . . . 10.0 110.728 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -51.19 -48.04 48.07 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.996 0.808 . . . . 10.0 113.228 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -54.73 -57.04 13.08 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.192 1.797 . . . . 10.0 112.656 172.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -53.02 -37.16 53.42 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.063 0.839 . . . . 10.0 113.596 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.58 -28.01 65.6 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 115.989 1.848 . . . . 10.0 115.989 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.62 -57.49 11.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 119.319 0.963 . . . . 10.0 108.445 165.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.83 -64.64 0.86 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.848 0.859 . . . . 10.0 113.186 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.317 1.599 . . . . 10.0 115.317 -171.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.4 15.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.141 0.976 . . . . 10.0 113.292 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 178.0 4.64 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.049 0.94 . . . . 10.0 111.019 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.744 0.818 . . . . 10.0 110.957 170.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.0 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.896 0.879 . . . . 10.0 112.1 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 128.897 2.879 . . . . 10.0 116.461 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.82 -55.45 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.731 1.212 . . . . 10.0 110.686 -175.278 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.44 40.12 Favored Glycine 0 C--O 1.239 0.451 0 C-N-CA 129.755 3.55 . . . . 10.0 119.677 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 128.484 2.714 . . . . 10.0 113.438 166.603 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.487 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_